Citrus Sinensis ID: 019568
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 339 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.952 | 0.319 | 0.441 | 3e-75 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.926 | 0.306 | 0.430 | 5e-67 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.820 | 0.269 | 0.444 | 1e-61 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.890 | 0.308 | 0.359 | 3e-53 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.882 | 0.254 | 0.365 | 6e-49 | |
| O49564 | 642 | Cysteine-rich receptor-li | no | no | 0.814 | 0.429 | 0.378 | 1e-47 | |
| C0LGR6 | 913 | Probable LRR receptor-lik | no | no | 0.825 | 0.306 | 0.371 | 2e-45 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.823 | 0.392 | 0.365 | 3e-45 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.828 | 0.224 | 0.37 | 6e-45 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.734 | 0.208 | 0.392 | 9e-45 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 282 bits (721), Expect = 3e-75, Method: Compositional matrix adjust.
Identities = 152/344 (44%), Positives = 214/344 (62%), Gaps = 21/344 (6%)
Query: 3 VILLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKAR 62
V L+ LR R++ K +N L + SY +L AT+ FS +N++G G FG+VYKA
Sbjct: 661 VTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKAL 720
Query: 63 L-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN-----EEFKALV 116
L + VAVKV N+Q A+KSF ECE +K IRHRNL+K++++CS+ EF+AL+
Sbjct: 721 LLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALI 780
Query: 117 LEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E+MP+GSL+ +L+ L + +RLNI IDVAS L+YLH PI HCDL
Sbjct: 781 YEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDL 840
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQ-----SMTQTQTFATIGYMAPEYGREGRVSA 223
KPSNVLLDD++ AH+SDF +A+LL+ D+ ++ TIGY APEYG G+ S
Sbjct: 841 KPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSI 900
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS-QEDIHF 282
NGDVYSFGI+L+E FTGK+PT+E+F G TL + LP L++VD ++L + F
Sbjct: 901 NGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGF 960
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
E C++ VF + + C ESP R+ +VK+L+ IR+ +
Sbjct: 961 PVVE-CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (650), Expect = 5e-67, Method: Compositional matrix adjust.
Identities = 145/337 (43%), Positives = 200/337 (59%), Gaps = 23/337 (6%)
Query: 13 RGKRPSNDASM-PLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVA 70
R ND S P+ + + SY EL + T FS +NLIG G FG+V+K LG VA
Sbjct: 687 RANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVA 746
Query: 71 VKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEF-----KALVLEYMPHGS 124
+KV NL C R A KSF ECE + IRHRNL+K+++ CS+ +F +ALV E+MP+G+
Sbjct: 747 IKVLNL-CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGN 805
Query: 125 LEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 176
L+ +L+ L +F RLNI IDVASAL YLH PI HCD+KPSN+LLD
Sbjct: 806 LDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLD 865
Query: 177 DNMVAHLSDFSIAKLLVGEDQSMTQTQ-----TFATIGYMAPEYGREGRVSANGDVYSFG 231
++ AH+SDF +A+LL+ D+ Q TIGY APEYG G S GDVYSFG
Sbjct: 866 KDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFG 925
Query: 232 IMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI-STLEVVDANLLSQEDIHFVAKEQCVS 290
I+L+E FTGK+PT+++F +TL + L L++ D +L +C++
Sbjct: 926 IVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLT 985
Query: 291 FVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
VF + ++C+ ESP RI+ E + KL+ IR+S R+
Sbjct: 986 LVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (603), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 137/308 (44%), Positives = 179/308 (58%), Gaps = 30/308 (9%)
Query: 33 SYLELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEM 91
SY EL AT FS NLIG G FG+V+K LG + VAVKV NL A KSF ECE
Sbjct: 701 SYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECET 760
Query: 92 MKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDI 138
K IRHRNL+K+I+ CS+ +F+ALV E+MP GSL+ +L + L
Sbjct: 761 FKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTP 820
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ- 197
++LNI IDVASALEYLH P+ HCD+KPSN+LLDD++ AH+SDF +A+LL D+
Sbjct: 821 AEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRE 880
Query: 198 ----SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 253
+ TIGY APEYG G+ S GDVYSFGI+L+E F+GKKPTDE F G+
Sbjct: 881 SFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYN 940
Query: 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
L + L T +N A ++ + V + + C+ E P R+ E
Sbjct: 941 LHSYTKSILSGCT-SSGGSN----------AIDEGLRLVLQVGIKCSEEYPRDRMRTDEA 989
Query: 314 VKKLLKIR 321
V++L+ IR
Sbjct: 990 VRELISIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 119/331 (35%), Positives = 188/331 (56%), Gaps = 29/331 (8%)
Query: 15 KRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVF 74
K+ ND P + SY +L AT F+ ++LIG G FG VYK L + +VAVKV
Sbjct: 638 KQNQNDPKYPRI------SYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVL 691
Query: 75 NLQCGRALK-SFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-- 131
+ + SF EC+++K RHRNLI++I++CS F ALVL MP+GSLE++LY
Sbjct: 692 DPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGE 751
Query: 132 -SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
S+ LD+ Q +NI DVA + YLH ++HCDLKPSN+LLDD M A ++DF I++
Sbjct: 752 YSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISR 811
Query: 191 LLVGEDQSMTQTQTFA----------TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG 240
L+ G +++++ + + ++GY+APEYG R S +GDVYSFG++L+E +G
Sbjct: 812 LVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSG 871
Query: 241 KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSF-------VF 293
++PTD + N +L ++ P +LE + LS+ E+C +
Sbjct: 872 RRPTDVLVNEGSSLHEFMKSHYP-DSLEGIIEQALSRWKPQG-KPEKCEKLWREVILEMI 929
Query: 294 NLAMACAVESPEQRINAKEIVKKLLKIRDSL 324
L + C +P R + ++ ++ ++++ L
Sbjct: 930 ELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (494), Expect = 6e-49, Method: Compositional matrix adjust.
Identities = 116/317 (36%), Positives = 186/317 (58%), Gaps = 18/317 (5%)
Query: 17 PSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNL 76
P D+++ L + F EL QATD F+ N+IG +VYK +L DG +AVKV NL
Sbjct: 847 PDLDSALKL----KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNL 902
Query: 77 Q--CGRALKSFNVECEMMKSIRHRNLIKVIS-SCSNEEFKALVLEYMPHGSLEKYLYSSN 133
+ + K F E + + ++HRNL+K++ + + + KALVL +M +G+LE ++ S
Sbjct: 903 KEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSA 962
Query: 134 C-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
I + +++++ + +AS ++YLH GY PI+HCDLKP+N+LLD + VAH+SDF A++L
Sbjct: 963 APIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARIL 1022
Query: 193 -VGEDQSMT-QTQTF-ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT--DEI 247
ED S T T F TIGY+APE+ +V+ DV+SFGI++ME T ++PT ++
Sbjct: 1023 GFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDE 1082
Query: 248 FNGEMTLKHWVNDWLP---ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESP 304
+ +MTL+ V + + V+D L + I + +E+ + L + C P
Sbjct: 1083 DSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLKLCLFCTSSRP 1140
Query: 305 EQRINAKEIVKKLLKIR 321
E R + EI+ L+K+R
Sbjct: 1141 EDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 190 bits (482), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 111/293 (37%), Positives = 166/293 (56%), Gaps = 17/293 (5%)
Query: 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM 91
F + + ATD+FS N IG+GGFG VYK L DG+E+AVK ++ G+ F E +
Sbjct: 321 FDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHSGQGNAEFKTEVLL 380
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVA 149
M ++H+NL+K+ E + LV E++P+ SL+++L+ LD +R NI++ V+
Sbjct: 381 MTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYNIIVGVS 440
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
L YLH G PIIH DLK SNVLLD+ M+ +SDF +A+ ++ + T G
Sbjct: 441 RGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRRVVGTYG 500
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT---LKHWVNDWLPIST 266
YMAPEY GR S DVYSFG++++E TGK+ + + GE T W N W+ ++
Sbjct: 501 YMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNSG-LGLGEGTDLPTFAWQN-WIEGTS 558
Query: 267 LEVVDANLLSQEDIHFVAKE--QCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+E++D LL D KE QC+ +A++C E+P +R +V L
Sbjct: 559 MELIDPVLLQTHD----KKESMQCL----EIALSCVQENPTKRPTMDSVVSML 603
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGR6|Y4291_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g29180 OS=Arabidopsis thaliana GN=At4g29180 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 183 bits (464), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 113/304 (37%), Positives = 164/304 (53%), Gaps = 24/304 (7%)
Query: 30 RTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFN-------------L 76
R F+Y E+ T+ F N +IGKGGFG VY L DG E+AVK+ N
Sbjct: 555 RRFTYSEVSSITNNF--NKVIGKGGFGIVYLGSLEDGTEIAVKMINDSSFGKSKGSSSSS 612
Query: 77 QCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-I 135
+ K F VE E++ ++ HRNL + C + AL+ EYM +G+L+ YL S N
Sbjct: 613 SSSQVSKEFQVEAELLLTVHHRNLASFVGYCDDGRSMALIYEYMANGNLQDYLSSENAED 672
Query: 136 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195
L +RL+I ID A LEYLH G PI+H D+K +N+LL+DN+ A ++DF ++K+ +
Sbjct: 673 LSWEKRLHIAIDSAQGLEYLHHGCRPPIVHRDVKTANILLNDNLEAKIADFGLSKVFPED 732
Query: 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE-MTL 254
D S T T GY+ PEY +++ DVYSFGI+L+E TGK+ + +GE M +
Sbjct: 733 DLSHVVTAVMGTPGYVDPEYYNTFKLNEKSDVYSFGIVLLELITGKRSIMKTDDGEKMNV 792
Query: 255 KHWVNDWLPISTLE-VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
H+V +L + ++ VVD L + FV +AM+C + R N +I
Sbjct: 793 VHYVEPFLKMGDIDGVVDPRLHGD-----FSSNSAWKFV-EVAMSCVRDRGTNRPNTNQI 846
Query: 314 VKKL 317
V L
Sbjct: 847 VSDL 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 3e-45, Method: Compositional matrix adjust.
Identities = 107/293 (36%), Positives = 165/293 (56%), Gaps = 14/293 (4%)
Query: 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM 91
F+Y EL T+ FS++N++G+GGFG VYK +L DG VAVK + G+ + F E E+
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVAS 150
+ + HR+L+ ++ C + + L+ EY+P+ +LE +L+ +L+ +R+ I I A
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAK 460
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
L YLH IIH D+K +N+LLDD A ++DF +AK L Q+ T+ T GY
Sbjct: 461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK-LNDSTQTHVSTRVMGTFGY 519
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN-GEMTLKHWVNDWL--PIST- 266
+APEY + G+++ DV+SFG++L+E TG+KP D+ GE +L W L I T
Sbjct: 520 LAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETG 579
Query: 267 --LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
E+VD L + H+V E V + A AC S +R ++V+ L
Sbjct: 580 DFSELVDRRL----EKHYVENE--VFRMIETAAACVRHSGPKRPRMVQVVRAL 626
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 6e-45, Method: Compositional matrix adjust.
Identities = 111/300 (37%), Positives = 165/300 (55%), Gaps = 19/300 (6%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVK-VFNLQCGRALKSFNVECEMMKS 94
++ +AT SE +IG GG G VYKA L +G VAVK + + KSF+ E + +
Sbjct: 943 DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGR 1002
Query: 95 IRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCIL-------DIFQRLNIM 145
IRHR+L+K++ CS+ E L+ EYM +GS+ +L+ +L D RL I
Sbjct: 1003 IRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIA 1062
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+ +A +EYLH PI+H D+K SNVLLD NM AHL DF +AK+L + T + T+
Sbjct: 1063 VGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW 1122
Query: 206 --ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ GY+APEY + + DVYS GI+LME TGK PTD +F EM + WV L
Sbjct: 1123 FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLE 1182
Query: 264 ISTL---EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
++ +++D L + + F C V +A+ C SP++R ++++ LL +
Sbjct: 1183 VAGSARDKLIDPKL--KPLLPFEEDAACQ--VLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (458), Expect = 9e-45, Method: Compositional matrix adjust.
Identities = 99/252 (39%), Positives = 144/252 (57%), Gaps = 3/252 (1%)
Query: 30 RTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVEC 89
R ++ +L QAT+ F ++LIG GGFG VYKA L DG VA+K G+ + F E
Sbjct: 869 RKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEM 928
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMI 146
E + I+HRNL+ ++ C + + LV E+M +GSLE L+ + L+ R I I
Sbjct: 929 ETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAI 988
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
A L +LH S IIH D+K SNVLLD+N+ A +SDF +A+L+ D ++ +
Sbjct: 989 GSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAG 1048
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266
T GY+ PEY + R S GDVYS+G++L+E TGK+PTD G+ L WV +
Sbjct: 1049 TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKLRI 1108
Query: 267 LEVVDANLLSQE 278
+V D L+ ++
Sbjct: 1109 SDVFDPELMKED 1120
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 339 | ||||||
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.952 | 0.316 | 0.592 | 1e-108 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.943 | 0.294 | 0.575 | 1e-103 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.941 | 0.300 | 0.574 | 1e-103 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.943 | 0.266 | 0.573 | 1e-102 | |
| 255583725 | 973 | serine-threonine protein kinase, plant-t | 0.952 | 0.331 | 0.548 | 1e-101 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.952 | 0.309 | 0.542 | 2e-99 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.952 | 0.227 | 0.575 | 4e-99 | |
| 359485176 | 1160 | PREDICTED: probable LRR receptor-like se | 0.941 | 0.275 | 0.582 | 1e-98 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.946 | 0.220 | 0.564 | 1e-97 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.964 | 0.300 | 0.527 | 4e-97 |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1024), Expect = e-108, Method: Compositional matrix adjust.
Identities = 192/324 (59%), Positives = 248/324 (76%), Gaps = 1/324 (0%)
Query: 4 ILLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARL 63
I L++ R+R ++ ++P+ A+ R SYLEL AT+EF E+NL+G G FGSVY+ RL
Sbjct: 691 IFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRL 750
Query: 64 GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123
DG+ VAVK+FNLQ RA +SF+ ECE+M++IRHRNL+K+I SCSN +FKALVLEYMP G
Sbjct: 751 RDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKG 810
Query: 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL 183
SLEK+LYS N LDI QR+NIMIDVASALEYLH GY +P++HCDLKPSNVLLD++MVAH+
Sbjct: 811 SLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHV 870
Query: 184 SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
DF IAKLL GE++S QT+T ATIGYMAPEYG +G VS DVYSFGIMLME T K+P
Sbjct: 871 CDFGIAKLL-GENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRP 929
Query: 244 TDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVES 303
TDE+F GEM+LK V + LP S +++VD+N+L++ D + V KE CV+ + LA+ C ES
Sbjct: 930 TDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNES 989
Query: 304 PEQRINAKEIVKKLLKIRDSLLRN 327
P +R+ EI+ +L I+ LR+
Sbjct: 990 PGERMAMVEILARLKNIKAEFLRD 1013
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 382 bits (981), Expect = e-103, Method: Compositional matrix adjust.
Identities = 186/323 (57%), Positives = 237/323 (73%), Gaps = 3/323 (0%)
Query: 1 MVVILLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYK 60
+ +I + R R+R + L A WR SY E+ QAT+ FS NL+G+G GSVY+
Sbjct: 761 LALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYR 820
Query: 61 ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFKALVLE 118
L DG A+KVFNLQ A KSF+ ECE+M IRHRNLIK++SSCSN +FKALVLE
Sbjct: 821 GTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLE 880
Query: 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN 178
Y+P+GSLE++LYS N LDI QRLNIMIDVA A+EYLH G S P++HCDLKPSN+LLD++
Sbjct: 881 YVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDED 940
Query: 179 MVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETF 238
H+ DF IAKLL E++S+ +TQT ATIGYMAP+Y G V+ +GDVYS+GI+LMETF
Sbjct: 941 FGGHVGDFGIAKLLR-EEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETF 999
Query: 239 TGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 298
T ++PTDEIF+ EM++K+WV DWL S EVVDANLL ED F+AK+QC+S + LAM
Sbjct: 1000 TRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQCISLILGLAMD 1059
Query: 299 CAVESPEQRINAKEIVKKLLKIR 321
C +SPE+RI K++V L KI+
Sbjct: 1060 CVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 380 bits (976), Expect = e-103, Method: Compositional matrix adjust.
Identities = 185/322 (57%), Positives = 245/322 (76%), Gaps = 3/322 (0%)
Query: 1 MVVILLILRYRQRGKRPSNDASMPLV-AMWRTFSYLELCQATDEFSENNLIGKGGFGSVY 59
+V+ L ++ +R+ KR + PL A WR SY EL +AT+ F+E NL+G G GSVY
Sbjct: 727 LVLALAVIIFRRSHKRKLSTQEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVY 786
Query: 60 KARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119
K L DG+ +AVKVF+LQ L F+ ECE+++ +RHRNL+K+ISSC N +FKAL+LE+
Sbjct: 787 KGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEF 846
Query: 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 179
+PHGSLEK+LYS N LDI QRLNIMIDVASALEYLH G + P++HCDLKPSNVL++++M
Sbjct: 847 IPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDM 906
Query: 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
VAH+SDF I++LL GE ++TQT T ATIGYMAPEYG EG VS GDVYS+GI LMETFT
Sbjct: 907 VAHVSDFGISRLL-GEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFT 965
Query: 240 GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 299
KKPTD++F GEM+LK+WV LP + EV+DANLL +E+ HFVAK+ C++ + NLA+ C
Sbjct: 966 RKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEE-HFVAKKDCITSILNLALEC 1024
Query: 300 AVESPEQRINAKEIVKKLLKIR 321
+ + P +RI ++++ L KI+
Sbjct: 1025 SADLPGERICMRDVLPALEKIK 1046
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 376 bits (966), Expect = e-102, Method: Compositional matrix adjust.
Identities = 188/328 (57%), Positives = 240/328 (73%), Gaps = 8/328 (2%)
Query: 1 MVVILLILRYRQRGKRPSN----DASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFG 56
+++++L +++++R + D S+P M R + EL AT+ F E+NLIGKG G
Sbjct: 873 IILVVLFVQWKRRQTKSETPIQVDLSLP--RMHRMIPHQELLYATNYFGEDNLIGKGSLG 930
Query: 57 SVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116
VYK L DG+ VAVKVFNL+ A KSF VECE+M++IRHRNL K+ISSCSN +FKALV
Sbjct: 931 MVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALV 990
Query: 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 176
LEYMP+GSLEK+LYS N LD QRL IMIDVAS LEYLH YS P++HCDLKPSNVLLD
Sbjct: 991 LEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLD 1050
Query: 177 DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLME 236
D+MVAH+SDF IAKLL+G + M +T+T T+GYMAPEYG EG VS GD+YS+GI+LME
Sbjct: 1051 DDMVAHISDFGIAKLLMG-SEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLME 1109
Query: 237 TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLA 296
TF KKPTDE+F E+TLK WV + +EV+DANLL++ED F K C S + LA
Sbjct: 1110 TFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDESFALKRACFSSIMTLA 1168
Query: 297 MACAVESPEQRINAKEIVKKLLKIRDSL 324
+ C VE PE+RIN K++V +L K+ + +
Sbjct: 1169 LDCTVEPPEKRINTKDVVVRLKKLLNQI 1196
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 373 bits (958), Expect = e-101, Method: Compositional matrix adjust.
Identities = 180/328 (54%), Positives = 242/328 (73%), Gaps = 5/328 (1%)
Query: 3 VILLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKAR 62
V+++ +R R+R +R + + +PL + R SY EL QATD+F+E NL+GKG FGSVYK
Sbjct: 648 VVIIFIRSRKRNRR-TTEGLLPLATLER-ISYRELEQATDKFNEINLLGKGSFGSVYKGI 705
Query: 63 LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS--NEEFKALVLEYM 120
DG VAVKVFNLQ A KSF+VE E+++ IRHRNL+K+I+SCS N EFKALVLE+M
Sbjct: 706 FSDGRSVAVKVFNLQAEGAFKSFDVESEVLRMIRHRNLVKIITSCSSVNIEFKALVLEFM 765
Query: 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180
P+ SLEK+LYS N L+ QRLNIM+DVASA+EYLH GY+ PI+HCDLKP+N+LLD+NM
Sbjct: 766 PNHSLEKWLYSPNHFLEFLQRLNIMLDVASAVEYLHHGYTTPIVHCDLKPNNILLDENMA 825
Query: 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG 240
AH++DF IAKLL G+++S +T T AT+GYMAPEYG EG VS GDVYSFGI+++ETFT
Sbjct: 826 AHVTDFGIAKLL-GDERSFIRTITLATVGYMAPEYGSEGVVSTGGDVYSFGILMIETFTS 884
Query: 241 KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACA 300
+KPTD++FN EM +K WV + L ++ D NLL ED H AK+ C+ + LA+ C+
Sbjct: 885 RKPTDDMFNEEMNMKQWVQESLAGGVTQIADPNLLRIEDEHLSAKKDCIISMMQLALQCS 944
Query: 301 VESPEQRINAKEIVKKLLKIRDSLLRNV 328
+ PE+R N ++++ L I+ L+ +
Sbjct: 945 ADLPEERPNIRDVLSTLNHIKVKFLKGI 972
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 368 bits (945), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 178/328 (54%), Positives = 243/328 (74%), Gaps = 5/328 (1%)
Query: 3 VILLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKAR 62
V ++ +R R+R R + + +PL + R SY EL QATD+F+E NL+G+G FGSVYK
Sbjct: 718 VAIIFIRSRKRNMRIT-EGLLPLATLKR-ISYRELEQATDKFNEMNLLGRGSFGSVYKGT 775
Query: 63 LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS--NEEFKALVLEYM 120
DG VAVKVFNLQ A KSF+VECE+++ IRHRNL+K+I+SCS N +FKALVLE+M
Sbjct: 776 FSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFM 835
Query: 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180
P+ SLEK+L S L++ +RLNIM+DVASA+EYLH GY+ PI+HCDLKPSN+LLD+NMV
Sbjct: 836 PNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMV 895
Query: 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG 240
AH++DF IAKLL G++ S QT T AT+GYMAPEYG EG VS GD+YSFGI+LMETFT
Sbjct: 896 AHVTDFGIAKLL-GDEHSFIQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTR 954
Query: 241 KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACA 300
KKPTD++FN E+++K WV + +P ++ D +LL E+ HF AK+ C+ V +A+ C+
Sbjct: 955 KKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCS 1014
Query: 301 VESPEQRINAKEIVKKLLKIRDSLLRNV 328
+ PE+R N ++++ L + L+++
Sbjct: 1015 ADLPEERPNIRDVLNTLNHTKVKFLKDI 1042
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 367 bits (942), Expect = 4e-99, Method: Compositional matrix adjust.
Identities = 187/325 (57%), Positives = 230/325 (70%), Gaps = 2/325 (0%)
Query: 1 MVVILLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYK 60
+VV+ + + RQ + L M R S+ EL AT F E NLIGKG G VYK
Sbjct: 876 LVVLFTLWKRRQTESESPVQVDLLLPRMHRLISHQELLYATSYFGEENLIGKGSLGMVYK 935
Query: 61 ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120
L DG+ VAVKVFNL+ A KSF VECE+M++IRHRNL K+ISSCSN +FKALVLEYM
Sbjct: 936 GVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYM 995
Query: 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180
P+ SLEK+LYS N LD QRL IMIDVAS LEYLH YS P++HCDLKPSNVLLDD+MV
Sbjct: 996 PNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMV 1055
Query: 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG 240
AH+SDF IAKLL+G + M +T+T TIGYMAPEYG EG VS D YS+GI+LME F
Sbjct: 1056 AHISDFGIAKLLMGS-EFMKRTKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIFVR 1114
Query: 241 KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACA 300
KKPTDE+F E+TLK WV + +EV+DANLL++ED F K+ C S + LA+ C
Sbjct: 1115 KKPTDEMFVEELTLKSWVESSAN-NIMEVIDANLLTEEDESFALKQACFSSIMTLALDCT 1173
Query: 301 VESPEQRINAKEIVKKLLKIRDSLL 325
+E PE+RIN K++V +L KI + ++
Sbjct: 1174 IEPPEKRINMKDVVARLKKILNQIV 1198
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485176|ref|XP_002280075.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 366 bits (939), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 188/323 (58%), Positives = 234/323 (72%), Gaps = 4/323 (1%)
Query: 4 ILLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARL 63
++LI R R + K P+ S L + R S+ EL AT+ F E+N+IG G G V++ L
Sbjct: 839 VVLIRRRRSKSKAPAQVNSFHLGKL-RRISHQELIYATNYFGEDNMIGTGSLGMVHRGVL 897
Query: 64 GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123
DG VAVKVFNL+ A KSF+ ECE+M++I+HRNL+K+ISSCS FKALVLEYMP+G
Sbjct: 898 SDGSIVAVKVFNLEFQGAFKSFDAECEIMRNIQHRNLVKIISSCSILNFKALVLEYMPNG 957
Query: 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAH 182
SLEK+LYS N L++ QRLNIMIDVASALEYLH +S P++HCDLKP+NVLLD+ MVA
Sbjct: 958 SLEKWLYSHNYCLNLVQRLNIMIDVASALEYLHHDFSVNPVVHCDLKPNNVLLDEEMVAR 1017
Query: 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKK 242
L DF I+KLL E +SM QT+T TIGYMAPEYG EG VS GDVYS+GIM+METF KK
Sbjct: 1018 LGDFGISKLLT-ETESMEQTRTLGTIGYMAPEYGSEGIVSTRGDVYSYGIMMMETFARKK 1076
Query: 243 PTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVE 302
PTDE+F GE+TL+ WV + L +EVVD NL+ +ED HF KE C+ + LA+ C E
Sbjct: 1077 PTDEMFGGEVTLRSWV-ESLAGRVMEVVDGNLVRREDQHFGIKESCLRSIMALALECTTE 1135
Query: 303 SPEQRINAKEIVKKLLKIRDSLL 325
SP RI+ KE+V +L KIR LL
Sbjct: 1136 SPRDRIDMKEVVVRLKKIRIKLL 1158
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 362 bits (930), Expect = 1e-97, Method: Compositional matrix adjust.
Identities = 184/326 (56%), Positives = 239/326 (73%), Gaps = 5/326 (1%)
Query: 1 MVVILLILRYRQRGKRPSN-DASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVY 59
+V ++L +R R+ + P+ D+ +P S+ +L AT+ F E+NLIGKG VY
Sbjct: 1132 VVFLVLWIRRRKNLEVPTPIDSWLP--GSHEKISHQQLLYATNYFGEDNLIGKGSLSMVY 1189
Query: 60 KARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119
K L +G+ VAVKVFNL+ A +SF+ ECE+M+SIRHRNL+K+I+ CSN +FKALVLEY
Sbjct: 1190 KGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEY 1249
Query: 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 179
MP GSL+K+LYS N LD+ QRLNIMIDVASALEYLH + ++HCDLKP+N+LLDD+M
Sbjct: 1250 MPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDM 1309
Query: 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
VAH+ DF IA+LL E +SM QT+T TIGYMAPEYG +G VS GDV+S+GIMLME F
Sbjct: 1310 VAHVGDFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFA 1368
Query: 240 GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 299
KKP DE+FNG++TLK WV + L S +EVVDANLL +ED F K C+S + LA+AC
Sbjct: 1369 RKKPMDEMFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFATKLSCLSSIMALALAC 1427
Query: 300 AVESPEQRINAKEIVKKLLKIRDSLL 325
+SPE+RI+ K++V L KI+ LL
Sbjct: 1428 TTDSPEERIDMKDVVVGLKKIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 360 bits (925), Expect = 4e-97, Method: Compositional matrix adjust.
Identities = 173/328 (52%), Positives = 233/328 (71%), Gaps = 1/328 (0%)
Query: 1 MVVILLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYK 60
+ ++++ RY +R + S + + R SY EL AT+ F E+N +G G FGSVYK
Sbjct: 759 LAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYK 818
Query: 61 ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120
L DG +A KVFNLQ RA KSF+ ECE+++++RHRNL+K+I+SCS FKALVLE+M
Sbjct: 819 GTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFM 878
Query: 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180
P+ SLEK+LYS + L+ QRLNIM+DVAS LEYLH GY+ P+ HCD+KPSNVLL+++MV
Sbjct: 879 PNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMV 938
Query: 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG 240
A L+DF I+KLL GE+ S+ QT T ATIGYMAPEYG EG VS GDVYS+G++LMETFT
Sbjct: 939 AFLADFGISKLL-GEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQ 997
Query: 241 KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACA 300
KKPTD++F +++LK WV L +V+DANLL E+ H AK+ C+ + LA+ C+
Sbjct: 998 KKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILKLALQCS 1057
Query: 301 VESPEQRINAKEIVKKLLKIRDSLLRNV 328
+ P RI+ K +V L KI+ LR++
Sbjct: 1058 ADLPHDRIDMKHVVTTLQKIKTKFLRDI 1085
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 339 | ||||||
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.955 | 0.321 | 0.420 | 1.3e-66 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.941 | 0.311 | 0.428 | 8.7e-62 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.890 | 0.292 | 0.420 | 3.9e-55 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.820 | 0.553 | 0.444 | 3.4e-54 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.784 | 0.259 | 0.426 | 1.6e-53 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.890 | 0.308 | 0.362 | 3.5e-48 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.941 | 0.271 | 0.357 | 5.9e-48 | |
| TAIR|locus:2127323 | 642 | CRK27 "cysteine-rich RLK (RECE | 0.908 | 0.479 | 0.351 | 3.8e-46 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.634 | 0.212 | 0.447 | 1.2e-45 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.831 | 0.397 | 0.358 | 1.1e-44 |
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 1.3e-66, P = 1.3e-66
Identities = 145/345 (42%), Positives = 212/345 (61%)
Query: 2 VVILLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKA 61
+V L + R+ ++ +N A L SY +L ATD FS +N++G G FG+V+KA
Sbjct: 659 IVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKA 718
Query: 62 RLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN-----EEFKAL 115
L + VAVKV N+Q A+KSF ECE +K IRHRNL+K++++C++ EF+AL
Sbjct: 719 LLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRAL 778
Query: 116 VLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+ E+MP+GSL+K+L+ L + +RLNI IDVAS L+YLH PI HCD
Sbjct: 779 IYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCD 838
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMAPEYGREGRVS 222
LKPSN+LLDD++ AH+SDF +A+LL+ DQ ++ TIGY APEYG G+ S
Sbjct: 839 LKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPS 898
Query: 223 ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL-SQEDIH 281
+GDVYSFG++++E FTGK+PT+E+F G TL + LP L++ D ++L S +
Sbjct: 899 IHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVG 958
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
F E C+ + ++ + C ESP R+ E K+L+ IR+ +
Sbjct: 959 FPVLE-CLKGILDVGLRCCEESPLNRLATSEAAKELISIRERFFK 1002
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 638 (229.6 bits), Expect = 8.7e-62, P = 8.7e-62
Identities = 147/343 (42%), Positives = 204/343 (59%)
Query: 8 LRYRQ-RGKRPSNDASM-PLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD 65
LR + R ND S P+ + + SY EL + T FS +NLIG G FG+V+K LG
Sbjct: 681 LRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGS 740
Query: 66 -GMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEF-----KALVLE 118
VA+KV NL C R A KSF ECE + IRHRNL+K+++ CS+ +F +ALV E
Sbjct: 741 KNKAVAIKVLNL-CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYE 799
Query: 119 YMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP 170
+MP+G+L+ +L+ L +F RLNI IDVASAL YLH PI HCD+KP
Sbjct: 800 FMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKP 859
Query: 171 SNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-----TIGYMAPEYGREGRVSANG 225
SN+LLD ++ AH+SDF +A+LL+ D+ Q + TIGY APEYG G S G
Sbjct: 860 SNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMG 919
Query: 226 DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI-STLEVVDANLLSQEDIHFVA 284
DVYSFGI+L+E FTGK+PT+++F +TL + L L++ D +L
Sbjct: 920 DVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFN 979
Query: 285 KEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
+C++ VF + ++C+ ESP RI+ E + KL+ IR+S R+
Sbjct: 980 MVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 577 (208.2 bits), Expect = 3.9e-55, P = 3.9e-55
Identities = 140/333 (42%), Positives = 188/333 (56%)
Query: 9 RYRQRGKRPSNDASMPLVAMWRT-FSYLELCQATDEFSENNLIGKGGFGSVYKARLG-DG 66
R ++ N + + M+ SY EL AT FS NLIG G FG+V+K LG +
Sbjct: 676 RKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPEN 735
Query: 67 MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMP 121
VAVKV NL A KSF ECE K IRHRNL+K+I+ CS+ +F+ALV E+MP
Sbjct: 736 KLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMP 795
Query: 122 HGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV 173
GSL+ +L + L ++LNI IDVASALEYLH P+ HCD+KPSN+
Sbjct: 796 KGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNI 855
Query: 174 LLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-----TIGYMAPEYGREGRVSANGDVY 228
LLDD++ AH+SDF +A+LL D+ Q + TIGY APEYG G+ S GDVY
Sbjct: 856 LLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVY 915
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
SFGI+L+E F+GKKPTDE F G+ L + L T +N + ++
Sbjct: 916 SFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSG-GSNAI----------DEG 964
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
+ V + + C+ E P R+ E V++L+ IR
Sbjct: 965 LRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 560 (202.2 bits), Expect = 3.4e-54, P = 3.4e-54
Identities = 137/308 (44%), Positives = 178/308 (57%)
Query: 33 SYLELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEM 91
SY EL AT FS +NLIG G F V+K LG + VAVKV NL A KSF ECE
Sbjct: 198 SYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAECES 257
Query: 92 MKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLY-----SSNC---ILDI 138
K IRHRNL K+I+ CS+ +F+ALV E+MP GSL+ +L S+N L
Sbjct: 258 FKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSLTF 317
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
+++NI IDVASALEYLH P+ HCD+KPSNVLLDD++ AH+SDF +A+LL D+
Sbjct: 318 AEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEK 377
Query: 199 MTQTQTFA-----TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 253
Q + TIGY APEYG + S GDVYSFG++L+E FTGKKPTD F G
Sbjct: 378 TFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYN 437
Query: 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
L + L ST S+ V ++ + V + + C+ E P R+ E
Sbjct: 438 LHGYTKSVLSCST---------SRGGRTMV--DEWLRLVLEVGIKCSEEYPRDRMGMAEA 486
Query: 314 VKKLLKIR 321
V++L+ I+
Sbjct: 487 VRELVSIK 494
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 1.6e-53, P = 1.6e-53
Identities = 124/291 (42%), Positives = 185/291 (63%)
Query: 4 ILLILRYRQRGKR--PSNDASM--PLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVY 59
+ L++ + +R K+ PS + PLV SY +L +ATD F+ NL+G G FGSVY
Sbjct: 670 LYLLITWHKRTKKGAPSRTSMKGHPLV------SYSQLVKATDGFAPTNLLGSGSFGSVY 723
Query: 60 KARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN-----EEFKA 114
K +L VAVKV L+ +ALKSF ECE ++++RHRNL+K+++ CS+ +FKA
Sbjct: 724 KGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKA 783
Query: 115 LVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+V ++MP+GSLE +++ + L++ +R+ I++DVA AL+YLH P++HCD+
Sbjct: 784 IVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDI 843
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLV-GED--QSMTQTQTF-ATIGYMAPEYGREGRVSAN 224
K SNVLLD +MVAH+ DF +A++LV G Q T + F TIGY APEYG S +
Sbjct: 844 KSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTH 903
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
GD+YS+GI+++E TGK+PTD F ++ L+ +V L +VVD L+
Sbjct: 904 GDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLI 954
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 3.5e-48, P = 3.5e-48
Identities = 120/331 (36%), Positives = 190/331 (57%)
Query: 15 KRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVF 74
K+ ND P + SY +L AT F+ ++LIG G FG VYK L + +VAVKV
Sbjct: 638 KQNQNDPKYPRI------SYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVL 691
Query: 75 NLQCGRALK-SFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-- 131
+ + SF EC+++K RHRNLI++I++CS F ALVL MP+GSLE++LY
Sbjct: 692 DPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGE 751
Query: 132 -SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
S+ LD+ Q +NI DVA + YLH ++HCDLKPSN+LLDD M A ++DF I++
Sbjct: 752 YSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISR 811
Query: 191 LLVGEDQSMTQTQTFA----------TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG 240
L+ G +++++ + + ++GY+APEYG R S +GDVYSFG++L+E +G
Sbjct: 812 LVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSG 871
Query: 241 KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ-------EDIHFVAKEQCVSFVF 293
++PTD + N +L ++ P S LE + LS+ E + +E + +
Sbjct: 872 RRPTDVLVNEGSSLHEFMKSHYPDS-LEGIIEQALSRWKPQGKPEKCEKLWREVILEMI- 929
Query: 294 NLAMACAVESPEQRINAKEIVKKLLKIRDSL 324
L + C +P R + ++ ++ ++++ L
Sbjct: 930 ELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 5.9e-48, P = 5.9e-48
Identities = 120/336 (35%), Positives = 199/336 (59%)
Query: 1 MVVILLILRYRQRGKRPSNDASMPLV--AM-WRTFSYLELCQATDEFSENNLIGKGGFGS 57
+V+IL + +++ S+++S+P + A+ + F EL QATD F+ N+IG +
Sbjct: 824 LVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLST 883
Query: 58 VYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVIS-SCSNEEFKA 114
VYK +L DG +AVKV NL+ + K F E + + ++HRNL+K++ + + + KA
Sbjct: 884 VYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKA 943
Query: 115 LVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV 173
LVL +M +G+LE ++ S I + +++++ + +AS ++YLH GY PI+HCDLKP+N+
Sbjct: 944 LVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANI 1003
Query: 174 LLDDNMVAHLSDFSIAKLL-VGEDQSMT-QTQTF-ATIGYMAPEYGREGRVSANGDVYSF 230
LLD + VAH+SDF A++L ED S T T F TIGY+APE+ +V+ DV+SF
Sbjct: 1004 LLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSF 1063
Query: 231 GIMLMETFTGKKPT--DEIFNGEMTLKHWVNDWLPIST---LEVVDANLLSQEDIHFVAK 285
GI++ME T ++PT ++ + +MTL+ V + + V+D L + I + +
Sbjct: 1064 GIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQ 1121
Query: 286 EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
E+ + L + C PE R + EI+ L+K+R
Sbjct: 1122 EEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
| TAIR|locus:2127323 CRK27 "cysteine-rich RLK (RECEPTOR-like protein kinase) 27" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.8e-46, P = 3.8e-46
Identities = 114/324 (35%), Positives = 179/324 (55%)
Query: 1 MVVILLILRYRQRGKRPSNDASMPLVAMWRT-FSYLELCQATDEFSENNLIGKGGFGSVY 59
+V + + L+ R++ K +A + F + + ATD+FS N IG+GGFG VY
Sbjct: 289 LVFLFIYLKRRRKKKTLKENAENEFESTDSLHFDFETIRVATDDFSLTNKIGEGGFGVVY 348
Query: 60 KARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119
K L DG+E+AVK ++ G+ F E +M ++H+NL+K+ E + LV E+
Sbjct: 349 KGHLPDGLEIAVKRLSIHSGQGNAEFKTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEF 408
Query: 120 MPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD 177
+P+ SL+++L+ LD +R NI++ V+ L YLH G PIIH DLK SNVLLD+
Sbjct: 409 IPNTSLDRFLFDPIKQKQLDWEKRYNIIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDE 468
Query: 178 NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMET 237
M+ +SDF +A+ ++ + T GYMAPEY GR S DVYSFG++++E
Sbjct: 469 QMLPKISDFGMARQFDFDNTQAVTRRVVGTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEI 528
Query: 238 FTGKKPTD-EIFNG-EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKE--QCVSFVF 293
TGK+ + + G ++ W N W+ +++E++D LL D KE QC+
Sbjct: 529 ITGKRNSGLGLGEGTDLPTFAWQN-WIEGTSMELIDPVLLQTHD----KKESMQCLE--- 580
Query: 294 NLAMACAVESPEQRINAKEIVKKL 317
+A++C E+P +R +V L
Sbjct: 581 -IALSCVQENPTKRPTMDSVVSML 603
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 1.2e-45, P = 1.2e-45
Identities = 103/230 (44%), Positives = 144/230 (62%)
Query: 111 EFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGYSAP 162
EF+AL+ E+MP+GSL+ +L+ L + +RLNI IDVAS L+YLH P
Sbjct: 775 EFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 834
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMAPEYGR 217
I HCDLKPSNVLLDD++ AH+SDF +A+LL+ D+ ++ TIGY APEYG
Sbjct: 835 IAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGV 894
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
G+ S NGDVYSFGI+L+E FTGK+PT+E+F G TL + LP L++VD ++L
Sbjct: 895 GGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHI 954
Query: 278 E-DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
+ F E C++ VF + + C ESP R+ +VK+L+ IR+ +
Sbjct: 955 GLRVGFPVVE-CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 1.1e-44, P = 1.1e-44
Identities = 104/290 (35%), Positives = 165/290 (56%)
Query: 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM 91
F+Y EL T+ FS++N++G+GGFG VYK +L DG VAVK + G+ + F E E+
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVAS 150
+ + HR+L+ ++ C + + L+ EY+P+ +LE +L+ +L+ +R+ I I A
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAK 460
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
L YLH IIH D+K +N+LLDD A ++DF +AKL Q+ T+ T GY
Sbjct: 461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLN-DSTQTHVSTRVMGTFGY 519
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN-GEMTLKHWVNDWLPISTLEV 269
+APEY + G+++ DV+SFG++L+E TG+KP D+ GE +L W L +E
Sbjct: 520 LAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLH-KAIET 578
Query: 270 VD-ANLLSQE-DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
D + L+ + + H+V E V + A AC S +R ++V+ L
Sbjct: 579 GDFSELVDRRLEKHYVENE--VFRMIETAAACVRHSGPKRPRMVQVVRAL 626
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XVI000210 | hypothetical protein (1019 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 339 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 | |
| COG2334 | 331 | COG2334, COG2334, Putative homoserine kinase type | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 5e-51
Identities = 70/191 (36%), Positives = 101/191 (52%), Gaps = 9/191 (4%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSC 107
+G+GGFG+VY AR G +VA+K+ + L+ E E++K + H N++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+E LV+EY GSL+ L + L + L I++ + LEYLH S IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 168 LKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR-EGRVSANG 225
LKP N+LLD DN L+DF ++KLL T YMAPE +G S
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 226 DVYSFGIMLME 236
D++S G++L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 4e-49
Identities = 86/279 (30%), Positives = 130/279 (46%), Gaps = 42/279 (15%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV----ECEMMKSIRHRNLIKVI 104
+G G FG+VYKA+ G G VAVK+ + + E +++ + H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +++ LV+EY G L YL S L + I + + LEYLH S II
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPE-------YG 216
H DLKP N+LLD+N V ++DF +AK L+ S+T TF T YMAPE YG
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT---TFVGTPWYMAPEVLLGGNGYG 177
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
+ DV+S G++L E TGK P + L+ P + + S
Sbjct: 178 PK------VDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGS 230
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+E + K C + P +R A+EI++
Sbjct: 231 EEAKDLIKK-------------CLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 9e-49
Identities = 77/270 (28%), Positives = 119/270 (44%), Gaps = 26/270 (9%)
Query: 48 NLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVIS 105
+G+G FG VY AR G VA+KV + + + E +++K ++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+E+ LV+EY G L L L + + + SALEYLH S I+H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DLKP N+LLD++ L+DF +A+ L D T T YMAPE
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 226 DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285
D++S G++L E TGK P F G+ L +S E +
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI-- 231
Query: 286 EQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ V + PE+R+ A+E ++
Sbjct: 232 RKL--LVKD---------PEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 5e-47
Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 47 NNLIGKGGFGSVYKARLGD-----GMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNL 100
+G+G FG VYK +L +EVAVK ++ F E +M+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+K++ C+ EE +V+EYM G L YL + L + L+ + +A +EYL S
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
IH DL N L+ +N+V +SDF +++ L +D + I +MAPE +EG+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 221 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
++ DV+SFG++L E FT G++P M+ + + + + L Q
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--------LKNGYRLPQP- 225
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
C +++L + C E PE R E+V+ L
Sbjct: 226 ------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 7e-45
Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 32/279 (11%)
Query: 47 NNLIGKGGFGSVYKARLGDG-----MEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNL 100
+G+G FG VYK L +EVAVK + ++ F E +M+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+K++ C+ EE +V+EYMP G L YL + L + L+ + +A +EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
S IH DL N L+ +N+V +SDF +++ L +D I +MAPE +EG
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ ++ DV+SFG++L E FT G++P M+ + + L +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--------LKKGYRLPKP 226
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
C ++ L + C E PE R E+V+ L
Sbjct: 227 -------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 4e-44
Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 30/275 (10%)
Query: 50 IGKGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG VYK L G +VAVK + F E +MK + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
+ C+ E +V EYMP G L +L L + L + + +A +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA 223
+H DL N L+ +N+V +SDF +++ + +D + I +MAPE ++G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+SFG++L E FT G++P + N E+ + D L +
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL-------------LEDGYRLPRP---- 226
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
E C ++ L + C PE R E+V+ L
Sbjct: 227 ---ENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 8e-42
Identities = 86/286 (30%), Positives = 135/286 (47%), Gaps = 41/286 (14%)
Query: 48 NLIGKGGFGSVYKARL----GDGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNL 100
+G+G FG VYK +L G EVAVK L+ K F E +MK + H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASAL 152
++++ C+ EE LVLEYM G L YL S L + L+ I +A +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
EYL S +H DL N L+ +++V +SDF +++ + +D +T I +MA
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271
PE ++G ++ DV+SFG++L E FT G P + N E+ L++ +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY------------LRK 222
Query: 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L + E C ++ L ++C PE R E+V++L
Sbjct: 223 GYRLPK-------PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 1e-39
Identities = 83/290 (28%), Positives = 121/290 (41%), Gaps = 47/290 (16%)
Query: 43 EFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRA--LKSFNVECEMMKSIRHRN 99
E++ L+G+G FGSVY A D G +AVK L L++ E ++ S++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 100 LIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNI------MIDVASA 151
+++ S +EE L LEY+ GSL L F +L +
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEG 113
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L YLH S I+H D+K +N+L+D + V L+DF AK L + T +M
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271
APE R D++S G ++E TGK P E+ N L I +
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-------IGSSGEPP 223
Query: 272 A--NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
LS+E F+ K C P++R A E LL+
Sbjct: 224 EIPEHLSEEAKDFLRK-------------CLRRDPKKRPTADE----LLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-35
Identities = 87/296 (29%), Positives = 128/296 (43%), Gaps = 33/296 (11%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRH-RNLIKVI 104
+G+G FG VY AR D VA+KV + + ++ F E +++ S+ H N++K+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+E LV+EY+ GSLE L L + L I+ + SALEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 163 IIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFA----TIGYMAPEY-- 215
IIH D+KP N+LLD D V L DF +AKLL + + + T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 216 -GREGRVSANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVNDWLPISTLEVVD 271
S++ D++S GI L E TG P TLK + P +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
+N E +L + P+ R+++ + L L +
Sbjct: 242 SN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 84/294 (28%), Positives = 129/294 (43%), Gaps = 50/294 (17%)
Query: 50 IGKGGFGSVYKARL------GDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIK 102
+G+G FG V+ D VAVK A K F E E++ + +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS------------SNCI-LDIFQRLNIMIDVA 149
C+ + +V EYM HG L K+L S S L + Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 150 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
S + YL HF +H DL N L+ ++V + DF +++ + D T
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265
I +M PE + + DV+SFG++L E FT GK+P + N E+
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------------- 233
Query: 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
+E + L Q C S V+++ + C P+QRIN K+I ++L K
Sbjct: 234 -IECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 38/274 (13%)
Query: 49 LIGKGGFGSVYKARLGD--GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVIS 105
IGKG FG V LGD G +VAVK L+ A ++F E +M ++RH NL++++
Sbjct: 13 TIGKGEFGDVM---LGDYRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+V EYM GSL YL S ++ + Q+L +DV +EYL +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DL NVL+ +++VA +SDF +AK + S Q + + APE RE + S
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 225 GDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFV 283
DV+SFGI+L E ++ G+ P I P+ +VV ++
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRI---------------PLK--DVVPH---VEKGYRME 219
Query: 284 AKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
A E C V+ + C P +R K++ ++L
Sbjct: 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 67/196 (34%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IGKGGFG VYKAR G EVA+KV L+ + E +++K +H N++K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
++ +V+E+ GSL+ L S+N L Q + ++ LEYLH S IIH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSANGDV 227
K +N+LL + L DF ++ L T T +MAPE D+
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL----SDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180
Query: 228 YSFGIMLMETFTGKKP 243
+S GI +E GK P
Sbjct: 181 WSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-32
Identities = 82/270 (30%), Positives = 125/270 (46%), Gaps = 23/270 (8%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIKVISSC 107
IGKG FG VYK L EVAVK LK F E E++K H N++K+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
++ +V+E +P GSL +L L + + L + +D A+ +EYL S IH D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N V +SDF +++ G +++ I + APE GR ++ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
+S+GI+L ETF+ G+ N T E +++ A +
Sbjct: 179 WSYGILLWETFSL---------GDTPYPGMSNQ----QTRERIESGY------RMPAPQL 219
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKL 317
C ++ L + C PE R + EI +L
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-31
Identities = 70/277 (25%), Positives = 124/277 (44%), Gaps = 27/277 (9%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
EF+ +G G FG V++ + + VA+K+ + F E + +K +RH++LI
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSA 161
+ + CS E ++ E M GSL +L S +L + +++ VA + YL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQ 123
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH DL N+L+ +++V ++DF +A+L+ ++ + + APE G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280
S DV+SFGI+L E FT G+ P + N E + + A
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------------VYDQITAGY------ 221
Query: 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+C ++ + + C PE R + K + ++L
Sbjct: 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 48 NLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---LKSFNVECEMMKSIRHRNLIKV 103
IGKG FG VY R DG +K +L + N E +++K + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKY 64
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGYS 160
S + +V+EY G L + + F Q L+ + + AL+YLH S
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---S 121
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGREG 219
I+H D+KP N+ L N + L DF I+K+L ++ +T T Y++PE +
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSPELCQNK 178
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
+ D++S G +L E T K P F GE
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 76/276 (27%), Positives = 116/276 (42%), Gaps = 45/276 (16%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH--RNLIKVIS- 105
+G+G G VYK R G A+K + + + E K + + L S
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIH---------VDGDEEFRKQLLRELKTLRSCESP 59
Query: 106 ---SCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
C +K ++VLEYM GSL L I + I + L+YLH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH-- 116
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGR 217
IIH D+KPSN+L++ ++DF I+K+L + ++ Q TF T+ YM+PE +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQ 173
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP-TDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
S D++S G+ L+E GK P L + D P S + A S
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS----LPAEEFS 229
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKE 312
E F++ AC + P++R +A E
Sbjct: 230 PEFRDFIS-------------ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 70/211 (33%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 50 IGKGGFGSVYKARLGD-----GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKG FG V R D M+V K ++ + E ++ I H ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKLH 59
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ EE LVLEY P G L +L + R ++ ALEYLH S II
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGII 115
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSA 223
+ DLKP N+LLD + L+DF +AK L E +T TF T Y+APE
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 224 NGDVYSFGIMLMETFTGKKP-----TDEIFN 249
D +S G++L E TGK P EI+
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 37/293 (12%)
Query: 48 NLIGKGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLI 101
+G+G FG V R G +VAVK N +S F E E+++++ H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 102 KVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
K C ++ L++EY+P GSL YL +++ + L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
S IH DL N+L++ + +SDF +AK+L +D + + I + APE R
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDE----------IFNGEMTLKHWVNDWLPISTLE 268
+ S+ DV+SFG+ L E FT P+ I G+M + +
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE--------- 237
Query: 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
L +E C V++L C P+ R + +++ + ++R
Sbjct: 238 ------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 78/300 (26%), Positives = 123/300 (41%), Gaps = 76/300 (25%)
Query: 49 LIGKGGFGSVYKARL-GDGMEVAVKVFN---LQCGRALKSFNVECE-MMKSIRHRNLIKV 103
+IG+G F +V A+ E A+K+ + L + +K +E E + + H +IK+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ +EE VLEY P+G L +Y+ Y S LD ++ ALEYLH S
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG------------ 209
IIH DLKP N+LLD +M ++DF AK+L + S + AT
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 210 -------YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262
Y++PE E + D+++ G ++ + TGK P F G N++L
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRG-------SNEYL 229
Query: 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN--AKEIVKKLLKI 320
F + P AK++++KLL +
Sbjct: 230 -----------------------------TFQKILKLEYSFPP-NFPPDAKDLIEKLLVL 259
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 75/267 (28%), Positives = 117/267 (43%), Gaps = 25/267 (9%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G VYKA G EVA+K L+ N E +MK +H N++ S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+EYM GSL + + ++ Q + +V LEYLH S +IH D+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL + L+DF A L +++S + T +MAPE + D++
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIW 200
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
S GIM +E G+ P L +P + + S E F+ K
Sbjct: 201 SLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP----PLKNPEKWSPEFKDFLNK--- 252
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVK 315
C V+ PE+R +A+E+++
Sbjct: 253 ----------CLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 79/264 (29%), Positives = 124/264 (46%), Gaps = 35/264 (13%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG V+ +VAVK L+ G + ++F E ++MK +RH L+++ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID----VASALEYLHFGYSAPII 164
EE +V EYM GSL +L S RL ++D +A + YL S I
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DL N+L+ +N+V ++DF +A+L+ +D+ + I + APE GR +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 225 GDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFV 283
DV+SFGI+L E T G+ P + N E LE V+
Sbjct: 185 SDVWSFGILLTEIVTYGRVPYPGMTNRE--------------VLEQVERGY------RMP 224
Query: 284 AKEQCVSFVFNLAMACAVESPEQR 307
C +++L + C + PE+R
Sbjct: 225 RPPNCPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 45/290 (15%)
Query: 50 IGKGGFGSVYKAR------LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V+ A D M VAVK A K F E E++ +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYS---------------SNCILDIFQRLNIMIDV 148
C + + +V EYM HG L K+L + + L + Q L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
AS + YL S +H DL N L+ N++ + DF +++ + D T I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTL 267
+M PE + + DV+SFG++L E FT GK+P W +S
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------------WFQLSNT 232
Query: 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
EV++ ++Q + C V+++ + C P+QR+N KEI K L
Sbjct: 233 EVIEC--ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 48 NLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVI 104
+LIG+G FG VYK L G VA+K +L+ ALKS E +++K+++H N++K I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFG 158
S + ++LEY +GSL + + + ++Q V L YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VLQGLAYLH-- 116
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+IH D+K +N+L + V L+DF +A L + T +MAPE
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--GTPYWMAPEVIEM 173
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G ++E TG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 9/205 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRA-LKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG V++ + VAVK L+ G K F E ++MK +RH LI++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
EE +V E M +GSL +YL L + Q +++ VAS + YL + IH D
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L NVL+ +N + ++DF +A+++ ED + I + APE R S DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGE 251
+SFGI+L E T G+ P + N E
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 78/273 (28%), Positives = 120/273 (43%), Gaps = 30/273 (10%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIKVISSC 107
L+GKG FG V+K L D VAVK + LK F E ++K H N++K+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+ + +V+E +P G +L L Q + +D A+ + YL S IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPEYGREGRVSANG 225
L N L+ +N V +SDF +++ ED + + I + APE GR S+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 226 DVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVA 284
DV+S+GI+L ETF+ G P + N + A ++
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQ--------------------AREQVEKGYRMSC 215
Query: 285 KEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
++C V+ + C PE R E+ K+L
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 50/294 (17%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V+ A D M VAVK A + F E E++ ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNC---ILD-----------IFQRLNIMIDVA 149
C+ +V EYM HG L ++L S IL + Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 150 SALEY---LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
S + Y LHF +H DL N L+ +V + DF +++ + D +T
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265
I +M PE + + D++SFG++L E FT GK+P W +S
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-----------------WYQLS 229
Query: 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
E ++ +E C V+ + C P+QR+ K+I +L
Sbjct: 230 NTEAIECITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-25
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 6/212 (2%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
E + IG G FG V+ + +VA+K + + + F E ++M + H L+
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ C+ LV E+M HG L YL + L + +DV + YL S+
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SS 119
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
+IH DL N L+ +N V +SDF + + ++ +DQ + T T + + +PE +
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
S+ DV+SFG+++ E F+ GK P + N E+
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-24
Identities = 75/272 (27%), Positives = 137/272 (50%), Gaps = 34/272 (12%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IG+G FG+V + G +VAVK N++C ++F E +M + H+NL++++ +
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 110 EEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+V+E M G+L +L + ++ + Q L +DVA +EYL S ++H DL
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
N+L+ ++ VA +SDF +A++ SM + + + APE + + S+ DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
S+G++L E F+ G+ P +M+LK EV + ++ E
Sbjct: 182 SYGVLLWEVFSYGRAPYP-----KMSLK------------EVKEC---VEKGYRMEPPEG 221
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
C + V+ L +C P++R + ++ +KL K
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 68/204 (33%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQ-CGRALKSFNV--ECEMMKSIRHRN 99
F +IGKG FG V + D ++ A+K N Q C NV E +++ + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
L+ + S +EE LV++ + G L +Y S Q + ++ ALEYLH
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLH--- 117
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
S IIH D+KP N+LLD+ H++DF+IA + + + T T T GYMAPE
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQ 174
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
S D +S G+ E GK+P
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 73/203 (35%), Positives = 105/203 (51%), Gaps = 18/203 (8%)
Query: 50 IGKGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
IGKG FG V LGD G +VAVK ++ ++F E +M +RH NL++++
Sbjct: 14 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 108 SNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
E+ +V EYM GSL YL S +L L +DV A+EYL + +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DL NVL+ ++ VA +SDF + K + S TQ + + APE RE + S
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 226 DVYSFGIMLMETFT-GKKPTDEI 247
DV+SFGI+L E ++ G+ P I
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRI 203
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-24
Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 49 LIGKGGFGSVYKA-RLGDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVI 104
+GKG +GSVYK RL D A+K +L + N E ++ S+ H N+I
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPNII--- 62
Query: 105 SSCSNEEF-----KALVLEYMPHGSLEKYLYSSNCILDIFQR---LNIMIDVASALEYLH 156
E F +V+EY P G L K + + I I + L+ LH
Sbjct: 63 --SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
I+H DLK +N+LL N + + D I+K+L ++M +TQ T YMAPE
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYMAPEVW 173
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
+ S D++S G +L E T P F
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP----FEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 5e-24
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAL-KSFNVECEMMKSIRHRNLIKVISSC 107
+G G G V K G +AVK L+ A+ K E +++ ++ +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
N ++ +EYM GSL+K L + I + V L YLH + IIH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSANGD 226
+KPSN+L++ L DF ++ LV + +TF T YMAPE + S D
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVN-----SLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 227 VYSFGIMLMETFTGKKP 243
++S G+ L+E TG+ P
Sbjct: 182 IWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 8e-24
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 6/203 (2%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ + ++VA+K+ + + F E ++M + H NL+++ C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ +V EYM +G L YL L L++ DV A+EYL S IH DL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+ ++ V +SDF +A+ ++ +DQ + T + + PE R S+ DV+S
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 230 FGIMLMETFT-GKKPTDEIFNGE 251
FG+++ E F+ GK P + N E
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 76/278 (27%), Positives = 122/278 (43%), Gaps = 35/278 (12%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
IG G VY A L + +VA+K +L +C ++ E + M H N++K +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 108 SNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ LV+ Y+ GSL K Y LD ++ +V LEYLH S I
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSI-AKLLVGEDQSMTQTQTFA-TIGYMAPEYGREGR-V 221
H D+K N+LL ++ ++DF + A L G D++ +TF T +MAPE +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGE---MTLKHWVNDWLPISTLEV-VDANLLSQ 277
D++SFGI +E TG P + + +TL++ +LE D S+
Sbjct: 185 DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN------DPPSLETGADYKKYSK 238
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
++ C + P +R A+E++K
Sbjct: 239 SFRKMISL-------------CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-23
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 43 EFSENNLIGKGGFGSVYKAR---LGDG--MEVAVKVFNLQCGR-ALKSFNVECEMMKSIR 96
E + ++G G FG+VYK G+ + VA+KV + A K E +M S+
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H ++++++ C + + L+ + MP G L Y+ + + LN + +A + YL
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL +++ I +MA E
Sbjct: 127 ---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEI 247
+ DV+S+G+ + E T G KP + I
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-23
Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 26/272 (9%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKVISSC 107
IG+G FG V+ RL D VAVK LK+ F E ++K H N++++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+ ++ +V+E + G +L + L + + + ++ + A+ +EYL S IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ + V +SDF +++ + T + + APE GR S+ DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKE 286
+SFGI+L E F+ G P + N + T E + ++ + E
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQ--------------TREAI------EQGVRLPCPE 219
Query: 287 QCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
C V+ L C P QR + + ++L
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 8e-23
Identities = 70/206 (33%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 48 NLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGR--ALKSFNVECEMMKSIRHRNLIKVI 104
N IG G FG VY A L G +AVK +Q +K E ++++ ++H NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD--IFQRLNIMIDVASALEYLHFGYSAP 162
+ E + +EY G+LE+ L ILD + + + + L YLH S
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SHG 119
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFA-TIGYMAPEYGREGR 220
I+H D+KP+N+ LD N V L DF A L +M + Q+ A T YMAPE G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 221 VSANG---DVYSFGIMLMETFTGKKP 243
+G D++S G +++E TGK+P
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 8e-23
Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 109 NEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
EE +V EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 72 -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-23
Identities = 77/305 (25%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARL-GDGME-----VAVKVFNLQCGRALKS-FNVE 88
E+ + F E +G+G FG VYK L G VA+K ++ F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 89 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN--------------- 133
E+M ++H N++ ++ C+ E+ ++ EY+ HG L ++L ++
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 134 CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193
LD L+I I +A+ +EYL S +H DL N L+ + + +SDF +++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
D Q+++ + +M PE G+ + D++SFG++L E F+ G +P + G
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP----YYG-- 229
Query: 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKE 312
S EV++ + + E C + V+ L + C E P +R K+
Sbjct: 230 -----------FSNQEVIE---MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKD 275
Query: 313 IVKKL 317
I +L
Sbjct: 276 IHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-22
Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR------ALKSFNVECEMMKSIRHRNLIK 102
IG+G +G VYKAR G VA+K ++ + A++ E ++++ +RH N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 103 ----VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
V S + +V EYM H L L S Q M + L+YLH
Sbjct: 63 LKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH-- 117
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE---- 214
S I+H D+K SN+L++++ V L+DF +A+ S T T+ Y PE
Sbjct: 118 -SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLG 175
Query: 215 ---YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
YG E V D++S G +L E F GK IF G
Sbjct: 176 ATRYGPE--V----DMWSVGCILAELFLGKP----IFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-22
Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKS 94
E+ + + + + +G G +G VY+ + VAVK + ++ F E +MK
Sbjct: 2 EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 58
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALE 153
I+H NL++++ C+ E ++ E+M +G+L YL N ++ L + ++SA+E
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL IH DL N L+ +N + ++DF +++L+ G+ + F I + AP
Sbjct: 119 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAP 174
Query: 214 EYGREGRVSANGDVYSFGIMLMETFT 239
E + S DV++FG++L E T
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 79/290 (27%), Positives = 120/290 (41%), Gaps = 56/290 (19%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
+ F +G+G +GSVYKA G VA+KV + L+ E ++K +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYI 60
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN----------IMIDVAS 150
+K S +V+EY GS + DI + N I+
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLK 110
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG- 209
LEYLH S IH D+K N+LL++ A L+DF ++ L +M + T IG
Sbjct: 111 GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTV--IGT 162
Query: 210 --YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEI--FNGEMTLKHWVNDWLPIS 265
+MAPE +E + D++S GI +E GK P +I + + P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-----PPP 217
Query: 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
TL D S E FV K C V+ PE+R +A ++++
Sbjct: 218 TLS--DPEKWSPEFNDFVKK-------------CLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-22
Identities = 76/283 (26%), Positives = 124/283 (43%), Gaps = 42/283 (14%)
Query: 50 IGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V+ A D + VAVK A K F+ E E++ +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASA 151
C + +V EYM HG L K+L + L Q L+I +A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ YL S +H DL N L+ +N++ + DF +++ + D T I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270
PE + + DV+S G++L E FT GK+P W +S EV+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------------WYQLSNNEVI 232
Query: 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
+ ++Q + C V++L + C P R+N KEI
Sbjct: 233 EC--ITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-22
Identities = 74/290 (25%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 49 LIGKGGFGSVYKARL----GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIK 102
++G+G FGSV + +L G ++VAVK L ++ F E MK H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 103 VISSC----SNEEFKA--LVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASA 151
+I C S ++ ++L +M HG L +L S L + L M+D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+EYL + IH DL N +L ++M ++DF ++K + D + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270
A E + ++ DV++FG+ + E T G+ P + N E+ D+L
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY------DYL-------R 229
Query: 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
N L Q E C+ +++L +C P+ R ++ + L I
Sbjct: 230 HGNRLKQ-------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-21
Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 50 IGKGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKV 103
+G+G FG V G G VAVK +CG+ S + E ++K++ H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 104 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
CS + K L++EY+P GSL YL L++ Q L + + YLH S
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREGR 220
IH DL NVLLD++ + + DF +AK + G + + + + + A E +E +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 221 VSANGDVYSFGIMLMETFT 239
S DV+SFG+ L E T
Sbjct: 187 FSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 29/278 (10%)
Query: 46 ENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEM----MKSIRHRNL 100
E N+I +G G+ YK + + +GM+ VK + N M ++H N+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVK--------EINDVNSIPSSEIADMGKLQHPNI 745
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+K+I C +E+ L+ EY+ +L + L + L +R I I +A AL +LH S
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCS 801
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
++ +L P +++D HL S+ LL T T+ F + Y+APE
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKD 854
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV-VDANLLSQED 279
++ D+Y FG++L+E TGK P D F ++ W L++ +D ++
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
++ + + V V NLA+ C P R A +++K L
Sbjct: 915 VN---QNEIVE-VMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 67/200 (33%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 49 LIGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK- 102
+GKG FGSV R L D G VAVK L+ F E E++KS++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 103 --VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
V S + LV+EY+P+GSL YL LD + L + +EYL S
Sbjct: 71 KGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---S 126
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+H DL N+L++ + DF + K+L ++ + + I + APE E
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 220 RVSANGDVYSFGIMLMETFT 239
+ S DV+SFG++L E FT
Sbjct: 187 KFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 18/216 (8%)
Query: 43 EFSENN---LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHR 98
E+ EN ++GKG +G VY AR L + +A+K + R ++ + E + ++HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI----DVASALEY 154
N+++ + S S F + +E +P GSL L S L + +I + L+Y
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKY 123
Query: 155 LHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
LH I+H D+K NVL++ + V +SDF +K L G + T+T T T+ YMAP
Sbjct: 124 LH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMAP 178
Query: 214 EYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEI 247
E +G A D++S G ++E TGK P E+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNL-QCGRALKSFNV-ECEMMKSIRHRN 99
++ IGKG FG+V K R DG + K + K V E +++ ++H N
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 100 LIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRL------NIMIDVASA 151
+++ + + L V+EY G L + + C + + + I+ + A
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKE-RKYIEEEFIWRILTQLLLA 117
Query: 152 LEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TI 208
L H ++H DLKP+N+ LD N L DF +AK+L G D S +T+ T
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSF--AKTYVGTP 174
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
YM+PE D++S G ++ E P
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-21
Identities = 82/304 (26%), Positives = 130/304 (42%), Gaps = 49/304 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD------GMEVAVKVFNLQCG-RALKSFNVECEMMKS 94
D + +G+G FG V KA VAVK+ + L E EMMK
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 95 I-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRL-- 142
I +H+N+I ++ C+ E +V+EY HG+L +L S + + L
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 143 ----NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
+ VA +E+L S IH DL NVL+ ++ V ++DF +A+ + D
Sbjct: 132 KDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHW 257
T + +MAPE + + DV+SFG++L E FT G P
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP-------------- 234
Query: 258 VNDWLPISTLEVVDANLLSQEDIHFVAKEQ-CVSFVFNLAMACAVESPEQRINAKEIVKK 316
+ I E+ LL + + + K Q C +++L C E P QR K++V+
Sbjct: 235 ---YPGIPVEELFK--LLKEG--YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287
Query: 317 LLKI 320
L ++
Sbjct: 288 LDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-21
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 6/207 (2%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VA+K+ + + F E ++M + H L+++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ +V EYM +G L YL Q L + DV + YL S IH DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+DD +SDF +++ ++ +D+ + + + + PE + S+ DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLK 255
FG+++ E ++ GK P + N E K
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-21
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG V+ +VAVK L+ G + +SF E ++MK +RH L+++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L L + +++ VA+ + Y+ IH D
Sbjct: 72 EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ D +V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNREV 212
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-21
Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRAL-KSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ +VA+K L+ G + ++F E ++MK +RH L+ + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
EE +V E+M GSL +L + L + Q +++ +A + Y+ IH D
Sbjct: 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ DN+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-21
Identities = 73/284 (25%), Positives = 134/284 (47%), Gaps = 32/284 (11%)
Query: 45 SENNLIGKGGFGSVYKA--RLGDGMEVAVKVFNLQCGRALKS---FNVECEMMKSIRHRN 99
++ +IG G FG V++ ++ EVAV + L+ G K F E +M H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I++ + + ++ EYM +G+L+KYL + +Q + ++ +A+ ++YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG--YMAPEYGR 217
+H DL N+L++ N+ +SDF ++++L +D T T + I + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 218 EGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
+ ++ DV+SFGI++ E + G++P +W +S EV+ A
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERP------------YW-----DMSNHEVMKA---I 223
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ A C S V+ L + C + +R +IV L K+
Sbjct: 224 NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-21
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 49 LIGKGGFGSVYKARLG----DGMEVAVKVFNLQCGRA---------LKSFNVECEMMKSI 95
LIG G FGSVY LG G +AVK L A L + E ++K +
Sbjct: 7 LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+H N+++ + S + + + LEY+P GS+ L + + R N + + L YL
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYL 122
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT---QTQTF-ATIGYM 211
H + IIH D+K +N+L+D+ +SDF I+K L S + ++ +M
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
APE ++ + D++S G +++E TGK P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 9e-21
Identities = 76/278 (27%), Positives = 129/278 (46%), Gaps = 42/278 (15%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSIRH---RN 99
LIG+G +G+VY+ + + G VA+K+ NL +V E ++ +R N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+ K S +++EY GS+ + L + I + + + I+ +V AL+Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY-MAPEYGRE 218
+IH D+K +N+L+ + L DF +A LL Q+ ++ TF Y MAPE E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITE 175
Query: 219 GRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
G+ D++S GI + E TG P ++ +P S ++ N S+
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDV------DAFRAMMLIPKSKPPRLEDNGYSK 229
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
FVA AC E P++R++A+E++K
Sbjct: 230 LLREFVA-------------ACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
+++ IG G +G VYKAR + G VA+KV L+ G + E M+K RH N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN----------IMIDVAS 150
+ S + +V+EY GSL+ DI+Q + +
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLK 112
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG- 209
L YLH IH D+K +N+LL ++ L+DF ++ L ++ + ++F IG
Sbjct: 113 GLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSF--IGT 164
Query: 210 --YMAPEYG---REGRVSANGDVYSFGIMLMETFTGKKP 243
+MAPE R+G D+++ GI +E + P
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 49 LIGKGGFGSVYKA-RLGDGMEVAVKVFNL----QCGR-ALKSFNVECEMMKSIRHRNLIK 102
L+G G FGSVY+ L DG AVK +L Q G+ A+K E ++ ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ + E+ + LE +P GSL K L + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAPEY-GRE 218
+H D+K +N+L+D N V L+DF +AK Q + + + G +MAPE ++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
G D++S G ++E TGK P
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 49 LIGKGGFGSVYKARLGD-GMEVAVKVFNL-----QCGRALKSFNVECEMMKSIRHRNLIK 102
L+G+G FG VY D G E+AVK + + + + E +++K+++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
++E ++ +EYMP GS++ L + + + R + +EYLH S
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-----ATIGYMAPE--- 214
I+H D+K +N+L D L DF +K L Q++ + T T +M+PE
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 215 ---YGREGRVSANGDVYSFGIMLMETFTGKKP 243
YGR+ DV+S G ++E T K P
Sbjct: 181 GEGYGRK------ADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 50 IGKGGFGSVYKAR---LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKV 103
I KG +G V+ A+ GD A+KV + + E +++ + ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
S ++ LV+EY+P G L L + LD + ++ ALEYLH S I
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGI 114
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKL-LVGEDQSMTQT-----QTFATIGYMAPEYGR 217
IH DLKP N+L+D N L+DF ++K+ LV ++ + T Y+APE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
S D +S G +L E G P F+GE
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPP----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-20
Identities = 70/216 (32%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKVI 104
+G G FGSV Y + G +EVAVK + A K F E +M + H ++++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYL---HFGY 159
C E LV+E P G L KYL + D+ + VA + YL HF
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF-- 116
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
+H DL NVLL + A +SDF +++ L G D T + + APE
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 219 GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
G+ S+ DV+S+G+ L E F+ G KP E+ E+
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-20
Identities = 67/261 (25%), Positives = 122/261 (46%), Gaps = 30/261 (11%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG V+ +VA+K +L+ G + ++F E +MK ++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ EYM +GSL +L + I L I + +++ +A + ++ IH D
Sbjct: 72 QEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ + + ++DF +A+L+ + + + F I + APE G + DV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDV 186
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKE 286
+SFGI+L E T G+ P + N E+ I LE +
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEV-----------IQNLE---------RGYRMPRPD 226
Query: 287 QCVSFVFNLAMACAVESPEQR 307
C ++ L C E PE+R
Sbjct: 227 NCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 33/221 (14%)
Query: 48 NLIGKGGFGSVYKAR----LGDGME---VAVKVFNLQCGRAL---KSFNVECEMMKSIRH 97
N +G G FG VY+ LG G VAVK L+ G K F E +M + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNH 58
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASA 151
N++K++ C E + +++E M G L YL + +L + + L+I +DVA
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 152 LEYL---HFGYSAPIIHCDLKPSNVLL-----DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
YL HF IH DL N L+ D + V + DF +A+ + D + +
Sbjct: 119 CVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE +G+ + DV+SFG+++ E T G++P
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-19
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 41/296 (13%)
Query: 44 FSENNLIGKGGFGSVYKARL----GDGMEVAVKVF--NLQCGRALKSFNVECEMMKSIRH 97
F+ ++GKG FGSV +A+L G +VAVK+ ++ ++ F E MK H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 98 RNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMI 146
N+IK+I K ++L +M HG L +L S L + + MI
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
D+AS +EYL S IH DL N +L++NM ++DF ++K + D +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265
+ ++A E + + + DV++FG+ + E T G+ P + N E + ++L
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNYL--- 228
Query: 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
+ N L Q C+ V+ L C P+ R + + + +L I
Sbjct: 229 ----IKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-19
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 21/223 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ-CGRALKSFNV-ECEMMKSIRHRN 99
+F N IGKG FG V+K R D A+K +L R + + E ++ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASAL 152
+I+ S ++ +V+EY +G L K L + + F I + L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGL 114
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+LH S I+H D+K N+ LD + D +AKLL D + T Y++
Sbjct: 115 AHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLS 169
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
PE + + DV++ G++L E TGK P D G + LK
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 68/269 (25%), Positives = 124/269 (46%), Gaps = 26/269 (9%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ + ++VA+K N + + + F E ++M + H L+++ C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
++ +V E+M +G L YL L L++ DV +EYL IH DL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+ V +SDF + + ++ +D+ + + + + PE + S+ DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
FG+++ E FT GK P F + S EVV+ +S+ + K
Sbjct: 187 FGVLMWEVFTEGKMP----FEKK-------------SNYEVVEM--ISRGFRLYRPKLAS 227
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKL 317
++ V+ + +C E PE R E+++ +
Sbjct: 228 MT-VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 51/270 (18%)
Query: 48 NLIGKGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRALKSFNVECEMMKSIRHRNL 100
IG G +G V A G +VA+K + + R L+ E ++++ +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 101 IK---VISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
I ++ S E+F + V E M L K + S + D + + + L+YL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF--ATIGYMAP 213
H SA +IH DLKPSN+L++ N + DF +A+ V D+ T T Y AP
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLAR-GVDPDEDEKGFLTEYVVTRWYRAP 175
Query: 214 E-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW-LPIS 265
E Y + D++S G + E T KP +F G + +++ L +
Sbjct: 176 ELLLSSSRY------TKAIDIWSVGCIFAELLTR-KP---LFPG----RDYIDQLNLIVE 221
Query: 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNL 295
L S+ED+ F+ E+ +++ +L
Sbjct: 222 VLGTP-----SEEDLKFITSEKARNYLKSL 246
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 63/308 (20%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR-LG-----DGMEVAVKVFNLQCGRALKS-FNVECE 90
E+ NN+ IG+G FG V++AR G VAVK+ + +++ F E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------------- 133
+M H N++K++ C+ + L+ EYM +G L ++L +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 134 ----CILDIFQRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186
L ++L I VA+ + YL F +H DL N L+ +NMV ++DF
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADF 174
Query: 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTD 245
+++ + D I +M PE R + DV+++G++L E F+ G +P
Sbjct: 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234
Query: 246 EIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPE 305
+ + E + + V D N+LS + C ++NL C + P
Sbjct: 235 GMAH-EEVIYY------------VRDGNVLS-------CPDNCPLELYNLMRLCWSKLPS 274
Query: 306 QRINAKEI 313
R + I
Sbjct: 275 DRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 72/293 (24%), Positives = 129/293 (44%), Gaps = 50/293 (17%)
Query: 50 IGKGGFGSVYKARLG-DGME----VAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+ FG +YK L GM+ VA+K ++ + F E +M + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLY----------------SSNCILDIFQRLNIMID 147
+ + E+ ++ EY+ G L ++L + LD L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 148 VASALEYL--HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+A+ +EYL HF +H DL N+L+ + + +SD +++ + D Q ++
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 264
I +M PE G+ S++ D++SFG++L E F+ G +P N E+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV------------ 235
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+E+V L E C +++L C E P +R K+I +L
Sbjct: 236 --IEMVRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 33/283 (11%)
Query: 47 NNLIGKGGFGSVYKA----RLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLI 101
IG+G FG VY+ + + VAVK +++ F E +M+ H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
K+I + E +V+E P G L YL + LD+ + +++AL YL S
Sbjct: 71 KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIGYMAPEYGREGR 220
+H D+ NVL+ L DF +++ L ED+S ++ I +MAPE R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRR 184
Query: 221 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
++ DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP-------------- 230
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
C +++L C P +R E+ +L I
Sbjct: 231 ------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-19
Identities = 59/206 (28%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG V+ + +VAVK L+ G ++++F E +MK+++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL-NIMIDVASALEYLHFGYSAPIIHCD 167
EE ++ EYM GSL +L S + +L + +A + Y+ IH D
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +NVL+ ++++ ++DF +A+++ + + + F I + APE G + DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDV 187
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEM 252
+SFGI+L E T GK P + N ++
Sbjct: 188 WSFGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-19
Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 37/284 (13%)
Query: 49 LIGKGGFGSVYKARL------GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
+G+G FG V+ A+ G V VK + F E +M + + H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--------LDIFQRLNIMIDVASALE 153
+++ C E ++LEY G L+++L ++ L Q++ + +A ++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
+L +A +H DL N L+ +S S++K V + + ++AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLRWLAP 187
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273
E +E S DV+SFG+++ E FT GE+ ++ EV+ N
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT---------QGELPFYGLSDE-------EVL--N 229
Query: 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L + E C S ++ L C +P+ R + E+V L
Sbjct: 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 7e-19
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQ------CGRALKSFNVECEMMKSIRHRNLIK 102
IG+G +G VYKAR G VA+K L+ AL+ E +++K + H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
++ ++ LV E+M L K + L + + + L + H S
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--YGREGR 220
I+H DLKP N+L++ V L+DF +A+ T T Y APE G +G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLGDKG- 175
Query: 221 VSANGDVYSFGIMLMET------FTGKKPTDEIF 248
S D++S G + E F GK D++F
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 69/282 (24%), Positives = 109/282 (38%), Gaps = 37/282 (13%)
Query: 49 LIGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G G FG V + G + VAVK + + + F E +M S+ H NLI++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAP 162
+V E P GSL L I + + +A+ + YL S
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAK-LLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH DL N+LL + + DF + + L ED + + + APE R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS---TLEVVDANLLSQ 277
S DV+ FG+ L E FT G++P W +S L+ +D
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEP-----------------WAGLSGSQILKKIDKEG--- 217
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
E + E C ++N+ + C +P R + + L +
Sbjct: 218 ERLE--RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 68/224 (30%), Positives = 109/224 (48%), Gaps = 37/224 (16%)
Query: 49 LIGKGGFGSVY---KARLGDGMEVA-VKVFNLQCGR-------ALKSFNVECEMMKSIRH 97
LIGKG +G VY G+ M V V++ GR +K+ E E +K + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDIFQRLNIMIDVASALE 153
N+++ + + EE+ ++ LEY+P GS L Y ++ F V L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLA 122
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL---LVGEDQSMTQTQTFATIGY 210
YLH S I+H DLK N+L+D + + +SDF I+K + DQ+M+ ++ +
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFW 176
Query: 211 MAPE----YGREGRVSANGDVYSFGIMLMETFTGKKP--TDEIF 248
MAPE Y + SA D++S G +++E F G++P +E
Sbjct: 177 MAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 48 NLIGKGGFGSVYKARL---GDGMEVAVKVFN-LQCGRALKSFNVECEMM-KSIRHRNLIK 102
++IG+G FG V +A + G M A+K+ + F E E++ K H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 147
++ +C N + + +EY P+G+L +L S + L Q L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA+ ++YL IH DL NVL+ +N+ + ++DF +++ GE+ + +T
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLME 236
+ +MA E + DV+SFG++L E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG------RALKSFNVECEMMKSIR 96
E+++ ++GKG +G+VY G +AVK L + + E +++KS++
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI-FQRLNIMIDVASALEYL 155
H N+++ + +C ++ ++ +E++P GS+ L + + F + I + YL
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYL 118
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG----YM 211
H + ++H D+K +NV+L N + L DF A+ L T + ++ +M
Sbjct: 119 H---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
APE E D++S G + E TGK P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 37/276 (13%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG VYKA+ + G+ A K+ ++ L+ F VE +++ +H N++ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E +++E+ G+L+ + L Q + + AL +LH S +IH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAPEY-----GREGR 220
K N+LL + L+DF ++ Q + TF IG +MAPE ++
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQ---KRDTF--IGTPYWMAPEVVACETFKDNP 184
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA-NLLSQED 279
D++S GI L+E + P E+ + LK + S +D + S
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK------ILKSEPPTLDQPSKWSSSF 238
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ C V+ P+ R A E++K
Sbjct: 239 NDFLKS-------------CLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 66/209 (31%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRAL-KSFNVECEMMKSIRHRN 99
++ E + +G+G GSV K RL GM A+K L K E E+ KS +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 100 LIKVISSCSNEEFK--ALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEY 154
++K + +E + +EY GSL+ K + + I V L Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
LH S IIH D+KPSN+LL L DF ++ LV S+ T T T YMAPE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFT-GTSFYMAPE 173
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ S DV+S G+ L+E + P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-18
Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 12/209 (5%)
Query: 49 LIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKV 103
+IG G FG V RL E+ V + L+ G + + F E +M H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGYSAP 162
+ + +V EYM +GSL+ +L + + Q + ++ +AS ++YL GY
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE-DQSMTQTQTFATIGYMAPEYGREGRV 221
+H DL N+L++ N+V +SDF ++++L + + + T I + APE +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFN 249
++ DV+S+GI++ E + G++P E+ N
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-18
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 11/217 (5%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RALKSFNVECEMMKSIR 96
E ++G G FG+VYK + +G + VA+K+ N G +A F E +M S+
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H +L++++ C + + LV + MPHG L Y++ + LN + +A + YL
Sbjct: 68 HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +A+LL G+++ I +MA E
Sbjct: 127 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
+ + DV+S+G+ + E T G KP D I E+
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVA---VKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS 105
IGKG F VYKA L DG VA V++F + +A + E +++K + H N+IK ++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 106 SCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
S +VLE G L K+ ++ + + SALE++H S
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKR 126
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAPEYGREG 219
I+H D+KP+NV + V L D + + S T + +G YM+PE E
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 220 RVSANGDVYSFGIMLME 236
+ D++S G +L E
Sbjct: 182 GYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 7e-18
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 48 NLIGKGGFGSVYKAR-LGDGMEVAVK------VFNLQCG---RALKSFNVECEMMKSIRH 97
+G+G + VYKAR G VA+K + G AL+ E ++++ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLLQELKH 61
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N+I ++ ++ LV E+M LEK + + +L + M+ LEYLH
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--Y 215
+ I+H DLKP+N+L+ + V L+DF +A+ ++ MT Q T Y APE +
Sbjct: 121 NW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQVV-TRWYRAPELLF 175
Query: 216 G-REGRVSANGDVYSFGIMLME 236
G R V D++S G + E
Sbjct: 176 GARHYGVGV--DMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-18
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 48 NLIGKGGFGSVYKARL-GDG--MEVAVKVFNLQCGRA-LKSFNVECEMMKSI-RHRNLIK 102
++IG+G FG V KAR+ DG M+ A+K + + F E E++ + H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 147
++ +C + + L +EY PHG+L +L S + L Q L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA ++YL IH DL N+L+ +N VA ++DF +++ G++ + +T
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLME 236
+ +MA E + N DV+S+G++L E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-18
Identities = 75/288 (26%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 50 IGKGGFGSVYKARLGDG---MEVAVKVFNLQ-CGRA-LKSFNVECEMMKSIRHRNLIKVI 104
+G+G FGSV + +L ++VAVK + C R+ ++ F E MK H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 105 SSC----SNEEFKA--LVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALE 153
C +E + + ++L +M HG L +L S L + M D+AS +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL S IH DL N +L++NM ++DF ++K + D + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 214 EYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E + + DV+SFG+ + E T G+ P + N E + D+L
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYDYLR-------QG 230
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
N L Q C+ +++L +C + +P+ R + + + +L K
Sbjct: 231 NRLKQ-------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-18
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 11/210 (5%)
Query: 41 TDEFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQCGRALKSFNVECEMM---KS 94
E + L+G G FG+V+K GD +++ V + +Q ++F + M S
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ H +++++ C + LV + P GSL ++ LD + LN + +A + Y
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
L ++H +L N+LL + + ++DF +A LL +D+ ++ I +MA E
Sbjct: 125 LE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 215 YGREGRVSANGDVYSFGIMLMETFT-GKKP 243
GR + DV+S+G+ + E + G +P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 9e-18
Identities = 81/301 (26%), Positives = 123/301 (40%), Gaps = 64/301 (21%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVEC--EM--MKSIRHRNLIKVI 104
+G+G +G VYKAR G VA+K L + E+ +K ++H N++K++
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
E LV EY L+KYL L +IM + L Y H S I+
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRIL 120
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-------YGR 217
H DLKP N+L++ + V L+DF +A+ ++ T T+ Y APE Y
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHYST 178
Query: 218 EGRVSANGDVYSFGIMLMETFTGK--------------------KPTDEIFNGEMTLKHW 257
V D++S G + E TGK PT+E + G L +
Sbjct: 179 A--V----DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 258 VND---WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
+ P +V+ L E I ++K +N P +RI+AKE +
Sbjct: 233 KPTFPKFPPKDLEKVL--PRLDPEGIDLLSK----MLQYN---------PAKRISAKEAL 277
Query: 315 K 315
K
Sbjct: 278 K 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 47 NNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLI 101
+IG G FG V + RL ++VA+K + F E +M H N+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYS 160
++ + ++ EYM +GSL+K+L ++ + Q + ++ +AS ++YL Y
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
+H DL N+L++ N+V +SDF +++ L + + T I + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 221 VSANGDVYSFGIMLMETFT-GKKP 243
++ DV+SFGI++ E + G++P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 69/298 (23%), Positives = 118/298 (39%), Gaps = 45/298 (15%)
Query: 43 EFSENNL-----IGKGGFGSVYK---ARLGDG---MEVAVK-VFNLQCGRALKSFNVECE 90
E + +G+G FG VY+ + G VA+K V R F E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCILDIFQRLNI 144
+MK ++++++ S + +V+E M G L+ YL S +N L
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 145 M---IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201
+ ++A + YL + +H DL N ++ +++ + DF + + + D
Sbjct: 122 IQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 260
+ + +MAPE ++G + DV+SFG++L E T ++P + N E LK
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKF---- 233
Query: 261 WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
V+D L E C + L C +P+ R EIV L
Sbjct: 234 --------VIDGGHLDL-------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVK------VFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+G GGFG V ++ A+K + + S E E+++ H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ + ++++ +++EY G L L + D + + V A EYLH +
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRG 113
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE------Y 215
II+ DLKP N+LLD N L DF AK L +S +T TF T Y+APE Y
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPEIILNKGY 169
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
S D +S GI+L E TG+ P
Sbjct: 170 DF----SV--DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRN 99
+ F+ IGKG FG VYKA VA+KV +L+ ++ E + + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+ K S +++EY GS L LD I+ +V LEYLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLH--- 115
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGRE 218
IH D+K +N+LL + L+DF ++ L +M++ TF T +MAPE ++
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
D++S GI +E G+ P
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G+VY A + G EVA+K NLQ + E +M+ +H N++ + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+EY+ GSL + + +D Q + + ALE+LH S +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL + L+DF + E QS T T +MAPE D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 229 SFGIMLMETFTGKKP 243
S GIM +E G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 67/283 (23%), Positives = 130/283 (45%), Gaps = 36/283 (12%)
Query: 49 LIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKV 103
+IG G FG V + RL E+ V + L+ G + + F E +M H N+I +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
+ ++ E+M +G+L+ +L ++ + Q + ++ +A+ ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-----TIGYMAPEYGRE 218
+H DL N+L++ N+V +SDF +++ L ED + T T + I + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 219 GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
+ ++ DV+S+GI++ E + G++P +W +S +V++A +
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP------------YW-----DMSNQDVINA---IE 225
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+D C + + L + C + R +IV L K+
Sbjct: 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-17
Identities = 54/193 (27%), Positives = 99/193 (51%), Gaps = 11/193 (5%)
Query: 49 LIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVIS 105
++G+G FG V+ R D V +K ++ + EC+++K + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ ++ +V+EY P G+L +Y+ N +LD L+ + + AL ++H + I+
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123
Query: 165 HCDLKPSNVLLDDN-MVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA 223
H DLK N+LLD + MV + DF I+K+L + ++ T T Y++PE +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYNQ 180
Query: 224 NGDVYSFGIMLME 236
D+++ G +L E
Sbjct: 181 KSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 76/235 (32%), Positives = 110/235 (46%), Gaps = 39/235 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV----ECEMMKSIR 96
D+F IG+G +G VYKAR D G VA+K L + + F + E ++++ +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 97 HRNLIK----VISSCSNEEFKA------LVLEYMPH---GSLEKYL--YSSNCILDIFQR 141
HRN++ V +FK LV EYM H G LE L +S + I ++
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 142 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201
L LE L++ + +H D+K SN+LL++ L+DF +A+L E+
Sbjct: 125 L---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-Y 174
Query: 202 TQTFATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254
T T+ Y PE G E R DV+S G +L E FT KKP IF L
Sbjct: 175 TNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFT-KKP---IFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 34/232 (14%)
Query: 43 EFSENNL-----IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVE 88
EFS + L +G+G FG V K + + + VAVK+ + L E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 89 CEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCIL 136
EMMK I +H+N+I ++ +C+ + +++EY G+L +YL Y +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 137 D---IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
D F+ L + VA +EYL S IH DL NVL+ +N V ++DF +A+ +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
D T + +MAPE + + DV+SFG+++ E FT G P
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 49 LIGKGGFGSVYKARLGD-GMEVAVKVF-NLQCGRALKSFNV-ECEMMKSIRHRNLIKVIS 105
L+G+G +G V K + + G VA+K F + + +K + E M+K +RH NL+ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 106 SCSNEEFKALVLEYMPH---GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
++ LV E++ H LEKY LD + + + +E+ H S
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCH---SHN 120
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-------Y 215
IIH D+KP N+L+ + V L DF A+ L + T AT Y APE Y
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKY 178
Query: 216 GREGRVSANGDVYSFGIMLMETFTG 240
GR D+++ G ++ E TG
Sbjct: 179 GRA------VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 42/225 (18%)
Query: 40 ATDEFSE---NNLIGKGGFGSVYKAR-LGDGMEVAVKV-FNLQCGRALKSFNVECEMMKS 94
A SE N IG G G+VYK G A+KV + + E E+++
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128
Query: 95 IRHRNLIKVISSC-----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
+ H N++K C N E + L LE+M GSLE I D ++ +
Sbjct: 129 VNHPNVVK----CHDMFDHNGEIQVL-LEFMDGGSLE-----GTHIADEQFLADVARQIL 178
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATI 208
S + YLH I+H D+KPSN+L++ ++DF ++++L Q+M + TI
Sbjct: 179 SGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL---AQTMDPCNSSVGTI 232
Query: 209 GYMAPEYGREGRVSAN----------GDVYSFGIMLMETFTGKKP 243
YM+PE R++ + GD++S G+ ++E + G+ P
Sbjct: 233 AYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCGR----ALKSFNV 87
EF NNL +G G FG V +A + M+VAVK+ AL S
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS--- 87
Query: 88 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIM 145
E ++M + H N++ ++ +C+ ++ EY +G L +L L + L+
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
VA + +L S IH DL NVLL + + DF +A+ ++ + + +
Sbjct: 148 YQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204
Query: 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+ +MAPE + DV+S+GI+L E F+
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 50 IGKGGFGSVYKARLGDGME-VAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVIS 105
+G+GG+G V+ A+ D E VA+K L ++ E +++ + + L+K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGYSAPII 164
+ ++E+ L +EY+P G L + + + R M ++ A++ LH GY I
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGY----I 123
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DLKP N L+D + L+DF ++K +V S+ + YMAPE R
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPD-----YMAPEVLRGKGYDFT 178
Query: 225 GDVYSFGIMLMETFTGKKP-----TDEIFNGEMTLKHW 257
D +S G ML E G P +E + LK+W
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 72/203 (35%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 49 LIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALK---SFNVECE---MMKSIRHRNLI 101
+IGKG FG V A R DG AVKV LQ LK ++ E ++K+++H L+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ S E VL+Y+ G L +L C L+ R +VASA+ YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGR 220
II+ DLKP N+LLD L+DF + K V +++ T TF T Y+APE R+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPEYLAPEVLRKEP 172
Query: 221 VSANGDVYSFGIMLMETFTGKKP 243
D + G +L E G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 48 NLIGKGGFGSVYKA----RLGDG--MEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
+G G FG VY+ R GD ++VAVK C +S F +E +M H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCILDIFQRLNIMIDVASA 151
+++I + ++LE M G L+ +L SS + D+ L DVA
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LFCARDVAKG 128
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
+YL IH D+ N LL VA ++DF +A+ + + I
Sbjct: 129 CKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+M PE +G ++ DV+SFG++L E F+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKARLGDGMEVA----VKVFNLQCGRALKSFNVECEMMK 93
C++ EF + N IG+G +G VY+AR E+ V++ N + G + S E ++
Sbjct: 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61
Query: 94 SIRHRNLIK----VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
++RH N+++ V+ + F LV+EY L L + Q +M+ +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
L+YLH + IIH DLK SN+LL D ++DF +A+ + M T T+
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLW 173
Query: 210 YMAPE--YGREGRVSANGDVYSFGIMLMETFTGK 241
Y APE G +A D+++ G +L E K
Sbjct: 174 YRAPELLLGCTTYTTAI-DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 39/211 (18%)
Query: 50 IGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKS---FNVECEMMKSIRHRNLIKVIS 105
+G G FG V R + A+K+ + LK E +++SIRH L+ +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGY 159
S ++ LV+EY+P G L +L S R + V ALEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEYLH--- 118
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE---- 214
S I++ DLKP N+LLD + ++DF AK + G +T T T Y+APE
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLAPEIILS 172
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKP 243
YG+ + D ++ GI++ E G P
Sbjct: 173 KGYGK----AV--DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKS---FNVECEMMKSIRH 97
D+ +G G FG V+ R A+KV + LK + E ++K + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
+I++ + ++ F +++EY+P G L YL +S + ++ ALEYLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH- 118
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-YG 216
S I++ DLKP N+LLD L+DF AK L D++ T T Y+APE
Sbjct: 119 --SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLC---GTPEYLAPEVIQ 171
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+G A D ++ GI++ E G P
Sbjct: 172 SKGHNKAV-DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 44 FSENNL-----IGKGGFGSVYKARLGD-GMEVAVKVFNLQC-GRALKSFNVECE-MMKSI 95
F+ +L IG+G FG+V K G +AVK + K ++ + +M+S
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA----SA 151
++K + E + +E M SL+K+ +L I+ +A A
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L YL IIH D+KPSN+LLD N L DF I+ LV S+ +T+ YM
Sbjct: 120 LNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYM 174
Query: 212 APEYGREGRVSANG--------DVYSFGIMLMETFTGKKPTDE 246
APE R+ + DV+S GI L E TGK P +
Sbjct: 175 APE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-16
Identities = 66/285 (23%), Positives = 121/285 (42%), Gaps = 37/285 (12%)
Query: 50 IGKGGFGSVYKARL---GD--GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V R GD G +VAVK + G + E E+++++ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 104 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
C+ + L++E++P GSL++YL + +++ Q+L + + ++YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGR 220
+H DL NVL++ + DF + K + + + T + + + APE + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 221 VSANGDVYSFGIMLMETFT----GKKPTDEIF------NGEMTLKHWVNDWLPISTLEVV 270
DV+SFG+ L E T P +G+MT+ V
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR----------- 237
Query: 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ +E C V+ L C P +R + +++
Sbjct: 238 ----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 68/305 (22%), Positives = 134/305 (43%), Gaps = 48/305 (15%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARL-----GDGME-VAVKVFNLQCGRALKS-FNVE 88
E+ +T F E +G+ FG VYK L G+ + VA+K + L+ F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 89 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------------SSN 133
M ++H N++ ++ + E+ +++ Y H L ++L +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 134 CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193
L+ ++I+ +A+ +E+L S ++H DL NVL+ D + +SD + + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
D + I +M+PE G+ S + D++S+G++L E F+ G +P
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--------- 226
Query: 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKE 312
+ S +V++ ++ + + C ++V+ L + C E P +R K+
Sbjct: 227 --------YCGYSNQDVIE--MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKD 275
Query: 313 IVKKL 317
I +L
Sbjct: 276 IHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ A +VAVK ++++F E +MK+++H L+K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDL 168
E ++ E+M GSL +L S Q L +ID ++ + E + F IH DL
Sbjct: 73 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ ++V ++DF +A+++ + + + F I + APE G + DV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDVW 187
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEM 252
SFGI+LME T G+ P + N E+
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-16
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 48 NLIGKGGFGSVYKARL---GDGMEVAVKVFNLQCGRA-LKSFNVECEMM-KSIRHRNLIK 102
++IG+G FG V KAR+ G M+ A+K + + F E E++ K H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 147
++ +C + + L +EY PHG+L +L S + L Q L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA ++YL IH DL N+L+ +N VA ++DF +++ G++ + +T
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLME 236
+ +MA E + N DV+S+G++L E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-16
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 43 EFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR----- 96
E+ + +G G F S Y+AR + G +AVK + + V + K IR
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 97 -HRNLIKVISSCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDIFQRLNIMIDVASA 151
H ++I+++ + + L +E+M GS L KY ++ +N +
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLV--GEDQSMTQTQTFATI 208
L YLH IIH D+K +N+L+D ++DF A L G Q Q TI
Sbjct: 116 LSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP--TDEIFN 249
+MAPE R + + DV+S G +++E T K P ++ N
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 50 IGKGGFGSVYKARLGDGME---------VAVKVFNLQCG-RALKSFNVECEMMKSI-RHR 98
+G+G FG V A G++ VAVK+ + L E EMMK I +H+
Sbjct: 26 LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI----LDIFQRLN 143
N+I ++ +C+ + +++EY G+L +YL Y+ + L ++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 145 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIKVI 104
+G G FG V YK R ++VA+KV + ++++ E E+M + + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
C E LV+E G L K+L + + + +M V+ ++YL +
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPEYGREGRVS 222
H DL NVLL + A +SDF ++K L G D S + ++ + + APE + S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 223 ANGDVYSFGIMLMETFT-GKKP 243
+ DV+S+GI + E F+ G+KP
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 72/250 (28%), Positives = 111/250 (44%), Gaps = 31/250 (12%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAL-KSFNVECEMMKSIRHRNLIKVISSC 107
+G G G+VYKA L +AVKV L L K E E++ +I +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M GSL+ Y +L I + V L YL +S I+H D
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRD 120
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
+KPSN+L++ L DF ++ LV S+ +T T YMAPE + + DV
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYV-GTNAYMAPERISGEQYGIHSDV 176
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE--------VVDANLLSQED 279
+S GI ME G+ P +I + +L +P+ L+ V+ S++
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPPVLPVGQFSEKF 229
Query: 280 IHFVAKEQCV 289
+HF+ QC+
Sbjct: 230 VHFIT--QCM 237
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 75/224 (33%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEM------MKSIRHRNLIK 102
IGKG FG V A+ DG AVKV LQ LK + M +K+++H L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ S + VL+Y+ G L +L + R ++ASAL YLH S
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRV 221
II+ DLKP N+LLD L+DF + K G + S T T TF T Y+APE R+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKT-TSTFCGTPEYLAPEVLRKQPY 173
Query: 222 SANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKH 256
D + G +L E G P D I N + LK
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 69/302 (22%), Positives = 127/302 (42%), Gaps = 54/302 (17%)
Query: 50 IGKGGFGSVYKAR------LGDGMEVAVKVFNLQCGRA-LKSFNVECEMMKSIRHRNLIK 102
+G+G FG V KA VAVK+ + L+ E ++K + H ++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----------------------LDIF 139
+ +CS + L++EY +GSL +L S + L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 140 QRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199
++ ++ ++YL ++H DL NVL+ + +SDF +++ + ED +
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWV 258
+++ + +MA E + + DV+SFG++L E T G P + G + +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPGIAPERLF- 239
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
NLL + E C ++NL + C + P++R +I K+L
Sbjct: 240 --------------NLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
Query: 319 KI 320
K+
Sbjct: 285 KM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 70/232 (30%), Positives = 108/232 (46%), Gaps = 34/232 (14%)
Query: 43 EFSENNL-----IGKGGFGSVY--------KARLGDGMEVAVKVF-NLQCGRALKSFNVE 88
E S L +G+G FG V K + + VAVK+ + + L E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 89 CEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YS-SNCILD 137
EMMK I +H+N+I ++ +C+ + +++EY G+L +YL YS C L
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 138 ----IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
F+ L + VA +EYL S IH DL NVL+ ++ V ++DF +A+ +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
D T + +MAPE + + DV+SFG++L E FT G P
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 48 NLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLIK 102
+IGKG FG VY L G + AVK N + ++ F E +MK H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 103 VISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ C E LV L YM HG L ++ S + + + VA +EYL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPEYGREG 219
+H DL N +LD++ ++DF +A+ + ++ T A + +MA E +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
+ + DV+SFG++L E T P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 70/234 (29%), Positives = 106/234 (45%), Gaps = 45/234 (19%)
Query: 49 LIGKGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
++GKGG+G V++ R G M+V K ++ + E ++++++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI-MIDVAS--------A 151
+ +I + L+LEY+ G L +L +R I M D A A
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEISLA 112
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGY 210
LE+LH II+ DLKP N+LLD L+DF + K + E T TF TI Y
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT---VTHTFCGTIEY 166
Query: 211 MAPE-YGREGRVSANGDVYSFGIMLMETFTG---------KKPTDEIFNGEMTL 254
MAPE R G A D +S G ++ + TG KK D+I G++ L
Sbjct: 167 MAPEILMRSGHGKAV-DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 25/199 (12%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMMKSIRHRNLIKVI- 104
IG+G G V+KA+ G VA+K + L+ G ++ E + +++ +H ++K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 105 -----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
S LV+EYMP L + L L Q + M + + Y+H
Sbjct: 67 VFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH--- 116
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--YGR 217
+ I+H DLKP+N+L+ + V ++DF +A+L E++ + AT Y APE YG
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 218 EGRVSANGDVYSFGIMLME 236
+ D+++ G + E
Sbjct: 176 R-KYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 49 LIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV-------ECEMMKSIRHRNL 100
++G+G +G V K R G VA+K F + + E ++++ +RH N+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-----KESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ + + + LV EY+ LE L +S L + + + A+ Y H S
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---S 118
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE------ 214
IIH D+KP N+L+ ++ V L DF A+ L S T AT Y APE
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDT 177
Query: 215 -YGREGRVSANGDVYSFGIMLMETFTG 240
YG+ DV++ G ++ E G
Sbjct: 178 NYGKP------VDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 32/288 (11%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL +++ I +MA E
Sbjct: 127 ---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
+ DV+S+G+ + E T G KP D I E++ S LE L
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SILE--KGERL 230
Query: 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI-RD 322
Q I C V+ + + C + + R +E++ + K+ RD
Sbjct: 231 PQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-15
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
++F IG G +G VYKAR + G A+KV L+ G E MMK +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ S + + +E+ GSL+ +Y L Q + + L YLH S
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---S 124
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG--- 216
+H D+K +N+LL DN L+DF ++ + ++ + ++F T +MAPE
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA---TIAKRKSFIGTPYWMAPEVAAVE 181
Query: 217 REGRVSANGDVYSFGIMLME 236
R+G + D+++ GI +E
Sbjct: 182 RKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 11/199 (5%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVIS 105
+GKGGFG V ++ G A K + L+ + + E ++++ + R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ ++ LV+ M G L+ ++Y+ + + + LE+LH I+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
+ DLKP NVLLDD+ +SD +A L G T GYMAPE + +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 225 GDVYSFGIMLMETFTGKKP 243
D ++ G L E G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 83/310 (26%), Positives = 134/310 (43%), Gaps = 56/310 (18%)
Query: 43 EFSENNLI-----GKGGFGSVYKARLGDGME---------VAVKVF-NLQCGRALKSFNV 87
EF + L+ G+G FG V +A G++ VAVK+ + + L
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS 66
Query: 88 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-----NCILDI--- 138
E E+MK I +H+N+I ++ C+ E +++EY G+L ++L + + DI
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 139 ------FQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191
F+ L + VA +EYL S IH DL NVL+ ++ V ++DF +A+
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNG 250
+ D + + +MAPE + + DV+SFGI++ E FT G P I
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--- 240
Query: 251 EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA 310
P+ L LL +E C ++ L C P QR
Sbjct: 241 ------------PVEEL----FKLL-REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTF 283
Query: 311 KEIVKKLLKI 320
K++V+ L K+
Sbjct: 284 KQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 49 LIGKGGFGSVYKARLGD-GMEVAVKV--FNLQCGRALKSFN-VECE--MMKSIRHRNLIK 102
L+G+G FG VY D G E+AVK F+ K N +ECE ++K++RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 103 VISSCSNEEFKALVL--EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ E K L + EYMP GS++ L + + + R + + YLH S
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY-MAPE----- 214
I+H D+K +N+L D L DF +K + S T ++ Y M+PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 215 -YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
YGR+ DV+S ++E T K P E
Sbjct: 185 GYGRK------ADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 64/306 (20%), Positives = 120/306 (39%), Gaps = 57/306 (18%)
Query: 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG---RALKSFNVE 88
F + LC+A + + + L VAVKV L+ A + F E
Sbjct: 18 FGEVHLCEADG-LQDFSEKAFAENDNADAPVL-----VAVKV--LRPDASDNAREDFLKE 69
Query: 89 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----------------SS 132
+++ + N+ +++ C+ + +++EYM +G L ++L S
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
+ + L + +AS + YL S +H DL N L+ N ++DF +++ L
Sbjct: 130 STL------LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIFNG 250
D Q + I +MA E G+ + DV++FG+ L E T ++P + + +
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239
Query: 251 EMTLKHWVNDWLPISTLEVVDANLLSQED---IHFVAKEQCVSFVFNLAMACAVESPEQR 307
V + +A ++D I+ C ++ L + C E R
Sbjct: 240 -----QQV----------IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284
Query: 308 INAKEI 313
+EI
Sbjct: 285 PTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VYKAR L G AVK+ L+ G E M+K +H N++ S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ E + +EY GSL+ +Y L Q + + L YLH S +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSANG-- 225
K +N+LL DN L+DF +A + ++ + ++F T +MAPE V NG
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWMAPEV---AAVEKNGGY 186
Query: 226 ----DVYSFGIMLME 236
D+++ GI +E
Sbjct: 187 NQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 44 FSENNLIGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMMKSIRHRN 99
F IG+G F VY+A L DG+ VA+K +F+L +A E +++K + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+IK +S + +VLE G L K+ ++ + + SALE++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAP 213
S ++H D+KP+NV + V L D + + S T + +G YM+P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSP 175
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKP 243
E E + D++S G +L E + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 60/240 (25%), Positives = 95/240 (39%), Gaps = 52/240 (21%)
Query: 47 NNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL---------------QCG------RALKS 84
+G+G +G V KA G VA+K + CG R LK
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK- 72
Query: 85 FNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
+M I+H N++ ++ +F LV++ M L+K + L Q I
Sbjct: 73 ------IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCI 124
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ--- 201
++ + + L LH Y +H DL P+N+ ++ + ++DF +A+ S T
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 202 ---------TQTFATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKK---PTDEI 247
T T+ Y APE G E A D++S G + E TGK +EI
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV-DMWSVGCIFAELLTGKPLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 4e-14
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 43 EFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+++ IG+G G+V+ A + G EVA+K NLQ + E +MK +++ N++
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 102 KVISS--CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+ S +E F +V+EY+ GSL + + C +D Q + + ALE+LH
Sbjct: 80 NFLDSFLVGDELF--VVMEYLAGGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLH--- 132
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +IH D+K NVLL + L+DF + E QS T T +MAPE
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTMV-GTPYWMAPEVVTRK 190
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
D++S GIM +E G+ P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 4e-14
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G+VY A + G EVA++ NLQ + E +M+ ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+EY+ GSL + + C +D Q + + ALE+LH S +IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL + L+DF + E ++ T +MAPE D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 229 SFGIMLMETFTGKKP 243
S GIM +E G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 50 IGKGGFGSVYKARLGDGM---EVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVIS 105
IG G FG V + G +V VK + + F E + +S++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGY 159
C+ LV+E+ P G L+ YL S QR+ ++A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH--- 117
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE- 218
IH DL N LL ++ + D+ ++ ED +T Q + + ++APE E
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 219 -GRV-----SANGDVYSFGIMLMETFT-GKKP 243
G + + +V+S G+ + E F G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG VYKA+ + G A KV + L+ + VE E++ + H ++K++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDI-FQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+ +++E+ P G+++ + LD I + LE L + +S IIH D
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY-----GREGRV 221
LK NVLL + L+DF ++ V +++ + +F T +MAPE ++
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNV---KTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEI 247
D++S GI L+E + P E+
Sbjct: 193 DYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-14
Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 29/282 (10%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLI 101
F++ IGKG FG V+K +V A+K+ +L+ ++ E ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
K S + +++EY+ GS L LD Q I+ ++ L+YLH S
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH D+K +NVLL ++ L+DF +A L D + + T +MAPE ++
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
+ D++S GI +E G+ P E+ ++ +P + ++ N S+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLF------LIPKNNPPTLEGN-YSKPLKE 231
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
FV AC + P R AKE++K +R +
Sbjct: 232 FVE-------------ACLNKEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 45/224 (20%)
Query: 42 DEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV---FNLQ--CGRALKSFNVECEMMKSI 95
+ + IG+G +G V A G++VA+K F Q C R L+ E ++++
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRF 60
Query: 96 RHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD-----IFQRLNIM 145
+H N+I +I S E F +V E M L K + + + D ++Q L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR-- 117
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQT 204
L+Y+H SA ++H DLKPSN+LL+ N + DF +A++ D + T+
Sbjct: 118 -----GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 205 FATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGK 241
AT Y APE Y + D++S G +L E + +
Sbjct: 170 VATRWYRAPEIMLNSKGY------TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-14
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G+VY A + G EVA+K NLQ + E +M+ ++ N++ + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+EY+ GSL + + C +D Q + + AL++LH S +IH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL + L+DF + E QS T T +MAPE D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 229 SFGIMLMETFTGKKP 243
S GIM +E G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRAL-KSFNVECEMMKSIRHRNLIKVISSC 107
+G G GSV K + G +A KV ++ ++ K E ++M R ++ +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
NE + +E+M GSL++ I ++I + I + V L YL+ I+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSANG 225
D+KPSN+L++ L DF ++ L+ + TF T YM+PE + G+ +
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELIN-----SIADTFVGTSTYMSPERIQGGKYTVKS 183
Query: 226 DVYSFGIMLMETFTGKKPTDE 246
DV+S GI ++E GK P
Sbjct: 184 DVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 37/230 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKARLGDGME----------------VAVKVFNLQCGR- 80
EF L +G+G FG V+ +G+ VAVK+ +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT 59
Query: 81 ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----YS---- 131
A F E ++M +++ N+I+++ C +++ ++ EYM +G L ++L S
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 132 SNCI--LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
+N I + I L + + +AS ++YL S +H DL N L+ ++ ++DF ++
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+ L D Q + I +MA E G+ + DV++FG+ L E FT
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 38/109 (34%), Positives = 54/109 (49%), Gaps = 19/109 (17%)
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ + + AL YL + +IH D+KPSN+LLD + L DF I+ LV S +T+
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173
Query: 204 TFATIGYMAPEYGREGRVSAN---------GDVYSFGIMLMETFTGKKP 243
+ YMAPE R+ DV+S GI L+E TG+ P
Sbjct: 174 SAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 19/215 (8%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSF-NVECE---MMKSIRHRNLIKVI 104
I KG FGSVY A+ G A+KV A NV+ E MM + K+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
S ++++ LV+EY+ G + + + + + + + +V +E LH II
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGII 119
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H D+KP N+L+D L+DF +++ G + T Y+APE
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR--NGL----ENKKFVGTPDYLAPETILGVGDDKM 173
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
D +S G ++ E G P F+ E + N
Sbjct: 174 SDWWSLGCVIFEFLFGYPP----FHAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLI 101
F++ IGKG FG V+K +V A+K+ +L+ ++ E ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
K S +++EY+ GS L + D FQ ++ ++ L+YLH S
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH---SE 120
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH D+K +NVLL + L+DF +A L D + + T +MAPE ++
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEI 247
+ D++S GI +E G+ P ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 38/284 (13%)
Query: 50 IGKGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY+ D ++ VAVK N R F E +MK ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS-----SNCILDIFQRLNIMI----DVASALE 153
++ S + +V+E M HG L+ YL S N L MI ++A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H DL N ++ + + DF + + + D + + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273
E ++G + + D++SFG++L E + + + + E LK V+D
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 238
Query: 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L Q + C V +L C +P+ R EIV L
Sbjct: 239 YLDQ-------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 24/229 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVA-VKVFNLQCGRALK---SFNVECEMMKSIRHRNLIKVIS 105
IG G FG V GM A V V L+ F E + + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCIL------DIFQRLNIMIDVASALEYLHFGY 159
C LVLE+ P G L+ YL S+ ++ D+ QR+ +VAS L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE- 218
A IH DL N L ++ + D+ +A ED +T+ + ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 219 ------GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 260
+ +++S G+ + E FT +P ++ + E LK V +
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKS------FNVECEMMKSIRHRNLI 101
+IGKG FG V AR + AVKV LQ LK + ++K+++H L+
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ S + VL+Y+ G L +L C L+ R ++ASAL YLH S
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGR 220
I++ DLKP N+LLD L+DF + K + + + T TF T Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFCGTPEYLAPEVLHKQP 172
Query: 221 VSANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLK 255
D + G +L E G P D I N + LK
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMM-KSI-----RHRNLI 101
++GKG FG V A L E+ AVKV L+ L+ +VEC M K + +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ S ++ V+EY+ G L ++ S D + ++ L++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGR 220
II+ DLK NVLLD ++DF + K + + T TF T Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILSYQP 172
Query: 221 VSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
D ++ G++L E G+ P DE+F
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 50 IGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFN---VECEMMKSIRHRNLIKVIS 105
IG G FG+VY AR E VA+K + ++ + + E ++ +RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 106 SCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDI----FQRLNIMIDVASALEYLHFGYS 160
C E A LV+EY L S++ IL++ Q + I AL+ L + +S
Sbjct: 82 GCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY---G 216
IH D+K N+LL + L+DF A L ++ +F T +MAPE
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASL-------VSPANSFVGTPYWMAPEVILAM 186
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 249
EG+ DV+S GI +E K P +FN
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP---LFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-13
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 29/215 (13%)
Query: 49 LIGKGGFGSVYKARLGD-GMEVAVKVFNL-----QCGRALKSFNVECEMMKSIRHRNLIK 102
L+G+G FG VY D G E+A K + + + + E +++K+++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 103 VISSCSNEEFKALV--LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ K L +EYMP GS++ L + + + R + + YLH S
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAPE--- 214
I+H D+K +N+L D L DF +K L + M+ T + G +M+PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 215 ---YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
YGR+ DV+S G ++E T K P E
Sbjct: 183 GEGYGRK------ADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 23/185 (12%)
Query: 44 FSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV--ECEMMKSIR---H 97
+ E IG+G +G+VYKAR L G VA+K + + E ++K + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 98 RNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNIMIDVA 149
N+++++ C ++ E K LV E++ L YL S C L ++M +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIKDLMRQLL 117
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
+++LH S I+H DLKP N+L+ + ++DF +A++ M T T+
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLW 171
Query: 210 YMAPE 214
Y APE
Sbjct: 172 YRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 44/213 (20%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNL--QCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG+G G V A G +VAVK +L Q R L FN E +M+ +H N++++ SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL-LFN-EVVIMRDYQHPNIVEMYSS 84
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ +V+E++ G+L + + ++ Q + + V AL +LH + +IH
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHR 139
Query: 167 DLKPSNVLLDDNMVAHLSDFSIA----------KLLVGEDQSMTQTQTFATIGYMAPE-- 214
D+K ++LL + LSDF K LVG T +MAPE
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG------------TPYWMAPEVI 187
Query: 215 ----YGREGRVSANGDVYSFGIMLMETFTGKKP 243
YG E D++S GIM++E G+ P
Sbjct: 188 SRLPYGTE------VDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 41/106 (38%), Positives = 55/106 (51%), Gaps = 9/106 (8%)
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
I + + ALEYLH S +IH D+KPSNVL++ N L DF I+ LV S+ +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162
Query: 204 TFATIGYMAPEY----GREGRVSANGDVYSFGIMLMETFTGKKPTD 245
YMAPE + DV+S GI ++E TG+ P D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS 105
IG+G F VY+A L D VA+K +F + +A + E +++K + H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 106 SCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
S + +VLE G L KY ++ + + SA+E++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAPEYGREG 219
++H D+KP+NV + V L D + + S T + +G YM+PE E
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G +L E + P
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 66/200 (33%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 49 LIGKGGFGSVYKA-RLGDGMEVAVKVFNLQC---GRALKSFNVECE-MMKSIRHRNLIKV 103
+IGKG FG V A R DG AVKV + + K E ++K+++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
S E VL+++ G L +L + R ++ASAL YLH S I
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA 223
++ DLKP N+LLD L+DF + K G QS T T T Y+APE R+
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 224 NGDVYSFGIMLMETFTGKKP 243
D + G +L E G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 16/188 (8%)
Query: 66 GMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMP 121
G EVA+K+ F E + + H N++ ++ S V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDN 178
+L + L +++ L + +M+ V AL H + I+H DLKP N+++
Sbjct: 63 GRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118
Query: 179 MVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IG---YMAPEYGREGRVSANGDVYSFGIM 233
A + DF I LL G + T T T +G Y APE R V+ N D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 234 LMETFTGK 241
+E TG+
Sbjct: 179 FLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMMK------SIRHRNLI 101
++GKG FG V A L E A+K L+ L+ +VEC M++ + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ + +E V+EY+ G L ++ SS D + ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KK 115
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LVGEDQSMTQTQTF-ATIGYMAPEYGREG 219
II+ DLK NVLLD + ++DF + K + GE + TF T Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GKASTFCGTPDYIAPEILKGQ 171
Query: 220 RVSANGDVYSFGIMLMETFTGKKP-----TDEIF 248
+ + + D +SFG++L E G+ P DE+F
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-13
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 44 FSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRHRN 99
F + ++GKGGFG V ++ G A K + + K ++ E ++++ + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFG 158
++ + + ++ LVL M G L+ ++Y + + + ++ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I++ DLKP N+LLDD+ +SD +A + V E Q++ T+GYMAPE +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGR--VGTVGYMAPEVVKN 175
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
R + + D ++ G +L E G+ P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 49 LIGKGGFGSVYKA--RLGDGMEVAVKVFNLQCGRALK---SFNVECEMMKSIRHRNLIKV 103
++G G FG + + +L E+ V + L+ G + K F E + H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAP 162
+ +V EYM +G+L+ +L L Q + ++ +AS ++YL GY
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG------YMAPEYG 216
+H L VL++ ++V +S F + ED+S + T+ + APE
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEA---IYTTMSGKSPVLWAAPEAI 180
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKP 243
+ S+ DV+SFGI++ E + G++P
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 49 LIGKGGFGSVYKARLGD-GMEVAVKV--FNLQCGRALKSFN-VECE--MMKSIRHRNLIK 102
L+G+G FG VY D G E+AVK F+ + K N +ECE ++K++ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 103 VISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFGY 159
+ E ++ +E+MP GS++ L S + + + ++ I LE + + +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY-MAPE---- 214
S I+H D+K +N+L D L DF +K L S T ++ Y M+PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
YGR+ D++S G ++E T K P E
Sbjct: 184 EGYGRK------ADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 50 IGKGGFGS--VYKARLGDGMEVAVKVFNL----QCGRALKSFNVECEMMKSIRHRNLIKV 103
+GKG FG +Y+ R D V K NL + R + N E ++ ++H N+I
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRD-ALN-EIVILSLLQHPNIIAY 64
Query: 104 ISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ ++ + +EY G+L +K + + + L + + SA+ Y+H A
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAG 121
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS 222
I+H D+K N+ L + L DF I+K+L G + SM +T T YM+PE + + +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSPELCQGVKYN 179
Query: 223 ANGDVYSFGIMLMETFTGKK 242
D+++ G +L E T K+
Sbjct: 180 FKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 50 IGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY K + D E VA+K N R F E +MK ++++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 153
++ S + +++E M G L+ YL S + + + + ++A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H DL N ++ ++ + DF + + + D + + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273
E ++G + DV+SFG++L E T + + + E L+ V++
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------------VMEGG 238
Query: 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
LL + D C +F L C +P+ R + EI+ +
Sbjct: 239 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALK-SFNVECEMMKSIRHRNLIKV 103
+G G FG+V YK + + VAVK+ N ALK E +M+ + + ++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
I C E + LV+E G L K+L + + + ++ V+ ++YL
Sbjct: 62 IGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNF 116
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPEYGREGRV 221
+H DL NVLL A +SDF ++K L G D++ + +T + + APE +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 49 LIGKGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
++G G +G V+ R G M+V K +Q + ++ E +++ +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 101 IKVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEYLH 156
+ + E K L+L+Y+ G + +LY D F + ++ ALE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH 122
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY 215
I++ D+K N+LLD L+DF ++K + E++ +T +F TI YMAPE
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE--RTYSFCGTIEYMAPEI 177
Query: 216 --GREGRVSANGDVYSFGIMLMETFTGKKP 243
G+ G A D +S GI++ E TG P
Sbjct: 178 IRGKGGHGKAV-DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 50 IGKGGFGSVYKAR-LG---DGMEVAVKVFN----LQCGRALKSFNVECEMMKSIRHRNLI 101
+G G +G V+ R +G G A+KV +Q + + E ++++++R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 102 KVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ + K L+L+Y+ G L +LY + R+ I ++ AL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREG 219
II+ D+K N+LLD L+DF ++K + E++ + +F TI YMAPE R G
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE--RAYSFCGTIEYMAPEVIRGG 181
Query: 220 RVSANG--DVYSFGIMLMETFTGKKP 243
+ D +S G++ E TG P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISS 106
IG+G FG +Y A+ D +K +L + ++ E ++ ++H N++ +S
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 107 CSNEEFKALVLEYMPHGSLEK-------YLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+V+EY G L K L+S + IL F + ++ L+++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIH--- 118
Query: 160 SAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGR 217
I+H D+K N+ L N MVA L DF IA+ L + SM T T Y++PE +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQ 175
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G +L E T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 62/213 (29%), Positives = 88/213 (41%), Gaps = 46/213 (21%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVF-----NLQCGR-ALKSFNVECEMMKSIRHRNLIK 102
IG+G +G V+K R + G VA+K F + + AL+ E M+K ++H NL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 103 VISSCSNEEFKA-----LVLEYMPH---GSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+I E F+ LV EY H LEK + I+ A+ +
Sbjct: 65 LI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNF 115
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
H IH D+KP N+L+ L DF A++L G T AT Y APE
Sbjct: 116 CH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPE 170
Query: 215 -------YGREGRVSANGDVYSFGIMLMETFTG 240
YG DV++ G + E TG
Sbjct: 171 LLVGDTQYG------PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 21/192 (10%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV----ECEMM 92
C ++ + IG+G FG V+KAR VA+K + + F + E +++
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKIL 65
Query: 93 KSIRHRNLIKVISSCSNE-----EFKA---LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
+ ++H N++ +I C + +K LV E+ H L L + N + + +
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV 124
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV--GEDQSMTQT 202
M + + L Y+H I+H D+K +N+L+ + + L+DF +A+ + T
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 203 QTFATIGYMAPE 214
T+ Y PE
Sbjct: 182 NRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 57/236 (24%), Positives = 104/236 (44%), Gaps = 26/236 (11%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKARLGDGM-----EVAVKVFN-----LQCGRALKSFN 86
+ + D + ++L+ +G FG ++ L D EV VK +Q L+
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ--- 57
Query: 87 VECEMMKSIRHRNLIKVISSCSNEEFKALVLE-YMPHGSLEKYLYSSNCI-------LDI 138
E ++ + H+N++ ++ C + VL YM G+L+ +L L
Sbjct: 58 -ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q +++ I +A + YLH +IH D+ N ++D+ + ++D ++++ L D
Sbjct: 117 QQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ +MA E S+ DV+SFG++L E T G+ P EI EM
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 29/280 (10%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLI 101
F++ IGKG FG VYK EV A+K+ +L+ ++ E ++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ S +++EY+ GS L L+ I+ ++ L+YLH S
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---SE 120
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH D+K +NVLL + L+DF +A L D + + T +MAPE ++
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
D++S GI +E G+ P +D P+ L ++ N S +
Sbjct: 179 DFKADIWSLGITAIELAKGEPPN--------------SDLHPMRVLFLIPKN--SPPTLE 222
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
+ FV AC + P R AKE++K R
Sbjct: 223 GQYSKPFKEFV----EACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 66/274 (24%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVK----VFN--LQCGRALKSFNVECEMMKSIRHRNLIK 102
IG+G +G V A+ + +VA+K F+ + R L+ E ++++ + H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68
Query: 103 ---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD------IFQRLNIMIDVASA 151
++ E F +V E M L + + SS + D ++Q L
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------G 120
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L+Y+H SA ++H DLKPSN+LL+ N + DF +A+ + M T+ T Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYR 175
Query: 212 APE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
APE Y DV+S G + E G+KP +F G K +V+ I
Sbjct: 176 APELLLNCSEYT------TAIDVWSVGCIFAELL-GRKP---LFPG----KDYVHQLKLI 221
Query: 265 STLEVVDANLL---SQEDIHFVAKEQCVSFVFNL 295
+ LL S+ED+ F+ E+ ++ +L
Sbjct: 222 T-------ELLGSPSEEDLGFIRNEKARRYIRSL 248
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 49 LIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMK------SIRHRNLI 101
++GKG FG V+ A L G A+K L+ L +VEC M++ + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ + +E V+EY+ G L ++ S + D+ + ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SK 115
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LVGEDQSMTQTQTF-ATIGYMAPEYGREG 219
I++ DLK N+LLD + ++DF + K ++G+ +T TF T Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AKTCTFCGTPDYIAPEILLGQ 171
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
+ + + D +SFG++L E G+ P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-ALKSFNV-ECEMMKSIR---HRNLIKV 103
IG G +G+VYKAR G VA+K +Q L V E ++K + H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 104 ISSC----SNEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIFQRLNIMIDVASA 151
+ C ++ E K LV E++ L YL + I D+ ++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L++LH I+H DLKP N+L+ L+DF +A++ M T T+ Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYR 174
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
APE + + D++S G + E F +KP
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 66/230 (28%), Positives = 98/230 (42%), Gaps = 42/230 (18%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSI-RH 97
T F +IG+G +G VYKAR G VA+K+ ++ + E +++ H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62
Query: 98 RNL-------IKVISSCSNEEFKALVLEYMPHGS---LEKYLYSSNCILDIFQRLN---- 143
N+ IK ++++ LV+E GS L K L +RL
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSVTDLVKGLRKKG------KRLKEEWI 115
Query: 144 --IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201
I+ + L YLH +IH D+K N+LL N L DF ++ L D ++ +
Sbjct: 116 AYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGR 169
Query: 202 TQTFATIG---YMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP 243
TF IG +MAPE + A DV+S GI +E GK P
Sbjct: 170 RNTF--IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG VYKA+ + G+ A KV + + L+ + VE +++ S H N++K++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E +++E+ G+++ + L Q + AL YLH IIH DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY-----GREGRVS 222
K N+L + L+DF ++ +++ + +F T +MAPE ++
Sbjct: 130 KAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 223 ANGDVYSFGIMLMETFTGKKPTDEI 247
DV+S GI L+E + P E+
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 50 IGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNV-ECEMMKSIRHRNLIKVISSC 107
+G+G + +VYK R E VA+K +L S + E +MK ++H N++++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 108 SNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
E LV EYM L+KY+ + LD + + + + H ++H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA----TIGYMAPEYGREGRV 221
DLKP N+L++ L+DF +A+ TF+ T+ Y AP+ R
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAF------GIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 222 -SANGDVYSFGIMLMETFTGK 241
S + D++S G ++ E TG+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-12
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQ-----CGRALKSFNVECEMMKSIRHRNLIKV 103
+GKGGFG V ++ + G A K + + G K +E E+++ + ++ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE--KMALLEKEILEKVNSPFIVNL 58
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAP 162
+ ++ LV+ M G L+ ++Y+ L++ + ++ + + +LH S
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS 222
I++ D+KP NVLLDD LSD +A V T TQ T GYMAPE +E S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 223 ANGDVYSFGIMLMETFTGKKP 243
D ++ G + E G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-12
Identities = 68/290 (23%), Positives = 118/290 (40%), Gaps = 56/290 (19%)
Query: 50 IGKGGFGSVYKARL---------GDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHRN 99
+G+G F ++YK L G G EV+V + L R +F +M + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
L+K+ C +E +V EY+ G L+ +L+ + + +L++ +ASAL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118
Query: 160 SAPIIHCDLKPSNVLL---DDNM----VAHLSD--FSIAKLLVGEDQSMTQTQTFATIGY 210
++H ++ N+L+ N LSD I L E I +
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE--------RIPW 170
Query: 211 MAPEYGREGRVS--ANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTL 267
+APE R G+ S D +SFG L+E + G++P + + E + LP+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM--- 227
Query: 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
++ NL C P +R + + I++ L
Sbjct: 228 -------PDCAEL------------ANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 49 LIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMK----SIRHRN--LI 101
++GKG FG V A L G G AVK L+ L +VEC M++ ++ N L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ + +E V+E++ G L ++ D+++ ++ L++LH S
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SK 115
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LVGEDQSMTQTQTFATIGYMAPEYGREGR 220
II+ DLK NV+LD + ++DF + K + G++++ T T Y+APE + +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC---GTPDYIAPEILQGLK 172
Query: 221 VSANGDVYSFGIMLMETFTGKKP-----TDEIF 248
+ + D +SFG++L E G+ P DE+F
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRHRNLIKVIS 105
+GKGGFG V ++ G A K N + + K + VE ++ + R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ + LV+ M G L ++Y+ N + + S LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTFA-TIGYMAPEYGREGR 220
II+ DLKP NVLLD++ +SD +A +L G+ ++T+ +A T G+MAPE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----SKTKGYAGTPGFMAPELLQGEE 173
Query: 221 VSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+ L E + P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 42/216 (19%)
Query: 49 LIGKGGFGSVYKARLGDGMEV----AVKVF---NLQCGRALKSFNVECEMMKSIRHRNLI 101
++G+G FG V+ R G + A+KV L+ +++ +E +++ + H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN--IMI----------DVA 149
K+ + E L+L+++ G D+F RL+ +M ++A
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 108
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATI 208
AL++LH S II+ DLKP N+LLD+ L+DF ++K + ++ + +F T+
Sbjct: 109 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTV 162
Query: 209 GYMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKP 243
YMAPE R G + + D +SFG+++ E TG P
Sbjct: 163 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 69/225 (30%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 49 LIGKGGFGSV-YKARLGDGMEVAVKVFNLQ------CGRALKSFNVECEM---MKSIR-- 96
++G G G+V R+ DG AVKV +++ RA V C + SI
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA--QAEVCCLLNCDFFSIVKC 96
Query: 97 HRNLIKVISSCSNEE---FKALVLEYMPHGSLEKYLYSSNCILDIFQRLN---IMIDVAS 150
H + K N E ALVL+Y G L + + S F+ + I V
Sbjct: 97 HEDFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL---VGEDQSMTQTQTF-A 206
A+ ++H S +IH D+K +N+LL N + L DF +K+ V +D +TF
Sbjct: 155 AVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG----RTFCG 207
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
T Y+APE R S D++S G++L E T K+P F+GE
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE 248
|
Length = 496 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 11/212 (5%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RALKSFNVECEMMKSIR 96
E + ++G G FG+VYK + DG + VA+KV +A K E +M +
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ +++ C + LV + MP+G L Y+ + + LN + +A + YL
Sbjct: 68 SPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +A+LL ++ I +MA E
Sbjct: 127 ---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEI 247
R + DV+S+G+ + E T G KP D I
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHR 98
D + + +G G +G V A G +VA+K + Q K E ++K + H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 99 NLIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMI 146
N+I ++ + S E+F+ LV M L + Q+L+ ++
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVY 125
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+ L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D M T A
Sbjct: 126 QILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM--TGYVA 177
Query: 207 TIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGK 241
T Y APE + D++S G ++ E TGK
Sbjct: 178 TRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 41/236 (17%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFN-----LQCGRALKSFNVECEMMKSI 95
D+F +IG+G FG V+ R D +V A+KV + A E +++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADA 58
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
++K+ S +EE LV+EYMP G L L + + R I ++ AL+ +
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSV 117
Query: 156 H-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK------------------------ 190
H G+ IH D+KP N+L+D + L+DF + K
Sbjct: 118 HKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 191 LLVGEDQSMTQTQTFATIG---YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
L+ D + + +T+G Y+APE R D +S G++L E G P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 50 IGKGGFGSVYKARLGDGME------------------VAVKVFNLQCGR-ALKSFNVECE 90
+G+G FG V+ +GME VAVK+ + A F E +
Sbjct: 13 LGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQR 141
+M ++ N+I++++ C + ++ EYM +G L ++L ++ + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 142 LNIM-IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200
L M +AS ++YL S +H DL N L+ N ++DF +++ L D
Sbjct: 132 LIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
Q + I +M+ E G+ + DV++FG+ L E T
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 28/181 (15%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNV---------ECEMMKSIRHRN 99
IG G +G V A G +VA+K + +F+V E ++++ +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 100 L--IKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+ I+ I +FK +V++ M L ++S + + R + + L+Y+
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYI 123
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG--EDQSMTQTQTFATIGYMAP 213
H SA +IH DLKPSN+L++++ + DF +A+ L + T+ AT Y AP
Sbjct: 124 H---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 214 E 214
E
Sbjct: 181 E 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVA---VKVFNLQCGRALKSFNVECEMMK 93
C++ DE+ + N I +G +G VY+AR G VA +K+ + G + S E ++
Sbjct: 1 CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59
Query: 94 SIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
++H N++ V + SN + +V+EY+ H L+ + + + +M+ + S
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ +LH + I+H DLK SN+LL++ + + DF +A+ + TQ T+ Y
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYR 173
Query: 212 APE--YGREGRVSANGDVYS----FGIMLMET--FTGKKPTDEI 247
APE G S D++S F +L + F GK D++
Sbjct: 174 APELLLG-AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHRNLIKVISS 106
IG+G +G VYKAR G VA+K L + S + E ++K + H N++K++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E LV E++ H L+K++ +S + I L I + L+ L F +S ++H
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPL-IKSYLFQLLQGLAFCHSHRVLHR 124
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG- 225
DLKP N+L++ L+DF +A+ + T T T+ Y APE + +
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 226 DVYSFGIMLMET------FTGKKPTDEIF 248
D++S G + E F G D++F
Sbjct: 183 DIWSLGCIFAEMVTRRALFPGDSEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-11
Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 22/182 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D + + +G+G + +VYK + +G VA+KV LQ + E ++K ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKY-------LYSSNCILDIFQRLNIMIDVASAL 152
++ + +E LV EY+ H L +Y L+ N L +FQ L L
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GL 116
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
Y+H Y I+H DLKP N+L+ D L+DF +A+ S T + T+ Y
Sbjct: 117 SYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRP 171
Query: 213 PE 214
P+
Sbjct: 172 PD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMMK 93
C ++ +G+G FG VYKAR + G VA+K + N + G + + E +++K
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62
Query: 94 SIRHRNLIK----VISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 145
++H N++ + + K +V YM H L L + + L Q M
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYM 121
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ---- 201
+ + + YLH I+H D+K +N+L+D+ + ++DF +A+ G +
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 202 -----TQTFATIGYMAPEY--GREGRVSANGDVYSFGIMLMETFTGK 241
T T Y PE G E R + D++ G + E FT +
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMMK------SIRHRNLI 101
++GKG FG V A L EV A+KV L+ L+ +V+C M + + +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ ++ V+EY+ G L + S + R +V AL +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGR 220
+I+ DLK N+LLD L+DF + K + + T TF T Y+APE +E
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TTTFCGTPDYIAPEILQELE 172
Query: 221 VSANGDVYSFGIMLMETFTGKKP-----TDEIF 248
+ D ++ G+++ E G+ P D++F
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 49 LIGKGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
++G G +G V+ R G M+V K +Q + + E ++++ IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 101 IKVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEYLHFG 158
+ + + K L+L+Y+ G L +L + Q + I ++ ALE+LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH-- 122
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
II+ D+K N+LLD N L+DF ++K ED+ TI YMAP+ R
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180
Query: 219 GRVSANG--DVYSFGIMLMETFTGKKP 243
G + D +S G+++ E TG P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 50 IGKGGFGSV-----------------YKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEM 91
+G+G FG V + R G + VAVK+ + A F E ++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS----------------SNCI 135
+ ++ N+I+++ C +E+ ++ EYM +G L ++L S ++C+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 136 LDIFQR--LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193
I L++ + +AS ++YL S +H DL N L+ +N+ ++DF +++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLME 236
D Q + I +MA E G+ + DV++FG+ L E
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 44 FSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRHRN 99
F + ++GKGGFG V ++ G A K + + K ++ E ++++ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFG 158
++ + + ++ LVL M G L+ ++Y+ N + + L ++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
++ DLKP N+LLDD +SD +A + + E +S+ T+GYMAPE
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGR--VGTVGYMAPEVLNN 175
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
R + + D + G ++ E G+ P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 73/231 (31%), Positives = 109/231 (47%), Gaps = 52/231 (22%)
Query: 50 IGKGGFGSVYKARLGD---GMEVAVK-VF----NLQCGRALKSFNVECEMM--KSIR-HR 98
+GKG +G V+KA D VA+K +F N A ++F E+M + + H
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNAT--DAQRTFR---EIMFLQELGDHP 67
Query: 99 NLIKVISSCSNEEFKA-------LVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDV 148
N++K+++ KA LV EYM H + N + D+ +R IM +
Sbjct: 68 NIVKLLNV-----IKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IMYQL 116
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL---VGEDQSMTQTQTF 205
AL+Y+H S +IH DLKPSN+LL+ + L+DF +A+ L ++ T
Sbjct: 117 LKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 206 ATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254
AT Y APE G R + D++S G +L E GK +F G TL
Sbjct: 174 ATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKP----LFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V AR G +VAVK+ +L+ + + E +M+ +H+N++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E +++E++ G+L + S L+ Q + V AL YLH S +IH D+
Sbjct: 89 VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLL---VGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
K ++LL + LSDF + V + +S+ T +MAPE
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-----WMAPEVISRTPYGTEV 198
Query: 226 DVYSFGIMLMETFTGKKP 243
D++S GIM++E G+ P
Sbjct: 199 DIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 43/144 (29%), Positives = 77/144 (53%), Gaps = 7/144 (4%)
Query: 50 IGKGGFGSVYKARLGDGME-VAVKVFNLQ-CGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
IG+G +G+V+KA+ + E VA+K L + S + E ++K ++H+N++++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+++ LV EY L+KY S N +D + M + L + H S ++H
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAK 190
DLKP N+L++ N L+DF +A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 6e-11
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 40/221 (18%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMM---KSIR----HRNLI 101
+G G FGSVY AR G VA+K + S+ EC + KS+R H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 102 K---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLH- 156
K V N+E V EYM G+L + + +I+ + L ++H
Sbjct: 62 KLKEVFRE--NDELY-FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIGYMAPE- 214
G+ H DLKP N+L+ V ++DF +A+ E +S T +T Y APE
Sbjct: 118 HGF----FHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAPEI 169
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP-------TDEIF 248
R S+ D+++ G ++ E +T +P D+++
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL-RPLFPGSSEIDQLY 209
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 58/255 (22%)
Query: 50 IGKGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
+G+G + +VYK +R+ +G VA+KV +++ + + E ++K ++H N++ +
Sbjct: 13 LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 107 CSNEEFKALVLEYMPHGSLEKY-------LYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+E V EYM H L +Y L+ N L +FQ L L Y+H +
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQH 123
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP------ 213
I+H DLKP N+L+ L+DF +A+ S T + T+ Y P
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 214 -EYGREGRVSANGDVYSFGIMLMETFTGKK---------------------PTDEIFNGE 251
+Y S+ D++ G + +E G+ PT++ + G
Sbjct: 179 TDY------SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232
Query: 252 MTLKHWVNDWLPIST 266
L ++ +W
Sbjct: 233 SKLPNYKPEWFLPCK 247
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 46/291 (15%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNL---QCGRALKSFNVECEMMKSIRHRN 99
F++ IG G FG+VY AR EV A+K + Q + E + ++ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYL 155
I+ E LV+EY L S++ +L++ ++ +++A+ AL+ L
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGL 138
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY-MAPE 214
+ +S +IH D+K N+LL + L+DF A + + +F Y MAPE
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI-------ASPANSFVGTPYWMAPE 191
Query: 215 Y---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271
EG+ DV+S GI +E +KP N L H
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYH--------------- 235
Query: 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
++Q + + + + N +C + P+ R ++E++K + +R+
Sbjct: 236 ---IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 34/224 (15%)
Query: 43 EFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHRN 99
++++ IG+G +G VYK R G VA+K L+ + S + E ++K ++H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH--- 156
++ + E L+ E++ L+KYL S +D YL+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQIL 111
Query: 157 ----FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL---VGEDQSMTQTQTFATIG 209
F +S ++H DLKP N+L+D+ V L+DF +A+ V T T+
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-----RVYTHEVVTLW 166
Query: 210 YMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
Y APE G R S D++S G + E T KKP +F+G+
Sbjct: 167 YRAPEVLLGSP-RYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 42/219 (19%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---------ECE 90
T+ + + +G G FG V AR G VA+K + +K F+ E +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELK 61
Query: 91 MMKSIRHRNLIKVISS-CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
++K +RH N+I + S E V E + G+ L +S + F + + +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQY-FLYQIL 118
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
L+Y+H SA ++H DLKPSN+L+++N + DF +A++ +D M T +T
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM--TGYVSTRY 170
Query: 210 YMAPE-------YGREGRVSANGDVYSFGIMLMETFTGK 241
Y APE Y E D++S G + E GK
Sbjct: 171 YRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS-- 106
+IG+GGFG VY R D K++ ++C + + E + ++ R ++ ++S+
Sbjct: 1 IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVSTGD 55
Query: 107 -----CSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
C F +L+ M G L +L + R ++ LE++H
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH 114
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ-TFATIGYMAPEY 215
+ +++ DLKP+N+LLD++ +SD +A D S + + T GYMAPE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPEV 166
Query: 216 GREGRV-SANGDVYSFGIMLMETFTGKKP 243
++G ++ D +S G ML + G P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 26/228 (11%)
Query: 49 LIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMK------SIRHRNLI 101
++GKG FG V ARL G AVKV L+ L+ +VEC M + + H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ + V+E++ G L ++ S + R ++ SAL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGR 220
II+ DLK NVLLD L+DF + K + ++ T TF T Y+APE +E
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TSTFCGTPDYIAPEILQEML 172
Query: 221 VSANGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTLKHWVN 259
+ D ++ G++L E G P D++F N E+ W++
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISS 106
+GKG +G V R DG + +K NL+ R K+ E +++ ++H N++ S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 107 CSNEE-FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPII 164
E+ +V+ + G L L +L Q + + +A AL+YLH I+
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DLK NV L + + D IA++L E+Q + T YM+PE +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 225 GDVYSFGIMLMETFTGK 241
DV++ G + E T K
Sbjct: 183 SDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 50 IGKGGFG---SVYKARLGDGMEVAVK----VF-NL-QCGRALKSFNVECEMMKSIRHRNL 100
IG G FG SV R DG VA+K VF NL C R + E +M+ +H N+
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNV 61
Query: 101 IKVIS-------SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ + E + V+ + L K + S + ++ + + L+
Sbjct: 62 LSALDILQPPHIDPFEEIY---VVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLK 117
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE-DQSMTQTQTFATIGYMA 212
YLH SA I+H D+KP N+L++ N V + DF +A+ V E D+S TQ T Y A
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEPDESKHMTQEVVTQYYRA 172
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGK 241
PE G SA D++S G + E +
Sbjct: 173 PEILMGSRHYTSAV-DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-LKSFNVECEMMKSIRHRN 99
DE + +GKG +GSVYK G+ +A+K L+ + +E +++
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLH 156
++ + E + +EYM GSL+K LY + + I V L++L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAP 213
++ IIH D+KP+NVL++ N L DF ++ LV S+ +T IG YMAP
Sbjct: 120 EEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAP 170
Query: 214 EYGREGRVSANG------DVYSFGIMLMETFTGKKP 243
E + G + N DV+S G+ ++E G+ P
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 66/233 (28%), Positives = 98/233 (42%), Gaps = 28/233 (12%)
Query: 44 FSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRALKSFNVECEMMKSIRHRN 99
FS+ IG G FG+VY AR + + VA+K + Q + E ++ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI----FQRLNIMIDVASALEYL 155
I+ E LV+EY L S++ +L++ Q + I AL+ L
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY-MAPE 214
+ +S +IH D+K N+LL + + L DF A + M F Y MAPE
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-------MAPANXFVGTPYWMAPE 181
Query: 215 Y---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
EG+ DV+S GI +E +KP N L H + P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPA 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 44 FSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALK------SFNVECEMMKSIR 96
F ++GKGGFG V ++ G A K L+ R K + N E ++++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALN-EKQILEKVN 58
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYL 155
R ++ + + ++ LVL M G L+ ++Y+ N D + + ++ LE L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H I++ DLKP N+LLDD +SD +A V + T T+GYMAPE
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLA---VEIPEGETIRGRVGTVGYMAPEV 172
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
+ R + + D + G ++ E GK P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRHRNLIKVI 104
L+GKG FG V R G A+K+ + A E ++K+ RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
S ++ V+EY+ G L +L + R ++ SAL+YLH S I+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SGKIV 117
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA 223
+ DLK N++LD + ++DF + K + + +M +TF T Y+APE +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLEDNDYGR 174
Query: 224 NGDVYSFGIMLMETFTGKKP 243
D + G+++ E G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC------GRALKSFNVECEMMKSIRHRNLIK 102
IG+G +G VYKAR G VA+K L+ A++ E ++K + H N+++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ +E LV E++ L+KY+ S LD + + + + Y H S
Sbjct: 63 LLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SH 118
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAK---LLVGEDQSMTQTQTFATIGYMAPEYGRE 218
++H DLKP N+L+D L+DF +A+ + V T T T+ Y APE
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-----RTYTHEVVTLWYRAPEILLG 173
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIF 248
R + D++S G + E F G D++F
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 59/281 (20%)
Query: 57 SVYKARLGDGMEVAVKVF---NLQCGRALKSFNVECEMMKSIRHRNLIKV----ISSCSN 109
S+YK + EV ++ F + + E + ++ I N++K+ I +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+L+LEY G L + L L +L++ ID L L+ + P + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN----- 224
+ L+ +N K++ + + + F + +M Y ++ +
Sbjct: 151 SVSFLVTEN--------YKLKIICHGLEKILSSPPFKNVNFMV--Y-FSYKMLNDIFSEY 199
Query: 225 ---GDVYSFGIMLMETFTGKKP-----TDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
D+YS G++L E FTGK P T EI++ + + + LP+
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD--LIINKNNSLKLPLD----------- 246
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
C + + AC +R N KEI+ L
Sbjct: 247 -----------CPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-10
Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 36/237 (15%)
Query: 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKS---FNVECEMMKSIRHR 98
+F +G G FG V A+ G G A+K + +K E ++ + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEY 154
++ ++ S +E +LE++ G L +L + N + + ++ A EY
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEY 133
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YM 211
LH S II+ DLKP N+LLD+ ++DF AK +TF G Y+
Sbjct: 134 LH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCGTPEYL 182
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKHWVN 259
APE + D ++ G++L E G P ++I G + +W +
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239
|
Length = 329 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 36/220 (16%)
Query: 50 IGKGGFGSVYKAR--LGDGMEVAVKVFNLQC---GRALKSFN--VECEMMKSIRHRNLIK 102
IG+G +G V+KAR G VA+K +Q G L + +++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 103 VISSCS----NEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIFQRLNIMIDVAS 150
+ C+ + E K LV E++ L YL + I D+ M +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM------MFQLLR 121
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
L++LH S ++H DLKP N+L+ + L+DF +A++ + M T T+ Y
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWY 175
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
APE + + D++S G + E F +KP +F G
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS-- 106
+IG+GGFG VY R D K++ ++C K ++ ++ R ++ ++S+
Sbjct: 1 IIGRGGFGEVYGCRKAD----TGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGD 55
Query: 107 -----CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
C + F + +L+ M G L +L S + + + ++ LE++H
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ-TFATIGYMAPEY 215
+ +++ DLKP+N+LLD++ +SD +A D S + + T GYMAPE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPEV 166
Query: 216 GREGRV-SANGDVYSFGIMLMETFTGKKP 243
++G ++ D +S G ML + G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + +G G G V K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I +I +++I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 122
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 176
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 49 LIGKGGFGSVYKARLGDG-------MEVAVKVFNLQCGRALKSFNV-----ECEMMK-SI 95
+G G FG VYK R + E+ V + + ++ E ++K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRL-NIMIDVASAL 152
RH N+++ + + +V++ + L ++ S F +R+ NI + + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
YLH I+H DL P+N++L ++ ++DF +AK + + T TI Y
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL--TSVVGTILYSC 181
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
PE + DV++FG +L + T + P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 48 NLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
N+IG G FG VY+A D E VA+K + + + N E +MK++ H N+I +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 107 CSNEEFKA--------LVLEYMPHGSLEKYL--YS-SNCILDIFQRLNIMIDVASALEYL 155
E FK +V+E++P ++ KY+ Y+ +N L +F + AL Y+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
H S I H DLKP N+L+D N L DF AK L+ +S++ + Y APE
Sbjct: 187 H---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPE 240
Query: 215 YGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
+ + D++S G ++ E G IF+G+ ++ V
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNL-QCGRALKSFNV-ECEMMKSIRHR 98
D++ + IG+G +G VYKAR E +A+K L Q + S + E ++K ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI----MIDVASALEY 154
N++++ +E+ LV EY+ L+K++ SS D + + + + + Y
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAY 117
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
H S ++H DLKP N+L+D A L+DF +A+ T T T+ Y AP
Sbjct: 118 CH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAP 172
Query: 214 EYGREGR-VSANGDVYSFGIMLMET------FTGKKPTDEIF 248
E R S D++S G + E F G DE+F
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 122
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 176
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 50 IGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IGKG FG VY+ R D + A+KV + + A K E+ +I RN++ V +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNIL-VRTLLD 53
Query: 109 NEEFKA-------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEY 154
F LV +YM G L +L + R I ++ ALE+
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEH 111
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAP 213
LH I++ DLKP N+LLD L DF ++K + ++++ T TF T Y+AP
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAP 165
Query: 214 EYGREGR-VSANGDVYSFGIMLMETFTGKKP 243
E + + + + D +S G+++ E G P
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 39/127 (30%), Positives = 63/127 (49%), Gaps = 7/127 (5%)
Query: 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 176
+E+M GSL++ L + I + I I V L YL + I+H D+KPSN+L++
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134
Query: 177 DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLME 236
L DF ++ L+ SM + T YM+PE + + D++S G+ L+E
Sbjct: 135 SRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 237 TFTGKKP 243
G+ P
Sbjct: 191 MAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 44 FSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALK------SFNVECEMMKSIR 96
F ++GKGGFG V ++ G A K L+ R K + N E +++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALN-EKRILEKVN 58
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYL 155
R ++ + + ++ LVL M G L+ ++Y+ N D + + ++ LE L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
I++ DLKP N+LLDD +SD +A V + T T+GYMAPE
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLA---VQIPEGETVRGRVGTVGYMAPEV 172
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
+ + + D + G ++ E G+ P
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 11/153 (7%)
Query: 87 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNI 144
+E +++++ H ++I++ + + +VL PH S + Y Y + L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
+ L YLH + IIH D+K N+ ++D + D A+ V + T
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMET 237
T APE + ++ D++S GI+L E
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 49/234 (20%)
Query: 49 LIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRHRNLIKVI 104
L+GKG G V+ RL G G A+KV + + E E++ ++ H L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLH-FGYSA 161
+S E + LV++Y P G L + L C+ + R +V ALEYLH G
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLLG--- 123
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL---------------VGEDQSMTQTQTFA 206
I++ DLKP N+LL ++ LSDF ++K + ++TF+
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 207 TIG------------YMAPEYGREGRVSANG-----DVYSFGIMLMETFTGKKP 243
Y+APE +S +G D ++ GI+L E G P
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEV-----ISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVI-- 104
++G G +G VYK R + G A+KV ++ + +E M+K HRN+
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81
Query: 105 ----SSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFG 158
S +++ LV+E+ GS+ + ++ N + + + I ++ L +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH-- 138
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY-- 215
+ +IH D+K NVLL +N L DF ++ L D+++ + TF T +MAPE
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 194
Query: 216 ---GREGRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S GI +E G P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 14/222 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-VAVKVF-NLQCGRALKSFNV-ECEMMKSIRHR 98
++F ++G+G +G V K R + E VA+K F + + +K + E +M+++++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++++ + LV EY+ LE N + R I ++ +H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWC 116
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KP N+L+ N V L DF A+ L E + T+ AT Y +PE
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLG 175
Query: 219 GRVSANGDVYSFGIMLME------TFTGKKPTDEIFNGEMTL 254
D++S G +L E F G+ D++F + L
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 46/227 (20%)
Query: 50 IGKGGFGSVYKAR---LGDGMEVAVK----VFN--LQCGRALKSFNVECEMMKSIR-HRN 99
+G+G +G V AR + VA+K VF+ + RAL+ E ++++ R H+N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63
Query: 100 LIK------VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD------IFQRLNIMID 147
+ V NE + L E M L + + S + D I+Q L
Sbjct: 64 ITCLYDMDIVFPGNFNELY--LYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL----- 115
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL--VGEDQSMTQTQTF 205
L+Y+H SA ++H DLKP N+L++ + + DF +A+ + + T+
Sbjct: 116 --CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 206 ATIGYMAPEYGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGE 251
AT Y APE + DV+S G +L E G+KP +F G+
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V A + G VAVK +L+ + + E +M+ +H N++++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+E++ G+L + + ++ Q + + V AL LH + +IH D+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + E + T +MAPE D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ-EDIHFVAKEQ 287
S GIM++E G+ P FN P+ ++++ NL + +++H V+
Sbjct: 201 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPKLKNLHKVSP-S 245
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ L V P QR A E++K
Sbjct: 246 LKGFLDRL----LVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRNLIKVIS--- 105
IGKG FG V + R D +++ L+ R K+ V E+ ++ R ++ ++
Sbjct: 1 IGKGSFGKVMQVRKRD----TQRIYALKTIR--KAHIVSRSEVTHTLAERTVLAQVNCPF 54
Query: 106 ------SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
S + E LVL ++ G L +L D+ + ++ ALE LH
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH--- 110
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGRE 218
+I+ DLKP N+LLD L DF + KL + +D +T TF T Y+APE
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLG 167
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G++L E TG P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 50 IGKGGFGSVY-----KARLGDGMEV--AVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+GKG FG+VY KA + ++V + V L +++ N E +++ + H ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 103 VISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+S + ++ EY L+ + L + L Q I + + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--- 123
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE-DQSMTQTQTFATIGYMAPEYGRE 218
I+H DLK N+ L +N++ + DF +++LL+G D + T T T YM+PE +
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEALKH 179
Query: 219 GRVSANGDVYSFGIMLME 236
+ D++S G +L E
Sbjct: 180 QGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V A G +VAVK +L+ + + E +M+ H N++ + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+E++ G+L + + ++ Q + + V AL YLH + +IH D+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + E + T +MAPE D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 229 SFGIMLMETFTGKKP 243
S GIM++E G+ P
Sbjct: 203 SLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 34/217 (15%)
Query: 49 LIGK----GGFGSVYKARLGDGMEVAVKVFNL--QCGRALKSFNVECEMMKSIRHRNLIK 102
LIGK + K + + + VAVK NL LK E + ++H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---NIMIDVASALEYLHFGY 159
++S + +V M +GS E L + + L I+ DV +AL+Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH--- 118
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT-----IGYMAPE 214
S IH +K S++LL + LS + ++ + F + +++PE
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 215 --------YGREGRVSANGDVYSFGIMLMETFTGKKP 243
Y D+YS GI E G P
Sbjct: 179 VLQQNLQGYN------EKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 50 IGKGGFGSVYKA---RLGDG-----MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+G+G F ++K +GD EV +KV + +SF MM + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
C + +V EY+ GSL+ YL + +++I +L + +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119
Query: 162 PIIHCDLKPSNVLL---DDNMVAH-----LSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
+ H ++ NVLL +D + LSD I+ ++ ++ + + I ++ P
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER------IPWVPP 173
Query: 214 EYGREGR-VSANGDVYSFGIMLMETFTG 240
E + +S D +SFG L E F+G
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRHRNLIKVI 104
L+GKG FG V R G A+K+ + A E ++++ RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ + V+EY G L +L + R ++ SALEYLH S ++
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA 223
+ D+K N++LD + ++DF + K + + +M +TF T Y+APE +
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLEDNDYGR 174
Query: 224 NGDVYSFGIMLMETFTGKKP 243
D + G+++ E G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKSFNVECEMMK 93
+ + + + + +G G +GSV A G+ VAVK + Q K E ++K
Sbjct: 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71
Query: 94 SIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
++H N+I ++ + S EEF + L ++ L + D Q L + +
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQI 129
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D MT
Sbjct: 130 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-------- 175
Query: 209 GYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
GY+A + R + N D++S G ++ E TG+
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 50/228 (21%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKS------- 94
++F +IG+G FG V R + + +V+ ++ L F EM+K
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVR----HKSSKQVYAMKL---LSKF----EMIKRSDSAFFW 91
Query: 95 -----IRHRN---LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 146
+ H N ++++ + ++++ +V+EYMP G L L S+ I + + R
Sbjct: 92 EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA- 149
Query: 147 DVASALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+V AL+ +H G+ IH D+KP N+LLD + L+DF + + + +
Sbjct: 150 EVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAV 204
Query: 206 ATIGYMAPE----------YGREGRVSANGDVYSFGIMLMETFTGKKP 243
T Y++PE YGRE D +S G+ L E G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRE------CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 136 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195
L L+ VA +E+L S +H DL NVLL + + DF +A+ ++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+++ TF + +MAPE + + DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVE---CE-----MMKSIRHRNL 100
+G+G FG V A G A+K L+ G + VE CE S RH L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS---ALEYLHF 157
+ + + E+ V+EY G L ++++ D+F + A L+YLH
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH- 118
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
I++ DLK N+LLD ++DF + K +G +T TF T ++APE
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAPEVL 173
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
E + D + G+++ E G+ P +E+F+
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNL------ 100
L+G G +G VYK R + G A+KV ++ G + E M+K HRN+
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 101 -IKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHF 157
IK +++ LV+E+ GS+ + ++ N + + + I ++ L +LH
Sbjct: 72 FIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH- 128
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY- 215
+IH D+K NVLL +N L DF ++ L D+++ + TF T +MAPE
Sbjct: 129 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVI 183
Query: 216 ----GREGRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S GI +E G P
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 50 IGKGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
+G+G + +VYK R L D + VA+K L+ + E ++K ++H N++ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ LV EY+ L++YL +++ N+ + + L L++ + ++H
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--YGREGRVSAN 224
DLKP N+L+++ L+DF +A+ + T + T+ Y P+ G S
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGST-DYSTQ 185
Query: 225 GDVYSFGIMLMETFTGK 241
D++ G + E TG+
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSIR 96
++F+ +G G FG V A + V + + + +K V E +++ I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALE 153
H + + S +E + LVLE++ G +L + + F I++ E
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFE 145
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---Y 210
YL S I++ DLKP N+LLD + ++DF AK++ T+T+ G Y
Sbjct: 146 YLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--------DTRTYTLCGTPEY 194
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE D ++ GI + E G P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 50 IGKGGFGSVYKARLGDGME-VAVKVFNL---QCGRALKSFNVECEMMKSIRHRNLIKVIS 105
IG G FG+VY A E VAVK + Q + E + ++ ++H N I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI----FQRLNIMIDVASALEYLHFGYSA 161
E LV+EY L S++ +L++ Q + I AL+ L + +S
Sbjct: 89 CYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY-MAPEY---GR 217
+IH D+K N+LL + L+DF G + +F Y MAPE
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADF-------GSASKSSPANSFVGTPYWMAPEVILAMD 193
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 249
EG+ DV+S GI +E K P +FN
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPP---LFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+IG+G FG V R +V A+K+ F + F E ++M ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ ++++ +V+EYMP G L L S+ + + + + +V AL+ +H S +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH---SMGLI 164
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYMAPEY----GREG 219
H D+KP N+LLD + L+DF + ++ M + T T Y++PE G +G
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
D +S G+ L E G P
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 4/128 (3%)
Query: 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180
P + L + + L + VA+ +E+L S +H DL NVL+ + +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277
Query: 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT- 239
+ DF +A+ ++ + +++ TF + +MAPE + DV+SFGI+L E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337
Query: 240 GKKPTDEI 247
G P E+
Sbjct: 338 GGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-08
Identities = 32/150 (21%), Positives = 65/150 (43%), Gaps = 23/150 (15%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECE--MMKSIRHRNLI--KVI 104
L+ G VY D + +K+ K + E E +++ + + L KV+
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINP----SREKGADREREVAILQLLARKGLPVPKVL 59
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI- 163
+S ++ + L++E++ +L++ + ++ +I +A L LH P+
Sbjct: 60 ASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH---QLPLL 108
Query: 164 --IHCDLKPSNVLLDDNMVAHLSDFSIAKL 191
H DL P N+L+DD + + D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 62/240 (25%), Positives = 93/240 (38%), Gaps = 63/240 (26%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR--ALKS--------------FNVECEMM 92
LIGKGG G VY A ++ C R ALK F E ++
Sbjct: 9 LIGKGGMGEVYLA------------YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIA 56
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPH--GSLEKYLYSSNCILDIFQR--------- 141
+ H ++ V S CS+ + V MP+ G K L S + +
Sbjct: 57 ADLIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG 113
Query: 142 --LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ-- 197
L+I + + +EY+H S ++H DLKP N+LL + D+ A E++
Sbjct: 114 AFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 198 -------------SMTQT-QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
SMT + T YMAPE S + D+Y+ G++L + T P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 53/218 (24%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSF------NVECEMMKSIRHRNL 100
+G G +GSV Y RL +VAVK + R +S E ++K ++H N+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 101 IKVIS----SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVAS 150
I ++ + S E F + L G+ N I+ Q+L+ ++ +
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLSDEHVQFLIYQLLR 129
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
L+Y+H SA IIH DLKPSNV ++++ + DF +A+ D MT GY
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMT--------GY 175
Query: 211 MAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
+A + R + N D++S G ++ E GK
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 50 IGKGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
+G+G + +V+K R L + + VA+K L+ + E ++K+++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E LV EY+ L++YL NC ++ N+ I + L L + + I+H
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYL--DNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP-------EYGREG 219
DLKP N+L+++ L+DF +A+ + T + T+ Y P EY
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEY---- 181
Query: 220 RVSANGDVYSFGIMLMETFTGK 241
S D++ G +L E TG+
Sbjct: 182 --STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 43/186 (23%), Positives = 79/186 (42%), Gaps = 29/186 (15%)
Query: 50 IGKGGFGSVYKARL---GDGMEVAVKVFNLQCGRALKSFNV--------ECEMMKSIRHR 98
IG+G +G VYKA+ DG E A+K F + K E +++ ++H
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62
Query: 99 NLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL---NIMIDVASALE 153
N++ ++ K+ L+ +Y H + + +++ + + +
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 154 YLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATI 208
YLH S ++H DLKP+N+L+ + V + D +A+L + + TI
Sbjct: 123 YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 209 GYMAPE 214
Y APE
Sbjct: 180 WYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 4/109 (3%)
Query: 136 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195
LD+ L VA +++L S IH D+ NVLL D VA + DF +A+ ++ +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + +MAPE + + DV+S+GI+L E F+ GK P
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 50/230 (21%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVI---- 104
+G G G V+ A D VAVK L +++K E ++++ + H N++KV
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 105 --SSCSNEEFKAL--------VLEYMP---HGSLEKYLYSSNCI-LDIFQRLNIMIDVAS 150
S E+ +L V EYM LE+ S L ++Q L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQ----TQTF 205
L+Y+H SA ++H DLKP+NV ++ +++V + DF +A+++ D + ++
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGL 179
Query: 206 ATIGYMAPEYGREGRVSANG-----DVYSFGIMLMETFTGKKPTDEIFNG 250
T Y +P +S N D+++ G + E TGK +F G
Sbjct: 180 VTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKSFNVECEM 91
+L +++ +IG+G FG V R +V A+K+ F + F E ++
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
M ++++ + ++ + +V+EYMP G L L S+ + + + R +V A
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLA 154
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L+ +H S IH D+KP N+LLD + L+DF + + ++ + T Y+
Sbjct: 155 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYI 210
Query: 212 APEY----GREGRVSANGDVYSFGIMLMETFTGKKP 243
+PE G +G D +S G+ L E G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 45/196 (22%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 50 IGKGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
+G+G + +V+K R L + + VA+K L+ + E ++K ++H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
++ LV EY+ L++Y+ I+ + N+ I + L L + + ++H
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR-EGRVSANG 225
DLKP N+L+++ L+DF +A+ + T + T+ Y P+ S
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 226 DVYSFGIMLMETFTGK 241
D++ G + E +G+
Sbjct: 187 DMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 49 LIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMK------SIRHRNLI 101
++GKG FG V A R G A+K+ L+ ++ +VEC M++ S + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ S + V+EY+ G L + + F+ + + A L F +S
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGR 220
II+ DLK NV+LD ++DF + K + + T+TF T Y+APE
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQP 177
Query: 221 VSANGDVYSFGIMLMETFTGKKP-----TDEIFNGEM 252
+ D ++FG++L E G+ P DE+F M
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 18/217 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMMKSIR 96
+F +L+G+G FG V R GD M+V +K L + F E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ + +++ LV+EY P G L L N D F +A + +H
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIH 116
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDF-SIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
+ +H D+KP NVL+D L+DF S A+L ++ + T Y+APE
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA--NKMVNSKLPVGTPDYIAPEV 174
Query: 216 ------GREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
+G D +S G++ E G+ P E
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 22/200 (11%)
Query: 66 GMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVIS----SCSNEEFKA--LVL 117
G+ VAVK + Q K E ++K + H+N+I +++ S EEF+ LV+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD 177
E M +L + ++ LD + ++ + +++LH SA IIH DLKPSN+++
Sbjct: 106 ELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 158
Query: 178 NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMET 237
+ + DF +A+ + T T Y APE N D++S G ++ E
Sbjct: 159 DCTLKILDFGLART---ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
Query: 238 FTGKKPTDEIFNGEMTLKHW 257
G IF G + W
Sbjct: 216 VKGSV----IFQGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 52/218 (23%)
Query: 49 LIGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVI- 104
+G G +GSV A G +VA+K + Q K E ++K ++H N+I ++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 105 ---SSCSNEEFKA--LVLEYM---------PHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
S+ S +EF+ LV+ YM S +K Y ++Q L
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL------VYQML-------C 128
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
L+Y+H SA IIH DLKP N+ ++++ + DF +A+ D MT GY
Sbjct: 129 GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT--------GY 174
Query: 211 MAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
+ + R V N D++S G ++ E TGK
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVI 104
+IG+G + V RL ++ A+KV + + E + + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 105 SSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
SC + LV+EY+ G L ++ + + R ++ AL +LH I
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVS 222
I+ DLK NVLLD + L+D+ + K +G + T TF T Y+APE R
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEILRGEEYG 174
Query: 223 ANGDVYSFGIMLMETFTGKKPTDEI 247
+ D ++ G+++ E G+ P D I
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 48/172 (27%), Positives = 72/172 (41%), Gaps = 40/172 (23%)
Query: 88 ECEMMKSIRHRNLIKVIS----SCSNEEFKA--LVLEYMP------------HGSLEKYL 129
E +MK + H+N+I +++ S EEF+ LV+E M H + L
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL 124
Query: 130 YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
Y C +++LH SA IIH DLKPSN+++ + + DF +A
Sbjct: 125 YQMLC----------------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
Query: 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 241
+ G M T T Y APE N D++S G ++ E G
Sbjct: 166 R-TAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMK------SI 95
+F+ ++GKG FG V A R G A+K+ L+ ++ +VEC M++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPG 58
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+ L ++ S + V+EY+ G L ++ + F+ + + A L
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGL 114
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE 214
F +S II+ DLK NV+LD ++DF + K + ++ T+TF T Y+APE
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPE 171
Query: 215 ------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFNGEM 252
YG+ + D ++FG++L E G+ P DE+F M
Sbjct: 172 IIAYQPYGK------SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 23/228 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVA-VKVFNLQCGRALK---SFNVECEMMKSIRHRNLIKVIS 105
IG G FG V + + VA V V L+ + K F + + + ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYS 160
C LV EY G L+ YL N L + QR+ ++A+ + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMH---K 117
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY--GRE 218
+H DL N L ++ + D+ I ED T+ + ++APE
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 219 GRVSAN-----GDVYSFGIMLMETF-TGKKPTDEIFNGEMTLKHWVND 260
G + +V++ G+ L E F +P + + E+ L H + D
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-LNHVIKD 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA +E+L S IH DL N+LL +N V + DF +A+ + + + +
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA +E+L S IH DL N+LL +N V + DF +A+ + + + +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 56/207 (27%), Positives = 83/207 (40%), Gaps = 35/207 (16%)
Query: 53 GGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111
G G V+ + GD V V + G+ E +++K+I HR +I +I +
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR---EIDILKTISHRAIINLIHAYRW-- 157
Query: 112 FKALVLEYMPHGSLEKYLY-------SSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
K+ V MP + + Y + I +RL AL YLH II
Sbjct: 158 -KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL------LEALAYLH---GRGII 207
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM---APEYGREGRV 221
H D+K N+ LD+ A L DF A L D Q + G + +PE
Sbjct: 208 HRDVKTENIFLDEPENAVLGDFGAACKL---DAHPDTPQCYGWSGTLETNSPELLALDPY 264
Query: 222 SANGDVYSFGIMLME------TFTGKK 242
A D++S G++L E T GK+
Sbjct: 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNL--QCGRALKS-FNVECEMMKSIRH 97
++F +IG+G FG V +L + +V A+K+ N RA + F E +++ + +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQ-RLNIMIDVASALEY 154
+ + + + +E LV++Y G L L + D+ + L M+ ++
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF-SIAKLLVGEDQSMTQTQTFATIGYMAP 213
LH+ +H D+KP N+L+D N L+DF S KL+ ED ++ + T Y++P
Sbjct: 121 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISP 172
Query: 214 EYGR-----EGRVSANGDVYSFGIMLMETFTGKKP 243
E + +G+ D +S G+ + E G+ P
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA +E+L S IH DL N+LL +N V + DF +A+ + + + +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNL--QCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG+G FG + DG + +K N+ + + E ++ +++H N+++ S
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM---IDVASALEYLHFGYSAPI 163
+V++Y G L K + + +L F I+ + + AL+++H I
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVH---DRKI 122
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYMAPEYGREGRVS 222
+H D+K N+ L + L DF IA++L + ++ +T T Y++PE +
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 223 ANGDVYSFGIMLMETFTGK 241
D+++ G +L E T K
Sbjct: 180 NKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI 95
L TD + IGKG +G VYK DG AVK+ + + E +++S+
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSL 75
Query: 96 -RHRNLIKVI------SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN----- 143
H N++K + LVLE GS+ + + +L QRL+
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKG---LLICGQRLDEAMIS 131
Query: 144 -IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202
I+ L++LH + IIH D+K +N+LL L DF ++ L + +
Sbjct: 132 YILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRN 186
Query: 203 QTFATIGYMAPEY-----GREGRVSANGDVYSFGIMLMETFTGKKPTDEI 247
+ T +MAPE + A DV+S GI +E G P ++
Sbjct: 187 TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 69/315 (21%), Positives = 117/315 (37%), Gaps = 66/315 (20%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR------ALKSFNVECEMMKS 94
D + + IG+G +G VYKAR G VA+K L+ AL+ E +++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQM 56
Query: 95 IRHRNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYS----SNCILDIFQRLNI 144
+ I + + E K LV EY+ L+K++ S L +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLVGEDQSMTQTQ 203
M + + + H ++H DLKP N+L+D + ++D + + +S T
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--TH 170
Query: 204 TFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGK--------------------K 242
T+ Y APE S D++S G + E +
Sbjct: 171 EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230
Query: 243 PTDEIFNGEMTLKHW--VNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACA 300
PT++++ G L+ W W P V LS E + + K ++
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD--LSPEGLDLLQK----MLRYD------ 278
Query: 301 VESPEQRINAKEIVK 315
P +RI+AK +
Sbjct: 279 ---PAKRISAKAALT 290
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 11/200 (5%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRHRNLIKVI 104
L+GKG FG V + G A+K+ + A E ++++ RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
S + V+EY G L +L + R ++ SAL+YLH ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNVV 118
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA 223
+ DLK N++LD + ++DF + K + + +M +TF T Y+APE +
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLEDNDYGR 175
Query: 224 NGDVYSFGIMLMETFTGKKP 243
D + G+++ E G+ P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFN---------LQCGRALKSF--NVEC 89
D+F +IG+G FG V ++ + A+K+ N C R ++ N +C
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNI--MI 146
+ + ++ + + +E + LV++Y G L L + + + R I M+
Sbjct: 61 QWITTLHY--------AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV 112
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
++ LH+ +H D+KP NVLLD N L+DF + L + +D ++ +
Sbjct: 113 LAIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVG 165
Query: 207 TIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKP 243
T Y++PE + G+ D +S G+ + E G+ P
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 50 IGKG--GFGSVYKAR-LGDGMEVAVKVFNLQ-CGRA-LKSFNVECEMMKSIRHRNLIKVI 104
IG+G SVY AR G V V++ +L+ C LK+ E + RH N++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLH-FGYSA 161
+ + + ++ +M +GS L Y + + NI+ L YLH GY
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQNGY-- 122
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-----ATIGYMAPEYG 216
IH ++K S++L+ + + LS S LV Q F + + +++PE
Sbjct: 123 --IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180
Query: 217 REGRVSAN--GDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
R+ N D+YS GI E TG+ P ++ +M L+
Sbjct: 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 32/156 (20%)
Query: 50 IGKGGFGSVYKAR--LGDGMEVAVKVFNLQ------CGRALKSFNVECEMMKSIRHRNLI 101
+G+G + +VYK R L + VA+K L+ A++ E ++K ++H N++
Sbjct: 13 LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPF-TAIR----EASLLKDLKHANIV 66
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-------IFQRLNIMIDVASALEY 154
+ ++ LV EY+ L++Y+ L +FQ L L Y
Sbjct: 67 TLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAY 118
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
H ++H DLKP N+L+ + L+DF +A+
Sbjct: 119 CH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 44/218 (20%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRALKSFNVECEMMKSIRHRNLI 101
+IGKG +G V A G +VA+K N R L+ E ++++ +RH +++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62
Query: 102 KVIS---SCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILD------IFQRLNIMIDVAS 150
++ S EFK + V E M L + + +++ + ++Q L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF----- 205
AL+Y+H +A + H DLKP N+L + + + DF +A++ + T T F
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND----TPTAIFWTDYV 167
Query: 206 ATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGK 241
AT Y APE + + D++S G + E TGK
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 40/232 (17%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMK----SIRH 97
+F+ ++GKG FG V A R G A+K+ L+ ++ +VEC M++ +++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 98 RN--LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+ L ++ S + V+EY+ G L ++ + Q + +++ L +L
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLFFL 117
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ---TQTF-ATIGYM 211
H II+ DLK NV+LD ++DF + K + M T+TF T Y+
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK------EHMVDGVTTRTFCGTPDYI 168
Query: 212 APE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFNGEM 252
APE YG+ + D +++G++L E G+ P DE+F M
Sbjct: 169 APEIIAYQPYGK------SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVI 104
+IG+G + V RL + A+KV + + E + + + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 105 SSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
SC E + V+EY+ G L ++ + + R +++ AL YLH I
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA 223
I+ DLK NVLLD L+D+ + K G T + T Y+APE R
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 224 NGDVYSFGIMLMETFTGKKPTD 245
+ D ++ G+++ E G+ P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFN---VECEMMKSIRHRNLIKVI 104
L+GKG FG V R + A+K+ + A E ++++ RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM-IDVASALEYLHFGYSAPI 163
S + V+EY G L + + S + R ++ SAL YLH S +
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDV 116
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTF-ATIGYMAPE------Y 215
++ DLK N++LD + ++DF + K E S +TF T Y+APE Y
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
GR D + G+++ E G+ P
Sbjct: 173 GRA------VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 26/169 (15%)
Query: 88 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN---- 143
E + + H ++K +++ L++EY G L K I QRL
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLP 165
Query: 144 --------IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195
+ + AL+ +H S ++H DLK +N+ L + L DF +K +
Sbjct: 166 FQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY-SD 221
Query: 196 DQSMTQTQTF-ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
S+ +F T Y+APE R S D++S G++L E T +P
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 20/176 (11%)
Query: 88 ECEMMKSIRHRNLIKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQR 141
E +MK + H+N+I +++ S EEF+ + V+E M +L + + LD +
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 128
Query: 142 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201
++ + +++LH SA IIH DLKPSN+++ + + DF +A+ S
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
T T Y APE N D++S G ++ E G +F G + W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 31/109 (28%), Positives = 50/109 (45%), Gaps = 4/109 (3%)
Query: 136 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195
LD L+ VA + +L S IH DL N+LL + + DF +A+ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + +MAPE + DV+S+GI+L E F+ G P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 57/233 (24%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
D+F +IG+G FG V ++ + +V A+K+ N + EM+K
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN------------KWEMLK------- 41
Query: 101 IKVISSCSNEEFKALV---------LEYMPHGSLEKYL----YSSNCILDIFQRLNIMI- 146
+ ++C EE LV L Y YL Y +L + + +
Sbjct: 42 -RAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 147 -DVAS--------ALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDF-SIAKLLVGE 195
D+A A++ +H GY +H D+KP NVLLD N L+DF S +LL
Sbjct: 101 EDMARFYLAEMVLAIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLL--A 154
Query: 196 DQSMTQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKP 243
D ++ T Y++PE + +GR D +S G+ + E G+ P
Sbjct: 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 25/172 (14%)
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNI 144
+MK + N IK+ S + + L+++Y+ G L E L + I Q
Sbjct: 64 LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ---- 117
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-AHLSDFSIAKLLVGEDQSMTQTQ 203
+ AL LH IIH D+K NVL D +L D+ + K ++G
Sbjct: 118 ---LVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTPSCYD--- 167
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
T+ Y +PE + + D ++ G++ E TGK P E + E+ L+
Sbjct: 168 --GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAP 213
L+F + II+ DLK NVLLD L+D+ + K + + T TF T Y+AP
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFCGTPNYIAP 165
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKPTD 245
E R + D ++ G+++ E G+ P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + + +G G +G+V A G +VA+K L RA + E ++K
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70
Query: 95 IRHRNLIKVI----SSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
++H N+I ++ S + F LV+ +M L K + D Q L + +
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFL--VYQM 127
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
L+Y+H +A IIH DLKP N+ ++++ + DF +A+ D M T T
Sbjct: 128 LKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TGYVVTR 179
Query: 209 GYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241
Y APE + D++S G ++ E TGK
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 20/176 (11%)
Query: 88 ECEMMKSIRHRNLIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQR 141
E +MK + H+N+I +++ + EEF+ LV+E M +L + + LD +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 121
Query: 142 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201
++ + +++LH SA IIH DLKPSN+++ + + DF +A+ S
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 175
Query: 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
T T Y APE N D++S G ++ E K +F G + W
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 28/190 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMMKSIR-HRN 99
+EF I +G FG VY R + ++ AVKV K+ + M+ ++ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK-------KADMINKNMVHQVQAERD 56
Query: 100 ---------LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR---LNIMID 147
++ + S + LV+EY+ G ++ L+ I F + + +
Sbjct: 57 ALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISE 112
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA AL+YLH IIH DLKP N+L+ + L+DF ++K+ + + +M T +
Sbjct: 113 VALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPS 169
Query: 208 IGYMAPEYGR 217
+ +Y R
Sbjct: 170 MAKPKNDYSR 179
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 88 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMI 146
E ++++I H ++I++ + + +F L+L P + Y Y ++ + I L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF- 205
V A++YLH IIH D+K N+ ++ L DF A V + + +
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV----DINANKYYG 242
Query: 206 --ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 241
TI APE D++S GI+L E T
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 38/122 (31%), Positives = 54/122 (44%), Gaps = 33/122 (27%)
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK---------LLVGEDQSMTQ 201
ALEYLH + I+H DLKP N+L+ L+DF ++K L G + T+
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 202 ----TQTFATIGYMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDE 246
Q T Y+APE YG+ D ++ GI+L E G P +E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVGCVPFFGDTPEE 223
Query: 247 IF 248
+F
Sbjct: 224 LF 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 56/247 (22%), Positives = 99/247 (40%), Gaps = 57/247 (23%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN- 99
D+F +IG+G FG V + D G A+K+ K+ +E E + IR
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53
Query: 100 ---------LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
++K+ S ++ L++E++P G + L + + + + I +
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVL 112
Query: 151 ALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED------------- 196
A++ +H G+ IH D+KP N+LLD LSDF + L
Sbjct: 113 AIDAIHQLGF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 197 -----QSMTQTQ------------TFATIG---YMAPEYGREGRVSANGDVYSFGIMLME 236
Q+M + ++T+G Y+APE + + D +S G+++ E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 237 TFTGKKP 243
G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 48/206 (23%), Positives = 90/206 (43%), Gaps = 15/206 (7%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLI---KVIS 105
+G+G +G VYKA+ DG + G + S E +++ ++H N+I KV
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 106 SCSNEEFKALVLEYMPHG--SLEKYLYSSNCILDIFQRLNIMID--VASALEYLHFGYSA 161
S S+ + L+ +Y H + K+ +S Q M+ + L+ +H+ ++
Sbjct: 69 SHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 162 PIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLVGEDQSMTQTQ-TFATIGYMAPEYG 216
++H DLKP+N+L+ + ++D A+L + + T Y APE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 217 REGRVSANG-DVYSFGIMLMETFTGK 241
R D+++ G + E T +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 39/173 (22%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
MM+ + H++++ + C + +V E++ G L+ +++ + +L + + +AS
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLL-------DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
AL YL ++H ++ N+LL + LSD I + +++ +
Sbjct: 117 ALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQE 167
Query: 204 TFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
I ++APE + + S D +SFG L E +NGE+ LK
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 57/247 (23%), Positives = 101/247 (40%), Gaps = 57/247 (23%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN- 99
++F +IG+G FG V + D G A+K+ K+ +E E + IR
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERD 53
Query: 100 ---------LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
++K+ S ++ L++E++P G + L + + + + I +
Sbjct: 54 ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVL 112
Query: 151 ALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL---------------VG 194
A++ +H G+ IH D+KP N+LLD LSDF + L +
Sbjct: 113 AIDSIHQLGF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168
Query: 195 ED---QSMTQTQ------------TFATIG---YMAPEYGREGRVSANGDVYSFGIMLME 236
D Q+M + F+T+G Y+APE + + D +S G+++ E
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 237 TFTGKKP 243
G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
E+ + LIG GGFG VY+ + + N Q +++ E +M+++ + N+
Sbjct: 13 EWKIDKLIGCGGFGCVYETQCASDHCI-----NNQAVAKIENLENETIVMETLVYNNIYD 67
Query: 103 VISSCSNEEFKAL----VLEYMPHGS------------LEKYLYSSNCILDIFQRL---- 142
+ + + + +Y GS LEK + ++ +IF+R+
Sbjct: 68 IDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTK---EIFKRIKCKN 124
Query: 143 -----NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV--GE 195
NIM D+ + LEY+H I H D+KP N+++D N ++ D+ IA + G+
Sbjct: 125 KKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGK 181
Query: 196 DQSMTQTQT---FATIGYMAPEYGREGRVSANGDVYSFGIMLME 236
++ Q T+ Y + V+ GD+ S G +++
Sbjct: 182 HIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 45/205 (21%), Positives = 84/205 (40%), Gaps = 22/205 (10%)
Query: 49 LIGKGGFGS--VYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
++G+G FG + + D ++ + A++ E ++ ++H N++ S
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 107 CSNEEFKALVLEYMPHGSLEK-------YLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+ +V+EY G L + L+ + IL F + + ++++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF------VQMCLGVQHIH--- 117
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGRE 218
++H D+K N+ L N L DF A+LL T+ T Y+ PE
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---SPGAYACTYVGTPYYVPPEIWEN 174
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G +L E T K P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN--VECEMMKSIR-HRNLIKVIS 105
IG+G F V KA+ G A+K + ++L+ N E + ++ + H N++++I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 106 SCSNEEFK--ALVLEYMPHGSLE-----KYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
+ + ALV E M E K + + M + +L+++H
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVK------SYMYQLLKSLDHMH-- 117
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE---- 214
I H D+KP N+L+ D+++ L+DF + G T+ +T Y APE
Sbjct: 118 -RNGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAPECLLT 172
Query: 215 ---YGREGRVSANGDVYSFGIM-LMETFTGKKPTDEI 247
YG + + A G V+ F I+ L F G D+I
Sbjct: 173 DGYYGPKMDIWAVGCVF-FEILSLFPLFPGTNELDQI 208
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSC 107
IGKG +G V+K +G + AVK+ + + E ++K++ H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 108 SNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLH 156
++ K LVLE GS+ + L +R+ I+ + L++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY- 215
+ IH D+K +N+LL L DF ++ L + + + T +MAPE
Sbjct: 142 VNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEVI 196
Query: 216 ----GREGRVSANGDVYSFGIMLMETFTGKKPTDEI 247
+ A DV+S GI +E G P ++
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 24/161 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRN 99
D+F +IG+G FG V + D G A+K KS +E E + +R R+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERD 53
Query: 100 L---------IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
+ +K+ S +E + L++EY+P G + L + + R I +
Sbjct: 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL 112
Query: 151 ALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
A++ +H GY IH D+KP N+LLD LSDF +
Sbjct: 113 AIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 48/240 (20%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV----AVKVFNLQCGRALKSFNVECEMMKSIRH 97
+E+ IG G FG V+ + E A+ L+ R +E +M+ ++H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKH 71
Query: 98 RNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYL---------YSSNCILDIFQRLNIMI 146
+N+++ I N+ + L ++E+ G L + + + I+DI ++L
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL---- 127
Query: 147 DVASALEYLHFGYSAP----IIHCDLKPSNVLLDDNM-----------------VAHLSD 185
AL Y H P ++H DLKP N+ L + +A + D
Sbjct: 128 --LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN--GDVYSFGIMLMETFTGKKP 243
F ++K + E SM + T Y +PE S + D+++ G ++ E +GK P
Sbjct: 186 FGLSKNIGIE--SMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 32/180 (17%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMK--SIRH-- 97
++F +IGKG FG V RL + K++ A+K+ ++ EM K + H
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTG-KIY------AMKTL-LKSEMFKKDQLAHVK 49
Query: 98 --RNL---------IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 146
R++ + + S + ++ L++E++P G L L + + R M
Sbjct: 50 AERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMA 108
Query: 147 DVASALEYLH-FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+ A+E +H G+ IH D+KP N+L+D LSDF ++ + S +
Sbjct: 109 ECVLAIEAVHKLGF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 18/192 (9%)
Query: 64 GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123
G + V +KV + +F +M + H +L V C +V E++ HG
Sbjct: 42 GRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHG 101
Query: 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH- 182
L+ L + + ++ + +ASAL YL ++H ++ N+LL +A
Sbjct: 102 PLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158
Query: 183 ------LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLM 235
LSD ++ + ++ + + I ++APE G +S D +SFG L+
Sbjct: 159 TSPFIKLSDPGVSFTALSREERVER------IPWIAPECVPGGNSLSTAADKWSFGTTLL 212
Query: 236 ET-FTGKKPTDE 246
E F G+ P E
Sbjct: 213 EICFDGEVPLKE 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 9e-04
Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 15/206 (7%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLI---KVIS 105
+G+G +G VYKA+ DG + G + S E +++ ++H N+I KV
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 106 SCSNEEFKALVLEYMPHG--SLEKYLYSSNCILDIFQRLNIMID--VASALEYLHFGYSA 161
S ++ + L+ +Y H + K+ +S Q M+ + L+ +H+ ++
Sbjct: 69 SHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 162 PIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLVGEDQSMTQTQ-TFATIGYMAPEYG 216
++H DLKP+N+L+ + ++D A+L + + T Y APE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 217 REGRVSANG-DVYSFGIMLMETFTGK 241
R D+++ G + E T +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 11/144 (7%)
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHF 157
N++ + +E+ LVL++ G L ++ N + +R ++ AL+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRW--AAEMVVALDALH- 102
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
I+ DL P+N+LLDD L+ FS + ED + Y APE G
Sbjct: 103 --REGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM---YCAPEVGG 155
Query: 218 EGRVSANGDVYSFGIMLMETFTGK 241
+ D +S G +L E TGK
Sbjct: 156 ISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 20/75 (26%), Positives = 26/75 (34%), Gaps = 6/75 (8%)
Query: 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL--HF-GYSAPIIHCDLKPSN 172
LE+ + R ++ + L L H IIH DL P N
Sbjct: 151 RLEWDILEPRALLRLDL--VEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDN 208
Query: 173 VLLD-DNMVAHLSDF 186
VL D D V+ DF
Sbjct: 209 VLFDDDTDVSGFIDF 223
|
Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 339 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.57 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.1 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.0 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.83 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.81 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.68 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.67 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.59 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.43 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.3 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.25 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.22 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.16 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.1 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.05 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.05 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.03 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.99 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.8 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.65 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.48 | |
| PLN02236 | 344 | choline kinase | 97.48 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.39 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.38 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.36 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.34 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.27 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.13 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.93 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.87 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.73 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.67 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.64 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.52 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.47 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.13 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.0 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.98 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=367.01 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=217.4
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
.+|...+.||+|+|+.+|.++. .+|..||+|++.+. +....+.+.+|+++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999986 78999999999764 3566788899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+|..++|..+++ ..+.+++.+++.++.||+.||.||| +.+|+|||||..|+|++++.+|||+|||+++.+...
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-- 171 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc--
Confidence 9999999999997 5569999999999999999999999 999999999999999999999999999999988533
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......+|||.|.|||++.....+..+||||+||++|.|+.|++||+...-.+.....
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I--------------------- 230 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI--------------------- 230 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH---------------------
Confidence 23455678999999999999999999999999999999999999999875322211111
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...+...|...+.++++||.++|+.||.+|||+++|+.|
T Consensus 231 k~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 231 KLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111222345678889999999999999999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=345.95 Aligned_cols=257 Identities=24% Similarity=0.311 Sum_probs=215.5
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce-eEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF-KALVL 117 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 117 (339)
.++.+.++.||+|..|+|+++.++ +++-+|+|++... ++...+++.+|+++++..+||+||++|+.|..++. .+++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 357888999999999999999765 6999999999655 35667789999999999999999999999999884 99999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++|+|++++... +.+++..+..++.+++.||.|||. .++|+||||||+|||++..|.|||+|||.+..+...
T Consensus 158 EYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999766 479999999999999999999993 499999999999999999999999999999876322
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
......||..|||||.+.+..|+.++||||||++++|+++|+.||.....+..............
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~------------- 297 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE------------- 297 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-------------
Confidence 45667799999999999999999999999999999999999999887522222222221111110
Q ss_pred cchhhhhhH-HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 278 EDIHFVAKE-QCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 278 ~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
. ....+. .+++++++||..||++||.+||+++++++|=+-
T Consensus 298 p--pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 298 P--PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred C--CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 0 011123 488999999999999999999999999997443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=351.16 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=215.7
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchh-------hhHHHHHHHHHHHhCCCcceeeEeeeee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-------ALKSFNVECEMMKSIRHRNLIKVISSCS 108 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (339)
.+...+.|.+.+.||+|+||.|-+|. .++|+.||||+++..... ......+|+++|++|+||+||+++++|.
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 34577899999999999999999996 558999999999765211 2234568999999999999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC---CcEEEcc
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSD 185 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~---~~v~l~D 185 (339)
..+..|+||||++||+|.+.+..+. .+.+.....++.||+.|+.||| ++||+||||||+|||++.+ ..+||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999999986655 7888888999999999999999 9999999999999999765 7899999
Q ss_pred cccceeccCCCCccccccccCCCCccCCccccCCC---CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
||++... .........+|||.|.|||++.+.. ++.+.|+||+||+||-+++|.+||........... .+
T Consensus 323 FGlAK~~---g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e-QI---- 394 (475)
T KOG0615|consen 323 FGLAKVS---GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE-QI---- 394 (475)
T ss_pred cchhhcc---ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH-HH----
Confidence 9999875 3445567788999999999998764 45688999999999999999999987654431111 10
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
......+....+..++.+..+||.+||..||++|||+.|+|+|=|
T Consensus 395 -----------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 395 -----------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred -----------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 011122233456788999999999999999999999999999754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=334.49 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=210.8
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEee-eeecCc-eeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVIS-SCSNEE-FKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~-~~~ 114 (339)
...+|++++.||.|+||+||++. ..+|..+|.|.++-. +.........|+.+|++|+||||+++++ .|..+. .++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 45689999999999999999995 668999999988744 3556677888999999999999999999 454444 489
Q ss_pred EEEEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 115 LVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
+|||+|++|+|..+++. ..+.+++..+|.++.|++.||..+|..+. ..+.||||||.||+++.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999864 34579999999999999999999993221 239999999999999999999999999999
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
.+. ..........|||.|||||.+.+..|+.+|||||+||++|||+.-++||.+. .-..+...
T Consensus 177 ~l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~K------------- 239 (375)
T KOG0591|consen 177 FLS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKK------------- 239 (375)
T ss_pred Hhc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHH-------------
Confidence 873 3344556788999999999999999999999999999999999999999875 11111111
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
+............+|.++..||.-|+.+||+.||+...++..+++
T Consensus 240 ----I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 240 ----IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111122222346788999999999999999999986555444433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=339.18 Aligned_cols=204 Identities=31% Similarity=0.511 Sum_probs=185.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
...+|.+.+.||.|+|++||+|++. ++..||||.+... +.+..+.+..|+.+|+.++|||||++++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4578999999999999999999754 6899999999877 567778889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC------CcEEEcccccce
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN------MVAHLSDFSIAK 190 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~------~~v~l~Dfg~~~ 190 (339)
||||+||+|.+++++.+ .+++..+..++.||+.|+.+|| +++|+||||||.|||++.. -.+||.|||+++
T Consensus 88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999998776 7999999999999999999999 9999999999999999754 468999999999
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccC
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~ 250 (339)
.+. ........+|+|.|||||++..+.|+.|+|+||+|+++|+|++|+.||......
T Consensus 164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 873 344556778999999999999999999999999999999999999999965443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=341.79 Aligned_cols=267 Identities=30% Similarity=0.464 Sum_probs=221.6
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-eeE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE-FKA 114 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 114 (339)
....+...+.+.||.|+||+||+|.+.....||||++.... ....+.|.+|+.+|++++||||++++|++.... .++
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 33456667777799999999999999544449999997653 222568999999999999999999999999887 799
Q ss_pred EEEEecCCCCHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHhhccCCCC-eEecCCCCCCeEeCCCC-cEEEccccccee
Q 019568 115 LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAP-IIHCDLKPSNVLLDDNM-VAHLSDFSIAKL 191 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~-i~h~di~p~Nil~~~~~-~v~l~Dfg~~~~ 191 (339)
+||||+++|+|.+++.. ....++...+..++.+|+.|+.||| +++ |+|+||||+|||++.++ ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999999999999988 4678999999999999999999999 999 99999999999999998 999999999987
Q ss_pred ccCCCCccccccccCCCCccCCcccc--CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGR--EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
..... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||............ .
T Consensus 194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v--~---------- 259 (362)
T KOG0192|consen 194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV--V---------- 259 (362)
T ss_pred ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--H----------
Confidence 53221 3334467899999999999 568999999999999999999999999987652211111 0
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccc
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNV 328 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~ 328 (339)
....+...+..+++.+..||.+||+.||.+||++.+++..|+.+........
T Consensus 260 -------~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~ 311 (362)
T KOG0192|consen 260 -------VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG 311 (362)
T ss_pred -------hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence 1111222244478889999999999999999999999999999998766533
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=318.67 Aligned_cols=269 Identities=22% Similarity=0.297 Sum_probs=213.0
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
+.|+.+.++|+|+||.|++++++ +|+-||||+|-.. ++...+...+|+++|++++|+|+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 57899999999999999999865 6999999998543 24455667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
||+. ++.+-+++.....+...+..++.|++.|+.|+| +.+++||||||+||+++.+|.+||+|||+++.+.. ..
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PG 155 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC--Cc
Confidence 9977 888888888888999999999999999999999 99999999999999999999999999999998743 33
Q ss_pred cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhH--hhhhccc-----cccccc
Q 019568 199 MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW--VNDWLPI-----STLEVV 270 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~--~~~~~~~-----~~~~~~ 270 (339)
.....+..|.+|+|||++.+ .+|+.+.||||+||++.||++|.+.|.+.++-...+... .....+. ..-.++
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 44556778999999998877 689999999999999999999999887654322111111 0110000 000011
Q ss_pred cccccCccch---hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLSQEDI---HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....++...- -...-+..+..+.+|+++||..||.+|++.++++.|
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111 111224566789999999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=344.33 Aligned_cols=264 Identities=31% Similarity=0.490 Sum_probs=226.3
Q ss_pred HHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 34 YLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 34 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
...+....+.++..+.||+|.||.||.|.++....||+|.+... ....+.|.+|+++|++|+|++||++++++..++.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 44455556677889999999999999999977789999998765 34446788999999999999999999999998899
Q ss_pred EEEEEecCCCCHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 114 ALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
||||||+..|+|.++++. .+..+.....+.++.||++|++||+ +++++||||.+.||||+++..+||+|||+++..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999987 4557889999999999999999999 999999999999999999999999999999943
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
. .+.........-+..|+|||.+..+.++.||||||||++|||++| |+.|+..+.+.+...
T Consensus 354 ~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~----------------- 415 (468)
T KOG0197|consen 354 G-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE----------------- 415 (468)
T ss_pred C-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH-----------------
Confidence 2 223333333334567999999999999999999999999999999 888888765443211
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
..+.+.++..|..||+++.++|..||..+|++|||++.+...|..+..
T Consensus 416 ---~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 416 ---LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ---HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 234566778899999999999999999999999999999988887765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=326.87 Aligned_cols=251 Identities=29% Similarity=0.354 Sum_probs=211.5
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++++.||+|+||.|+.++ .++++-+|+|++++.. .........|..+|..++||+|++++-.|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 46899999999999999999996 4479999999987652 4456788899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
|+||+.||.|...+++.+ .+++..+..++..|+.||.||| ++||+|||+||+|||++.+|.++|+|||++... .
T Consensus 103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~--~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKED--L 176 (357)
T ss_pred EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhc--c
Confidence 999999999999997655 7899999999999999999999 999999999999999999999999999999854 2
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.........+||+.|||||++.+..|+.++|+||||+++|+|++|.+||................
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------------- 241 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------------- 241 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------------
Confidence 23334555789999999999999999999999999999999999999998764433222111000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC----CHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI----NAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~ell~~ 316 (339)
....+...+.+.++|++++|+.||++|. .+.+|-+|
T Consensus 242 -----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred -----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 0111233677899999999999999995 56665554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=340.63 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=213.7
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeecc---chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|..++.||.|+|++|++|+ ..+++.+|||++.+. .+....-+..|-++|.+| .||+|++++-.|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 45799999999999999999997 447999999998654 234445667799999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+|+||+++|+|.++|.+.+ .+++...+.++.+|+.||.||| +.||+||||||+|||++++++++|+|||.+..+..
T Consensus 151 FvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 9999999999999998875 8999999999999999999999 99999999999999999999999999999988754
Q ss_pred CCCc---------ccc--ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc
Q 019568 195 EDQS---------MTQ--TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263 (339)
Q Consensus 195 ~~~~---------~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~ 263 (339)
.... ... ...+||..|.+||++..+..+.++|+|+|||++|+|+.|.+||....+ +..+..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yliFqk---- 298 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLIFQK---- 298 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHHHHH----
Confidence 3222 111 346799999999999999999999999999999999999999986422 111100
Q ss_pred ccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........++.+++.+++||.++|..||.+|+++++|-+|
T Consensus 299 -------------I~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 -------------IQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------------HHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 0111222356667889999999999999999999999886
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=330.85 Aligned_cols=289 Identities=42% Similarity=0.673 Sum_probs=235.7
Q ss_pred ceeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeee
Q 019568 28 MWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107 (339)
Q Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (339)
....|++.++..++++|...+.||+|+||.||+|...+++.||||.+..........|.+|++++.+++|||+++++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 68899999999999999999999999999999999888899999987665433135599999999999999999999999
Q ss_pred ecCc-eeEEEEEecCCCCHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 108 SNEE-FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 108 ~~~~-~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
.+.+ ...+|+||+.+|+|.+.+..... .++|.....|+.++|.||+|||......|+|+|||++|||+|++...||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9888 59999999999999999987766 899999999999999999999964444699999999999999999999999
Q ss_pred cccceeccCCCCccccccc-cCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccc-cCccchHhHhhhhcc
Q 019568 186 FSIAKLLVGEDQSMTQTQT-FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF-NGEMTLKHWVNDWLP 263 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~-~~~~~~~~~~~~~~~ 263 (339)
||++...... ....... .||.+|++||+...+..+.|+||||||++++|++||+.|.+... ..+.....|......
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999543110 1111122 78999999999999999999999999999999999998887654 333345555433333
Q ss_pred c-cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 264 I-STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 264 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
. ...+++|+.+...... ....-..+..+..+|++.+|.+||++.++++.|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~----~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYP----DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCC----hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 3 5666666665421100 00334448889999999999999999999998855543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=325.85 Aligned_cols=261 Identities=30% Similarity=0.429 Sum_probs=213.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc--eeEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE--FKALVL 117 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 117 (339)
..+|...+.||+|+||+||++... +|...|||.+...+....+.+.+|+++|++++|||||++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 567999999999999999999754 58999999998775444677899999999999999999999854444 689999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-CCcEEEcccccceeccC-C
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLVG-E 195 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-~~~v~l~Dfg~~~~~~~-~ 195 (339)
||+.+|+|.+++.+.+..+++..+..+..|+++||.||| ++|++|+||||+|||++. ++.+||+|||++..... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999887768999999999999999999999 999999999999999999 79999999999886643 1
Q ss_pred CCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCccc-ccCccchHhHhhhhcccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEI-FNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
..........||+.|||||++.++ ....++|||||||++.||+||+.||... ............
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~-------------- 238 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE-------------- 238 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc--------------
Confidence 122334456799999999999863 3446999999999999999999999874 111111110000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
......+..++.++++|+.+|+..||++||||+++|+|-..-.+.
T Consensus 239 -----~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 239 -----DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -----CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 011133566788899999999999999999999999998765543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=339.44 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=219.4
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
....|+...+||+|+.|.||.|. ..+++.||||.+........+.+.+|+.+|+..+|+|||++++.|...+.+|.|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 45689999999999999999995 55789999999998887777889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|++||+|.|++.... +++.+++.++..++.||.||| .+||+|+|||.+|||++.+|.+||+|||+|..+... .
T Consensus 351 ym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--Q 423 (550)
T ss_pred ecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc--c
Confidence 999999999987665 999999999999999999999 999999999999999999999999999999887432 2
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......+|||+|||||++....|+.+.||||||++++||+-|++||-....-. +.+... ...
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr---AlyLIa---------------~ng 485 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIA---------------TNG 485 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH---HHHHHh---------------hcC
Confidence 34456679999999999999999999999999999999999999987632211 111111 112
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..++..+...+..+++|+.+||+.|+.+|++++|||+|
T Consensus 486 ~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 23344467788999999999999999999999999996
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=324.22 Aligned_cols=273 Identities=25% Similarity=0.326 Sum_probs=226.4
Q ss_pred eeeeHHHHhhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeee
Q 019568 30 RTFSYLELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSC 107 (339)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (339)
...+-.++....+.|++...||.|..++||+|. ...++.||||++..+. ......+.+|+..++.++||||+.++..|
T Consensus 14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred cccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 334445566678999999999999999999996 6678999999998874 44468899999999999999999999999
Q ss_pred ecCceeEEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 108 SNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 108 ~~~~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
..+..+|+||+|+.+|++.++++.. ...+++..+..++++++.||.||| .+|.+|||||+.|||++.+|.|+|+||
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCc
Confidence 9999999999999999999999764 456999999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCcccc--ccccCCCCccCCccccCC--CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 187 SIAKLLVGEDQSMTQ--TQTFATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 187 g~~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
|....+......... ....++++|||||++..+ .|+.|+||||||+++.||.+|..||....+......+..++..
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 988766543322211 344689999999986543 6999999999999999999999999988776665555444333
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.... ...+......++..++.+|..||+.||++|||++++++|
T Consensus 251 ~~~t-----------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 251 TLLT-----------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred Cccc-----------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 2221 111222234455679999999999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=335.99 Aligned_cols=269 Identities=22% Similarity=0.269 Sum_probs=213.5
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhh-hHHHHHHHHHHHhCC-CcceeeEeeeeecCc-ee
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRA-LKSFNVECEMMKSIR-HRNLIKVISSCSNEE-FK 113 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~ 113 (339)
....++|.+.++||.|+||+||+|+. .+|..||||..+..-... .-.-.+|+..|++++ ||||+++.+++.+.+ .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 34678999999999999999999974 479999999886553222 223367999999998 999999999998877 99
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
|+||||++. +|+++++.+++.+++..+..|+.||++||+++| .+|++|||+||+|||+..+..+||+|||+++.+.
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc
Confidence 999999965 999999999999999999999999999999999 9999999999999999999999999999999763
Q ss_pred CCCCccccccccCCCCccCCccc-cCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.......++.|.+|+|||++ ..+.|+.+.|+||+||+++|+.+-++.|.+... .+.-..+-...+.+....+..
T Consensus 162 ---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 ---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--IDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--HHHHHHHHHHhCCCccccchh
Confidence 33445667789999999965 567899999999999999999999988765422 222111212222211111111
Q ss_pred c------------ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 N------------LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ......+.... ++++.++.+||.+||.+||.+||||+++++|
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0 11112222233 3488999999999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=306.24 Aligned_cols=267 Identities=24% Similarity=0.330 Sum_probs=214.1
Q ss_pred cCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchh--hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR--ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|...++||+|.||.||+|+ .++|+.||||+++..+.. ......+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 589999999999999999996 568999999999877432 34567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|++. +|+.+++.....++...+..++.+++.|++||| .+.|.||||||.|+|++.+|.+||.|||+++.+... .
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p--~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP--N 155 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCC--C
Confidence 9976 999999998889999999999999999999999 999999999999999999999999999999987433 3
Q ss_pred cccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc--c-------cc
Q 019568 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS--T-------LE 268 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~--~-------~~ 268 (339)
........|.+|+|||++.|. .|+...|+||+||++.||+-|.+-|.+..+- ..+.........+. . .+
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCcccCcccccccc
Confidence 333344678899999988876 5999999999999999999998876654321 12222221111111 0 01
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....+..+....+. .-+.+++++.+|+.+||.+||.+|+|++|+++|
T Consensus 235 Y~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111122222222 234567778999999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=332.12 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=212.9
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc----ch-hhhHHHHHHHHHHHhCC-CcceeeEeeeeecC
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ----CG-RALKSFNVECEMMKSIR-HRNLIKVISSCSNE 110 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 110 (339)
.....+|.+.+.||+|+||+|+.|.. .++..||+|++... .. .....+.+|+.+++.+. ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 34568999999999999999999964 47899999977653 12 33456778999999998 99999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-CcEEEcccccc
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIA 189 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~-~~v~l~Dfg~~ 189 (339)
..+|+||||+.||+|.+++.. .+++.+..+..+++|+++|++||| ++||+||||||+||+++.+ +++||+|||++
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999999988 558999999999999999999999 9999999999999999999 99999999999
Q ss_pred eeccCCCCccccccccCCCCccCCccccCCC-C-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGR-V-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
.... .........+||+.|+|||++.+.. | +.++||||+|++||.|++|..||+.......... .
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-i---------- 235 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-I---------- 235 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-H----------
Confidence 8652 2334456678999999999999877 7 5899999999999999999999998322211111 0
Q ss_pred ccccccccCccchhhhhhHHH-HHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQC-VSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.......+..+ +.++++|+.+||..||.+|+|+.++++|=|-
T Consensus 236 ----------~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~ 278 (370)
T KOG0583|consen 236 ----------RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWF 278 (370)
T ss_pred ----------hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence 00111223334 7789999999999999999999999966443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=325.15 Aligned_cols=269 Identities=25% Similarity=0.315 Sum_probs=214.1
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--ceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 114 (339)
..+.|+.+++||+|+||.||+|+ ..+|+-||+|++.... ........+|+.+|++|.||||+++.+..... +.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34678999999999999999997 5579999999998775 44556678899999999999999999998765 7899
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+|+||++. +|..++....-.+++.++..++.||++||.||| ++|+.|||||.+|||+|.+|.+||+|||+++++..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999987 999999887778999999999999999999999 99999999999999999999999999999998754
Q ss_pred CCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc--
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD-- 271 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 271 (339)
.... .....+.|.+|+|||++.|. .|+.+.|+||+||||.||++|++.|.+...- .....+....+.+..+.+.
T Consensus 271 ~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv--eQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 271 SGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV--EQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH--HHHHHHHHHhCCCChhccccc
Confidence 3332 34556679999999988776 6999999999999999999999998765322 1212121111111111111
Q ss_pred ---------ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 ---------ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....-...+. ..-..++....+|+..||..||.+|.||.++|.+
T Consensus 348 kLP~~~~~kp~~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHH-HHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111011111 1134567778899999999999999999998863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=332.25 Aligned_cols=277 Identities=27% Similarity=0.399 Sum_probs=230.1
Q ss_pred ccceeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeE
Q 019568 26 VAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKV 103 (339)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~ 103 (339)
.......+..++....+...+...||+|.||+||+|.| ...||||++... .....+.|++|+.++++-+|.||+-+
T Consensus 376 ~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w--hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLF 453 (678)
T KOG0193|consen 376 KNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRW--HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLF 453 (678)
T ss_pred ccccCCccccccccCHHHhhccceeccccccceeeccc--ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheee
Confidence 44556667788888999999999999999999999997 357999998776 45678899999999999999999999
Q ss_pred eeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEE
Q 019568 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL 183 (339)
Q Consensus 104 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l 183 (339)
.|++..++. .||+-||+|.+|+.++.-....+.......|++|+++|+.||| .++|+|+|+|..|||+.++++|+|
T Consensus 454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 454 MGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred ehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEE
Confidence 999998887 8999999999999999888888999999999999999999999 999999999999999999999999
Q ss_pred cccccceeccCCCCccccccccCCCCccCCccccCC---CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh
Q 019568 184 SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG---RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~ 260 (339)
+|||++..-.............+...|||||++..+ +|+..+||||||+++|||++|..||.. .+++ .+...+.
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~d-qIifmVG- 606 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRD-QIIFMVG- 606 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChh-heEEEec-
Confidence 999999865444334444555678889999988755 589999999999999999999999983 2221 1100000
Q ss_pred hccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 261 WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
.+.. ..........|+.++++|+..||.+++++||.+.+|+..|..+..++
T Consensus 607 -----------rG~l--~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 607 -----------RGYL--MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred -----------cccc--CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 0000 01112234678889999999999999999999999999999888765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=326.42 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=210.2
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++++.||+|+||.||+|+ ..+|..+|+|++++.. ......++.|-.+|....+|.||++|..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 67899999999999999999997 4479999999997663 4566788889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||++||++..++.+.+ .+++..+..++.+++.|+..+| +.|++|+||||+|+|+|..|++||+|||++.-+...
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999997665 8999999999999999999999 999999999999999999999999999998543210
Q ss_pred ---------------------CCcc-----c-------------------cccccCCCCccCCccccCCCCCCcchhhHH
Q 019568 196 ---------------------DQSM-----T-------------------QTQTFATIGYMAPEYGREGRVSANGDVYSF 230 (339)
Q Consensus 196 ---------------------~~~~-----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 230 (339)
.... . .-..+|||-|+|||++.+..|+...|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0 013459999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC--
Q 019568 231 GIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-- 308 (339)
Q Consensus 231 G~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-- 308 (339)
|||+||||.|.+||.+....+ .|....... ....+.....+++++++||++||. ||.+|.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~----T~rkI~nwr-------------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQE----TYRKIVNWR-------------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHH----HHHHHHHHh-------------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999998764432 222111111 112222344556889999999999 999997
Q ss_pred -CHHHHHHH
Q 019568 309 -NAKEIVKK 316 (339)
Q Consensus 309 -s~~ell~~ 316 (339)
.++||-+|
T Consensus 437 ~G~~EIK~H 445 (550)
T KOG0605|consen 437 KGAEEIKKH 445 (550)
T ss_pred ccHHHHhcC
Confidence 57777664
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=301.43 Aligned_cols=238 Identities=26% Similarity=0.311 Sum_probs=206.4
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|+.++.||.|+||.|.+++.+ +|..+|+|++.+.. -+..++..+|..+|+.+.||+++++++.+.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 468999999999999999999855 68999999997764 34556778899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||.+||.|..++++.+ .+++..++.++.|++.||.||| +.+|++||+||+|||+|.+|.+||+|||.+..+.
T Consensus 123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 99999999999997766 7999999999999999999999 9999999999999999999999999999998762
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
...-..+|||.|+|||++....++.++|.||||+++|||+.|.+||...... ..+.+...
T Consensus 196 --~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-~iY~KI~~----------------- 255 (355)
T KOG0616|consen 196 --GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-QIYEKILE----------------- 255 (355)
T ss_pred --CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-HHHHHHHh-----------------
Confidence 2355678999999999999999999999999999999999999999876441 11111111
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 308 (339)
. +...|..++.++++|++++|+.|-++|.
T Consensus 256 -~--~v~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 256 -G--KVKFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred -C--cccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 0 1122566788899999999999999993
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=329.30 Aligned_cols=260 Identities=27% Similarity=0.382 Sum_probs=217.9
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|-+.+.||+|+||.||+|+. .+.+.||+|.+.+.. .+..+.+.+|+++++.++||||+.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6899999999999999999974 479999999997653 4567889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+.| +|..++.... .+++..+..++.+++.||.||| +.+|.|+|+||.||+++++|.+|++|||+++... ...
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcc--cCc
Confidence 9987 9999996554 8999999999999999999999 9999999999999999999999999999998763 234
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
.......|||.|||||++.++.|+..+|+|||||++||+.+|++||-...-...... ... .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~-----I~~--------------d 215 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS-----ILK--------------D 215 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH-----Hhc--------------C
Confidence 445566799999999999999999999999999999999999999976422111110 000 0
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH-HHHHHHHHccccc
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK-LLKIRDSLLRNVG 329 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~-l~~~~~~~~~~~~ 329 (339)
+...+...+..+.+|+..+|..||.+|.++.+++.| +++=...+++.+.
T Consensus 216 --~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~ 265 (808)
T KOG0597|consen 216 --PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPA 265 (808)
T ss_pred --CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccc
Confidence 111144778889999999999999999999999986 4444444444433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=324.70 Aligned_cols=262 Identities=24% Similarity=0.408 Sum_probs=207.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecC-
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSNE- 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 110 (339)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 457899999999999999999963 235789999986543 33446788899999999 899999999988654
Q ss_pred ceeEEEEEecCCCCHHHHHhhcC---------------------------------------------------------
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSN--------------------------------------------------------- 133 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~--------------------------------------------------------- 133 (339)
+..+++|||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46889999999999999986431
Q ss_pred ----CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCC
Q 019568 134 ----CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209 (339)
Q Consensus 134 ----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 209 (339)
..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++................+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 24777888999999999999999 99999999999999999999999999999876532222222233345678
Q ss_pred ccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHH
Q 019568 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288 (339)
Q Consensus 210 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (339)
|+|||.+.+..++.++||||||+++|+|++ |..||......+..... .. . ......+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~-~~---~---------------~~~~~~~~~~ 302 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR-LK---D---------------GTRMRAPENA 302 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-Hh---c---------------CCCCCCCCCC
Confidence 999999999999999999999999999997 99998764322111110 00 0 0001113345
Q ss_pred HHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 289 ~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
+.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 67799999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=332.79 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=215.2
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
..-|++++.||.|+.|.|.+|++ .+|+..|||++.+.. ......+.+|+-+|+-+.|||++++|+++++...+|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45689999999999999999974 489999999997652 23345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
.||++||.|.+++.+.+ ++++.+++.+++||+.|+.|+| ..+|||+|+||+|++++..+++||+|||++..- .
T Consensus 91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE---V 163 (786)
T ss_pred EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc---c
Confidence 99999999999997666 7899999999999999999999 999999999999999999999999999999753 2
Q ss_pred CccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
....-...+|+|.|.|||++.|.+| +.++||||.|+|||.|+||+.||++.. ......
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LLl---------------- 222 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLLL---------------- 222 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHHH----------------
Confidence 3333456779999999999999987 789999999999999999999998421 111111
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.-....+..+..++.++++||.+||.+||++|.|.+||++|-+-.
T Consensus 223 KV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 223 KVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred HHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 111223445688899999999999999999999999999997643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=322.38 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=215.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
....|+....||+|+||.||+|.. .+++.||+|++..+. ....+++.+|+.+|.+++++||.++|+.+..+..++++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 456788889999999999999974 479999999998875 455788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+.||++.+.++... .+.+..+..+++.++.|+.||| .++.+|+|||+.||++..+|.++|.|||++..+....
T Consensus 91 ey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred HHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 9999999999996655 5588899999999999999999 9999999999999999999999999999998764322
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......|||.|||||++....|+.|+||||||++++||++|.+|+....+....+. +.+
T Consensus 166 -~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------------Ipk 225 (467)
T KOG0201|consen 166 -KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------------IPK 225 (467)
T ss_pred -hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------------ccC
Confidence 223667899999999999988999999999999999999999999988765322111 111
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ........++..+++||..||+.||+.||+|+++|+|
T Consensus 226 ~-~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 S-APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred C-CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1 1111233677889999999999999999999999986
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=315.76 Aligned_cols=271 Identities=23% Similarity=0.287 Sum_probs=205.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++......++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3578999999999999999999854 689999999875432 22345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+. ++|.+.+......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 156 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-- 156 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--
Confidence 9996 5888888776667899999999999999999999 999999999999999999999999999998754221
Q ss_pred ccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc--c------c
Q 019568 198 SMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST--L------E 268 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~------~ 268 (339)
........+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...................+.. + .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 122234557889999998765 458899999999999999999999998653322222111111100000 0 0
Q ss_pred ccccc---ccCccc-hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 VVDAN---LLSQED-IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 ~~~~~---~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... ...... .........++.+.+|+.+||+.||.+|||++++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 000000 0011112234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=309.82 Aligned_cols=251 Identities=21% Similarity=0.286 Sum_probs=203.1
Q ss_pred CCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccch---hhhHHHHHHHHHHHhCCCcceeeEeeeeec----CceeEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSN----EEFKAL 115 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 115 (339)
+......||+|+++.||+|.. +|+.||||.+..... .....+.+|+.++++++||||+++++++.+ ....++
T Consensus 21 ~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 21 DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEE
Confidence 333347899999999999988 789999999876532 225678899999999999999999999866 356889
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||||+++++|.+++.... .+++.....++.+++.|+.+|| + .+++|+||+|+||++++++.++|+|||++..+..
T Consensus 100 v~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 100 ILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 999999999999997654 6888899999999999999999 7 4889999999999999999999999999875422
Q ss_pred CCCccccccccCCCCccCCccccC--CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
. .....++..|+|||++.+ ..++.++||||||+++|+|++|..||........ ......
T Consensus 176 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~--~~~i~~------------ 236 (283)
T PHA02988 176 P-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI--YDLIIN------------ 236 (283)
T ss_pred c-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHh------------
Confidence 1 123457788999999876 6799999999999999999999999986532211 110000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
.......+..++..+.+|+.+||+.||.+|||++++++.|+.++.
T Consensus 237 -----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 237 -----KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -----cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 000111123467789999999999999999999999999998875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=311.10 Aligned_cols=270 Identities=21% Similarity=0.276 Sum_probs=205.2
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.++|++.+.||.|+||+||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467999999999999999999754 68999999987543 2233467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++ +|.+++......+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--T 157 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--C
Confidence 9976 999988776667889999999999999999999 999999999999999999999999999998754221 1
Q ss_pred cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc-ccccc-cc-----c
Q 019568 199 MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-PISTL-EV-----V 270 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~-~~-----~ 270 (339)
.......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||......+........... ....+ .+ .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12233457889999998765 56899999999999999999999999764322211111000000 00000 00 0
Q ss_pred cccccCcc--chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLSQE--DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........ .......+..+.++++||.+||++||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 00011123456789999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=310.12 Aligned_cols=269 Identities=19% Similarity=0.233 Sum_probs=204.5
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|++.+.||+|+||+||+|... +++.+|+|++.... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999864 68899999987542 2344667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|++++.+..+ ......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~l~~~-~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 155 (287)
T cd07848 81 YVEKNMLELL-EEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N 155 (287)
T ss_pred cCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence 9988666544 444457899999999999999999999 9999999999999999999999999999987653211 1
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc--ccc---------
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--STL--------- 267 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~--------- 267 (339)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........... ......+. ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT-IQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhhCCCCHHHHHhhhccchh
Confidence 122234578899999999988899999999999999999999999976432111100 00000000 000
Q ss_pred -ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 -EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....................++.++.+||.+||++||++|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000111111223467889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=315.29 Aligned_cols=247 Identities=25% Similarity=0.325 Sum_probs=204.5
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999754 68999999987542 234456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--- 153 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccC---
Confidence 9999999999987654 6889999999999999999999 99999999999999999999999999999876522
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||........ .. .....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-~~---~i~~~-------------- 213 (291)
T cd05612 154 --RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-YE---KILAG-------------- 213 (291)
T ss_pred --CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH---HHHhC--------------
Confidence 12234588999999999998999999999999999999999999975422110 00 00000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKKLL 318 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~l~ 318 (339)
....+..++..+++||.+||+.||.+||+ ++++++|-+
T Consensus 214 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 214 ---KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ---CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 00112234667999999999999999995 999999854
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=320.07 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=217.2
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce-eEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF-KALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 116 (339)
.++|..++.+|+|+||.+++++.+ +++.+|+|.+.... ....+...+|+.+++++.||||+.+.+.|..++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 478999999999999999999644 68899999987764 3444577889999999999999999999998888 9999
Q ss_pred EEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 117 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
|+||+||++.+.+.+.. ..+++..+..|+.|++.|+.||| +..|.|||||+.|||+++++.|+|+|||++..+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998766 67999999999999999999999 999999999999999999999999999999987322
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
........|||.|++||++.+.+|+.|+|||||||++|||++-+++|..............
T Consensus 160 --~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~----------------- 220 (426)
T KOG0589|consen 160 --DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR----------------- 220 (426)
T ss_pred --hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh-----------------
Confidence 2355667899999999999999999999999999999999999999987654332222110
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..-...+..++.+++.+|+.||..+|..||++.++|.+
T Consensus 221 ---~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 ---GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11223366778999999999999999999999999996
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=292.34 Aligned_cols=266 Identities=22% Similarity=0.297 Sum_probs=216.8
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec-----
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN----- 109 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 109 (339)
.+....+||++.+.+|+|+|+.|++++ ..+++.+|+|++...+.+..+...+|++..++++|||+++++++...
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 345567899999999999999999997 55799999999999888888999999999999999999999988643
Q ss_pred CceeEEEEEecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeCCCCcEEEc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLS 184 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~~~~~v~l~ 184 (339)
....|++++|+..|+|.+.+... +..+++..++.|+.++++||.+|| +.. +.|+||||.||++++.+.++++
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEE
Confidence 34589999999999999998653 347999999999999999999999 777 9999999999999999999999
Q ss_pred ccccceeccCCCCcc-------ccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccch
Q 019568 185 DFSIAKLLVGEDQSM-------TQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~ 254 (339)
|||+++...-.-... .......|..|+|||++. +...++++|||||||++|.|+.|..||+...+.-...
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 999987642111110 011223578899999875 4567999999999999999999999998754422211
Q ss_pred HhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 255 KHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.. . .......++....++..+.+||+.||+.||.+||++.+++.++..+.
T Consensus 252 aL-----------A------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 AL-----------A------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EE-----------e------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 10 1 12223334445558889999999999999999999999999998764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.72 Aligned_cols=269 Identities=20% Similarity=0.282 Sum_probs=208.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.++|++.+.||+|+||.||+++.. ++..+|+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 578999999999999999999754 68899999987653 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++++|.+++.... .+++..+..++.|++.||.||| +. +++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 999999999986644 6889999999999999999999 75 699999999999999999999999999875421
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc---cc-------
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS---TL------- 267 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~---~~------- 267 (339)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......+. ........... ..
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccccCCccccCccc
Confidence 122334588999999999999999999999999999999999999965432111 00000000000 00
Q ss_pred -----cc--ccccc------------cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 268 -----EV--VDANL------------LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 268 -----~~--~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.. ..... .............++.++++||.+||..||++|||++++++|-+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00 00000 000000011122467789999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=305.07 Aligned_cols=277 Identities=25% Similarity=0.299 Sum_probs=214.9
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEee--ccchhhhHHHHHHHHHHHhCCCcceeeEeeeee
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (339)
..+.........|...+.||.|++|.|+.|.. .+|+.||||++. -.+....++..+|+.+|+.++|+||+.+++++.
T Consensus 12 ~~~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 12 EVFGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred EeeeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 33445566778888899999999999999964 479999999987 445677788999999999999999999999985
Q ss_pred c-----CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEE
Q 019568 109 N-----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL 183 (339)
Q Consensus 109 ~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l 183 (339)
. -...|+|+|+++ .+|..+++... .+++..+..++.|++.||.|+| +.+++|||+||+|++++.+..+||
T Consensus 92 p~~~~~f~DvYiV~elMe-tDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELME-TDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred cccccccceeEEehhHHh-hHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEe
Confidence 5 346899999995 59999996554 6999999999999999999999 999999999999999999999999
Q ss_pred cccccceeccCCCCccccccccCCCCccCCccc-cCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 184 SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
+|||+++................|.+|.|||++ ....|+.+.||||+|||+.||++|++.|.+...- ..........
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~l 244 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELL 244 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhc
Confidence 999999986433233344667789999999965 4567999999999999999999999988764321 1111111111
Q ss_pred cccc---ccccc--------ccc--cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 263 PIST---LEVVD--------ANL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 263 ~~~~---~~~~~--------~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
+.+. ...+. ..+ .....+.. .-+.+++.+.+|+.+||.+||.+|+|++|+|+|
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~-~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSS-IFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHH-HcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1110 00000 001 11111111 124778889999999999999999999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=308.80 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=215.7
Q ss_pred hhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
-....+|++.+.||+|.||.|-+|. ...|+.||||.+++. .....-++.+|+++|+.|+||||+++|.+|++.+..
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 3455799999999999999999996 467999999998765 355667889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
.+||||..+|.|+|++...+ .+++.++..++.||.+|+.|+| ..+++|+|+|.+|||+|.++++||.|||++..+.
T Consensus 129 vivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999997665 7999999999999999999999 9999999999999999999999999999998763
Q ss_pred CCCCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
. .......+|+|.|.+||++.|.+| ++..|-||||++||-|+.|..||++......-..
T Consensus 205 ~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ----------------- 264 (668)
T KOG0611|consen 205 D---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ----------------- 264 (668)
T ss_pred c---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH-----------------
Confidence 2 233456779999999999999887 6889999999999999999999997643321111
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
+....++ .+.-+.+..-||+.||-+||++|.|+.+|.+|.|-
T Consensus 265 --Is~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 265 --ISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred --hhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 0111111 12234557889999999999999999999999873
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=298.65 Aligned_cols=277 Identities=24% Similarity=0.271 Sum_probs=215.5
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchh--hhHHHHHHHHHHHhCCCcceeeEeeeeec--
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGR--ALKSFNVECEMMKSIRHRNLIKVISSCSN-- 109 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 109 (339)
..-|...+.|+.+++|++|+||.||+|+++ +++-||+|.++.+... .--.-.+|+.+|.+.+||||+.+-.+...
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 456778899999999999999999999754 7999999999876432 22345779999999999999999998743
Q ss_pred CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
-+..|+||||++. +|..++..-..++...++..++.|++.|+.||| ...|+|||+|++|+|++..|.+|++|||++
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchh
Confidence 4568999999987 999999888788999999999999999999999 999999999999999999999999999999
Q ss_pred eeccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhh-------hh
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN-------DW 261 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~-------~~ 261 (339)
+.+. ...........|.+|+|||++.+. .|+.+.|+||+|||+.|++++++.|.+.+.-......+.. .+
T Consensus 225 R~yg--sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 225 REYG--SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhc--CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 9873 333445566679999999988876 5999999999999999999999988765433221111111 11
Q ss_pred ccccccccccccccCccchhhhh----hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 262 LPISTLEVVDANLLSQEDIHFVA----KEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.+...+................. ....+....+|+..+|.+||.+|.||++.|+|=
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 11111111111111221111111 112567889999999999999999999999873
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=298.17 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=215.2
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+.++|++...||+|.|+.|+++. ..+|+.+++|++... +....+.+.+|+++-+.|+||||+++.+.+...+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 56889999999999999999985 457999999988654 234667889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---CCCCcEEEcccccceecc
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~---~~~~~v~l~Dfg~~~~~~ 193 (339)
+|+++|++|..-|-++ ..+++..+...++||+++|.|+| ..+|+|+|+||+|+++ +...-+||+|||++..+.
T Consensus 89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999997666444 36888999999999999999999 9999999999999999 355679999999998874
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
.........|||.|+|||++...+|+..+|||+.|++||-|+.|.+||.+..........
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I----------------- 224 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI----------------- 224 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH-----------------
Confidence 333455677999999999999999999999999999999999999999875332211110
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.......+....+.++++.++|+++||..||.+|+|+.|.|+|=|--
T Consensus 225 ~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 225 KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 11112233334677888999999999999999999999999986643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=318.54 Aligned_cols=246 Identities=21% Similarity=0.260 Sum_probs=204.0
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 478999999999999999999754 68999999987542 23445678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+.+++|.+.+.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 99999999999987654 6888899999999999999999 99999999999999999999999999999876522
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....... .+......
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~------------- 230 (329)
T PTZ00263 171 ---RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----IYEKILAG------------- 230 (329)
T ss_pred ---CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----HHHHHhcC-------------
Confidence 1223468899999999999999999999999999999999999996532211 00000000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
....+..++..+++||.+||+.||.+||+ ++++++|
T Consensus 231 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 ----RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00112234567899999999999999996 7999987
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=316.17 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=198.8
Q ss_pred ceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCC
Q 019568 48 NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
+.||+|+||.||++.. .+|+.+|+|++.... ......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999975 479999999987542 234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccccc
Q 019568 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203 (339)
Q Consensus 124 ~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~ 203 (339)
+|.+.+.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... .......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccc
Confidence 9999886544 7899999999999999999999 99999999999999999999999999999865321 1122334
Q ss_pred ccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhh
Q 019568 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFV 283 (339)
Q Consensus 204 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (339)
..|++.|+|||++.+..++.++|||||||++|+|++|..||.......... ... . . ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--~~~--~-------------~----~~~ 213 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE--LIL--M-------------E----EIR 213 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH--HHH--c-------------C----CCC
Confidence 568999999999999999999999999999999999999997532211100 000 0 0 001
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 284 AKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 284 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
.+..++.++.+||.+||+.||++|| ++.++++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1234577799999999999999999 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=306.20 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=203.0
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++|++|+++++++..++..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378899999999999999974 479999999986542 2223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++++|.+.+... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--- 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--- 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---
Confidence 99999998887543 346889999999999999999999 99999999999999999999999999999876421
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........+++.|+|||++.+..++.++||||||+++|+|++|+.||........... . .....
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-~-~~~~~-------------- 218 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE-V-DRRVK-------------- 218 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH-H-HHHhh--------------
Confidence 1122344688999999999999999999999999999999999999986533211000 0 00000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
......+..++.++.+|+.+||+.||.+||+ ++++++|
T Consensus 219 -~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 -EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0001113345677999999999999999997 8999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=319.16 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=205.0
Q ss_pred hcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCce
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEF 112 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 112 (339)
.++|++.+.||+|+||.||+|++ .++..||||+++... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 46899999999999999999962 246689999986543 33445788899999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcC-----------------------------------------------------------
Q 019568 113 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 133 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~----------------------------------------------------------- 133 (339)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886422
Q ss_pred ---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 134 ---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 134 ---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 14677888999999999999999 999999999999999999999999999998765332222
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||........... .....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~-~~~~~---------------- 333 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK-MIKEG---------------- 333 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH-HHHhC----------------
Confidence 22222334567999999999999999999999999999998 8889875432211111 10000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.....+...+.++.+|+.+||+.||++||++.++++.|++.
T Consensus 334 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 --YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00111223456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=308.05 Aligned_cols=262 Identities=23% Similarity=0.408 Sum_probs=203.5
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-----------------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-----------------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIK 102 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-----------------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 102 (339)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 468999999999999999999642 23479999987653 334567889999999999999999
Q ss_pred EeeeeecCceeEEEEEecCCCCHHHHHhhcC------------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeE
Q 019568 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------------CILDIFQRLNIMIDVASALEYLHFGYSAPII 164 (339)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~ 164 (339)
+++++...+..+++|||+.+++|.+++.... ..++...++.++.|++.||.||| +.+++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 9999999999999999999999999885432 23567788999999999999999 99999
Q ss_pred ecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh--CCC
Q 019568 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKK 242 (339)
Q Consensus 165 h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~ 242 (339)
|+||||+||+++.++.++|+|||++..+.............++..|+|||.+.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999876533322222233445778999999988889999999999999999987 567
Q ss_pred CCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 243 PTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 243 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
||......... .......... ........++.++..+.+||.+||+.||.+|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVI--ENAGEFFRDQ-----------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHH--HHHHHHhhhc-----------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77654322110 0000000000 000001113456778999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.51 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=205.8
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999864 68999999987542 234456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.... .+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999996554 6889999999999999999999 99999999999999999999999999999875422
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
......+++.|+|||.+.+..++.++|||||||++|+|++|..||......+.. .. ...... .......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~-i~~~~~-----~~~~~~~-- 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-EN-LKYWKE-----TLQRPVY-- 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-HH-HHhccc-----cccCCCC--
Confidence 233456889999999999999999999999999999999999999754321110 00 000000 0000000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......++.++.+||.+||..+|.+||+++++++|
T Consensus 223 ----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 ----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00012457789999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=309.19 Aligned_cols=264 Identities=25% Similarity=0.344 Sum_probs=210.6
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch--------------hhhHHHHHHHHHHHhCCCcc
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--------------RALKSFNVECEMMKSIRHRN 99 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ 99 (339)
.+-....++|++.+.||+|.||.|-+|+. .+++.||||++.+... ...+..++|+.+|+++.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 33445678999999999999999999974 4699999999965421 22357889999999999999
Q ss_pred eeeEeeeeec--CceeEEEEEecCCCCHHHHHhhcCCc-cCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC
Q 019568 100 LIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 176 (339)
Q Consensus 100 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~ 176 (339)
||+++.+..+ .+.+|+|+|||..|.+.+. ...++ +++.+++.++.+++.||.||| .+||+||||||+|+|++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS 244 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence 9999999865 4679999999988887653 33345 899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccccceeccCC---CCccccccccCCCCccCCccccCCC----CCCcchhhHHHHHHHHHHhCCCCCccccc
Q 019568 177 DNMVAHLSDFSIAKLLVGE---DQSMTQTQTFATIGYMAPEYGREGR----VSANGDVYSFGIMLMETFTGKKPTDEIFN 249 (339)
Q Consensus 177 ~~~~v~l~Dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~P~~~~~~ 249 (339)
.+|.+||+|||.+...... ..........|||-|+|||...++. .+.+.||||+|++||.|+.|+.||-....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999998765221 1112224577999999999877633 47889999999999999999999875432
Q ss_pred CccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 250 GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
- ..+-. +.+..+.+...+....++++||.+||.+||++|.+..+|..|.|.-+.
T Consensus 325 ~----~l~~K---------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 L----ELFDK---------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred H----HHHHH---------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1 11111 112223333344567789999999999999999999999999887654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=311.46 Aligned_cols=242 Identities=23% Similarity=0.303 Sum_probs=198.3
Q ss_pred ceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCC
Q 019568 48 NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
+.||+|+||.||++.. .+|..||+|++.... ......+.+|+++++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999975 469999999987542 234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccccc
Q 019568 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203 (339)
Q Consensus 124 ~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~ 203 (339)
+|..++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... .......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCcccc
Confidence 9998886554 6899999999999999999999 99999999999999999999999999998865321 1112233
Q ss_pred ccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhh
Q 019568 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFV 283 (339)
Q Consensus 204 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (339)
..+++.|+|||.+.+..++.++|+|||||++|+|++|..||............. . . ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~-~----------------~----~~~ 213 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-M----------------E----EIR 213 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh-c----------------C----CCC
Confidence 558899999999999999999999999999999999999997543221110000 0 0 001
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 284 AKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 284 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
.+..+++++.+||.+||+.||.+|| ++.++++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1234567799999999999999998 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=317.22 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=207.2
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeec
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSN 109 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (339)
.-..++|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+++++.+ +|+||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 34557899999999999999999863 124579999987543 33456788899999999 89999999999999
Q ss_pred CceeEEEEEecCCCCHHHHHhhcC--------------------------------------------------------
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSN-------------------------------------------------------- 133 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~-------------------------------------------------------- 133 (339)
.+..++||||+++++|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999885421
Q ss_pred -------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 134 -------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 134 -------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
..+++..++.++.|++.||.||| +.+++|+||||+||++++++.++|+|||++..+........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 24677889999999999999999 99999999999999999999999999999876532221111
Q ss_pred cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||........... .... .
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~-~~~~------------------~ 331 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK-MVKR------------------G 331 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH-HHHc------------------c
Confidence 222234567999999988899999999999999999997 9999976533221111 0000 0
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.....+...+.++.+++.+||+.||.+||++.++++.|+++.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 001112234677999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=303.43 Aligned_cols=257 Identities=28% Similarity=0.517 Sum_probs=208.3
Q ss_pred hcCCCCCceeeecCccEEEEEEeCC-C-----cEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGD-G-----MEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~-~-----~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
.++|++.+.||+|+||.||+|.... + ..+++|.+.... ......+.+|+++++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3589999999999999999997432 2 578999886543 33456688999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC
Q 019568 114 ALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN 178 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~ 178 (339)
++++||+++++|.+++.... ..++...++.++.|++.||.||| +.+++|+||+|+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 99999999999999986532 35788899999999999999999 9999999999999999999
Q ss_pred CcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhH
Q 019568 179 MVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHW 257 (339)
Q Consensus 179 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~ 257 (339)
+.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ...
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~--~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV--IEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH
Confidence 9999999999876533322222334456788999999988889999999999999999998 9999876432211 100
Q ss_pred hhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 258 VNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.. . ......+..++.++.+|+.+||+.||.+||++.+|+++|+++
T Consensus 239 i~---~---------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IR---S---------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HH---c---------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 00 0 001112456788899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=325.98 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=217.7
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeCC-CcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeee-eec---C
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISS-CSN---E 110 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~---~ 110 (339)
++....++++.+.|.+|+|+.||+|++.. |..+|+|+.-..+....+.+.+|+++|++|. |+|||.+++. ... .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 33455788999999999999999998655 4999999998888888999999999999995 9999999993 211 1
Q ss_pred ---ceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeCCCCcEEEc
Q 019568 111 ---EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLS 184 (339)
Q Consensus 111 ---~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~~~~~v~l~ 184 (339)
-...|+||||.|+.|.|++.++. ..+++.+++.|+.++++|+++|| ... ++|||||-+|||++.+|..|||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH---~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH---YLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh---cCCCccchhhhhhhheEEcCCCCEEeC
Confidence 24569999999999999997542 35999999999999999999999 776 9999999999999999999999
Q ss_pred ccccceeccCCCCc-------cccccccCCCCccCCccc---cCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccch
Q 019568 185 DFSIAKLLVGEDQS-------MTQTQTFATIGYMAPEYG---REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254 (339)
Q Consensus 185 Dfg~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~ 254 (339)
|||.++-....... ......+.|+.|+|||++ .+...++|+|||+|||+||-|++..+||+....-.
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--- 265 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--- 265 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---
Confidence 99998754222211 011244579999999954 67789999999999999999999999999753221
Q ss_pred HhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 255 KHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
+....+.+...+.+++.+.+||+.||+.||.+||++-+++.++.+++..-
T Consensus 266 --------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 --------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 23344455556789999999999999999999999999999999998643
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=309.25 Aligned_cols=268 Identities=21% Similarity=0.290 Sum_probs=206.1
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.++|++.+.||+|+||.||++... ++..+++|++.... ......+.+|+++++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 579999999999999999999765 68889999887653 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+.+++|.+++.... .+++..+..++.|++.|+.||| +. +++|+||||+||+++.++.++|+|||++..+..
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 999999999986644 6888999999999999999999 74 799999999999999999999999999865421
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc--------cc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL--------EV 269 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 269 (339)
.......++..|+|||.+.+..++.++|+|||||++|++++|+.||.......... ........... ..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL--MFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH--HhcCcccCCccccccCcccCC
Confidence 11223457889999999999899999999999999999999999997543221110 00000000000 00
Q ss_pred -------cccccc------------CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 270 -------VDANLL------------SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 270 -------~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
...... ............++.++++||.+||+.||++|||++|+++|-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000 0000000001124677999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=300.91 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=213.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..+.|+++++||+|.-|+||++... ++..+|+|++.+.. .+...+...|-+||+.+.||.++.+|+.|+.+...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3468999999999999999999864 57999999997763 4556677889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||.||+|..+.+++. +.+++..++.++..++.||.||| ..||++||+||+|||+-++|+|.|+||+++.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999999988765 57999999999999999999999 99999999999999999999999999998644311
Q ss_pred CC---------------------------------C---------------------ccccccccCCCCccCCccccCCC
Q 019568 195 ED---------------------------------Q---------------------SMTQTQTFATIGYMAPEYGREGR 220 (339)
Q Consensus 195 ~~---------------------------------~---------------------~~~~~~~~~~~~y~aPE~~~~~~ 220 (339)
.. . .......+||-.|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 0 01112334888999999999999
Q ss_pred CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhc
Q 019568 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACA 300 (339)
Q Consensus 221 ~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 300 (339)
.+.+.|+|+||+++|||++|..||.+..+.+.-.. +......+...+..+.+++|||+++|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N-------------------Iv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN-------------------IVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH-------------------HhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 99999999999999999999999998765543222 11223334444567888999999999
Q ss_pred CCCCCCCCC----HHHHHHH
Q 019568 301 VESPEQRIN----AKEIVKK 316 (339)
Q Consensus 301 ~~dP~~Rps----~~ell~~ 316 (339)
.+||++|.. +.||-+|
T Consensus 373 vKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ccChhhhhccccchHHhhcC
Confidence 999999998 8888774
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=300.32 Aligned_cols=256 Identities=22% Similarity=0.388 Sum_probs=206.8
Q ss_pred hcCCCCCceeeecCccEEEEEEe----CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
.++|++.+.||+|+||.||+|.+ ..+..|++|.++... ......+.+|+..+++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 46799999999999999999964 246789999987653 3344578889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++++|||........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999776667899999999999999999999 999999999999999999999999999976543211
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
. ........++..|+|||.+.+..++.++||||||+++|++++ |..||........ ......
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--~~~~~~-------------- 223 (266)
T cd05064 161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--IKAVED-------------- 223 (266)
T ss_pred c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHHHC--------------
Confidence 1 111112234567999999999999999999999999999775 9999976532211 110000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
......+..++..+.+++.+||+.+|.+||++++|++.|.++
T Consensus 224 ----~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 ----GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 001112345677899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.23 Aligned_cols=257 Identities=26% Similarity=0.456 Sum_probs=208.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
.++|++.+.||+|+||+||+|.+. +...|++|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 367999999999999999999753 24679999887553 3345678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
+|||+++++|.+++......+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..+...
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999776667899999999999999999999 999999999999999999999999999999876422
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
..........+++.|+|||.+.+..++.++|+||||+++|++++ |..||........ .......
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~--~~~~~~~------------- 224 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IKAVEDG------------- 224 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH--HHHHHcC-------------
Confidence 22222222334567999999998899999999999999999998 9999865432211 1111000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.....+..++..+.+++.+||+.+|.+||++.+++++|.++
T Consensus 225 -----~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 -----YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011234567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=314.28 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=203.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-C-CcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-D-GMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~-~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|++.+.||+|+||.||+|... + +..||+|++.... ......+.+|+++++.++||||+++++++...+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4568999999999999999999743 3 4689999986542 334556788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||+.+++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999997654 6889999999999999999999 99999999999999999999999999999876421
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
......||+.|+|||++.+..++.++|+|||||++|+|++|..||........ ...... .
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~i~~------------~-- 243 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-YQKILE------------G-- 243 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-HHHHhc------------C--
Confidence 12345688999999999988899999999999999999999999975422110 010000 0
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....+..++..+.++|.+||+.||++|+ +++++++|
T Consensus 244 ------~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 ------IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0011233456789999999999999995 89999997
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=323.91 Aligned_cols=254 Identities=20% Similarity=0.247 Sum_probs=207.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-C-CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-D-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
....|.+.+.||+|++|.||.|... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 3455999999999999999999643 4 6788999876665555667788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 118 EYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 118 e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||+++++|.+.+... ..++++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999887542 346889999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||......+....... . .
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~----~-~--------- 287 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY----G-K--------- 287 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C-C---------
Confidence 2222223445689999999999999999999999999999999999999975432111000000 0 0
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....+..++.++.+||.+||..||++||++.+++.+
T Consensus 288 ------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 288 ------YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 000123456779999999999999999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=310.57 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=198.5
Q ss_pred ceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCC
Q 019568 48 NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.+.||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999975 469999999987542 334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccccc
Q 019568 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203 (339)
Q Consensus 124 ~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~ 203 (339)
+|.+.+.... .+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++..... .......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--ccccccc
Confidence 9998886543 6889999999999999999999 99999999999999999999999999999865321 1122234
Q ss_pred ccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhh
Q 019568 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFV 283 (339)
Q Consensus 204 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (339)
..+++.|+|||.+.+..++.++|||||||++|+|++|..||........ ...... ....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-----~~~~~~----------------~~~~ 213 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILM----------------EDIK 213 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-----HHHhcc----------------CCcc
Confidence 5689999999999999999999999999999999999999975422111 000000 0001
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 284 AKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 284 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
.+..++.++.+||.+||+.||.+|| ++.++++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1234567799999999999999997 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.12 Aligned_cols=260 Identities=28% Similarity=0.482 Sum_probs=210.4
Q ss_pred hcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
.++|.+.+.||+|+||.||++.. .++..+++|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46899999999999999999963 235668999887666666678899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEE
Q 019568 115 LVLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 182 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~ 182 (339)
+++||+++++|.+++.... ..+++..++.++.|++.||.+|| +.|++|+||+|+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 24899999999999999999999 99999999999999999999999
Q ss_pred EcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhh
Q 019568 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
|+|||++................+++.|+|||.+.+..++.++|+||||+++++|++ |..||......... .....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~-~~i~~-- 237 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-ECITQ-- 237 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHc--
Confidence 999999875532222222233335678999999998899999999999999999998 89998755332110 00000
Q ss_pred ccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
. .. ...+..++.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 238 --~---------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 --G---------RV------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --C---------Cc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0 00 001223456799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=300.95 Aligned_cols=257 Identities=27% Similarity=0.492 Sum_probs=212.3
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
....+|++.+.||.|+||.||+|...++..+++|.+..........+.+|+++++.++|+||+++++++......+++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34578999999999999999999877799999999887766566788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++++|.+++... ...++...+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~-- 157 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED-- 157 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCc--
Confidence 99999999999764 346889999999999999999999 999999999999999999999999999998765321
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
........++..|+|||...+..++.++|+||||+++++|++ |+.||......+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~--~~----------------- 218 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ--IT----------------- 218 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH--HH-----------------
Confidence 111223335667999999988889999999999999999998 8999875432111110 00
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.......+..++..+.++|.+||+.||.+|||++++++.|+++
T Consensus 219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 219 -AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0001112345567799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=295.78 Aligned_cols=258 Identities=23% Similarity=0.337 Sum_probs=208.9
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||+|... +++.|+||.+... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999754 7899999987643 2344456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 118 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 118 e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 2345888999999999999999999 99999999999999999999999999998876532
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
. ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.................
T Consensus 159 ~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------------- 223 (267)
T cd08228 159 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC------------- 223 (267)
T ss_pred h--hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC-------------
Confidence 1 1122234577889999999888899999999999999999999999865432211111111100
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.........++..+.++|.+||+.+|++||++.++++.++.++
T Consensus 224 ----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 ----DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0001112345677999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=318.34 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=210.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|.+++.||+|+||.|+++..+ +++.+|||++++.. ....+....|.++++.. +||.+++++.+|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4589999999999999999999754 68999999998763 56677888899999988 5999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||+.||++..+. +...+++..+..++..++.||.||| +.||++||||.+|||+|.+|.+||+|||++...
T Consensus 446 fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~-- 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG-- 518 (694)
T ss_pred EEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc--
Confidence 999999999944433 2236999999999999999999999 999999999999999999999999999999864
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
......+...+|||.|+|||++.++.|+.+.|+|||||+||+|+.|+.||.+....+.--....
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~---------------- 582 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN---------------- 582 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------------
Confidence 3334466778899999999999999999999999999999999999999987544332211111
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
.+...|..++.+..++++++|..+|++|.- +.+|..|
T Consensus 583 -----d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 583 -----DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred -----CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 112235667888999999999999999984 4555553
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=315.31 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=218.9
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
+.|+...+....++-||.|+.|.||+|+. .++.||||+++- .-..+++.|++|+||||+.+.++|.....+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 34445556667788999999999999998 688999998752 2223788999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||||||..|.|..+++... +++......|..+|+.++.||| ...|+|+|||.-||||..+..|||+|||-+..+..
T Consensus 189 IiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999996655 8889999999999999999999 99999999999999999999999999998876532
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
. ...-...||..|||||++.+.+.++|.|||||||+||||+||..||.+.....+-. .
T Consensus 265 ~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----------------G--- 322 (904)
T KOG4721|consen 265 K---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----------------G--- 322 (904)
T ss_pred h---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE----------------e---
Confidence 2 33345668999999999999999999999999999999999999998764332211 1
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
+..-.+.+..+..||+-++-||++||+-.|.+||++.+++.||.-+..++..
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 1223345666889999999999999999999999999999999877665543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=308.47 Aligned_cols=240 Identities=25% Similarity=0.288 Sum_probs=196.4
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 50 ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999754 6889999998653 233456678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccccccc
Q 019568 126 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205 (339)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~ 205 (339)
.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..... .........
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCcccccc
Confidence 99987644 6889999999999999999999 99999999999999999999999999999875321 112233456
Q ss_pred CCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhh
Q 019568 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285 (339)
Q Consensus 206 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (339)
|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ...... .....+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-----~~~~~~----------------~~~~~~ 213 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-----YRKILQ----------------EPLRFP 213 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-----HHHHHc----------------CCCCCC
Confidence 89999999999999999999999999999999999999975422111 000000 001113
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCC---CHHHHHHH
Q 019568 286 EQCVSFVFNLAMACAVESPEQRI---NAKEIVKK 316 (339)
Q Consensus 286 ~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 316 (339)
..++.++.+||.+||+.||.+|| ++.++++|
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 34567799999999999999997 57888876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=310.68 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=198.1
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----ceeE
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE-----EFKA 114 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 114 (339)
+|++.+.||+|+||.||+|.. .++..||||++... .......+.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 689999999999999999975 46899999998643 223345678899999999999999999987432 3579
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 58999886554 6899999999999999999999 99999999999999999999999999999875422
Q ss_pred CCC-ccccccccCCCCccCCccccC--CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 195 EDQ-SMTQTQTFATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 195 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
... ........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..........+......
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCCHHHHH
Confidence 111 112234568899999998866 6789999999999999999999999965432110 00000000000000000
Q ss_pred -----------ccccCccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 -----------ANLLSQEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 -----------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......... ....+.++..+.+++.+||+.||++|||++|+++|
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 00112346678999999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=282.98 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=215.3
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|++.+.||+|-||.||+|+. +++--||+|++.+.. ......+.+|+++-+.|+||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 57899999999999999999974 468889999986653 33446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 117 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
+||..+|.+...+.... +.+++...+.+..|++.|+.|+| ..+++||||||+|+|++..+.++++|||.+..-
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--- 174 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec---
Confidence 99999999999987443 46999999999999999999999 999999999999999999999999999988642
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
........+||..|.+||+..+..++.+.|+|++|++.||++.|.+||++...++. +...
T Consensus 175 -p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-YkrI------------------ 234 (281)
T KOG0580|consen 175 -PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-YKRI------------------ 234 (281)
T ss_pred -CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-HHHH------------------
Confidence 23344556799999999999999999999999999999999999999998763322 2111
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
...+...+..++.+++++|.+||..+|.+|.+..|++.|-+-.
T Consensus 235 --~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 235 --RKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred --HHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 1112223567788899999999999999999999999997754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=316.83 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=203.3
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999754 68999999997542 334456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+.+++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999987654 6899999999999999999999 99999999999999999999999999999865422110
Q ss_pred cc------------------------------------ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCC
Q 019568 198 SM------------------------------------TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 241 (339)
Q Consensus 198 ~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 241 (339)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 001235899999999999999999999999999999999999
Q ss_pred CCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHHH
Q 019568 242 KPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN---AKEIVKK 316 (339)
Q Consensus 242 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 316 (339)
.||......+.. . ...... ..........+++++.+||.+||. +|.+|++ ++++++|
T Consensus 237 ~Pf~~~~~~~~~-~-~i~~~~---------------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQETY-R-KIINWK---------------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHHH-H-HHHcCC---------------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999764321110 0 000000 000011112346779999999997 9999997 9999997
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=300.66 Aligned_cols=255 Identities=31% Similarity=0.512 Sum_probs=206.7
Q ss_pred hcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
.++|.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+++++.+.|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 467999999999999999999642 3578999998765443 457889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcC-------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 114 ALVLEYMPHGSLEKYLYSSN-------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~-------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
+++|||+++++|.+++.... ..+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999996542 34788889999999999999999 999999999999999999999
Q ss_pred EEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhh
Q 019568 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~ 259 (339)
++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... ....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~--~~~~ 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI--ECIT 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHH
Confidence 99999999876432222222233345678999999999999999999999999999998 99998754322110 0000
Q ss_pred hhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 260 DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.. .....+..++..+.+++.+||+.||.+||++.|+++.|+
T Consensus 239 ------------~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ------------QG------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ------------cC------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 000112345677999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=308.59 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=197.7
Q ss_pred CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHH---HhCCCcceeeEeeeeecCceeEEE
Q 019568 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMM---KSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
|++.+.||+|+||.||+|... +++.||||++.... ......+.+|.+++ +.+.||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678999999999999999754 68999999987542 23345566666655 566899999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+++++|...+... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~-- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG-- 153 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--
Confidence 9999999999887543 5899999999999999999999 99999999999999999999999999998864321
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.........+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... ...
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~-i~~----------------- 215 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS-IVN----------------- 215 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh-----------------
Confidence 11223345688999999999999999999999999999999999999975432111000 000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKKL 317 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~l 317 (339)
.....+..++..+.++|.+||+.||.+|| ++.++++|-
T Consensus 216 ---~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 216 ---DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 00011234567789999999999999999 688888863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=315.83 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=206.8
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999854 69999999987542 234567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC-
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED- 196 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~- 196 (339)
||+++++|.+++.+. ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999766 47899999999999999999999 9999999999999999999999999999987653222
Q ss_pred --------------------------CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccC
Q 019568 197 --------------------------QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250 (339)
Q Consensus 197 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~ 250 (339)
.........+|+.|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001223445899999999999999999999999999999999999999765321
Q ss_pred ccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHHH
Q 019568 251 EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-AKEIVKKL 317 (339)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~l 317 (339)
.... . ...+. ..........++.++.+||.+||. ||.+||+ ++++++|-
T Consensus 237 ~~~~-~-i~~~~---------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 237 ETYN-K-IINWK---------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHH-H-HhccC---------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 1100 0 00000 000111112257789999999997 9999999 99999973
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=312.60 Aligned_cols=261 Identities=23% Similarity=0.398 Sum_probs=208.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCc
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIR-HRNLIKVISSCSNEE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 111 (339)
..++|++.+.||+|+||.||+|... .+..||||++.... ......+.+|+++++++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4679999999999999999999742 23469999987543 334467889999999995 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC----------------------------------------------------------
Q 019568 112 FKALVLEYMPHGSLEKYLYSSN---------------------------------------------------------- 133 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~---------------------------------------------------------- 133 (339)
..|+||||+++++|.+++.+..
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999875421
Q ss_pred -------------------------------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC
Q 019568 134 -------------------------------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 176 (339)
Q Consensus 134 -------------------------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~ 176 (339)
..+++..+..++.|++.||.||| +.+++|+||+|+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence 23677788999999999999999 99999999999999999
Q ss_pred CCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchH
Q 019568 177 DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 255 (339)
Q Consensus 177 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~ 255 (339)
.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999999876533222222333446678999999988889999999999999999997 9999876432211111
Q ss_pred hHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 256 HWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
... .......+..++..+.+++.+||+.||++||++.++.+.|+++..
T Consensus 352 ~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 KIK-------------------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHh-------------------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 000 000111234567789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=313.37 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=200.4
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||+||++... +++.+|+|++.... ......+.+|+.++..++|++|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999754 68999999987542 234456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||++|++|.+++.+.. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999997654 7899999999999999999999 99999999999999999999999999999875422110
Q ss_pred c---------------------------------cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCC
Q 019568 198 S---------------------------------MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT 244 (339)
Q Consensus 198 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~ 244 (339)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346899999999999999999999999999999999999999
Q ss_pred cccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCC---CCCCHHHHHHH
Q 019568 245 DEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPE---QRINAKEIVKK 316 (339)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rps~~ell~~ 316 (339)
......+.. . ..... .....+.....++.++++||.+|+. +|. .||+++||++|
T Consensus 237 ~~~~~~~~~-~---~i~~~-------------~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETY-K---KVMNW-------------KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHH-H---HHHcC-------------cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 754321110 0 00000 0000111112356778999998775 444 46899999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.78 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=206.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeec-C
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSN-E 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 110 (339)
..++|++.+.||.|+||.||+|.. .+++.||+|++.... ......+..|+++++++ +|+||+++++++.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 457899999999999999999952 235789999987543 23345677899999999 89999999998754 4
Q ss_pred ceeEEEEEecCCCCHHHHHhhcC---------------------------------------------------------
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSN--------------------------------------------------------- 133 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~--------------------------------------------------------- 133 (339)
...++++||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 57889999999999999885421
Q ss_pred ---CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCc
Q 019568 134 ---CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210 (339)
Q Consensus 134 ---~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 210 (339)
..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 25788889999999999999999 999999999999999999999999999999865333222223334456779
Q ss_pred cCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHH
Q 019568 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCV 289 (339)
Q Consensus 211 ~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (339)
+|||.+.+..++.++|||||||++++|++ |..||......+. ........ .....+..++
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~------------------~~~~~~~~~~ 302 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLKEG------------------TRMRAPEYAT 302 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHhcc------------------CCCCCCccCC
Confidence 99999999999999999999999999998 9999875432211 11100000 0001123445
Q ss_pred HHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 290 SFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 290 ~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
.++.+++.+||+.+|++||++.+++++|..+.+
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 679999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=297.51 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=204.6
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.++|++.+.||+|+||.||+|.. .+++.+++|++..........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 46899999999999999999975 46899999998766555556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++.... .+++..+..++.|++.|+.+|| +.+++|+|++|+||+++.++.++|+|||++..+... ..
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA 161 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence 99999999886543 7899999999999999999999 999999999999999999999999999998765321 11
Q ss_pred ccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 200 TQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
......+++.|+|||.+. ...++.++|+||+|+++|+|++|..||............ ......
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------------~~~~~~ 227 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------------SKSNFQ 227 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------------ecCCCC
Confidence 122345778899999874 345788999999999999999999998654321110000 000000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.. .......++..+.+||.+||+.||++||+++++++|+
T Consensus 228 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PP--KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CC--CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 0011223466799999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=313.40 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=204.9
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|.+.+.||+|+||+||++... +++.||+|++.... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999754 68999999987642 234456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.+....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999877668999999999999999999999 99999999999999999999999999999976532211
Q ss_pred ccccccccCCCCccCCcccc------CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 198 SMTQTQTFATIGYMAPEYGR------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
.......+++.|+|||++. +..++.++||||||+++|+|++|..||........ ...... .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~---~-------- 224 (330)
T cd05601 158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNIMN---F-------- 224 (330)
T ss_pred -eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HHHHHc---C--------
Confidence 1223345889999999876 45678999999999999999999999975432111 110000 0
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.....+.....++.++.+|+.+||+ +|.+||+++++++|
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 -----QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0001111123456779999999998 99999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.40 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=227.2
Q ss_pred hcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
..+....+.||+|.||.||+|+. +....||||.++..... ...+|++|++++..++|||||+++|+|..++-+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 45677889999999999999962 34577999999877655 778999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcC---------C----ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 114 ALVLEYMPHGSLEKYLYSSN---------C----ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~---------~----~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
++|+||+..|+|.+++..+. . +++..+.+.++.||+.|+.||- ++.++|+||...|.||+++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence 99999999999999996431 1 2888899999999999999999 999999999999999999999
Q ss_pred EEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhh
Q 019568 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~ 259 (339)
|||+|||+++.+...+............+|||||.+..++++.+|||||+||+|||+++ |..||.+..+.+.-..
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~---- 717 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC---- 717 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH----
Confidence 99999999998877776666667777889999999999999999999999999999999 8899988766543221
Q ss_pred hhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 260 DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
+..... +..+.+||.++.+||..||+.+|++||+++||-..|+++-+.
T Consensus 718 ---------------i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 ---------------IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ---------------HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 112222 566889999999999999999999999999999999988653
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=307.11 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=197.9
Q ss_pred CceeeecCccEEEEEEe----CCCcEEEEEEeeccc----hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 46899999999999964 358899999987532 2334556789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+.+++|.+.+.+.. .+.+..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (323)
T cd05584 81 YLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--G 154 (323)
T ss_pred CCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--C
Confidence 999999999986654 6788889999999999999999 999999999999999999999999999998653211 1
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||........ .......
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-----~~~~~~~-------------- 215 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-----IDKILKG-------------- 215 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-----HHHHHcC--------------
Confidence 222334589999999999988899999999999999999999999975432110 0000000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKKL 317 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~l 317 (339)
....++.+++.+.+||.+||+.||++|| ++.++++|-
T Consensus 216 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 216 --KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 0111334567799999999999999999 899998863
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.39 Aligned_cols=256 Identities=23% Similarity=0.292 Sum_probs=219.5
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch---hhhHHHHHHHHHHHhCC-CcceeeEeeeeecCce
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIR-HRNLIKVISSCSNEEF 112 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 112 (339)
....+.|++.+.||.|.||.||.+..+ +|+.+|+|++.+... .....+.+|+++|+++. ||||+.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 446678999999999999999999754 599999999976643 34568899999999998 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC----CCcEEEccccc
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD----NMVAHLSDFSI 188 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~----~~~v~l~Dfg~ 188 (339)
.++|||+++||.|.+.+.+. .+++..+..++.|++.++.||| +.|++|+|+||+|+|+.. ++.++++|||+
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999999777 3999999999999999999999 999999999999999942 35899999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
+..... .......+||+.|+|||++....|+...|+||+|+++|.|++|..||.............
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~----------- 251 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL----------- 251 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-----------
Confidence 988643 445667789999999999999999999999999999999999999998765433322111
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.....+.....+.++..+++||++||..||.+|+|+.++|+|-|
T Consensus 252 ------~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 252 ------RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ------cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 11123333446777889999999999999999999999999955
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=294.45 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=202.5
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
++|++.+.||+|+||.||++.++++..+++|.+... ......+.+|+++++.++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 568899999999999999998877788999987643 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 99999998765556889999999999999999999 99999999999999999999999999998875422111 111
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....++..|+|||.+.+..++.++|+||||+++|++++ |+.||........... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~--i~~~~------------------ 218 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM--ISRGF------------------ 218 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHCCC------------------
Confidence 22234567999999988889999999999999999999 8999875432211110 00000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....+...+..+.+++.+||+.||.+||+++++++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0001122345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=313.36 Aligned_cols=255 Identities=21% Similarity=0.295 Sum_probs=201.1
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..|++++.||+|+||+||+|.. .+++.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3689999999999999999974 468999999987542 344567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999986654 6889999999999999999999 99999999999999999999999999998753311000
Q ss_pred ---------------------------------------------ccccccccCCCCccCCccccCCCCCCcchhhHHHH
Q 019568 198 ---------------------------------------------SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGI 232 (339)
Q Consensus 198 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 232 (339)
........||+.|+|||.+.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00011245899999999999889999999999999
Q ss_pred HHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcC--CCCCCCCCH
Q 019568 233 MLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAV--ESPEQRINA 310 (339)
Q Consensus 233 il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dP~~Rps~ 310 (339)
++|+|++|..||............. .. ...........+++++.+||.+|+. .+|..||++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~--~~---------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVI--NW---------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHH--cc---------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999997643222111100 00 0000111122356779999999654 455569999
Q ss_pred HHHHHHH
Q 019568 311 KEIVKKL 317 (339)
Q Consensus 311 ~ell~~l 317 (339)
+++++|=
T Consensus 300 ~~~l~hp 306 (381)
T cd05626 300 DDIKAHP 306 (381)
T ss_pred HHHhcCc
Confidence 9999973
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=306.83 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=201.6
Q ss_pred CCCCCceeeecCccEEEEEEe----CCCcEEEEEEeeccc----hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCcee
Q 019568 43 EFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (339)
+|++.+.||+|+||.||+++. .+++.+|+|++.... ......+..|+.+++.+ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999864 358999999986532 23345678899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++||||+++++|.+.+.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999986544 6899999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.... .......||+.|+|||.+.+. .++.++||||||+++|+|++|..||........... .......
T Consensus 157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~--------- 225 (332)
T cd05614 157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE-VSRRILK--------- 225 (332)
T ss_pred ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH-HHHHHhc---------
Confidence 2211 122234689999999998765 478999999999999999999999975432211111 0000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKKL 317 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~l 317 (339)
.....+..++..+.+|+.+||+.||++|| +++++++|-
T Consensus 226 -------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 226 -------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 00111234567799999999999999999 888999873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=309.11 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=199.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++|+||+++++++...+.+++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 467889999999999999999754 68999999986543 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++++|.+.. ...+..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++..+... .
T Consensus 153 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--M 222 (353)
T ss_pred cCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--c
Confidence 99999986532 3567788899999999999999 999999999999999999999999999998765321 1
Q ss_pred cccccccCCCCccCCccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 199 MTQTQTFATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
.......++..|+|||.+.. ...+.++|||||||++|+|++|+.||........ ........
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~----------- 289 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--ASLMCAIC----------- 289 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHHh-----------
Confidence 12234468899999998743 2345789999999999999999999973322111 10000000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.......+..++.++++||.+||+.||++||++.|+++|=+-..
T Consensus 290 ----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 290 ----MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred ----ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 00011113345677999999999999999999999999855333
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=309.08 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=197.1
Q ss_pred ceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCC
Q 019568 48 NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.+.||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999974 479999999987542 234456678999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 124 ~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
+|.+.+.... .+++..+..++.|++.||.||| + .+++|+||||+||+++.++.++|+|||++...... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccccc
Confidence 9998886544 6899999999999999999999 7 79999999999999999999999999998653211 11223
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||++.+..++.++||||||+++|+|++|..||.......... ... . . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~--~i~--~-------------~----~~ 213 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE--LIL--M-------------E----EI 213 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH--HHh--c-------------C----CC
Confidence 3458999999999999999999999999999999999999996532211100 000 0 0 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
..+..++.++.+|+.+||+.||++|+ ++.++++|
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11233567799999999999999997 99999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=295.90 Aligned_cols=256 Identities=24% Similarity=0.424 Sum_probs=207.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|++.++||+|++|.||+|...++..+++|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 457899999999999999999987778889999876543 3356788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+.+++|.+++... ...++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 9999999998654 346888899999999999999999 99999999999999999999999999999976532111
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......... ......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~--~~~~~~---------------- 220 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM--SALQRG---------------- 220 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH--HHHHcC----------------
Confidence 11122234567999999988889999999999999999998 99998754322111 100000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
........++.++.+++.+||+.+|++||+++++++.|+++
T Consensus 221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 221 --YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00111233566799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=304.00 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=208.1
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCc----EEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGM----EVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~----~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..+|++.+.||+|+||.||+|.+. ++. .||+|++.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 467999999999999999999743 333 48999986543 34456788899999999999999999998765 567
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
++++|+.+++|.+++......++...++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999877667889999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
............+..|+|||.+.+..++.++||||||+++|+|++ |..||......+. ......
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--~~~~~~------------- 226 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSILEK------------- 226 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHhC-------------
Confidence 222222223334667999999999999999999999999999998 9999875422111 110000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
......++.++.++.+++.+||..||.+||++.+++.++..+....
T Consensus 227 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 227 -----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0011112345567899999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=298.73 Aligned_cols=267 Identities=23% Similarity=0.300 Sum_probs=197.9
Q ss_pred cCCCCCceeeecCccEEEEEEe-C-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhC---CCcceeeEeeeee-----c
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-G-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSI---RHRNLIKVISSCS-----N 109 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~ 109 (339)
.+|++.+.||+|+||.||+|.. . ++..||+|.+.... ......+.+|+.+++.+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999975 2 47889999987543 22233455677777766 6999999999874 3
Q ss_pred CceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
....++|+||+.+ +|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 4568999999964 9999886543 45889999999999999999999 99999999999999999999999999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc---c
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI---S 265 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~---~ 265 (339)
+...... .......+++.|+|||.+.+..++.++||||||+++|+|++|.+||........ ..........+ .
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhh
Confidence 8765322 223345578999999999888999999999999999999999999986533211 11111100000 0
Q ss_pred cccc--ccccccC-ccc-hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 266 TLEV--VDANLLS-QED-IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 266 ~~~~--~~~~~~~-~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.... ....... ... ......+.++..+.+|+.+||+.||++|||+.++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 0000000 000 0001123467788999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=293.86 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=206.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|++.+.||+|++|.||+|...+++.|++|.++... .....+.+|++++++++||||+++++++...+..++++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 356799999999999999999987677889999986543 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+.+++|.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999986543 46899999999999999999999 99999999999999999999999999999887632111
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........+..|+|||...+..++.++|+||||+++++|++ |+.||......... .....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--~~~~~----------------- 219 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL--QQVDQ----------------- 219 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHHc-----------------
Confidence 11111222457999999998899999999999999999999 99998754321110 00000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
......+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 220 -GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 000111234567799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=292.03 Aligned_cols=248 Identities=27% Similarity=0.446 Sum_probs=198.0
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
+.||+|+||.||+|... +++.+++|.+.... ......+.+|+++++.++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999754 68999999876443 34456788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccccccc
Q 019568 126 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205 (339)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~ 205 (339)
.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766556899999999999999999999 9999999999999999999999999999987542111111111112
Q ss_pred CCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhh
Q 019568 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVA 284 (339)
Q Consensus 206 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (339)
.+..|+|||.+.+..++.++|+||||+++|++++ |..||........ ...... ......
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~~~~~------------------~~~~~~ 217 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REAIEQ------------------GVRLPC 217 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HHHHHc------------------CCCCCC
Confidence 2456999999998889999999999999999998 8888865432111 000000 000111
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 285 KEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 285 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
+..++..+.+|+.+||+.||++|||+.++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3345677999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=298.51 Aligned_cols=260 Identities=30% Similarity=0.491 Sum_probs=210.4
Q ss_pred hcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..+|.+.+.||+|+||.||+|.. .++..+++|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 35688999999999999999963 235568899887666555677889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC
Q 019568 115 LVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 179 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~ 179 (339)
+||||+++++|.+++.... ..+++..++.++.|++.|+.+|| +++++|+||+|+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence 9999999999999986532 24788999999999999999999 99999999999999999999
Q ss_pred cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHh
Q 019568 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~ 258 (339)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~----- 235 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI----- 235 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----
Confidence 999999999875532222222233445778999999998899999999999999999998 99998765332210
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
..... ... ...+..++..+.+++.+||+.||.+||+++++++.|.++...
T Consensus 236 ~~~~~---------~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQ---------GRV------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhC---------CCC------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 00000 000 001223567799999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=305.97 Aligned_cols=247 Identities=22% Similarity=0.266 Sum_probs=199.2
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCC-cceeeEeeeeecCceeEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRH-RNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 117 (339)
+|++.+.||+|+||.||+|... +++.||||++.... ......+..|.+++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999754 68899999987542 3345667789999999976 46888999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-- 154 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--
Confidence 9999999999886554 6889999999999999999999 999999999999999999999999999988643211
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........|++.|+|||++.+..++.++|+||+|+++|+|++|+.||......+.... .. .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~--i~--~--------------- 215 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS--IM--E--------------- 215 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--HH--c---------------
Confidence 1122344589999999999999999999999999999999999999975432111000 00 0
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINA-----KEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 316 (339)
.....+..++.++.+++.+||+.||.+|++. .++++|
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 216 --HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0001123356678999999999999999976 788776
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.23 Aligned_cols=242 Identities=25% Similarity=0.328 Sum_probs=196.3
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||+||+|... +++.||+|++.... ......+..|..++..+ .||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999754 68999999987542 23445667788888877 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+.+.+.. .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccc
Confidence 99999886654 6899999999999999999999 99999999999999999999999999999865321 112233
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...|++.|+|||.+.+..++.++|+||||+++|+|++|+.||........ ....... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~----------------~~ 213 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILND----------------EV 213 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-----HHHHhcC----------------CC
Confidence 45689999999999999999999999999999999999999975432111 0000000 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINA------KEIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 316 (339)
..+..++.++.+|+.+||+.||.+||++ +++++|
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1122356779999999999999999998 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=314.83 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=200.6
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+++++++.||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999974 479999999986542 334567788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999998654 36889999999999999999999 99999999999999999999999999998863311000
Q ss_pred c-----------c----------------------------------ccccccCCCCccCCccccCCCCCCcchhhHHHH
Q 019568 198 S-----------M----------------------------------TQTQTFATIGYMAPEYGREGRVSANGDVYSFGI 232 (339)
Q Consensus 198 ~-----------~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 232 (339)
. . ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001245899999999999999999999999999
Q ss_pred HHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCC---CC
Q 019568 233 MLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR---IN 309 (339)
Q Consensus 233 il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps 309 (339)
++|+|++|..||......+. +..... . . ....+.....++.++.+||.+||. +|.+| ++
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~-~--~-------------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET-YRKIIN-W--R-------------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH-HHHHHc-c--C-------------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999975432111 110000 0 0 000011112346679999999998 77665 59
Q ss_pred HHHHHHHH
Q 019568 310 AKEIVKKL 317 (339)
Q Consensus 310 ~~ell~~l 317 (339)
+.++++|-
T Consensus 299 ~~~~l~hp 306 (377)
T cd05629 299 AHEIKSHP 306 (377)
T ss_pred HHHHhcCC
Confidence 99999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=293.07 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=204.6
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-----hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-----GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
++|.+.+.||+|++|.||.+.. .+++.+++|.+.... ......+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999974 468999999986542 1234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
++||+++++|.+.+.... .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999986554 6888999999999999999999 999999999999999999999999999998765321
Q ss_pred CCccc-cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMT-QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
..... .....++..|+|||.+.+..++.++|+||||+++|++++|+.||.......... ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~------------ 221 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIAT------------ 221 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH----HHhc------------
Confidence 11111 123446778999999999889999999999999999999999987542211100 0000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.......+..++..+.++|.+||..+|.+||++.++++|.
T Consensus 222 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 222 ---QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 0001112334567799999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=298.12 Aligned_cols=278 Identities=26% Similarity=0.321 Sum_probs=211.2
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-----eeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE-----FKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 114 (339)
.-.|+..+++|.|+||.||.|.. .+++.||||++..+.. --.+|+++|+.+.||||+++.-+|.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 34688999999999999999974 4689999999865532 2245999999999999999998884321 445
Q ss_pred EEEEecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-CcEEEcccccce
Q 019568 115 LVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAK 190 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~-~~v~l~Dfg~~~ 190 (339)
+||||++. +|.++++.. +..++.-.+.-+..||+.||+||| +.|||||||||.|+|+|.+ |.+||+|||++.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999976 999998742 456888889999999999999999 9999999999999999965 999999999999
Q ss_pred eccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
.+..... ......|..|+|||++.|. .|+.+.||||.||++.||+.|++-|.+.+ +...+.........+...++
T Consensus 175 ~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 175 VLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHH
Confidence 8743332 3445567889999988876 69999999999999999999999988743 22333332222222211111
Q ss_pred ----------ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHHHHHHHcccccCc
Q 019568 270 ----------VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK--KLLKIRDSLLRNVGGR 331 (339)
Q Consensus 270 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~l~~~~~~~~~~~~~~ 331 (339)
..+....... ........++++.+|+.++|.++|.+|.++.|++. .+..++......++|.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~-~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~ 323 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPW-HKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGR 323 (364)
T ss_pred hhcCcccccccCcccccccc-eeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCC
Confidence 1111111111 11234566788999999999999999999999997 4777777666665554
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=285.84 Aligned_cols=270 Identities=25% Similarity=0.334 Sum_probs=218.3
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc--------hhhhHHHHHHHHHHHhC-CCcceeeEee
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--------GRALKSFNVECEMMKSI-RHRNLIKVIS 105 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 105 (339)
+-.+.-+.|...+.||.|..++|.++. ..+|..+++|++.... ....+.-.+|+.+|+++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 345567889999999999999999885 4478999999885432 12334557799999999 6999999999
Q ss_pred eeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 106 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
+++.+...++|+|.++.|.|.|++... ..+++.....++.|+++++.||| .++|+|+|+||+|||++++.+++|+|
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence 999999999999999999999999554 48999999999999999999999 99999999999999999999999999
Q ss_pred cccceeccCCCCccccccccCCCCccCCcccc------CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhh
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~ 259 (339)
||+++.+.. .......+|||+|+|||.+. ...|+...|+|++|+++|.|+.|.+||....+--+.-.
T Consensus 167 FGFa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~---- 239 (411)
T KOG0599|consen 167 FGFACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRM---- 239 (411)
T ss_pred cceeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHH----
Confidence 999987643 33445678999999999774 34588899999999999999999999987533211100
Q ss_pred hhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH--HHHHHHccccc
Q 019568 260 DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL--KIRDSLLRNVG 329 (339)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~--~~~~~~~~~~~ 329 (339)
. +..+..+....+.+++.+.++||.+||+.||++|.|++|+|.|=. .+...-.+.+.
T Consensus 240 I-------------meGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~ms 298 (411)
T KOG0599|consen 240 I-------------MEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMS 298 (411)
T ss_pred H-------------HhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccC
Confidence 0 011122333446788999999999999999999999999999743 33344444433
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=294.03 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=203.6
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
++|++.+.||+|++|.||.|...++..+++|.+.... .....+.+|+.+++.++||||+++++++......+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5689999999999999999987667779999886443 234668889999999999999999999998888999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+++|.+++......+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence 99999999776557899999999999999999999 9999999999999999999999999999887653221 1111
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....++..|+|||...+..++.++|+||||+++|+|++ |..||........ ........
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~~~~~~~------------------ 218 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VEKVSQGL------------------ 218 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHHhcCC------------------
Confidence 22234567999999988889999999999999999998 9999875432211 00000000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+...+..+++++.+||+.||.+||++.++++.|+
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00011223567999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=305.96 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=196.6
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... +++.||+|++.... ......+..|.+++..+ +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999754 58899999987542 23445567788888876 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+.+.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccc
Confidence 99999886554 6888999999999999999999 999999999999999999999999999998754221 12223
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||++.+..++.++|+||||+++|+|++|+.||........... ... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-i~~---~-----------------~~ 213 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES-ILH---D-----------------DV 213 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH-HHc---C-----------------CC
Confidence 44588999999999999999999999999999999999999975432111000 000 0 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCC-------CHHHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRI-------NAKEIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~ell~~ 316 (339)
..+..++.++.+|+.+||+.||.+|| +++++++|
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11223466799999999999999999 89999987
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.92 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=209.2
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.++|++.+.||.|++|.||+|... +++.+++|++..........+.+|+++++.++||||+++++.+......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 468999999999999999999754 6889999999877666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+.+++|.+++......+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 9999999998776567999999999999999999999 999999999999999999999999999988765321 11
Q ss_pred ccccccCCCCccCCccccCC---CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 200 TQTQTFATIGYMAPEYGREG---RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
......++..|+|||.+.+. .++.++|+||||+++++|++|..||................ .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~--------------~- 221 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN--------------F- 221 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------C-
Confidence 12234567889999998776 78999999999999999999999987643222111100000 0
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...........+.++.+|+.+||..+|.+|||++++++|
T Consensus 222 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 222 -PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000111234567789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=310.10 Aligned_cols=266 Identities=20% Similarity=0.174 Sum_probs=200.2
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..+|++.+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36899999999999999999975 468999999743 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+. ++|..++.... .+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++....... ..
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 95 58888886543 6889999999999999999999 9999999999999999999999999999986532211 11
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCc------cchHhHhhhhcccc--cc----
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE------MTLKHWVNDWLPIS--TL---- 267 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~------~~~~~~~~~~~~~~--~~---- 267 (339)
......||+.|+|||++.+..++.++|||||||++|+|++|..||-...... .............+ ..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 2234568999999999999999999999999999999999998764322110 11111110000000 00
Q ss_pred ----ccc---cccccCcc--chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 268 ----EVV---DANLLSQE--DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 268 ----~~~---~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
... ........ ...+......+.++.+||.+||+.||.+|||++|+++|=+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 000 00000000 0011122345678999999999999999999999998643
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=298.78 Aligned_cols=249 Identities=35% Similarity=0.574 Sum_probs=196.9
Q ss_pred CCceeeecCccEEEEEEeC-----CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 46 ENNLIGKGGFGSVYKARLG-----DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~-----~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+.+.||.|.||.||+|.+. .+..|+||.+.... ......+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999764 37889999996543 34478899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++... ...+++..++.++.|++.||.||| +.+++|++|+++||+++.++.+||+|||+..........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999887 557999999999999999999999 999999999999999999999999999999876322223
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
...........|+|||.+.+..++.++||||||+++||+++ |..||....... ......
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~~~------------------ 219 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEKLK------------------ 219 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHHHH------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccc------------------
Confidence 33334446677999999999999999999999999999999 678887652221 111110
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.......+..++..+.++|.+||..||.+|||+.++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111122445677799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=314.92 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=201.4
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+++++++.|+||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999975 468999999986542 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.+.. .+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999997654 6888899999999999999999 99999999999999999999999999998753210000
Q ss_pred -----------------------------------------ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHH
Q 019568 198 -----------------------------------------SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLME 236 (339)
Q Consensus 198 -----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 236 (339)
........||+.|+|||++.+..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC---CHHHH
Q 019568 237 TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI---NAKEI 313 (339)
Q Consensus 237 ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~el 313 (339)
|++|+.||......+.... ...+. ..........++.++.++|.+|+ .+|.+|+ ++.++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~--i~~~~---------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 237 MLVGQPPFLADTPAETQLK--VINWE---------------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred hhhCCCCCCCCCHHHHHHH--HhccC---------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 9999999976532211110 00000 00011112235667889999976 5999999 99999
Q ss_pred HHH
Q 019568 314 VKK 316 (339)
Q Consensus 314 l~~ 316 (339)
++|
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=292.97 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=203.3
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
.+|++.+.||+|++|.||++.+.++..+++|.+.... .....+.+|+++++.++||||+++++++...+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4689999999999999999987777789999876432 223467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+++|.+++......+++..++.++.|++.|+++|| +.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-cccc
Confidence 99999999776667899999999999999999999 9999999999999999999999999999887653211 1111
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.. ..... ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~~~------------------~~ 218 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV--ESVSA------------------GY 218 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHHHc------------------CC
Confidence 11223457999999998899999999999999999999 89998754322111 00000 00
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111234577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.44 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=200.8
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++++.||+|+||+||+|.. .+++.+|+|++.... ......+.+|+++++++.|+||+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 3689999999999999999975 468999999987542 334567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 81 DYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999986653 6888999999999999999999 99999999999999999999999999998753210000
Q ss_pred ---------------------------------------------ccccccccCCCCccCCccccCCCCCCcchhhHHHH
Q 019568 198 ---------------------------------------------SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGI 232 (339)
Q Consensus 198 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 232 (339)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235899999999999999999999999999
Q ss_pred HHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC---
Q 019568 233 MLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN--- 309 (339)
Q Consensus 233 il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps--- 309 (339)
++|+|++|+.||......+..... .. . ...........+++++.++|.+|+ .+|.+|++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i-~~-~---------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKV-IN-W---------------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHH-Hc-c---------------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 999999999999764322111100 00 0 000111112345677899999876 59999997
Q ss_pred HHHHHHH
Q 019568 310 AKEIVKK 316 (339)
Q Consensus 310 ~~ell~~ 316 (339)
+.++++|
T Consensus 299 ~~ei~~h 305 (382)
T cd05625 299 ADEIKAH 305 (382)
T ss_pred HHHHhcC
Confidence 9999886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=314.86 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=204.0
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
...++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999754 68999999986432 223345778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||+++++|.+++... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999998654 4788889999999999999999 99999999999999999999999999999876532
Q ss_pred CCCccccccccCCCCccCCccccCC----CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREG----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
.. ........|++.|+|||++.+. .++.++|+|||||++|+|++|..||....... .+.......
T Consensus 195 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~------ 263 (370)
T cd05596 195 NG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMDHK------ 263 (370)
T ss_pred CC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCC------
Confidence 11 1122345689999999987653 47899999999999999999999997643211 111100000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ--RINAKEIVKKL 317 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~l 317 (339)
....+.....++.++.+||.+||+.+|.+ |++++++++|-
T Consensus 264 -------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 264 -------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred -------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 00111112245778999999999999988 99999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=301.83 Aligned_cols=270 Identities=19% Similarity=0.262 Sum_probs=204.4
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.++|++.+.||+|+||+||+|... +++.+|+|.+..... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 478999999999999999999754 688999999875532 233456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++ +|.+.+......++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 158 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--T 158 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC--c
Confidence 9976 898888776667889999999999999999999 999999999999999999999999999998754221 1
Q ss_pred cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc--cccccc-c---
Q 019568 199 MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--STLEVV-D--- 271 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~--- 271 (339)
.......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+.... .......+ ..+... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL-IFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCCHHHHhhhcchhh
Confidence 12223456889999998765 4689999999999999999999999976433211110 00000000 000000 0
Q ss_pred --ccccCc--cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 272 --ANLLSQ--EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 272 --~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
...... ........+.++.++++||.+||+.||.+|||+.|+++|-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 000000 0000112234677899999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=289.73 Aligned_cols=273 Identities=24% Similarity=0.260 Sum_probs=208.6
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcc-eeeEeeeeecCc-----
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRN-LIKVISSCSNEE----- 111 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 111 (339)
...|..+++||+|+||+||+|+. .+|+.||+|++..+.. .......+|+.+|+.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 56688888999999999999974 4789999999987744 24566788999999999999 999999998776
Q ss_pred -eeEEEEEecCCCCHHHHHhhcC---CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccc
Q 019568 112 -FKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187 (339)
Q Consensus 112 -~~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg 187 (339)
.+++|+||++. +|..++.... ..++...+..++.||+.||+||| +++|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 88999999966 9999997765 46888899999999999999999 9999999999999999999999999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc--
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI-- 264 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~-- 264 (339)
+++.+.- .........+|..|+|||++.+. .|+...||||+||+++||++++..|.....-.. ..........+
T Consensus 166 lAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q-l~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ-LFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH-HHHHHHHcCCCCc
Confidence 9985521 22224455678899999998887 699999999999999999999998877654211 11111111111
Q ss_pred ccccccc-cc----ccCccc-hh--hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHH
Q 019568 265 STLEVVD-AN----LLSQED-IH--FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKI 320 (339)
Q Consensus 265 ~~~~~~~-~~----~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~ 320 (339)
..+.... .. ...... .. ....+....+..+++.+||+++|.+|.|++.+++| +..+
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111110 00 000110 00 00112222578999999999999999999999998 5544
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=304.66 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=197.6
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||++... +++.||+|+++... ......+..|..+++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999754 68999999997542 33445678899999998 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+++.+. +.+++..++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTS 154 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccc
Confidence 9999888655 37999999999999999999999 99999999999999999999999999998864211 112223
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCc---cchHhHhhhhccccccccccccccCccc
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE---MTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||....... .....+...... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-------~-------- 219 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-------E-------- 219 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-------c--------
Confidence 4568999999999999999999999999999999999999997432211 001111100000 0
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRIN------AKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~ell~~ 316 (339)
.....+..++..+.++|.+||+.||.+||+ ++++++|
T Consensus 220 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 220 KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 001113345677999999999999999997 6888876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=296.15 Aligned_cols=257 Identities=23% Similarity=0.415 Sum_probs=202.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
...++|++.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45688999999999999999998642 35679999875432 233456788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC---------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEE
Q 019568 112 FKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 182 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~ 182 (339)
..++||||+.+++|.+++.... ...+...+..++.|++.||.||| +.+++|+||+|+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999986532 23567788999999999999999 99999999999999999999999
Q ss_pred EcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhh
Q 019568 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||....... ... ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-~~~-~~~-- 235 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-VLR-FVM-- 235 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH-HHH--
Confidence 999999875432222222222344678999999998889999999999999999999 788886542211 010 000
Q ss_pred ccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.... ...+..++..+.+++.+||+.||.+|||+.|++++|+
T Consensus 236 -~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 -EGGL---------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -cCCc---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0000 0012234667999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=319.04 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=206.9
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc--
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE-- 111 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (339)
.....++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+..+..++|+||+++...+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344567999999999999999999974 479999999987653 344566788999999999999999988764322
Q ss_pred ------eeEEEEEecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEE
Q 019568 112 ------FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 182 (339)
Q Consensus 112 ------~~~lv~e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~ 182 (339)
..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence 468999999999999998643 346899999999999999999999 99999999999999999999999
Q ss_pred EcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
|+|||++..+.............||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+ ......
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-----~~~~~~ 258 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-----VMHKTL 258 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHh
Confidence 999999876543222223344568999999999999999999999999999999999999997542211 110000
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. .....+..+++++.+++.+||+.||.+||++.++++|
T Consensus 259 ~~---------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AG---------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cC---------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 0001234567789999999999999999999999986
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=297.50 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=208.8
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.++|++.+.||.|++|.||++... ++..+++|.+..........+.+|+++++.++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 578999999999999999999754 6899999999877666677888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++......+++..++.++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~--~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQ 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc--ccc
Confidence 9999999999877668999999999999999999999 99999999999999999999999999998765422 122
Q ss_pred ccccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 200 TQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
......+++.|+|||.+. ...++.++|+||||+++|+|++|..||......... ..... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~---~----------- 223 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-LKILK---S----------- 223 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-HHHhc---C-----------
Confidence 223345788899999874 345678999999999999999999998765322111 00000 0
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.......+..++.++.++|.+||+.||.+||++.++++|=
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 224 ---EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred ---CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 0001111334567799999999999999999999999973
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=289.76 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=208.9
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|++|.||+|... +++.+++|.++.. .......+.+|++++++++|++++++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999865 7999999988643 2333567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 118 EYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 118 e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||+++++|.+++... ...++...++.++.+++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 345889999999999999999999 99999999999999999999999999999876422
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
. ........+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ......... .
T Consensus 159 ~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~---------~-- 222 (267)
T cd08224 159 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIE---------K-- 222 (267)
T ss_pred C--CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhhhh---------c--
Confidence 1 11122345778899999998888999999999999999999999998654311 111100000 0
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
..........++..+.++|.+||..+|++||++.+|++.|+.++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 ---CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00001112255677999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.00 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=206.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
..+.|++.+.||.|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||+++++.+..++..++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 3478999999999999999999754 589999999987777777888899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++++|..++.+....+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+..... ..
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~ 164 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TL 164 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc--cc
Confidence 99999999888766667899999999999999999999 99999999999999999999999999998865421 11
Q ss_pred cccccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 199 MTQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|..||........ ...... ..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----~~-------- 231 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK----SE-------- 231 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HHHHhc----CC--------
Confidence 1223345778899999874 34568899999999999999999999865422110 000000 00
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+..++.++.++|.+||..||++||+++++++|
T Consensus 232 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 -----PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00011123445678999999999999999999999885
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=296.23 Aligned_cols=255 Identities=28% Similarity=0.475 Sum_probs=206.2
Q ss_pred hcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..+|+..++||+|+||.||++.. .++..+++|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46789999999999999999952 236678999887666666678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC--------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 115 LVLEYMPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
+++||+++++|.+++.... ..+++..++.++.|++.|+.||| +.+++|+||+|+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 9999999999999986542 24788999999999999999999 999999999999999999999
Q ss_pred EEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhh
Q 019568 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~ 259 (339)
++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||......+.... ..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC--IT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH--HH
Confidence 99999999875532221112223334678999999998899999999999999999998 8999865433211100 00
Q ss_pred hhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 260 DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.......+..++..+.+|+.+||+.||.+||+++++++.|+
T Consensus 239 ------------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ------------------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------------------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00001112345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=304.79 Aligned_cols=248 Identities=22% Similarity=0.290 Sum_probs=196.8
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... +++.+|+|++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999754 6889999998754 233445677889988877 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+.+.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccc
Confidence 99998886543 7899999999999999999999 99999999999999999999999999999864321 112223
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCcc---chHhHhhhhccccccccccccccCccc
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM---TLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ....+..... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-------~~-------- 219 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------LE-------- 219 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-------hc--------
Confidence 45689999999999999999999999999999999999999964322111 0001100000 00
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRIN------AKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~ell~~ 316 (339)
.....+..++..+.+||.+||+.||.+||+ +.++++|
T Consensus 220 ~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 220 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 001123345677899999999999999998 4788877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=305.70 Aligned_cols=268 Identities=23% Similarity=0.258 Sum_probs=200.8
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc----
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE---- 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 111 (339)
...++|++.+.||+|+||.||++.. .++..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4568999999999999999999975 46899999998654 2344566788999999999999999999986443
Q ss_pred --eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 112 --FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 112 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
..|+||||+++ +|.+.+.. .++...+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 47899999976 67666632 4788889999999999999999 999999999999999999999999999998
Q ss_pred eeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
.... .........+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ........... +....
T Consensus 171 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~-~~~~~ 245 (359)
T cd07876 171 RTAC---TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGT-PSAEF 245 (359)
T ss_pred cccc---cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCC-CcHHH
Confidence 7542 1222334567889999999999999999999999999999999999997643211 00000000000 00000
Q ss_pred c-----------c----------ccccCcc--chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 270 V-----------D----------ANLLSQE--DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 270 ~-----------~----------~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
. . ....... ..........+..+++||.+||+.||.+|||+.|+++|-+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0 0 0000000 0000011223567899999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=302.53 Aligned_cols=242 Identities=24% Similarity=0.300 Sum_probs=196.6
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... +++.||||++.... ......+..|.++++.+ .||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999754 58899999987542 23445667788999888 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+.+.+.. .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCccc
Confidence 99999886654 6899999999999999999999 99999999999999999999999999998864311 111223
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||++.+..++.++|+|||||++|+|++|..||........ ...... . ..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-----~~~i~~--------~--------~~ 213 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-----FQSILE--------D--------EV 213 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-----HHHHHc--------C--------CC
Confidence 34578999999999999999999999999999999999999975432111 000000 0 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINA-----KEIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 316 (339)
..+..++..+.+||.+||+.||.+||++ .++++|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1123456779999999999999999999 999886
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=295.78 Aligned_cols=255 Identities=26% Similarity=0.458 Sum_probs=204.3
Q ss_pred cCCCCCceeeecCccEEEEEEe-----CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-----GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
++|++.+.||+|+||.||+|.. ..+..+++|.+.... ......+.+|+++++.++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 6789999999999999999963 246789999986543 3344678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhc----------------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC
Q 019568 116 VLEYMPHGSLEKYLYSS----------------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 179 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~----------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~ 179 (339)
+|||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 99999999999998532 124778889999999999999999 99999999999999999999
Q ss_pred cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHh
Q 019568 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~ 258 (339)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+ .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~--~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--VIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence 999999999876533222222333345667999999988889999999999999999998 888986542211 11111
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.... ....+..++..+.+++.+||+.||++||++.+++++|..
T Consensus 240 ~~~~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQ------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000 011123456779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=302.41 Aligned_cols=242 Identities=24% Similarity=0.303 Sum_probs=193.0
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... +++.||+|+++... ......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999754 68899999987542 22334455677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...... .....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCccc
Confidence 99999886654 6899999999999999999999 999999999999999999999999999998754221 12233
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...||+.|+|||.+.+..++.++|+|||||++|+|++|..||......... ..... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-----~~i~~----------------~~~ 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-----DSILN----------------DRP 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHc----------------CCC
Confidence 456899999999999989999999999999999999999999754321110 00000 000
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINAK-EIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~ 316 (339)
..+..++.++.+|+.+||+.||.+||++. ++++|
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11233566789999999999999999875 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=302.26 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=193.6
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... +++.||+|+++... .........|..++... .||+|+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999754 68999999987542 23345566788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+.+.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCcee
Confidence 99999886643 6889999999999999999999 99999999999999999999999999998864321 112233
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||++.+..++.++|+||||+++|+|++|..||........ ..... .. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~--~~~~~--~~-----------------~~ 213 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL--FESIR--VD-----------------TP 213 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHH--hC-----------------CC
Confidence 45689999999999999999999999999999999999999975432111 00000 00 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCH-HHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINA-KEIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~ 316 (339)
..+..++.++++||.+||+.||++||++ +++++|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0122356679999999999999999998 467654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.25 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=208.3
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.++|++.+.||+|++|.||+|... ++..+++|.+..... ...+.+|+++++.++|+||+++++.+......|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 478999999999999999999865 488999999876533 67889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+.+++|.+++......+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~ 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence 9999999999776678999999999999999999999 9999999999999999999999999999987653221 1
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
......++..|+|||.+.+..++.++|+||||+++++|++|..||............ . ....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-----~-------------~~~~ 216 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-----P-------------NKPP 216 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-----c-------------cCCC
Confidence 223344678899999998889999999999999999999999998764332111100 0 0000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.....+..++..+.++|.+||+.||.+|||++++++|
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1111234456779999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=293.76 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=204.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
..++|++.+.||+|+||.||+|.. .+++.+++|+++.........+.+|+.+++.++||||+++++.+...+..++++|
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346899999999999999999974 4689999999887655556678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++++|.+++.... .+++..++.++.|++.++.||| +.|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~ 160 (267)
T cd06645 87 FCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TI 160 (267)
T ss_pred ccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cc
Confidence 999999999986554 7899999999999999999999 99999999999999999999999999999876532 12
Q ss_pred cccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 199 MTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|..||............... . .
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~---~-----------~ 226 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS---N-----------F 226 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc---C-----------C
Confidence 2223446788999999874 455889999999999999999999998654322111100000 0 0
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
... .......++..+.++|.+||+.||++||+++++++|
T Consensus 227 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 227 QPP--KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCC--cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 000011245568999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.49 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=202.6
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
+|++.+.||+|+||+||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999975 468999999986542 2223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++++|.+.+.... ..+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--
Confidence 999999998886543 46899999999999999999999 999999999999999999999999999998764221
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......+++.|+|||.+.+..++.++|+||+|+++|++++|..||........ .........
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~~~~~~~~--------------- 218 (285)
T cd05605 156 -ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-REEVERRVK--------------- 218 (285)
T ss_pred -CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HHHHHHHhh---------------
Confidence 112234578899999999888899999999999999999999999975432110 000000000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
......+..++..+.+||.+||+.||.+|| +++++++|
T Consensus 219 -~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 219 -EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 000111234577799999999999999999 89999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.25 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=196.5
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 50 ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
||+|+||+||++... +++.+|+|.+.... ......+..|+++++.++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999754 68999999986542 22335667899999999999999999999999999999999999999
Q ss_pred HHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 126 EKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 126 ~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
.+.+.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+..+.... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 887743 2346899999999999999999999 9999999999999999999999999999987653221 1223
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........... ....... ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~----------------~~~ 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-LKQRILN----------------DSV 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH-HHHhhcc----------------cCC
Confidence 34578899999999999999999999999999999999999975432211100 0000000 001
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
..+..++.++.+++.+||+.||++|| +++++++|
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11334677899999999999999999 78999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=294.54 Aligned_cols=253 Identities=30% Similarity=0.459 Sum_probs=202.2
Q ss_pred CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhH--HHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALK--SFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
|++.+.||+|+||+||++... +++.+|+|++......... ...+|+.++++++||||+++++++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999865 5779999999877543322 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
++++|.+++... ..+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+... ......
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred cccccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccccc
Confidence 999999999733 36899999999999999999999 999999999999999999999999999998764 223334
Q ss_pred cccccCCCCccCCcccc-CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 201 QTQTFATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
.....+++.|+|||.+. +..++.++|+||||+++++|++|..||....... ......... .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~------------~~~~~ 220 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKIL------------KRPLP 220 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHHH------------HTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhcc------------ccccc
Confidence 45566788999999998 8889999999999999999999999998651110 000000000 00000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.........+..+.+++.+||+.||++||++.++++|
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011123679999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=309.32 Aligned_cols=258 Identities=21% Similarity=0.273 Sum_probs=203.3
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
+....++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344579999999999999999999754 68899999986432 2234557789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.|+||||+++++|.+++... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999999998654 4888899999999999999999 999999999999999999999999999998765
Q ss_pred cCCCCccccccccCCCCccCCccccCC----CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREG----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||........ ... ....
T Consensus 193 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-~~~---i~~~----- 262 (370)
T cd05621 193 DETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-YSK---IMDH----- 262 (370)
T ss_pred ccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-HHH---HHhC-----
Confidence 3211 1122345689999999988654 378999999999999999999999975432110 110 0000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ--RINAKEIVKKL 317 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~l 317 (339)
.....+.....++..+++++.+||..++.+ |+++.++++|=
T Consensus 263 --------~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 263 --------KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred --------CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 000111112245677899999999866544 89999999983
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=302.35 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=198.7
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+..|..++..+ .|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999754 68899999987542 22334566688888877 5899999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+.+.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..... .
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--D 154 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--C
Confidence 9999999999886554 6889999999999999999999 99999999999999999999999999999875321 1
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||........ .......
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~~i~~~---------------- 216 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIMEH---------------- 216 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HHHHHhC----------------
Confidence 1222345689999999999999999999999999999999999999976432111 0000000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINA-----KEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 316 (339)
....+..++.++.+|+.+||+.||.+|++. .++++|
T Consensus 217 ---~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 217 ---NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ---CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 001123456779999999999999999974 777765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=296.83 Aligned_cols=260 Identities=30% Similarity=0.461 Sum_probs=207.1
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecC
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSNE 110 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (339)
...++|++.+.||+|+||.||++... ....+++|.+.... ......+.+|+++++.+ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34578999999999999999999742 24678999887542 33446688899999999 799999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhc---------------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe
Q 019568 111 EFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 175 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~---------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~ 175 (339)
+..+++|||+.+++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence 9999999999999999998642 246888999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccch
Q 019568 176 DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTL 254 (339)
Q Consensus 176 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~ 254 (339)
+.++.++|+|||.+..+.............++..|+|||.+.+..++.++||||||+++|++++ |..||..........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999876533222222222334567999999988899999999999999999997 889986542211100
Q ss_pred HhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 255 KHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
... .......+..++..+.+|+.+||..||.+|||+.+++++|.++.
T Consensus 246 --~~~------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 --LLK------------------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHH------------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 000 00001112344667999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.23 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=193.5
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... +++.||+|+++... .........|..++... .||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999754 58899999987542 22334566678888764 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTC 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCcee
Confidence 9999998654 36888999999999999999999 99999999999999999999999999999865321 112223
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||++.+..++.++|+||+||++|+|++|..||........ ...... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~~~i~~--~-----------------~~ 213 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL--FQSIRM--D-----------------NP 213 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh--C-----------------CC
Confidence 45688999999999999999999999999999999999999975432111 000000 0 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINAK-EIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~ 316 (339)
..+..++.++.+|+.+||+.||++||++. ++++|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 01223456789999999999999999997 67664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=290.44 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=201.3
Q ss_pred CCCCceeeecCccEEEEEEeC----CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce-----
Q 019568 44 FSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF----- 112 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 112 (339)
|.+.+.||+|+||.||.|... .+..+|+|.++... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678999999999999999743 24779999987543 3345678899999999999999999998755443
Q ss_pred -eEEEEEecCCCCHHHHHhhc-----CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 113 -KALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 113 -~~lv~e~~~~~~L~~~i~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
.++++||+++++|..++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999888542 236888999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~ 265 (339)
|++.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ..... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~--~~~~~---~~- 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI--YDYLR---HG- 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHH---cC-
Confidence 99876543222222222234567999999988889999999999999999999 8899865432211 11110 00
Q ss_pred ccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.....+..++..+.+++.+||+.||.+||++.+++++|+.+
T Consensus 232 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 --------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111334567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.37 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=204.9
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
+.|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.+.|||++++++++...+..++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34788999999999999999754 57888999987666666778889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
++++|..++.+...++++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~ 159 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 159 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccc
Confidence 999999988765567999999999999999999999 999999999999999999999999999998654221 112
Q ss_pred cccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 201 QTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.....+++.|+|||.+. +..++.++|+||+|+++|+|++|..||............ ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~------------ 223 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI----AKS------------ 223 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH----hhc------------
Confidence 23345788899999873 345788999999999999999999998754321111110 000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.......+..++..+.+||.+||+.||.+||++.++++|-+
T Consensus 224 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 224 --EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred --CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 00001112345677999999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=296.75 Aligned_cols=255 Identities=25% Similarity=0.314 Sum_probs=207.8
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.....+|++.+.||+|++|.||+|.. .+++.+++|.+..........+.+|+.+++.+.|+|++++++.+......++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 34557999999999999999999975 46899999998776555567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+||+++++|.+++... .++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999999998653 4788899999999999999999 9999999999999999999999999999887542211
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||........... ....
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~----~~~~------------- 231 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATN------------- 231 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH----HhcC-------------
Confidence 112234578889999999888899999999999999999999999975432111000 0000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.......+..++..+.++|.+||..||++||++.+++++=
T Consensus 232 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 232 -GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred -CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 0000011234566799999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=297.52 Aligned_cols=260 Identities=24% Similarity=0.395 Sum_probs=207.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecC
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSNE 110 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (339)
-..++|.+.+.||+|+||.||++.. ..+..+|+|.+.... ......+.+|+.+++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3457899999999999999999963 135579999886543 34456788999999999 799999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
+..++++||+.+++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999987543 34899999999999999999999 999999999999999999999999999998
Q ss_pred eeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
................++..|+|||.+.+..++.++||||+|+++|++++ |..||........... ....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-~~~~-------- 259 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-LIKE-------- 259 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH-HHHc--------
Confidence 76532222112223345678999999998899999999999999999998 9999876433221111 0000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
......+...+..+.+|+.+||+.+|++||++.++++.|.++
T Consensus 260 ----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 ----------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000011223356799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.18 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=207.0
Q ss_pred hcCCCCCceeeecCccEEEEEEeC--------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecC
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSNE 110 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (339)
.++|.+.+.||+|+||.||++... +...+|+|.+.... ......+.+|+++++.+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 478999999999999999999642 23569999987642 34456788899999999 799999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 175 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~ 175 (339)
+..++|+||+.+++|.+++.... ..++...++.++.|++.||.+|| +.|++|+||+|+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 99999999999999999997542 24788889999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccch
Q 019568 176 DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTL 254 (339)
Q Consensus 176 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~ 254 (339)
+.++.++|+|||.+................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||....... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--~ 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--H
Confidence 9999999999999875532111111222234567999999988889999999999999999998 888886432111 0
Q ss_pred HhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 255 KHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
..... . ......+..++.++.+|+.+||..+|.+||++.++++.|.++.+.
T Consensus 252 ~~~~~---~---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 FKLLK---E---------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHH---c---------------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 00000 0 001111334567899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=290.65 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=205.4
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..+|++.+.||.|++|.||+|... +++.+++|.+... ......+.+|+++++.+.|+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 356889999999999999999754 5889999998654 33456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++.... ..+++..++.++.|++.+|.+|| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 99999999986543 45888999999999999999999 99999999999999999999999999999876532111
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .. ....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~-~~~~----------------- 220 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YE-LLEK----------------- 220 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HH-HHHC-----------------
Confidence 11112223567999999988899999999999999999998 8999865322110 00 0000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
......+..++.++.+++.+||+.||++||++.++++.|+.+
T Consensus 221 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 -GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 001111334567899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=294.16 Aligned_cols=270 Identities=25% Similarity=0.399 Sum_probs=205.1
Q ss_pred hcCC-CCCceeeecCccEEEEEE-----eCCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeec--Cc
Q 019568 41 TDEF-SENNLIGKGGFGSVYKAR-----LGDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSN--EE 111 (339)
Q Consensus 41 ~~~y-~~~~~ig~g~~~~v~~~~-----~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 111 (339)
.++| ++.+.||+|+||+||++. ..++..||+|.+.... ......+.+|+++++.++||||+++++++.. ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 3556 999999999999998864 2357889999987653 2345677889999999999999999998754 34
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..+++|||+++++|.+++... .+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 688999999999999998764 4899999999999999999999 99999999999999999999999999999876
Q ss_pred ccCCCCcc-ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhh-hhcccccccc
Q 019568 192 LVGEDQSM-TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN-DWLPISTLEV 269 (339)
Q Consensus 192 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~ 269 (339)
........ ......++..|+|||.+.+..++.++|+||||+++++|++|..||............... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 53222111 112223456699999998888999999999999999999999998654322111100000 0000000000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.+ .......+..++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 237 ~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LE------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hh------cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00 01111123456788999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=289.46 Aligned_cols=248 Identities=33% Similarity=0.568 Sum_probs=204.8
Q ss_pred ceeeecCccEEEEEEeC-C---CcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-D---GMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~---~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... . +..+++|.+...... ....+.+|++.++.++|+|++++++++......++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 47999999999999754 3 889999998766433 367788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc--------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 123 GSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 123 ~~L~~~i~~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
++|.+++... ...+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 467999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
...........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||........ ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~------------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--LEYLRK------------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHc-------------
Confidence 322233344556788999999988889999999999999999999 6999876522111 100000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
......+..++.++.+++.+||+.||.+|||+.+++++|+
T Consensus 223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111223445778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=295.22 Aligned_cols=269 Identities=22% Similarity=0.287 Sum_probs=206.2
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|++.+.||+|+||.||++... ++..+++|.+.... ......+.+|++++++++||||+++++++..++..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999754 68889999887552 33455688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++.+. ..+++..+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 9999999999765 46889999999999999999999 7 5899999999999999999999999998865421
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc-c--------
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE-V-------- 269 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~-------- 269 (339)
.......+++.|+|||.+.+..++.++|+||||+++++|++|..||....... ............... .
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccCCC
Confidence 11233457889999999988889999999999999999999999986543211 111111000000000 0
Q ss_pred cc-cc---------ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 270 VD-AN---------LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 270 ~~-~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.+ .. ..............++.++.+|+.+||..||++||+++++++|-+=.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 00 00 00000000001123567899999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=297.11 Aligned_cols=269 Identities=22% Similarity=0.295 Sum_probs=204.2
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 478999999999999999999754 68999999987543 2333467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++ +|.+++......+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 85 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~ 158 (301)
T cd07873 85 YLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 158 (301)
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--C
Confidence 9975 999988776667899999999999999999999 999999999999999999999999999998654211 1
Q ss_pred cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc---ccc-cccccc
Q 019568 199 MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI---STL-EVVDAN 273 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~ 273 (339)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. .. ........ ..+ ......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LH-FIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHcCCCChhhchhhhccc
Confidence 11223346788999998765 4578999999999999999999999975432111 00 00000000 000 000000
Q ss_pred -----ccCc--cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 274 -----LLSQ--EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 274 -----~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.... ..........+++.+++||.+||+.||.+|||++|+++|=
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000 0000112234677899999999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=289.83 Aligned_cols=258 Identities=23% Similarity=0.340 Sum_probs=208.3
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|++|.||++.. .++..++||.+... .......+.+|+.+++.+.|+||+++++++..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5799999999999999999974 47999999987643 2334467888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 118 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 118 e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||+++++|.+++.. ....+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998864 2346889999999999999999999 99999999999999999999999999998875522
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||................
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 222 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-------------- 222 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc--------------
Confidence 11 11223457888999999988889999999999999999999999986532221111111000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
..........++..+.+++.+||+.||++|||+.+|++.++++.
T Consensus 223 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 ---CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00001112346778999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=297.17 Aligned_cols=269 Identities=28% Similarity=0.411 Sum_probs=211.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC--------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeec
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSN 109 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (339)
..++|.+.+.||+|+||.||+++.. ....+++|.+.... ......+.+|+++++++ .||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4478999999999999999999631 24568999887542 34456788899999999 69999999999999
Q ss_pred CceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeE
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 174 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil 174 (339)
.+..++++||+.+++|.+++.... ..++...+..++.|++.||.||| +.|++|+||+|+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence 899999999999999999986532 35788889999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccc
Q 019568 175 LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253 (339)
Q Consensus 175 ~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~ 253 (339)
++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|++++ |..||.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999876532221111122223457999999988889999999999999999999 888886542111
Q ss_pred hHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccccCc
Q 019568 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGR 331 (339)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~~~ 331 (339)
...... . ......+..++.++.+++.+||+.||.+|||+.++++.|+++......+....
T Consensus 245 ~~~~~~---~---------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~~ 304 (314)
T cd05099 245 LFKLLR---E---------------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDL 304 (314)
T ss_pred HHHHHH---c---------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCceee
Confidence 000000 0 00011133456679999999999999999999999999999988766665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=289.44 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=203.1
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
+|++.+.||.|+||.||+++.. ++..+++|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999754 68999999986542 345567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 121 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 121 ~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
++++|.+++... ...+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||.+...... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GA 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--cc
Confidence 999999988653 346889999999999999999999 999999999999999999999999999998765321 11
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||........ ....... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~~~--------------~ 216 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-----ILKVCQG--------------S 216 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-----HHHHhcC--------------C
Confidence 22334578889999999988899999999999999999999999975321111 0000000 0
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....+..++..+.+||.+||+.||.+||++.++++.
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 -YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000123345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=292.57 Aligned_cols=257 Identities=23% Similarity=0.387 Sum_probs=203.5
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCc----EEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGM----EVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~----~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
++|++.+.||+|+||+||+|.+. ++. .+++|.+.... ......+..|+..++.+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 67899999999999999999753 344 47778775432 2344567778889999999999999998764 45778
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
++||+.+++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999877667999999999999999999999 999999999999999999999999999999765333
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
..........++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ....... ..
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~------------~~ 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEK------------GE 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHC------------CC
Confidence 22222233445678999999988889999999999999999998 999987643221 1111110 00
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
....+..++.++.+++.+||..||.+|||+.|+++.|..+.+
T Consensus 229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 ------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 000112245568899999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=305.28 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=196.1
Q ss_pred CceeeecCccEEEEEEe----CCCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
++.||+|+||.||++.. .+++.+|+|++..... .....+.+|++++++++||||+++++++...+..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36899999999999863 3589999999875432 23345677999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
++++|.+++.+.. .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK 154 (318)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence 9999999986543 6899999999999999999999 999999999999999999999999999998754221 112
Q ss_pred cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......... .... . .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~--~~i~---~------------~---- 213 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM--TMIL---K------------A---- 213 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH--HHHH---c------------C----
Confidence 23446889999999999888999999999999999999999999754321110 0000 0 0
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
....+..++..+.+||.+||+.||++||+ +.++++|
T Consensus 214 ~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 214 KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 00112345677999999999999999999 5667765
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=292.49 Aligned_cols=260 Identities=25% Similarity=0.395 Sum_probs=206.3
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCc----EEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGM----EVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~----~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
.++|++.+.||+|+||+||+|.+ .++. .||+|++.... ......+.+|+.++..+.|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 46899999999999999999974 3444 48999886543 34456788899999999999999999998754 467
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
++++|+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999776667899999999999999999999 99999999999999999999999999999886633
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
...........+++.|+|||...+..++.++||||||+++|+|++ |..||....... ........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~------------ 227 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLEKG------------ 227 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCC------------
Confidence 222212222334667999999988899999999999999999998 899987543211 11111100
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
.....+..++.++.+++.+||+.||++||++.++++.|.++..+.
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 ------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 000112345667999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=290.01 Aligned_cols=255 Identities=24% Similarity=0.429 Sum_probs=205.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
...++|++.++||+|+||.||+|...+++.+++|.+..... ....+.+|+.+++.++|+||+++++++. .+..++++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 34678999999999999999999887889999999875433 3467888999999999999999999875 456889999
Q ss_pred ecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+.+++|.+++... ...++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE- 156 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence 99999999998653 346888999999999999999999 9999999999999999999999999999987653211
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
........++..|+|||.+.+..++.++|+||||++++++++ |..||.......... ....
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~--~~~~---------------- 218 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ--NLER---------------- 218 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH--HHHc----------------
Confidence 111122334667999999988889999999999999999999 999997543221110 0000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
......+..++.++.+++.+||+.+|++||+++++++.|+.
T Consensus 219 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 219 --GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00011123346679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=293.30 Aligned_cols=273 Identities=27% Similarity=0.379 Sum_probs=205.9
Q ss_pred hcCCCCCceeeecCccEEEEEEe-----CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeee--cCcee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS--NEEFK 113 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 113 (339)
..+|++.+.||+|+||+||.+.. .++..|++|.+..........+.+|+++++.++||||+++++++. .....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35789999999999999999863 358899999987776666778899999999999999999999764 34568
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++|+||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 8999999999999999776667899999999999999999999 9999999999999999999999999999988653
Q ss_pred CCCCccc-cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMT-QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
....... .....++..|+|||.+.+..++.++|+||||+++++|++|..|+....... ........... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~ 235 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF---MRMMGNDKQGQ-MIVYHL 235 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh---hhhcccccccc-cchHHH
Confidence 2221111 111223445999999988889999999999999999999887754332110 00000000000 000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
............+..++.++.+|+.+||..+|++|||+.++++.|..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000111112345667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=287.42 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=204.6
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||+|++|.||+|... +++.+++|.+... .......+.+|+++++.++|||++++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788999999999999999754 6899999998654 234556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++... ...++...++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 9999999998765 457889999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
.......+++.|+|||+..+..++.++|+||||+++++|++|..||........ ...... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-----------------~ 216 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL--ILKIIR-----------------G 216 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHc-----------------C
Confidence 112233577889999999988899999999999999999999999975542111 000000 0
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ....+..++..+.+++.+||+.+|++||++.+++++
T Consensus 217 ~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 V-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred C-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0 001122456779999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=307.74 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=205.4
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNE 110 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (339)
..+....++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|..+++.++||||+++++.+...
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556689999999999999999999754 68999999986432 23345577899999999999999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
+..++||||+++++|.+++... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999998654 4888889999999999999999 9999999999999999999999999999987
Q ss_pred eccCCCCccccccccCCCCccCCccccCC----CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREG----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .+......
T Consensus 191 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~--- 262 (371)
T cd05622 191 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYSKIMNH--- 262 (371)
T ss_pred EcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----HHHHHHcC---
Confidence 653211 1122345689999999988654 37899999999999999999999997542211 11110000
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ--RINAKEIVKKLL 318 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~l~ 318 (339)
.....+.....++..+++||.+||..++.+ |++++++++|.+
T Consensus 263 ----------~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 263 ----------KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred ----------CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 001111122356777999999999844443 789999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=297.00 Aligned_cols=259 Identities=25% Similarity=0.330 Sum_probs=210.7
Q ss_pred HHHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 34 YLELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 34 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..+......+|++.+.||.|++|.||+|.. .+++.|++|.+..........+.+|+.+++.++|||++++++++.....
T Consensus 11 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 11 IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred HHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 334555567899999999999999999974 4799999999876655556778899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++|+||+++++|.+++... .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 99999999999999988654 4889999999999999999999 999999999999999999999999999988754
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.... .......+++.|+|||.+.+..++.++|+||||+++|++++|..||........... .....
T Consensus 166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~--~~~~~---------- 231 (296)
T cd06655 166 TPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IATNG---------- 231 (296)
T ss_pred cccc--ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhcC----------
Confidence 3221 112234578889999999988899999999999999999999999976432211110 00000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
......+..+++.+.+||.+||..||++||++.+++.|=
T Consensus 232 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 232 ------TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred ------CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 000111334567799999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=289.29 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=203.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|++.+.||+|++|.||+|...++..+++|.+..... ....+.+|+.+++.++|++++++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 4578999999999999999999877788899999875433 23568889999999999999999998854 567899999
Q ss_pred cCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+..+.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence 99999999987543 45889999999999999999999 99999999999999999999999999999976532211
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......++..|+|||...+..++.++|+||||+++|+|++ |..||......+ ........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~---------------- 219 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVERG---------------- 219 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcC----------------
Confidence 11112224557999999988889999999999999999999 889987543221 11111000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.....+...+..+.+|+.+||..||.+|||+.++++.|+.
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 --YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011123456679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=302.03 Aligned_cols=242 Identities=29% Similarity=0.342 Sum_probs=192.3
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHH-HHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||+||+|... +++.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999754 69999999987542 222234444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+++.... .+++..+..++.||+.||.||| +.|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccc
Confidence 99999886543 7889999999999999999999 99999999999999999999999999998864321 122233
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+. ...... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~--------~--------~~ 213 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-----YDNILN--------K--------PL 213 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-----HHHHHc--------C--------CC
Confidence 45689999999999999999999999999999999999999975422111 000000 0 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINA----KEIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~----~ell~~ 316 (339)
..++..+..+.++|.+||+.||.+||++ .++++|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 1123346779999999999999999988 577765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.80 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=196.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec--------C
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN--------E 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~ 110 (339)
...+|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++.. .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346899999999999999999975 468999999875432 234569999999999999999887632 2
Q ss_pred ceeEEEEEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-cEEEccc
Q 019568 111 EFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDF 186 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-~v~l~Df 186 (339)
..+++||||+++ +|.+++.. ....+++..++.++.|++.||.||| +.+++||||||+||+++.++ .++|+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 256799999975 78777643 3457899999999999999999999 99999999999999998655 7999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc-
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI- 264 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~- 264 (339)
|++..+... .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||........ ..........+
T Consensus 216 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCC
Confidence 999765321 122334678899999987654 689999999999999999999999976432211 11111000000
Q ss_pred ---------cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 265 ---------STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 265 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
......... ..........+...+.++.+||.+||++||.+|||+.|+++|=
T Consensus 292 ~~~~~~~~~~~~~~~~~~-~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPD-VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHHHHhchhhhcccCCc-cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 000000000 1111222223445678899999999999999999999999863
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=292.72 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=202.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..++|.+.+.||+|++|.||+|... .+..|++|.+.... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4578999999999999999999753 45778999876443 3334568889999999999999999999988889
Q ss_pred eEEEEEecCCCCHHHHHhhcC------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC---cEEE
Q 019568 113 KALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHL 183 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~---~v~l 183 (339)
.+++|||+++++|.+++.... ..+++..+..++.|++.++.||| +.+++|+||+|+||+++.++ .++|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999986543 25888999999999999999999 99999999999999998654 5899
Q ss_pred cccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhc
Q 019568 184 SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||........ .......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~~~- 237 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--MEFVTGG- 237 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHcC-
Confidence 99999876532221111222233567999999988899999999999999999997 9999875432211 1111000
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.....+..++..+.+++.+||+.+|.+||++.+++++|+
T Consensus 238 -----------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 -----------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 001112345677999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=290.99 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=191.3
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 50 ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
||+|+||.||++... +|+.+|+|.+.... ......+..|++++++++||||+++++++..+...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999754 69999999986432 12233456699999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccc
Q 019568 126 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204 (339)
Q Consensus 126 ~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~ 204 (339)
.+.+.... ..+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 98875543 35888889999999999999999 999999999999999999999999999998765321 122334
Q ss_pred cCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhh
Q 019568 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVA 284 (339)
Q Consensus 205 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (339)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|..||........... ....... .... ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~--------------~~~~-~~ 218 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE-LKRRTLE--------------DEVK-FE 218 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH-HHHHhhc--------------cccc-cc
Confidence 578899999999888899999999999999999999999875322111100 0000000 0000 01
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 019568 285 KEQCVSFVFNLAMACAVESPEQRINAKEIV 314 (339)
Q Consensus 285 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell 314 (339)
...++.++++|+.+||+.||++||+++|++
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 124567799999999999999999996554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=295.31 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=208.9
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
......+|++.+.||+|++|.||++.. .+++.|++|.+..........+.+|+.+++.++|+||+++++++...+..++
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 345668999999999999999999975 4799999999976655555678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
|+||+++++|.+++.+. .+++..+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 94 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 94 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred eecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999999998654 4788899999999999999999 999999999999999999999999999998764322
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
. .......+++.|+|||.+.+..++.++|+||||+++|++++|..||..............
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~----------------- 229 (297)
T cd06656 169 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----------------- 229 (297)
T ss_pred c--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-----------------
Confidence 1 122334578889999999988899999999999999999999999965432111000000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........+...+..+++|+.+||..||.+||+++++++|
T Consensus 230 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 -NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011133456778999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.53 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=203.9
Q ss_pred cCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
.+|++.+.||+|+||.||+|... .+..||+|++..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 56889999999999999999742 257899999875533 33466888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhc---------------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC
Q 019568 115 LVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 179 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~---------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~ 179 (339)
+++||+.+++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 999999999999998532 124788889999999999999999 99999999999999999999
Q ss_pred cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHh
Q 019568 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~ 258 (339)
.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+ ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~ 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-----VI 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HH
Confidence 999999999876533222222233445678999999988889999999999999999998 888886542211 11
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
....... ....+..++..+.+|+.+||+.+|.+||++++|+..|++
T Consensus 237 ~~i~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQ---------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCC---------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1100000 001134567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=288.77 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=203.6
Q ss_pred CCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc------hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC------GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+++++.++|+||+++.+++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 589999999999999999987789999999886542 22345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+||+++++|.+++.+.. .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999996654 6789999999999999999999 9999999999999999999999999999887542111
Q ss_pred C----ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 197 Q----SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 197 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
. ........++..|+|||.+.+..++.++|+||||+++++|++|..||........... ... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~--~~~--~--------- 223 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY--IGA--H--------- 223 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH--hhh--c---------
Confidence 1 1112234578889999999988899999999999999999999999975432111100 000 0
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+..++.++.++|.+||..+|.+||++.++++|
T Consensus 224 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 224 -----RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000011123456779999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=288.68 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=203.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|++.+.||+|+||.||+|...+...|++|++..... ....+.+|+++++.++|+||+++++.+.. ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 3468999999999999999999876667799999875322 23567889999999999999999998754 557899999
Q ss_pred cCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++... ...+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..+.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 9999999999754 345788999999999999999999 99999999999999999999999999999876532221
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......++..|+|||...+..++.++|+||||+++|++++ |..||........... . ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~--~--~~~-------------- 219 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--V--ERG-------------- 219 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH--H--hcC--------------
Confidence 11122335567999999988889999999999999999999 8888875432211100 0 000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
........++..+.+++.+||+.||.+||+++++++.|+.+
T Consensus 220 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 --YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00111234567799999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=304.83 Aligned_cols=268 Identities=24% Similarity=0.298 Sum_probs=200.6
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-----eeE
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE-----FKA 114 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 114 (339)
+|++.+.||+|+||.||++.. .+++.||||++... .......+.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 488999999999999999975 47999999998643 2234567888999999999999999999997766 789
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+|+||+.+ +|.+.+... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~~-~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQS-DLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeecccc-CHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999964 888877544 37899999999999999999999 99999999999999999999999999999876432
Q ss_pred CCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc----
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV---- 269 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---- 269 (339)
.. ........+++.|+|||.+.+. .++.++||||+||++|+|++|+.||....... .... .....+......
T Consensus 156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~-i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDL-ITDLLGTPSLEAMRSA 232 (372)
T ss_pred Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHH-HHHHcCCCCHHHHHHh
Confidence 21 1122334568889999988774 47999999999999999999999997643211 0100 000000000000
Q ss_pred -------cccccc--CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 270 -------VDANLL--SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 270 -------~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
...... .............+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 000000 0000000112334677999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=293.47 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=204.3
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CC--cEEEEEEeecc-chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DG--MEVAVKVFNLQ-CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~--~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 116 (339)
++|++.+.||+|+||.||+|... ++ ..+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 68999999999999999999754 33 34688887643 234456788899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcE
Q 019568 117 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA 181 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v 181 (339)
+||+++++|.+++.... ..+++..++.++.|++.||.+|| +.|++|+||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999986532 24788899999999999999999 9999999999999999999999
Q ss_pred EEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhh
Q 019568 182 HLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 182 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~ 260 (339)
+|+|||++.... ..........+..|+|||...+..++.++||||||+++|+|++ |..||......... ..
T Consensus 159 kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-----~~ 230 (297)
T cd05089 159 KIADFGLSRGEE---VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-----EK 230 (297)
T ss_pred EECCcCCCcccc---ceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----HH
Confidence 999999875321 1111111223456999999988889999999999999999997 99998754322110 00
Q ss_pred hccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 261 WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
.. .......+..++..+.+|+.+||+.+|.+||+++++++.|..+.+..
T Consensus 231 ~~---------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LP---------------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred Hh---------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 00011112345677999999999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=289.36 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=206.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|++.+.||.|++|.||+|..+++..++||.+.... .....+.+|+.+++.++|+||+++++++......++++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457999999999999999999987778889999987543 3346788899999999999999999999988899999999
Q ss_pred cCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++.... ..++...+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EY 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch-hh
Confidence 99999999997643 46889999999999999999999 999999999999999999999999999998765321 11
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........+..|+|||.+.+..++.++|+||+|++++++++ |+.||....... .......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~------------------ 219 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVER------------------ 219 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc------------------
Confidence 11112223567999999998889999999999999999998 999986542211 1110000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
......+..++.++.+++.+||+.+|.+||+++++++.|+.
T Consensus 220 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 -GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011122335679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=308.17 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=201.2
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++..++|++|+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999754 68999999987542 334567788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||++|++|.+++.+.. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999986654 6899999999999999999999 99999999999999999999999999999865421110
Q ss_pred c---------------------------------cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCC
Q 019568 198 S---------------------------------MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT 244 (339)
Q Consensus 198 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~ 244 (339)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011345899999999999999999999999999999999999999
Q ss_pred cccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC---CHHHHHHH
Q 019568 245 DEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI---NAKEIVKK 316 (339)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 316 (339)
.......... ..... .....+.....++.++++||.+|+ .||.+|+ ++.++++|
T Consensus 237 ~~~~~~~~~~----~i~~~-------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQETYR----KVMNW-------------KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHHHH----HHHcC-------------CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 7643221100 00000 000011111235677999999977 4999998 47888887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=286.68 Aligned_cols=250 Identities=32% Similarity=0.506 Sum_probs=205.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
.++|++.+.||.|++|.||+|.. .++.|++|.+..... ....+.+|+.+++.++|+||+++++++......++|+||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 56899999999999999999987 488999999876644 4567888999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 121 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 121 ~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
++++|.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~---- 155 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc----
Confidence 9999999987654 36899999999999999999999 999999999999999999999999999998765211
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......+..|+|||.+.+..++.++|+||||++++++++ |..||........ ......
T Consensus 156 -~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~------------------ 214 (256)
T cd05039 156 -QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPHVEK------------------ 214 (256)
T ss_pred -cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHhc------------------
Confidence 112234557999999988889999999999999999997 9999865422111 000000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
......+..+++.+.++|.+||+.+|++||+++++++.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 215 GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 000111234567799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=307.23 Aligned_cols=266 Identities=28% Similarity=0.415 Sum_probs=219.9
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC--CC---cEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG--DG---MEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCS 108 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~--~~---~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (339)
|+-..++..+.++||+|.||.||+|+.. ++ ..||+|..... .......+.+|++++++++||||+++||+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4445677888899999999999999743 22 23899988753 3667788999999999999999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
....+++|||+|.||+|.+++++..+.++..+...++.+.+.||+||| +++++||||-..|+|++.++.+||+|||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 999999999999999999999998878999999999999999999999 99999999999999999999999999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
+..-. ..............|+|||.+....++.++||||+|+++||+.+ |..||........... +
T Consensus 309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k--I--------- 375 (474)
T KOG0194|consen 309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK--I--------- 375 (474)
T ss_pred ccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHH--H---------
Confidence 87532 11111212235677999999999999999999999999999999 7889887644321111 1
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
.....+...+...+.++..++.+|+..||++||++.++.+.++.+......
T Consensus 376 --------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 376 --------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred --------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 012223333456678899999999999999999999999999999876553
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=291.93 Aligned_cols=266 Identities=24% Similarity=0.300 Sum_probs=195.9
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhC---CCcceeeEeeeeec-----Cc
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSI---RHRNLIKVISSCSN-----EE 111 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 111 (339)
+|++.+.||+|+||+||+|... +++.||+|.+.... ......+.+|+++++.+ .||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999754 68999999987542 12223455677766655 79999999998754 34
Q ss_pred eeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 112 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
..++++||+.+ +|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 8988886543 35899999999999999999999 9999999999999999999999999999987
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc-
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV- 269 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 269 (339)
..... .......+++.|+|||.+.+..++.++||||+||++|+|++|.+||....... .................
T Consensus 157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCc
Confidence 65321 12233457888999999988899999999999999999999999986543221 11111110000000000
Q ss_pred --c--cccccCc--cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 --V--DANLLSQ--EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 --~--~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ....... ........+.++..+.+||.+||+.||++|||+.+++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000000 000011123466778999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=303.50 Aligned_cols=267 Identities=22% Similarity=0.220 Sum_probs=199.7
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNE----- 110 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 110 (339)
...++|++.+.||+|+||.||++... +++.+|||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45689999999999999999999753 68999999987542 33456777899999999999999999988543
Q ss_pred -ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 111 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 111 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
...++||||+++ ++.+.+.. .++...+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357899999976 77776643 4788889999999999999999 999999999999999999999999999998
Q ss_pred eeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc-----
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI----- 264 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~----- 264 (339)
..... ........+++.|+|||++.+..++.++|+||||+++|+|++|+.||........ ...........
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence 75421 2222344678999999999999999999999999999999999999975421110 00000000000
Q ss_pred ---------------cccccccccccCcc--chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 265 ---------------STLEVVDANLLSQE--DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 265 ---------------~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.............. ..........+..+++||.+||+.||++|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000000 00001122235678999999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=288.50 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=208.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCC----CcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGD----GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~----~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|++.+.||+|+||.||+|...+ ...++||...... ....+.+.+|+.+++.+.||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34679999999999999999997422 3568999887654 4455678899999999999999999999875 4567
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
++|||+++++|.+++......++...++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999999776656899999999999999999999 99999999999999999999999999999876533
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
... .......++..|+|||.+.+..++.++|+||||++++++++ |..||......+.... ...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~--~~~------------- 223 (270)
T cd05056 160 ESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR--IEN------------- 223 (270)
T ss_pred ccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHc-------------
Confidence 211 11122234567999999888889999999999999999986 9999876543221110 000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
......+..++..+.++|.+|+..+|.+|||+.++++.|.+++..
T Consensus 224 -----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 224 -----GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001112345577899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=293.95 Aligned_cols=262 Identities=27% Similarity=0.426 Sum_probs=208.5
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe--------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeee
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL--------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCS 108 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~--------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (339)
...++|.+.+.||+|+||.||+|+. .++..+++|.+.... ......+.+|+.+++.+ .||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4568899999999999999999963 124578999886542 34456788999999999 8999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCe
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV 173 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Ni 173 (339)
.....+++|||+.+++|.+++.... ..++...+..++.|++.||.||| +.|++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 9999999999999999999986532 24677889999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCcc
Q 019568 174 LLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252 (339)
Q Consensus 174 l~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~ 252 (339)
+++.++.++|+|||.+................+++.|+|||.+.+..++.++||||||+++|++++ |..||.......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 999999999999999876533222222233345677999999988889999999999999999998 778876442111
Q ss_pred chHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
....... ......+..++..+.+|+.+||..+|.+||++.++++.|+++..-
T Consensus 248 ----~~~~~~~---------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 ----LFKLLKE---------------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ----HHHHHHc---------------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1110000 000111234567799999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=292.52 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=204.4
Q ss_pred CCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.+.||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5889999999999999999642 23568888876553 3345678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC-----------------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCC
Q 019568 116 VLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSN 172 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~N 172 (339)
++||+.+++|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999885421 24778899999999999999999 9999999999999
Q ss_pred eEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCc
Q 019568 173 VLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251 (339)
Q Consensus 173 il~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~ 251 (339)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++++|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876532222222223335667999999888889999999999999999998 999986532111
Q ss_pred cchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
...... . ......+..++.++.+++.+||+.+|.+||+++++++.|+++..
T Consensus 238 -----~~~~~~---------~------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -----LFNLLK---------T------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -----HHHHHh---------C------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 000000 0 00111133456779999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=288.34 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=198.0
Q ss_pred CCCCceeeecCccEEEEEEeCC-Cc--EEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeec------Cce
Q 019568 44 FSENNLIGKGGFGSVYKARLGD-GM--EVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSN------EEF 112 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~-~~--~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 112 (339)
+.+.+.||+|+||.||+|.... +. .+|+|.++.. .......+.+|+++++.++|+||+++++++.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578999999999999997543 33 6899987654 34456778889999999999999999997632 224
Q ss_pred eEEEEEecCCCCHHHHHhh-----cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccc
Q 019568 113 KALVLEYMPHGSLEKYLYS-----SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg 187 (339)
.++++||+.+++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 2245889999999999999999999 9999999999999999999999999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
++..+..............++.|++||...+..++.++|+||||+++|+|++ |..||....... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~---~~- 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYDYLRQ---GN- 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHc---CC-
Confidence 9876532221111222335677999999999999999999999999999999 788987543211 1111100 00
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
....+..++..+.++|.+||+.||++|||+.+++++|+++
T Consensus 232 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 --------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011234566799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=293.31 Aligned_cols=268 Identities=24% Similarity=0.272 Sum_probs=201.4
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||+|++|.||+|... +|+.+++|.+.... ......+.+|++++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5889999999999999999754 68999999987542 22235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++ +|.+++......+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R 154 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence 975 888888766667999999999999999999999 9999999999999999999999999999987542211 1
Q ss_pred ccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc--c----ccccc
Q 019568 200 TQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST--L----EVVDA 272 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~ 272 (339)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|..|+...................... . ...+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234467889999987665 47899999999999999999999864432222111111000000000 0 00000
Q ss_pred cc---cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NL---LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ...........+.++.++++||.+||+.||.+|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 000000011123467889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=286.11 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=197.5
Q ss_pred eeeecCccEEEEEEeC---CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCC
Q 019568 49 LIGKGGFGSVYKARLG---DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 124 (339)
Q Consensus 49 ~ig~g~~~~v~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 124 (339)
.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999642 35679999986653 3344668899999999999999999998864 46789999999999
Q ss_pred HHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc-ccc
Q 019568 125 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT-QTQ 203 (339)
Q Consensus 125 L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~-~~~ 203 (339)
|.+++......+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++........... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999766667999999999999999999999 99999999999999999999999999999875432221111 111
Q ss_pred ccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 204 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
..++..|+|||.+.+..++.++|+||||+++|++++ |..||........ ...... ....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~------------------~~~~ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--MSFIEQ------------------GKRL 217 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHHHC------------------CCCC
Confidence 223567999999988889999999999999999996 9999976533211 000000 0011
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
..+..++.++.++|.+||..||++||++.++++.|+++
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12345577899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=290.21 Aligned_cols=249 Identities=26% Similarity=0.358 Sum_probs=204.8
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+++++.++|+|++++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999754 68999999987653 34456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++... .+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 9999999998765 6899999999999999999999 9999999999999999999999999999987763221 2
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... .. . ..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~--~~------------~-----~~ 214 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL--IP------------K-----NN 214 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH--hh------------h-----cC
Confidence 22334577889999999988899999999999999999999999975432111000 00 0 00
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........++..+.+++.+||..||.+||+++++++|
T Consensus 215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0000011156679999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=300.13 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=203.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeec-C
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSN-E 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 110 (339)
..++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|+.++.++ +||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 357899999999999999999962 347889999987543 33456788899999999 68999999998754 4
Q ss_pred ceeEEEEEecCCCCHHHHHhhcC---------------------------------------------------------
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSN--------------------------------------------------------- 133 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~--------------------------------------------------------- 133 (339)
...+++|||+++++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999999986421
Q ss_pred ---------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccc
Q 019568 134 ---------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204 (339)
Q Consensus 134 ---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~ 204 (339)
..++...+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 13567778899999999999999 999999999999999999999999999998765322222222233
Q ss_pred cCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccchhhh
Q 019568 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFV 283 (339)
Q Consensus 205 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (339)
.+++.|+|||.+.+..++.++|+||||+++|++++ |..||............... . ....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------------~------~~~~ 302 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-------------G------TRMR 302 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-------------c------CCCC
Confidence 34667999999988899999999999999999997 89998654322111100000 0 0001
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 284 AKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 284 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
.+..+++++.+++.+||+.||.+||++.+++++|+.+.+.
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1122355689999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.85 Aligned_cols=266 Identities=22% Similarity=0.195 Sum_probs=201.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEe---CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
...+|.+.+.||+|+||.||++.. ..+..|++|.+... ....+|+++++.++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 346799999999999999999963 24678999987643 2345799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
||++. ++|.+++.. ...+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+....
T Consensus 165 ~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 165 MPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred ehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99996 588888843 347899999999999999999999 9999999999999999999999999999987654333
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccc--hHhHhhhhccccccccc----
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT--LKHWVNDWLPISTLEVV---- 270 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~--~~~~~~~~~~~~~~~~~---- 270 (339)
.........+|+.|+|||++.+..++.++|||||||++|+|++|+.||......... +....... .....+..
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~-~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM-QVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh-ccCccccCCccc
Confidence 322333456899999999999999999999999999999999999998764332110 10000000 00000000
Q ss_pred ----------cccccCcc-chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 ----------DANLLSQE-DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ----------~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........ .........++.++.+||.+||..||++|||+.|++.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00011122345678999999999999999999999987
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=284.25 Aligned_cols=248 Identities=32% Similarity=0.498 Sum_probs=200.2
Q ss_pred ceeeecCccEEEEEEeCCCcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHH
Q 019568 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 126 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 126 (339)
++||+|++|.||++....++.|++|.+...... ....+.+|+++++++.|+||+++++++......++|+||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999998656999999998765433 4567889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccC
Q 019568 127 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206 (339)
Q Consensus 127 ~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~ 206 (339)
+++......++...+..++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999776667889999999999999999999 99999999999999999999999999999875431111111112223
Q ss_pred CCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhh
Q 019568 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285 (339)
Q Consensus 207 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (339)
+..|+|||.+.++.++.++|+||||+++|+|++ |..||.......... .... ......+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~--~~~~------------------~~~~~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE--RIES------------------GYRMPAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH--HHhc------------------CCCCCCC
Confidence 556999999988889999999999999999999 888886553221111 0000 0001112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 286 EQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 286 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..++..+.+++.+||+.+|.+||++.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=292.26 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=219.5
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.+..+-|.++.+||+|+||+||+|.+ .+|+.+|||.+..+ ..++.+..|+.++++...|+++++|+.+.....+|+|
T Consensus 29 K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 29 KPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred CChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 34556789999999999999999964 47999999998766 5567788899999999999999999999989999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
||||..|++.|+++.+++++++.++..+++.-+.+|.||| ...-+|||||..|||++.+|..||.|||.+..+++
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-- 181 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-- 181 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--
Confidence 9999999999999999999999999999999999999999 89999999999999999999999999999987632
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.........|||.|||||++..-.|+.++||||||++..+|..|++||....+...-+. ...
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------------------IPT 243 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------------------IPT 243 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------------------ccC
Confidence 23334556799999999999999999999999999999999999999987654322111 011
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
++...+..+..-++++.+|+++||..+|++|.|+.++++|
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2223344466778899999999999999999999999987
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=305.14 Aligned_cols=263 Identities=24% Similarity=0.387 Sum_probs=208.2
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCC-CcceeeEeeeee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIR-HRNLIKVISSCS 108 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 108 (339)
+....++|.+.+.||+|+||.||+|.+. .+..||||++.... ......+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4445678999999999999999999742 34689999997553 333456888999999997 999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcC-------------------------------------------------------
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSN------------------------------------------------------- 133 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~------------------------------------------------------- 133 (339)
..+..++|+||+.+++|.+++.+..
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9899999999999999999986432
Q ss_pred ------------------------------------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCC
Q 019568 134 ------------------------------------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPS 171 (339)
Q Consensus 134 ------------------------------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~ 171 (339)
..+++..++.++.|++.||.||| +.+++|+||+|+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 12556678889999999999999 999999999999
Q ss_pred CeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccC
Q 019568 172 NVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNG 250 (339)
Q Consensus 172 Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~ 250 (339)
||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++++|++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999876532222222223446778999999988889999999999999999998 88998754322
Q ss_pred ccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 251 EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
+........ ......+..++.++.+|+.+||..+|.+||++++|++.|+.+.
T Consensus 349 ~~~~~~~~~-------------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQFYNAIKR-------------------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHc-------------------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 211110000 0011123345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=292.44 Aligned_cols=262 Identities=23% Similarity=0.397 Sum_probs=205.0
Q ss_pred hcCCCCCceeeecCccEEEEEEeCC-----------------CcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGD-----------------GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIK 102 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~-----------------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 102 (339)
..+|++.+.||+|+||.||+|.... +..+++|.+.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999986432 2458999887553 344567888999999999999999
Q ss_pred EeeeeecCceeEEEEEecCCCCHHHHHhhcC----------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCC
Q 019568 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSN 172 (339)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~N 172 (339)
+++++..++..++++|++.+++|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999986543 26889999999999999999999 9999999999999
Q ss_pred eEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh--CCCCCcccccC
Q 019568 173 VLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIFNG 250 (339)
Q Consensus 173 il~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~P~~~~~~~ 250 (339)
|+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876533322222333445678999999988889999999999999999998 67787654321
Q ss_pred ccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 251 EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.. .... ... .... ........+..++.++.+++.+||+.||++|||+.+|++.|+
T Consensus 241 ~~-~~~~-~~~--------~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QV-IENA-GHF--------FRDD---GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH-HHHH-Hhc--------cccc---cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 0000 000 0000 000001112345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=288.78 Aligned_cols=256 Identities=24% Similarity=0.460 Sum_probs=205.0
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CC---cEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DG---MEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~---~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
..|++.+.||+|+||.||+|... ++ ..|+||.+... .......+..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46889999999999999999753 23 36999998755 344567789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+||+++++|.+++......++...++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999776667899999999999999999999 9999999999999999999999999999887553222
Q ss_pred Ccccccccc---CCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 197 QSMTQTQTF---ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 197 ~~~~~~~~~---~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
......... .+..|+|||.+.+..++.++|+||+|+++|++++ |..||....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~~------------ 226 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIEQ------------ 226 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHHc------------
Confidence 111111111 1346999999998899999999999999999886 999987543211 1111100
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
......+..++..+.+++.+||..+|.+||++.++++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 ------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001111234567789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=325.10 Aligned_cols=267 Identities=28% Similarity=0.481 Sum_probs=227.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC--CCc----EEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG--DGM----EVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~--~~~----~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..++.+..+.||+|.||.||.|... .+. .||||.+... +.....+|.+|..+|+.+.||||++++|++.+.+.
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3467778899999999999999743 343 3788887654 45677899999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhc------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 113 KALVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
.++++||++||+|..++++. ...++...++.++.+++.|+.||+ +++++||||...|.|++....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999887 667999999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~ 265 (339)
|+++...................|||||.+..+.++.|+||||||+++||++| |..||.+..+.+....
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~---------- 916 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD---------- 916 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH----------
Confidence 99997655555555554455678999999999999999999999999999999 8899887655432221
Q ss_pred ccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccccc
Q 019568 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVG 329 (339)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~ 329 (339)
..... ++..+..||+.+.++|.+||+.+|++||++..|++++..+.+.+.....
T Consensus 917 ---------~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 917 ---------VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred ---------HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 11122 5666889999999999999999999999999999999999886655443
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=291.22 Aligned_cols=266 Identities=23% Similarity=0.292 Sum_probs=207.4
Q ss_pred eeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeee
Q 019568 29 WRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISS 106 (339)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 106 (339)
..+..++.+....++|++.+.||+|+||.||++... +++.+++|++.... .....+.+|+.+++.+ +||||++++++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 5 GKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred CceEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 344566778889999999999999999999999754 68899999876432 2335677899999999 69999999998
Q ss_pred ee-----cCceeEEEEEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC
Q 019568 107 CS-----NEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN 178 (339)
Q Consensus 107 ~~-----~~~~~~lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~ 178 (339)
+. ..+..+++|||+++++|.+++.. ....+++..++.++.|++.|+.||| +.+++|+||+|+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCC
Confidence 73 45678999999999999998753 2346888899999999999999999 9999999999999999999
Q ss_pred CcEEEcccccceeccCCCCccccccccCCCCccCCccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccc
Q 019568 179 MVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 253 (339)
Q Consensus 179 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~ 253 (339)
+.++|+|||++...... ........+++.|+|||.+.. ..++.++|+||+|+++|+|++|..||.........
T Consensus 161 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~ 238 (286)
T cd06638 161 GGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238 (286)
T ss_pred CCEEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence 99999999998765321 112223457889999998753 45788999999999999999999998754321110
Q ss_pred hHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.. .. .. .......+..++..+.+||.+||+.||++|||+.|+++|..
T Consensus 239 ~~----~~----------~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 239 FK----IP----------RN----PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred hh----cc----------cc----CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 00 00 00 00000112234566999999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=298.37 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=197.7
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 117 (339)
+|+..+.||+|+||+||+|.. .+++.||+|++.... ......+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478889999999999999975 468999999987542 233456677888888885 577888999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.... .+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++..... .
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--D 154 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCC--C
Confidence 9999999999986654 6899999999999999999999 99999999999999999999999999998864321 1
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........|++.|+|||++.+..++.++|+||+|+++|+|++|..||........ ......
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~~----------------- 215 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL--FQSIME----------------- 215 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHh-----------------
Confidence 1122344588999999999988999999999999999999999999976432111 000000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
.....+..++.++.+++.+||+.||.+|++ .+++++|
T Consensus 216 --~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 216 --HNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred --CCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 000112345667899999999999999997 4667766
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=298.44 Aligned_cols=248 Identities=22% Similarity=0.285 Sum_probs=197.1
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... +++.+|+|++.... ......+.+|..++.++ .||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999754 68899999997642 33455678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+.+.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCcee
Confidence 99998886544 6999999999999999999999 99999999999999999999999999998864321 112223
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCcc-chHhHhhhhccccccccccccccCccchh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM-TLKHWVNDWLPISTLEVVDANLLSQEDIH 281 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (339)
...|++.|+|||.+.+..++.++|+||||+++|+|++|..||........ ........... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------------~--~~ 219 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-------------E--KP 219 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-------------h--CC
Confidence 45689999999999999999999999999999999999999975432211 11111100000 0 00
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHHH
Q 019568 282 FVAKEQCVSFVFNLAMACAVESPEQRIN------AKEIVKK 316 (339)
Q Consensus 282 ~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~ell~~ 316 (339)
...+...+..+.+++.+||+.||.+|++ ++++++|
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1113345667899999999999999998 4688776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=288.75 Aligned_cols=271 Identities=23% Similarity=0.392 Sum_probs=204.9
Q ss_pred cCCCCCceeeecCccEEEEEEe-----CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--cee
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-----GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFK 113 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 113 (339)
.-|++.+.||+|+||.||++.. .++..|++|.+.... ......+.+|+++++.+.|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478999999999999999963 358889999987553 34456788999999999999999999998765 568
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++||||+++++|.+++.+....+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999999776556899999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCCcc-ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSM-TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
...... ......++..|+|||.+.+..++.++|+||||+++|+|+++..|+........ .................
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL---KMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh---hhcccccccccHHHHHH
Confidence 222211 11233456679999999888899999999999999999998776443211000 00000000000000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.. ........+..++..+.+|+.+||+.||.+||+++++++.|+.+
T Consensus 238 -~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 -VL-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HH-HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 00001112344677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=300.35 Aligned_cols=243 Identities=28% Similarity=0.326 Sum_probs=191.2
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHH-HHHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVE-CEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||+||+|... +++.+|+|++.... ......+..| ..+++.+.||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999754 67889999987542 1222233334 4457888999999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+++.... .+.+..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTS 154 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcc
Confidence 99999986644 6788888999999999999999 99999999999999999999999999999865321 122233
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...|++.|+|||++.+..++.++|||||||++|+|++|..||......+.. ...... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-----~~i~~~----------------~~ 213 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-----DNILNK----------------PL 213 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-----HHHHhC----------------Cc
Confidence 456899999999999999999999999999999999999999754322110 000000 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHH----HHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINAK----EIVKKL 317 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~----ell~~l 317 (339)
...+.++..+.+++.+||+.||.+||++. ++++|.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 11234567799999999999999999876 555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=290.44 Aligned_cols=261 Identities=23% Similarity=0.384 Sum_probs=208.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCC-----CcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeec-Cce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGD-----GMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSN-EEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 112 (339)
..++|++.+.||+|+||.||+|.... +..|++|.+... .......+.+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999997544 688999987644 23445678889999999999999999998755 567
Q ss_pred eEEEEEecCCCCHHHHHhhcC-------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 113 KALVLEYMPHGSLEKYLYSSN-------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
.+++++|+.+++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 889999999999999986532 35889999999999999999999 99999999999999999999999999
Q ss_pred cccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccc
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
||++..+.............++..|+|||.+.+..++.++||||||+++|++++ |+.||...... ....+....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~--- 235 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAYLKDG--- 235 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHHHHcC---
Confidence 999875532222212222334567999999988889999999999999999999 99998754221 111111110
Q ss_pred cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
........+++++.+++.+||..||++|||+.++++.|..+...
T Consensus 236 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 236 ---------------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00111223466799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=307.55 Aligned_cols=266 Identities=18% Similarity=0.158 Sum_probs=199.2
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..+|.+.+.||+|+||.||++... .++.|+||... ...+.+|++++++++|+||+++++++...+..++++|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999754 58899999643 23456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+. ++|.+++......+++..++.++.|++.||.||| +.||+|+||||+||+++.++.++|+|||++..........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 5999988776667999999999999999999999 9999999999999999999999999999987653322222
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCc--c----chHhHhhhhc--ccccccccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE--M----TLKHWVNDWL--PISTLEVVD 271 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~--~----~~~~~~~~~~--~~~~~~~~~ 271 (339)
......||+.|+|||++.+..++.++|||||||++|+|++|..|+-...... . .....+.... .........
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2223458999999999999999999999999999999999886643321110 0 0111110000 000000000
Q ss_pred cc------------ccCcc-chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 AN------------LLSQE-DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ~~------------~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ..... ...+......+.++.+||.+||+.||.+|||+.|+|+|
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00000 00011112345678999999999999999999999987
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=287.12 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=205.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..+|++.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 367899999999999999999742 23478999886543 3345678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
+|||+++++|.+++......++...+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..+...
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999876667899999999999999999999 999999999999999999999999999998765322
Q ss_pred CCccc-cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 196 DQSMT-QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 196 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
..... ......+..|+|||.+.+..++.++|+||||+++|++++ |..||......+. .......
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--~~~~~~~------------ 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--IKAIEEG------------ 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--HHHHhCC------------
Confidence 21111 111223457999999998889999999999999999886 9999876532211 1111000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
.....+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 226 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111233466789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=292.11 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=201.3
Q ss_pred hcCCCCCceeeecCccEEEEEEeCC---------------CcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGD---------------GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVI 104 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~---------------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 104 (339)
.++|++.+.||+|+||.||++.... ...||+|.++... ......+.+|+++++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999986421 2348999987542 33456788999999999999999999
Q ss_pred eeeecCceeEEEEEecCCCCHHHHHhhcC-----------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCe
Q 019568 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSN-----------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV 173 (339)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Ni 173 (339)
+++...+..++||||+.+++|.+++.... ..+++..++.++.|++.|+.||| +.+++|+||+|+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 99999999999999999999999985432 13677888999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh--CCCCCcccccCc
Q 019568 174 LLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIFNGE 251 (339)
Q Consensus 174 l~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~P~~~~~~~~ 251 (339)
+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|+||||+++++|++ +..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999876532222222223334678999999988889999999999999999998 667776543221
Q ss_pred cchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.... ..... .... .......++.++..+.+|+.+||..||++|||++++++.|+
T Consensus 241 ~~~~-~~~~~---------~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIEN-TGEFF---------RNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH-HHHhh---------hhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1100 00000 0000 00000112234667999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.42 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=204.6
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+...++......||+|+||.||+|.. .++..|++|.+........+.+.+|+++++.++|+||+++++++...+..+++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34556677778999999999999974 46888999998777666667889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCcc--CHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-CCcEEEcccccceecc
Q 019568 117 LEYMPHGSLEKYLYSSNCIL--DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLV 193 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~--~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-~~~v~l~Dfg~~~~~~ 193 (339)
+||+++++|.+++......+ +...+..++.|++.|+.+|| +.+++|+||+|+||+++. ++.++|+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999997654445 78888999999999999999 999999999999999976 6799999999987653
Q ss_pred CCCCccccccccCCCCccCCccccCCC--CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
.. ........+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||............ ..
T Consensus 161 ~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--~~----------- 225 (268)
T cd06624 161 GI--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VG----------- 225 (268)
T ss_pred cC--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--hh-----------
Confidence 21 12222334788899999876543 789999999999999999999998754221111100 00
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. .......+..+++++.+|+.+||+.+|.+|||+.+++.|
T Consensus 226 --~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 226 --M---FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --h---hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 000111233456779999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.92 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=214.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+..-|.+.+.||+|.|+.|-+|++ =+|..||||++.+..- -....+.+|++.|+.++||||+++|.+......+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 556799999999999999999963 3899999999987642 3345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe-CCCCcEEEcccccceeccCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-DDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~-~~~~~v~l~Dfg~~~~~~~~ 195 (339)
+|.-++|+|.|+|.++...+.+..+..++.||+.|+.|+| +..++|+|+||+||.+ .+-|-|||+|||++..+.+.
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999999999999999999999999999999999 9999999999999866 68899999999998776433
Q ss_pred CCccccccccCCCCccCCccccCCCCC-CcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVS-ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.. ....+|+..|.|||++.|..|+ ++.||||||+|||.|++|+.||+.-...+..-.. .
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--m--------------- 232 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--M--------------- 232 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--h---------------
Confidence 33 3345688899999999999885 6889999999999999999999875443321110 0
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
-. +...+...+.+.++||..||..||++|.+.+||..+=|
T Consensus 233 DC----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 233 DC----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred cc----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 01 12236778899999999999999999999999987644
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.35 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=207.7
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeecc--chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCcee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (339)
+......|+++++||+|+.+.||++...+.+.+|+|.+... ......-+.+|+..|.+| .|.+|++++++-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 34456789999999999999999998777788888876443 456677899999999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
|+|||+-+ .+|..++++.........+..+..||+.|+.++| ..||+|.||||.|+++-+ |.+||+|||.+..+.
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99999985 4999999887766666689999999999999999 999999999999999865 799999999999887
Q ss_pred CCCCccccccccCCCCccCCccccCC-----------CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREG-----------RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
....+......+||+.|||||.+... +.++++||||||||||+|++|+.||....+....+. ....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~---aI~~ 587 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLH---AITD 587 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHH---hhcC
Confidence 77777777888999999999976432 257899999999999999999999987532211111 1110
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
+. ....+...+. ..++.++++.||..||.+||++.|+|+|
T Consensus 588 P~-------------~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 588 PN-------------HEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CC-------------ccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 00 0000000000 1228999999999999999999999985
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.64 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=202.0
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch---------hhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG---------RALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
+|.+.+.||+|++|.||+|... +++.+++|.+..... .....+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999753 689999998865422 223567889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++++||+++++|.+++... ..+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999999665 36888899999999999999999 999999999999999999999999999998766
Q ss_pred cCCCCcc----ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 193 VGEDQSM----TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 193 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~---~~~~------ 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IF---KIGE------ 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-HH---HHhc------
Confidence 4211111 11223467889999999888899999999999999999999999976422110 00 0000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+..++..+.++|.+||+.||.+||++.++++|
T Consensus 227 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00011123456779999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=289.49 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=200.9
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|++.+.||+|+||.||+|.. .+++.+++|.+.... ......+.+|+++++++.||||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4688999999999999999974 478999999986552 33446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|..+. .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~ 148 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----S 148 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----c
Confidence 9999886542 4678889999999999999999 99999999999999999999999999999875421 1
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchH--hHhhhhccccccccccccccCc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK--HWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ........
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 214 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-------------- 214 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc--------------
Confidence 22334678899999999998999999999999999999999999976432221110 00000000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
...........+.++.++|.+||+.||.+||+++++++|-+
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 00000012234567899999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=301.40 Aligned_cols=267 Identities=22% Similarity=0.234 Sum_probs=200.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE----- 110 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 110 (339)
...++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45689999999999999999999754 6899999998654 234456678899999999999999999987543
Q ss_pred -ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 111 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 111 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
...|+||||+++ +|.+.+.. .++...+..++.|++.||.+|| +.|++|+||||+||+++.++.++|+|||++
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999976 78777743 4788889999999999999999 999999999999999999999999999998
Q ss_pred eeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
..... ........+++.|+|||++.+..++.++|||||||++|+|++|+.||........ ....... ...+..+.
T Consensus 174 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~-~~~~~~~~ 248 (364)
T cd07875 174 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQ-LGTPCPEF 248 (364)
T ss_pred cccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-cCCCCHHH
Confidence 75421 1222334578899999999999999999999999999999999999975432111 0000000 00000000
Q ss_pred ---cc------------------ccccCc--cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 270 ---VD------------------ANLLSQ--EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 270 ---~~------------------~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.. ...... ...........+..+++||.+||+.||.+|||+.++++|=
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00 000000 0000011112346789999999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.44 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=201.6
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec-CceeEEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN-EEFKALVLE 118 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 118 (339)
+|++.+.||.|++|.||++... +++.+++|.+.... ......+.+|++++++++|+|++++++.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999754 58899999986543 3445668889999999999999999998764 456899999
Q ss_pred ecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++++|.+++... ...+++..++.++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-- 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-- 155 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc--
Confidence 99999999998764 346899999999999999999999 999999999999999999999999999998765321
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........+++.|+|||.+.+..++.++|+||||++++++++|+.||........... .... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~-------------~~-- 219 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR-IIEG-------------KL-- 219 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHhc-------------CC--
Confidence 1222344578899999999999999999999999999999999999875322111000 0000 00
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...+..++..+.+|+.+||+.||++||++.++++|
T Consensus 220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01123456779999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=297.62 Aligned_cols=255 Identities=21% Similarity=0.262 Sum_probs=200.9
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||++... +++.||+|++... .......+.+|..+++.++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999754 6899999998753 2234456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.+....+++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG- 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-
Confidence 999999999999776667999999999999999999999 9999999999999999999999999999987653211
Q ss_pred ccccccccCCCCccCCccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 198 SMTQTQTFATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
........+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||......+.. . ........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-~---~i~~~~~~------ 226 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-G---KIMNHKEH------ 226 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH-H---HHHcCCCc------
Confidence 111223458999999998863 45788999999999999999999999754221110 0 00000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ--RINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 316 (339)
. .. ......++..+++||.+||..++.+ |++++++++|
T Consensus 227 --~---~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 --F---QF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --c---cC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 00 0011235777999999998765544 7899999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=290.44 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=203.6
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
...++|++.+.||+|+||.||+|... .+..|++|.+.... ......+.+|+.+++.+.||||+++++++....
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45689999999999999999998532 25579999876443 233346778999999999999999999999888
Q ss_pred eeEEEEEecCCCCHHHHHhhcC---------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEE
Q 019568 112 FKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 182 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~ 182 (339)
..+++|||+++++|.+++.... ...+...+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999996532 23456778899999999999999 99999999999999999999999
Q ss_pred EcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhh
Q 019568 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
|+|||++................++..|+|||.+.++.++.++|+||||+++|++++ |..||....... ......
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~-- 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFVM-- 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH--
Confidence 999999875432222222222334667999999998889999999999999999998 788886543211 111100
Q ss_pred ccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.... ...+..++..+.+++.+||+.||.+|||+.++++.|++..
T Consensus 236 -~~~~---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 -DGGY---------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -cCCC---------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0000 0012234567999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=289.37 Aligned_cols=256 Identities=24% Similarity=0.409 Sum_probs=204.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..++|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3578999999999999999999643 24789999986543 2334567889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcC---------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEE
Q 019568 113 KALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL 183 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l 183 (339)
.++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence 999999999999999986432 23677889999999999999999 999999999999999999999999
Q ss_pred cccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhc
Q 019568 184 SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
+|||++..+.............++..|+|||.+.+..++.++|+||||+++|++++ |..||........ .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~~--- 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--LKFVI--- 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--HHHHh---
Confidence 99999876533222222233345678999999988889999999999999999998 8999865432111 11110
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
. ......+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 D---------------GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred c---------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 0001112334677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=290.17 Aligned_cols=268 Identities=24% Similarity=0.290 Sum_probs=200.2
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||+|++|.||+|... ++..|++|++.... ......+.+|+.+++.+.|||++++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999754 68999999986543 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 120 MPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 120 ~~~~~L~~~i~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
+. ++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 154 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-- 154 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence 97 48988876533 46899999999999999999999 999999999999999999999999999998754221
Q ss_pred ccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh-------cccccccc
Q 019568 198 SMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW-------LPISTLEV 269 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 269 (339)
........+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||................. ........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112223346788999998765 4578999999999999999999999975432111110000000 00000000
Q ss_pred ccccccC-ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VDANLLS-QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....... ...........++.++.+||.+||+.||.+|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 0000011123467889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.64 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=202.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|.+.+.||.|++|.||+|....+..+++|.+.... .....+.+|+++++.+.|+|++++++++.. +..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence 346799999999999999999987666789999876443 234567889999999999999999998864 567899999
Q ss_pred cCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+.+++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence 99999999997643 35788999999999999999999 99999999999999999999999999999876532211
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......++..|+|||...+..++.++|+||||+++|+|++ |..||......+. ........
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~~~~~~--------------- 220 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV--LEQVERGY--------------- 220 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCC---------------
Confidence 11122234567999999988889999999999999999999 8999876432211 11110000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
....+...+..+.+++.+||+.||.+||+++++++.|++
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 ---RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001123446779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.68 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=202.4
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|+.++++++|++++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999754 68999999986542 2223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+.+++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--
Confidence 999999999885433 36889999999999999999999 999999999999999999999999999988654211
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||........... ..... .
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~---------~------ 218 (285)
T cd05630 156 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLV---------K------ 218 (285)
T ss_pred -ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhh---------h------
Confidence 112234688999999999998999999999999999999999999976432211000 00000 0
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKKLL 318 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~l~ 318 (339)
......+..+++++.+|+.+||+.||++||| ++|+++|=+
T Consensus 219 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 219 -EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred -hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 0000112345677999999999999999999 899999644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.84 Aligned_cols=240 Identities=21% Similarity=0.364 Sum_probs=191.2
Q ss_pred ceeeecCccEEEEEEeCC-------------CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 48 NLIGKGGFGSVYKARLGD-------------GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~-------------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
+.||+|+||.||+|.... ...+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997421 2358899887665556667888999999999999999999999988999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc-------EEEcccc
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-------AHLSDFS 187 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~-------v~l~Dfg 187 (339)
++|||+++++|..++......+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988766667899999999999999999999 999999999999999987664 8999999
Q ss_pred cceeccCCCCccccccccCCCCccCCcccc-CCCCCCcchhhHHHHHHHHHH-hCCCCCcccccCccchHhHhhhhcccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETF-TGKKPTDEIFNGEMTLKHWVNDWLPIS 265 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll-~g~~P~~~~~~~~~~~~~~~~~~~~~~ 265 (339)
++.... ......++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+. ......
T Consensus 158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~----- 224 (262)
T cd05077 158 IPITVL------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFYEG----- 224 (262)
T ss_pred CCcccc------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHHhc-----
Confidence 886542 122334677899999886 466899999999999999998 58888765322111 000000
Q ss_pred ccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
. .......+.++.+||.+||+.||.+||++++|+++|+
T Consensus 225 -------~--------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 -------Q--------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -------C--------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0001123466899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=286.14 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=206.6
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
...|+..+.||.|+||.||.|... ++..+|+|.+.... ......+.+|+.+++.+.|+||+++++++.++...++|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 457889999999999999999754 68999999987553 3455678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++++|.+++... .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 83 YLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred cCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 99999999998653 5888899999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||........... .. .
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--------------~~------~ 215 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL--------------IP------K 215 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh--------------hh------c
Confidence 122234567789999999888899999999999999999999999875432211000 00 0
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.........++..+.+++.+||+.+|++||+++++++|-.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 0011123456778999999999999999999999999844
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=293.06 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=202.6
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCc--EEEEEEeecc-chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGM--EVAVKVFNLQ-CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~--~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (339)
.++|++.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|++++.++ +|+||+++++++...+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 468999999999999999999753 454 4567765532 233446788899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 116 VLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
++||+++++|.+++.... ..+++..++.++.|++.|+.||| +.|++|+||+|+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 999999999999986542 25788999999999999999999 999999999999999999999
Q ss_pred EEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhh
Q 019568 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~ 259 (339)
++|+|||++.... ..........+..|+|||.+.+..++.++||||||+++++|+| |..||......+. ..
T Consensus 163 ~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~ 234 (303)
T cd05088 163 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----YE 234 (303)
T ss_pred EEeCccccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-----HH
Confidence 9999999885321 1111112223567999999988889999999999999999998 9999865432211 00
Q ss_pred hhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 260 DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
.... ......+..++.++.+|+.+||+.+|.+||++.+++..|..+...-
T Consensus 235 ~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 235 KLPQ---------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHhc---------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000 0000112234567899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.60 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=197.0
Q ss_pred ceeeecCccEEEEEEe---CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARL---GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~---~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|.+ .++..+++|++.... ......+.+|+.+++.+.||||+++++++.. +..++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 3689999999999953 357889999986543 3345678889999999999999999998864 466899999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc-c
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT-Q 201 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~-~ 201 (339)
++|.+++.... .+++..+..++.|++.|+.+|| +.+++|+||+|.||+++.++.++|+|||++..+........ .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999986543 6889999999999999999999 99999999999999999999999999999876532221111 1
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||........ ...... . .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~i~~------------~------~ 215 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV--TQMIES------------G------E 215 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHC------------C------C
Confidence 12223568999999988889999999999999999998 9999976432211 111110 0 0
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
....+..++.++.++|.+||+.||++||++.+|.+.|+++
T Consensus 216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0112334677899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=298.50 Aligned_cols=268 Identities=24% Similarity=0.282 Sum_probs=199.9
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNE-- 110 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 110 (339)
......++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 3445678999999999999999999974 468899999986542 22345677899999999999999999987543
Q ss_pred ----ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 111 ----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 111 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
...|++++++ +++|.+++... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 66998887543 5899999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 265 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~ 265 (339)
|++..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... ........... .
T Consensus 163 g~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~-~ 235 (343)
T cd07878 163 GLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGT-P 235 (343)
T ss_pred ccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCC-C
Confidence 99876422 2233457889999998876 568999999999999999999999996532111 11111100000 0
Q ss_pred ccccccc-----------cc--cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 266 TLEVVDA-----------NL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 266 ~~~~~~~-----------~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....... .. ....... ......++.+.+||.+||+.||.+|||+.++++|=
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000000 00 0000000 00112345688999999999999999999999973
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=285.44 Aligned_cols=257 Identities=26% Similarity=0.477 Sum_probs=205.8
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CC---cEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DG---MEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~---~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
.++|+..+.||+|++|.||+|... ++ ..+++|.+.... ......+.+|+++++.++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 468899999999999999999753 23 378999886552 3445678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++......+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999776667899999999999999999999 999999999999999999999999999998765322
Q ss_pred CCcccc-ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 196 DQSMTQ-TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 196 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
...... .....++.|+|||.+.+..++.++|+||||+++|++++ |..||....... ........
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i~~~------------ 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAINDG------------ 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhcC------------
Confidence 211111 11223456999999988889999999999999999997 999986543211 11111000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
........++.++.+++.+||+.+|.+||++.++++.|.++
T Consensus 227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011223467799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=288.90 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=200.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeec------C
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSN------E 110 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~ 110 (339)
.+.+.|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++.+ +|+|++++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46688999999999999999999754 68999999987553 2335678899999998 69999999999864 2
Q ss_pred ceeEEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 111 EFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
...++++||+.+++|.+++... ...+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4688999999999999998764 346889999999999999999999 999999999999999999999999999998
Q ss_pred eeccCCCCccccccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
...... ........+++.|+|||++. +..++.++|+||+|+++|+|++|..||............ ..
T Consensus 159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~~-- 230 (272)
T cd06637 159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PR-- 230 (272)
T ss_pred eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----hc--
Confidence 754221 11223345788899999875 335788999999999999999999998654321111100 00
Q ss_pred cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..........++.++.+|+.+||..||.+|||+.++++|
T Consensus 231 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 -------------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -------------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000011122345679999999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=285.08 Aligned_cols=249 Identities=31% Similarity=0.456 Sum_probs=200.6
Q ss_pred hcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeee-ecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC-SNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~ 119 (339)
.++|++.+.||+|+||.||++.. .+..+++|.+... .....+.+|+.+++.++|++++++++++ ...+..++++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46899999999999999999976 5888999987644 2345688899999999999999999975 455678999999
Q ss_pred cCCCCHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++..... .+++..++.++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 155 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc---
Confidence 999999999876543 4788999999999999999999 999999999999999999999999999988754221
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||........ ......
T Consensus 156 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~--~~~~~~----------------- 214 (256)
T cd05082 156 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEK----------------- 214 (256)
T ss_pred --CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHhc-----------------
Confidence 112223457999999988889999999999999999997 9999864321110 000000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
......++.++..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 215 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 -GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 000111234567799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=281.85 Aligned_cols=247 Identities=30% Similarity=0.448 Sum_probs=198.7
Q ss_pred ceeeecCccEEEEEEeCCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHH
Q 019568 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 126 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 126 (339)
+.||+|+||.||+|...++..+++|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4689999999999987778999999986553 333456888999999999999999999999999999999999999999
Q ss_pred HHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccC
Q 019568 127 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206 (339)
Q Consensus 127 ~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~ 206 (339)
+++......+++..+..++.+++.++.++| +.+++|+||+|+||+++.++.++|+|||++....... ........+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 998766656889999999999999999999 9999999999999999999999999999886532111 111112233
Q ss_pred CCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhh
Q 019568 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285 (339)
Q Consensus 207 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (339)
+..|+|||.+.+..++.++|+||||+++|++++ |..||.......... .... . .....+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~--~~~~--~----------------~~~~~~ 216 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE--QVEK--G----------------YRMSCP 216 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHHc--C----------------CCCCCC
Confidence 567999999988889999999999999999998 999986542221110 0000 0 000112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 286 EQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 286 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 335677999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.60 Aligned_cols=262 Identities=22% Similarity=0.399 Sum_probs=202.4
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-----------------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-----------------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIK 102 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-----------------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 102 (339)
.++|++.+.||+|+||.||++... +...+++|++.... ......+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 467999999999999999998532 23468999887543 334567889999999999999999
Q ss_pred EeeeeecCceeEEEEEecCCCCHHHHHhhcC----------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCC
Q 019568 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSN 172 (339)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~N 172 (339)
+++++...+..+++|||+++++|.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 9999999999999999999999999986542 23667789999999999999999 9999999999999
Q ss_pred eEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh--CCCCCcccccC
Q 019568 173 VLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIFNG 250 (339)
Q Consensus 173 il~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~P~~~~~~~ 250 (339)
|+++.++.++|+|||++..+.............+++.|++||...+..++.++|+||||+++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999876532222122222334567999998888889999999999999999998 77888754332
Q ss_pred ccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 251 EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
+.... ... ...... .......+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 241 ~~~~~--~~~--------~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIEN--TGE--------FFRDQG---RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHH--HHH--------HHhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 21100 000 000000 00001112345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=282.31 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=205.5
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|+..+.||.|+||.|+.++. .+++.+++|.+.... ......+.+|++++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999999964 468999999987542 44456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++.+. ...+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765 346899999999999999999999 99999999999999999999999999999876532221
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+.... ....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~-----~~~~-------------- 216 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK-----IVQG-------------- 216 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHcC--------------
Confidence 22344578899999999888899999999999999999999999865322111000 0000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.. ...+..++..+.+++.+||..+|.+||+++++++++
T Consensus 217 ~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 217 NY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 00 001234567799999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=299.44 Aligned_cols=242 Identities=30% Similarity=0.347 Sum_probs=191.3
Q ss_pred ceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHH-HHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|.. .+|+.+|+|++.... ......+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999975 468999999986542 223334444544 57778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|...+.+.. .+++..+..++.||+.||.||| +.|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcc
Confidence 99998886543 7899999999999999999999 99999999999999999999999999999864321 122233
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||.+.+..++.++|||||||++|+|++|..||......+.. . .... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-~----~~~~--------~--------~~ 213 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-D----NILH--------K--------PL 213 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-H----HHHc--------C--------Cc
Confidence 456889999999999999999999999999999999999999754321110 0 0000 0 00
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHH----HHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINAK----EIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~----ell~~ 316 (339)
...+..+..+.+++.+||..||.+||++. ++++|
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 11223466788999999999999999875 66654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=286.61 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=207.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCc----EEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGM----EVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~----~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..+|++.+.||+|+||.||+|... ++. .+++|...... ......+.+|+..++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 468899999999999999999743 333 58899876554 3345678889999999999999999999887 7889
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+++||+++++|.+++......+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999876667999999999999999999999 99999999999999999999999999999876542
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
...........++..|+|||.+.+..++.++|+||||++++++++ |..||......+. ......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~------------- 226 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--PDLLEK------------- 226 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHHhC-------------
Confidence 222111122223567999999988889999999999999999998 9999876432111 111000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
......+..++.++.+++.+||..||.+||++.++++.|.++.+..
T Consensus 227 -----~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 227 -----GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0001112334566899999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=284.58 Aligned_cols=255 Identities=25% Similarity=0.437 Sum_probs=205.0
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
...++|++.+.||+|+||.||++....+..+++|.+... ......+.+|+++++.++|+||+++++.+.. ...++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 456899999999999999999998767788999987654 2334678889999999999999999999887 77899999
Q ss_pred ecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++++|.+++.+. ....+...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999764 345788889999999999999999 99999999999999999999999999999876532211
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.......++..|+|||.+.+..++.++|+||||+++|++++ |..||........ .......
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~~~~--------------- 219 (260)
T cd05073 158 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IRALERG--------------- 219 (260)
T ss_pred -ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHhCC---------------
Confidence 11122234567999999988889999999999999999998 8999875432211 1110000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.........+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 ---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001123446679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=293.88 Aligned_cols=268 Identities=19% Similarity=0.269 Sum_probs=197.9
Q ss_pred CCceeeec--CccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 46 ENNLIGKG--GFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 46 ~~~~ig~g--~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
+.++||+| +|++||++.. .+|+.||+|.+.... ......+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 6789999974 479999999987652 344567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 121 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 121 ~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++++||+............
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998654 345889999999999999999999 9999999999999999999999999998654332111111
Q ss_pred -----ccccccCCCCccCCccccC--CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc--------c
Q 019568 200 -----TQTQTFATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP--------I 264 (339)
Q Consensus 200 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~--------~ 264 (339)
......++..|+|||.+.+ ..++.++|||||||++++|++|..||................... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 1122345667999998875 468999999999999999999999997643322111110000000 0
Q ss_pred ccc-----------cccccccc------CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 265 STL-----------EVVDANLL------SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 265 ~~~-----------~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
... ........ ............+++.+.+|+.+||+.||++|||++++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 00000000 00000011223456789999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.93 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=204.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..++|++.+.||+|+||.||+|... ++..+++|++.... ......+.+|+.+++.+.||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3578999999999999999999742 47889999987553 3344668889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcC---------------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCC
Q 019568 113 KALVLEYMPHGSLEKYLYSSN---------------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPS 171 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~---------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~ 171 (339)
.++++||+++++|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||+|+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence 999999999999999986421 24677888999999999999999 999999999999
Q ss_pred CeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccC
Q 019568 172 NVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNG 250 (339)
Q Consensus 172 Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~ 250 (339)
||+++.++.++|+|||++..+..............+..|+|||...+..++.++|+||||+++|+|++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876532222122222334567999999988899999999999999999997 88888644221
Q ss_pred ccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 251 EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
+. ........ ....+..++.++.+|+.+||+.||++|||+.|+++.|++
T Consensus 240 ~~-----~~~~~~~~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EV-----IYYVRDGN---------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH-----HHHHhcCC---------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 00000000 001123456779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=304.07 Aligned_cols=249 Identities=27% Similarity=0.348 Sum_probs=210.3
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
...|..++.||.|+||.||.|+. .+.+.||||+.... +.+...++..|+++|+++.|||++.+-++|..+...|+|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 35688899999999999999974 46889999998654 356678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
||||-| +-.|++.-..+++.+..|..|+.+.+.||+||| +.+.+|+|||+.|||+++.|.|||.|||++...
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---- 176 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---- 176 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhc----
Confidence 999965 999999888889999999999999999999999 999999999999999999999999999998764
Q ss_pred CccccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
......+|||+|||||++. .+.|+-+.||||||+++.+|.-.++|+-++.. ....+.......+++
T Consensus 177 --~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---MSALYHIAQNesPtL------ 245 (948)
T KOG0577|consen 177 --APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPTL------ 245 (948)
T ss_pred --CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---HHHHHHHHhcCCCCC------
Confidence 3455678999999999775 46799999999999999999999999665432 222222222211111
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..+.-++.+++|+..||+.-|++|||.+++++|--
T Consensus 246 ----------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 246 ----------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred ----------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 13445777999999999999999999999998743
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=283.65 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=202.9
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
++|++.+.||+|+||.||++.+.++..+++|.+..... ....+.+|++++++++||+++++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 57889999999999999999876688999998864422 23567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+++|.+++......+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence 99999998766667889999999999999999999 9999999999999999999999999999887542211 1111
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||........... ... . .
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--~~~------------~------~ 218 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET--INA------------G------F 218 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH--HhC------------C------C
Confidence 22234567999999988889999999999999999998 9999875432211100 000 0 0
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+...+..+.+|+.+||+.+|++||++.+++++|.
T Consensus 219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 00011223567999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=287.62 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=202.8
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999865 6999999988754 334456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 120 MPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 120 ~~~~~L~~~i~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+++++|..++... ...+++..+..++.|++.|+.||| + .+++|+||+|+||+++.++.++|+|||.+..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 155 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-- 155 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC--
Confidence 9999999988664 236899999999999999999999 6 5999999999999999999999999998875421
Q ss_pred CccccccccCCCCccCCccccCCC------CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGR------VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......... . .......
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~-~~~~~~~------- 224 (286)
T cd06622 156 --SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-A-QLSAIVD------- 224 (286)
T ss_pred --CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-H-HHHHHhh-------
Confidence 1222334677899999875543 588999999999999999999999653221110 0 0000000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
......+..++.++.+||.+||+.+|.+||+++++++|-+
T Consensus 225 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 225 --------GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred --------cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 0001123346788999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=287.02 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=201.3
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.|+..+.||+|+||+||.|... +++.+|+|.+.... ......+.+|+++++.++|++|+++.+.+..++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3778899999999999999754 68999999986542 2233456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++++|.+.+.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--
Confidence 999999998886533 36899999999999999999999 999999999999999999999999999988754221
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .........
T Consensus 156 -~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~-~~~~~~~~~------------- 220 (285)
T cd05632 156 -ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE-EVDRRVLET------------- 220 (285)
T ss_pred -CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhhhcc-------------
Confidence 11223457899999999988899999999999999999999999997543221110 000000000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
....+..++.++.+|+.+||+.||++||+ +.++++|
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 ---EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00112345667899999999999999999 7888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=294.02 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=206.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC--------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeec
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSN 109 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (339)
...+|++.+.||+|+||.||.|... +...+++|.+.... ......+.+|+++++++ .||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3468999999999999999999631 12368999887542 34456788899999999 79999999999999
Q ss_pred CceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeE
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 174 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil 174 (339)
.+..++++||+.+++|.+++.+.. ..++...+..++.|++.||.||| +.|++|+||+|+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEE
Confidence 999999999999999999986532 24777888999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccc
Q 019568 175 LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253 (339)
Q Consensus 175 ~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~ 253 (339)
++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 244 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 244 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 99999999999999876532221112222233567999999999999999999999999999998 888886542111
Q ss_pred hHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
....... ......+..++.++.+|+.+||+.+|.+||++.+++++|+++....
T Consensus 245 ---~~~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 ---LFKLLKE---------------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ---HHHHHHc---------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1110000 0001112345667999999999999999999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=316.86 Aligned_cols=261 Identities=25% Similarity=0.318 Sum_probs=206.1
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||+|... +++.||+|++.... .....++.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999754 68999999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc----------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccc
Q 019568 118 EYMPHGSLEKYLYSS----------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187 (339)
Q Consensus 118 e~~~~~~L~~~i~~~----------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg 187 (339)
||++|++|.+++... ....+...++.++.|++.||.||| +.|++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988642 123556678899999999999999 9999999999999999999999999999
Q ss_pred cceeccCCCC----------------ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCc
Q 019568 188 IAKLLVGEDQ----------------SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251 (339)
Q Consensus 188 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~ 251 (339)
++........ ........||+.|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9876521110 011123458999999999999999999999999999999999999997632221
Q ss_pred cchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHHHHH
Q 019568 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-NAKEIVKKLLKIRDS 323 (339)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~l~~~~~~ 323 (339)
...... .. ..........+++.+.+++.+||..||++|| +++++++.|+.+.+.
T Consensus 239 i~~~~~---i~---------------~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYRDV---IL---------------SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhh---cc---------------ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 111100 00 0000111234567799999999999999996 677777778777653
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=302.14 Aligned_cols=205 Identities=25% Similarity=0.355 Sum_probs=174.9
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-C-----cceeeEe
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-H-----RNLIKVI 104 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~ 104 (339)
+.+..-..+.-+|.+.+.||+|+||.|.+|. .++++.||||+++.. .........|+.+|..++ | -|+|+++
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 4444444455599999999999999999996 557999999998754 445566777999999996 3 4899999
Q ss_pred eeeecCceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC--CCcE
Q 019568 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVA 181 (339)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~--~~~v 181 (339)
++|...+++|||+|.+. .+|+++++.+. .+++...++.++.||+.+|..|| ..+|+|.||||+|||+.. ...|
T Consensus 255 d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred eccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCce
Confidence 99999999999999995 59999997654 57999999999999999999999 999999999999999953 4479
Q ss_pred EEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcc
Q 019568 182 HLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246 (339)
Q Consensus 182 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~ 246 (339)
|++|||+++... ......+-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+
T Consensus 331 KVIDFGSSc~~~-----q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 331 KVIDFGSSCFES-----QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred eEEecccccccC-----CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 999999998752 122255567789999999999999999999999999999999887655
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=285.82 Aligned_cols=269 Identities=24% Similarity=0.309 Sum_probs=202.0
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|++.+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++|+|++++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999999865 68999999886543 2233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|++++.|..++.. ...+++..++.++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9998777776644 346899999999999999999999 99999999999999999999999999999886532221
Q ss_pred cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh--hhhccc-----cccccc
Q 019568 199 MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV--NDWLPI-----STLEVV 270 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~ 270 (339)
......++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+....... ...... ......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 2223346778999998765 5678999999999999999999999976543221111000 000000 000000
Q ss_pred cccccCccc-h--hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLSQED-I--HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......... . .....+..+..+.+|+.+||+.||++||++.+++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000 0 001123456789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=291.10 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=188.5
Q ss_pred CceeeecCccEEEEEEeC---CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec--CceeEEEEEecC
Q 019568 47 NNLIGKGGFGSVYKARLG---DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMP 121 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 121 (339)
.++||+|+||+||+|... +++.+|+|.+.... ....+.+|+++++.++||||+++++++.. +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 568999999999999743 56889999886542 22456789999999999999999998843 556889999996
Q ss_pred CCCHHHHHhhc--------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe----CCCCcEEEcccccc
Q 019568 122 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIA 189 (339)
Q Consensus 122 ~~~L~~~i~~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~----~~~~~v~l~Dfg~~ 189 (339)
+ +|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 888887532 125888999999999999999999 9999999999999999 46678999999999
Q ss_pred eeccCCCCc-cccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccch--------HhHhh
Q 019568 190 KLLVGEDQS-MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL--------KHWVN 259 (339)
Q Consensus 190 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~--------~~~~~ 259 (339)
..+...... .......+|+.|+|||++.+. .++.++|+||+||++|+|++|.+||.......... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 765322111 122345678999999988764 58999999999999999999999997543221100 00000
Q ss_pred hhcccc--cccc-------------ccccccCccc-hhh--hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 260 DWLPIS--TLEV-------------VDANLLSQED-IHF--VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 260 ~~~~~~--~~~~-------------~~~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....+. .++. .......... ... ......+..+.+||.+||+.||.+|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0000 0000000000 000 0011123568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=282.91 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=203.2
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||+|+||.+|.+.. .+++.+++|.+.... ......+.+|+++++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999974 468999999987542 33446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+.+++|.+.+.... ..+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||.+..+... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--V 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--h
Confidence 99999999886543 35788999999999999999999 999999999999999999999999999998765321 1
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
.......+++.|+|||.+.+..++.++|+||||++++++++|..||......+. .......
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----~~~~~~~-------------- 216 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-----VLKIIRG-------------- 216 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-----HHHHhcC--------------
Confidence 112234467889999999988899999999999999999999999865322111 0000000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.....+..++.++.++|.+||+.+|.+||++.++++|
T Consensus 217 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 -SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0001133456779999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=296.17 Aligned_cols=242 Identities=29% Similarity=0.322 Sum_probs=190.3
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHH-HHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVEC-EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... +++.+|+|++.... ......+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999754 68999999987542 22233444444 467889999999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+.+... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTS 154 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccc
Confidence 9998888654 36888899999999999999999 99999999999999999999999999998864311 112223
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||.+.+..++.++|+|||||++|+|++|..||........ ....... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~----------------~~ 213 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-----YDNILHK----------------PL 213 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-----HHHHhcC----------------CC
Confidence 44588999999999988999999999999999999999999976421110 0000000 01
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCHH----HHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINAK----EIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~----ell~~ 316 (339)
..++..+..+.+++.+||+.||.+||++. ++++|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 11233466799999999999999999764 66554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=306.75 Aligned_cols=269 Identities=21% Similarity=0.245 Sum_probs=194.5
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC------cceeeEeeeeec
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH------RNLIKVISSCSN 109 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~ 109 (339)
+....++|++.+.||+|+||+||+|.. .+++.||||+++.. .........|+++++.+.| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 344568999999999999999999975 46889999998643 2223445667777777654 458889888865
Q ss_pred C-ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCC--------
Q 019568 110 E-EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNM-------- 179 (339)
Q Consensus 110 ~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~-------- 179 (339)
. ..+++||+++ +++|.+++.+.. .+++..+..++.|++.||.||| + .||+|+||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5788999998 668988886653 6899999999999999999999 8 5999999999999998665
Q ss_pred --------cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCc
Q 019568 180 --------VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251 (339)
Q Consensus 180 --------~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~ 251 (339)
.+||+|||.+... ........+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999987532 222334568999999999999999999999999999999999999997643211
Q ss_pred cchHhHhhhhccc------------cccccccccccCccch-----------hhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 019568 252 MTLKHWVNDWLPI------------STLEVVDANLLSQEDI-----------HFVAKEQCVSFVFNLAMACAVESPEQRI 308 (339)
Q Consensus 252 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp 308 (339)
. .......... ................ .........+.+.+||.+||++||++||
T Consensus 353 ~--~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 353 H--LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred H--HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 0 0000000000 0000000000000000 0000111245688999999999999999
Q ss_pred CHHHHHHHHH
Q 019568 309 NAKEIVKKLL 318 (339)
Q Consensus 309 s~~ell~~l~ 318 (339)
|++|+++|=+
T Consensus 431 ta~e~L~Hp~ 440 (467)
T PTZ00284 431 NARQMTTHPY 440 (467)
T ss_pred CHHHHhcCcc
Confidence 9999999743
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=286.90 Aligned_cols=271 Identities=25% Similarity=0.394 Sum_probs=207.8
Q ss_pred cCCCCCceeeecCccEEEEEEeC-----CCcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeec--Ccee
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-----DGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSN--EEFK 113 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-----~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 113 (339)
..|++.+.||+|+||.||+|... ++..+|||++...... ....+.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 57888999999999999999742 3788999998766443 56788999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++++||+++++|.+++......++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999776657899999999999999999999 9999999999999999999999999999988653
Q ss_pred CCCCccc-cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMT-QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
....... .....++..|++||.+.+..++.++|+||||+++++|++|..|+........... ..............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI---GIAQGQMIVTRLLE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccc---ccccccccHHHHHH
Confidence 2211111 1122334569999999888899999999999999999999999765432211100 00000000000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
..........+..++.++.+++.+||+.+|.+||++.|+++.|.++
T Consensus 238 --~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 --LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred --HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000111112334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.47 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=199.4
Q ss_pred ceeeecCccEEEEEEeC--CC--cEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG--DG--MEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~--~~--~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|++|.||+|.+. ++ ..++||.+..... .....+.+|++.+++++||||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 46899999999999753 23 3689999877655 566788999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc-c
Q 019568 123 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-T 200 (339)
Q Consensus 123 ~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~-~ 200 (339)
++|.+.+.... ..+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997755 57899999999999999999999 9999999999999999999999999999987663322111 1
Q ss_pred cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
.....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+.... ... . .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~--~~~--~---------------~ 217 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK--IDK--E---------------G 217 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HHh--c---------------C
Confidence 122345678999999999999999999999999999998 9999865422211110 000 0 0
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.....+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000112334677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=285.46 Aligned_cols=254 Identities=25% Similarity=0.316 Sum_probs=201.8
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCc-----
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEE----- 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~----- 111 (339)
...++|++.+.||+|++|.||+|... +++.+++|++..... ....+.+|+++++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999864 688999999876543 346788999999999 7999999999986543
Q ss_pred -eeEEEEEecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccc
Q 019568 112 -FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187 (339)
Q Consensus 112 -~~~lv~e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg 187 (339)
..++||||+++++|.+++... ...+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 589999999999999988653 357899999999999999999999 9999999999999999999999999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
.+...... ........+++.|+|||.+.. ..++.++|+||||++++++++|..||........... . ..
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~---~~ 232 (275)
T cd06608 159 VSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-I---PR 232 (275)
T ss_pred cceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH-h---hc
Confidence 98765221 122234457888999998753 3467899999999999999999999975422111110 0 00
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. .......+..++.++.+||.+||..||++|||+.++++|
T Consensus 233 ~--------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 N--------------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred c--------------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 000111133456789999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=296.40 Aligned_cols=264 Identities=20% Similarity=0.209 Sum_probs=196.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
...+|++.+.||+|+||.||+|... ++..||+|+.... ....|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999754 5788999975322 23459999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
++.+ +|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..... .
T Consensus 138 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~ 210 (357)
T PHA03209 138 HYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---A 210 (357)
T ss_pred ccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc---C
Confidence 9954 899988777778999999999999999999999 99999999999999999999999999999864321 1
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCC-cccccCccc--------hHhHhhhhc--ccccc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT-DEIFNGEMT--------LKHWVNDWL--PISTL 267 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~-~~~~~~~~~--------~~~~~~~~~--~~~~~ 267 (339)
.......+++.|+|||++.+..++.++|||||||++|+|+++..|+ ......... ......... +....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 1223345789999999999999999999999999999999865554 332111000 000000000 00000
Q ss_pred ---------cccccc-c--cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 ---------EVVDAN-L--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 ---------~~~~~~-~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.+.+.. . .............++.++.+||.+||+.||.+|||+.|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000000 0 000000111122456678889999999999999999999987
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=286.55 Aligned_cols=268 Identities=23% Similarity=0.283 Sum_probs=205.0
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||.|++|.||+|... +++.+++|++.... ......+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999854 68999999987654 33456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+ +++|.+++......+++..++.++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 88999999776678999999999999999999999 99999999999999999999999999999876532221 1
Q ss_pred ccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc---ccccc-----c
Q 019568 200 TQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI---STLEV-----V 270 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~ 270 (339)
......++..|+|||.+.+. .++.++||||+|+++++|++|.+||....... ............ ..... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcchh
Confidence 22334578889999987654 46899999999999999999988876543211 111111100000 00000 0
Q ss_pred cccccC-ccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLS-QEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~-~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...... ..... ....+..+..+.+||.+||+.||.+||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00000 01123456889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=280.86 Aligned_cols=248 Identities=29% Similarity=0.438 Sum_probs=197.1
Q ss_pred ceeeecCccEEEEEEeC-C---CcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-D---GMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~---~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|.+. . +..+++|.+..... .....+.+|+++++.+.|+|++++++++.. +..++++||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 47999999999999642 2 37899999876543 345678889999999999999999998764 457899999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc-c
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT-Q 201 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~-~ 201 (339)
++|.+++.... .+++..+..++.|++.++.+|| ..+++|+||+|+||+++.++.++|+|||++........... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997655 7899999999999999999999 99999999999999999999999999999876532221111 1
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ........ .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~~~~------------------~ 215 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAMLESG------------------E 215 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcC------------------C
Confidence 11123457999999988899999999999999999998 999987653221 11111100 0
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
....+..++..++++|.+||+.||.+||++.++++.|+++
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0112334567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=281.99 Aligned_cols=248 Identities=26% Similarity=0.359 Sum_probs=203.0
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-----hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+|+..+.||+|++|.||+|... +++.+++|.+.... ......+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888999999999999999765 78999999986543 23556788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+||+++++|.+++.+.. .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999986654 6889999999999999999999 9999999999999999999999999999987653221
Q ss_pred CccccccccCCCCccCCccccCCC-CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
......+++.|++||.+.... ++.++|+||||+++|++++|..||........... ....
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~-------------- 217 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK--IGRS-------------- 217 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH--HHhc--------------
Confidence 223445788899999887766 89999999999999999999999876532111000 0000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+..++..+.+++.+||+.+|.+||+++++++|
T Consensus 218 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 218 ---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00001123456778999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=286.54 Aligned_cols=271 Identities=21% Similarity=0.245 Sum_probs=201.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||.||+|.. .+++.+++|.+..... .....+.+|+.+++.++|+||+++++++......++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999974 4689999999865532 22335678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+. +++.+.+......+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-- 156 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--
Confidence 9996 5888777665556888889999999999999999 999999999999999999999999999988654221
Q ss_pred ccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc------------
Q 019568 198 SMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI------------ 264 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~------------ 264 (339)
........+++.|+|||.+.+. .++.++|+||||+++++|++|..||...................+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 1112333467889999988754 578899999999999999999999976543211111111100000
Q ss_pred cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........................+..+.+++.+||..||.+|||+++++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000000001124678899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=287.14 Aligned_cols=270 Identities=22% Similarity=0.305 Sum_probs=201.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||.|++|.||+|... +++.|++|.+..... .....+.+|++++++++|+||+++++++......++||
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 3578999999999999999999754 689999999865432 22345667999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+.+ +|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 156 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-- 156 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC--
Confidence 99975 999998776667899999999999999999999 999999999999999999999999999988653211
Q ss_pred ccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc--ccc-------
Q 019568 198 SMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--STL------- 267 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~------- 267 (339)
........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.................... ...
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 111222345778999998765 4588999999999999999999999975432211111111100000 000
Q ss_pred ccccc--cccCccchhhhhhHHHH--HHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 EVVDA--NLLSQEDIHFVAKEQCV--SFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 ~~~~~--~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... ........ .......+ ..+.+++.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPL-INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhH-HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 00000000 00001122 668899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.09 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=204.0
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.+.|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.+.||||+++++.+......++|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 356788899999999999999754 58899999987543 3455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++..+... .
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~ 155 (277)
T cd06642 83 YLGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--Q 155 (277)
T ss_pred ccCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCc--c
Confidence 99999999988643 5889999999999999999999 999999999999999999999999999998765321 1
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
.......++..|+|||.+.+..++.++|+||||+++++|++|..||.......... .. ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~------------~~~----- 216 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--LI------------PKN----- 216 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--hh------------hcC-----
Confidence 12223346788999999998889999999999999999999999987543221110 00 000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
........++..+.++|.+||+.+|.+||++.++++|-+
T Consensus 217 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 217 -SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred -CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 000112345667999999999999999999999999744
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=281.28 Aligned_cols=257 Identities=26% Similarity=0.338 Sum_probs=206.1
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|++.+.||.|++|+||+|... ++..+++|++.... ......+.+|+++++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999999743 68899999986543 33567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 120 MPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 120 ~~~~~L~~~i~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
+++++|.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997542 46899999999999999999999 99999999999999999999999999999876643322
Q ss_pred cc--ccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 198 SM--TQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 198 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.. ......++..|+|||.+... .++.++|+||||+++++|++|+.||........ ....... ... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~--~~~--------~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQN--DPP--------S 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcC--CCC--------C
Confidence 21 12333578889999988776 789999999999999999999999976533211 1110000 000 0
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. .......++..+.+++.+||..||++||+++++++|
T Consensus 227 ~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LE----TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cC----CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 000023556779999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=295.12 Aligned_cols=255 Identities=19% Similarity=0.228 Sum_probs=200.8
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|..++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999754 58889999986432 233345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.+....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence 999999999999876667899999999999999999999 9999999999999999999999999999986542211
Q ss_pred ccccccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 198 SMTQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
........||+.|+|||++. ...++.++|+||||+++|+|++|+.||......+... ........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~----~i~~~~~~------ 226 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----KIMNHKER------ 226 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH----HHhCCCcc------
Confidence 11223346899999999875 3467899999999999999999999997543211100 00000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ--RINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 316 (339)
.. .......++.++++|+.+||..++.+ |++++++++|
T Consensus 227 -----~~-~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 -----FQ-FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----cc-CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 00012345778999999999775555 6899999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=283.63 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=206.3
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|+..+.||.|++|.||++... +++.+++|.+.... ......+.+|+++++.+.||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999765 68999999987653 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+.+++|.+++......+++..+..++.|++.++.+|| + .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9989999999876568899999999999999999999 8 99999999999999999999999999988654211
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......++..|+|||.+.+..++.++|+||||++++++++|..||....................
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 219 (265)
T cd06605 155 -LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-------------- 219 (265)
T ss_pred -HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC--------------
Confidence 11125577889999999988999999999999999999999999876533222111111110000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.........++..+.++|.+||..||++|||+.++++|
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00000111267779999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=280.40 Aligned_cols=250 Identities=32% Similarity=0.573 Sum_probs=201.6
Q ss_pred CCCCceeeecCccEEEEEEeCC-----CcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 44 FSENNLIGKGGFGSVYKARLGD-----GMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~-----~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
+++.+.||.|+||.||++.... +..+++|.+...... ....+.+|+++++.++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678999999999999997543 388999998665433 5678889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCc-cCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 118 EYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
||+++++|.+++...... +++..+..++.|++.|+++|| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765534 899999999999999999999 9999999999999999999999999999987664332
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.... ....+++.|+|||.+.+..++.++|+||+|+++++|++ |..||........ ..... ..
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~--~~~~~---~~----------- 220 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV--LEYLK---KG----------- 220 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHh---cC-----------
Confidence 2111 12336678999999988889999999999999999998 7888765322111 00000 00
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.....+..++.++.+++.+||+.||++|||+.++++.|
T Consensus 221 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 ----YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00111223577799999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=285.25 Aligned_cols=254 Identities=25% Similarity=0.442 Sum_probs=203.7
Q ss_pred cCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
++|++.+.||.|+||.||+|+.. +...+++|.+...... ....+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 68999999999999999999743 3567899988665443 5677899999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHHhhcC--------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 115 LVLEYMPHGSLEKYLYSSN--------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~--------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
+||||+++++|.+++.... ..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999986543 15889999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~ 265 (339)
|++...... .........++..|+|||.+.+..++.++|+||||+++|++++ |..||........ ......
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-----~~~~~~-- 233 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-----LNRLQA-- 233 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-----HHHHHc--
Confidence 987643211 1112223345667999999988889999999999999999998 7888865422111 000000
Q ss_pred ccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.......+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus 234 ------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 ------------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00011112345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=285.16 Aligned_cols=238 Identities=24% Similarity=0.362 Sum_probs=188.9
Q ss_pred eeeecCccEEEEEEeC-------------------------CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeE
Q 019568 49 LIGKGGFGSVYKARLG-------------------------DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103 (339)
Q Consensus 49 ~ig~g~~~~v~~~~~~-------------------------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 103 (339)
+||+|+||.||+|... ....|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998631 124588898876555555678889999999999999999
Q ss_pred eeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC----
Q 019568 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---- 179 (339)
Q Consensus 104 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~---- 179 (339)
++++......++||||+++++|..++.+....+++..+..++.|++.||.||| +++++|+||+|+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766667899999999999999999999 99999999999999997543
Q ss_pred ---cEEEcccccceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHH-hCCCCCcccccCccch
Q 019568 180 ---VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETF-TGKKPTDEIFNGEMTL 254 (339)
Q Consensus 180 ---~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll-~g~~P~~~~~~~~~~~ 254 (339)
.++++|||.+.... ......++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||......+.
T Consensus 159 ~~~~~kl~d~g~~~~~~------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL------SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred ccceeeecCCccccccc------cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 48999999875431 1122346778999998865 56899999999999999985 68999876533221
Q ss_pred HhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 255 KHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....... ...+...+..+.++|.+||+.+|++||++++++++|
T Consensus 231 ~~~~~~~--------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERFYEKK--------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHhc--------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1110000 000112234689999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=285.98 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=203.7
Q ss_pred eHHHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeee--
Q 019568 33 SYLELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCS-- 108 (339)
Q Consensus 33 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-- 108 (339)
++.+.....+.|++.+.||.|+||.||+|.. .+++.+++|++.... .....+..|+.+++.+ .|+|++++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4556666778999999999999999999975 468999999986653 3335678899999998 7999999999984
Q ss_pred ----cCceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEE
Q 019568 109 ----NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL 183 (339)
Q Consensus 109 ----~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l 183 (339)
.....+++|||+.+++|.+++.... ..+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 2457899999999999999986543 35888889999999999999999 999999999999999999999999
Q ss_pred cccccceeccCCCCccccccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh
Q 019568 184 SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~ 258 (339)
+|||++...... ........+++.|+|||.+. +..++.++|+||||+++|+|++|..||...........
T Consensus 163 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--- 237 (282)
T cd06636 163 VDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--- 237 (282)
T ss_pred eeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---
Confidence 999988654211 11223345788899999875 34578899999999999999999999865432111100
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ............++.++.+||.+||+.||.+||++.|+++|
T Consensus 238 -~---------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 -I---------------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -H---------------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 00000001123456779999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.93 Aligned_cols=255 Identities=20% Similarity=0.228 Sum_probs=200.9
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||+||+++.. +++.+|+|++.... ......+.+|..++..+.|++|+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999754 68899999986531 233455778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+.|++|.+++.+....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999876667899999999999999999999 99999999999999999999999999999876532211
Q ss_pred ccccccccCCCCccCCccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 198 SMTQTQTFATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.......|++.|+|||.+.+ +.++.++|+||||+++|+|++|+.||......+. ... .......
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~---i~~~~~~------ 226 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGK---IMNHEER------ 226 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-HHH---HHcCCCc------
Confidence 12233458999999998865 4678999999999999999999999975422111 000 0000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ--RINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 316 (339)
... ......++.++++|+.+||..++.+ |++++++++|
T Consensus 227 -----~~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 -----FQF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -----ccC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 0001234677999999999876654 5689999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=287.10 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=208.1
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
+....++|.+.+.||+|+||.||++.. .++..+++|.+..........+.+|+.+++.++|||++++++.+...+..|+
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 444568999999999999999999974 4688999999876555555778889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
|+||+++++|.+++.+. .++...+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 94 v~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 94 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999999998654 4788899999999999999999 999999999999999999999999999988755322
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
. .......+++.|++||.+.+..++.++|+||||+++|++++|..||.............
T Consensus 169 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------------------ 228 (293)
T cd06647 169 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------------ 228 (293)
T ss_pred c--cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------------------
Confidence 2 12233457788999999988889999999999999999999999997543221100000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+..+...+..+.++|.+||..+|++||++.+++.|
T Consensus 229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 229 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111233456679999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=280.88 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=202.8
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc------hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC------GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
+|+..+.||+|++|.||++.. .+++.+++|++.... ......+.+|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999974 478999999986543 2245678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-cEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-~v~l~Dfg~~~~~~~ 194 (339)
|+||+++++|.+++.... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999986544 7889999999999999999999 99999999999999998765 699999999876532
Q ss_pred CCCc--cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 195 EDQS--MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 195 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.... .......++..|+|||.+.+..++.++|+||+|+++++|++|..||............. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~----------- 224 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-KIA----------- 224 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH-HHh-----------
Confidence 2111 11123346788999999988889999999999999999999999986432211111000 000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........+...+.++.+++.+||..+|.+||++.++++|
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 225 ----SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ----ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0000111234566779999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=280.93 Aligned_cols=252 Identities=26% Similarity=0.447 Sum_probs=194.5
Q ss_pred ceeeecCccEEEEEEeC----CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeee-cCceeEEEEEecC
Q 019568 48 NLIGKGGFGSVYKARLG----DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCS-NEEFKALVLEYMP 121 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 121 (339)
+.||+|+||.||+|... ....+|+|.+... .......+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999742 2467999987543 2344567888999999999999999999764 4566889999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc--c
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS--M 199 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~--~ 199 (339)
+++|.+++.......+...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999766556777888999999999999999 999999999999999999999999999998754321111 1
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhC-CCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG-KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......+++.|+|||.+.+..++.++||||||+++|+|++| .+||....... .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~~~------------------ 217 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLLQ------------------ 217 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhc------------------
Confidence 11123346679999999888899999999999999999995 55665432111 1111000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
......+..++..+.+++.+||..+|++||++.++++.|+++..
T Consensus 218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00011122345679999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=287.10 Aligned_cols=246 Identities=26% Similarity=0.295 Sum_probs=203.7
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|++|.||++... +++.+++|++.... ......+.+|+++++++.||||+++++++...+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999754 68999999986542 234567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++... ..+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998765 47899999999999999999999 999999999999999999999999999998765322
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ...... ..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~---~~-------------- 213 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-IYEKIL---EG-------------- 213 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHh---cC--------------
Confidence 233457889999999988888999999999999999999999987543111 000000 00
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKKL 317 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~l 317 (339)
....+...+..++++|.+||..||.+|+ +++|+++|=
T Consensus 214 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 214 ---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred ---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 0011223466799999999999999999 889998763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=281.32 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=198.4
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-----hhhhHHHHHHHHHHHhCCCcceeeEeeeeec--Ccee
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-----GRALKSFNVECEMMKSIRHRNLIKVISSCSN--EEFK 113 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 113 (339)
.+|++.+.||+|+||.||+|.. .++..+++|.+.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4799999999999999999975 468999999886432 2344568889999999999999999998865 4678
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++++||+++++|.+++.... .++...++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999986654 5888899999999999999999 9999999999999999999999999999987542
Q ss_pred CCCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
..... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~---------- 223 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IAT---------- 223 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----Hhc----------
Confidence 21111 111223467889999999988899999999999999999999999975422111100 000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+..++..+.+++ +||..+|++||+++|+++|
T Consensus 224 -----~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 224 -----QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -----CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0001111334566688888 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.33 Aligned_cols=256 Identities=20% Similarity=0.287 Sum_probs=200.6
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeec--
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSN-- 109 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 109 (339)
.......++|++.+.||+|+||+||+|... ++..+++|++... .......+..|+.+++++.||||++++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 344556789999999999999999999754 5888999998654 23445678889999999999999999998844
Q ss_pred CceeEEEEEecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCC-------CCeEecCCCCCCeEeCC--
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYS-------APIIHCDLKPSNVLLDD-- 177 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~-------~~i~h~di~p~Nil~~~-- 177 (339)
...+|+||||+++++|.+++... ...+++..++.++.||+.||.||| + .+|+|+||||+|||++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH---s~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH---NLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hcccccccCCceeccCcHHHeEeecCc
Confidence 45789999999999999998653 246999999999999999999999 6 45999999999999954
Q ss_pred ---------------CCcEEEcccccceeccCCCCccccccccCCCCccCCccccC--CCCCCcchhhHHHHHHHHHHhC
Q 019568 178 ---------------NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTG 240 (339)
Q Consensus 178 ---------------~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g 240 (339)
.+.++|+|||++..+... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 335899999998765221 12234468999999998854 4588999999999999999999
Q ss_pred CCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 241 KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 241 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..||....... ......... .. ......+.++.+||..||+.+|.+||++.++|.+
T Consensus 240 k~PF~~~~~~~----qli~~lk~~-------------p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 240 KTPFHKANNFS----QLISELKRG-------------PD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCCcCCcHH----HHHHHHhcC-------------CC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 99996532211 111110000 00 0012346679999999999999999999999975
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=290.66 Aligned_cols=253 Identities=28% Similarity=0.363 Sum_probs=204.3
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch---hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|++|+||+|... +++.+++|.+..... .....+.+|+++++.+.|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47899999999999999999754 589999999876532 24567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 118 EYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 118 e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
||+.+++|.+++... ...+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998754 346899999999999999999999 9999999999999999999999999999876542111
Q ss_pred Cc---------------------------cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCccccc
Q 019568 197 QS---------------------------MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 249 (339)
Q Consensus 197 ~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~ 249 (339)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 011123467889999999988899999999999999999999999975533
Q ss_pred CccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC----HHHHHHH
Q 019568 250 GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN----AKEIVKK 316 (339)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 316 (339)
...... ... ...........+..+.+++.+||..||++||+ ++++++|
T Consensus 238 ~~~~~~----~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DETFSN----ILK---------------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHH----Hhc---------------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 211110 000 00001111225677999999999999999999 9999886
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=282.96 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=200.5
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch----------hhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG----------RALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
+|.+.+.||.|++|.||+|.. .+++.+++|.+..... ...+.+.+|+++++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999974 3689999998864311 12346778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..++|+||+++++|.+++.... .++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++++|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999987664 7888999999999999999999 99999999999999999999999999999875
Q ss_pred ccCCCCccccccccCCCCccCCccccCCC--CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
..............++..|+|||.+.+.. ++.++|+||||++++++++|..||........ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~----- 228 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA----MFKLGNKR----- 228 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH----HHHhhccc-----
Confidence 42211111122334678899999887654 78999999999999999999999864322111 10000000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
............++..+.++|.+||+.||.+||+++++++|
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 ------SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ------cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000011123456789999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=285.72 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=204.5
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeec
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSN 109 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (339)
+.+.++....++|.+.+.||+|+||.||++.. .+++.+++|++.... .....+.+|+.+++.+ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 55667777889999999999999999999975 468999999986542 2335677899999999 89999999999864
Q ss_pred C-----ceeEEEEEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcE
Q 019568 110 E-----EFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA 181 (339)
Q Consensus 110 ~-----~~~~lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v 181 (339)
. +..++|+||+++++|.+++.. ....+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence 3 368999999999999998753 3346899999999999999999999 9999999999999999999999
Q ss_pred EEcccccceeccCCCCccccccccCCCCccCCccccCC-----CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHh
Q 019568 182 HLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256 (339)
Q Consensus 182 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~ 256 (339)
+|+|||++....... .......++..|+|||.+... .++.++|+||||+++|+|++|..||.......... .
T Consensus 168 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-K 244 (291)
T ss_pred EEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-H
Confidence 999999987653211 112234577889999987543 36899999999999999999999987543211110 0
Q ss_pred HhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ..... .....+...+..+.+||.+||+.||++||++.++++|
T Consensus 245 ~----~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 I----PRNPP-------------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H----hcCCC-------------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 00000 0011122345569999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.01 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=199.6
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-----hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--cee
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-----GRALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFK 113 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 113 (339)
++|++.+.||+|+||.||.|... ++..|+||.+.... ......+.+|+++++.+.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999754 68999999875431 23456788899999999999999999988653 568
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++++||+++++|.+++.... .+++..+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999987654 5788889999999999999999 9999999999999999999999999999887543
Q ss_pred CCCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~---~~~~---------- 223 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IF---KIAT---------- 223 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HH---HHhc----------
Confidence 21111 112234477889999999888899999999999999999999999875421111 00 0000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+...+..+.+++.+|+. +|++||+++++++|
T Consensus 224 -----~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 -----QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 000111244566778999999995 99999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=282.94 Aligned_cols=248 Identities=29% Similarity=0.503 Sum_probs=196.8
Q ss_pred ceeeecCccEEEEEEeCC-------CcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 48 NLIGKGGFGSVYKARLGD-------GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~-------~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+.||+|+||.||+|+..+ +..+++|.+.... ......+.+|+++++.+.||||+++++++...+..++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999997532 2578999876543 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-----cEEEccccc
Q 019568 120 MPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-----VAHLSDFSI 188 (339)
Q Consensus 120 ~~~~~L~~~i~~~------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-----~v~l~Dfg~ 188 (339)
+++++|.+++... ...+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998642 234788889999999999999999 99999999999999999877 899999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
+.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~--~~~~~-------- 227 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--LQHVT-------- 227 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH--HHHHh--------
Confidence 876532222222223345678999999999999999999999999999998 9999875432211 10000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.......+..++..+.++|.+||..+|.+||+++++++.|+
T Consensus 228 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 ----------AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----------cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00011123445678999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=277.16 Aligned_cols=250 Identities=30% Similarity=0.422 Sum_probs=206.7
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
.|++.+.||+|++|.||++... ++..+++|++..........+.+|+++++.+.|++++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4888999999999999999864 689999999987655566788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+++|.+++......+++..++.++.|++.++.+|| ..+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999877567999999999999999999999 99999999999999999999999999998876532211 2
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchh
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (339)
....++..|+|||.+.+..++.++|+||||+++++|++|..||........... ... .. ...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~---~~-------------~~~ 216 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK--IAT---NG-------------PPG 216 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--HHh---cC-------------CCC
Confidence 344577889999999888899999999999999999999999875432111110 000 00 000
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 282 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......++..+.++|.+||+.||++|||+.++++|
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00112235679999999999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=278.86 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=207.1
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|++.+.||.|++|.||+|... +++.+++|++..... .....+.+|++.+..++|+|++++++++...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999765 599999999877644 4557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++++|.+++... ..+++..++.++.|++.++.+|| + .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 9999999999765 47899999999999999999999 9 9999999999999999999999999999876532211
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...........
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~-------------- 218 (264)
T cd06623 156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAICDG-------------- 218 (264)
T ss_pred -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHHhcC--------------
Confidence 1123456788999999998899999999999999999999999997764311 00000000000
Q ss_pred chhhhhhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 279 DIHFVAKEQ-CVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 279 ~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ....+.. ++..+.++|.+||..+|++||++.+++++
T Consensus 219 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 P-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0001122 56779999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=280.40 Aligned_cols=247 Identities=28% Similarity=0.506 Sum_probs=199.5
Q ss_pred hcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
.++|++.+.||+|+||.||.+.. +++.+++|.+.... ....+.+|+.+++.++|||++++++++..++ .+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence 36799999999999999999875 68889999986542 3357888999999999999999999987654 68999999
Q ss_pred CCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 121 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 121 ~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
.+++|.+++.... ..+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~----- 152 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM----- 152 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccc-----
Confidence 9999999997653 35788999999999999999999 99999999999999999999999999998875421
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ......
T Consensus 153 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~------------------ 212 (254)
T cd05083 153 GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--KECVEK------------------ 212 (254)
T ss_pred cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHhC------------------
Confidence 1112233567999999988889999999999999999997 9999875432211 000000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
......+..++..+.+++.+||+.+|.+||+++++++.|++
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00011123456779999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=312.51 Aligned_cols=271 Identities=24% Similarity=0.430 Sum_probs=232.1
Q ss_pred eeeeeHHHHhhhhc---------CCCCCceeeecCccEEEEEEeC----CCcEEEEEEeeccc-hhhhHHHHHHHHHHHh
Q 019568 29 WRTFSYLELCQATD---------EFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQC-GRALKSFNVECEMMKS 94 (339)
Q Consensus 29 ~~~~~~~~~~~~~~---------~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~ 94 (339)
.+-++|++..++.. ...|.+.||.|.||.|++|+.+ ....||||.++... ++...+|..|+.||-+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 44566776666554 3458899999999999999753 35679999998764 5667789999999999
Q ss_pred CCCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeE
Q 019568 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 174 (339)
Q Consensus 95 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil 174 (339)
+.||||+++.|+.....-..||+||+++|+|+.+++.+.+.++..++.-+++.|+.|+.||. +++++||||.+.|||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL 763 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence 99999999999999999999999999999999999999888999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccccceeccCCCCccc-cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCcc
Q 019568 175 LDDNMVAHLSDFSIAKLLVGEDQSMT-QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252 (339)
Q Consensus 175 ~~~~~~v~l~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~ 252 (339)
++.+...|++|||+++.+.+...... .....-..+|.|||.+...+++.+|||||+|++|||.++ |+.||.++.+.+.
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 99999999999999998754442211 112223567999999999999999999999999999887 9999998866543
Q ss_pred chHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
-.. .+.++++..|..||..|.+||..||++|-.+||.+.+|+.+|.++..
T Consensus 844 Ika--------------------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 844 IKA--------------------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred HHH--------------------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 221 23556777789999999999999999999999999999999998874
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=288.30 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=205.1
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCc----EEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGM----EVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~----~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
.++|+..+.||+|+||.||+|.+. ++. .+++|.+..... .....+.+|+.+++.+.||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 467889999999999999999743 343 578888765432 3334678899999999999999999998654 467
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+++||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999999876667889999999999999999999 99999999999999999999999999999986543
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
...........++..|+|||.+.+..++.++||||||+++|++++ |..||....... ........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~------------ 227 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEKG------------ 227 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHCC------------
Confidence 222222223334668999999988899999999999999999997 899986542211 11111100
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
.....+..++..+.+++.+||..+|++||+++++++.|+.+....
T Consensus 228 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 228 ------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 001112234567899999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=296.73 Aligned_cols=241 Identities=24% Similarity=0.281 Sum_probs=188.7
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC---CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI---RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 50 ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
||+|+||+||+|... +++.||+|++.... .........|..++... .||+|+++++.+......|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999754 68999999986542 22233445566776655 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+.+.+.. .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCcc
Confidence 99999886543 6899999999999999999999 99999999999999999999999999999865321 112233
Q ss_pred cccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchh
Q 019568 203 QTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (339)
...|++.|+|||.+.+. .++.++||||||+++|+|++|..||........ +...... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----~~~i~~~---------------~~~ 215 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YRNIAFG---------------KVR 215 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----HHHHHcC---------------CCC
Confidence 45689999999988765 489999999999999999999999875422111 0000000 000
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCC----CHHHHHHH
Q 019568 282 FVAKEQCVSFVFNLAMACAVESPEQRI----NAKEIVKK 316 (339)
Q Consensus 282 ~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~ell~~ 316 (339)
.....++.++.+|+.+||+.||.+|| ++.++++|
T Consensus 216 -~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 216 -FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred -CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 00123466789999999999999998 68888876
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=289.17 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=204.0
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
...+.|.....||+|+||.||++... ++..++||.+..........+.+|+.+++.++|+|++++++.+...+..++|+
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34566666788999999999999754 68999999987666566677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++... .+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-- 171 (292)
T cd06658 99 EFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-- 171 (292)
T ss_pred eCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--
Confidence 999999999987543 4888999999999999999999 999999999999999999999999999988654221
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........+++.|+|||.+.+..++.++|+||||+++++|++|..||........ .... .... ..
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~-~~~~--------~~----- 236 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRI-RDNL--------PP----- 236 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HhcC--------CC-----
Confidence 1122334578889999999888899999999999999999999999875322110 0000 0000 00
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........+..+.+++.+||..||.+|||++++++|
T Consensus 237 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 237 ---RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000122345678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=287.70 Aligned_cols=266 Identities=22% Similarity=0.318 Sum_probs=208.1
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.++|++.+.||+|++|+||++... +++.+++|++.... ......+.+|+++++.++||||+++++++...+..++|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 468999999999999999999754 68999999886553 3445778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++++|.+++... +.+++..+..++.+++.++.||| + .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~--- 156 (284)
T cd06620 84 FMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--- 156 (284)
T ss_pred cCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh---
Confidence 99999999988664 36899999999999999999999 6 5899999999999999999999999998765421
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......++..|+|||.+.+..++.++|+|||||++|++++|..||.............. ........ ....
T Consensus 157 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~------~~~~~~~~-~~~~ 228 (284)
T cd06620 157 -SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM------GILDLLQQ-IVQE 228 (284)
T ss_pred -hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh------HHHHHHHH-Hhhc
Confidence 112234578899999998888899999999999999999999999986543211000000 00000000 0000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
. ........++..+.+|+.+||+.||.+|||++|++++..-++.
T Consensus 229 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 229 P-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred c-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 0001112356779999999999999999999999998655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=289.12 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=203.7
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
...|.....||+|+||.||++... +++.|++|.+..........+.+|+.+++.+.|||++++++.+...+..++++||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 355666778999999999999754 6899999998765555556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 100 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~--~~~ 172 (297)
T cd06659 100 LQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVP 172 (297)
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccc--ccc
Confidence 9999999987553 5889999999999999999999 99999999999999999999999999998865421 112
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
......+++.|+|||.+.+..++.++|+||||+++++|++|+.||........ ........ .
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~----------------~ 234 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLRDSP----------------P 234 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhccC----------------C
Confidence 22334578899999999888899999999999999999999999875322111 00000000 0
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
........++..+.++|.+||+.+|++||+++++++|-.
T Consensus 235 ~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 235 PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 000112234566899999999999999999999999744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.25 Aligned_cols=266 Identities=23% Similarity=0.296 Sum_probs=201.4
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchh-----hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGR-----ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+|++.+.||+|++|.||+|... +++.|++|.+...... ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5888999999999999999754 6899999998765322 334567799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+ +++|.+++......+++..++.++.|+++||.+|| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 78999999765557899999999999999999999 9999999999999999999999999999987653221
Q ss_pred CccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc---------cc
Q 019568 197 QSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI---------ST 266 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~---------~~ 266 (339)
.......+++.|+|||.+.+ ..++.++|+||||+++++|++|.+||....... ............ ..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccc
Confidence 12223345778999998754 457899999999999999999988776543211 111111100000 00
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.............. .......+..+.+||.+||+.||.+|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 11123456789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.09 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=202.0
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||+|++|.||++.. .+++.+++|.+.... ......+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 589999999999999999974 468999999987642 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-CcEEEcccccceeccCCCC
Q 019568 120 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 120 ~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~-~~v~l~Dfg~~~~~~~~~~ 197 (339)
+++++|.+++... ...+++..+..++.+++.++.+|| +.+++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 9999999999764 345899999999999999999999 9999999999999999754 46799999998765321
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||........... ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~-----~~~~------------- 216 (256)
T cd08220 156 -SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK-----IMSG------------- 216 (256)
T ss_pred -ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH-----HHhc-------------
Confidence 122234578889999999988899999999999999999999999865432211100 0000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.....+..++..+.+++.+||..||.+|||+.++++|
T Consensus 217 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 --TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0001123356779999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=283.62 Aligned_cols=257 Identities=27% Similarity=0.340 Sum_probs=209.7
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
....+.|++.+.||+|++|.||+|... ++..+++|++..... ....+.+|+++++.++|+|++++++.+...+..+++
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 456788999999999999999999865 689999999876644 456788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+||+++++|.+++......++...+..++.|++.+|.+|| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999876557999999999999999999999 9999999999999999999999999999886543221
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... ....
T Consensus 171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~--~~~~--------------- 231 (286)
T cd06614 171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL--ITTK--------------- 231 (286)
T ss_pred --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhc---------------
Confidence 112233467889999999888899999999999999999999999865322111000 0000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..........++..+.++|.+||+.+|.+||++.+++++-.
T Consensus 232 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 232 -GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred -CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 00001112335677999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.03 Aligned_cols=248 Identities=29% Similarity=0.477 Sum_probs=194.5
Q ss_pred ceeeecCccEEEEEEeC-CCc--EEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG-DGM--EVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~--~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|... ++. .+++|.+.... ......+.+|+++++++ .||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999754 343 46888876432 34456788899999999 799999999999999999999999999
Q ss_pred CCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccc
Q 019568 123 GSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187 (339)
Q Consensus 123 ~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg 187 (339)
++|.+++.... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 24788899999999999999999 9999999999999999999999999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
++.... ..........+..|+|||.+.+..++.++|+||||+++++|++ |..||........ .......
T Consensus 158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~-- 227 (270)
T cd05047 158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----YEKLPQG-- 227 (270)
T ss_pred Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-----HHHHhCC--
Confidence 875321 1111112223556999999988889999999999999999997 9999865432111 0000000
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.....+..++.++.+++.+||..||.+|||+.+++..|..+.
T Consensus 228 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 -------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000112234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=277.97 Aligned_cols=253 Identities=30% Similarity=0.413 Sum_probs=203.9
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|.+.+.||+|++|.||+|.. .+++.+++|.+..... .....+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 689999999999999999975 4689999999876644 3667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++.... .+++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999987653 5788899999999999999999 9999999999999999999999999999987653322211
Q ss_pred c--cccccCCCCccCCccccCCC---CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 200 T--QTQTFATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 200 ~--~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
. .....+++.|+|||.+.+.. ++.++|+||||++++++++|..||........ ........
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~~------------- 222 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGAG------------- 222 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhcC-------------
Confidence 1 11245678899999987766 88999999999999999999999975432111 11110000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..........++..+.++|.+||+.+|.+||++.+++.|
T Consensus 223 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 ---HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ---CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000001112336678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.68 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=214.3
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.+-|.|+..||.|+||.||+|..+ ++-.-|.|++...+.+.++++.-|++||....||+|+++++.|...+.+|++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 356778889999999999999765 3455577999988899999999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
|.||.+..++-.-+..+++..+..++.|++.||.||| +++|+|+|+|+.|||+.-+|.++|.|||.+.... ....
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQ 185 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHh
Confidence 9999999998887889999999999999999999999 9999999999999999999999999999886542 2233
Q ss_pred ccccccCCCCccCCccc-----cCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 200 TQTQTFATIGYMAPEYG-----REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
......|||+|||||+. ...+|+.++||||||++|.+|..+.+|..........+...
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia----------------- 248 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----------------- 248 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh-----------------
Confidence 34567799999999964 56789999999999999999999999977654433222211
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...+..+..+..-+..+.+|+.+||..||..||++.++++|
T Consensus 249 -KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 249 -KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11112233355667789999999999999999999999986
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.58 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=202.5
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
.+|...+.||+|++|.||++.. .+++.+++|++..........+.+|+.+++.+.|||++++++++...+..++++||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 3577778999999999999974 468999999987665555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
++++|.+++.. ..++...+..++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~ 171 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPR 171 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccc
Confidence 99999999876 35889999999999999999999 999999999999999999999999999987654221 112
Q ss_pred cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
.....+++.|+|||.+.+..++.++|+||||+++++|++|..||........ .... ... . ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-~~~~-~~~-~---------------~~ 233 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-MKRI-RDN-L---------------PP 233 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHH-Hhc-C---------------CC
Confidence 2234578899999999888899999999999999999999999865321110 0000 000 0 00
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......++..+.+|+.+||+.+|++||++.++++|
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 234 KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 000122356679999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=285.28 Aligned_cols=264 Identities=20% Similarity=0.232 Sum_probs=188.3
Q ss_pred CceeeecCccEEEEEEeC---CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeee--cCceeEEEEEecC
Q 019568 47 NNLIGKGGFGSVYKARLG---DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS--NEEFKALVLEYMP 121 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~ 121 (339)
..+||+|+||.||+|... ++..+|+|.+.... ....+.+|+++++.++||||+++++++. .+...++++||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999743 46789999886542 2345778999999999999999999884 4567899999996
Q ss_pred CCCHHHHHhhc--------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe----CCCCcEEEcccccc
Q 019568 122 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIA 189 (339)
Q Consensus 122 ~~~L~~~i~~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~----~~~~~v~l~Dfg~~ 189 (339)
+ +|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 888877422 225788899999999999999999 9999999999999999 56779999999999
Q ss_pred eeccCCCCc-cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccch--------HhHhh
Q 019568 190 KLLVGEDQS-MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL--------KHWVN 259 (339)
Q Consensus 190 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~--------~~~~~ 259 (339)
......... .......+++.|+|||.+.+ ..++.++||||||+++|+|+||.+||.......... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 765322211 12233457889999998876 458999999999999999999999997543211100 00000
Q ss_pred hhccc--ccc-------------ccccccccCccchh---hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 260 DWLPI--STL-------------EVVDANLLSQEDIH---FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 260 ~~~~~--~~~-------------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... ..+ .............. .......+..+.+|+.+||+.||.+|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 000 00000000000000 00011234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=279.53 Aligned_cols=258 Identities=25% Similarity=0.282 Sum_probs=201.7
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeec--CceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSN--EEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 117 (339)
++|+..+.||.|++|.||++... +++.+++|.+..... .....+.+|+++++.++||||+++++++.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47889999999999999999864 689999999875432 345678889999999999999999998854 44789999
Q ss_pred EecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 118 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 118 e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999888653 3346888999999999999999999 99999999999999999999999999999865421
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCc---cchHhHhhhhcccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE---MTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 271 (339)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .....+........ .
T Consensus 158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 228 (287)
T cd06621 158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE---L-- 228 (287)
T ss_pred c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh---h--
Confidence 1 1123346778999999999999999999999999999999999998653211 11111111100000 0
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..........++.+.+||.+||..||.+|||+.|+++|=+
T Consensus 229 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 229 -------KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred -------ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0000001124567999999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=277.84 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=189.9
Q ss_pred ceeeecCccEEEEEEeC---CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCC
Q 019568 48 NLIGKGGFGSVYKARLG---DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~---~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999743 356789998865532 33356888999999999999999999999988999999999999
Q ss_pred CHHHHHhhcC----CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 124 SLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 124 ~L~~~i~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+|.+++.... ...+...+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986532 24566777889999999999999 9999999999999999999999999999886532222112
Q ss_pred ccccccCCCCccCCccccCC-------CCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 200 TQTQTFATIGYMAPEYGREG-------RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+.......... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----~~--- 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ-----LK--- 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc-----CC---
Confidence 22233457789999987542 35789999999999999996 9999976533221111000000 00
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..... .....+..+.+++.+|+ .+|++|||+++|+..|.
T Consensus 230 ---~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 ---LPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---CCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000 11224556889999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=275.17 Aligned_cols=252 Identities=28% Similarity=0.366 Sum_probs=207.7
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecC--ceeEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFKALVL 117 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 117 (339)
+|.+.+.||+|++|.||+|... +++.+++|++..... .....+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5888999999999999999865 699999999876642 4567888999999999999999999999888 8899999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.... .+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999997665 7899999999999999999999 99999999999999999999999999999887643322
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........++..|+|||.+.+...+.++|+||||+++++|++|..||........ ...... .
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~---------------~ 218 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIG---------------S 218 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhcc---------------c
Confidence 1123345578889999999888899999999999999999999999976541110 000000 0
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+...+..+.++|.+||+.||.+||++.++++|
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 001111233446779999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.99 Aligned_cols=272 Identities=25% Similarity=0.275 Sum_probs=202.5
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecC--cee
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFK 113 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 113 (339)
...++|++.+.||.|+||.||+|... +|+.||+|.+..... .......+|+.++++++|+||+++++++... +..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 35688999999999999999999754 699999999875432 2223456799999999999999999998654 568
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++|+||+.+ +|.+++......+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999999975 899888766567999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc---
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV--- 269 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--- 269 (339)
... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ...... .........
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~~~~~-~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LDLIIQ-LLGTPNESIWPG 235 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hcCCCChhhchh
Confidence 221 12223335778999998765 4579999999999999999999999975432211 111100 000000000
Q ss_pred ------ccccccCccchh--hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 270 ------VDANLLSQEDIH--FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 270 ------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
............ .......+..+.+||.+||+.||++|||++++++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 000000000000 0011224677899999999999999999999998744
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=281.26 Aligned_cols=251 Identities=27% Similarity=0.357 Sum_probs=194.4
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHH-HHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEM-MKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|++.+.||+|+||.||++... +|+.||+|.+.... ......+..|... ++.++||||+++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999754 69999999987653 2223344556554 666799999999999999999999999
Q ss_pred ecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 119 YMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 119 ~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
|+++ +|.+++.. ....+++..++.++.|++.|+.||| ++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9974 88887754 2346899999999999999999999 87 999999999999999999999999999876421
Q ss_pred CCCccccccccCCCCccCCccccC----CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGRE----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
........++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||............... .
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~------- 223 (283)
T cd06617 157 ---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---E------- 223 (283)
T ss_pred ---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh---c-------
Confidence 111222456788999998765 44688999999999999999999998653322111111100 0
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.........++.++.++|.+||..+|.+||+++++++|=
T Consensus 224 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 224 --------PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred --------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000001123567799999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=281.96 Aligned_cols=269 Identities=24% Similarity=0.301 Sum_probs=202.6
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|++.+.||+|++|.||+|... +++.|++|.++... ......+.+|+++++.++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999754 68899999886542 3344678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|++++.+..+. .....++...++.++.|++.|+.+|| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 99885555544 44456899999999999999999999 99999999999999999999999999999876533222
Q ss_pred cccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc--cccccccc-----
Q 019568 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL--PISTLEVV----- 270 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~----- 270 (339)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... ...... ........
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL-IQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHhhhcccCcc
Confidence 122334567889999998887 789999999999999999999999875422111000 000000 00000000
Q ss_pred -cc----cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 -DA----NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 -~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ............+..++.++.+||.+||..+|++||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00000111111223457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.76 Aligned_cols=264 Identities=23% Similarity=0.405 Sum_probs=223.0
Q ss_pred hcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.+...+.++||+|-||.|.++....+..||||.++.... ...++|.+|+++|.+++||||+.++++|..++.+++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 357789999999999999999987789999999988754 4458899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCcc-CHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSNCIL-DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~-~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++|+|.+++.++.-+. .......++.||++|++||. +.+++||||.+.|+|++.++++||+|||+++.+...+..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999998885333 55566789999999999999 999999999999999999999999999999988777777
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh--CCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
..........+|||+|.+..++++.++|+|+||+++||+++ .+.||+.+.+....-. ...+.+.+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven----------~~~~~~~~--- 760 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN----------AGEFFRDQ--- 760 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh----------hhhhcCCC---
Confidence 77777778899999999999999999999999999999876 6678887654322111 00111100
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
....-...+..|+..+.++|.+||..|-++|||++++-.+|+..
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 01112344778899999999999999999999999999999864
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=283.53 Aligned_cols=268 Identities=25% Similarity=0.326 Sum_probs=201.1
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|++.+.||+|++|.||+|... +++.+|+|++..... .....+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999864 589999998765422 234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++++|.++.... ..+++..++.++.|++.++.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence 99998888766443 35899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc--cccccccc-----
Q 019568 199 MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL--PISTLEVV----- 270 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~----- 270 (339)
.......++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+. ......... ........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchhhHHHhccchH
Confidence 22223446788999998765 4578899999999999999999999865432110 000000000 00000000
Q ss_pred -ccccc---CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 -DANLL---SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 -~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... ..........+.++..+.+|+.+||+.+|.+||+++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 00000111234567889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=283.84 Aligned_cols=251 Identities=26% Similarity=0.336 Sum_probs=201.7
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
...++|++.+.||+|+||+||+|... +++.|++|.+.... ......+.+|+++++.++||||+++.+++...+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34577999999999999999999754 68999999986432 234456888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+|+||+.+ ++.+.+......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99999975 888877665567999999999999999999999 99999999999999999999999999998865421
Q ss_pred CCCccccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
.....+++.|+|||.+. ...++.++|+||||+++|+|++|..||........... ... .
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~--~~~-~--------- 229 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQ-N--------- 229 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH--Hhc-C---------
Confidence 12334677899999874 45688999999999999999999999865422111000 000 0
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.........++..+.++|.+||+.||.+||++.+++.|.+
T Consensus 230 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 230 -------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred -------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0000112235677999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=283.16 Aligned_cols=269 Identities=23% Similarity=0.260 Sum_probs=202.1
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecC--ceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 115 (339)
.++|++.+.||.|++|.||+|... +++.+++|.++.... .....+.+|+.+++++.||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 468999999999999999999865 589999999875532 2233567899999999999999999998776 88999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
|+||+++ +|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999975 999998776667999999999999999999999 999999999999999999999999999988765322
Q ss_pred CCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc--c------c
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--S------T 266 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--~------~ 266 (339)
. .......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||........ ..........+ . .
T Consensus 160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhc
Confidence 1 122334467889999988654 468999999999999999999999975432111 11000000000 0 0
Q ss_pred ccccccccc---CccchhhhhhHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 267 LEVVDANLL---SQEDIHFVAKEQ-CVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 267 ~~~~~~~~~---~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......... .........+.. ++..+.++|.+||+.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 000001111111 46779999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=283.11 Aligned_cols=253 Identities=24% Similarity=0.303 Sum_probs=199.0
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||.||++... +++.|++|.+.... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999754 58899999987553 233456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||++|++|.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999996654 6889999999999999999999 99999999999999999999999999998753110000
Q ss_pred -------------ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc
Q 019568 198 -------------SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 198 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
........++..|+|||.+.+..++.++|+||||+++|++++|..||......+.. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~-~~~~~~~--- 232 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-GQVISDD--- 232 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcc---
Confidence 00111234677899999998888999999999999999999999998643221100 0000000
Q ss_pred cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHHH
Q 019568 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN---AKEIVKK 316 (339)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 316 (339)
.. .......++.++.++|.+||+.||++||+ +.++++|
T Consensus 233 -------------~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 -------------IE-WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -------------cC-CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 00011245677999999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=276.00 Aligned_cols=237 Identities=25% Similarity=0.429 Sum_probs=189.1
Q ss_pred ceeeecCccEEEEEEeCC-C----------cEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 48 NLIGKGGFGSVYKARLGD-G----------MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~-~----------~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+.||+|+||.||+|.... + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999997643 3 25788877655433 5778899999999999999999999887 778999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-------cEEEcccccc
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-------VAHLSDFSIA 189 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-------~v~l~Dfg~~ 189 (339)
+||+++++|.+++......++...+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999876657899999999999999999999 99999999999999999887 7999999998
Q ss_pred eeccCCCCccccccccCCCCccCCccccCC--CCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
..... .....++..|+|||.+.+. .++.++|+||||+++++|++ |..||......+. ........
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--~~~~~~~~---- 223 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--ERFYQDQH---- 223 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--HHHHhcCC----
Confidence 76422 2233456679999998776 78999999999999999999 5777766532111 11110000
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.. +......+.+++.+||+.+|.+|||+.++++.|
T Consensus 224 -------~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 -------RL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------CC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 000115689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=279.55 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=200.7
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCC---CcceeeEeeeeecCceeEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIR---HRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 117 (339)
.|++.+.||.|+||.||+|.. .+++.+++|.+.... ......+.+|+.+++.+. |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588899999999999999975 468999999986542 344567788999999986 999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++... .+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+..+....
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 999999999998654 6889999999999999999999 9999999999999999999999999999988764322
Q ss_pred ccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 198 SMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.......++..|+|||.+.++ .++.++|+||||+++|+|++|..||........ ......
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~~~~~------------- 216 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MMLIPK------------- 216 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hhcccc-------------
Confidence 222334578889999987654 578999999999999999999999975422110 000000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
..........++.++.+++.+||+.||.+||++.+++++-
T Consensus 217 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 217 -SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred -CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 0000000112466799999999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=281.71 Aligned_cols=239 Identities=26% Similarity=0.383 Sum_probs=189.9
Q ss_pred ceeeecCccEEEEEEeC-C-------CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 48 NLIGKGGFGSVYKARLG-D-------GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~-------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+.||.|+||.||+|... . ...+++|.+..........+.+|+.+++.+.|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46899999999999642 2 234888887665555567788899999999999999999999988899999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc--------EEEccccccee
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--------AHLSDFSIAKL 191 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~--------v~l~Dfg~~~~ 191 (339)
+++++|.+++......+++..+..++.|++.|+.||| +.+++|+||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876667899999999999999999999 999999999999999987665 68999998764
Q ss_pred ccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCC-CCCcccccCccchHhHhhhhcccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK-KPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|. .|+........ .. ....
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~-~~~~--------- 220 (258)
T cd05078 158 VL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQ-FYED--------- 220 (258)
T ss_pred cC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HH-HHHc---------
Confidence 32 12223467789999988764 5799999999999999999985 55544322110 00 0000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....+...+.++.+|+.+||+.||.+|||++++++.|
T Consensus 221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0011223346689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=277.17 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=199.9
Q ss_pred CCCCCceeeecCccEEEEEEeC--CCcEEEEEEeeccc----------hhhhHHHHHHHHHHHh-CCCcceeeEeeeeec
Q 019568 43 EFSENNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQC----------GRALKSFNVECEMMKS-IRHRNLIKVISSCSN 109 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~--~~~~v~vK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 109 (339)
.|++.+.||+|+||.||.|... +++.+++|.+.... ......+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4889999999999999999854 37889999875431 2334556778888875 699999999999999
Q ss_pred CceeEEEEEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
++..++++||+++++|.+++.. ....+++..++.++.|++.++.+|| + .+++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3446899999999999999999999 6 6899999999999999999999999
Q ss_pred cccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 265 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~ 265 (339)
||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||........ . .....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--~---~~~~~-- 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--A---TKIVE-- 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH--H---HHHhh--
Confidence 99987653221 23345578889999999988899999999999999999999999865422111 0 00000
Q ss_pred ccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..........++..+.++|.+||+.||.+||++.|+.+++.
T Consensus 228 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 ------------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000011234567999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=277.52 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+-|++.+.||.|+||.||+|.. .++..+|||.+.... ......+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 4578899999999999999975 468999999876543 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++... .++...+..++.|++.++.+|| +.+++|+||+|+||+++.++.++++|||++..+... ..
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~ 156 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QI 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hh
Confidence 9999999988654 5889999999999999999999 999999999999999999999999999988765321 11
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
......++..|+|||.+.+..++.++|+||+|++++++++|..||........ ..... ..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~---~~--------------- 216 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--LFLIP---KN--------------- 216 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--HHHHh---cC---------------
Confidence 22234567889999999888889999999999999999999999875422110 00000 00
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........++.++.+++.+||..+|.+||++.++++|
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0001123346678999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=275.56 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=202.0
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeee--cCceeEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCS--NEEFKALVL 117 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 117 (339)
+|++.+.||.|+||.||++.. .+++.+++|.+... .......+.+|+++++.++|+||+++++++. .....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999974 46899999998654 2344567888999999999999999999775 345688999
Q ss_pred EecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccC--CCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 118 EYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGY--SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 118 e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~--~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
||+++++|.+++... ...+++..++.++.|++.||.+||..+ +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998654 457899999999999999999999432 567999999999999999999999999998865
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
..... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||....... .......
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~------------ 224 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LASKIKE------------ 224 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHHHHhc------------
Confidence 32221 1223457889999999988889999999999999999999999997653211 1111000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ....+..++..+.+++.+||+.+|.+||++++|++|
T Consensus 225 ~~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GK------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 001133456779999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.13 Aligned_cols=249 Identities=27% Similarity=0.331 Sum_probs=204.3
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
+|++.+.||.|+||.||+|... +++.+++|++.... ......+.+|++++++++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999764 69999999987543 2445678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+.+++|.+.+... .++++..+..++.|++++|.+|| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998765 47899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......++..|+|||.+.+..++.++|+||||+++|++++|..||....... ..........
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~--------------- 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQET--------------- 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhcc---------------
Confidence 2233446778999999988889999999999999999999999998654321 1111100000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH--HHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINA--KEIVKK 316 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~ell~~ 316 (339)
.....+...+..+.++|.+||..||.+||++ +|+++|
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 0111133456789999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=280.57 Aligned_cols=265 Identities=23% Similarity=0.284 Sum_probs=198.9
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||.|++|.||+|... +++.++||.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5889999999999999999754 68999999886543 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+. ++|.+++... ...+++..++.++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--V 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--c
Confidence 96 5898887654 346889999999999999999999 999999999999999999999999999988654211 1
Q ss_pred cccccccCCCCccCCccccCCC-CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc--ccc------
Q 019568 199 MTQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST--LEV------ 269 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~------ 269 (339)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|+||+.||........... .......... ...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-IFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCChhhhhhhhHHHH
Confidence 1122334577899999876644 68899999999999999999999875432111111 0000000000 000
Q ss_pred ---ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 ---VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.... ...... ....+.++.+++++|.+||+.||.+||+++++++|
T Consensus 234 ~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPK-WARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhccc-ccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 000000 01123456778999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=278.41 Aligned_cols=267 Identities=23% Similarity=0.304 Sum_probs=201.4
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
+|++.+.||.|++|.||+|+.. ++..|+||++..... .....+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999864 689999999876532 23456678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 121 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 121 ~~~~L~~~i~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
++ +|.+++.... ..+++..+..++.|++.||.+|| +.+++|+||+|+||++++++.++|+|||++...... .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~ 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--V 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--c
Confidence 86 8988886543 46899999999999999999999 999999999999999999999999999988654211 1
Q ss_pred cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc--------cccc
Q 019568 199 MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS--------TLEV 269 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 269 (339)
.......+++.|++||.+.+ ..++.++|+||||+++|++++|..||......+... ........+. ....
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL-KIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCChhhHHHHhcCch
Confidence 11223346788999998765 457899999999999999999999997654322111 1111000000 0000
Q ss_pred ccccccC-ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VDANLLS-QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....... .........+.++..+++++.+||+.||.+||+++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 0000111223457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=283.38 Aligned_cols=270 Identities=21% Similarity=0.268 Sum_probs=199.6
Q ss_pred CCCCCceeeecCccEEEEEEeC---CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--ceeE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG---DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFKA 114 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~---~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 114 (339)
+|++.+.||+|++|.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5889999999999999999753 47999999987643 34446678899999999999999999999887 7899
Q ss_pred EEEEecCCCCHHHHHhhcC----CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC----CCcEEEccc
Q 019568 115 LVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD----NMVAHLSDF 186 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~----~~~v~l~Df 186 (339)
+|+||+++ ++.+.+.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++.++|+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 7777764322 26889999999999999999999 999999999999999999 999999999
Q ss_pred ccceeccCCCC-ccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCcc--------chHh
Q 019568 187 SIAKLLVGEDQ-SMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM--------TLKH 256 (339)
Q Consensus 187 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~--------~~~~ 256 (339)
|++........ ........+++.|+|||.+.+. .++.++|+||||+++++|++|..||........ ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876532222 1122234567889999977664 578999999999999999999999976543220 0000
Q ss_pred Hhhhhcc------------ccccc---cccccccCccchhhhhhH--HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 257 WVNDWLP------------ISTLE---VVDANLLSQEDIHFVAKE--QCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 257 ~~~~~~~------------~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....... ..... .................. ..+..+.+++.+||+.||++|||+.|+++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 00000 000000010111111111 455679999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=276.44 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=187.9
Q ss_pred ceeeecCccEEEEEEeC---CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCC
Q 019568 48 NLIGKGGFGSVYKARLG---DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
+.||+|+||.||+|... ....+++|.+.... ......+.+|++.++.++|+||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 46899999999999643 24568888765443 333456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCC----ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 124 SLEKYLYSSNC----ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 124 ~L~~~i~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+|.+++..... ..++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999876432 3456778899999999999999 9999999999999999999999999999886432221111
Q ss_pred ccccccCCCCccCCcccc-------CCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 200 TQTQTFATIGYMAPEYGR-------EGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
......+++.|+|||++. ...++.++|+||||+++|+|++ |..||................ . ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~--~---~~--- 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ--D---IK--- 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc--C---cc---
Confidence 222333566799999764 3456889999999999999999 778886543221111100000 0 00
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.. ....+..++..+.+++..|+ .||.+|||+++|++.|
T Consensus 230 ---~~----~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 ---LP----KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ---CC----CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00 00112345667888999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=297.30 Aligned_cols=245 Identities=28% Similarity=0.426 Sum_probs=210.2
Q ss_pred ceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHH
Q 019568 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 126 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 126 (339)
-.||+|.||+||.|++. +....|||-+........+-+.+|+..-++|.|.||++++|.+..++++-+.||-.+||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 47999999999999854 57778999988777777788899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCcc--CHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-CCCcEEEcccccceeccCCCCcccccc
Q 019568 127 KYLYSSNCIL--DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQ 203 (339)
Q Consensus 127 ~~i~~~~~~~--~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-~~~~v~l~Dfg~~~~~~~~~~~~~~~~ 203 (339)
++++..=+++ .+.++..+.+||++||.||| ...|+|||||-+||+++ -.|.+||+|||-+..+.+ .+..+..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence 9998765666 78899999999999999999 99999999999999996 688999999999988743 3445566
Q ss_pred ccCCCCccCCccccCC--CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchh
Q 019568 204 TFATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281 (339)
Q Consensus 204 ~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (339)
..||..|||||++-.+ .|+.++|||||||++.||.||++||..+..+...+-. .++ ....
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---------------VGm---yKvH 797 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---------------VGM---YKVH 797 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---------------hcc---eecC
Confidence 6799999999988765 4899999999999999999999999987665432221 111 1223
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 019568 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315 (339)
Q Consensus 282 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 315 (339)
...|...+.+.++||.+|+.+||..||+++++|.
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 4457788999999999999999999999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=273.97 Aligned_cols=249 Identities=29% Similarity=0.373 Sum_probs=206.0
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|.+.+.||.|++|.||++... ++..+++|++..... .....+.+|+++++.++|+|++++.+.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999754 689999999876533 4556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 120 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 120 ~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+++++|.+.+... ...+++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998765 367999999999999999999999 9999999999999999999999999999987653222
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.......+++.|+|||...+..++.++|+||+|+++++|++|..||........... .....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-----~~~~~----------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK-----ILKGQ----------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH-----HhcCC-----------
Confidence 123334578889999998888899999999999999999999999875532211110 00000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....+..++..+.+++.+||+.+|++||++.++++|
T Consensus 220 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 ----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000122456779999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=279.21 Aligned_cols=266 Identities=24% Similarity=0.271 Sum_probs=199.0
Q ss_pred CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
|++.+.||.|++|.||+|... +|..|++|++.... ......+.+|+++++.++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678999999999999999754 69999999987653 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 121 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 121 ~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+ ++|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VR 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cc
Confidence 5 58999886544 46899999999999999999999 999999999999999999999999999998654211 11
Q ss_pred ccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc---------cccc
Q 019568 200 TQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS---------TLEV 269 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 269 (339)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||........ ..........+. ..+.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchhh
Confidence 12223457889999987654 578999999999999999999999875432111 000000000000 0000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
................+.++..+.++|.+||+.||++|||++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000011123456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=281.75 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=202.6
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
...|...+.||+|+||.||++.. .++..+++|.+.... ......+.+|+++++.++|+|++++++++..+...++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 35588999999999999999975 468999999986542 23445788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+||+.+ +|.+.+.....++++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~--- 176 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS--- 176 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccC---
Confidence 999975 888887666667999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
......+++.|+|||.+. ++.++.++|+||||+++|+|++|..||........... ....
T Consensus 177 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~------------- 239 (317)
T cd06635 177 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQN------------- 239 (317)
T ss_pred ---CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHhc-------------
Confidence 122345778899999873 45688999999999999999999999875422111110 0000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.........++..+.+|+.+||+.+|.+||++.++++|...+.
T Consensus 240 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 -----ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0001112345667999999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=276.23 Aligned_cols=254 Identities=29% Similarity=0.481 Sum_probs=198.1
Q ss_pred CCCCceeeecCccEEEEEEe----CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc------
Q 019568 44 FSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE------ 111 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 111 (339)
|.+.+.||+|+||.||+|.. .++..+|||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 67889999999999999963 24788999998654 2344567888999999999999999999875432
Q ss_pred eeEEEEEecCCCCHHHHHhhc-----CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 112 FKALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
..+++++|+.+++|.+++... ...++...++.++.|++.|+.||| +.+++|+||+|+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 346889999999998887432 124788889999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~ 265 (339)
|++................+++.|++||.+.+..++.++|+||||+++|+|++ |..||......+ ...+... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~--~~- 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLIK--GN- 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHHc--CC-
Confidence 99876532222222223334567999999988889999999999999999999 888887543211 1111000 00
Q ss_pred ccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
....+..++..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 233 ---------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 ---------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=286.10 Aligned_cols=267 Identities=23% Similarity=0.249 Sum_probs=199.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecC------
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE------ 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 110 (339)
..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 5689999999999999999999754 7999999998643 233445677899999999999999999988543
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
...|+|+||+.+ +|.+.+... ++...+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 357899999965 888877543 788899999999999999999 9999999999999999999999999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc------
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI------ 264 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~------ 264 (339)
..... .......+++.|+|||.+.+..++.++|+||||+++++|++|+.||....... ...........+
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 167 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 65221 11223456788999999999999999999999999999999999997543211 011000000000
Q ss_pred ----cccccccc----------cccCccch---hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 265 ----STLEVVDA----------NLLSQEDI---HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 265 ----~~~~~~~~----------~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
........ ........ ........+..+++||.+||+.||++|||+.|+++|=
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 00000000 00000000 0000223466789999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=278.91 Aligned_cols=267 Identities=22% Similarity=0.237 Sum_probs=197.5
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCC-CcceeeEeeeeecCce-----
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIR-HRNLIKVISSCSNEEF----- 112 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 112 (339)
++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999754 689999998865432 23456788999999995 6999999999876655
Q ss_pred eEEEEEecCCCCHHHHHhhc----CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-CCcEEEcccc
Q 019568 113 KALVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFS 187 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-~~~v~l~Dfg 187 (339)
.|++|||+++ +|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 888887543 235899999999999999999999 999999999999999998 8999999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
.+..+... ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||............ ......+ .
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~-~ 232 (295)
T cd07837 157 LGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI-FKLLGTP-T 232 (295)
T ss_pred cceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HHHhCCC-C
Confidence 98755221 111222345778999998765 45799999999999999999999999754322111110 0000000 0
Q ss_pred cccccc-------cccCc--cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 267 LEVVDA-------NLLSQ--EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 267 ~~~~~~-------~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...... ..... ........+.++..+.+||.+||..||.+||++++++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 00000 000001123467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=276.00 Aligned_cols=245 Identities=24% Similarity=0.305 Sum_probs=195.4
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 50 ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
||+|+||+||++... +++.+++|.+.... ......+.+|+++++.++|||++++++.+...+..|+|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 68999999986542 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccc
Q 019568 126 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204 (339)
Q Consensus 126 ~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~ 204 (339)
.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 99986644 36899999999999999999999 99999999999999999999999999998875422 1122334
Q ss_pred cCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhh
Q 019568 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVA 284 (339)
Q Consensus 205 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (339)
.++..|+|||.+.+..++.++|+||||+++++|++|+.||.......... ...... .......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~----------------~~~~~~~ 217 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKRRT----------------LEMAVEY 217 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-HHHhcc----------------ccccccC
Confidence 46778999999888889999999999999999999999997543311100 000000 0001112
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHHH
Q 019568 285 KEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKKL 317 (339)
Q Consensus 285 ~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~l 317 (339)
+..+++.+.++|.+||+.||.+|| ++.++++|-
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence 334577799999999999999999 888888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=280.51 Aligned_cols=273 Identities=22% Similarity=0.309 Sum_probs=199.0
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc---
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE--- 111 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 111 (339)
....++|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+++++.++||||+++++++...+
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 345578999999999999999999754 69999999886543 222345567999999999999999999876543
Q ss_pred -----eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 112 -----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 112 -----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
..++|+||+.+ +|.+.+......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcC
Confidence 45899999965 898888776667899999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCc--cccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc
Q 019568 187 SIAKLLVGEDQS--MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263 (339)
Q Consensus 187 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~ 263 (339)
|++..+...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... ..........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~ 241 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCG 241 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 998765322211 111233467789999987664 47889999999999999999999986543211 0000000000
Q ss_pred ---ccc------cccccccccCccc---h-hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 264 ---IST------LEVVDANLLSQED---I-HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 264 ---~~~------~~~~~~~~~~~~~---~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
... ....+........ . ........+..+.+||.+||..||.+|||++++++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 0000000000000 0 000011234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=273.37 Aligned_cols=250 Identities=22% Similarity=0.258 Sum_probs=197.8
Q ss_pred HHHhhhhcCCCCCcee--eecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecC
Q 019568 35 LELCQATDEFSENNLI--GKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNE 110 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~i--g~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (339)
.+.....++|++.+.+ |.|+||.||++.. .++..+++|.+........ |......+ +||||+++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 4455566888888887 9999999999974 4688999999865422211 22222223 799999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-cEEEcccccc
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIA 189 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-~v~l~Dfg~~ 189 (339)
+..++||||+++++|.+++.... .+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++ .++|+|||.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999999997664 7899999999999999999999 99999999999999999888 9999999988
Q ss_pred eeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
..... .....++..|+|||.+.+..++.++|+||+|+++++|++|..||............+....
T Consensus 158 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 223 (267)
T PHA03390 158 KIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-------- 223 (267)
T ss_pred eecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--------
Confidence 75421 1223467889999999988899999999999999999999999985543332222221111
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-AKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~ 316 (339)
.........++..+.+||.+||+.||.+||+ ++++++|
T Consensus 224 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 ---------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0011112356778999999999999999995 6999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=276.61 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=195.3
Q ss_pred CCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCC-CcceeeEeeeeecC--ceeEEEEE
Q 019568 44 FSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIR-HRNLIKVISSCSNE--EFKALVLE 118 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e 118 (339)
|++.+.||+|+||.||+|.. .+++.+++|.++... ........+|+.+++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67889999999999999975 468999999886542 222233456888899885 99999999999877 88999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++ +|.+.+......+++..++.++.|++.||.+|| +.+++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 9975 888888766567899999999999999999999 999999999999999999 999999999987653221
Q ss_pred cccccccCCCCccCCcccc-CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc---ccccc-
Q 019568 199 MTQTQTFATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE---VVDAN- 273 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~- 273 (339)
......+++.|+|||.+. +..++.++|+||+|+++|+|++|..||......+. .. ............ .....
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ-IA-KIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-HH-HHHHHcCCCCHHHHHhhcccc
Confidence 112344678899999654 45678999999999999999999999965432110 00 000000000000 00000
Q ss_pred ----ccCcc--chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 274 ----LLSQE--DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 274 ----~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... ..-......++..+.+||.+||++||++||+++++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 00011123567889999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=270.55 Aligned_cols=248 Identities=28% Similarity=0.385 Sum_probs=204.8
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||+|++|.+|++... +++.+++|.+..... .....+.+|+++++++.|+|++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999754 688999999876643 4567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++... ..+++..++.++.|++.++.+|| +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-- 154 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence 9999999998765 47899999999999999999999 99999999999999999999999999999987633222
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
......++..|+|||...+..++.++|+||+|+++++|++|..||........ .......
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~---------------- 214 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIVQD---------------- 214 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHhcc----------------
Confidence 12334568889999998888889999999999999999999999875432111 1000000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.....+..++..+.+++.+||+.+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 0011123446779999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=274.41 Aligned_cols=266 Identities=23% Similarity=0.245 Sum_probs=204.0
Q ss_pred CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
|++.+.||.|++|.||+|... +++.+++|.+..... .....+.+|+++++.++|++|+++++++......++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 678899999999999999754 689999999876532 34567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
++ +|.+++......+++..+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 76 898888776567999999999999999999999 9999999999999999999999999999987653322 12
Q ss_pred cccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc---ccccccc---cc
Q 019568 201 QTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI---STLEVVD---AN 273 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~ 273 (339)
.....++..|+|||.+.+. .++.++|+||||+++|++++|+.||......+ ............ ....... ..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhh
Confidence 2234567789999988776 78999999999999999999999986543211 111111100000 0000000 00
Q ss_pred --ccC--ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 274 --LLS--QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 274 --~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
... .........+.++..+++||.+||+.||.+||++.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0000111234578889999999999999999999999976
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=299.13 Aligned_cols=274 Identities=17% Similarity=0.167 Sum_probs=191.6
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC--CCcEEEEEEee-----------------ccchhhhHHHHHHHHHHHhCCCcc
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG--DGMEVAVKVFN-----------------LQCGRALKSFNVECEMMKSIRHRN 99 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~--~~~~v~vK~~~-----------------~~~~~~~~~~~~e~~~l~~l~h~~ 99 (339)
...++|++.+.||+|+||+||++... .+...++|.+. .........+.+|++++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 35679999999999999999998532 22222222110 011223456788999999999999
Q ss_pred eeeEeeeeecCceeEEEEEecCCCCHHHHHhhcC----CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe
Q 019568 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 175 (339)
Q Consensus 100 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~ 175 (339)
|+++++++...+..|++++++.+ +|.+++.... .......+..++.|++.||.||| +.+|+|+||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 99999999999999999999954 7877764432 12345667889999999999999 9999999999999999
Q ss_pred CCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCC-CcccccCc-cc
Q 019568 176 DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP-TDEIFNGE-MT 253 (339)
Q Consensus 176 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P-~~~~~~~~-~~ 253 (339)
+.++.++|+|||++..+..... .......|++.|+|||++.+..++.++|||||||++|+|++|..+ +....... ..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999976532211 122235689999999999999999999999999999999998864 43222111 11
Q ss_pred hHhHhhhhcc--cc-------cccccccccc---CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 254 LKHWVNDWLP--IS-------TLEVVDANLL---SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 254 ~~~~~~~~~~--~~-------~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.......... .. ....+..... .............+.++.++|.+||++||.+|||+.|+++|=
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 1111110000 00 0000000000 000111112223456788999999999999999999999873
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.55 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=200.8
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc-----chhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--cee
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ-----CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFK 113 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 113 (339)
.+|++.+.||+|++|.||+|.. .++..+++|.+... .......+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999975 46999999987542 134456788899999999999999999998653 468
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++++||+++++|.+.+.... .+++..+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999986544 5788899999999999999999 9999999999999999999999999999987653
Q ss_pred CCCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
..... .......++..|+|||.+.+..++.++|+||||+++++|++|..||.......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~----------- 222 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF----KIA----------- 222 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH----HHH-----------
Confidence 21111 11123457888999999998889999999999999999999999997542211100 000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........+..+++.+.+++.+||+ +|.+||++.++++|
T Consensus 223 ----~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 ----TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0111122245567889999999999 57999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=274.79 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=189.0
Q ss_pred eeeecCccEEEEEEe-CCCcEEEEEEeeccch---hhhHHHHHHHHHHH---hCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 49 LIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG---RALKSFNVECEMMK---SIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 49 ~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
.||+|+||.||++.. .+++.+|+|.+..... .....+.+|..+++ ...||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999975 4689999998865421 11223344444433 3479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+++|.+++.... .+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence 999999886554 6899999999999999999999 999999999999999999999999999998654221 12
Q ss_pred ccccCCCCccCCcccc-CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....+++.|+|||.+. +..++.++|+||+|+++|+|++|..||............... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------------~~~ 214 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------------LTV 214 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh------------------hcC
Confidence 2345788999999876 456899999999999999999999999765332211110000 000
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....++.++.++.++|.+||+.||.+|| +++++++|
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1112345677899999999999999999 69999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=284.61 Aligned_cols=274 Identities=22% Similarity=0.266 Sum_probs=201.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----ce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNE-----EF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 112 (339)
..++|++.+.||+|++|.||+|.. .+++.||||++.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 457999999999999999999974 468999999986432 33456678899999999999999999886543 35
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++++||+.+ +|.+.+... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 7899999965 888877543 5899999999999999999999 999999999999999999999999999998765
Q ss_pred cCCCCcc-ccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 193 VGEDQSM-TQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 193 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
....... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||....... ....... ....+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~-~~~~~~~~~~ 234 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILG-VLGTPSQEDL 234 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HcCCCCHHHH
Confidence 3222111 1123457888999997654 568999999999999999999999996532110 0100000 0000000000
Q ss_pred c-----------ccccCccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHHH
Q 019568 271 D-----------ANLLSQEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKIR 321 (339)
Q Consensus 271 ~-----------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~~ 321 (339)
. .......... ....+..+.++.+||.+||+.||++|||+.++++| ++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 0000000000 01123456779999999999999999999999998 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=273.05 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=197.4
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 50 ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
||.|++|.||++... +++.+++|++.... ......+.+|+++++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999864 58999999987543 23446788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccccccc
Q 019568 126 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205 (339)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~ 205 (339)
.+++.+.. .++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99997653 5889999999999999999999 9999999999999999999999999999987653221 222345
Q ss_pred CCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhh
Q 019568 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285 (339)
Q Consensus 206 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (339)
+++.|++||.+.+..++.++|+||+|+++|++++|..||............... . .......+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~---------------~~~~~~~~ 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL--K---------------GNGKLEFP 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh--c---------------cCCCCCCC
Confidence 788899999988888999999999999999999999999765421111110000 0 00011112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 286 EQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 286 ~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
...+.++.++|.+||+.||.+||+ ++|+++|
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 333677999999999999999999 8888885
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=277.40 Aligned_cols=267 Identities=23% Similarity=0.275 Sum_probs=198.4
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|++.+.||.|++|+||+|... +++.+++|.+.... ......+.+|++++++++||||+++++++......++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 67999999999999999999754 68999999986543 2334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-CCcEEEcccccceeccCCC
Q 019568 119 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-~~~v~l~Dfg~~~~~~~~~ 196 (339)
|+++ +|.+.+.... ...++..++.++.|++.||.+|| +++++|+||+|+||+++. ++.++|+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 9965 8888775543 23678888999999999999999 999999999999999985 567999999998654211
Q ss_pred CccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc----
Q 019568 197 QSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD---- 271 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 271 (339)
........+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||............ .. ...........
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI-FR-ILGTPNEETWPGVTS 233 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HH-HhCCCChhhcccccc
Confidence 1112233467889999987664 5789999999999999999999999764332111111 00 00000000000
Q ss_pred ----ccccC--ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 ----ANLLS--QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ----~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... .........+..+..+.+++.+||+.+|++||++.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0000111123456779999999999999999999999985
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=275.50 Aligned_cols=267 Identities=25% Similarity=0.320 Sum_probs=201.7
Q ss_pred CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--ceeEEEEE
Q 019568 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFKALVLE 118 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 118 (339)
|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+++++.+.|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999765 58999999998663 33445678899999999999999999999887 88999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++ +|.+++......+++..++.++.|++.|+.+|| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 999988776567999999999999999999999 99999999999999999999999999999886633221
Q ss_pred cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc---cccc-----
Q 019568 199 MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS---TLEV----- 269 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~----- 269 (339)
.......++..|+|||.+.+ ..++.++|+||||+++++|++|..||....... ............. ....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccchh
Confidence 11223345778999997664 457899999999999999999999997643211 1111111000000 0000
Q ss_pred ---ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 ---VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..................++..+.+++.+||+.+|.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000001111112237789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=285.80 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=218.6
Q ss_pred cCCCCCceeeecCccEEEEEEe--C-C--CcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL--G-D--GMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~--~-~--~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
+..+..+.||.|.||.||.|.. . . .-.||||..+.+ .....+.|..|.-+|+++.||||++++|++.+. ..|+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 3445678899999999999963 1 2 345788887764 345678899999999999999999999999865 4689
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
|||.++-|.|..+++.+...++...+..++.||+.||+||| +...+||||...|||+....-|||+|||+++.+.+.
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999998888999999999999999999999 999999999999999999999999999999987554
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
..... +......-|||||.+.-..++.+||||.||+.+||++. |..||....+... -.
T Consensus 545 ~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------------------I~ 603 (974)
T KOG4257|consen 545 AYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------------------IG 603 (974)
T ss_pred chhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------------------EE
Confidence 43332 24445677999999999999999999999999999987 8899987655422 11
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
..+.+.+...+++||+.|..|+.+||.+||.+||.+.++...|..+.+
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 233455677899999999999999999999999999999999988876
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=273.03 Aligned_cols=249 Identities=23% Similarity=0.302 Sum_probs=200.5
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||.|+||.||++... ++..+++|.+.... ......+.+|+++++.++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999754 58899999986542 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc-EEEcccccceeccCCCC
Q 019568 120 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-AHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 120 ~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~-v~l~Dfg~~~~~~~~~~ 197 (339)
+.+++|.+++.... ..+++..+..++.|++.|+.+|| +.+++|+||+|+||++++++. ++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999986543 35789999999999999999999 999999999999999988764 6999999887653211
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
.......+++.|+|||.+.+..++.++|+||||++++++++|..||....... ..........
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~----------- 219 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKICQGYF----------- 219 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhcccC-----------
Confidence 11223357888999999988889999999999999999999999986542211 1111100000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....+.++.++.+++.+||..+|++|||+.++++|
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 ----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00123345679999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=278.32 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=200.1
Q ss_pred CCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 43 EFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
.|.....||+|+||.||++.. .++..|++|++..........+.+|+.+++.++|+|++++++.+...+..+++|||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 344457899999999999975 4789999999876555566778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+++|.+++... .+++..+..++.|++.++.+|| +.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 101 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~ 173 (292)
T cd06657 101 GGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRR 173 (292)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccc--cccc
Confidence 99999987543 4788999999999999999999 999999999999999999999999999988654221 1122
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchh
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (339)
....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ ......... ..
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--~~~~~~~~~----------------~~ 235 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRDNLP----------------PK 235 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhhCC----------------cc
Confidence 334578889999999888889999999999999999999999875321110 000000000 00
Q ss_pred hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 282 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......++..+.+++.+||+.||.+||++.++++|
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 236 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 00122345668899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=265.43 Aligned_cols=263 Identities=21% Similarity=0.224 Sum_probs=210.0
Q ss_pred HHhhhhcCCCCC-ceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeec---
Q 019568 36 ELCQATDEFSEN-NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSN--- 109 (339)
Q Consensus 36 ~~~~~~~~y~~~-~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--- 109 (339)
.-.+++++|++. +.||-|-.|.|..+.. .+++.+|+|++.- ....++|++.--.. .|||||.++++|++
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 334467888775 6789999999998854 4799999999742 25667789875555 79999999999854
Q ss_pred -CceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC---CCCcEEEc
Q 019568 110 -EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLS 184 (339)
Q Consensus 110 -~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~---~~~~v~l~ 184 (339)
...+.+|||.++||.|...++.++ ..+++.++..|+.||..|+.||| +.+|.||||||+|+|.. .|..+||+
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence 456789999999999999998765 46999999999999999999999 99999999999999995 56789999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
|||++..-. ........+-||.|.|||++...+|+...|+||+|+++|-|++|.+||.+.......-.-...
T Consensus 207 DfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r----- 278 (400)
T KOG0604|consen 207 DFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR----- 278 (400)
T ss_pred ccccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH-----
Confidence 999997532 233344556799999999999999999999999999999999999999876442211100000
Q ss_pred cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
+ ......+....+..+|.+.+++|+.+|..+|++|.|+.++++|=|--+.
T Consensus 279 -----I---~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 279 -----I---RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred -----h---hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 0 0111233444578899999999999999999999999999998665443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=284.55 Aligned_cols=276 Identities=22% Similarity=0.246 Sum_probs=204.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----c
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE-----E 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 111 (339)
+.++|.+.+.||+|+||+||+|.. .+++.|+||.+... .......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 457899999999999999999974 46999999998653 233345667899999999999999999987543 3
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..++++||+. ++|.+++... ..+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 4799999996 5898888654 47999999999999999999999 99999999999999999999999999999876
Q ss_pred ccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc--cccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--STLE 268 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~ 268 (339)
..... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... ............ +...
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhh
Confidence 53221 12223446788999997764 468999999999999999999999996542111 010000000000 0000
Q ss_pred c---------ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHHHHH
Q 019568 269 V---------VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKIRDS 323 (339)
Q Consensus 269 ~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~~~~ 323 (339)
. ................+.++..+.+||.+||+.||++|||++++++| +..+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0 00000000000011224577889999999999999999999999998 6655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=271.51 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=186.8
Q ss_pred ceeeecCccEEEEEEeCC---CcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCC
Q 019568 48 NLIGKGGFGSVYKARLGD---GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~---~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 469999999999996433 3456677665443 344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcC---CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 124 SLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 124 ~L~~~i~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
+|.+++.+.. ...+...++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999987542 34666778899999999999999 99999999999999999999999999998754221111112
Q ss_pred cccccCCCCccCCccccC-------CCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 201 QTQTFATIGYMAPEYGRE-------GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.....++..|+|||++.. ..++.++|+||||+++|+|++ |..||......+.... ... .......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~~----~~~~~~~~- 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH-VIK----DQQVKLFK- 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHh----hcccccCC-
Confidence 233456788999998743 245789999999999999997 5668765432111110 000 00000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
......+++.+.+++..|| .+|.+||+++++++.|.
T Consensus 232 ---------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 ---------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1112234567889999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=286.51 Aligned_cols=256 Identities=27% Similarity=0.353 Sum_probs=215.9
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
......|.+.+.||+|.|+.|.+|++ .++..||||.++... ......+.+|+++|..++||||++++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34567999999999999999999974 479999999998764 344456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||+.+|.+.+++.+.. ...+..+..++.|+.+|+.||| +++++|+|||++|++++.+.+++|+|||++..+.
T Consensus 132 lV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec-
Confidence 9999999999999998877 4445889999999999999999 9999999999999999999999999999999874
Q ss_pred CCCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
........+|++.|.|||++.+..| ++..|+||+|+++|.|+.|..||+...-.+. +..
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------------------r~r 266 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------------------RPR 266 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc------------------cch
Confidence 3444566789999999999998876 7899999999999999999999986422111 111
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.+ ..++..+..++.+..++|+++|..+|.+|++++++.++-|.-.
T Consensus 267 vl---~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 267 VL---RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred he---eeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 10 1112224445667899999999999999999999999877543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=270.71 Aligned_cols=247 Identities=26% Similarity=0.336 Sum_probs=203.1
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+|++.+.||.|++|.||++... +++.+++|.+.... ......+.+|+++++.++|+||+++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5889999999999999999744 68899999987542 33445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 120 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 120 ~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+++++|.+++... ...+++..++.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 246889999999999999999999 999999999999999999999999999998765322
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
......+++.|+|||.+.+..++.++|+||||++++++++|+.||......+... ....
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~~---------------- 215 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--KVQR---------------- 215 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHhc----------------
Confidence 2223457888999999999889999999999999999999999987543221111 0000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ....+..++.++.+++.+||+.+|.+||++.++++|
T Consensus 216 -~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 -GK-YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CC-CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 001123567779999999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=278.74 Aligned_cols=269 Identities=23% Similarity=0.321 Sum_probs=197.7
Q ss_pred ceeeec--CccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKG--GFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g--~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
..||.| +|++||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||++++++|...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 8899999975 479999999987543 33456788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc-
Q 019568 123 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT- 200 (339)
Q Consensus 123 ~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~- 200 (339)
+++.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999887643 35889999999999999999999 99999999999999999999999999976543321111100
Q ss_pred ----cccccCCCCccCCccccCC--CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc--------cc
Q 019568 201 ----QTQTFATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--------ST 266 (339)
Q Consensus 201 ----~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--------~~ 266 (339)
.....++..|+|||.+.+. .++.++|+||+|+++++|++|..||...................+ ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 1112235569999998764 478999999999999999999999976543222111110000000 00
Q ss_pred cc-----------ccccc-------ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 267 LE-----------VVDAN-------LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 267 ~~-----------~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.. ..... ..............++..+.+|+.+||+.||++|||++++++|-+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 00 00000 0001111222345678889999999999999999999999987553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=277.32 Aligned_cols=248 Identities=25% Similarity=0.285 Sum_probs=198.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..+.|...+.||+|+||.||+|+.. +++.+++|++.... ......+.+|+++++.++|||++++++++.+....|+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3445888889999999999999753 68999999986542 2344567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
++||+.+ ++.+.+......+++..++.++.|++.++.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-- 172 (313)
T cd06633 99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-- 172 (313)
T ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC--
Confidence 9999965 888888766667899999999999999999999 9999999999999999999999999999875421
Q ss_pred CCccccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
......++..|+|||.+. +..++.++|+||||+++|+|++|..||.............. ..
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~--------- 236 (313)
T cd06633 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---ND--------- 236 (313)
T ss_pred ----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---cC---------
Confidence 122345778899999874 45688899999999999999999999866432111110000 00
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........++..+.+|+.+||+.+|.+||++.++++|
T Consensus 237 -------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 -------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001122345668999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=275.80 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=204.0
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 116 (339)
++|.+.+.||+|++|.||+|... +++.+++|++... .......+.+|+++++++. |+||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999754 7999999998653 2334467788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
||++++++|.+++.+.. .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999997664 7999999999999999999999 9999999999999999999999999999987653322
Q ss_pred Cc------------------cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh
Q 019568 197 QS------------------MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 197 ~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~ 258 (339)
.. .......++..|+|||...+..++.++|+||||++++++++|..||....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~ 232 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----TFQ 232 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----HHH
Confidence 11 11223346788999999888889999999999999999999999988654211 000
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHHH
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA----KEIVKK 316 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~ell~~ 316 (339)
... ......+...+..+.+||.+||+.||.+||++ +++++|
T Consensus 233 ~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 233 KIL-----------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHH-----------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 000 00011123336678999999999999999999 888876
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=275.74 Aligned_cols=272 Identities=25% Similarity=0.267 Sum_probs=202.1
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc---
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE--- 111 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 111 (339)
....++|++.+.||+|++|.||+|..+ +++.|++|.++... ......+.+|+++++.++|||++++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 356789999999999999999999865 58999999987653 223346678999999999999999999886544
Q ss_pred -------eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEc
Q 019568 112 -------FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 184 (339)
Q Consensus 112 -------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~ 184 (339)
..++++||+++ ++.+.+......+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 888877766557899999999999999999999 9999999999999999999999999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~ 263 (339)
|||.+........ .......++..|+|||.+.+ ..++.++|+||||+++++|++|++||...... ............
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGS 236 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 9999876533221 11122335677999997764 45789999999999999999999999753221 111111111000
Q ss_pred c---ccccc--------ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 264 I---STLEV--------VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 264 ~---~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ..... .+....... ........++..+.+++.+||+.||.+||+++++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRR-RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhccccccccccccccccccccc-chhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00000 000000000 0001122356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=276.58 Aligned_cols=270 Identities=20% Similarity=0.253 Sum_probs=198.2
Q ss_pred CCCceeeecCccEEEEEEeCCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 45 SENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 45 ~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
.+.+.+|.|+++.++++.. +++.+|||++... .......+.+|+++++.++|+||+++++++...+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444445555555555444 7999999998765 345567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc---
Q 019568 123 GSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS--- 198 (339)
Q Consensus 123 ~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~--- 198 (339)
++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++||+.+..+......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999998754 346889999999999999999999 999999999999999999999999999988755322211
Q ss_pred --cccccccCCCCccCCccccC--CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc--------cc--
Q 019568 199 --MTQTQTFATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL--------PI-- 264 (339)
Q Consensus 199 --~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~--------~~-- 264 (339)
.......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.................. +.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 11122335677999998865 35889999999999999999999999865332211111100000 00
Q ss_pred -cccccc--cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 265 -STLEVV--DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 265 -~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
...... .................++.++.+|+.+||+.||.+|||++++++|-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000000 000001111223334566788999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.23 Aligned_cols=269 Identities=28% Similarity=0.456 Sum_probs=205.1
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
......+...+.||+|+||.||+|.. .++..||||.+..... ....|++.+++++||||+++++++.+.+..++|
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 33456788899999999999999985 4789999998864322 123468899999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+++++|.+++.. +++..+..++.|++.|++|||...+.+++|+||||+||+++.++..++. ++......
T Consensus 762 ~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 762 HEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred EeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 999999999999853 7888899999999999999994435599999999999999988887764 54433221
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc-ccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI-STLEVVDANLL 275 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 275 (339)
......+++.|+|||++.+..++.++||||||+++|||++|+.||............|....... ......++...
T Consensus 834 ---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 834 ---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 11223578899999999999999999999999999999999999965444433444443322111 11111222111
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
.. .........++.+++.+||+.||++||+++|+++.|+++.+...
T Consensus 911 ~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 911 GD----VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CC----CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 11 11123445678899999999999999999999999998876443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=273.27 Aligned_cols=244 Identities=28% Similarity=0.375 Sum_probs=195.1
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeeccch---hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 50 ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
||.|+||.||++... +++.+++|++..... .....+.+|+++++.+.||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999865 599999999865533 4556788899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC------cc
Q 019568 126 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ------SM 199 (339)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~------~~ 199 (339)
.+++.+.. .+++..++.++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997655 7899999999999999999999 99999999999999999999999999998875432211 11
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
......++..|++||...+...+.++|+||||++++++++|..||......... ..... ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~~~~-----------------~~ 217 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF--QNILN-----------------GK 217 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhc-----------------CC
Confidence 223345678899999998888999999999999999999999998754321110 00000 00
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH---HHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINA---KEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 316 (339)
.........+..+.+++.+||+.+|.+|||+ .++++|
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0000011136779999999999999999999 666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=281.16 Aligned_cols=272 Identities=25% Similarity=0.272 Sum_probs=207.2
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-----eeE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE-----FKA 114 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 114 (339)
+|++.+.||.|++|.||+|... +++.++||++.... ....+.+.+|+++++.++|+||+++.+++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999854 58999999987653 344567888999999999999999999987765 789
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+++||+.+ +|.+++.... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999975 8988886554 7999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCc-cccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc------
Q 019568 195 EDQS-MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST------ 266 (339)
Q Consensus 195 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~------ 266 (339)
.... .......+++.|+|||.+.+. .++.++|+||||+++++|++|..||......+. .... ........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i-~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLI-VEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHH-HHhcCCCChhHhhh
Confidence 2210 112334568889999998887 789999999999999999999999976542111 1100 00000000
Q ss_pred ------cccccccccCccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHHHH
Q 019568 267 ------LEVVDANLLSQEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKIRD 322 (339)
Q Consensus 267 ------~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~~~ 322 (339)
...... ........ ....+..+..+.+||.+||+.||.+||++++++.| ++.++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000 00000000 01123367789999999999999999999999997 555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=277.44 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=201.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..+.|+..+.||+|++|.||+|... ++..+++|.+... .......+.+|+++++.++|+|++++.+++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3456888999999999999999854 6889999988643 23344567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
|+||+.+ ++.+.+......+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 9999964 888887666667899999999999999999999 99999999999999999999999999998875421
Q ss_pred CCccccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.....+++.|+|||.+. ...++.++||||||+++|+|++|..||........... ...
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~------------- 228 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQ------------- 228 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-Hhh-------------
Confidence 12334678899999864 34578899999999999999999999865422111110 000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
..........++..+.+||.+||+.+|.+||++.++++|-+...
T Consensus 229 -----~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 229 -----NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -----cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 00011112345677999999999999999999999999866443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=276.18 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=195.6
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..++++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46777889999999999999754 68999999987543 334557788999999996 9999999999998889999999
Q ss_pred ecCCCCHHHHHh----hcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 119 YMPHGSLEKYLY----SSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 119 ~~~~~~L~~~i~----~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
|+.. ++.++.. .....+++..+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 6665432 12346899999999999999999999 6 599999999999999999999999999987543
Q ss_pred CCCCccccccccCCCCccCCccccCC---CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREG---RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
.. .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||...... .. .........
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~-~~~~~~~~~----- 227 (288)
T cd06616 160 DS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV---FD-QLTQVVKGD----- 227 (288)
T ss_pred cC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH---HH-HHhhhcCCC-----
Confidence 21 112233567889999988766 6899999999999999999999998754310 00 000000000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........+..++.++.+||.+||+.||.+|||++++++|
T Consensus 228 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 ------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111123467789999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.59 Aligned_cols=273 Identities=22% Similarity=0.267 Sum_probs=202.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec----Cce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN----EEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 112 (339)
..++|++.+.||.|++|.||+|.. .+++.|++|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 348999999999999999999974 469999999987542 2344567789999999999999999998753 356
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++|+||+. ++|.+++.... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 899999996 48988886544 6899999999999999999999 999999999999999999999999999998765
Q ss_pred cCCCCc--cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 193 VGEDQS--MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 193 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ...... ..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~~~~~-~~g~~~~~~ 235 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LKLILS-VLGSPSEEV 235 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HHHHHH-HhCCChhHh
Confidence 322211 11123457888999998765 5689999999999999999999999965432111 000000 000000000
Q ss_pred cc-----------ccccCccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 270 VD-----------ANLLSQEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 270 ~~-----------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.. .......... ....+..+..+.++|.+||+.||.+||++++++.|-+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 00 0000000000 01123457889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=282.89 Aligned_cols=270 Identities=21% Similarity=0.243 Sum_probs=198.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--------
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNE-------- 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------- 110 (339)
...+|++.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+++++.++||||+++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 357999999999999999999975 46899999998776666667788899999999999999999876543
Q ss_pred ------ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-CCCcEEE
Q 019568 111 ------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHL 183 (339)
Q Consensus 111 ------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-~~~~v~l 183 (339)
...++++||+++ +|.+++... .+++..++.++.|+++||.+|| +.|++|+||+|+||+++ .++.+++
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEE
Confidence 357899999975 898887543 5889999999999999999999 99999999999999997 5567899
Q ss_pred cccccceeccCCCCcc-ccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh
Q 019568 184 SDFSIAKLLVGEDQSM-TQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
+|||.+.......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||........... .....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~-~~~~~ 235 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL-ILESV 235 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhc
Confidence 9999987653221111 1122346778999997654 5688999999999999999999999975432111110 00000
Q ss_pred ccc------ccc----ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 262 LPI------STL----EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 262 ~~~------~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
... ... ..................+..+.++.+||.+||+.||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 000 0000000000000001123456779999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.36 Aligned_cols=275 Identities=25% Similarity=0.302 Sum_probs=202.6
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecC--ce
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNE--EF 112 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~ 112 (339)
.+.++|++.+.||+|+||.||+|... +++.+++|.+... .......+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35689999999999999999999754 6889999987542 233345677899999999 999999999998543 46
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++|+||+++ +|.+++... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 8999999975 999988654 6788889999999999999999 999999999999999999999999999998765
Q ss_pred cCCCCc---cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc----
Q 019568 193 VGEDQS---MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI---- 264 (339)
Q Consensus 193 ~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~---- 264 (339)
...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHH
Confidence 432221 12233457888999997754 4578999999999999999999999965432211 11100000000
Q ss_pred -------cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHH
Q 019568 265 -------STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKI 320 (339)
Q Consensus 265 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~ 320 (339)
.....................+.++.++.++|.+||+.||.+|||+.++++| ++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000000000000000011112367889999999999999999999999997 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=281.53 Aligned_cols=269 Identities=22% Similarity=0.261 Sum_probs=201.1
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE- 111 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 111 (339)
.++...++|++.+.||+|++|.||++.. .++..||||++.... ......+.+|+++++.++||||+++++++..+.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 4555788999999999999999999974 479999999986432 233456788999999999999999999986543
Q ss_pred -----eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 112 -----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 112 -----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
.+++|+|++ +++|.+++... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 66998888643 5899999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc-
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI- 264 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~- 264 (339)
|.+..... ......+++.|+|||.+.+ ..++.++|+||||++++++++|..||........ ...........
T Consensus 163 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPS 236 (343)
T ss_pred cccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCC
Confidence 99875421 1223346788999998776 4588999999999999999999999975432111 11100000000
Q ss_pred -cccccccc--------ccc-CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 265 -STLEVVDA--------NLL-SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 265 -~~~~~~~~--------~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.....+.. ... ............++..+.++|.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000 00000011123566779999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=278.17 Aligned_cols=273 Identities=21% Similarity=0.237 Sum_probs=200.9
Q ss_pred hhcCCCC-CceeeecCccEEEEEEeC-CCcEEEEEEeeccchhh--------------hHHHHHHHHHHHhCCCcceeeE
Q 019568 40 ATDEFSE-NNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRA--------------LKSFNVECEMMKSIRHRNLIKV 103 (339)
Q Consensus 40 ~~~~y~~-~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~ 103 (339)
..++|.. .+.||.|+||+||+|... +++.||||++....... ...+.+|+++++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4567764 577999999999999754 69999999986542211 1246789999999999999999
Q ss_pred eeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEE
Q 019568 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL 183 (339)
Q Consensus 104 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l 183 (339)
++++...+..+++|||+.+ +|.+++... ..+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMAS-DLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred eEEEecCCcEEEEEecccc-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEE
Confidence 9999999999999999975 999988654 36899999999999999999999 999999999999999999999999
Q ss_pred cccccceeccCCC------------CccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccC
Q 019568 184 SDFSIAKLLVGED------------QSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250 (339)
Q Consensus 184 ~Dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~ 250 (339)
+|||.+....... .........+++.|+|||.+.+. .++.++|+||||+++++|++|..||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987653110 01111223457789999988765 4689999999999999999999999765432
Q ss_pred ccchHhHhhhhccccc---ccc-----ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 251 EMTLKHWVNDWLPIST---LEV-----VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 251 ~~~~~~~~~~~~~~~~---~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
+. ..........+.. ... ..................++..+.++|.+||+.+|++|||+++++.|-+
T Consensus 241 ~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 241 DQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 11 1111111100000 000 0000000000011112345677999999999999999999999998644
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=274.38 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=198.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 116 (339)
..++|++.+.||+|++|.||+|... +++.+|||.+.... ......+..|+.++... .|+||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3478999999999999999999865 48999999987543 23344566677777666 499999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
|||+.+ ++.+++......+++..+..++.|++.++.||| + .+++|+||+|+||+++.++.++|+|||.+..+...
T Consensus 93 ~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999954 888887765568899999999999999999999 7 59999999999999999999999999998765321
Q ss_pred CCccccccccCCCCccCCccccCCC----CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGR----VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||................. ..
T Consensus 169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~------- 237 (296)
T cd06618 169 K---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PP------- 237 (296)
T ss_pred C---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CC-------
Confidence 1 122334677899999887553 78999999999999999999999875322211111111100 00
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.......++.++.+|+.+||+.||.+||+++++++|-+
T Consensus 238 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 238 ---------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 00001134667999999999999999999999999755
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=273.34 Aligned_cols=319 Identities=25% Similarity=0.283 Sum_probs=231.3
Q ss_pred hhHHHHHhcCCCCCCCCccccccceeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHH
Q 019568 5 LLILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKS 84 (339)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~ 84 (339)
...||+|+-.+...++-..|..++-.-.| .-.......+..+.||+|.||.||+|+. +++.||||++... ....
T Consensus 175 ~~~~r~~k~~~~~~e~~~~p~~d~~~~~s--spl~~l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs 248 (534)
T KOG3653|consen 175 FLGYRQRKNAREEIEPVLIPLEDSGPAPS--SPLLELDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQS 248 (534)
T ss_pred HHHHHHhhcccccCccCcccCCCCCCCCC--cccccCCchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHH
Confidence 34566666666555555555443333222 2223367888999999999999999998 5799999999744 3466
Q ss_pred HHHHHHHHHhC--CCcceeeEeeeeecCc----eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhcc
Q 019568 85 FNVECEMMKSI--RHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158 (339)
Q Consensus 85 ~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~ 158 (339)
+.+|.++.+.. +|+||+++++.-.... .++||++|.+.|+|.+++..+- +++.....++..|+.||+|||..
T Consensus 249 ~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee 326 (534)
T KOG3653|consen 249 FQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEE 326 (534)
T ss_pred HHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhccc
Confidence 77788887764 8999999999865444 7899999999999999997764 99999999999999999999962
Q ss_pred C------CCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCC-CC-----Ccch
Q 019568 159 Y------SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR-VS-----ANGD 226 (339)
Q Consensus 159 ~------~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~D 226 (339)
. ...|+|||||..|||+..+++..|+|||++..+.............||.+|||||++.+.- .. .+.|
T Consensus 327 ~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~D 406 (534)
T KOG3653|consen 327 LPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRID 406 (534)
T ss_pred CCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHH
Confidence 2 3479999999999999999999999999999887666666666688999999999987763 22 3689
Q ss_pred hhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc-----ccccCccchhhhhhHHHHHHHHHHHhhhcC
Q 019568 227 VYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD-----ANLLSQEDIHFVAKEQCVSFVFNLAMACAV 301 (339)
Q Consensus 227 iwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 301 (339)
|||+|.++||+++...-+.....++.........-.. +..+... .+..+.. ......-.....+++.+..||.
T Consensus 407 vYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h-Pt~e~mq~~VV~kK~RP~~-p~~W~~h~~~~~l~et~EeCWD 484 (534)
T KOG3653|consen 407 VYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH-PTLEEMQELVVRKKQRPKI-PDAWRKHAGMAVLCETIEECWD 484 (534)
T ss_pred HHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC-CCHHHHHHHHHhhccCCCC-hhhhhcCccHHHHHHHHHHHcC
Confidence 9999999999999765443211222222211111111 1111111 1111111 1122223556679999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHcccccCcee
Q 019568 302 ESPEQRINAKEIVKKLLKIRDSLLRNVGGRCI 333 (339)
Q Consensus 302 ~dP~~Rps~~ell~~l~~~~~~~~~~~~~~~~ 333 (339)
.||+.|.|+.=+.++++.+........+.+|.
T Consensus 485 hDaeARLTA~Cv~eR~~~l~~~~~~~~~~s~~ 516 (534)
T KOG3653|consen 485 HDAEARLTAGCVEERMAELMMLWEDSSGESSS 516 (534)
T ss_pred CchhhhhhhHHHHHHHHHHhccCCccCCcccc
Confidence 99999999999999999998766653444433
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=268.47 Aligned_cols=242 Identities=24% Similarity=0.299 Sum_probs=188.1
Q ss_pred ceeeecCccEEEEEEe-CCCcEEEEEEeeccch---hhhHHHHHHHHH-HHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG---RALKSFNVECEM-MKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||.|++|.||+|.. .+++.||+|.+..... .....+..|..+ .....|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 6799999999999975 4689999999865421 222334445444 3455899999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
++|.+++.... .+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999986544 6899999999999999999999 99999999999999999999999999998865321 22
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||.+.+..++.++|+||||+++|++++|..||........ ..... ... .....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~--~~~--------------~~~~~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNIL--SRR--------------INWPE 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHH--hcc--------------cCCCC
Confidence 33467889999998888899999999999999999999999965432111 00000 000 00000
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCH---HHHHHH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINA---KEIVKK 316 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 316 (339)
.....++..+.+++.+||+.||.+||++ +|+++|
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1122456779999999999999999965 577665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=276.84 Aligned_cols=266 Identities=25% Similarity=0.301 Sum_probs=199.2
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec-Ccee
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN-EEFK 113 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 113 (339)
..+.++|++.+.||.|+||.||+|.. .+++.+++|++.... ......+.+|+++++.+.||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678999999999999999999974 479999999876432 2344667789999999999999999999865 5678
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++++||+ +++|.+++... +++...+..++.|+++||.+|| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 8999999 55898887543 4788888999999999999999 9999999999999999999999999999887532
Q ss_pred CCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhh-----------hh
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN-----------DW 261 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~-----------~~ 261 (339)
. ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||....... ....... ..
T Consensus 160 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 160 P-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhc
Confidence 1 1122346778999998765 568999999999999999999999996543211 0000000 00
Q ss_pred ccccccccccccccCccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 262 LPISTLEVVDANLLSQEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+... ........ ....+.++..+.++|.+||+.+|++||++++++.|
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 00000000 01112456789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=268.16 Aligned_cols=242 Identities=21% Similarity=0.293 Sum_probs=188.3
Q ss_pred eeeecCccEEEEEEe-CCCcEEEEEEeeccch---hhhHHHHHHH---HHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 49 LIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG---RALKSFNVEC---EMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 49 ~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|. ..++...||+|+++.+++...+..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999975 4689999999865421 1111233333 34455679999999999999999999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
|++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP 152 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence 99999988654 47899999999999999999999 999999999999999999999999999998754221 22
Q ss_pred ccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....++..|+|||.+.++ .++.++|+||+|+++|+|++|..||................ ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~ 214 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------------------TM 214 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh------------------cc
Confidence 234578899999998754 68999999999999999999999997653321111100000 00
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....+..++..+.+++.+||..+|.+|| ++.++++|
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1111233467799999999999999999 99999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=268.50 Aligned_cols=265 Identities=24% Similarity=0.291 Sum_probs=197.2
Q ss_pred CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhC---CCcceeeEeeeeecCce-----
Q 019568 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSI---RHRNLIKVISSCSNEEF----- 112 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 112 (339)
|++.+.||+|+||.||+|... +++.+++|.+..... .....+.+|+.+++++ .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999865 589999999875422 2234556687777666 59999999999987766
Q ss_pred eEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 113 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
.++++||+.+ +|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8988886643 35899999999999999999999 99999999999999999999999999999876
Q ss_pred ccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
+.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......+ ...................
T Consensus 157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCC
Confidence 53221 1122346778999999998899999999999999999999999987643321 1111111110000000000
Q ss_pred -----ccccCcc-ch-hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 -----ANLLSQE-DI-HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 -----~~~~~~~-~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....... .. .....+..+..+.++|.+||+.||.+||++.+++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000 00 011123456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=275.45 Aligned_cols=272 Identities=21% Similarity=0.254 Sum_probs=197.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecC------
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNE------ 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 110 (339)
..++|++.+.||+|++|.||+|... +++.+++|++..... .....+.+|+++++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 4689999999999999999999754 689999999865432 2234567899999999999999999987433
Q ss_pred --ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 111 --EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 111 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
...++|+||+.+ ++...+......+++..+..++.|+++||.+|| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 356899999965 788877665567999999999999999999999 99999999999999999999999999999
Q ss_pred ceeccCCCCccc---------cccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh
Q 019568 189 AKLLVGEDQSMT---------QTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 189 ~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~ 258 (339)
+........... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||........ .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 876532221111 1122457789999987654 578999999999999999999999875432111 11110
Q ss_pred hhhccc--c-------ccccccccccCc-cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 259 NDWLPI--S-------TLEVVDANLLSQ-EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 259 ~~~~~~--~-------~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...... . ............ ...........+..+.+||.+||+.||.+|||+.+++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000 0 000000000000 000000112334678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=266.86 Aligned_cols=250 Identities=23% Similarity=0.288 Sum_probs=209.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|..++.||+|.||.|-+++- .+++.+|+|+++++- .....+-..|-++|+..+||.+..+.-.|+..+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 457999999999999999999974 479999999987662 3444556779999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||..||.|.-.+.+. ..+++.....+...|++||.||| +++|+++|+|.+|.++|++|.+||+|||++..- .
T Consensus 246 VMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--I 319 (516)
T ss_pred EEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc--c
Confidence 99999999998887554 47889899999999999999999 999999999999999999999999999999742 3
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.........+|||.|+|||++....|+.+.|.|.+|+++|+|++|+.||.+......--....
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~----------------- 382 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM----------------- 382 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----------------
Confidence 445556778899999999999999999999999999999999999999987543321100000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
.+...+...+++.+.|+..+|..||.+|. .++||.+|
T Consensus 383 ----ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 383 ----EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ----hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 01122566788899999999999999996 45555553
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=270.99 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=187.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-C---CcEEEEEEeeccchhhhH-----------HHHHHHHHHHhCCCcceeeEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-D---GMEVAVKVFNLQCGRALK-----------SFNVECEMMKSIRHRNLIKVI 104 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~---~~~v~vK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~~i~~~~ 104 (339)
..++|.+.+.||+|+||+||+|... + +..+++|+.......... ....+...+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 3478999999999999999999753 3 456677764433221110 112233445567899999999
Q ss_pred eeeecCc----eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 105 SSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 105 ~~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
+++.... ..+++++++.. ++.+.+... ...++..+..++.|++.||.||| +.+++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence 8765433 34678888744 777766543 24577888999999999999999 999999999999999999999
Q ss_pred EEEcccccceeccCCCCc-----cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchH
Q 019568 181 AHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~ 255 (339)
++|+|||++..+...... .......+|+.|+|||.+.+..++.++||||||+++++|++|..||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999766322111 111223589999999999999999999999999999999999999987633221111
Q ss_pred hHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 256 HWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....+.. .. ..... ...+.++..+.+++..|+..+|++||++.++++.|
T Consensus 245 ~~~~~~~--------~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFI--------KR--LHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHH--------HH--hhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1000000 00 00000 01234567799999999999999999999999865
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=278.82 Aligned_cols=275 Identities=22% Similarity=0.250 Sum_probs=203.0
Q ss_pred eeeHHHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeee
Q 019568 31 TFSYLELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSC 107 (339)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (339)
+....++....++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 344566777889999999999999999999974 478999999987542 22345677899999999999999999987
Q ss_pred ecC------ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcE
Q 019568 108 SNE------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA 181 (339)
Q Consensus 108 ~~~------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v 181 (339)
... ...+++++++ +++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence 532 3467888887 67998887554 4889999999999999999999 9999999999999999999999
Q ss_pred EEcccccceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh
Q 019568 182 HLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 182 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~ 260 (339)
+|+|||++.... .......+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||....... ........
T Consensus 160 kl~dfg~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~ 233 (345)
T cd07877 160 KILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRL 233 (345)
T ss_pred EEeccccccccc-----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 999999987532 12233456788999998766 568899999999999999999999986532211 11110000
Q ss_pred hcc--ccccccccc--------c--ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 261 WLP--ISTLEVVDA--------N--LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 261 ~~~--~~~~~~~~~--------~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
... ......... . ........ ......+..+.+||.+||+.||.+||++.++++|=+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 000 000000000 0 00000000 001124667899999999999999999999999743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=259.62 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=202.3
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc-chhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++...+..||.|+.|.||+++. .+|.-.|||..... +.+..+++...+.++..-+ +|+|++.+++|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3455778899999999999975 46899999998765 4556677788888877664 8999999999999988899999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
.+ ...++.++++-.+++++.-+-.+...++.||.||.+ .++|+|||+||+|||+|+.|++||+|||.+..+.+.
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--- 245 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--- 245 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc---
Confidence 98 446777777777789999999999999999999996 789999999999999999999999999999877432
Q ss_pred cccccccCCCCccCCccccC---CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 199 MTQTQTFATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.......|-+.|||||.+.. ..|+.++||||||++++||.||+.||..-...-..+.+.++.. ++
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-PP----------- 313 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-PP----------- 313 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-CC-----------
Confidence 23344456778999997753 4689999999999999999999999987433322233222211 11
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.+.....+++.+++|+..||+.|+.+||...++++|
T Consensus 314 -----~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 -----LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -----CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111122378889999999999999999999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=310.63 Aligned_cols=255 Identities=28% Similarity=0.379 Sum_probs=211.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
...-+|.-..+||.|.||.||.|. ..+|.-.|+|-+... .......+.+|..+|+.++|||++++|++-...+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345689999999999999999996 557999999987554 24455677889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
.||||++|+|.+.++... -.++.....+..|++.|++||| +.||||+||||.||+++.+|.+|++|||.+..+...
T Consensus 1312 FMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999986554 5777777889999999999999 999999999999999999999999999999887554
Q ss_pred CCccc--cccccCCCCccCCccccCCC---CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 196 DQSMT--QTQTFATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 196 ~~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
.+... -....|||.|||||++.+.+ -..++|||||||++.||+||+.||....+.- .....+..-+.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-aIMy~V~~gh~------- 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-AIMYHVAAGHK------- 1459 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-HHHhHHhccCC-------
Confidence 32222 23567999999999987654 5789999999999999999999999875432 22222222211
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...|...+++-++||.+||..||++|.++.++++|
T Consensus 1460 -----------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 -----------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22244578899999999999999999999888876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=281.06 Aligned_cols=267 Identities=24% Similarity=0.293 Sum_probs=200.1
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce-
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF- 112 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 112 (339)
...+.++|++.+.||+|++|.||+|... +++.|++|++.... ......+.+|+.+++.+.|+|++++.+++...+.
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3456789999999999999999999764 68999999986542 2344567789999999999999999998865544
Q ss_pred -----eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccc
Q 019568 113 -----KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187 (339)
Q Consensus 113 -----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg 187 (339)
.++|+||+ +++|.+++... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 56999988653 5899999999999999999999 9999999999999999999999999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
.+..... ......++..|+|||.+.+ ..++.++|+||||+++|++++|+.||....... ........ .....
T Consensus 164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~-~~~~~ 236 (343)
T cd07851 164 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNL-VGTPD 236 (343)
T ss_pred ccccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHh-cCCCC
Confidence 9876421 1223356778999998765 367899999999999999999999997543211 11111000 00000
Q ss_pred ccccc-----------ccccCccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 267 LEVVD-----------ANLLSQEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 267 ~~~~~-----------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... .......... ......++..+.+||.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 0000000000 01112347789999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=278.16 Aligned_cols=271 Identities=23% Similarity=0.283 Sum_probs=199.9
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC----
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNE---- 110 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 110 (339)
....++|.+.+.||+|++|.||+|.. .+++.||||++.... ......+.+|+++++.+.||||+++++++...
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 34468999999999999999999975 469999999986542 23345678899999999999999999998654
Q ss_pred --ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 111 --EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 111 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
..+++|+||+.. +|..... ..+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred CCceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 346899999964 7776542 25888999999999999999999 99999999999999999999999999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
+..... ......+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||....... ....... ..+....
T Consensus 164 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~ 236 (342)
T cd07879 164 ARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK-VTGVPGP 236 (342)
T ss_pred CcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hcCCCCH
Confidence 865321 1223346778999998876 468899999999999999999999997542211 0110000 0000000
Q ss_pred cc---ccc-------cccCc-cchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHHHH
Q 019568 268 EV---VDA-------NLLSQ-EDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKIRD 322 (339)
Q Consensus 268 ~~---~~~-------~~~~~-~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~~~ 322 (339)
.. ... ..... .... ....+..+..+.+||.+||+.||.+||++++++.| ++.++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 000 00000 0000 00112456778999999999999999999999987 777664
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=268.01 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=198.1
Q ss_pred CCCCCceeeecCccEEEEEEe----CCCcEEEEEEeeccc----hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCcee
Q 019568 43 EFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (339)
+|++.+.||.|+||.||.+.. .+|..||+|++.... ......+.+|+++++++ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 588999999999999999974 368999999986532 23345678899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++|+||+++++|.+++.... .+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999986654 6889999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCCccccccccCCCCccCCccccCC--CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
... ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... ...........
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-------- 226 (290)
T cd05613 157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILK-------- 226 (290)
T ss_pred ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhc--------
Confidence 221 1112234478889999988753 46889999999999999999999986432111 11111100000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
. ....+..++..+.+++.+||+.||.+|| ++.++++|
T Consensus 227 ----~----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 227 ----S----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----c----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 0011233566789999999999999997 88888886
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=268.92 Aligned_cols=265 Identities=27% Similarity=0.296 Sum_probs=201.1
Q ss_pred CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
|+..+.||+|.+|.||+|... +++.+++|++.... ......+..|+++++.++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 677889999999999999754 59999999987653 334466778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
++ +|.+++.+....+++..+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 75 999999876557999999999999999999999 99999999999999999999999999999876532211 2
Q ss_pred cccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc--c------cccccc
Q 019568 201 QTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--S------TLEVVD 271 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--~------~~~~~~ 271 (339)
......+..|+|||.+.+. .++.++|+||||++++++++|..||........ ........... . .....+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhccccccc
Confidence 2233456779999988766 789999999999999999999999866432111 00000000000 0 000000
Q ss_pred ccccCccc--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 ANLLSQED--IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ...... ......+..+..+.++|.+||..||++||+++++++|
T Consensus 234 ~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 P-TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred c-cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 000000 0001112336779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=265.12 Aligned_cols=248 Identities=22% Similarity=0.278 Sum_probs=194.3
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc-----chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ-----CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+|.+.+.||+|+||.||++... .+..+++|+.+.. .......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6899999999999999999754 3455556555421 122334566799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 117 LEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
+||+++++|.+++.. ....+++..++.++.|++.|+.+|| +.+++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998854 3346899999999999999999999 999999999999999975 579999999987653
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
... .......+++.|+|||...+..++.++|+||+|+++++|++|..||....... .......
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~---------- 219 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-----VVLRIVE---------- 219 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHc----------
Confidence 221 12223446788999999888888999999999999999999999986432111 0000000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+..++.++.++|.+||..||++||++.++++|
T Consensus 220 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 -----GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -----CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00111134567789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=298.48 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=192.8
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE----- 110 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 110 (339)
+.-.++|+.++.||+|+||.||+++++ +|+.+|||++... +......+.+|+..|.+|+|||||+++..+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345678999999999999999999866 8999999999776 456667889999999999999999886421000
Q ss_pred --------------------------------------------------------------------------------
Q 019568 111 -------------------------------------------------------------------------------- 110 (339)
Q Consensus 111 -------------------------------------------------------------------------------- 110 (339)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhh
Q 019568 111 ----------------------------------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156 (339)
Q Consensus 111 ----------------------------------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH 156 (339)
..+||=||||+..++.+++.++...-.....|.++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1357889999987777777554422256788999999999999999
Q ss_pred ccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc----C------------CCCccccccccCCCCccCCccccCCC
Q 019568 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV----G------------EDQSMTQTQTFATIGYMAPEYGREGR 220 (339)
Q Consensus 157 ~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~----~------------~~~~~~~~~~~~~~~y~aPE~~~~~~ 220 (339)
++|++||||||.|||+++++.|||+|||+++... . ...........||..|.|||++.+..
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999998732 0 11111234566899999999987654
Q ss_pred ---CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHh
Q 019568 221 ---VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 297 (339)
Q Consensus 221 ---~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 297 (339)
|+.|.|+||||++++||+. ||.....+...+........+.+ ..+. .+-.+.-..+|.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~---------------~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFF---------------DPEHPEEASLIR 852 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccc---------------cccchHHHHHHH
Confidence 9999999999999999984 56544333222222211111111 1111 111223568999
Q ss_pred hhcCCCCCCCCCHHHHHH
Q 019568 298 ACAVESPEQRINAKEIVK 315 (339)
Q Consensus 298 ~~l~~dP~~Rps~~ell~ 315 (339)
+||+.||.+||||.|+|+
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999987
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=265.63 Aligned_cols=264 Identities=20% Similarity=0.243 Sum_probs=196.1
Q ss_pred CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEEEEec
Q 019568 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
|++.+.||+|++|+||+|... +++.++||.+..... .......+|+..++.+. |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678999999999999999864 588999998865422 22233456899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 121 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 121 ~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++|.+.+.... ..+++..+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~ 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---P 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---C
Confidence 679998886654 46899999999999999999999 999999999999999999999999999998765321 1
Q ss_pred ccccccCCCCccCCcccc-CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc---------cccc
Q 019568 200 TQTQTFATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS---------TLEV 269 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 269 (339)
......++..|+|||.+. +..++.++|+||||+++++|++|+.||........ ............ ....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122345678899999774 45679999999999999999999999865432111 110000000000 0000
Q ss_pred cccccc--CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VDANLL--SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...... ....... ..+..+..+.++|.+||+.||.+||+++|++.|
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQ-LIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHH-HcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 0000000 011225779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=267.31 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=195.1
Q ss_pred CCCCCceeeecCccEEEEEEe----CCCcEEEEEEeeccc----hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCcee
Q 019568 43 EFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (339)
+|++.+.||+|++|.||++.. .+++.++||++.... ......+.+|+++++++ +||+|+++.+.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999863 257889999986432 23345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++||||+.+++|.+.+... ..+++..+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999988654 36889999999999999999999 9999999999999999999999999999887653
Q ss_pred CCCCccccccccCCCCccCCccccCCC--CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
.... .......++..|+|||.+.+.. .+.++|+||||+++++|++|..||........ ..........
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~-------- 226 (288)
T cd05583 157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRILK-------- 226 (288)
T ss_pred cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHHHc--------
Confidence 2211 1122334688899999887665 78899999999999999999999864321111 1111000000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 315 (339)
.....+..++..+.+++.+||+.||++|||+.++.+
T Consensus 227 --------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~ 262 (288)
T cd05583 227 --------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADE 262 (288)
T ss_pred --------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHH
Confidence 001112345667899999999999999999655543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=260.29 Aligned_cols=276 Identities=21% Similarity=0.265 Sum_probs=203.5
Q ss_pred hhhcCCCCCceeeecCccEEEEEE-eC--C--CcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeec-C
Q 019568 39 QATDEFSENNLIGKGGFGSVYKAR-LG--D--GMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSN-E 110 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~-~~--~--~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 110 (339)
.....|++...||+|.+|.||+|. .+ + ...+|||.++.++. ..-...-+|+.+++.++|||++.+..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 345689999999999999999994 22 2 34789999876532 334567789999999999999999999976 8
Q ss_pred ceeEEEEEecCCCCHHHHHhhcC----CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC----CcEE
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN----MVAH 182 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~----~~v~ 182 (339)
...++++||.+. +|..+|+-+. +.++...+.++++||+.|+.||| +.=+.|||+||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 899999999987 9999986432 46889999999999999999999 9999999999999999776 9999
Q ss_pred EcccccceeccCCCCcc-ccccccCCCCccCCccccCCC-CCCcchhhHHHHHHHHHHhCCCCCcccccCccch------
Q 019568 183 LSDFSIAKLLVGEDQSM-TQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL------ 254 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~------ 254 (339)
|+|||+++.+...-... .......|..|+|||++.|.. |+.+.|+|++|||+.||+|-++.|......-...
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999875433322 233455699999999988875 8999999999999999999998876643321111
Q ss_pred --HhHhhhhccccccccccccccCcc-------c--------hh-hh-hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 019568 255 --KHWVNDWLPISTLEVVDANLLSQE-------D--------IH-FV-AKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315 (339)
Q Consensus 255 --~~~~~~~~~~~~~~~~~~~~~~~~-------~--------~~-~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 315 (339)
.........+.....-+....++. . +. .. ....-++...+|+.+||++||.+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 111111111111111111111111 0 00 00 00111233779999999999999999999998
Q ss_pred HHH
Q 019568 316 KLL 318 (339)
Q Consensus 316 ~l~ 318 (339)
|.-
T Consensus 337 h~y 339 (438)
T KOG0666|consen 337 HPY 339 (438)
T ss_pred ccc
Confidence 753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=261.70 Aligned_cols=240 Identities=30% Similarity=0.341 Sum_probs=195.7
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeeccch---hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 50 ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
||.|++|.||++... +++.+++|++..... .....+..|+++++.++|+|++++++.+..+...+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999754 589999999876532 2455788899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccccccc
Q 019568 126 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205 (339)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~ 205 (339)
.+++.... .+++..+..++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99997654 6899999999999999999999 9999999999999999999999999999987653221 2233445
Q ss_pred CCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhh
Q 019568 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285 (339)
Q Consensus 206 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (339)
++..|+|||...+...+.++|+||||+++|++++|..||........ .. ... . .....+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~-~~~---~----------------~~~~~~ 213 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-YE-KIL---K----------------DPLRFP 213 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HH-HHh---c----------------CCCCCC
Confidence 67889999999888889999999999999999999999975432110 00 000 0 011112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCH---HHHHHH
Q 019568 286 EQCVSFVFNLAMACAVESPEQRINA---KEIVKK 316 (339)
Q Consensus 286 ~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 316 (339)
...+..+.+++.+||..||++||++ +++++|
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 3336778999999999999999999 677654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=270.07 Aligned_cols=261 Identities=24% Similarity=0.327 Sum_probs=211.4
Q ss_pred eHHHHhhh-hcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeee
Q 019568 33 SYLELCQA-TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSC 107 (339)
Q Consensus 33 ~~~~~~~~-~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (339)
-+.+..+. .+.|+.-+.||+|+||.|+-++ ..+|+-+|.|.+.+.. ..-.....+|..+|+.++.+.||.+.-.|
T Consensus 175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred HHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 34444443 4788999999999999999996 4479999999876542 22234567899999999999999999999
Q ss_pred ecCceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 108 SNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 108 ~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
+..+.+++|+..+.||+|.-.|...+ ..+++..+..++.+|+.||.+|| ..+|++||+||+|||+|+.|+++|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeecc
Confidence 99999999999999999988776554 36999999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
|++..+. .........||.+|||||++.+..|+.+.|.|||||++|+|+.|+.||.........-
T Consensus 332 GLAvei~---~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e------------ 396 (591)
T KOG0986|consen 332 GLAVEIP---EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE------------ 396 (591)
T ss_pred ceEEecC---CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH------------
Confidence 9998763 2333444589999999999999999999999999999999999999998764332110
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
.++.... ......++.+++++++|.+.+|+.||++|.- +.++-+|
T Consensus 397 --Evdrr~~---~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 397 --EVDRRTL---EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred --HHHHHHh---cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 1111111 1122235778899999999999999999973 4455553
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=271.66 Aligned_cols=267 Identities=20% Similarity=0.210 Sum_probs=193.7
Q ss_pred CCCCCceeeecCccEEEEEEeC-C--CcEEEEEEeecc--chhhhHHHHHHHHHHHhC-CCcceeeEeeeeec----Cce
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-D--GMEVAVKVFNLQ--CGRALKSFNVECEMMKSI-RHRNLIKVISSCSN----EEF 112 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~--~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 112 (339)
+|++.+.||+|+||.||++... + +..+|+|.+... .......+.+|+++++++ .||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999753 4 789999988643 223345677899999999 59999999987432 245
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.+++++++. ++|.+.+... ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++..+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899986 5898888544 47899999999999999999999 999999999999999999999999999998765
Q ss_pred cCCCCc--cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc-------
Q 019568 193 VGEDQS--MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL------- 262 (339)
Q Consensus 193 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~------- 262 (339)
...... .......+++.|+|||.+.+ ..++.++|+||+|++++++++|..||....... ..........
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 322111 11223457888999997665 568999999999999999999999987543110 0000000000
Q ss_pred ----cccccccccc-cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 263 ----PISTLEVVDA-NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 263 ----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......... ........ ....+.++..+.+|+.+||+.||++|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 00000000 01112346779999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=281.80 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=210.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC--CC--cEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG--DG--MEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~--~~--~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..+.....++||+|+||.|++|.|. +| -.||||.+...... ...+|.+|+.+|.+|+|+|++++||+..+ ....
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 4467778899999999999999863 23 45799999876543 77899999999999999999999999987 5667
Q ss_pred EEEEecCCCCHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 115 LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
+|+|.++.|+|.+.+.+ ....+-...+..++.||+.|+.||. +++++|||+...|+++-....|||+|||+.+.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 99999999999999987 3446888889999999999999999 9999999999999999989999999999998875
Q ss_pred CCCCccc-cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 194 GEDQSMT-QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 194 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
....... .........|+|||.+....++.++|+|++|+++|||++ |+.||-+...-.+ ++.+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI--------------L~~i- 328 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI--------------LKNI- 328 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH--------------HHhc-
Confidence 4333332 233344667999999999999999999999999999999 7788876422110 1111
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
+...++..+..|+.++.+++..||..+|++|||+..|.+.+-
T Consensus 329 -----D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 329 -----DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -----cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 133455568899999999999999999999999999985443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.34 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=211.0
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
+..-..++|.+++.||+|+||.|.+++. ++++.+|.|++.+- ......-|..|-.+|..-..+=|+++.-.|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3444568999999999999999999975 47899999998652 2334456888999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
++|+||||++||+|..++.+.. .+++..+..++..|+.||..|| +.|++||||||+|||+|.+|+++|.|||.|-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence 9999999999999999998887 8999999999999999999999 99999999999999999999999999999977
Q ss_pred ccCCCCccccccccCCCCccCCccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
+.. +........+|||-|.|||++.. +.|+...|+||+|+++|||++|..||....--+ ++-....+.
T Consensus 225 m~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve----TY~KIm~hk-- 297 (1317)
T KOG0612|consen 225 MDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE----TYGKIMNHK-- 297 (1317)
T ss_pred cCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH----HHHHHhchh--
Confidence 642 33445567789999999998753 568999999999999999999999998643211 111111111
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN---AKEIVKK 316 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 316 (339)
..+.++....+|.++++||++.+ -+|+.|.. ++++-.|
T Consensus 298 -----------~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 298 -----------ESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -----------hhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 11222222346888999999877 57888887 9998886
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=279.82 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=201.3
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEE---EEeec-cchhhhHHHHHHHHHHHhCCCcceeeEeeeeec
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAV---KVFNL-QCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~v---K~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (339)
.+..+...-.+....||+|+|-+||+|.+. +|-.||= |.-.. ..+...+++..|+.+|+.|+||||+++|.++.+
T Consensus 33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 344444455677889999999999999653 4666643 32222 235667899999999999999999999999976
Q ss_pred Cce--eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-CCCcEEEccc
Q 019568 110 EEF--KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDF 186 (339)
Q Consensus 110 ~~~--~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-~~~~v~l~Df 186 (339)
... ..+|+|.+..|+|..+.++.+ ..+...+..|+.||+.||.|||. ..-.|+|||||.+||||+ ..|.|||+|+
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecch
Confidence 554 779999999999999998876 78888999999999999999992 133599999999999996 6789999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
|+++... ........|||.|||||+.. ..|++..||||||++++||+|+.+||..=.++..-+++......+..+
T Consensus 191 GLAtl~r----~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 191 GLATLLR----KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred hHHHHhh----ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 9998762 22333478999999999876 789999999999999999999999998755544333332222222111
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..+. .+++++||.+||.. ..+|||+.|+|++
T Consensus 266 ~kV~------------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 SKVK------------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hccC------------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1111 35589999999999 9999999999984
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=258.84 Aligned_cols=260 Identities=22% Similarity=0.324 Sum_probs=203.2
Q ss_pred CceeeecCccEEEEEE-eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecCCCC
Q 019568 47 NNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 124 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 124 (339)
.+.||+|+++.|-.+. ..+|..+|||++.+.......+..+|++++.+. .|+||++++++|+++..+|+|||.+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999998885 678999999999888777888999999999999 59999999999999999999999999999
Q ss_pred HHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC---CcEEEcccccceeccCCCC----
Q 019568 125 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLVGEDQ---- 197 (339)
Q Consensus 125 L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~---~~v~l~Dfg~~~~~~~~~~---- 197 (339)
|...|.++. .+++.++..+.+.|+.||.+|| .+||.|+|+||+|||.... .-|||+||+++.-......
T Consensus 163 lLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 163 LLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 999997766 7899999999999999999999 9999999999999999543 3589999988754321111
Q ss_pred -ccccccccCCCCccCCccc---cC--CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc----cccc
Q 019568 198 -SMTQTQTFATIGYMAPEYG---RE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP----ISTL 267 (339)
Q Consensus 198 -~~~~~~~~~~~~y~aPE~~---~~--~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~----~~~~ 267 (339)
.......+|+..|||||+. .+ ..|+.+.|.||||+++|-|++|.+||.+.-...=. |-....= ....
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---WdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---WDRGEVCRVCQNKLF 315 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---ccCCCccHHHHHHHH
Confidence 1112245578889999964 23 35899999999999999999999999875432110 0000000 0011
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
+.++.+ ...+....+..++.+.+++|..+|..|+.+|.++..+++|
T Consensus 316 esIQEG---kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 316 ESIQEG---KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHhcc---CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 111111 1222333456789999999999999999999999999984
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=276.79 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=220.2
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeCC-CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
++|+--..+.+...+||.|.||.||.|.|+. .-.||||.++. .....+.|..|..+|+.++|||+++++++|....-+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 5666666788889999999999999999875 67789998754 366778999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 114 ALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
|||+||+..|+|.+++++.++ .++...++.++.||.+|+.||. .++++|+|+...|.|+.++..||+.|||+++.+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999987653 4666778899999999999999 999999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
........ ....-.+-|.|||-+....++.|+|||+||++|||+.| |-.||....-. +
T Consensus 416 tgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------------------q 474 (1157)
T KOG4278|consen 416 TGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------------Q 474 (1157)
T ss_pred cCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------------------H
Confidence 54332222 22223567999999999999999999999999999998 55676543211 1
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
...+.+..+++..+..|++.+.+||+.||+++|.+||++.|+-+.++++-
T Consensus 475 VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 475 VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 11123345566678899999999999999999999999999999998875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=277.82 Aligned_cols=276 Identities=26% Similarity=0.303 Sum_probs=207.8
Q ss_pred cCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc------ee
Q 019568 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE------FK 113 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 113 (339)
-.|...+.||+|+||.||+|+ ..+|+.||||.+.... ....+...+|+++|++++|+|||+.+++-++.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 456678899999999999998 4579999999997653 344566788999999999999999999865543 45
Q ss_pred EEEEEecCCCCHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe--CCCC--cEEEcccc
Q 019568 114 ALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL--DDNM--VAHLSDFS 187 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~--~~~~--~v~l~Dfg 187 (339)
.+|||||.||+|...+.+.. ..+++.+++.++.++..|+.||| ..||+||||||.||++ ..+| ..||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 69999999999999997643 57999999999999999999999 9999999999999998 3334 46999999
Q ss_pred cceeccCCCCccccccccCCCCccCCcccc-CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh-hhhcccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV-NDWLPIS 265 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~-~~~~~~~ 265 (339)
.++.+. ........+||+.|++||+.. .+.|+...|.|||||++|+++||..||.....+........ .....++
T Consensus 170 ~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 998763 333566788999999999988 47899999999999999999999999988776643322222 2222221
Q ss_pred cc-cccccccc--Cccchhhhhh----HHHHHHHHHHHhhhcCCCCCCCC--CHHHHHHHHHHHHHH
Q 019568 266 TL-EVVDANLL--SQEDIHFVAK----EQCVSFVFNLAMACAVESPEQRI--NAKEIVKKLLKIRDS 323 (339)
Q Consensus 266 ~~-~~~~~~~~--~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rp--s~~ell~~l~~~~~~ 323 (339)
.. ...++... ......++.+ +..-..+-..+..+|..+|.+|- ...+....+..+.+.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11 11111111 0111111122 22223344667788999999998 777777777666653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=256.91 Aligned_cols=225 Identities=21% Similarity=0.163 Sum_probs=180.0
Q ss_pred cCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhh
Q 019568 53 GGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 131 (339)
Q Consensus 53 g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~ 131 (339)
|.++.||++.. .+++.+|+|.+.... ...+|...+....||||+++++++...+..+++|||+++++|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999975 468999999987553 223355555556799999999999999999999999999999999866
Q ss_pred cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCcc
Q 019568 132 SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211 (339)
Q Consensus 132 ~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 211 (339)
.. .+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++++|||.+..... ......++..|+
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYC 149 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCcccc
Confidence 54 6899999999999999999999 99999999999999999999999999998765421 122233566799
Q ss_pred CCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHH
Q 019568 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSF 291 (339)
Q Consensus 212 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (339)
|||...+..++.++|+||+|+++|++++|..|+........ .......+..++..
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------------------THTTLNIPEWVSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------------------cccccCCcccCCHH
Confidence 99999888899999999999999999999988653211100 00001113345677
Q ss_pred HHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 019568 292 VFNLAMACAVESPEQRINA-----KEIVKK 316 (339)
Q Consensus 292 l~~li~~~l~~dP~~Rps~-----~ell~~ 316 (339)
++++|.+||+.||.+||++ +++++|
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 9999999999999999986 666654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=263.72 Aligned_cols=271 Identities=21% Similarity=0.241 Sum_probs=203.7
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC--Cc----ceeeEeeeee
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR--HR----NLIKVISSCS 108 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--h~----~i~~~~~~~~ 108 (339)
..-...++|.+...+|+|+||.|..+-+ .++..||||+++.- ....+...-|+++|+++. .| -++++.++|.
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 3334588999999999999999999853 35899999998644 344456677999999993 23 2778888999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC----------
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---------- 177 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~---------- 177 (339)
..++.|+|+|.+ |-++.+++..++ .+++...+..++.|+++++.+|| +.+++|.|+||+||++..
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999 569999998754 47999999999999999999999 999999999999999821
Q ss_pred ----------CCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCccc
Q 019568 178 ----------NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 247 (339)
Q Consensus 178 ----------~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~ 247 (339)
+..|+++|||.++.- .........|..|.|||++.+-.++.++||||+||||+|+.+|...|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~-----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFD-----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCccee-----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 335899999999864 22235556788899999999999999999999999999999999998876
Q ss_pred ccCccc-hHhHhhhhccc-----------------ccccccccc----cc--Ccc-chhhhhhHHHHHHHHHHHhhhcCC
Q 019568 248 FNGEMT-LKHWVNDWLPI-----------------STLEVVDAN----LL--SQE-DIHFVAKEQCVSFVFNLAMACAVE 302 (339)
Q Consensus 248 ~~~~~~-~~~~~~~~~~~-----------------~~~~~~~~~----~~--~~~-~~~~~~~~~~~~~l~~li~~~l~~ 302 (339)
.+.+.. +...+....+. ++.+....+ .. ..+ ..-....+.....|.+|+++||.+
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 644321 11111110000 000000000 00 000 001122244556699999999999
Q ss_pred CCCCCCCHHHHHHH
Q 019568 303 SPEQRINAKEIVKK 316 (339)
Q Consensus 303 dP~~Rps~~ell~~ 316 (339)
||.+|+|+.|+|.|
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=275.82 Aligned_cols=244 Identities=23% Similarity=0.259 Sum_probs=200.3
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
+.+.|.+...+|.|+|+.+..+. ..+++..++|++.... ....+|+.++... +||||++..+.+.+....|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46789999999999999998885 4578999999987552 2334477665555 7999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe-CCCCcEEEcccccceeccCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-DDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~-~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|.+.|+-+.+.+.... .....+..|+.+|+.|+.||| .+|++|||+||+|||+ +..++++|+|||.+......
T Consensus 396 e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999998888876554 223678889999999999999 9999999999999999 69999999999998765322
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+.. .... +.
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-i~~~-----------------i~ 527 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-IHTR-----------------IQ 527 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-HHHh-----------------hc
Confidence 3344567889999999999999999999999999999999999987655511 1100 00
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.+.. ...+|+.+++|+.+||++||.+||++.+++.|=+.
T Consensus 528 ~~~~----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 MPKF----SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CCcc----ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 0111 25678889999999999999999999999998776
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=232.42 Aligned_cols=268 Identities=23% Similarity=0.254 Sum_probs=203.4
Q ss_pred cCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
.+|.-.++||+|.+|+||+|+ ..+++-||+|.++... +.......+|+-+|+.+.|.||+++++....+..+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 356778899999999999997 4578999999998764 3345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
||+. +|..++..-++.++.+.+.+++.|++.++.++| ++++.|+|+||.|.+++.+|.+|+.|||+++.+. -..
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafg--ipv 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFG--IPV 155 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcC--Cce
Confidence 9954 999999888888999999999999999999999 9999999999999999999999999999998652 112
Q ss_pred cccccccCCCCccCCccccCCC-CCCcchhhHHHHHHHHHHhCC-CCCcccccCccchHhHhh--hhccccccccc----
Q 019568 199 MTQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGK-KPTDEIFNGEMTLKHWVN--DWLPISTLEVV---- 270 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~-~P~~~~~~~~~~~~~~~~--~~~~~~~~~~~---- 270 (339)
.-.+....|..|.+|.++.+.+ |+.+.|+||.||++.|+.... +.|....- .+....... .....+.+...
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccccCC
Confidence 2233445688999999988875 899999999999999998844 44443221 112221111 11111111111
Q ss_pred cccccCcc--chh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLSQE--DIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~~~--~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
+-...+.. ... ...-+..+..-++|+.++|.-+|.+|.++++.++|
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111000 000 11124455567899999999999999999998875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=245.80 Aligned_cols=275 Identities=18% Similarity=0.266 Sum_probs=208.9
Q ss_pred ceeeeeHHHHhhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEee
Q 019568 28 MWRTFSYLELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVIS 105 (339)
Q Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 105 (339)
-|+..++..-.+..++|++.+++|+|-++.||.|. ..+++.++||++++- ..+.+.+|+.+|+.|. +|||+++++
T Consensus 24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhh
Confidence 46666666666788999999999999999999996 457899999998754 3366788999999996 999999999
Q ss_pred eeecC--ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-CCCcEE
Q 019568 106 SCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAH 182 (339)
Q Consensus 106 ~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-~~~~v~ 182 (339)
+..+. ....+++||+++.+...+.. +++...+...+.+++.||.|+| ++||.|+|+||.|++++ +...++
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceee
Confidence 98654 46789999999988777653 4778899999999999999999 99999999999999998 466799
Q ss_pred EcccccceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh
Q 019568 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
|+|+|++.++-... ...-...+..|--||++.. +.|+.+.|+|||||++..|+..+.||-......+.+-..+...
T Consensus 174 lIDWGLAEFYHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred eeecchHhhcCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 99999999873322 2233445667889998775 4589999999999999999999999865444433333322211
Q ss_pred cccccccc---------------ccccccCccchhhhh---hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 262 LPISTLEV---------------VDANLLSQEDIHFVA---KEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 262 ~~~~~~~~---------------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........ ..... .....++.. ..-.++++.+|+.++|.+|.++|+|++|++.|
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~-rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHS-RKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccc-cccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11111111 11110 011111111 12345889999999999999999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=269.39 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=205.1
Q ss_pred CceeeecCccEEEEEE-eCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCC
Q 019568 47 NNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
.+.||+|.||+||-|+ .++|+.||||++.+.. .+.-..+++|+.+|+++.||+|+.+-..|+..+..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5789999999999996 4579999999997653 23346788999999999999999999999999999999999965
Q ss_pred CHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC---CCCcEEEcccccceeccCCCCcc
Q 019568 124 SLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 124 ~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~---~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+..++|-.+ .+.+++..-..++.||+.||.||| -++|+|.|+||+|||+. .-..+||+|||+++++ ....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI---gEks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII---GEKS 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeec---chhh
Confidence 776666544 457999999999999999999999 99999999999999995 4457999999999986 3333
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
......|||.|+|||++.+..|+.+-|+||+|+++|.-++|..||....+-.+... ....-
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ-------------------NAaFM 782 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ-------------------NAAFM 782 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh-------------------ccccc
Confidence 44567799999999999999999999999999999999999999976533222221 11122
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
+....+..++.+..+||..+|+..-.+|.|....+.|-|
T Consensus 783 yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 783 YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 233346677888999999999999999999999988744
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=284.36 Aligned_cols=146 Identities=29% Similarity=0.412 Sum_probs=131.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|.+.++||+|+||.||+|... +++.||||++.... ......+..|+.++..++|+||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 578999999999999999999764 68999999987542 33446788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
|||+.+++|.+++.... .+++..++.++.||+.||.||| ..+|+|+||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999986654 6888899999999999999999 9999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=250.94 Aligned_cols=278 Identities=21% Similarity=0.318 Sum_probs=204.2
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec----
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN---- 109 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 109 (339)
.+...+.|.-..+||+|.||.||+|+. ++|+.|++|++-.++ ...-....+|+.+|+.+.|+|++.++.+|..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 344567788899999999999999974 468889998875543 2234566789999999999999999988733
Q ss_pred ----CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 110 ----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 110 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
...+|+||++|+. +|..++......++..++..++.++++||.|+| ...|+|||+|+.|++++.+|.++|.|
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeec
Confidence 2358999999976 999999777678999999999999999999999 99999999999999999999999999
Q ss_pred cccceeccCCCCccc--cccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccC-ccchHhHhhhh
Q 019568 186 FSIAKLLVGEDQSMT--QTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNG-EMTLKHWVNDW 261 (339)
Q Consensus 186 fg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~-~~~~~~~~~~~ 261 (339)
||+++.+........ ......|..|++||.+.|. .|+++.|+|+.||++.+|+++.+-+....+. ........-..
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 999976643332222 2344568999999977665 6999999999999999999999987654321 11111111111
Q ss_pred ccccccccccc-ccc--------Cccchhh----hhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 262 LPISTLEVVDA-NLL--------SQEDIHF----VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 262 ~~~~~~~~~~~-~~~--------~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..++.+...+. .+. .+...+. ..+..-.++..+|+.++|..||.+|+.++++++|-.
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 11111111110 000 0000000 001111346789999999999999999999998754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=257.44 Aligned_cols=262 Identities=22% Similarity=0.263 Sum_probs=206.4
Q ss_pred CCCccccccceeeeeHHHHhhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc---hhhhHHHHHHHHHHHh
Q 019568 19 NDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRALKSFNVECEMMKS 94 (339)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~ 94 (339)
++.-.+...+...++-.. -....+|..+..||+|+||.|.+|. ..+.+.+|||++++.- ....+--..|.++|..
T Consensus 327 ~~~~~~~~~~~~~~~~~d-~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL 405 (683)
T KOG0696|consen 327 EKKTMPTDSKFHNSSKRD-RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 405 (683)
T ss_pred CCCCCCCcccCCCCCccc-ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheec
Confidence 333344433333344333 3345789999999999999999995 4468889999987652 2333344557777776
Q ss_pred C-CCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCe
Q 019568 95 I-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV 173 (339)
Q Consensus 95 l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Ni 173 (339)
. +-|.++++..+|+.-+.+|+||||+.||+|--.|++-+ .+.+..+..++..|+-||-+|| ++||++||+|.+||
T Consensus 406 ~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNv 481 (683)
T KOG0696|consen 406 PGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNV 481 (683)
T ss_pred CCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccce
Confidence 6 45788999999999999999999999999998887766 6778888999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccc
Q 019568 174 LLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 253 (339)
Q Consensus 174 l~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~ 253 (339)
|++.+|.+||+|||++..- ......+...+|||.|+|||++..++|+.+.|+||+|++||||+.|++||+.....+.-
T Consensus 482 mLd~eGHiKi~DFGmcKEn--i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 482 MLDSEGHIKIADFGMCKEN--IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred EeccCCceEeeeccccccc--ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 9999999999999999743 22334455678999999999999999999999999999999999999999876543321
Q ss_pred hHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 019568 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308 (339)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 308 (339)
... . .-.-..+...+.++.++.+..|...|.+|.
T Consensus 560 ~aI----~-----------------ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 560 QAI----M-----------------EHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHH----H-----------------HccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 111 0 001122455677889999999999999996
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=277.39 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=220.0
Q ss_pred cCCCCCceeeecCccEEEEEEe-CC----CcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GD----GMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
...+..+.||+|+||+||+|.+ .. .-+|+||++... ..+....+.+|+-+|.++.|||++++++++.... ..|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4567788999999999999974 23 456788887654 3455678899999999999999999999998765 779
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
|++|++.|+|.|+++.+...+..+..+.|..||++|+.||| .+.++||||-..||||..-..+|+.|||++..+...
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999999998889999999999999999999999 999999999999999999999999999999887655
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
............+.|+|-|.+....++.++||||+|+++||++| |..|+......+....
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl------------------- 912 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL------------------- 912 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------------------
Confidence 55545455555677999999999999999999999999999999 8899887654432211
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
.+.+.++..++.|+.++..++.+||-.|+..||+++++...+.++.++
T Consensus 913 -le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 913 -LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 112334667899999999999999999999999999999999888754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=261.63 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=208.8
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccch-------hhhHHHHHHHHHHHhCCCcceeeEeeee
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCG-------RALKSFNVECEMMKSIRHRNLIKVISSC 107 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (339)
+--...++|-.+.+||+|+|+.||+|. ....+.||+|+-..... ...+...+|+++-+.|.||.||++|++|
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 334466799999999999999999996 44689999998765532 2345677899999999999999999999
Q ss_pred e-cCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---CCCCcEEE
Q 019568 108 S-NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHL 183 (339)
Q Consensus 108 ~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~---~~~~~v~l 183 (339)
. +.+.+|-|+|||+|.+|.-+++.+. .+++.++..|+.||+.||.||... +-.|+|-|+||.|||+ +..|.+||
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 6 4567889999999999988886554 899999999999999999999942 5679999999999999 45778999
Q ss_pred cccccceeccCCCCc-----cccccccCCCCccCCcccc----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccch
Q 019568 184 SDFSIAKLLVGEDQS-----MTQTQTFATIGYMAPEYGR----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~ 254 (339)
+|||++..+.+.... ..++...||.+|++||.+. .++.+.|.||||+|+++|++++|+.||.......+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-- 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-- 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--
Confidence 999999887654433 2235666899999999654 23568899999999999999999999986432111
Q ss_pred HhHhhhhcccccccccccc-ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 019568 255 KHWVNDWLPISTLEVVDAN-LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315 (339)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 315 (339)
++... ++......+...+.++.+.++||++||++--++|....++..
T Consensus 693 --------------ILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 --------------ILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --------------HHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111 122334455567788899999999999999999999888765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=276.04 Aligned_cols=264 Identities=28% Similarity=0.440 Sum_probs=214.6
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC--------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISS 106 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 106 (339)
++-..++..+.+.||.|.||.|++|... ....||||..+... ....+.+..|+++|+.+ .|+||+.++++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444566678889999999999999621 14568999886553 35667889999999999 69999999999
Q ss_pred eecCceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCC
Q 019568 107 CSNEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPS 171 (339)
Q Consensus 107 ~~~~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~ 171 (339)
+...+..++|.||+..|+|.++++... ..++...++.++.||+.|+.||+ +..++|||+.+.
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhh
Confidence 999999999999999999999997766 34889999999999999999999 999999999999
Q ss_pred CeEeCCCCcEEEcccccceeccCCCCcccc-ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCccccc
Q 019568 172 NVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFN 249 (339)
Q Consensus 172 Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~ 249 (339)
||++.++..+||+|||+++........... ........|||||.+....++.++||||+|++|||+++ |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999865433322211 11113456999999999999999999999999999999 7888876321
Q ss_pred CccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 250 GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
...... ....+.+...|..|++++.++|+.||+.+|++||++.++.+.+.....
T Consensus 528 ~~~l~~-------------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 TEELLE-------------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHH-------------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111111 122344455577889999999999999999999999999999998543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=247.81 Aligned_cols=276 Identities=26% Similarity=0.396 Sum_probs=209.3
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHh--CCCcceeeEeeeeec
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKS--IRHRNLIKVISSCSN 109 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~ 109 (339)
+++.-.-....+.++.+.||+|-||.||+|.| .|+.||||+|....+ ....+|.++.+- |+|+||+.+++.-..
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 34444445667899999999999999999999 799999999976644 455668888776 499999999987543
Q ss_pred C----ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhc-----cCCCCeEecCCCCCCeEeCCCCc
Q 019568 110 E----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-----GYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 110 ~----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~-----~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
+ ..+|||++|.+.|+|.|++.+. +++......++..++.||++||. +..-.|.|||||..||||.+++.
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 3 2588999999999999999874 59999999999999999999995 11235999999999999999999
Q ss_pred EEEcccccceeccCC--CCccccccccCCCCccCCccccCCCC------CCcchhhHHHHHHHHHHhC----------CC
Q 019568 181 AHLSDFSIAKLLVGE--DQSMTQTQTFATIGYMAPEYGREGRV------SANGDVYSFGIMLMETFTG----------KK 242 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~------~~~~DiwslG~il~~ll~g----------~~ 242 (339)
..|.|+|++-..... .........+||-+|||||++...-. =..+||||||.++||++-. +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 999999999765432 12233457789999999999866532 2469999999999999862 34
Q ss_pred CCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 243 PTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 243 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
||.+.-+..-.+..... .+...++.+..+.+ .....+-..+..+|+.||..+|.-|.|+-.|-+.|.++.+
T Consensus 435 Pyyd~Vp~DPs~eeMrk--------VVCv~~~RP~ipnr-W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRK--------VVCVQKLRPNIPNR-WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CcccCCCCCCCHHHHhc--------ceeecccCCCCCcc-cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 66655443333322211 11222222222222 2234555668899999999999999999999999998875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=242.66 Aligned_cols=238 Identities=31% Similarity=0.369 Sum_probs=193.1
Q ss_pred CccEEEEEEeC-CCcEEEEEEeeccchhh-hHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhh
Q 019568 54 GFGSVYKARLG-DGMEVAVKVFNLQCGRA-LKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 131 (339)
Q Consensus 54 ~~~~v~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~ 131 (339)
+||.||+|... +++.+++|++....... ...+.+|++.+++++|+|++++++++......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999865 58999999997765443 67889999999999999999999999998999999999999999999866
Q ss_pred cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCcc
Q 019568 132 SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211 (339)
Q Consensus 132 ~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 211 (339)
.. .++...++.++.+++.++.+|| +.+++|+||+|+||+++.++.++++|||.+....... ......++..|+
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 54 3889999999999999999999 9999999999999999999999999999988753221 233445678899
Q ss_pred CCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhh-hHHHHH
Q 019568 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVA-KEQCVS 290 (339)
Q Consensus 212 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 290 (339)
+||...+..++.++|+||||++++++++|..||............... ....... ...++.
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~ 215 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK------------------PKPPFPPPEWKISP 215 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc------------------cCCCCccccccCCH
Confidence 999998888899999999999999999999998764222111110000 0000000 011566
Q ss_pred HHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 291 FVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 291 ~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.+.+++.+||..+|.+||++.+++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhhC
Confidence 79999999999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=267.62 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=211.5
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeee----
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCS---- 108 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~---- 108 (339)
+...-..+-|++...||.|.+|.||+++. .+++..|+|+....... .+.+..|+++|+.. .|||++.++++|.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 33334567899999999999999999974 46899999988766433 35667799999998 6999999999983
Q ss_pred -cCceeEEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 109 -NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 109 -~~~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
.++.+|||||||.||++.|+++.. +..+.+..+..|+..++.|+.+|| ...++|+|||-.|||++.++.|||+||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeee
Confidence 357899999999999999998754 346899999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
|++..+. ..........|||.|||||++.- ..|+.++|+||||++..||.-|.+|+.++.+....+.
T Consensus 168 GvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~------ 239 (953)
T KOG0587|consen 168 GVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------ 239 (953)
T ss_pred eeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc------
Confidence 9998763 33344456679999999998753 3478899999999999999999999887755432221
Q ss_pred ccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....+......+..-+..+.+||..||..|-++||+..++++|
T Consensus 240 ------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 ------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1122333444466668889999999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=262.17 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=211.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCC-CcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..+++..+..||-|+||.|-+++.+. ...+|+|++++. .....+++..|-.+|.....|.|+++|..|.++...|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 45788889999999999999997643 234777776543 45667888999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
+||-|-||.|+..+..++ .+++..+..++..+++|+.||| .+||++||+||+|.+++.+|-+||+|||++..+..
T Consensus 498 LmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred hHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 999999999999997665 7888899999999999999999 99999999999999999999999999999988743
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
...+-..+|||.|.|||++.+...+.+.|.||||+++|||++|.+||....+. ..+.....+.+
T Consensus 573 --g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----ktYn~ILkGid---------- 636 (732)
T KOG0614|consen 573 --GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----KTYNLILKGID---------- 636 (732)
T ss_pred --CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHHhhhh----------
Confidence 33344567999999999999999999999999999999999999999875432 22222222211
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKKLL 318 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~l~ 318 (339)
.+..|..++....+||+++...+|.+|.- +.+|-+|-|
T Consensus 637 -----~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 637 -----KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred -----hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 12234556677889999999999999985 788888865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=271.35 Aligned_cols=245 Identities=27% Similarity=0.429 Sum_probs=192.6
Q ss_pred CCCCceeeecCccE-EEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEecC
Q 019568 44 FSENNLIGKGGFGS-VYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 44 y~~~~~ig~g~~~~-v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
|.-.+.+|.|+.|+ ||+|.. .|+.||||.+-.+ ......+|+..|+.- .||||+++|+.-.+.++.|++.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44556788999985 589988 6899999987533 334567899999998 79999999999999999999999996
Q ss_pred CCCHHHHHhhcCC---ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC---C--CcEEEcccccceecc
Q 019568 122 HGSLEKYLYSSNC---ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---N--MVAHLSDFSIAKLLV 193 (339)
Q Consensus 122 ~~~L~~~i~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~---~--~~v~l~Dfg~~~~~~ 193 (339)
. +|.++++.... .......+.++.|+++||++|| +.+|+|||+||.|||++. + .+++|+|||++..+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999987411 1222456889999999999999 999999999999999964 3 468999999999886
Q ss_pred CCCCccc-cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhC-CCCCcccccCccchHhHhhhhcccccccccc
Q 019568 194 GEDQSMT-QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG-KKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 194 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
....... .....||.+|+|||++.....+.+.||||+||++|+.++| .+||......+.....-... ..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~------L~--- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYT------LV--- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccc------ee---
Confidence 5444333 3456689999999999999989999999999999999996 89999865443322111000 00
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+ ++.+||.+|+++||..||+|.++|.|
T Consensus 734 ---------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 ---------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ---------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 00001111 68999999999999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=242.77 Aligned_cols=255 Identities=25% Similarity=0.276 Sum_probs=195.9
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch-hhhHHHHHHHHHHHh-CCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG-RALKSFNVECEMMKS-IRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++.+.+..||.|+||+|++-.. ..|+..|||.++.... ....++..|.+...+ -+.|||+++||+....+..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 4666788999999999999864 4699999999988754 666778888887554 478999999999999999999999
Q ss_pred ecCCCCHHHHHhh----cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 119 YMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 119 ~~~~~~L~~~i~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
.++ .+|..+.+. ....++++-+-.+....+.||.||-. ...++|||+||+|||++..|.+||+|||.+..+..
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 995 488766532 23468998889999999999999996 78999999999999999999999999999876532
Q ss_pred CCCccccccccCCCCccCCccccCC--CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
+.......|-..|+|||.+... .|+.+||+||||++|+|+.||..|+..... ....+......+......
T Consensus 221 ---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp~l~~- 292 (361)
T KOG1006|consen 221 ---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPPILLF- 292 (361)
T ss_pred ---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCCeecC-
Confidence 2222333455569999977543 489999999999999999999999876533 222222221111111100
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
... .-.++..++.+|..||..|-..||...+++++
T Consensus 293 ---~~~------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 ---DKE------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---ccc------ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 001 12356669999999999999999999998874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=267.52 Aligned_cols=260 Identities=20% Similarity=0.205 Sum_probs=170.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-C----CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeee------ee
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-D----GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS------CS 108 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~----~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~ 108 (339)
..++|.+.+.||+|+||.||+|... + +..||||.+...... +....+ .++...+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5689999999999999999999753 5 789999987543211 111111 1122222222222211 24
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcCCc-------------------cCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCC
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSNCI-------------------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~~~-------------------~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~ 169 (339)
.....++|+||+.+++|.+++...... .....+..++.|++.||.||| +.+|+|+|||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 556789999999999999998654311 123346689999999999999 9999999999
Q ss_pred CCCeEeCC-CCcEEEcccccceeccCCCCccccccccCCCCccCCccccCC----------------------CCCCcch
Q 019568 170 PSNVLLDD-NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG----------------------RVSANGD 226 (339)
Q Consensus 170 p~Nil~~~-~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D 226 (339)
|+|||++. ++.++|+|||++..+... .........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 689999999999754322 12223445678999999954322 2345679
Q ss_pred hhHHHHHHHHHHhCCCCCccccc--------CccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhh
Q 019568 227 VYSFGIMLMETFTGKKPTDEIFN--------GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 298 (339)
Q Consensus 227 iwslG~il~~ll~g~~P~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 298 (339)
|||+||++|+|+++..|+..... .......|..... ..........+...+......++||.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE---------PRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc---------cccchhhhhhhhhccccchHHHHHHHH
Confidence 99999999999998776543210 0001111111000 000000000011112223456799999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 019568 299 CAVESPEQRINAKEIVKK 316 (339)
Q Consensus 299 ~l~~dP~~Rps~~ell~~ 316 (339)
||+.||.+|||++++++|
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=258.54 Aligned_cols=265 Identities=20% Similarity=0.242 Sum_probs=183.4
Q ss_pred hcCCCCCceeeecCccEEEEEEe-----------------CCCcEEEEEEeeccchhhhHHH--------------HHHH
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-----------------GDGMEVAVKVFNLQCGRALKSF--------------NVEC 89 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-----------------~~~~~v~vK~~~~~~~~~~~~~--------------~~e~ 89 (339)
.++|++.++||+|+||+||+|.. ..++.||||.+..........+ ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57999999999999999999852 2356899999876543322222 3366
Q ss_pred HHHHhCCCcce-----eeEeeeeec--------CceeEEEEEecCCCCHHHHHhhcC-----------------------
Q 019568 90 EMMKSIRHRNL-----IKVISSCSN--------EEFKALVLEYMPHGSLEKYLYSSN----------------------- 133 (339)
Q Consensus 90 ~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~i~~~~----------------------- 133 (339)
.++.+++|.++ ++++++|.. .+..++|+||+.+++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777766544 566666542 356789999999999999886421
Q ss_pred CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCC
Q 019568 134 CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213 (339)
Q Consensus 134 ~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 213 (339)
..+++..++.++.|++.+|.||| +.+++|+||||+||+++.++.++|+|||++...... .........+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeCh
Confidence 12355678899999999999999 999999999999999999999999999998654221 11122223357899999
Q ss_pred ccccCCC--------------------C--CCcchhhHHHHHHHHHHhCCC-CCcccccCccchHhHhhhhccccccccc
Q 019568 214 EYGREGR--------------------V--SANGDVYSFGIMLMETFTGKK-PTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 214 E~~~~~~--------------------~--~~~~DiwslG~il~~ll~g~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
|.+.... + ..+.|+||+||++++|++|.. |+.....-......+..+.. .+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~------~~ 453 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN------RW 453 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH------HH
Confidence 9875432 1 234799999999999999885 66543211111111000000 00
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCC---CCCCCHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESP---EQRINAKEIVKKL 317 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~ell~~l 317 (339)
. ........+...+..++..++|+.+||..+| .+|+|++|+|+|=
T Consensus 454 r--~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 454 R--MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred H--hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0 0111112233345567889999999999876 6899999999883
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=244.66 Aligned_cols=130 Identities=28% Similarity=0.381 Sum_probs=112.9
Q ss_pred cCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-----C---cceeeEeeeee----
Q 019568 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-----H---RNLIKVISSCS---- 108 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~---- 108 (339)
.+|.+.++||+|.|++||++- .++.+.||+|+++.. ....+....|+++|+++. | ..||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 699999999999999999995 667899999998765 445567788999999983 2 46999999984
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 175 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~ 175 (339)
+..+.|+|+|++ |.+|..+|.... +.++...+..|+.|++.||.|||. ..||+|.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 456899999999 669999987765 479999999999999999999997 7899999999999997
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=238.86 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=201.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (339)
...+|.+++.||+|+++.|.+++. ++.+-+|+|+++++- .+.+.-.+.|..+..+. +||.++.+..+|+....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 446899999999999999999975 468889999997652 44555667788888887 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+|.||.+||+|--.+++.. .+++..+..+...|+.||.||| ++||+++|+|.+|++++..|.+||+|+|++..-
T Consensus 328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~-- 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-- 401 (593)
T ss_pred EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC--
Confidence 9999999999987776655 7999999999999999999999 999999999999999999999999999999743
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccc--cCccchHhHhhhhccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF--NGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
......++..+|||.|.|||++.+..|+.+.|.|+||+++++|+.|+.||+-.. +++..-..+.....- .+
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-------ek 474 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-------EK 474 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-------hh
Confidence 233445667789999999999999999999999999999999999999997543 333333333222111 11
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN 309 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 309 (339)
+. ..+...+-....+++..|+.||.+|..
T Consensus 475 qi--------riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 475 QI--------RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cc--------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11 112233344567888999999999863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=254.99 Aligned_cols=276 Identities=21% Similarity=0.212 Sum_probs=208.3
Q ss_pred eeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCC------Ccceee
Q 019568 30 RTFSYLELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIR------HRNLIK 102 (339)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~ 102 (339)
-.+++.-.+.+.++|.+....|+|-|++|.+|... .|..||||++...... .+.=..|+++|++|+ ..++++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 35566666778899999999999999999999754 5889999998755322 244567999999995 247899
Q ss_pred EeeeeecCceeEEEEEecCCCCHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-
Q 019568 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM- 179 (339)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~- 179 (339)
++..|...+++|+|||.+ ..+|.+++++.+. .+...++..++.|++.||..|- ..|++|.||||+||||++..
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcc
Confidence 999999999999999999 5699999988754 5778899999999999999999 99999999999999998654
Q ss_pred cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhh
Q 019568 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~ 259 (339)
.+||||||.+.... .+..++ +..+-.|.|||++.|-.|+...|+||+||+||||.||+..|.+..+..+.. +..
T Consensus 575 iLKLCDfGSA~~~~---eneitP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr--l~m 648 (752)
T KOG0670|consen 575 ILKLCDFGSASFAS---ENEITP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR--LFM 648 (752)
T ss_pred eeeeccCccccccc---cccccH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH--HHH
Confidence 67999999998652 222222 223456999999999999999999999999999999999887754432211 111
Q ss_pred hhcc-----------------cccccccc-------------ccccCccchh-----------hhhhHHHHHHHHHHHhh
Q 019568 260 DWLP-----------------ISTLEVVD-------------ANLLSQEDIH-----------FVAKEQCVSFVFNLAMA 298 (339)
Q Consensus 260 ~~~~-----------------~~~~~~~~-------------~~~~~~~~~~-----------~~~~~~~~~~l~~li~~ 298 (339)
+..+ ...+.++. .-...++... .-..+..-..|++|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 1111 00001100 0000011000 01123455679999999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 019568 299 CAVESPEQRINAKEIVKK 316 (339)
Q Consensus 299 ~l~~dP~~Rps~~ell~~ 316 (339)
||..||++|.|+.+.|+|
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=255.44 Aligned_cols=243 Identities=22% Similarity=0.338 Sum_probs=195.1
Q ss_pred cCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
+-|..++.||-|+||.|.+++ ..+...+|.|.+.+.. .......+.|-.||..-.++=||++|-.|++++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 456788999999999999995 5568888999887653 344556788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC-
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED- 196 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~- 196 (339)
+|++||++-.++-+-+ -+.+..++.++..+..|+.+.| .+|++||||||+|||+|.+|.+||+|||+|+=+...+
T Consensus 709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999886654 6888889999999999999999 9999999999999999999999999999986442200
Q ss_pred ---------------------------------------CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHH
Q 019568 197 ---------------------------------------QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMET 237 (339)
Q Consensus 197 ---------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 237 (339)
.........||+.|+|||++....|+...|+||.|++||+|
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 01111234589999999999999999999999999999999
Q ss_pred HhCCCCCcccccCccchH--hHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 019568 238 FTGKKPTDEIFNGEMTLK--HWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308 (339)
Q Consensus 238 l~g~~P~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 308 (339)
+.|+.||-....++..+. .|.. .+.+....+.+.+..++|.++. .++..|.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~-------------------~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRN-------------------FLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhh-------------------ccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 999999988776655442 1211 1223334455666777777643 4566664
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=242.22 Aligned_cols=268 Identities=24% Similarity=0.319 Sum_probs=221.6
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSC 107 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (339)
.++....+|++....+-+|.||.||.|.+ .+.+.|.+|.++-. ++.....+..|--.+....|||++++.++.
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 34444557888999999999999999954 33455677776544 355667788899999999999999999987
Q ss_pred e-cCceeEEEEEecCCCCHHHHHhh-------cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC
Q 019568 108 S-NEEFKALVLEYMPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 179 (339)
Q Consensus 108 ~-~~~~~~lv~e~~~~~~L~~~i~~-------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~ 179 (339)
. +....+.++.+..-|+|..++.. ....++..++..++.|++.|++||| ..+++|.||...|.++++..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 4 45677888999988999999872 1235778889999999999999999 99999999999999999999
Q ss_pred cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHh
Q 019568 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~ 258 (339)
.+||+|=.+++.+.+.+.+--......+..|||||.+.+..|+.++|+||||+++|||+| |+.|+...++-++.-
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~---- 509 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH---- 509 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH----
Confidence 999999999998877766665555666778999999999999999999999999999999 889988764432211
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
..+.+.+...|-+||+++..+|..||..+|++||+++++..-|.++...+.
T Consensus 510 ----------------ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 510 ----------------YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred ----------------HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 122344556688999999999999999999999999999999999887664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-30 Score=219.99 Aligned_cols=211 Identities=36% Similarity=0.554 Sum_probs=183.7
Q ss_pred eeecCccEEEEEEeC-CCcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHHH
Q 019568 50 IGKGGFGSVYKARLG-DGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 127 (339)
Q Consensus 50 ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 127 (339)
||+|.+|.||++... +++.+++|++...... ....+.+|++.++.+.|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999864 4999999998866443 34678889999999999999999999999899999999999899999
Q ss_pred HHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-CCcEEEcccccceeccCCCCccccccccC
Q 019568 128 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206 (339)
Q Consensus 128 ~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~ 206 (339)
++......++...++.++.+++.++.+|| +.+++|+||+|.||+++. ++.++|+||+.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 99776446889999999999999999999 999999999999999999 89999999999876532211 2333446
Q ss_pred CCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhh
Q 019568 207 TIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285 (339)
Q Consensus 207 ~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (339)
...|++||..... .++.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7789999998877 889999999999999999
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 286 EQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 286 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
..+.+++.+|++.||.+||++.++++++
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2388999999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=243.71 Aligned_cols=199 Identities=23% Similarity=0.343 Sum_probs=172.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--------hhhhHHHHHHHHHHHhCC---CcceeeEeeee
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--------GRALKSFNVECEMMKSIR---HRNLIKVISSC 107 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~ 107 (339)
....|+.++.+|.|+||.|++|.++ +...|+||.+.++. ...+-.+-.|+++|..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4467999999999999999999765 57788999886652 111223455999999996 99999999999
Q ss_pred ecCceeEEEEEec-CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 108 SNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 108 ~~~~~~~lv~e~~-~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
++++.+|++||.. +|.+|.++|.... .+++.++..+++|++.|+.+|| ++||+|||||-+|+.++.+|-+||+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeec
Confidence 9999999999985 6779999997665 7899999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDE 246 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~ 246 (339)
|.+... .+.......||..|.|||++.|.+| +..-|||+||++||.++....||.+
T Consensus 715 gsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999865 3334455678999999999999887 7789999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=226.66 Aligned_cols=262 Identities=24% Similarity=0.287 Sum_probs=197.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-----
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE----- 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 111 (339)
...+|..++.+|.|.- .|..+-+ -.+++|++|+...+ +....++..+|...+..++|+||++++.+|....
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4578999999999999 6666643 36999999988655 3345577888999999999999999999996543
Q ss_pred -eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 112 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 112 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
..|+|||++.. +|...+.. .++=..+..++.|++.|+.+|| +.||+|||+||+||++..++.+|+.|||++.
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhc
Confidence 46899999965 99998872 4666788999999999999999 9999999999999999999999999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhh--hhccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN--DWLPISTLE 268 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~--~~~~~~~~~ 268 (339)
.- ...........+..|.|||++.+..+.+..||||+||++.||++|..-|.+. +....|.. ...+.+...
T Consensus 167 ~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHH
Confidence 53 2234556677888999999998888999999999999999999999876632 11111110 000000000
Q ss_pred ---------------------cccccccCccch--hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 ---------------------VVDANLLSQEDI--HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 ---------------------~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
+-....+++... ....++.-+..+++++.+||..||++|.|++++|+|
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000011111111 111112334568999999999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=228.54 Aligned_cols=268 Identities=23% Similarity=0.301 Sum_probs=196.6
Q ss_pred CCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-----eeE
Q 019568 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE-----FKA 114 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 114 (339)
+.+-.+.||.|+||.||.+++. +|+.|++|++..-- -...+.+.+|+.+|+.++|.|++..+++.+... .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 5677899999999999999754 69999999875332 234567888999999999999999888875443 356
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
.++|.+.. +|..+|-. ...++...+.-++.||+.||.||| +.+|.|+||||.|.+++.|..+||+|||+++....
T Consensus 134 V~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 78888855 78777744 347888899999999999999999 99999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCCccccCCC-CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc----
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV---- 269 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---- 269 (339)
+..........|.+|.|||++.|.. |+.+.||||+||++.||+..+..|..-.. ......+.+..+.+..+.
T Consensus 209 -d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 209 -RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred -hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHHHH
Confidence 2333344555688999999998874 89999999999999999998887765321 111111111111111111
Q ss_pred --------cccccc-Cccc--hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 270 --------VDANLL-SQED--IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 270 --------~~~~~~-~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
+..... .... .....+..-..+...++.++|.+||.+|.+..+.+.|+-
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000 0000 111112334456778999999999999999999988764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=248.52 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=209.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
...++|..+.++|.|++|.||++++. +++..|+|+++..-.....-+.+|+-+++..+||||+.+++.+.....+|++|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 34689999999999999999999754 69999999999988888888899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|||.||+|.+...-.+ ++++-++..+++..+.++.||| ++|-+|||||-.||++++.|.+++.|||.+..+. ..
T Consensus 92 EycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqit--at 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT--AT 165 (829)
T ss_pred EecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhh--hh
Confidence 9999999999875544 8999999999999999999999 9999999999999999999999999999987662 23
Q ss_pred ccccccccCCCCccCCccc---cCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 198 SMTQTQTFATIGYMAPEYG---REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
-.......|||.|||||+- ..+.|+..+|+|++|+...++---++|.-...+... .+............
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~---l~LmTkS~~qpp~l----- 237 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA---LFLMTKSGFQPPTL----- 237 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH---HHHhhccCCCCCcc-----
Confidence 3344567799999999954 466799999999999999999888877433222111 11111111111111
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..+..-+..+.+|++.+|..+|.+||+++.+|.|
T Consensus 238 --------kDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 238 --------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred --------cCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1122235668999999999999999999998875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=206.60 Aligned_cols=208 Identities=25% Similarity=0.337 Sum_probs=169.9
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeecc-chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCcee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (339)
++...+...-...||+|++|.|-+-+ ..+|+-.|+|.+... +.+...+...|+.+..+. .+|.++.+|+.....+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 45566777788999999999987765 457999999998765 345556777788876655 789999999999999999
Q ss_pred EEEEEecCCCCHHHHHh---hcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 114 ALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~---~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
++.||.++- +|..+.. +.+..+++..+-.++..++.||.+||. ...++|||+||+|||++.+|.+|++|||.+.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999954 8877654 345689999999999999999999995 6789999999999999999999999999998
Q ss_pred eccCCCCccccccccCCCCccCCccccC----CCCCCcchhhHHHHHHHHHHhCCCCCcccccC
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGRE----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~ 250 (339)
.+.+. .......|-..|+|||.+.. ..|+.++||||||+++.||.++++||+....+
T Consensus 198 ~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 198 YLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred eehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 76321 11222334456999997643 36899999999999999999999999876544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=214.94 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=192.8
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeee-eecCcee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISS-CSNEEFK 113 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~ 113 (339)
.-...+.|.+.+.+|+|.||.+-++.+ ++.+.+|+|.++.+ .....+|.+|...-=.| .|.||+.-|+. |+..+.+
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 345779999999999999999999975 46899999998766 34557788888775566 58999988875 6777888
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe--CCCCcEEEccccccee
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL--DDNMVAHLSDFSIAKL 191 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~--~~~~~v~l~Dfg~~~~ 191 (339)
.+++||++.|+|..-+...+ +.+.....++.|+++|+.|+| +++++|||||.+|||+ .+..+|||+|||..+.
T Consensus 98 vF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred EEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 89999999999998876654 889999999999999999999 9999999999999999 3556899999999875
Q ss_pred ccCCCCccccccccCCCCccCCcccc---CCC--CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGR---EGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~--~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
... .-...-.+..|.+||... +.. .++.+|+|+||+++|.++||+.||....-....+..|..-.....
T Consensus 173 ~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~- 246 (378)
T KOG1345|consen 173 VGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN- 246 (378)
T ss_pred cCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC-
Confidence 421 112222345688999543 333 478999999999999999999999865544444443322211110
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCC---CCHHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR---INAKEIVKKL 317 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~ell~~l 317 (339)
...+. .-..+++.+..+.++-|..+|++| -+++...+.+
T Consensus 247 ---------~~~P~---~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 247 ---------PALPK---KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ---------ccCch---hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 00000 012345668899999999999999 3444444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=211.17 Aligned_cols=199 Identities=31% Similarity=0.443 Sum_probs=173.1
Q ss_pred CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
|.+.+.||.|+++.||++... +++.+++|.+...... ....+.+|++.++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 677899999999999999865 4899999999876554 66788899999999999999999999998899999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+++|.+++......+++..++.++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 99999999766533789999999999999999999 99999999999999999999999999999887633220 022
Q ss_pred ccccCCCCccCCccc-cCCCCCCcchhhHHHHHHHHHHhCCCCCcc
Q 019568 202 TQTFATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDE 246 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~P~~~ 246 (339)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334467789999988 666788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=225.49 Aligned_cols=271 Identities=23% Similarity=0.319 Sum_probs=201.3
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCc
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEE 111 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (339)
+....+.|...++||.|+|++||++... ..+.||+|.+...+ ...++.+|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4556789999999999999999999632 47889999986653 335688899999999 6899999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-CCCcEEEcccccce
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAK 190 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-~~~~v~l~Dfg~~~ 190 (339)
...+|+||++..+..++... ++...+..+++.++.||.++| ..||+|+||||+|++.+ ..++-.|+|||++.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999888888754 668889999999999999999 99999999999999997 56778999999987
Q ss_pred eccCCC------------C------------------------------ccccccccCCCCccCCccccC-CCCCCcchh
Q 019568 191 LLVGED------------Q------------------------------SMTQTQTFATIGYMAPEYGRE-GRVSANGDV 227 (339)
Q Consensus 191 ~~~~~~------------~------------------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 227 (339)
...... . ........||++|.|||++.. +..+.+.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321000 0 000012338999999998765 457899999
Q ss_pred hHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc----------c--ccc---------------ccc-ccccCccc
Q 019568 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI----------S--TLE---------------VVD-ANLLSQED 279 (339)
Q Consensus 228 wslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~----------~--~~~---------------~~~-~~~~~~~~ 279 (339)
||.|+++..++++.+||-...+.-............. . .++ ..+ ..+.....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999876544333322221100000 0 000 000 00000000
Q ss_pred ---hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 280 ---IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 280 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+.++..+.+|+.+||..||.+|.|+++.|+|
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1111223445678999999999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=198.78 Aligned_cols=171 Identities=21% Similarity=0.183 Sum_probs=132.1
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
|+|.+++......+++..++.++.|++.||.||| +.+ ||+||+++.++.+++ ||.+......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence 5899999876667999999999999999999999 777 999999999999999 9988764221
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
...+++.|+|||++.+..++.++||||||+++|+|++|..||..................... ....
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~~ 129 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------------PRDR 129 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------------cccc
Confidence 125789999999999999999999999999999999999998764332222222211111000 0000
Q ss_pred hhhHHHHH--HHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 283 VAKEQCVS--FVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 283 ~~~~~~~~--~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
......+. .+.++|.+||+.||.+||++.++++|+..+..+.
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 11223333 6999999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=242.92 Aligned_cols=198 Identities=16% Similarity=0.218 Sum_probs=139.5
Q ss_pred CCC-cceeeEeeee-------ecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEec
Q 019568 95 IRH-RNLIKVISSC-------SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166 (339)
Q Consensus 95 l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~ 166 (339)
++| +||++++++| .....+++++|++ +++|.+++......+++..++.++.||+.||.||| ++||+|+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 344 5777777776 2234677889988 55999999766667999999999999999999999 9999999
Q ss_pred CCCCCCeEeCCCCc-------------------EEEcccccceeccCCCC--------------ccccccccCCCCccCC
Q 019568 167 DLKPSNVLLDDNMV-------------------AHLSDFSIAKLLVGEDQ--------------SMTQTQTFATIGYMAP 213 (339)
Q Consensus 167 di~p~Nil~~~~~~-------------------v~l~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aP 213 (339)
||||+|||++..+. ++++|||+++....... ........+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999965444 45555555432110000 0000113468889999
Q ss_pred ccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHH
Q 019568 214 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVF 293 (339)
Q Consensus 214 E~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 293 (339)
|++.+..++.++|||||||++|||++|..|+...... ....... ..... .........
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~~~~~~~-------------~~~~~------~~~~~~~~~ 242 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---MSSLRHR-------------VLPPQ------ILLNWPKEA 242 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---HHHHHHh-------------hcChh------hhhcCHHHH
Confidence 9999999999999999999999999998886532110 0000000 00000 001123456
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 294 NLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 294 ~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
+++.+||+.||.+||++.|+++|-+
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchh
Confidence 8899999999999999999998644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=192.04 Aligned_cols=270 Identities=18% Similarity=0.154 Sum_probs=214.5
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..-.|++.++||+|+||.++.|+ .-++++||||.-... .....+..|++..+.| ..++|..+|-+.+...+..+|+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34689999999999999999996 447999999975444 3445677799999998 5689999999988888889999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-----CCcEEEcccccceec
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----NMVAHLSDFSIAKLL 192 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-----~~~v~l~Dfg~~~~~ 192 (339)
|.+ |.+|+|++.-.+..++..+++-++.||+.-+.++| ++.++.|||||+|+||.. ...|.++|||++..+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999 77999999888889999999999999999999999 999999999999999953 345899999999888
Q ss_pred cCCCCcc-----ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 193 VGEDQSM-----TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 193 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
.+..... ......||.+|||-....|.+.+.+.|+-|||-++++++-|..||..+..+.............
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K---- 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK---- 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc----
Confidence 6543321 2245669999999999999999999999999999999999999999987654433322111000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccc
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNV 328 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~ 328 (339)
. ...-......+|.++..-++-.=..+=.+-|..+-+.+-+..+.+.+..-.
T Consensus 256 --------r-~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~ 307 (449)
T KOG1165|consen 256 --------R-STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETD 307 (449)
T ss_pred --------c-cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence 0 001112234567777777777777777788999988888888877665443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=201.19 Aligned_cols=262 Identities=22% Similarity=0.256 Sum_probs=200.6
Q ss_pred CCCCCceeeecCccEEEEEEeCC--CcEEEEEEeeccchhhhHHHHHHHHHHHhCCC----cceeeEeeee-ecCceeEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKSFNVECEMMKSIRH----RNLIKVISSC-SNEEFKAL 115 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~-~~~~~~~l 115 (339)
+|.+.+.||+|+||.||.+.... ...+|+|............+..|..++..+.. +++..+++.+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999997544 35788888766533333367778888888862 6889999998 57888999
Q ss_pred EEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-----CcEEEcccccc
Q 019568 116 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-----MVAHLSDFSIA 189 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~-----~~v~l~Dfg~~ 189 (339)
||+.+ |.+|.++..... +.++..++..++.|++.+|.++| +.|++||||||+|+++... ..+.|+|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999 779999886655 78999999999999999999999 9999999999999999754 46999999999
Q ss_pred e--eccCCCCc--cc----cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh
Q 019568 190 K--LLVGEDQS--MT----QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 190 ~--~~~~~~~~--~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
+ .+...... .. .....||..|.|+....+...+++.|+||++.++.++..|..||.................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 43222211 11 1234499999999999999999999999999999999999999977654322111100000
Q ss_pred ccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
... .. . .....+..+..+...+-..+...+|....+.+.++......
T Consensus 255 -~~~---------~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 -KLL---------TD-R-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred -hhc---------cc-c-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 00 0 12233455777777777799999999999999988777654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-27 Score=193.86 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=199.3
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
....+..+|.+...|..|+|+++ |..+++|++.... ....++|.+|.-.|+.+.||||+++++.+....++.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 55667888999999999999995 6677888876543 34557899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 120 MPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
++.++|+.++..... ..+..++.+++.+++.+++||| +.. +.---+....+++|++.+.+|. ++-..
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflh---slep~ipr~~lns~hvmidedltaris-mad~k------ 338 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLH---SLEPMIPRFYLNSKHVMIDEDLTARIS-MADTK------ 338 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHh---hcchhhhhhhcccceEEecchhhhhee-cccce------
Confidence 999999999976543 4666788999999999999999 543 3344578889999998877764 11111
Q ss_pred CccccccccCCCCccCCccccCCC---CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
...........|.|++||.+...+ .-.++|+|||++++|||.|.+.||....+.+-..+..
T Consensus 339 fsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---------------- 402 (448)
T KOG0195|consen 339 FSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---------------- 402 (448)
T ss_pred eeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh----------------
Confidence 122223344578899999887654 3468999999999999999999999987766555432
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
-.+++...++..+..+..|+.-|++.||.+||.+..++-.|++++
T Consensus 403 ---leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 ---LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 233445557888889999999999999999999999999988874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=181.69 Aligned_cols=263 Identities=19% Similarity=0.171 Sum_probs=202.6
Q ss_pred hhcCCCCCceeeecCccEEEEEE-eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC-cceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH-RNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 117 (339)
....|.++++||+|+||.+|.|. ..+|..||||+-... .....+..|..+.+.|++ .+|..+..++.+.....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 45789999999999999999996 557999999986544 223456779999999965 78888888888888999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC---CCCcEEEcccccceeccC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~---~~~~v~l~Dfg~~~~~~~ 194 (339)
+.+ |.+|++++.-....++..+++-++-|++.-+.|+| .++++|+||||+|++.. ....+.++|||++..+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999 77999999877778999999999999999999999 99999999999999995 455789999999988754
Q ss_pred CCCccc-----cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 195 EDQSMT-----QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 195 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
...... .....||..|.|-....+...+.+.|+-|+|.+|.++.-|..||..........+.........+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s---- 242 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS---- 242 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC----
Confidence 333221 23456899999988888888899999999999999999999999988665433322111110000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.........+|.++.-.+.-|=..-=++-|...-+.+.++.+.
T Consensus 243 ---------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 243 ---------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred ---------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 0011223455666777777777776666777776666555544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=194.27 Aligned_cols=170 Identities=19% Similarity=0.186 Sum_probs=130.5
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC--CCcEEEEEEeecc-----chhhhHHHHHHHHHHHhCCCcceee-Eeee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQ-----CGRALKSFNVECEMMKSIRHRNLIK-VISS 106 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~--~~~~v~vK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~ 106 (339)
...-...++|++.+.||+|+||+||+|... +++.+|||+.... .......+.+|+++|++++|+|+++ ++..
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 344567889999999999999999999753 5777899986533 1223566899999999999999985 4432
Q ss_pred eecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCC-CCCCeEeCCCCcEEEcc
Q 019568 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL-KPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 107 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di-~p~Nil~~~~~~v~l~D 185 (339)
+..|+||||++|++|... .. .. ...++.|++++|.+|| +.|++|+|| ||+||+++.++.++|+|
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 457899999999999632 11 11 1467899999999999 999999999 99999999999999999
Q ss_pred cccceeccCCCCccc------cccccCCCCccCCccccCC
Q 019568 186 FSIAKLLVGEDQSMT------QTQTFATIGYMAPEYGREG 219 (339)
Q Consensus 186 fg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~ 219 (339)
||++..+........ -....+++.|++||.+...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999987643321111 1233467778999977543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-25 Score=209.08 Aligned_cols=255 Identities=20% Similarity=0.220 Sum_probs=191.9
Q ss_pred CCCceeeecCccEEEEEEe-CCCcEEEEEEeec-----cch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 45 SENNLIGKGGFGSVYKARL-GDGMEVAVKVFNL-----QCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 45 ~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~-----~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
.....+|.|++|.++.+.. .....++.|.+.. ... .....+-.|+-+-..+.|+|++.....+.+.......|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 5788999999997777752 2344445554431 111 11222566777888889999988888877766666669
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|||++ +|..++... ..++...+-.+++|++.|+.|+| +.|+.|+|+|++|+++..+|.++|+|||.+..+.....
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999998665 36888889999999999999999 99999999999999999999999999999887655444
Q ss_pred c--cccccccCCCCccCCccccCCCCC-CcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 198 S--MTQTQTFATIGYMAPEYGREGRVS-ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 198 ~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
. .......|+..|+|||++.+..|. ...||||.|++++.|.+|+.||.........+.. .. ....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----~~------~~~~-- 543 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----NN------YSDQ-- 543 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----hc------cccc--
Confidence 4 555677789999999999998885 5689999999999999999999865444332200 00 0000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..............+..-+.+|.+||+.||.+|.|+++|++-
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 111111222344566778899999999999999999999873
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-22 Score=180.73 Aligned_cols=258 Identities=31% Similarity=0.408 Sum_probs=199.0
Q ss_pred CCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchh---hhHHHHHHHHHHHhCCCc-ceeeEeeeeecCceeEEEEEe
Q 019568 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR---ALKSFNVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 119 (339)
|.+.+.||.|+|+.||.+... ..+++|.+...... ....+.+|..+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 788899999999999999875 78899998765432 467889999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-cEEEcccccceeccCCC
Q 019568 120 MPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLVGED 196 (339)
Q Consensus 120 ~~~~~L~~~i~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-~v~l~Dfg~~~~~~~~~ 196 (339)
+.++++.+++.... ..+.......++.|++.++.++| ..+++|+|+||+||+++..+ .++++|||.+..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776554 26889999999999999999999 99999999999999999988 79999999987553332
Q ss_pred Ccc----ccccccCCCCccCCccccC---CCCCCcchhhHHHHHHHHHHhCCCCCcccccC--ccchHhHhhhhcccccc
Q 019568 197 QSM----TQTQTFATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNG--EMTLKHWVNDWLPISTL 267 (339)
Q Consensus 197 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~--~~~~~~~~~~~~~~~~~ 267 (339)
... ......++..|++||.+.+ ..++...|+|++|++++++++|..||...... .................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 3456678999999999887 57899999999999999999999996655431 11111111111100000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..............+.+++.+|+..+|..|.+..+...+
T Consensus 237 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 ----------SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----------cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000002233568899999999999999999988876
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-24 Score=206.23 Aligned_cols=248 Identities=23% Similarity=0.263 Sum_probs=179.9
Q ss_pred CCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc-hhhhHHHHHHHHH--HHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC-GRALKSFNVECEM--MKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++...+-||.+.|=.|.+|++..|. |+||++-... .-..+.+.++++- ...+++||.+++..+...+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 7889999999999999999986666 9999986654 2333444333333 5556899999999888888888899999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC-CCc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE-DQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~-~~~ 198 (339)
... +|+|.+..++ .+...+.+.++.|++.||..+| ..||||||||.+|||+..=+.+.|+||..-....-. +..
T Consensus 103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 966 9999997776 7888888999999999999999 999999999999999999999999999765332211 111
Q ss_pred ccccccc----CCCCccCCccccCC-----------CCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhc
Q 019568 199 MTQTQTF----ATIGYMAPEYGREG-----------RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 199 ~~~~~~~----~~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
......+ .--+|.|||.+... ..+++-||||+||+++||++ |.+||.-.. +..+..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aYr~--- 249 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAYRS--- 249 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhHhc---
Confidence 1111111 12359999965331 14678999999999999998 577765320 000000
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
+. ...............+++||..|++.||.+|.|+++.|+.
T Consensus 250 ~~------------~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 GN------------ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cC------------ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 0000111111112348999999999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=175.20 Aligned_cols=171 Identities=15% Similarity=0.147 Sum_probs=132.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhh---hHH------HHHHHHHHHhCCCcceeeEeeeeecC
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRA---LKS------FNVECEMMKSIRHRNLIKVISSCSNE 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~---~~~------~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (339)
..++|++.+.+|.|+||.||++.. ++..+|||++....... ... +.+|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 568999999999999999999866 57789999997553222 222 57899999999999999988886532
Q ss_pred --------ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEE
Q 019568 111 --------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 182 (339)
Q Consensus 111 --------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~ 182 (339)
+..+++|||++|.+|.++.. +++ ....+++.++..+| ..|++|+|++|+||+++++| ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988731 233 24569999999999 99999999999999999988 99
Q ss_pred EcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHH
Q 019568 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETF 238 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 238 (339)
|+|||........ ... ..++....++.++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~----~a~----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQR----KAK----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccch----hhH----------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999977543100 000 00333445678999999999977664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=173.68 Aligned_cols=233 Identities=21% Similarity=0.276 Sum_probs=149.0
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCC----------cceeeEeee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRH----------RNLIKVISS 106 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~ 106 (339)
...+...+.||.|+++.||.+++. ++++++||++.... ....+.+.+|.-....+.+ -.++-.++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 345667889999999999999864 69999999987654 2344555555544444321 111111111
Q ss_pred ---------e---ecCc-----eeEEEEEecCCCCHHHHHhh---cC---CccCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 019568 107 ---------C---SNEE-----FKALVLEYMPHGSLEKYLYS---SN---CILDIFQRLNIMIDVASALEYLHFGYSAPI 163 (339)
Q Consensus 107 ---------~---~~~~-----~~~lv~e~~~~~~L~~~i~~---~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i 163 (339)
+ .... ..+++|+-..+ +|.+++.. .. ..+.......+..|++..+++|| ..|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~Gl 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGL 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcce
Confidence 1 1111 33678888854 88887642 22 12444555677799999999999 9999
Q ss_pred EecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccC--------CCCCCcchhhHHHHHHH
Q 019568 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE--------GRVSANGDVYSFGIMLM 235 (339)
Q Consensus 164 ~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 235 (339)
+|+||+|+|++++.+|.+.|+||+..... ...... ...+..|.+||.... -.++.+.|.|+||+++|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~----g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRA----GTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEET----TEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeec----Cceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999999999887653 111221 334567889996533 24788999999999999
Q ss_pred HHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCC
Q 019568 236 ETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR 307 (339)
Q Consensus 236 ~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 307 (339)
.|++|..||........... .+....++|..++.||..+|++||.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~-------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW-------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG-------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc-------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999986543221110 122223668889999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=163.69 Aligned_cols=140 Identities=18% Similarity=0.182 Sum_probs=108.3
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeeccchh--h------------------------hHHHHHHHHHHHhCCCcc
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR--A------------------------LKSFNVECEMMKSIRHRN 99 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~ 99 (339)
+...||+|++|.||+|...+|+.||||+++..... . ......|++.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 35789999999999998778999999998754211 0 012234999999998776
Q ss_pred eeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHh-hccCCCCeEecCCCCCCeEeCCC
Q 019568 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDN 178 (339)
Q Consensus 100 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~~i~h~di~p~Nil~~~~ 178 (339)
+.....+.. . ..++||||++|+++...... ...++...+..++.|++.+|.++ | +.|++|+||||+||+++ +
T Consensus 81 v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL-K-SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe-c-CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence 643332222 2 23799999988776554323 24688899999999999999999 8 89999999999999998 4
Q ss_pred CcEEEcccccceec
Q 019568 179 MVAHLSDFSIAKLL 192 (339)
Q Consensus 179 ~~v~l~Dfg~~~~~ 192 (339)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=192.19 Aligned_cols=202 Identities=23% Similarity=0.281 Sum_probs=166.8
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC---CcceeeEeeeeecCc
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR---HRNLIKVISSCSNEE 111 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~ 111 (339)
.++....+.|.|.+.||+|+||+||.|...+|+.||||+-++++.+.. .--.+++.+|+ -+.|..+...+...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 345556678999999999999999999877799999999887765432 22344445554 234556666666677
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-------CCCcEEEc
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-------DNMVAHLS 184 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-------~~~~v~l~ 184 (339)
..++|++|.+.|+|.+++. ..+..++.....+..||+..+..|| ..+|+||||||+|+++. .+..++|+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence 7889999999999999997 5568999999999999999999999 99999999999999993 35569999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCC
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P 243 (339)
|||.+..+..-..........+|..+-.+|+..|..+++..|.|.|+.+++.|+.|++-
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999887655555555666788999999999999999999999999999999999863
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=156.90 Aligned_cols=139 Identities=24% Similarity=0.243 Sum_probs=109.5
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeeccchh--------------------------hhHHHHHHHHHHHhCCCcc
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR--------------------------ALKSFNVECEMMKSIRHRN 99 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~ 99 (339)
+.+.||+|++|.||+|...+|+.||||+++..... ....+..|++.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 46789999999999998768999999998764211 0122357899999998887
Q ss_pred eeeEeeeeecCceeEEEEEecCCCCHHHH-HhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCC
Q 019568 100 LIKVISSCSNEEFKALVLEYMPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDD 177 (339)
Q Consensus 100 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~ 177 (339)
+.....+... ..++||||++|+++... +.. ..++......++.|++.++.++| . .|++|+||||+||+++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence 7433333222 24799999988755433 322 35778889999999999999999 8 9999999999999999
Q ss_pred CCcEEEcccccceec
Q 019568 178 NMVAHLSDFSIAKLL 192 (339)
Q Consensus 178 ~~~v~l~Dfg~~~~~ 192 (339)
++.++|+|||++...
T Consensus 153 ~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCCEEEEEcccceec
Confidence 889999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=152.82 Aligned_cols=189 Identities=14% Similarity=0.079 Sum_probs=139.1
Q ss_pred CCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhh----hHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEEEE
Q 019568 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRA----LKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 118 (339)
..+...|++|+||+|+.+.. .+.+++.+.+....... ...+.+|+++|+++. ++++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34678899999999998866 68888877765443211 125788999999995 5789998886 34689999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCC-CCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL-KPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di-~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+.|.+|...... ....++.|++.+|.++| ..|++|+|| +|.||+++.++.++|+|||++........
T Consensus 79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999888754321 11357889999999999 999999999 79999999999999999999985432221
Q ss_pred c---cc--------cccccCCCCccCCccccCC-CCC-CcchhhHHHHHHHHHHhCCCCCcccc
Q 019568 198 S---MT--------QTQTFATIGYMAPEYGREG-RVS-ANGDVYSFGIMLMETFTGKKPTDEIF 248 (339)
Q Consensus 198 ~---~~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~DiwslG~il~~ll~g~~P~~~~~ 248 (339)
. .. ......++.+++|+...-. ..+ .+.+.++.|..+|.++|+..|.....
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 00 0112246667777643322 223 56788999999999999998865543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=161.19 Aligned_cols=198 Identities=18% Similarity=0.238 Sum_probs=143.9
Q ss_pred CCcceeeEeeeeecC---------------------------ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHH
Q 019568 96 RHRNLIKVISSCSNE---------------------------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148 (339)
Q Consensus 96 ~h~~i~~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql 148 (339)
.||||++++++|.+. ..+|+||.-++. +|.+++-.+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 599999999877432 367899999865 9999885543 5666677799999
Q ss_pred HHHHHHhhccCCCCeEecCCCCCCeEe--CCCC--cEEEcccccceeccCCCCc----cccccccCCCCccCCccccCCC
Q 019568 149 ASALEYLHFGYSAPIIHCDLKPSNVLL--DDNM--VAHLSDFSIAKLLVGEDQS----MTQTQTFATIGYMAPEYGREGR 220 (339)
Q Consensus 149 ~~~l~~LH~~~~~~i~h~di~p~Nil~--~~~~--~v~l~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~ 220 (339)
++|+.||| .+|+.|+|+|.+||++ ++++ .+.+.|||.+---...... .......|....+|||+...-+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 9999999999999999 3333 5788999977432111111 1122334677799999765322
Q ss_pred ------CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHH
Q 019568 221 ------VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFN 294 (339)
Q Consensus 221 ------~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 294 (339)
.-.|+|.|+.|.+.||+++...||........+...+..... ...++.+++.+++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL-------------------Palp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL-------------------PALPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC-------------------CCCcccCChHHHH
Confidence 236899999999999999999999874333322222222211 2236677888999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 295 LAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 295 li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
++...|+.||++|+++.-..+.|+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999876665443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=170.47 Aligned_cols=216 Identities=29% Similarity=0.409 Sum_probs=165.1
Q ss_pred HHhCCCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCe-EecCCCC
Q 019568 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI-IHCDLKP 170 (339)
Q Consensus 92 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i-~h~di~p 170 (339)
|+++.|.|+.++++.+.+....+.|.+||..|+|.|.+....-.++......+.+.++.++.||| ...+ +|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 46789999999999999999999999999999999999887778889999999999999999999 5554 9999999
Q ss_pred CCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCC-------CCCcchhhHHHHHHHHHHhCCCC
Q 019568 171 SNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR-------VSANGDVYSFGIMLMETFTGKKP 243 (339)
Q Consensus 171 ~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~g~~P 243 (339)
.|.+++....+|++|||+.....................|.|||.+.+.. .+.+.|+||+|++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987763211112222223455699999887642 46779999999999999999999
Q ss_pred CcccccCccc--hHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 244 TDEIFNGEMT--LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 244 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
|......... ....+.. .......+.+ ......++++..++.+||..+|.+||+++.+-..+..+.
T Consensus 158 ~~~~~~~~~~~eii~~~~~----~~~~~~rP~i--------~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK----GGSNPFRPSI--------ELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cccccccCChHHHHHHHHh----cCCCCcCcch--------hhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9885544432 2211111 0000000000 001144557899999999999999999999988887765
Q ss_pred H
Q 019568 322 D 322 (339)
Q Consensus 322 ~ 322 (339)
.
T Consensus 226 ~ 226 (484)
T KOG1023|consen 226 K 226 (484)
T ss_pred c
Confidence 4
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.2e-22 Score=181.14 Aligned_cols=224 Identities=25% Similarity=0.277 Sum_probs=180.7
Q ss_pred eeecCccEEEEEE----eCCCcEEEEEEeeccch--hhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEEEEecCC
Q 019568 50 IGKGGFGSVYKAR----LGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 50 ig~g~~~~v~~~~----~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+|+|++|.|++++ ...+..++.|+...... ........|-.++...+ ||.++++...++.+...+++.++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999874 23477788888765431 11124555788888886 99999999999999999999999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
+.|...+.... .++......+...++.++..+| +.+++|+|+|++||+++.+|.+++.|||+....... .
T Consensus 82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------~ 151 (612)
T KOG0603|consen 82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------K 151 (612)
T ss_pred chhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhh------h
Confidence 99988876555 5667777888899999999999 999999999999999999999999999998765322 2
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhh
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (339)
..+||..|+|||++. ....++|.||+|+++++|++|..||.... ... .....+
T Consensus 152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~------~~~-------------------Il~~~~ 204 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT------MKR-------------------ILKAEL 204 (612)
T ss_pred hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH------HHH-------------------Hhhhcc
Confidence 228899999999988 66789999999999999999999988610 000 011133
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 019568 283 VAKEQCVSFVFNLAMACAVESPEQRINA 310 (339)
Q Consensus 283 ~~~~~~~~~l~~li~~~l~~dP~~Rps~ 310 (339)
..+...+..+++++..++..+|.+|.-.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 4467788889999999999999999754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.8e-19 Score=148.01 Aligned_cols=135 Identities=16% Similarity=0.282 Sum_probs=106.6
Q ss_pred CCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-----CCcceeeEeeeeecCc---e-eE
Q 019568 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-----RHRNLIKVISSCSNEE---F-KA 114 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~ 114 (339)
+.-.+.||+|+++.||. ...++.. +||++........+.+.+|+.+++.+ .||||++++++++++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45678999999999996 3224444 79998776444557789999999999 5799999999998763 3 33
Q ss_pred EEEEe--cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHH-HHhhccCCCCeEecCCCCCCeEeCC----CCcEEEcccc
Q 019568 115 LVLEY--MPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDLKPSNVLLDD----NMVAHLSDFS 187 (339)
Q Consensus 115 lv~e~--~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l-~~LH~~~~~~i~h~di~p~Nil~~~----~~~v~l~Dfg 187 (339)
+|+|| +.+++|.+++.+. .+++. ..++.+++.++ .||| +.+|+|+||||+||+++. ++.++|+|++
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5578999999664 35554 35677888777 9999 999999999999999963 3479999954
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-18 Score=145.56 Aligned_cols=135 Identities=24% Similarity=0.305 Sum_probs=112.4
Q ss_pred CceeeecCccEEEEEEeCCCcEEEEEEeeccch--------hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 47 NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG--------RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++.||+|++|.||+|.. .|..+++|+...... .....+.+|++++..+.|+++.....++......+++||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999987 678899998654321 112456789999999999888776666666777889999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
|++|++|.+.+.... . ....++.+++.++.++| +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999886533 2 77889999999999999 99999999999999999 78999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=150.86 Aligned_cols=152 Identities=19% Similarity=0.177 Sum_probs=115.8
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEE--eCCCcEEEEEEeeccchh------------------------hhHHH
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKAR--LGDGMEVAVKVFNLQCGR------------------------ALKSF 85 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~--~~~~~~v~vK~~~~~~~~------------------------~~~~~ 85 (339)
.....+.....-|.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+
T Consensus 18 ~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (237)
T smart00090 18 LALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA 97 (237)
T ss_pred HHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH
Confidence 3334444444569999999999999999998 457999999998754210 11235
Q ss_pred HHHHHHHHhCCCc--ceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCC-
Q 019568 86 NVECEMMKSIRHR--NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP- 162 (339)
Q Consensus 86 ~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~- 162 (339)
..|++.+.++.+. .+.++++. ...++||||++|.+|....... .......+..++.|++.++.+|| +.|
T Consensus 98 ~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~ 169 (237)
T smart00090 98 EKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGE 169 (237)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCC
Confidence 6799999999653 33444443 2357999999998876654222 24566667899999999999999 999
Q ss_pred eEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 163 i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
++|+||+|+||+++ ++.++|+|||.+...
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999988643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.2e-18 Score=141.42 Aligned_cols=143 Identities=24% Similarity=0.198 Sum_probs=111.9
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchh----------------------hhHHHHHHHHHHH
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR----------------------ALKSFNVECEMMK 93 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~----------------------~~~~~~~e~~~l~ 93 (339)
++.....-|.+.+.||+|+||.||++...+|+.++||++...... .......|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444458999999999999999998778999999987654210 1123567888999
Q ss_pred hCCCcc--eeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCC
Q 019568 94 SIRHRN--LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPS 171 (339)
Q Consensus 94 ~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~ 171 (339)
.+.+++ +..+++ ....+++|||++|++|.+.... .....++.+++.++.++| ..|++|+||+|+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcc
Confidence 887763 444443 2345899999999998765421 245678899999999999 999999999999
Q ss_pred CeEeCCCCcEEEcccccceec
Q 019568 172 NVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 172 Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
||++++++.++|+|||.+...
T Consensus 155 Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cEEEcCCCcEEEEECCccccC
Confidence 999999999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-17 Score=155.53 Aligned_cols=146 Identities=21% Similarity=0.279 Sum_probs=116.5
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeecc--c------hhhhHHHHHHHHHHHhCCCcceeeE
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQ--C------GRALKSFNVECEMMKSIRHRNLIKV 103 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~--~------~~~~~~~~~e~~~l~~l~h~~i~~~ 103 (339)
.++.........|...+.||+|+||+||++.+. +..+++|+.... . ......+.+|+++++.++|++++..
T Consensus 323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred eeeccccccccccCccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 444444555667788999999999999999874 444555543221 1 1123567889999999999999887
Q ss_pred eeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEE
Q 019568 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL 183 (339)
Q Consensus 104 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l 183 (339)
..++......++||||++|++|.+++. ....++.+++.++.+|| +.+++|+||||+||++ .++.++|
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEE
Confidence 777766677889999999999999874 34678999999999999 9999999999999999 6789999
Q ss_pred ccccccee
Q 019568 184 SDFSIAKL 191 (339)
Q Consensus 184 ~Dfg~~~~ 191 (339)
+|||++..
T Consensus 469 iDFGla~~ 476 (535)
T PRK09605 469 IDFGLGKY 476 (535)
T ss_pred EeCccccc
Confidence 99999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=139.51 Aligned_cols=130 Identities=22% Similarity=0.316 Sum_probs=104.7
Q ss_pred eeeecCccEEEEEEeCCCcEEEEEEeeccch--------hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCG--------RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 49 ~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
.||+|++|.||+|.+ ++..+++|+...... .....+.+|+++++.+.|+++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 678999998653311 12355678999999998876554444444556678999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
+|++|.+.+.... . .++.+++.+|.+|| +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875432 1 78999999999999 99999999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-18 Score=155.93 Aligned_cols=174 Identities=25% Similarity=0.385 Sum_probs=128.0
Q ss_pred ceeEEEEEecCCCCHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 111 EFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
..+|+.|++|+-.+|.+++... ....+......++.|++.++.| ++.+|+|++|.||++..+..++|.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999643 3456777889999999999987 6889999999999999999999999999
Q ss_pred ceeccCCC----CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcc
Q 019568 189 AKLLVGED----QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLP 263 (339)
Q Consensus 189 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~ 263 (339)
........ .........+|..||+||.+.+..|+.++||||||++|+|+++ -..+++.. .....
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d------- 471 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTD------- 471 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----Hhhhh-------
Confidence 98764333 1224456679999999999999999999999999999999997 33332221 11111
Q ss_pred ccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 019568 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313 (339)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 313 (339)
++...++. ....+ .+.-..|+.+|+...|.+||++.+.
T Consensus 472 ------~r~g~ip~-----~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 472 ------IRDGIIPP-----EFLQD-YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ------hhcCCCCh-----HHhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence 11111110 00011 1123479999999999999955443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.4e-18 Score=164.70 Aligned_cols=214 Identities=24% Similarity=0.285 Sum_probs=150.0
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
...+..++|..++.|..|++|.||+++++ +.+.+|.|+-+ . ..+.+. ++.....|.++
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q-----~lilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-Q-----NLILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcccc-c-----chhhhc--cccccCCccee-------------
Confidence 44567789999999999999999999765 57888885422 1 111111 33333444443
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
|+....++.. ++++.. ++.++.||| +-||+|+|+||+|.++..-|.+|++|||+......
T Consensus 136 --------gDc~tllk~~-g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 --------GDCATLLKNI-GPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred --------chhhhhcccC-CCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 3555544332 244442 278999999 99999999999999999999999999998754311
Q ss_pred CC-------------CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh
Q 019568 195 ED-------------QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 195 ~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
.. ........++||.|.|||++..+.|+...|+|++|+++|+.+.|+.||......+. +...+.+.
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~ 274 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDD 274 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhh
Confidence 00 00112345799999999999999999999999999999999999999887533321 11111111
Q ss_pred ccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 019568 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 308 (339)
.. . .......+.++++++.++|..+|..|-
T Consensus 275 i~-----------w------pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 275 IE-----------W------PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cc-----------c------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 10 0 011334567799999999999999995
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-18 Score=165.93 Aligned_cols=259 Identities=22% Similarity=0.279 Sum_probs=202.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC--CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~--~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 114 (339)
....|.+.+.||+|+++.|-..... ....++.|.+.... .....+...|..+-..+. |.|++.+++.....+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 4678899999999999999887543 34556666655443 334455566788777776 999999999999999999
Q ss_pred EEEEecCCCCHHHHH-hhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-cEEEcccccceec
Q 019568 115 LVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLL 192 (339)
Q Consensus 115 lv~e~~~~~~L~~~i-~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-~v~l~Dfg~~~~~ 192 (339)
+.+++.+|+++.+.+ .......+...+...+.|+..++.|+|. ..++.|+|++|+|.+++..+ .+++.|||++..+
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999999888 4433356777788999999999999995 67899999999999999999 9999999999987
Q ss_pred cC-CCCccccccccC-CCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 193 VG-EDQSMTQTQTFA-TIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 193 ~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
.. ...........| ++.|.|||...+. ...+..|+||.|+++..+++|..||.........+..|.....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~------- 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG------- 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc-------
Confidence 65 344444456667 9999999998885 5578999999999999999999999887665544433322210
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..........+....+++.+++..+|..|.+.+++-..
T Consensus 249 ---------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 249 ---------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---------ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 01122234445668899999999999999999987664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.3e-16 Score=128.82 Aligned_cols=136 Identities=24% Similarity=0.254 Sum_probs=97.3
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeeccchhh--hHH----------------------HHHHHHHHHhCCCcc--
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRA--LKS----------------------FNVECEMMKSIRHRN-- 99 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~~-- 99 (339)
+.+.||+|+||+||+|...+++.||||++....... ... ...|.+.+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 357899999999999987789999999987542111 010 134566666654332
Q ss_pred eeeEeeeeecCceeEEEEEecCCCCHHH-HHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCC
Q 019568 100 LIKVISSCSNEEFKALVLEYMPHGSLEK-YLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDD 177 (339)
Q Consensus 100 i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~ 177 (339)
+.+.++. ...+++|||++++.+.. .+.... .. ..+..++.+++.++.++| . .+++|+||+|+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence 3444433 23589999998843321 111111 11 567889999999999999 8 9999999999999999
Q ss_pred CCcEEEcccccceec
Q 019568 178 NMVAHLSDFSIAKLL 192 (339)
Q Consensus 178 ~~~v~l~Dfg~~~~~ 192 (339)
++.++++|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.3e-16 Score=122.28 Aligned_cols=135 Identities=20% Similarity=0.245 Sum_probs=111.8
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC--cceeeEeeeeecCceeEEEEEecCCC
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
+.+.||.|.++.||++... +..+++|....... ...+.+|+.+++.+.+ .++++++.++...+..++++||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 5688999999999999874 47899999865533 4568889999999976 58899999888888899999999887
Q ss_pred CHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 124 ~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
.+... +......++.+++.++..+|.....+++|+|++|.||++++.+.++++||+.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77643 4456677899999999999932124799999999999999999999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-15 Score=130.08 Aligned_cols=135 Identities=19% Similarity=0.257 Sum_probs=104.6
Q ss_pred Cceee-ecCccEEEEEEeCCCcEEEEEEeeccc-------------hhhhHHHHHHHHHHHhCCCcce--eeEeeeeecC
Q 019568 47 NNLIG-KGGFGSVYKARLGDGMEVAVKVFNLQC-------------GRALKSFNVECEMMKSIRHRNL--IKVISSCSNE 110 (339)
Q Consensus 47 ~~~ig-~g~~~~v~~~~~~~~~~v~vK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 110 (339)
...|| .|+.|+||.+.. .+..++||.+.... ......+.+|++++.++.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 899999999987 47889999885421 1223457789999999988774 6666654332
Q ss_pred -c---eeEEEEEecCC-CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 111 -E---FKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 111 -~---~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
. ..++|+|+++| .+|.+++... .+++. .+.+++.++.+|| +.|++|+||+|.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6898887553 34543 3568999999999 99999999999999999999999999
Q ss_pred ccccee
Q 019568 186 FSIAKL 191 (339)
Q Consensus 186 fg~~~~ 191 (339)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-13 Score=129.17 Aligned_cols=168 Identities=18% Similarity=0.253 Sum_probs=132.2
Q ss_pred eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHH
Q 019568 63 LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 142 (339)
Q Consensus 63 ~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~ 142 (339)
..++.+|.|...+..+........+-++.|+.++||+|+++++.+...++.|+|+|-+ ..|..++++.. .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHH
Confidence 4478899888887766655666788899999999999999999999999999999998 37877776533 66677
Q ss_pred HHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCC
Q 019568 143 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS 222 (339)
Q Consensus 143 ~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 222 (339)
.-+.||+.||.+||. ..+++|++|+-+.|+|+..|..+|++|.++........ .......-..|..|+......
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 789999999999985 78999999999999999999999999998876532221 122222233466666443222
Q ss_pred CcchhhHHHHHHHHHHhCCC
Q 019568 223 ANGDVYSFGIMLMETFTGKK 242 (339)
Q Consensus 223 ~~~DiwslG~il~~ll~g~~ 242 (339)
-..|.|.||+++++++.|..
T Consensus 182 ~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cchhhhhHHHHHHHHhCccc
Confidence 35799999999999999943
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.2e-13 Score=119.22 Aligned_cols=274 Identities=14% Similarity=0.093 Sum_probs=176.8
Q ss_pred CCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeee------eecC-ceeE
Q 019568 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISS------CSNE-EFKA 114 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~------~~~~-~~~~ 114 (339)
-....+.||+|+-+.+|..- .-...+.|+++.+......+ ....|... .||-+..-+.+ ..+. ....
T Consensus 12 ~i~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 12 PIPPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred ccCCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 34567899999999998753 22345778887764433222 33334443 45433221111 1222 2367
Q ss_pred EEEEecCCCCH-HHHHh----hcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 115 LVLEYMPHGSL-EKYLY----SSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 115 lv~e~~~~~~L-~~~i~----~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
++|+.+.|..- ..++. +.. -...+..++.++..++.+.+.|| ..|..-||++++|+|+++++.|.|+|=+.
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccc
Confidence 88888876432 22221 111 13778889999999999999999 99999999999999999999999998654
Q ss_pred ceeccCCCCccccccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhC-CCCCcccccCccchHhHhhhhc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTG-KKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g-~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
-... ..........+.+.|++||.-. +-..+..+|.|.||+++++++.| .+||.........-.-.-.+.-
T Consensus 164 fqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 164 FQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred eeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 4332 3344455677899999999543 44567889999999999999997 8999875432211100000000
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCC--CCCCCCHHHHHHHHHHHHHHHccc
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVES--PEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d--P~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
........+.+.-....-........++++..|..+|+... ++-|||++-++..|..+++++..+
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 00000011111111111122223456778999999999874 678999999999999999988765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.7e-14 Score=130.59 Aligned_cols=140 Identities=22% Similarity=0.275 Sum_probs=99.0
Q ss_pred CceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhH----------------------------------------HHH
Q 019568 47 NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALK----------------------------------------SFN 86 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~----------------------------------------~~~ 86 (339)
.+.||.|++|.||+|+..+|+.||||+.++....... ++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4789999999999999889999999998654211100 133
Q ss_pred HHHHHHHhC----CCcceeeEeeee-ecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHH-HHHHhhccCC
Q 019568 87 VECEMMKSI----RHRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-ALEYLHFGYS 160 (339)
Q Consensus 87 ~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~-~l~~LH~~~~ 160 (339)
+|.+.+.++ ++.+-+.+-.++ ...+..++||||++|.+|.++......... ...++..++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence 455544444 233333333333 223456899999999999887653322222 2345556655 467889 9
Q ss_pred CCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 161 ~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.|++|+|++|.||+++.++.++++|||++..+
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 99999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.4e-13 Score=128.47 Aligned_cols=143 Identities=20% Similarity=0.188 Sum_probs=93.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCC-CcEEEEEEeeccchhh----------------------------------hHH
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRA----------------------------------LKS 84 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~-~~~v~vK~~~~~~~~~----------------------------------~~~ 84 (339)
....|+. +.||+|++|.||+|+..+ |+.||||+.++..... .+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456777 899999999999999766 9999999997542110 111
Q ss_pred ------HHHHHHHHHhC----CCcceeeEeeeeec-CceeEEEEEecCCCCHHHHH--hhcCC---ccCHHHHHHHHHHH
Q 019568 85 ------FNVECEMMKSI----RHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYL--YSSNC---ILDIFQRLNIMIDV 148 (339)
Q Consensus 85 ------~~~e~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i--~~~~~---~~~~~~~~~i~~ql 148 (339)
+.+|...+.++ .+.+.+.+-.++.+ ....++||||++|+++.++. ...+. .+....+..++.
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~-- 274 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT-- 274 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH--
Confidence 22333333333 23333333333322 34567999999999998753 22221 122222333333
Q ss_pred HHHHHHhhccCCCCeEecCCCCCCeEeCCCC----cEEEcccccceecc
Q 019568 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLV 193 (339)
Q Consensus 149 ~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~----~v~l~Dfg~~~~~~ 193 (339)
.+. ..|++|+|++|.||+++.++ .++++|||++..+.
T Consensus 275 -----Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 -----QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 344 57999999999999999888 99999999988763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.5e-13 Score=127.12 Aligned_cols=251 Identities=22% Similarity=0.237 Sum_probs=186.3
Q ss_pred hhcCCCCCceeee--cCccEEEEEEe---CCCcEEEEEEeeccch--hhhHHHHHHHHHHHhC-CCcceeeEeeeeecCc
Q 019568 40 ATDEFSENNLIGK--GGFGSVYKARL---GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSI-RHRNLIKVISSCSNEE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~--g~~~~v~~~~~---~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (339)
....+.+...+|. |.+|.+|.+.. .++..+++|.-+..-. ..-.+-.+|+.....+ .|++.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 4457888999999 99999999964 3588899988544422 2223334566666666 5899999899999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHH----HHHHhhccCCCCeEecCCCCCCeEeCCC-CcEEEccc
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDF 186 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~----~l~~LH~~~~~~i~h~di~p~Nil~~~~-~~v~l~Df 186 (339)
..++-+|.+. .+|..+.......++...++..+.+... |+..+| +.+++|.|++|.||+...+ ...+++||
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence 9999999995 5888888776667889999999999999 999999 9999999999999999998 88999999
Q ss_pred ccceeccCCCCcccc---ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc
Q 019568 187 SIAKLLVGEDQSMTQ---TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263 (339)
Q Consensus 187 g~~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~ 263 (339)
|+...+......... ....+...|++||.. ++.++.++|+|++|.++.+..++.++.......
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------------- 333 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------------- 333 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------------
Confidence 999887543322221 122567779999986 445688999999999999999988764432110
Q ss_pred ccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 019568 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315 (339)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 315 (339)
.+..++...+. ...-...+.++...+..|+..+|-.|++++.+.+
T Consensus 334 --~W~~~r~~~ip-----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 --SWSQLRQGYIP-----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --CccccccccCc-----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111111110 0111222445666999999999999999987765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.1e-13 Score=109.53 Aligned_cols=127 Identities=23% Similarity=0.231 Sum_probs=95.3
Q ss_pred CceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEEEEecCCCCH
Q 019568 47 NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
.+.|+.|.++.||+++. .+..+++|+...... ....+..|+.+++.+.+.++ .+++.... ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 46788999999999987 478899998754432 22345779999999865444 34554433 235799999999877
Q ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCC-----eEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 126 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP-----IIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~-----i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
.+. . . ....++.+++.+++.|| ..+ ++|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~----~--~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE----D--F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----c--c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 643 0 1 11345679999999999 777 49999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-13 Score=118.39 Aligned_cols=207 Identities=20% Similarity=0.284 Sum_probs=140.7
Q ss_pred HHHhCCCcceeeEeeeeecC-----ceeEEEEEecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCC
Q 019568 91 MMKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAP 162 (339)
Q Consensus 91 ~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ 162 (339)
-|-++.|.|++++..++.+. ....+++||+..|++..++++. .+.+......+|+.||++||.|||. .+-.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 44556799999999988553 3577999999999999998753 3568888889999999999999992 2446
Q ss_pred eEecCCCCCCeEeCCCCcEEEcccc--cceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhC
Q 019568 163 IIHCDLKPSNVLLDDNMVAHLSDFS--IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG 240 (339)
Q Consensus 163 i~h~di~p~Nil~~~~~~v~l~Dfg--~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 240 (339)
++|+++..+.|++..+|-+++..-. ..................+.++|.+||.-...+.+.++|||++|....+|..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999888875211 11000000000111222356789999988777888999999999999999988
Q ss_pred CCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 241 KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 241 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
..--...... .... +.+....+.. ..+.-+.++.+|++..|..||++.+++.|.-.+
T Consensus 279 Eiq~tnseS~---~~~e----------e~ia~~i~~l----------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 279 EIQSTNSESK---VEVE----------ENIANVIIGL----------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eeccCCCcce---eehh----------hhhhhheeec----------cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 7532111110 0000 0000000000 011134789999999999999999999876544
Q ss_pred H
Q 019568 321 R 321 (339)
Q Consensus 321 ~ 321 (339)
.
T Consensus 336 e 336 (458)
T KOG1266|consen 336 E 336 (458)
T ss_pred e
Confidence 3
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.8e-11 Score=108.24 Aligned_cols=213 Identities=15% Similarity=0.160 Sum_probs=153.5
Q ss_pred ccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeee----cCceeEEEEEecCC-CCHHHH
Q 019568 55 FGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS----NEEFKALVLEYMPH-GSLEKY 128 (339)
Q Consensus 55 ~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~ 128 (339)
..+.|++... +|..+++|.++..........-.-+++++++.|.|+|++.++|. .+..+.+|++|+++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3577888643 79999999995554333333444688999999999999999886 35568899999875 477776
Q ss_pred Hhhc--------------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 129 LYSS--------------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 129 i~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
.... +...++..+|.++.|+..||.++| +.|+..+-+.+.+|+++.+.+++|...|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5321 235788999999999999999999 99999999999999999988999998887765522
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.+ . +.+.+ -.+.|.=.||.+++.|.||..--... +...
T Consensus 446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~----d~~~------------------- 483 (655)
T KOG3741|consen 446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRT----DSTQ------------------- 483 (655)
T ss_pred CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccc----cchH-------------------
Confidence 11 0 11111 23679999999999999996421100 0000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..........++.++++++.-....++.+ -++.+++.+
T Consensus 484 ---~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 484 ---SSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---HHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 01011235677888888888888888876 566666654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.3e-11 Score=100.38 Aligned_cols=136 Identities=22% Similarity=0.222 Sum_probs=97.9
Q ss_pred CceeeecCccEEEEEEeCC-------CcEEEEEEeeccc----------------------hhhhHHH----HHHHHHHH
Q 019568 47 NNLIGKGGFGSVYKARLGD-------GMEVAVKVFNLQC----------------------GRALKSF----NVECEMMK 93 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~-------~~~v~vK~~~~~~----------------------~~~~~~~----~~e~~~l~ 93 (339)
...||.|=-+.||.|...+ +..+|||+++... ......+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999996432 4799999975421 0112223 37999999
Q ss_pred hCCC--cceeeEeeeeecCceeEEEEEecCCCCHHH-HHhhcCCccCHHHHHHHHHHHHHHHHHh-hccCCCCeEecCCC
Q 019568 94 SIRH--RNLIKVISSCSNEEFKALVLEYMPHGSLEK-YLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAPIIHCDLK 169 (339)
Q Consensus 94 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~i~~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~~i~h~di~ 169 (339)
++.. -++..++++ ...++||||+.+..+.. .++.. .++...+..+..+++.++..+ | ..|++|+|++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 9853 345566654 45679999997643321 22221 345556677889999999988 8 9999999999
Q ss_pred CCCeEeCCCCcEEEcccccceec
Q 019568 170 PSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 170 p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
+.||++. ++.+.++|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.4e-11 Score=96.33 Aligned_cols=131 Identities=22% Similarity=0.309 Sum_probs=98.2
Q ss_pred ceeeecCccEEEEEEeCCCcEEEEEEeeccc---hh-----hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQC---GR-----ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~---~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..+++|+-+.++.+.+ -|.++++|.-.++. +. ...+-.+|++++.++.-..|.-..=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4678999999999976 45567777643321 11 223456799999998654544333334455556699999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
++|..|.+.+... ...++..+-..+.-|| ..||+|||+.++||++..++ +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888665 2557778888899999 99999999999999998765 89999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.1e-11 Score=95.49 Aligned_cols=142 Identities=18% Similarity=0.191 Sum_probs=107.0
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeeccc--------hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--------GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
.+..+.+|+-+.|+++.+ .|+..+||.-.... .-...+..+|+++|.++.--+|.-..-++.+.....+.|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 678899999999999988 68888888643321 122345678999999986555554444555666667999
Q ss_pred EecCC-CCHHHHHhhcCCc-cCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC---cEEEccccccee
Q 019568 118 EYMPH-GSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKL 191 (339)
Q Consensus 118 e~~~~-~~L~~~i~~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~---~v~l~Dfg~~~~ 191 (339)
||++| .++.+++...... ........++..+-+.+.-|| ..+++|||+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4788888665433 333344789999999999999 99999999999999995433 458999998864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=4e-11 Score=102.05 Aligned_cols=143 Identities=19% Similarity=0.215 Sum_probs=105.8
Q ss_pred CceeeecCccEEEEEEeCCCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCC--cceeeEeeeeecC---ceeEEEEEec
Q 019568 47 NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRH--RNLIKVISSCSNE---EFKALVLEYM 120 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~ 120 (339)
.+.|+.|..+.+|++...+|..+++|....... .....+..|+++++.+.+ .++.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999875668999999765432 134577889999999965 3456677776553 3668999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhcc------------------------------------------
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG------------------------------------------ 158 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~------------------------------------------ 158 (339)
+|.++.+.+.. ..++......++.+++.++..||..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888765421 2355666666777777777777731
Q ss_pred -----------CCCCeEecCCCCCCeEeCC--CCcEEEccccccee
Q 019568 159 -----------YSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKL 191 (339)
Q Consensus 159 -----------~~~~i~h~di~p~Nil~~~--~~~v~l~Dfg~~~~ 191 (339)
....++|+|+++.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0246799999999999988 66789999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-11 Score=113.92 Aligned_cols=249 Identities=20% Similarity=0.160 Sum_probs=177.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEe--CCCcEEEEEEeeccchhhhHHH--HHHHHHHHhC-CCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL--GDGMEVAVKVFNLQCGRALKSF--NVECEMMKSI-RHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~--~~~~~v~vK~~~~~~~~~~~~~--~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (339)
...+|..+..||.|.|+.|+.... .++..+++|-..........++ ..|+.+...+ .|.++++.+..+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 346889999999999999998753 3577888887654432222222 3466666666 5888888888887777788
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-CcEEEcccccceecc
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLV 193 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~-~~v~l~Dfg~~~~~~ 193 (339)
+-.|||+++++...+.. ...+.+...+.+..|++.++.++| +...+|.|++|+||++..+ +.-++.||+....+.
T Consensus 343 ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred CchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccc
Confidence 99999999888777632 235777888999999999999999 9999999999999999875 778899998876431
Q ss_pred CCCCccccccccCCCCcc--CCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYM--APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
.. .........++ ++.......+..+.|++|||..+.+.+++..--+...+ +..+.
T Consensus 419 ~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------------~~~i~ 476 (524)
T KOG0601|consen 419 FS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------------SLTIR 476 (524)
T ss_pred ee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------------ceeee
Confidence 11 11111222333 55566677889999999999999999998864222110 00011
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.. .....+.....+..+.+.++..++..||++.++..+..-.+
T Consensus 477 ~~-------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 477 SG-------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cc-------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 11 11112223366888999999999999999999887765544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.2e-12 Score=122.76 Aligned_cols=250 Identities=23% Similarity=0.247 Sum_probs=173.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..+.+.+.+.+-+|.++.++.+.- ..|...++|+.... .....+....+-.++-...+|.++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 457788888999999999998853 23544444443221 11122222223333333345777766666667778899
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
+++|+.+++|...+...+ ..+..........+..+..+|| +..+.|+|++|.|.+...++...+.||+........
T Consensus 882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999999887666 4555566777788889999999 888999999999999999999999999743322110
Q ss_pred -----------------------------CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcc
Q 019568 196 -----------------------------DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246 (339)
Q Consensus 196 -----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~ 246 (339)
..........+|+.|.+||.+.+......+|+|++|+++++.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 000112234479999999999999999999999999999999999999887
Q ss_pred cccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 019568 247 IFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK 311 (339)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 311 (339)
......--.. .. .... -...+...+.+.++++.+.+..+|.+|..+.
T Consensus 1038 ~tpq~~f~ni----~~----------~~~~----~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIFENI----LN----------RDIP----WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhhhcc----cc----------CCCC----CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 5433221100 00 0000 0111334466688999999999999998765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.3e-10 Score=91.17 Aligned_cols=125 Identities=26% Similarity=0.282 Sum_probs=82.7
Q ss_pred EEEEEEeCCCcEEEEEEeeccch--------------------------hhhHHHHHHHHHHHhCCCc--ceeeEeeeee
Q 019568 57 SVYKARLGDGMEVAVKVFNLQCG--------------------------RALKSFNVECEMMKSIRHR--NLIKVISSCS 108 (339)
Q Consensus 57 ~v~~~~~~~~~~v~vK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 108 (339)
.||.|...+|..+|||+.+.... .......+|++.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38899877899999999754210 0123457799999999765 456666543
Q ss_pred cCceeEEEEEecC--CCCHHHHHhhcCCccCHHHHHHHHHHHHHHH-HHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 109 NEEFKALVLEYMP--HGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 109 ~~~~~~lv~e~~~--~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l-~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
...+||||++ |..+..+.... ++......++.+++..+ ..+| ..|++|||+++.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3459999998 65555543222 11334566778888844 4468 9999999999999999887 999999
Q ss_pred cccceec
Q 019568 186 FSIAKLL 192 (339)
Q Consensus 186 fg~~~~~ 192 (339)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.5e-09 Score=93.14 Aligned_cols=139 Identities=16% Similarity=0.098 Sum_probs=98.9
Q ss_pred ceeeecCccEEEEEEeCCCcEEEEEEeeccchh-hhH----------HHHHHHHHHHhCCCcc--eeeEeeeeec-----
Q 019568 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALK----------SFNVECEMMKSIRHRN--LIKVISSCSN----- 109 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~~--i~~~~~~~~~----- 109 (339)
+.+.......|.++.. .|+.+.||........ ..+ .+.+|++.+..+...+ .+.+++++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667666 6788999977443311 111 3678999888884322 2334444432
Q ss_pred CceeEEEEEecCCC-CHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-------CCc
Q 019568 110 EEFKALVLEYMPHG-SLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-------NMV 180 (339)
Q Consensus 110 ~~~~~lv~e~~~~~-~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-------~~~ 180 (339)
....++|+|++++. +|.+++... ....+......++.+++..+..|| ..|++|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999886 798887532 234566677889999999999999 999999999999999975 568
Q ss_pred EEEcccccce
Q 019568 181 AHLSDFSIAK 190 (339)
Q Consensus 181 v~l~Dfg~~~ 190 (339)
+.++||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999775
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.4e-10 Score=94.79 Aligned_cols=145 Identities=23% Similarity=0.202 Sum_probs=108.7
Q ss_pred eHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccch----------------------hhhHHHHHHHH
Q 019568 33 SYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG----------------------RALKSFNVECE 90 (339)
Q Consensus 33 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~----------------------~~~~~~~~e~~ 90 (339)
.+........-..+...||-|--|.||.|..+.|.+++||.-+.... -......+|.+
T Consensus 82 AL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~ 161 (304)
T COG0478 82 ALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE 161 (304)
T ss_pred HHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence 33344444445678899999999999999998999999997432110 11234578999
Q ss_pred HHHhCCCc--ceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCC
Q 019568 91 MMKSIRHR--NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168 (339)
Q Consensus 91 ~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di 168 (339)
+|++|... .+.+.+++ +...+|||+++|..|...- ++...+..++..|+.-+..+- ..|++|+|+
T Consensus 162 ~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDl 228 (304)
T COG0478 162 ALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDL 228 (304)
T ss_pred HHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCC
Confidence 99999654 56665544 4567999999997665432 234455667778888887777 899999999
Q ss_pred CCCCeEeCCCCcEEEcccccce
Q 019568 169 KPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 169 ~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
++-||+++++|.+.++||-.+.
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred chheEEEecCCCEEEEeCcccc
Confidence 9999999999999999996654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.4e-09 Score=99.87 Aligned_cols=140 Identities=19% Similarity=0.209 Sum_probs=95.7
Q ss_pred ceeeecCccEEEEEEeCCCcEEEEEEeeccchhhh----------------------------------H------HHHH
Q 019568 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRAL----------------------------------K------SFNV 87 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~----------------------------------~------~~~~ 87 (339)
..|+.++-|.||+|+..+|+.||||+.++.-.... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 78999999999999998899999999865321111 0 1234
Q ss_pred HHHHHHhC----CCcceeeEeeee-ecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCC
Q 019568 88 ECEMMKSI----RHRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162 (339)
Q Consensus 88 e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ 162 (339)
|..-++++ ++..-+.+-.++ +..+.-.++|||++|..+.+.........+...+.....++..---+ ..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~-----~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL-----RDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-----hcC
Confidence 55444444 222223333333 23445669999999999999854333446654544444443333333 459
Q ss_pred eEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 163 i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
++|.|.+|.||+++.+|++.+.|||....+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999999999999999999998765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.8e-10 Score=105.14 Aligned_cols=150 Identities=19% Similarity=0.211 Sum_probs=104.5
Q ss_pred HHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc-------cccCCCCccCCccccCC
Q 019568 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT-------QTFATIGYMAPEYGREG 219 (339)
Q Consensus 147 ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~-------~~~~~~~y~aPE~~~~~ 219 (339)
+.+.|+.++|. +.+++|++|.|++|.++.++..||..|+++............. .......|.+||++.+.
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34489999996 8899999999999999999999999999886654322211111 11135569999999998
Q ss_pred CCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhh
Q 019568 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 298 (339)
Q Consensus 220 ~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 298 (339)
..+.++|+||+|+++|.+.. |+.-+....... .+..... ......+.....++.++++=+.+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~----------------~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRN----------------LLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhc----------------ccccccccccccCcHHHHHHHHH
Confidence 88999999999999999984 544443322111 1110000 00001112236678889999999
Q ss_pred hcCCCCCCCCCHHHHHH
Q 019568 299 CAVESPEQRINAKEIVK 315 (339)
Q Consensus 299 ~l~~dP~~Rps~~ell~ 315 (339)
++..++..||++.+++.
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 99999999997776654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.4e-08 Score=83.18 Aligned_cols=105 Identities=25% Similarity=0.288 Sum_probs=81.4
Q ss_pred HHHHHHHHHHHhCCCc--ceeeEeeeeecC----ceeEEEEEecCCC-CHHHHHhhcCCccCHHHHHHHHHHHHHHHHHh
Q 019568 83 KSFNVECEMMKSIRHR--NLIKVISSCSNE----EFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155 (339)
Q Consensus 83 ~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~L 155 (339)
....+|+..+..+... ....++++.... ...++|+|++++. +|.+++..... .+......++.+++..+..|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 4567788888877432 234455554332 2457999999874 79998876432 55667788999999999999
Q ss_pred hccCCCCeEecCCCCCCeEeCCCC---cEEEccccccee
Q 019568 156 HFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKL 191 (339)
Q Consensus 156 H~~~~~~i~h~di~p~Nil~~~~~---~v~l~Dfg~~~~ 191 (339)
| ..|++|+|+++.|||++.++ .+.++||+.+..
T Consensus 135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9 99999999999999998877 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.2e-08 Score=83.30 Aligned_cols=169 Identities=22% Similarity=0.226 Sum_probs=111.5
Q ss_pred hcCCCCCCCCccccccceeeeeHHHHhhhhcCCCCCceeeecCc---cEEEEEEeCCCcEEEEEEeeccchhh-------
Q 019568 12 QRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGF---GSVYKARLGDGMEVAVKVFNLQCGRA------- 81 (339)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~---~~v~~~~~~~~~~v~vK~~~~~~~~~------- 81 (339)
+|.|+..+..-.+++ -+..++..+..+.++..+....|..+. +.||+|...++..+|+|++.......
T Consensus 17 kr~Kd~~~~k~~~~v--~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi 94 (268)
T COG1718 17 KREKDKEDRKVVDEV--FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYI 94 (268)
T ss_pred HhhhcchHhhhhhhh--hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHH
Confidence 333444444444444 445566778888888888888776554 58999987789999999986542110
Q ss_pred -----------------hHHHHHHHHHHHhCCCc--ceeeEeeeeecCceeEEEEEecCCC-CHHHHHhhcCCccCHHHH
Q 019568 82 -----------------LKSFNVECEMMKSIRHR--NLIKVISSCSNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQR 141 (339)
Q Consensus 82 -----------------~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~ 141 (339)
......|+.-|+++... .+.+.+.+... .+||||+... .-.-.+.. .++....+
T Consensus 95 ~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~n----VLvMEfIg~~g~pAP~LkD--v~~e~~e~ 168 (268)
T COG1718 95 QGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRNN----VLVMEFIGDDGLPAPRLKD--VPLELEEA 168 (268)
T ss_pred hcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecCC----eEEEEeccCCCCCCCCccc--CCcCchhH
Confidence 01134577777777432 33444444332 3999998442 11111111 12333367
Q ss_pred HHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 142 LNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 142 ~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
..+..+++..+..|- . .+++|+|++.-|||+. ++.+.++||+.+...
T Consensus 169 ~~~~~~~v~~~~~l~---~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 169 EGLYEDVVEYMRRLY---KEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHHHHHHHHHHH---HhcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 778888888888888 5 8999999999999999 889999999987643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.2e-08 Score=80.69 Aligned_cols=136 Identities=16% Similarity=0.167 Sum_probs=92.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHH---------HHHHHHHHhC---CCcceeeEeeee
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSF---------NVECEMMKSI---RHRNLIKVISSC 107 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~---------~~e~~~l~~l---~h~~i~~~~~~~ 107 (339)
...+|.+.+.+.......|.+-.. +|+.+++|..........+.+ .+.+..+..+ .-.....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 557899999999888888888777 679999999876543322222 1222222222 222233333222
Q ss_pred -----ecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEE
Q 019568 108 -----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 182 (339)
Q Consensus 108 -----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~ 182 (339)
......+++|||++|..|.+... +++ .+...+.+++..+| ..|++|||.+|.|+++++++ ++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EE
Confidence 22345568999999988876531 222 24567778899999 99999999999999998654 99
Q ss_pred Ecccccc
Q 019568 183 LSDFSIA 189 (339)
Q Consensus 183 l~Dfg~~ 189 (339)
++|++..
T Consensus 175 iID~~~k 181 (229)
T PF06176_consen 175 IIDTQGK 181 (229)
T ss_pred EEECccc
Confidence 9999644
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-07 Score=80.66 Aligned_cols=135 Identities=11% Similarity=0.112 Sum_probs=85.1
Q ss_pred ceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCc--ceeeEeeeeecCceeEEEEEecCCCC-
Q 019568 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHR--NLIKVISSCSNEEFKALVLEYMPHGS- 124 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~- 124 (339)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+.+++.+....+..+++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 67899999999984 35568899876532 234568899999998543 35677888877778889999999863
Q ss_pred HHHHH--------------hh-----cC---CccCHHH-HHHH--------------HHHHHHHHHHhhccCCCCeEecC
Q 019568 125 LEKYL--------------YS-----SN---CILDIFQ-RLNI--------------MIDVASALEYLHFGYSAPIIHCD 167 (339)
Q Consensus 125 L~~~i--------------~~-----~~---~~~~~~~-~~~i--------------~~ql~~~l~~LH~~~~~~i~h~d 167 (339)
+...+ .+ +. ....... ...+ ...+...+.. + .....++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~-~-~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE-V-PDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh-C-CCCCceEecC
Confidence 21111 00 00 0001000 0000 0111111111 1 1134679999
Q ss_pred CCCCCeEeCCCCcEEEcccccce
Q 019568 168 LKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 168 i~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
++|.||++++++ +.++||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-07 Score=78.52 Aligned_cols=151 Identities=16% Similarity=0.110 Sum_probs=106.0
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc------hhhhHHHHHHHHHHHhCCCc--ceeeEeeee
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC------GRALKSFNVECEMMKSIRHR--NLIKVISSC 107 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~ 107 (339)
.+......+...=--|.|+-|.|++... .|..+-+|...... +.-...+.+|+..++++... ++.++. ++
T Consensus 12 ~~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~ 89 (216)
T PRK09902 12 HWWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FG 89 (216)
T ss_pred HHHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-ee
Confidence 3333333443333345688888998876 35578888764211 22346789999999998532 244444 22
Q ss_pred e---c--CceeEEEEEecCC-CCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 108 S---N--EEFKALVLEYMPH-GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 108 ~---~--~~~~~lv~e~~~~-~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
. . .-..+||+|-++| .+|.+++.... .+.+......++.+++.++..|| +.|+.|+|+-+.||+++.++.
T Consensus 90 ~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~ 166 (216)
T PRK09902 90 EAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGK 166 (216)
T ss_pred eeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCC
Confidence 1 1 2245799998753 58888875543 24577777899999999999999 999999999999999986677
Q ss_pred --EEEccccccee
Q 019568 181 --AHLSDFSIAKL 191 (339)
Q Consensus 181 --v~l~Dfg~~~~ 191 (339)
+.++||..++.
T Consensus 167 ~~v~lIDlEk~r~ 179 (216)
T PRK09902 167 AEAGFLDLEKSRR 179 (216)
T ss_pred eeEEEEEhhccch
Confidence 99999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.5e-07 Score=77.60 Aligned_cols=142 Identities=20% Similarity=0.271 Sum_probs=83.7
Q ss_pred CceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCc--ceeeEeeee---ecCceeEEEEEecC
Q 019568 47 NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHR--NLIKVISSC---SNEEFKALVLEYMP 121 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~lv~e~~~ 121 (339)
++.|+.|..+.+|+....+ ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4688999999999998865 69999997655 4556777888888888432 355666543 23345789999999
Q ss_pred CCCHHH----------------HHh---hc---CCccCHHH-------------------------HHHHHHHHHHHHHH
Q 019568 122 HGSLEK----------------YLY---SS---NCILDIFQ-------------------------RLNIMIDVASALEY 154 (339)
Q Consensus 122 ~~~L~~----------------~i~---~~---~~~~~~~~-------------------------~~~i~~ql~~~l~~ 154 (339)
|..+.. .+. .. ........ +..+..+++..+..
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 110 00 00000000 00111112222221
Q ss_pred -hhccCCCCeEecCCCCCCeEeC-CCCcEEEccccccee
Q 019568 155 -LHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKL 191 (339)
Q Consensus 155 -LH~~~~~~i~h~di~p~Nil~~-~~~~v~l~Dfg~~~~ 191 (339)
++......++|+|+.|.||+++ .++.+-++||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1101257799999999999999 667778999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2e-07 Score=87.78 Aligned_cols=139 Identities=22% Similarity=0.268 Sum_probs=92.6
Q ss_pred CceeeecCccEEEEEEeCCCcEEEEEEeeccchhh-------------------------------hHH------HHHHH
Q 019568 47 NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRA-------------------------------LKS------FNVEC 89 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~-------------------------------~~~------~~~e~ 89 (339)
-+.||..+.|.||+|+..+|+.||||+-++.-... .+. |.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 47899999999999999899999999976532111 011 22233
Q ss_pred HHHH----hCCCcc------eeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccC
Q 019568 90 EMMK----SIRHRN------LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159 (339)
Q Consensus 90 ~~l~----~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ 159 (339)
+-.+ .+.|-+ |.+++-.+. ..-.++|||++|..+.|.-.-....++...+..-+.+...-.-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf----- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF----- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH-----
Confidence 3222 223444 333333332 34569999999998877643333347777655555554444444
Q ss_pred CCCeEecCCCCCCeEeCC----CCcEEEcccccceec
Q 019568 160 SAPIIHCDLKPSNVLLDD----NMVAHLSDFSIAKLL 192 (339)
Q Consensus 160 ~~~i~h~di~p~Nil~~~----~~~v~l~Dfg~~~~~ 192 (339)
..|.+|.|-+|.||++.. ++.+.+.|||+....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 347999999999999983 678999999998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.4e-07 Score=76.77 Aligned_cols=138 Identities=16% Similarity=0.132 Sum_probs=84.9
Q ss_pred eeeecCc-cEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEEEEecCCCCHH
Q 019568 49 LIGKGGF-GSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLE 126 (339)
Q Consensus 49 ~ig~g~~-~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 126 (339)
.|..|.+ +.||+.... +..++||+..... ...+.+|+++++.+. +-.+.+++.+....+..++||++++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444555 788998763 4789999875442 345667999988883 344667788777667788999999998776
Q ss_pred HHHh-------------------hcC---CccCHH--HHHHH-----------------------HHHHHHHHHHhh-cc
Q 019568 127 KYLY-------------------SSN---CILDIF--QRLNI-----------------------MIDVASALEYLH-FG 158 (339)
Q Consensus 127 ~~i~-------------------~~~---~~~~~~--~~~~i-----------------------~~ql~~~l~~LH-~~ 158 (339)
.... ... .++... ..... ...+...+.... ..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4320 000 011100 00000 111111111111 00
Q ss_pred CCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 159 ~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13458999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.9e-07 Score=72.18 Aligned_cols=132 Identities=20% Similarity=0.221 Sum_probs=95.5
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCccee-eEeeeeecCceeEEEEEec
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI-KVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~ 120 (339)
-.....+.|++|++|.||++.+ .|..+|+|+-..+ .....+..|+++|..+.-.++. +++.+..+. +.|||+
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i 94 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYI 94 (201)
T ss_pred hhhhhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhh
Confidence 3456788999999999999998 5779999987665 3446788899999999766654 455544433 559999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCC-CCeEeCCCCcEEEccccccee
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP-SNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p-~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
+|..|.+..... +.. ....+++.-.-|. ..||-|+.|+- ...++-.++++.|+||..++.
T Consensus 95 ~G~~L~~~~~~~----~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG----DRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc----cHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998888765321 222 3345666666677 89999999864 344444445999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.43 E-value=9.1e-06 Score=67.51 Aligned_cols=130 Identities=22% Similarity=0.287 Sum_probs=92.5
Q ss_pred CCCceeeecCccEEEEEEeCCCcEEEEEEeeccc----------------hhhhHHHHHHHHHHHhCC------Ccceee
Q 019568 45 SENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC----------------GRALKSFNVECEMMKSIR------HRNLIK 102 (339)
Q Consensus 45 ~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~ 102 (339)
.-...||+|+.-.+|. +......+||+..... ........+|+....++. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3457899999999887 3456678999987665 122345566666666655 788999
Q ss_pred EeeeeecCceeEEEEEecCC------CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC
Q 019568 103 VISSCSNEEFKALVLEYMPH------GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 176 (339)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~------~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~ 176 (339)
++|+.+++....+|+|.+.+ .+|.+++.... ++. .+... +-+-..+|- ..+|+.+|++|.||++.
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~---L~~f~~~l~---~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQA---LDEFKRYLL---DHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHH---HHHHHHHHH---HcCCeecCCCcccEEEE
Confidence 99999999999999998632 36888885543 555 33433 344455666 78899999999999994
Q ss_pred C--CC--cEEEcc
Q 019568 177 D--NM--VAHLSD 185 (339)
Q Consensus 177 ~--~~--~v~l~D 185 (339)
. ++ .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 2 22 577776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.1e-05 Score=81.89 Aligned_cols=79 Identities=14% Similarity=0.291 Sum_probs=56.9
Q ss_pred CCceeeecCccEEEEEEeCCC---cEEEEEEeeccc-hhhhHHHHHHHHHHHhCC-Ccc--eeeEeeeeecC---ceeEE
Q 019568 46 ENNLIGKGGFGSVYKARLGDG---MEVAVKVFNLQC-GRALKSFNVECEMMKSIR-HRN--LIKVISSCSNE---EFKAL 115 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~---~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~---~~~~l 115 (339)
..+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.+ +.+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 367788999999999876443 467888764432 122346788999999995 555 47778777654 46789
Q ss_pred EEEecCCCC
Q 019568 116 VLEYMPHGS 124 (339)
Q Consensus 116 v~e~~~~~~ 124 (339)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.6e-05 Score=62.46 Aligned_cols=103 Identities=25% Similarity=0.284 Sum_probs=80.7
Q ss_pred HHHHHHHHhCCC-cceeeEeeeeecCceeEEEEEecCCCCHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHhhccCCCC
Q 019568 86 NVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY--SSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162 (339)
Q Consensus 86 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ 162 (339)
.+|.-+++.+++ +++++++|+|.. .++.||...+++..... ..-...++..+..++.++++.+.+++.+....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 348888888865 689999999954 48999997665542200 01114678899999999999999999554466
Q ss_pred eEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 163 i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
+...|++++|+-++++|+++++|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.2e-05 Score=69.13 Aligned_cols=74 Identities=8% Similarity=0.140 Sum_probs=47.2
Q ss_pred CceeeecCcc-EEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCc---ceeeEeeeeecC---ceeEEEEEe
Q 019568 47 NNLIGKGGFG-SVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHR---NLIKVISSCSNE---EFKALVLEY 119 (339)
Q Consensus 47 ~~~ig~g~~~-~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~ 119 (339)
++.|+.|+.. .||+. +..+++|..+.. .....+.+|.++++.+... .+.+++...... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567766666 58875 235788875542 2335788899999888532 344555544332 245789999
Q ss_pred cCCCCHH
Q 019568 120 MPHGSLE 126 (339)
Q Consensus 120 ~~~~~L~ 126 (339)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.1e-05 Score=70.31 Aligned_cols=136 Identities=13% Similarity=0.138 Sum_probs=77.8
Q ss_pred eeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEEEEecCCCCHHH
Q 019568 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGSLEK 127 (339)
Q Consensus 49 ~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~ 127 (339)
.+..|-...+|+... ++..+++|..........-...+|.++++.+...++ .+++.... .++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 456688889998874 577888997654322221235679999999864333 33443332 368999999866532
Q ss_pred H--------------Hh---hc---CCccCHH-HHHHHHHH------------HHHHHHHhhc--cCCCCeEecCCCCCC
Q 019568 128 Y--------------LY---SS---NCILDIF-QRLNIMID------------VASALEYLHF--GYSAPIIHCDLKPSN 172 (339)
Q Consensus 128 ~--------------i~---~~---~~~~~~~-~~~~i~~q------------l~~~l~~LH~--~~~~~i~h~di~p~N 172 (339)
. +. .. ..+++.. .+..+..+ +...+..... .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 10 00 1111211 11111111 1111111110 012368999999999
Q ss_pred eEeCCCCcEEEcccccce
Q 019568 173 VLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 173 il~~~~~~v~l~Dfg~~~ 190 (339)
|++++++ +.++||+.+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999877 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.16 E-value=2e-05 Score=70.19 Aligned_cols=140 Identities=16% Similarity=0.156 Sum_probs=82.4
Q ss_pred CceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc--eeeEeee------eecCceeEEEEE
Q 019568 47 NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN--LIKVISS------CSNEEFKALVLE 118 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e 118 (339)
.+.|..|....+|+.... +..+++|+.... ....+..|+++++.+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 566777888899998764 457899987642 2345666888888874322 4444332 123456789999
Q ss_pred ecCCCCHHH----HH----------hhc--C--C------ccCHHHH----------HHHHHHHHHHHHHhhc----cCC
Q 019568 119 YMPHGSLEK----YL----------YSS--N--C------ILDIFQR----------LNIMIDVASALEYLHF----GYS 160 (339)
Q Consensus 119 ~~~~~~L~~----~i----------~~~--~--~------~~~~~~~----------~~i~~ql~~~l~~LH~----~~~ 160 (339)
|++|..+.. .. ... . . ...+... ......+..++..+.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876422 11 000 0 0 0000000 0011112223333331 113
Q ss_pred CCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 161 ~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
.++||+|++|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999988777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.2e-05 Score=66.45 Aligned_cols=74 Identities=19% Similarity=0.241 Sum_probs=49.3
Q ss_pred CceeeecCccEEEEEEeCC--CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEEEEecCCC
Q 019568 47 NNLIGKGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
.+.|..|-...+|+....+ +..+++|+...... ......+|+.+++.+...++ .+++..+.. .+++||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCC
Confidence 4567788888999997654 67899998754322 22234568889998854333 444444331 3899999987
Q ss_pred CH
Q 019568 124 SL 125 (339)
Q Consensus 124 ~L 125 (339)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.10 E-value=0.00013 Score=65.72 Aligned_cols=157 Identities=16% Similarity=0.155 Sum_probs=86.1
Q ss_pred eeeeHHHHhhhhcCCCC-----CceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc--eee
Q 019568 30 RTFSYLELCQATDEFSE-----NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN--LIK 102 (339)
Q Consensus 30 ~~~~~~~~~~~~~~y~~-----~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~ 102 (339)
+..+..++......|.+ .+.|+.|...++|+....+| .+++|++.... ...+..|+.+++.|...+ +.+
T Consensus 5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~ 80 (319)
T PRK05231 5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPA 80 (319)
T ss_pred ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCc
Confidence 34555666666667755 35566777788999876544 68999876212 233344566666653211 333
Q ss_pred Eeee------eecCceeEEEEEecCCCCHH-----------HHHh---hcC--------CccC--H-HHH----------
Q 019568 103 VISS------CSNEEFKALVLEYMPHGSLE-----------KYLY---SSN--------CILD--I-FQR---------- 141 (339)
Q Consensus 103 ~~~~------~~~~~~~~lv~e~~~~~~L~-----------~~i~---~~~--------~~~~--~-~~~---------- 141 (339)
++.. ....+..+++++|++|..+. ..+. ... .... . ...
T Consensus 81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (319)
T PRK05231 81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD 160 (319)
T ss_pred ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence 3321 12345678999999886431 1111 000 0000 0 000
Q ss_pred --HHHHHHHH-HHHHHhhc----cCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 142 --LNIMIDVA-SALEYLHF----GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 142 --~~i~~ql~-~~l~~LH~----~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
...+.+.+ ..+..+.. .-..++||+|++|.||+++.+...-++||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 00111111 11222220 013589999999999999876556899998775
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.3e-06 Score=82.45 Aligned_cols=187 Identities=18% Similarity=0.192 Sum_probs=133.8
Q ss_pred CCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc-eeeEeeeeecCceeEEEEEecCC
Q 019568 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN-LIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.....+++++.+.+++.+.-..+....+.+... ....-++++|.+++||| .+..++.++.+...++.++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3444566788888888886433344445555433 33445899999999999 66667777778888999999977
Q ss_pred C-CHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 123 G-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 123 ~-~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+ +...........+.......+...-..+++++| +..-+|+| ||+..+ +..+..||+....+.... ..
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 6 333322222223555556667777778899999 66557777 666554 678999999887663322 34
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcc
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~ 246 (339)
....+++.++|||......+...-|.|++|.-..++.-|.+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 455689999999999999999999999999988888888887544
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.0001 Score=65.61 Aligned_cols=80 Identities=11% Similarity=0.054 Sum_probs=58.3
Q ss_pred CCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC---cceeeEeeeeec---CceeEEE
Q 019568 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH---RNLIKVISSCSN---EEFKALV 116 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv 116 (339)
...-.+.||.|..+.||.....++ .+++|..+. ......+..|.+.|+.+.. -.+.++++++.. .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 455667899999999999876445 477777542 1133577889999998843 357788877643 4668999
Q ss_pred EEecCCCCH
Q 019568 117 LEYMPHGSL 125 (339)
Q Consensus 117 ~e~~~~~~L 125 (339)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.4e-05 Score=78.67 Aligned_cols=195 Identities=21% Similarity=0.234 Sum_probs=130.8
Q ss_pred HHHHHHHHhCCCcceeeEeeeeecCcee----EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC
Q 019568 86 NVECEMMKSIRHRNLIKVISSCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161 (339)
Q Consensus 86 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~ 161 (339)
.-|.+.+....|+|+..++.+....... .+..+++...++...++.-. ..+....+.+..++.+++.++| +.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h---~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLH---SL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHH---Hh
Confidence 3466667778999999999887544322 24556777777777775444 7888899999999999999999 77
Q ss_pred CeEecCCCCC---CeEeCCCCcEEEc--ccccceeccCCCCccccccccCCCCccCCccccCCCCC--CcchhhHHHHHH
Q 019568 162 PIIHCDLKPS---NVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS--ANGDVYSFGIML 234 (339)
Q Consensus 162 ~i~h~di~p~---Nil~~~~~~v~l~--Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~DiwslG~il 234 (339)
...|.-+..+ +.-.+..+.+..+ ||+....+..... ......+..+.+||........ ...|+|.+|...
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 5555544444 4444566667766 8887766532221 1122234457788876665544 457999999999
Q ss_pred HHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 019568 235 METFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314 (339)
Q Consensus 235 ~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 314 (339)
..+..|..+-...... ....+..+...+.++..+|+.-++++|+++.+++
T Consensus 383 ~~~~~~~~i~~~~~~~------------------------------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVP------------------------------VSLLDVLSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred hhhhhcCcccccccch------------------------------hhhhccccchhhhhhhhhhcchhhhhccchhhhh
Confidence 9999988752211000 0000111112477889999999999999999999
Q ss_pred HHH
Q 019568 315 KKL 317 (339)
Q Consensus 315 ~~l 317 (339)
.|.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00012 Score=65.67 Aligned_cols=158 Identities=20% Similarity=0.236 Sum_probs=90.6
Q ss_pred eeeeHHHHhhhhcCCCC-----CceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc--eee
Q 019568 30 RTFSYLELCQATDEFSE-----NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN--LIK 102 (339)
Q Consensus 30 ~~~~~~~~~~~~~~y~~-----~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~ 102 (339)
++.+..++....++|.+ .+.++.|....+|+....++ .+++|+.+.... ...+..|.++++.|...+ +.+
T Consensus 5 ~~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~ 81 (307)
T TIGR00938 5 TSVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPK 81 (307)
T ss_pred ccCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCc
Confidence 34455666666666655 45677777789999876444 688898755321 234455777777774222 344
Q ss_pred Eeeee------ecCceeEEEEEecCCCCHH-----H------HH---hhcCCccC-------HHHHH-------------
Q 019568 103 VISSC------SNEEFKALVLEYMPHGSLE-----K------YL---YSSNCILD-------IFQRL------------- 142 (339)
Q Consensus 103 ~~~~~------~~~~~~~lv~e~~~~~~L~-----~------~i---~~~~~~~~-------~~~~~------------- 142 (339)
++... ...+..+++++|++|..+. + .+ ......++ ....+
T Consensus 82 ~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (307)
T TIGR00938 82 PVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQ 161 (307)
T ss_pred cccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccc
Confidence 44321 2245678999999885431 1 11 10000000 00000
Q ss_pred ---HHHHHHHHHHHHhhc----cCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 143 ---NIMIDVASALEYLHF----GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 143 ---~i~~ql~~~l~~LH~----~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
.....+...+.++.. ....++||+|+++.||+++.++.+.++||+.+.
T Consensus 162 l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 162 LEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001112233444431 114789999999999999988877899999775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00033 Score=64.56 Aligned_cols=76 Identities=24% Similarity=0.237 Sum_probs=54.6
Q ss_pred CceeeecCccEEEEEEeCCC-cEEEEEEeecc-----c--hhhhHHHHHHHHHHHhCC---CcceeeEeeeeecCceeEE
Q 019568 47 NNLIGKGGFGSVYKARLGDG-MEVAVKVFNLQ-----C--GRALKSFNVECEMMKSIR---HRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~~-~~v~vK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 115 (339)
.+.||.|.+..||++...+| +.++||.-.+. . +....+...|.+.|+.+. ...+++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46899999999999987666 58999985421 1 124456777899988873 2356677776 3355779
Q ss_pred EEEecCCCC
Q 019568 116 VLEYMPHGS 124 (339)
Q Consensus 116 v~e~~~~~~ 124 (339)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.2e-05 Score=70.53 Aligned_cols=145 Identities=19% Similarity=0.186 Sum_probs=103.7
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--------------------hhhhH--HHHHHH
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--------------------GRALK--SFNVEC 89 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--------------------~~~~~--~~~~e~ 89 (339)
+.+..+..-..-+.+.+.||-|--+-+|.+....|++.++|.-+... .-.+. ...+|+
T Consensus 82 LAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEf 161 (465)
T KOG2268|consen 82 LALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEF 161 (465)
T ss_pred HHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHH
Confidence 33344444445678999999999999999998889999999643221 00111 235688
Q ss_pred HHHHhCCC--cceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecC
Q 019568 90 EMMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167 (339)
Q Consensus 90 ~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~d 167 (339)
..|+.|.. -.+.+.++ .+..++|||+++|-+|...-.- ..+..+...++..+..|. ..|++|+|
T Consensus 162 afmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv~la---~~GlIHgD 227 (465)
T KOG2268|consen 162 AFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIVRLA---NHGLIHGD 227 (465)
T ss_pred HHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHHHHH---HcCceecc
Confidence 88888842 23444443 3556799999999887664321 123446667777788888 99999999
Q ss_pred CCCCCeEeCCCCcEEEcccccce
Q 019568 168 LKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 168 i~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
+.-=||++.+++.++++||-.+.
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cchheeEEecCCCEEEeechHhh
Confidence 99999999999999999997654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00015 Score=64.87 Aligned_cols=74 Identities=26% Similarity=0.353 Sum_probs=48.9
Q ss_pred ceeeecCccEEEEEEeCC-------CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEEEEe
Q 019568 48 NLIGKGGFGSVYKARLGD-------GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~ 119 (339)
+.+..|-...+|+....+ ++.+++|+..... .......+|.++++.+...++ .+++.++.. .+|++|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899987544 5789999976543 233456778889888854333 345555542 368999
Q ss_pred cCCCCHH
Q 019568 120 MPHGSLE 126 (339)
Q Consensus 120 ~~~~~L~ 126 (339)
++|..+.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00042 Score=57.34 Aligned_cols=125 Identities=27% Similarity=0.455 Sum_probs=90.4
Q ss_pred cCCCCCceeeecCc-cEEEEEEeCCCcEEEEEEeec---cch------------------hhhHHHHHHHHHHHhCC---
Q 019568 42 DEFSENNLIGKGGF-GSVYKARLGDGMEVAVKVFNL---QCG------------------RALKSFNVECEMMKSIR--- 96 (339)
Q Consensus 42 ~~y~~~~~ig~g~~-~~v~~~~~~~~~~v~vK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 96 (339)
..++.++.||.|.- |.||+++. +|+.+|||++.. ... .....|..|.++.-+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 89999999999999 99999998 688999999321 110 12345778999888774
Q ss_pred Ccce--eeEeeeeecC------------------ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhh
Q 019568 97 HRNL--IKVISSCSNE------------------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156 (339)
Q Consensus 97 h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH 156 (339)
+.+. ++.+|+..-. ....||.||.+... .++.. -+.+|.+-+..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHH
Confidence 4455 8888886211 12357888776532 12333 3457788888999
Q ss_pred ccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 157 ~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
..||+-+|+++.|.. + =+|+|||.+
T Consensus 182 ---k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 182 ---KLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred ---HCCeeeccCcccccc---C--CEEEecccC
Confidence 999999999999987 2 278898753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00071 Score=60.27 Aligned_cols=143 Identities=15% Similarity=0.162 Sum_probs=88.0
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEee-ccchhhhHHHHHHHHHHHhCCC--cceeeEeeeeecCc--eeEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRH--RNLIKVISSCSNEE--FKALV 116 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~-~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv 116 (339)
....+.+.+..|....+|.... +++.+++..-. ...........+|+++++.+.. -.+...++.+.... ..|.|
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CCCceeeeccCCcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3444555554454445555544 38889998221 1223445667778999888843 34555666665554 77999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHH-HHHHHHHHHhhc--------------------------------------
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIM-IDVASALEYLHF-------------------------------------- 157 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~-~ql~~~l~~LH~-------------------------------------- 157 (339)
|+|++|..+.+...... .. ...+ ..++..|+.||.
T Consensus 104 ~~~veGe~~~~~~~~~~--~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 104 MEWVEGEVVWSALPPES--LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEEecceeccCcCCccc--ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 99999854333221110 10 1111 345555555552
Q ss_pred -----------------cCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 158 -----------------GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 158 -----------------~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
.....++|||+++.|++++.++.+-++||+++..
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 0013689999999999999988899999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.019 Score=52.04 Aligned_cols=73 Identities=16% Similarity=0.196 Sum_probs=48.3
Q ss_pred ceeeecCccEEEEEEeCCC-cEEEEEEeecc------c-hhhhHHHHHHHHHHHhCC--Cc-ceeeEeeeeecCceeEEE
Q 019568 48 NLIGKGGFGSVYKARLGDG-MEVAVKVFNLQ------C-GRALKSFNVECEMMKSIR--HR-NLIKVISSCSNEEFKALV 116 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~~-~~v~vK~~~~~------~-~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv 116 (339)
+.||.|....||++..++| +.++||.-..- + +-...+..-|.+.|+... .| .+.+++.+ +.+...+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 3579999999999987544 68999975321 1 334455667888888773 24 34445444 44455689
Q ss_pred EEecCC
Q 019568 117 LEYMPH 122 (339)
Q Consensus 117 ~e~~~~ 122 (339)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00093 Score=60.84 Aligned_cols=139 Identities=16% Similarity=0.188 Sum_probs=81.0
Q ss_pred CceeeecCccEEEEEEeCC-----CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEEEEec
Q 019568 47 NNLIGKGGFGSVYKARLGD-----GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~ 120 (339)
.+.+..|-.-.+|++...+ ++.+++|+......... +..+|..+++.+...++ .++++.+... .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3455567778899986422 36899998765543332 33679999998854443 3455665432 579999
Q ss_pred CCCCHHHH----------H-------hhcC----C-ccCHHHHHHHHHHHH-----------------HH---HHH-hhc
Q 019568 121 PHGSLEKY----------L-------YSSN----C-ILDIFQRLNIMIDVA-----------------SA---LEY-LHF 157 (339)
Q Consensus 121 ~~~~L~~~----------i-------~~~~----~-~~~~~~~~~i~~ql~-----------------~~---l~~-LH~ 157 (339)
++.++... + .... . ......+..+..++. .. |.. +..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87665321 0 0000 0 111222333332221 11 111 110
Q ss_pred -cCCCCeEecCCCCCCeEeCC-CCcEEEcccccce
Q 019568 158 -GYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAK 190 (339)
Q Consensus 158 -~~~~~i~h~di~p~Nil~~~-~~~v~l~Dfg~~~ 190 (339)
.....+||+|+++.||++++ ++.+.++||+.+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11347899999999999976 5789999998775
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0025 Score=58.74 Aligned_cols=74 Identities=11% Similarity=0.070 Sum_probs=52.6
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeecc-----c--hhhhHHHHHHHHHHHhCC---CcceeeEeeeeecCceeEE
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQ-----C--GRALKSFNVECEMMKSIR---HRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 115 (339)
..+.||.|....||+.... +..++||.-... . +....+...|.+.|+.+. ...+.+++.++. +...+
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 4678899999999999864 567999986521 1 123455566788887764 246788888877 34568
Q ss_pred EEEecCC
Q 019568 116 VLEYMPH 122 (339)
Q Consensus 116 v~e~~~~ 122 (339)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0026 Score=57.06 Aligned_cols=32 Identities=22% Similarity=0.330 Sum_probs=28.5
Q ss_pred CCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 160 ~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..++||+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.002 Score=56.82 Aligned_cols=31 Identities=32% Similarity=0.644 Sum_probs=25.5
Q ss_pred CCeEecCCCCCCeEeCCCCc-EEEccccccee
Q 019568 161 APIIHCDLKPSNVLLDDNMV-AHLSDFSIAKL 191 (339)
Q Consensus 161 ~~i~h~di~p~Nil~~~~~~-v~l~Dfg~~~~ 191 (339)
..++|+|++|.||+++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997565 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0013 Score=59.00 Aligned_cols=137 Identities=20% Similarity=0.212 Sum_probs=89.5
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeecc------------------------ch--hhhHHHHHHHHHHHhCCCcc
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQ------------------------CG--RALKSFNVECEMMKSIRHRN 99 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~------------------------~~--~~~~~~~~e~~~l~~l~h~~ 99 (339)
+..-|..|--+.||.|...+|..+|||+++.. ++ ...-....|++-|.++...+
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 44456678888999998878999999997532 01 11112345777788876555
Q ss_pred eeeEeeeeecCceeEEEEEecCCCC-HHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC
Q 019568 100 LIKVISSCSNEEFKALVLEYMPHGS-LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN 178 (339)
Q Consensus 100 i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~ 178 (339)
|.- -....- ....|||+++.+.. ..-.++ ...++...+..+-.+++..+..|.+ ..++||.||+--|+|+-+
T Consensus 228 IP~-PePIlL-k~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 228 IPC-PEPILL-KNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCC-CCceee-ecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEEC-
Confidence 321 111111 13459999984311 111121 1246666788888888888887774 789999999999999854
Q ss_pred CcEEEcccccc
Q 019568 179 MVAHLSDFSIA 189 (339)
Q Consensus 179 ~~v~l~Dfg~~ 189 (339)
|.+.++|-+.+
T Consensus 301 G~lyiIDVSQS 311 (520)
T KOG2270|consen 301 GKLYIIDVSQS 311 (520)
T ss_pred CEEEEEEcccc
Confidence 67888887654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0012 Score=55.06 Aligned_cols=116 Identities=14% Similarity=0.116 Sum_probs=73.7
Q ss_pred cCccEEEEEEeCCCcEEEEEEee-ccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhh
Q 019568 53 GGFGSVYKARLGDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 131 (339)
Q Consensus 53 g~~~~v~~~~~~~~~~v~vK~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~ 131 (339)
++.++.-.++.+- .+..+|++. .+..-....+.++++++.++. +|+++..- +.-.+.++.|.|.....
T Consensus 73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 3444444444322 344555543 333323355678899999987 78888733 33456689999854211
Q ss_pred cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 132 SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 132 ~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
.+.. +...=+.+|...|.+ +.+..|||..|+|||-|+.|.+||.|-+.
T Consensus 142 ----~~~N----~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ----NFSN----FITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ----chhH----HHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 1111 111224667778832 67899999999999999999999999764
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00099 Score=56.19 Aligned_cols=31 Identities=32% Similarity=0.508 Sum_probs=22.4
Q ss_pred CCeEecCCCCCCeEe-CCCCcEEEccccccee
Q 019568 161 APIIHCDLKPSNVLL-DDNMVAHLSDFSIAKL 191 (339)
Q Consensus 161 ~~i~h~di~p~Nil~-~~~~~v~l~Dfg~~~~ 191 (339)
..++|+|+.+.||++ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8999999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0034 Score=56.84 Aligned_cols=140 Identities=14% Similarity=0.143 Sum_probs=78.7
Q ss_pred CceeeecCccEEEEEEeCC----CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEEEEecC
Q 019568 47 NNLIGKGGFGSVYKARLGD----GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~----~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~ 121 (339)
.+.|..|-...+|+....+ +..+++|+...... ..-.-.+|..+++.+...++ .++++++.. + +|.+|++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~ 93 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFIN 93 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeehhhc
Confidence 3455557777888886432 34799998765433 22334668999999865444 345555532 2 5889987
Q ss_pred CCCHHH-------HH----------hhcC----C-ccCHHHHHHHHHHH-------------------------HHHHHH
Q 019568 122 HGSLEK-------YL----------YSSN----C-ILDIFQRLNIMIDV-------------------------ASALEY 154 (339)
Q Consensus 122 ~~~L~~-------~i----------~~~~----~-~~~~~~~~~i~~ql-------------------------~~~l~~ 154 (339)
|.++.. .+ .... . +.....+..+..++ +..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 765421 01 0001 0 11122222222221 111111
Q ss_pred hhc--cCCCCeEecCCCCCCeEeCC-CCcEEEccccccee
Q 019568 155 LHF--GYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKL 191 (339)
Q Consensus 155 LH~--~~~~~i~h~di~p~Nil~~~-~~~v~l~Dfg~~~~ 191 (339)
+.. ....-.||+|+.+.||++++ ++.++++||+.+..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 110 01224899999999999974 57899999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0068 Score=54.31 Aligned_cols=30 Identities=27% Similarity=0.296 Sum_probs=26.0
Q ss_pred CCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 160 ~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
..+++|||+.+.||+++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 368999999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.011 Score=53.27 Aligned_cols=139 Identities=24% Similarity=0.295 Sum_probs=78.9
Q ss_pred ceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc------eeeEee----eeecCceeEEEE
Q 019568 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN------LIKVIS----SCSNEEFKALVL 117 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~----~~~~~~~~~lv~ 117 (339)
+.|.+ .-..+|+....+|+. ++|+.+.. .....+..|...+..|...+ +...=| ........+-++
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34444 556788888766666 99998766 34456677888888883211 111111 112223778899
Q ss_pred EecCCCCHHH-H----H----------hh--------cCC---ccCHH-------------HHHHHHHHHHHHHHHhhc-
Q 019568 118 EYMPHGSLEK-Y----L----------YS--------SNC---ILDIF-------------QRLNIMIDVASALEYLHF- 157 (339)
Q Consensus 118 e~~~~~~L~~-~----i----------~~--------~~~---~~~~~-------------~~~~i~~ql~~~l~~LH~- 157 (339)
+|++|..+.. . + .. +.. ...+. .......++...+..+..
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999977762 1 0 00 000 00110 001122222222332221
Q ss_pred ---cC-CCC--eEecCCCCCCeEeCCCCc-EEEcccccce
Q 019568 158 ---GY-SAP--IIHCDLKPSNVLLDDNMV-AHLSDFSIAK 190 (339)
Q Consensus 158 ---~~-~~~--i~h~di~p~Nil~~~~~~-v~l~Dfg~~~ 190 (339)
.. ..+ ++|+|+.|+||+++.+.. .-++||+-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 00 233 999999999999998875 8899999775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0074 Score=53.35 Aligned_cols=76 Identities=24% Similarity=0.306 Sum_probs=49.5
Q ss_pred CCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC---CcceeeEeeeeecCceeEEEEEec
Q 019568 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
.+-.+.++.|....+|+... +++.+.||+-. ......+..|.+-|+.|. .-.+.+++++....+..++++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~~-~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT-DGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEET-TS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEEC-CCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 55667888999999999884 78899999866 233456777888888883 345778888887777789999998
Q ss_pred CCC
Q 019568 121 PHG 123 (339)
Q Consensus 121 ~~~ 123 (339)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0029 Score=59.17 Aligned_cols=166 Identities=22% Similarity=0.290 Sum_probs=95.8
Q ss_pred HHHHHHHHHHHhCCCcceeeEeeeeec-CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC
Q 019568 83 KSFNVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161 (339)
Q Consensus 83 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~ 161 (339)
..+.-..++++.+.|++..+.+.+-.. .....+|+|++ +.+|++....+. +...... -|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~~------------~~----- 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDESLL------------AH----- 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhhhc------------cc-----
Confidence 345557889999999999999888643 34577999999 569999886654 2111111 12
Q ss_pred CeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCC
Q 019568 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 241 (339)
Q Consensus 162 ~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 241 (339)
++.| -|+ +..+| .+++. | |- ...+|+||||+|.++.++.-|.
T Consensus 87 ~~~~-----~~~-------~~~td-~~~t~------------------~--~~-----~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 87 GVLH-----LNI-------IYITD-HFLTK------------------Y--PS-----PIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred ccce-----ehh-------hhccc-ccccc------------------C--CC-----CCCcchhhhhHHHHHHHHHHhh
Confidence 2211 122 22333 11110 0 00 0113999999999999999988
Q ss_pred CCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 019568 242 KPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315 (339)
Q Consensus 242 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 315 (339)
.-+......+... ...... ..+... ..........-.++..++.+..+|+...|..||...++.+
T Consensus 129 ~l~~~~~~s~~l~--~i~k~~------~~d~~~-~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 129 SLEAELTESEYLE--ILLKYY------TDDQEL-LSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHH--HHHHhc------cCchhH-HHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 7655432221111 000000 001000 0111112344567777889999999999999997766654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.06 Score=48.65 Aligned_cols=92 Identities=11% Similarity=0.086 Sum_probs=53.7
Q ss_pred eeeHHHHhhhhcCCCCC-----ceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc--eeeE
Q 019568 31 TFSYLELCQATDEFSEN-----NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN--LIKV 103 (339)
Q Consensus 31 ~~~~~~~~~~~~~y~~~-----~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 103 (339)
+++...+..+...+-+. ..| .+....||+....++..+++|+.+.. ......+..|.+.+..|.... ++..
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l-~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p 87 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLAL-NSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAP 87 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEee-ccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 34445555555444332 222 34456789988767888999987543 234456677888888773211 2221
Q ss_pred e---e--eeecCceeEEEEEecCCCC
Q 019568 104 I---S--SCSNEEFKALVLEYMPHGS 124 (339)
Q Consensus 104 ~---~--~~~~~~~~~lv~e~~~~~~ 124 (339)
. + ....++..+.++++++|..
T Consensus 88 ~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 88 LAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 1 1 1223456788999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.011 Score=54.32 Aligned_cols=74 Identities=16% Similarity=0.180 Sum_probs=50.1
Q ss_pred CceeeecCccEEEEEEeC-CCcEEEEEEeecc-----c-hhhhHHHHHHHHHHHhCC--Cc-ceeeEeeeeecCceeEEE
Q 019568 47 NNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ-----C-GRALKSFNVECEMMKSIR--HR-NLIKVISSCSNEEFKALV 116 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~-----~-~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv 116 (339)
.+.||.|....||++... +++.|+||.-..- + +-...+..-|.++|+... .| .+++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678899999999999864 3678999975321 1 234566677889988873 34 35555544 44455688
Q ss_pred EEecCC
Q 019568 117 LEYMPH 122 (339)
Q Consensus 117 ~e~~~~ 122 (339)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.018 Score=53.19 Aligned_cols=76 Identities=20% Similarity=0.293 Sum_probs=46.2
Q ss_pred CCceeeecCccEEEEEEeCCC--cE-----EEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEEE
Q 019568 46 ENNLIGKGGFGSVYKARLGDG--ME-----VAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALVL 117 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~--~~-----v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 117 (339)
..+.|..|-...+|++...++ .. |+++... ......-+-.+|+++++.+...++ .++++.+.. +++.
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ 128 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ 128 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence 445665688889999864332 22 4444322 222222234568999999965444 566666653 4999
Q ss_pred EecCCCCHH
Q 019568 118 EYMPHGSLE 126 (339)
Q Consensus 118 e~~~~~~L~ 126 (339)
||++|.+|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.03 Score=52.74 Aligned_cols=75 Identities=15% Similarity=0.234 Sum_probs=48.0
Q ss_pred CCceeeecCccEEEEEEeCC---------CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCccee-eEeeeeecCceeEE
Q 019568 46 ENNLIGKGGFGSVYKARLGD---------GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI-KVISSCSNEEFKAL 115 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~l 115 (339)
..+.|..|-.-.+|++...+ ++.|++++......... .-.+|..+++.+...+|- ++++.+.. +.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~g----g~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFSG----GR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeCC----CE
Confidence 55666667777888886431 46789998765543333 445688888888544443 45555542 36
Q ss_pred EEEecCCCCH
Q 019568 116 VLEYMPHGSL 125 (339)
Q Consensus 116 v~e~~~~~~L 125 (339)
+.+|++|.+|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 7899988644
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.046 Score=46.18 Aligned_cols=80 Identities=25% Similarity=0.390 Sum_probs=57.8
Q ss_pred CCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC---CcceeeEeeeeecCceeEEEEEe
Q 019568 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 43 ~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
+.+..+.+..|.--..|...+ ...++.||+-. ......|..|+.-|+.|. .-.+.+++.+....++.|+|+||
T Consensus 17 ~i~er~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred hhhcccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 444455566666666677665 56788888743 344567778888888874 34678889999999999999999
Q ss_pred cCCCCHH
Q 019568 120 MPHGSLE 126 (339)
Q Consensus 120 ~~~~~L~ 126 (339)
++-+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9875553
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.00082 Score=70.01 Aligned_cols=162 Identities=10% Similarity=-0.068 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHhCCCcceeeEeeeeec--CceeEEEEEecCCCCHHHHHhhcCC---ccCHHHHHHHHHHHHHHHHHhhc
Q 019568 83 KSFNVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNC---ILDIFQRLNIMIDVASALEYLHF 157 (339)
Q Consensus 83 ~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~---~~~~~~~~~i~~ql~~~l~~LH~ 157 (339)
+....|...++...|+++...+.-... ....+..++++.+|.+.+.+-++.+ .....-+....++.+.+..-+|.
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 334445566667788888776655433 3356788999999999999866543 23333333333343666666553
Q ss_pred cC--CCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHH
Q 019568 158 GY--SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLM 235 (339)
Q Consensus 158 ~~--~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 235 (339)
.+ +.-.+|.++++.|.++..+.++++.++|+.+.. .+.........+++.|++|++...-.++.++|+|..|+.+|
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 21 233689999999999999999999999998732 12222233444677788888888888999999999999999
Q ss_pred HHHhCCCCCcc
Q 019568 236 ETFTGKKPTDE 246 (339)
Q Consensus 236 ~ll~g~~P~~~ 246 (339)
....|..+|-.
T Consensus 1432 ~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1432 LRSDGNAYFIF 1442 (2724)
T ss_pred HHhcccHHHHH
Confidence 99888877543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.096 Score=54.68 Aligned_cols=146 Identities=18% Similarity=0.218 Sum_probs=79.6
Q ss_pred cCCCCC---ceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-------CcceeeEe-----ee
Q 019568 42 DEFSEN---NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-------HRNLIKVI-----SS 106 (339)
Q Consensus 42 ~~y~~~---~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-------h~~i~~~~-----~~ 106 (339)
..|-+. +.|+ |..-..|+....+|..+++|+.+.... ......|...|..|. .|.+++-. ..
T Consensus 22 ~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~ 98 (1013)
T PRK06148 22 QHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLAS 98 (1013)
T ss_pred HHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEE
Confidence 445443 4554 455778888876788999999876532 223334555665552 22333221 11
Q ss_pred eec-Cc--eeEEEEEecCCCCHHHHH-------h----------h------cC---CccCH-----------------HH
Q 019568 107 CSN-EE--FKALVLEYMPHGSLEKYL-------Y----------S------SN---CILDI-----------------FQ 140 (339)
Q Consensus 107 ~~~-~~--~~~lv~e~~~~~~L~~~i-------~----------~------~~---~~~~~-----------------~~ 140 (339)
... ++ ..+.+++|++|..+.+.. . . .. ..+.+ ..
T Consensus 99 v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~ 178 (1013)
T PRK06148 99 AQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPE 178 (1013)
T ss_pred eecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHH
Confidence 111 22 467789999997775511 0 0 00 00001 11
Q ss_pred HHHHHHHHHHHHH-----HhhccCCCCeEecCCCCCCeEeCCCC--cEE-Eccccccee
Q 019568 141 RLNIMIDVASALE-----YLHFGYSAPIIHCDLKPSNVLLDDNM--VAH-LSDFSIAKL 191 (339)
Q Consensus 141 ~~~i~~ql~~~l~-----~LH~~~~~~i~h~di~p~Nil~~~~~--~v~-l~Dfg~~~~ 191 (339)
...++..++..+. .+. .-..+++|+|+.+.||+++.++ .+. |+|||.+..
T Consensus 179 ~r~~l~~~~~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 179 DRALVERFLARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 1222223333222 121 0136799999999999998775 555 999997753
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.034 Score=48.12 Aligned_cols=80 Identities=19% Similarity=0.189 Sum_probs=54.4
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec-CCCC
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM-PHGS 124 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~ 124 (339)
....+..|..+.|+.+...+|++.++|+........ ........|+..+-.+.+++++.-. ..-.+++|.+ .+.+
T Consensus 6 ~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~--~E~~g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~~ 81 (253)
T PF04655_consen 6 PDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE--HEARGEAALRWWNGRGAVRLLAADP--ERGALLLERLDPGRS 81 (253)
T ss_pred cCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch--hhhhHHhHhheeCCCCceeeecccc--ccchhhhhhccCCCc
Confidence 345566799999999998899999999976442211 1111225688887778899988753 3345888888 4556
Q ss_pred HHHHH
Q 019568 125 LEKYL 129 (339)
Q Consensus 125 L~~~i 129 (339)
|.+..
T Consensus 82 L~~~~ 86 (253)
T PF04655_consen 82 LASLP 86 (253)
T ss_pred hhhcc
Confidence 65543
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 339 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-21 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-13 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-11 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-89
Identities = 97/321 (30%), Positives = 157/321 (48%), Gaps = 17/321 (5%)
Query: 13 RGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVK 72
+ +S + ++L +AT+ F LIG G FG VYK L DG +VA+K
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 73 VFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 132
+ + ++ F E E + RH +L+ +I C L+ +YM +G+L+++LY S
Sbjct: 70 RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 133 N---CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
+ + QRL I I A L YLH IIH D+K N+LLD+N V ++DF I+
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF- 248
K DQ+ T T+GY+ PEY +GR++ DVYSFG++L E + +
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 249 NGEMTLKHWVNDWLPISTL-EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR 307
+ L W + L ++VD NL + + K + A+ C S E R
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK------FGDTAVKCLALSSEDR 300
Query: 308 INAKEIVKKL---LKIRDSLL 325
+ +++ KL L++++S++
Sbjct: 301 PSMGDVLWKLEYALRLQESVI 321
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 2e-84
Identities = 101/299 (33%), Positives = 150/299 (50%), Gaps = 19/299 (6%)
Query: 29 WRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKS-FNV 87
+ FS EL A+D FS N++G+GGFG VYK RL DG VAVK + + + F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 88 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNI 144
E EM+ HRNL+++ C + LV YM +GS+ L S LD +R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
+ A L YLH IIH D+K +N+LLD+ A + DF +AKL+ + T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAV 195
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF---NGEMTLKHWVNDW 261
TIG++APEY G+ S DV+ +G+ML+E TG++ D + ++ L WV
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--K 253
Query: 262 LPIST---LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+ +VD +L ++ +E V + +A+ C SP +R E+V+ L
Sbjct: 254 GLLKEKKLEALVDVDLQG----NYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-75
Identities = 86/308 (27%), Positives = 140/308 (45%), Gaps = 27/308 (8%)
Query: 30 RTFSYLELCQATDEFSE------NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRA-- 81
+FS+ EL T+ F E N +G+GGFG VYK + + VAVK
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 82 --LKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY--SSNCILD 137
+ F+ E ++M +H NL++++ S+ + LV YMP+GSL L L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
R I A+ + +LH IH D+K +N+LLD+ A +SDF +A+ Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
++ ++ T YMAPE R G ++ D+YSFG++L+E TG DE L
Sbjct: 189 TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDI 246
Query: 258 VNDWL--PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ + + +D + D + E ++A C E +R + K++ +
Sbjct: 247 KEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQCLHEKKNKRPDIKKVQQ 299
Query: 316 KLLKIRDS 323
L ++ S
Sbjct: 300 LLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-66
Identities = 63/308 (20%), Positives = 121/308 (39%), Gaps = 24/308 (7%)
Query: 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM 91
L + + +G FG V+KA+L VAVK+F +Q ++ + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 92 MKSIRHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 147
+ ++H N+++ I + L+ + GSL +L ++ ++ + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129
Query: 148 VASALEYLH-------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200
+A L YLH G+ I H D+K NVLL +N+ A ++DF +A +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 201 QTQTFATIGYMAPEYGREGRVSANG-----DVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
T YMAPE D+Y+ G++L E + D + M
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 256 HWVNDWLPISTLEVVDANLLSQEDIHF---VAKEQCVSFVFNLAMACAVESPEQRINAKE 312
P S ++ + + ++ K ++ + C E R++A
Sbjct: 250 EEEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 313 IVKKLLKI 320
+ +++ ++
Sbjct: 309 VGERITQM 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-61
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-------LKSFNVECEMMK 93
+E IGKGGFG V+K R + D VA+K L + F E +M
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 94 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
++ H N++K+ N +V+E++P G L L + +L +M+D+A +E
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 154 YLHFGYSAPIIHCDLKPSNVLLD-----DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
Y+ + PI+H DL+ N+ L + A ++DF +++ + +
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNF 190
Query: 209 GYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW---LP 263
+MAPE E + D YSF ++L TG+ P DE G++ + + +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
I E C + N+ C P++R + IVK+L ++
Sbjct: 251 IP--------------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-61
Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 27/288 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRN 99
+ + IG G FG+V++A G +VAVK+ Q + F E +MK +RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHF 157
++ + + + ++V EY+ GSL + L+ S LD +RL++ DVA + YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
+ PI+H +LK N+L+D + DF +++L S T +MAPE R
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLR 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
+ + DVYSFG++L E T ++P + ++ +VV A +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP----WGN-------------LNPAQVVAA--VGF 253
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ V + C P +R + I+ L + S +
Sbjct: 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 6e-60
Identities = 75/288 (26%), Positives = 118/288 (40%), Gaps = 35/288 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
E ++G+G FG V KA+ +VA+K + K+F VE + + H N++
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIV 64
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGY 159
K+ +C N LV+EY GSL L+ + ++ + + + YLH
Sbjct: 65 KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 160 SAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+IH DLKP N+LL V + DF A D T + +MAPE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL--PISTLEVVDANLLS 276
S DV+S+GI+L E T +KP DEI + V++ P+
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI----------- 226
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324
+ + +L C + P QR + +EIVK + +
Sbjct: 227 ---------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-59
Identities = 71/281 (25%), Positives = 127/281 (45%), Gaps = 26/281 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRN 99
+ + IG G FG+VYK + +VAVK+ N+ + L++F E +++ RH N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ + + + A+V ++ SL +L++S ++ + ++I A ++YLH
Sbjct: 82 ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE---YG 216
+ IIH DLK +N+ L ++ + DF +A S Q +I +MAPE
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
S DVY+FGI+L E TG+ P I N + +E+V LS
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------------IIEMVGRGSLS 244
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+ + C + L C + ++R + I+ ++
Sbjct: 245 PDLS--KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-59
Identities = 63/290 (21%), Positives = 115/290 (39%), Gaps = 38/290 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRN 99
+ + + + G ++K R G ++ VKV ++ R + FN EC ++ H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 100 LIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLH 156
++ V+ +C + L+ +MP+GSL L+ +D Q + +D+A + +LH
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
I L +V++D++M A +S + S ++APE
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEAL 180
Query: 217 REGRVSANG---DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW-LPISTLEVVDA 272
++ N D++SF ++L E T + P ++ N E+ +K + I
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP------- 233
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V L C E P +R IV L K++D
Sbjct: 234 -------------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-57
Identities = 77/329 (23%), Positives = 119/329 (36%), Gaps = 41/329 (12%)
Query: 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM 91
+ E D LIG+G +G+VYK L D VAVKVF+ ++F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58
Query: 92 MK--SIRHRNLIKVISSC-----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
+ + H N+ + I LV+EY P+GSL KYL D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116
Query: 145 MIDVASALEYLH------FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
V L YLH Y I H DL NVL+ ++ +SDF ++ L G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 199 MTQTQTFA------TIGYMAPEYGRE-------GRVSANGDVYSFGIMLMETFTGKKPTD 245
+ A TI YMAPE D+Y+ G++ E F TD
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TD 234
Query: 246 EIFNGEMT-----LKHWVNDWLPISTLE--VVDANLLSQEDIHFVAKEQCVSFVFNLAMA 298
+ + V + ++ V + + V +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 299 CAVESPEQRINAKEIVKKLLKIRDSLLRN 327
C + E R+ A+ +++ ++ RN
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-57
Identities = 56/293 (19%), Positives = 114/293 (38%), Gaps = 39/293 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRN 99
++ LIGKG FG VY R EVA+++ +++ LK+F E + RH N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ + +C + A++ +L + + +LD+ + I ++ + YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--- 147
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL---LVGEDQSMTQTQTFATIGYMAPEYG 216
+ I+H DLK NV D+ V ++DF + + L + + ++APE
Sbjct: 148 AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 217 REGRVSANG---------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267
R+ DV++ G + E + P F + +
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP---------AEAII 252
Query: 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ + +++ + ++ + C E+R +++ L K+
Sbjct: 253 WQMGTGMKPN-----LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-56
Identities = 77/291 (26%), Positives = 119/291 (40%), Gaps = 38/291 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC----GRALKSFNVECEMMKSIRH 97
E + +IG GGFG VY+A G EVAVK + +++ E ++ ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N+I + C E LV+E+ G L + L + +N + +A + YLH
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHD 123
Query: 158 GYSAPIIHCDLKPSNVLLD--------DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
PIIH DLK SN+L+ N + ++DF +A+ M+ +A
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYA--- 179
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
+MAPE R S DV+S+G++L E TG+ P F G I L V
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRG-------------IDGLAV 222
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
++ + C L C P R + I+ +L I
Sbjct: 223 AYG--VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-54
Identities = 70/302 (23%), Positives = 119/302 (39%), Gaps = 38/302 (12%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+GKG FG K G + +K ++F E ++M+ + H N++K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
++ + EY+ G+L + S + QR++ D+AS + YLH S IIH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA------------TIGYMAPEYG 216
N L+ +N ++DF +A+L+V E ++ +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
DV+SFGI+L E D+LP + +D L
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADP--------------DYLPRT----MDFGLNV 236
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGRCIRQS 336
+ + C F + + C PE+R + ++ L ++L ++ G
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL----ETLRMHLAGHLPLGP 292
Query: 337 NL 338
L
Sbjct: 293 QL 294
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 9e-54
Identities = 69/305 (22%), Positives = 118/305 (38%), Gaps = 30/305 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM--MKSIRHRN 99
+ IGKG +G V+ + G +VAVKVF S+ E E+ +RH N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 100 LIKVISSCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
++ I++ L+ +Y +GSL YL S+ LD L + S L +L
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHL 150
Query: 156 H-----FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TI 208
H I H DLK N+L+ N ++D +A + + + T
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 209 GYMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262
YM PE + D+YSFG++L E + ++ V
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV--PS 268
Query: 263 PISTLEVVDANLLSQE--DI-HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
S ++ + + + + + ++C+ + L C +P R+ A + K L K
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 320 IRDSL 324
+ +S
Sbjct: 329 MSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-52
Identities = 69/297 (23%), Positives = 113/297 (38%), Gaps = 34/297 (11%)
Query: 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM--MKSIRHRNLIKVIS 105
+GKG +G V++ G VAVK+F+ + KS+ E E+ +RH N++ I+
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 106 SCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH----- 156
S + L+ Y GSL YL LD L I++ +AS L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPE 214
I H DLK N+L+ N ++D +A + + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 215 ------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268
D+++FG++L E + + + V + +
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 269 --VVDANL---LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
V + + ++ + L C ++P R+ A I K L KI
Sbjct: 248 KVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 9e-49
Identities = 64/297 (21%), Positives = 114/297 (38%), Gaps = 28/297 (9%)
Query: 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM--MKSIRHRNLIKVIS 105
IGKG FG V++ + G EVAVK+F+ + +S+ E E+ +RH N++ I+
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103
Query: 106 SCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH----- 156
+ + + LV +Y HGSL YL + + + + + AS L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPE 214
I H DLK N+L+ N ++D +A ++ T YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 215 ------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268
+ D+Y+ G++ E + ++ V + +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 269 --VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V + L + + + + + C + R+ A I K L ++
Sbjct: 282 KVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 6e-42
Identities = 77/290 (26%), Positives = 120/290 (41%), Gaps = 40/290 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRN 99
++ IG+G FG V+ RL D VAVK F E ++K H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++++I C+ ++ +V+E + G +L + L + L ++ D A+ +EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE--- 230
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
S IH DL N L+ + V +SDF +++ + + + + APE G
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
R S+ DV+SFGI+L ETF+ G P + +S +
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP----YPN-------------LSNQQT--------- 324
Query: 279 DIHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
FV K E C VF L C P QR + I ++L IR
Sbjct: 325 -REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 78/329 (23%), Positives = 141/329 (42%), Gaps = 24/329 (7%)
Query: 9 RYRQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNL-----IGKGGFGSVYKARL 63
+ P+ + AM F + +F E +L +GKG FGSV R
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSAFEDRDPT----QFEERHLKFLQQLGKGNFGSVEMCRY 62
Query: 64 -----GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA--LV 116
G VAVK L+ F E E++KS++H N++K C + + L+
Sbjct: 63 DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122
Query: 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 176
+EY+P+GSL YL +D + L + +EYL + IH DL N+L++
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVE 179
Query: 177 DNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLM 235
+ + DF + K+L ++ + + I + APE E + S DV+SFG++L
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
Query: 236 ETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNL 295
E FT + + M + + +++ L + + + C ++ +
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHLIE---LLKNNGRLPRPDGCPDEIYMI 295
Query: 296 AMACAVESPEQRINAKEIVKKLLKIRDSL 324
C + QR + +++ ++ +IRD +
Sbjct: 296 MTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-40
Identities = 74/295 (25%), Positives = 134/295 (45%), Gaps = 20/295 (6%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R G VAVK L+ F E E++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 93 KSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L ++ + + I
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
+ APE E + S DV+SFG++L E FT + + M + + +
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHL 241
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324
++ L + + + C ++ + C + QR + +++ ++ +IRD++
Sbjct: 242 IE---LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 28/276 (10%)
Query: 48 NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
+ +G G +G VY+ + VAVK + ++ F E +MK I+H NL++++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
C+ E ++ E+M +G+L YL N + L + ++SA+EYL IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
+L N L+ +N + ++DF +++L+ G+ + F I + APE + S
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKS 400
Query: 226 DVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVA 284
DV++FG++L E T G P I + E+++ +D
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQ--------------VYELLE------KDYRMER 440
Query: 285 KEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
E C V+ L AC +P R + EI + +
Sbjct: 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 28/281 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+ +G+G FG V+ VA+K + ++F E ++MK +RH L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYS 160
++ + S E +V EYM GSL +L L + Q +++ +AS + Y+
Sbjct: 326 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 381
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
+H DL+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGR 440
Query: 221 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
+ DV+SFGI+L E T G+ P + N E L+ V+
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------------VLDQVE------RG 480
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+C + +L C + PE+R + + L
Sbjct: 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 63/282 (22%), Positives = 110/282 (39%), Gaps = 39/282 (13%)
Query: 47 NNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL--QCGRALKSFNVECEMMKSIRHRNLIKV 103
+ IG+G F +VYK +EVA + F E EM+K ++H N+++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 104 ISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
S + LV E M G+L+ YL ++ I + + L++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 160 SAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGR 217
+ PIIH DLK N+ + + D +A L + + T +MAPE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPEFMAPEMYE 203
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
E + DVY+FG+ ++E T + P E + V + ++ + +
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFD----KVAIP 257
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
E + C ++ ++R + K+ LL
Sbjct: 258 EVKEIIEG-------------CIRQNKDERYSIKD----LLN 282
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 62/307 (20%), Positives = 124/307 (40%), Gaps = 44/307 (14%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKSFNVECEM 91
F + L +G+G FG V R G +VAVK + G + E E+
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 92 MKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
++++ H N++K C+ + L++E++P GSL++YL + +++ Q+L + +
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT-- 207
++YL S +H DL NVL++ + DF + K + D+ +
Sbjct: 137 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSP 192
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 266
+ + APE + + DV+SFG+ L E T + + + +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM---TV 249
Query: 267 LEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
+ ++ + + C V+ L C P R + + +++
Sbjct: 250 TRL----------VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF-- 297
Query: 320 IRDSLLR 326
++LL+
Sbjct: 298 --EALLK 302
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 28/281 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+ +G+G FG V+ VA+K + ++F E ++MK +RH L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYS 160
++ + S E +V EYM GSL +L L + Q +++ +AS + Y+
Sbjct: 243 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 298
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
+H DL+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGR 357
Query: 221 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
+ DV+SFGI+L E T G+ P + N E L+ V+
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------------VLDQVE------RG 397
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+C + +L C + PE+R + + L
Sbjct: 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-39
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 46/287 (16%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IG G FG V+ + +VA+K + + + F E E+M + H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAPIIHC 166
+ LV E+M HG L YL + + L + +DV + YL IH
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHR 128
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGD 226
DL N L+ +N V +SDF + + ++ + + + F + + +PE R S+ D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-VKWASPEVFSFSRYSSKSD 187
Query: 227 VYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285
V+SFG+++ E F+ GK P + N E + ++
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSN---------------------------SEVVEDIST 220
Query: 286 -------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ V+ + C E PE R ++++L +I +S L
Sbjct: 221 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-39
Identities = 73/315 (23%), Positives = 120/315 (38%), Gaps = 37/315 (11%)
Query: 30 RTFSYLELCQATDEFSENNL-----IGKGGFGSVYKARL-----GDGMEVAVKVFNLQCG 79
+ L CQ F E +L +GKG FGSV R G VAVK
Sbjct: 6 HHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP 65
Query: 80 RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD 137
+ F E +++K++ ++K ++ LV+EY+P G L +L LD
Sbjct: 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGED 196
+ L + +EYL S +H DL N+L++ ++DF +AKLL + +D
Sbjct: 126 ASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 255
+ + + I + APE + S DV+SFG++L E FT K
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------------ 230
Query: 256 HWVNDWLPISTLEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAMACAVESPEQRI 308
+ + + + + C + V L C SP+ R
Sbjct: 231 -CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289
Query: 309 NAKEIVKKLLKIRDS 323
+ + +L +
Sbjct: 290 SFSALGPQLDMLWSG 304
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-39
Identities = 75/291 (25%), Positives = 126/291 (43%), Gaps = 40/291 (13%)
Query: 49 LIGKGGFGSVYKA---RLGDGMEVAVKVFNLQCGR---ALKSFNVECEMMKSIRHRNLIK 102
+G GG +VY A L ++VA+K + LK F E + H+N++
Sbjct: 18 KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+I ++ LV+EY+ +L +Y+ S+ L + +N + +++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRV 221
I+H D+KP N+L+D N + DF IAK L + S+TQT T+ Y +PE +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLPISTLEVVDANLLSQ 277
D+YS GI+L E G+ P FNGE + +KH + D +P T +V + Q
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDVRKD--IPQ 242
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQR-INAKEIVKKLLKIRDSLLRN 327
+ + + A + R +E+ L + N
Sbjct: 243 SLSNVILR----------ATE---KDKANRYKTIQEMKDDLSSVLHENRAN 280
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 73/307 (23%), Positives = 128/307 (41%), Gaps = 51/307 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL----GDGMEVAVKVFNLQCG--RALKSFNVECEM 91
N L +G+G FGSV + L G ++VAVK L R ++ F E
Sbjct: 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 92 MKSIRHRNLIKVISSCSNEEFKA-----LVLEYMPHGSLEKYL-----YSSNCILDIFQR 141
MK H N+I+++ C + ++L +M +G L YL + + +
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 142 LNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
L M+D+A +EYL +F +H DL N +L D+M ++DF ++K + D
Sbjct: 150 LKFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHW 257
+ ++A E + ++ DV++FG+ + E T G P + N EM +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-YDY- 261
Query: 258 VNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
++ + L Q E C+ ++ + +C P R + +L
Sbjct: 262 -----------LLHGHRLKQ-------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303
Query: 318 LKIRDSL 324
K+ +SL
Sbjct: 304 EKLLESL 310
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-38
Identities = 65/298 (21%), Positives = 119/298 (39%), Gaps = 52/298 (17%)
Query: 48 NLIGKGGFGSVYKARL----GDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+IG+G FG VY L G + AVK N + F E +MK H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 103 VISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 158
++ C E L VL YM HG L ++ + + + + VA +++L F
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPEYG 216
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
+ + + DV+SFG++L E T G P ++ ++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------------- 305
Query: 276 SQEDIHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
++ + E C ++ + + C E R + E+V ++ I + +
Sbjct: 306 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-38
Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 16/222 (7%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKSFNVECEM 91
F E L +G G FG+V+K + V +KV + G ++ ++
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
+ S+ H ++++++ C + LV +Y+P GSL ++ L LN + +A
Sbjct: 69 IGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ YL ++H +L NVLL ++DF +A LL +D+ + ++ I +M
Sbjct: 128 MYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
A E G+ + DV+S+G+ + E T G +P + E+
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-38
Identities = 68/284 (23%), Positives = 118/284 (41%), Gaps = 46/284 (16%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VAVK+ + + F E + M + H L+K CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAPIIHC 166
E +V EY+ +G L YL S L+ Q L + DV + +L F IH
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHR 128
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGD 226
DL N L+D ++ +SDF + + ++ + + F + + APE + S+ D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-VKWSAPEVFHYFKYSSKSD 187
Query: 227 VYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285
V++FGI++ E F+ GK P D N E + V++
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTN---------------------------SEVVLKVSQ 220
Query: 286 -------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
++ + +C E PE+R ++++ + +R+
Sbjct: 221 GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 42/282 (14%)
Query: 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
+G G FG V+ A +VAVK ++++F E +MK+++H L+K+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ E ++ E+M GSL +L S + + ++ +A + ++ IH
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGD 226
DL+ +N+L+ ++V ++DF +A+++ + + + F I + APE G + D
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSD 367
Query: 227 VYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285
V+SFGI+LME T G+ P + N E I + +
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSN---------------------------PEVIRALER 400
Query: 286 -------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
E C ++N+ M C PE+R + I L
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-38
Identities = 68/300 (22%), Positives = 125/300 (41%), Gaps = 52/300 (17%)
Query: 46 ENNLIGKGGFGSVYKARLGDG----MEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNL 100
+ +IGKG FG VY D ++ A+K + + +++F E +M+ + H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 101 IKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---H 156
+ +I E ++L YM HG L +++ S + ++ + VA +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPE 214
F +H DL N +LD++ ++DF +A+ ++ + Q A + + A E
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 215 YGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273
+ R + DV+SFG++L E T G P I ++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--------------------- 237
Query: 274 LLSQEDIHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
HF+A+ E C ++ + C P R + +V ++ +I +LL
Sbjct: 238 ------THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-38
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-----VAVKVFNLQCG-RALKSFNVECEMMKSI 95
EF + ++G G FG+VYK E VA+K +A K E +M S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 156 ---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H DL NVL+ ++DF +AKLL E++ I +MA
Sbjct: 134 EDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251
E + DV+S+G+ + E T G KP D I E
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-38
Identities = 70/297 (23%), Positives = 111/297 (37%), Gaps = 38/297 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFN---LQCGRALKSFNVECEMMKS 94
+ +G G FG V + G + VAVK L A+ F E M S
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ HRNLI++ K +V E P GSL L + + VA + Y
Sbjct: 78 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 155 L---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT-IGY 210
L F IH DL N+LL + + DF + + L D + +
Sbjct: 137 LESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
APE + S D + FG+ L E FT G++P W+ ++ ++
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQI 233
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
+ + +E E C ++N+ + C PE R + LL+ + + +R
Sbjct: 234 LHK--IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 52/296 (17%)
Query: 48 NLIGKGGFGSVYKARL----GDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+IG+G FG VY L G + AVK N + F E +MK H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 103 VISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 158
++ C E L VL YM HG L ++ + + + + VA ++YL F
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPEYG 216
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
+ + + DV+SFG++L E T G P ++ ++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------------- 241
Query: 276 SQEDIHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324
++ + E C ++ + + C E R + E+V ++ I +
Sbjct: 242 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 61/285 (21%), Positives = 119/285 (41%), Gaps = 46/285 (16%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VA+K+ + + F E ++M ++ H L+++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAPIIHC 166
+ ++ EYM +G L YL Q L + DV A+EYL F +H
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHR 144
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGD 226
DL N L++D V +SDF +++ ++ ++ + + F + + PE + S+ D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWSPPEVLMYSKFSSKSD 203
Query: 227 VYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK 285
+++FG+++ E ++ GK P + N E +A+
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTN---------------------------SETAEHIAQ 236
Query: 286 -------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V+ + +C E ++R K ++ +L + D
Sbjct: 237 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 67/303 (22%), Positives = 121/303 (39%), Gaps = 40/303 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKSFNVECEM 91
F + L +G+G FG V G G VAVK G + + E ++
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 92 MKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
++++ H ++IK C + + LV+EY+P GSL YL + + + Q L +
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQIC 144
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATI 208
+ YLH + IH DL NVLLD++ + + DF +AK + G + + + +
Sbjct: 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTL 267
+ APE +E + DV+SFG+ L E T + + +
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG------IAQGQM 255
Query: 268 EVVDANLLSQEDIHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
V+ + + ++C + V++L C R + ++ L +
Sbjct: 256 TVLRL-------TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
Query: 321 RDS 323
+
Sbjct: 309 HEK 311
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 61/281 (21%), Positives = 113/281 (40%), Gaps = 39/281 (13%)
Query: 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNL--IKV 103
IG GG V++ A+K NL+ + L S+ E + ++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
+++ +V+E + L +L +D ++R + ++ A+ +H I
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--------- 214
+H DLKP+N L+ D M+ L DF IA + + S+ + T+ YM PE
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
+ ++S DV+S G +L GK P +I N L ++ I ++
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-- 265
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
++ + C P+QRI+ E+
Sbjct: 266 ---EKDLQDVLKC-------------CLKRDPKQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 61/281 (21%), Positives = 114/281 (40%), Gaps = 39/281 (13%)
Query: 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNL--IKV 103
IG GG V++ A+K NL+ + L S+ E + ++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
+++ +V+E + L +L +D ++R + ++ A+ +H I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 176
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--------- 214
+H DLKP+N L+ D M+ L DF IA + + S+ + + YM PE
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
+ ++S DV+S G +L GK P +I N L ++ I ++ +
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
+L ++ C P+QRI+ E+
Sbjct: 296 DLQ------------------DVLKCCLKRDPKQRISIPEL 318
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 80/279 (28%), Positives = 123/279 (44%), Gaps = 34/279 (12%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IGKG FG V G +VAVK ++ ++F E +M +RH NL++++
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 110 EEFKA-LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E+ +V EYM GSL YL S +L L +DV A+EYL +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L NVL+ ++ VA +SDF + K + S TQ + + APE RE + S DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKE 286
+SFGI+L E ++ G+ P I + + V+ + A +
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD--------------VVPRVE------KGYKMDAPD 409
Query: 287 QCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
C V+++ C R ++ ++L IR L
Sbjct: 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 73/308 (23%), Positives = 129/308 (41%), Gaps = 52/308 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL----GDGMEVAVKVFNLQCG--RALKSFNVECEM 91
E +GKG FGSV +A+L G ++VAVK+ ++ F E
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 92 MKSIRHRNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSS-----NCILDIFQ 140
MK H ++ K++ K ++L +M HG L +L +S L +
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 141 RLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
+ M+D+A +EYL +F IH DL N +L ++M ++DF +++ + D
Sbjct: 139 LVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKH 256
+ + ++A E + + + DV++FG+ + E T G+ P I N E+ +
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNY 251
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
++ N L Q +C+ V++L C P+QR + + +
Sbjct: 252 ------------LIGGNRLKQ-------PPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
Query: 317 LLKIRDSL 324
L I L
Sbjct: 293 LENILGHL 300
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 61/281 (21%), Positives = 113/281 (40%), Gaps = 39/281 (13%)
Query: 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNL--IKV 103
IG GG V++ A+K NL+ + L S+ E + ++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
+++ +V+E + L +L +D ++R + ++ A+ +H I
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 129
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--------- 214
+H DLKP+N L+ D M+ L DF IA + + S+ + T+ YM PE
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
+ ++S DV+S G +L GK P +I N L ++ I ++
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-- 246
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
++ + C P+QRI+ E+
Sbjct: 247 ---EKDLQDVLKC-------------CLKRDPKQRISIPEL 271
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 22/218 (10%)
Query: 49 LIGKGGFGSVYKA---RLGDGMEVAVKVFNLQCGR---ALKSFNVECEMMKSIRHRNLIK 102
L+G+GG G VY+A VA+K+ + E ++ +++
Sbjct: 41 LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ + + + + L L L + + I+ + SAL+ H +A
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRV 221
H D+KP N+L+ + A+L DF IA D+ +TQ T+ YMAPE E
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGE---MTLKH 256
+ D+Y+ +L E TG P + G+ + H
Sbjct: 213 TYRADIYALTCVLYECLTGSPP----YQGDQLSVMGAH 246
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 70/281 (24%), Positives = 119/281 (42%), Gaps = 42/281 (14%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N + L + ++SA+EYL IH D
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 195
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK- 285
++FG++L E T G P I ++ + K
Sbjct: 196 WAFGVLLWEIATYGMSPYPGIDLSQV---------------------------YELLEKD 228
Query: 286 ------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
E C V+ L AC +P R + EI + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 26/230 (11%)
Query: 49 LIGKGGFGSVYKA---RLGDGMEVAVKVFNLQCGR---ALKSFNVECEMMKSIRHRNLIK 102
++G GG V+ A R +VAVKV R F E + ++ H ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 103 VISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
V + E +V+EY+ +L + + + + + ++ D AL + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYMAPEYGR 217
IIH D+KP+N+++ + DF IA+ + S+TQT T Y++PE R
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLP 263
V A DVYS G +L E TG+ P F G+ + +H V +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQH-VREDPI 237
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-----VAVKVFNLQCG-RALKSFNVECEMMKSI 95
EF + ++G G FG+VYK E VA+K +A K E +M S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 156 ---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H DL NVL+ ++DF +AKLL E++ I +MA
Sbjct: 134 EDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251
E + DV+S+G+ + E T G KP D I E
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 61/308 (19%), Positives = 125/308 (40%), Gaps = 45/308 (14%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECE 90
E + + +G+G FG VY+ VA+K N R F E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQR 141
+MK ++++++ S + +++E M G L+ YL + +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 142 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201
+ + ++A + YL+ + +H DL N ++ ++ + DF + + + D
Sbjct: 141 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 260
+ + +M+PE ++G + DV+SFG++L E T ++P + N ++ L+
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-LRF---- 252
Query: 261 WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
V++ LL + + C +F L C +P+ R + EI+ + +
Sbjct: 253 --------VMEGGLLDK-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 321 RDSLLRNV 328
+ R V
Sbjct: 298 MEPGFREV 305
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-36
Identities = 75/310 (24%), Positives = 133/310 (42%), Gaps = 56/310 (18%)
Query: 50 IGKGGFGSVYKARL----GDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVI 104
+G G FG V RL + VA+K + + + F E +M H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 161
+ + +V EYM +GSL+ +L + + Q + ++ +AS ++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT---IGYMAPEYGRE 218
+H DL N+L++ N+V +SDF + ++L ED T I + +PE
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 219 GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
+ ++ DV+S+GI+L E + G++P E+ N Q
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------------Q 257
Query: 278 EDIHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK-IRD-SLLRNV 328
+ I V + C + ++ L + C + R ++IV L K IR+ L+ +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317
Query: 329 GGRCIRQSNL 338
R SNL
Sbjct: 318 TSAAARPSNL 327
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-36
Identities = 66/295 (22%), Positives = 122/295 (41%), Gaps = 44/295 (14%)
Query: 50 IGKGGFGSVYKARL---GDGMEVAVKVFNLQCGRALKS---FNVECEMMKSIRHRNLIKV 103
+G G FGSV + ++VA+KV L+ G E ++M + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYS 160
I C E LV+E G L K+L + + ++ V+ ++YL +F
Sbjct: 76 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPEYGRE 218
+H DL NVLL + A +SDF ++K L G D S ++ + + APE
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINF 187
Query: 219 GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN-LLS 276
+ S+ DV+S+G+ + E + G+KP ++ E + ++ +
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGKRME 233
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGR 331
+C ++ L C + E R + + +++ SL V G
Sbjct: 234 C-------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-36
Identities = 63/294 (21%), Positives = 110/294 (37%), Gaps = 45/294 (15%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
+G+GGF V L DG A+K + + E +M + H N++++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGYS 160
E L+L + G+L + + Q L +++ + LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDF---SIAKLLVGEDQSMTQTQTFA----TIGYMAP 213
H DLKP+N+LL D L D + A + V + Q +A TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 214 E------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267
E + + DV+S G +L G+ P D +F ++ V + L I
Sbjct: 213 ELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP-- 267
Query: 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
+ S + P QR + ++ +L ++
Sbjct: 268 ---QSPRHSSALWQLLNS-------------MMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 58/285 (20%), Positives = 114/285 (40%), Gaps = 38/285 (13%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMK-SIRHRNLI 101
F +++G G G++ + D +VAVK +C E ++++ S H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ + + +F+ + +E +L++Y+ + + + ++ S L +LH S
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 162 PIIHCDLKPSNVLL-----DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEY 215
I+H DLKP N+L+ + A +SDF + K L S ++ T G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 216 ---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
+ + D++S G + + P A
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH-------------------PFGKSLQRQA 238
Query: 273 NLLSQE-DIHFVAKEQCVSFVF-NLAMACAVESPEQRINAKEIVK 315
N+L + + E+ + L P++R +AK ++K
Sbjct: 239 NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 73/295 (24%), Positives = 121/295 (41%), Gaps = 54/295 (18%)
Query: 50 IGKGGFGSVYKARL----GDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVI 104
IG G G V RL + VA+K R + F E +M H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 161
+ +V EYM +GSL+ +L + + I Q + ++ V + + YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG-EDQSMTQTQTFATIGYMAPEYGREGR 220
+H DL NVL+D N+V +SDF ++++L D + T T I + APE
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 221 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
S+ DV+SFG+++ E G++P + N ++
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTN---------------------------RDV 263
Query: 280 IHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
I V + C + L + C + QR +IV L D+L+R+
Sbjct: 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
IGKG FG V G +VAVK ++ ++F E +M +RH NL++++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 108 SNEEFKA-LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
E+ +V EYM GSL YL S +L L +DV A+EYL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DL NVL+ ++ VA +SDF + K + S TQ + + APE RE + S
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 226 DVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVA 284
DV+SFGI+L E ++ G+ P I ++ + V
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPL---------------------------KDVVPRVE 228
Query: 285 K-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
K + C V+ + C R + ++ ++L I+
Sbjct: 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 8/204 (3%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 110 EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + L I + L++ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 194
Query: 229 SFGIMLMETFT-GKKPTDEIFNGE 251
SFGI+L E T G+ P + N E
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPE 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
++GKG +G VY R L + + +A+K + R + + E + K ++H+N+++ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLHFGYSAPIIH 165
S F + +E +P GSL L S L ++ + L+YLH I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 166 CDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSA 223
D+K NVL++ + V +SDF +K L G T+TF T+ YMAPE +G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 224 NG--DVYSFGIMLMETFTGKKP 243
D++S G ++E TGK P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 66/305 (21%), Positives = 123/305 (40%), Gaps = 56/305 (18%)
Query: 50 IGKGGFGSVYKARL---GDGMEVAVKVFNLQCGRALKS---FNVECEMMKSIRHRNLIKV 103
+G G FGSV + ++VA+KV L+ G E ++M + + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYS 160
I C E LV+E G L K+L + + ++ V+ ++YL +F
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPEYGRE 218
+H +L NVLL + A +SDF ++K L G D S ++ + + APE
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINF 513
Query: 219 GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
+ S+ DV+S+G+ + E + G+KP ++
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---------------------------P 546
Query: 278 EDIHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGG 330
E + F+ + +C ++ L C + E R + + +++ SL V G
Sbjct: 547 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606
Query: 331 RCIRQ 335
+
Sbjct: 607 GSALE 611
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 68/306 (22%), Positives = 118/306 (38%), Gaps = 51/306 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKSFNVECE 90
E N+ +G G FG VY+ ++ ++VAVK C + F +E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQRLNI 144
++ H+N+++ I + +++E M G L+ +L + L + L++
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 145 MIDVASALEYL---HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQS 198
D+A +YL HF IH D+ N LL VA + DF +A+ +
Sbjct: 146 ARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHW 257
+ +M PE EG ++ D +SFG++L E F+ G P N E+ L+
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-LEF- 257
Query: 258 VNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 258 -----------VTSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
Query: 318 LKIRDS 323
Sbjct: 300 EYCTQD 305
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 55/291 (18%)
Query: 50 IGKGGFGSVYKARL-----GDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKV 103
IG G FG VYK L + VA+K + F E +M H N+I++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYS 160
S + ++ EYM +G+L+K+L + + Q + ++ +A+ ++YL ++
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT---IGYMAPEYGR 217
+H DL N+L++ N+V +SDF ++++L ED T I + APE
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 218 EGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
+ ++ DV+SFGI++ E T G++P E+ N
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------------------------- 256
Query: 277 QEDIHFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
E + + C S ++ L M C + +R +IV L K+
Sbjct: 257 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 49/201 (24%), Positives = 80/201 (39%), Gaps = 14/201 (6%)
Query: 48 NLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
+G+G FG V++ + G + AVK L+ R E + ++ + +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGA 118
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + +E + GSL + + C L + L + LEYLH + I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHG 174
Query: 167 DLKPSNVLLDDN-MVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAPEYGREGRVS 222
D+K NVLL + A L DF A L + + G +MAPE
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 223 ANGDVYSFGIMLMETFTGKKP 243
A D++S M++ G P
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP 255
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 44/213 (20%), Positives = 83/213 (38%), Gaps = 30/213 (14%)
Query: 49 LIGKGGFGSVYKA---RLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVI 104
I GG G +Y A + +G V +K A E + + + H +++++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 105 -----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+ + +V+EY+ SL++ L + + + ++++ AL YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYMAPEYGRE 218
S +++ DLKP N++L + + L D + + T G+ APE R
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEIVR- 250
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
+ D+Y+ G L NG
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 66/289 (22%), Positives = 116/289 (40%), Gaps = 46/289 (15%)
Query: 50 IGKGGFGSVYKARL---GDGMEVAVKVFNLQCG----RALKSFNVECEMMKSIRHRNLIK 102
+G G FG+V K VAVK+ L+ E +M+ + + +++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGY 159
+I C E + LV+E G L KYL N + + ++ V+ ++YL +F
Sbjct: 83 MIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF-- 138
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IGYMAPEYGR 217
+H DL NVLL A +SDF ++K L D++ + QT + + APE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECIN 193
Query: 218 EGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL-L 275
+ S+ DV+SFG+++ E F+ G+KP + E +++ +
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGERM 239
Query: 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324
C +++L C E R + +L +
Sbjct: 240 GC-------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 82/318 (25%), Positives = 131/318 (41%), Gaps = 70/318 (22%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKSFNVECEM 91
++ +G+G FG V+ A D M VAVK A K F E E+
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCIL 136
+ +++H +++K C + + +V EYM HG L K+L + L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 137 DIFQRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193
+ Q L+I +AS + YL HF +H DL N L+ N++ + DF +++ +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
D T I +M PE + + DV+SFG++L E FT GK+P
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------- 235
Query: 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAMACAVESPE 305
W +S EV I + + C V+++ + C P+
Sbjct: 236 --------WFQLSNTEV----------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQ 277
Query: 306 QRINAKEIVKKLLKIRDS 323
QR+N KEI K L + +
Sbjct: 278 QRLNIKEIYKILHALGKA 295
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-35
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 50 IGKGGFGSVYKARL----GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVI 104
+G+G FG VY+ G+ + VAVK C + F E +MK++ H +++K+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 161
E +++E P+G L YL + L + + + + A+ YL +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
+H D+ N+L+ L DF +++ + ED I +M+PE R
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 191
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251
+ DV+ F + + E + GK+P + N +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-35
Identities = 69/306 (22%), Positives = 118/306 (38%), Gaps = 51/306 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKSFNVECE 90
E N+ +G G FG VY+ ++ ++VAVK C + F +E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQRLNI 144
++ H+N+++ I + ++LE M G L+ +L + L + L++
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 145 MIDVASALEYL---HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQS 198
D+A +YL HF IH D+ N LL VA + DF +A+ +
Sbjct: 187 ARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHW 257
+ +M PE EG ++ D +SFG++L E F+ G P N E+ L+
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-LEF- 298
Query: 258 VNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 299 -----------VTSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340
Query: 318 LKIRDS 323
Sbjct: 341 EYCTQD 346
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-35
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMMKSIRH 97
F IG+G F VY+A L DG+ VA+K +F+L +A E +++K + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEY 154
N+IK +S + +VLE G L + + + + + SALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAP 213
+H S ++H D+KP+NV + V L D + + T + T YM+P
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSP 205
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKP 243
E E + D++S G +L E + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 55/310 (17%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKSFNVECEM 91
++ +G+G FG V+ A D M VAVK A + F E E+
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--------------NCILD 137
+ ++H+++++ C+ +V EYM HG L ++L S L
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 138 IFQRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194
+ Q L + VA+ + YL HF +H DL N L+ +V + DF +++ +
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
D +T I +M PE + + DV+SFG++L E FT GK+P ++ N E
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA- 269
Query: 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
+ + L + C V+ + C P+QR + K++
Sbjct: 270 IDC------------ITQGRELER-------PRACPPEVYAIMRGCWQREPQQRHSIKDV 310
Query: 314 VKKLLKIRDS 323
+L + +
Sbjct: 311 HARLQALAQA 320
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 59/290 (20%), Positives = 103/290 (35%), Gaps = 51/290 (17%)
Query: 50 IGKGGFGSVYKARL----GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V++ + VA+K + F E M+ H +++K+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 161
+ +++E G L +L LD+ + +++AL YL F
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
+H D+ NVL+ N L DF +++ + I +MAPE R
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRF 194
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280
++ DV+ FG+ + E G KP + N + I
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKN---------------------------NDVI 227
Query: 281 HFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
+ C +++L C P +R E+ +L I +
Sbjct: 228 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 28/226 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
+F E LIG GGFG V+KA+ DG +K +A + E + + + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNI 66
Query: 101 IKVISSCSNEEFKA----------------LVLEYMPHGSLEKYLYSSNCI-LDIFQRLN 143
+ ++ + +E+ G+LE+++ LD L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ + ++Y+H S +I+ DLKPSN+ L D + DF + L + +
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK- 182
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 249
T+ YM+PE D+Y+ G++L E E
Sbjct: 183 --GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 16/220 (7%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHR 98
+++ IG G +G K R DG + K + + E +++ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 99 NLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALE 153
N+++ + L V+EY G L + L +M + AL+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 154 YLH--FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
H ++H DLKP+NV LD L DF +A++L D S +T T YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYM 183
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
+PE + D++S G +L E P F
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 45/207 (21%), Positives = 91/207 (43%), Gaps = 11/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHR 98
+++ IG+G FG + DG + +K N+ + + E ++ +++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHF 157
N+++ S +V++Y G L K + + Q L+ + + AL+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYG 216
I+H D+K N+ L + L DF IA++L + ++ + T Y++PE
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEIC 197
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D+++ G +L E T K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 59/285 (20%), Positives = 97/285 (34%), Gaps = 48/285 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL------QCGRALKSFNVECEMMKS 94
F + +G G +G V+K R DG AVK R L E +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA----EVGSHEK 112
Query: 95 I-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +H +++ + L E SL+++ + L Q + D AL
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMA 212
+LH S ++H D+KP+N+ L L DF + L + + YMA
Sbjct: 172 HLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPRYMA 224
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--STLEVV 270
PE + +A DV+S G+ ++E + GE W + L
Sbjct: 225 PELLQGSYGTA-ADVFSLGLTILEVACNMELP---HGGE--------GWQQLRQGYLPPE 272
Query: 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
LS E + P+ R A+ ++
Sbjct: 273 FTAGLSSELRSVLVM-------------MLEPDPKLRATAEALLA 304
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 60/290 (20%), Positives = 103/290 (35%), Gaps = 51/290 (17%)
Query: 50 IGKGGFGSVYKARL----GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V++ M VA+K + F E M+ H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 161
+ +++E G L +L LD+ + +++AL YL F
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
+H D+ NVL+ N L DF +++ + I +MAPE R
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IKWMAPESINFRRF 569
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280
++ DV+ FG+ + E G KP + N + I
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKN---------------------------NDVI 602
Query: 281 HFVAK-------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
+ C +++L C P +R E+ +L I +
Sbjct: 603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 33/215 (15%)
Query: 50 IGKGGFGSVYKARL--------GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+G+G F ++K EV +KV + +SF MM + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 158
C + LV E++ GSL+ YL + ++I +L + +A+A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134
Query: 159 YSAPIIHCDLKPSNVLLD--------DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
IH ++ N+LL + LSD I+ + + + Q I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQ----ERIPW 183
Query: 211 MAPEYGREGRV-SANGDVYSFGIMLMETFT-GKKP 243
+ PE + + D +SFG L E + G KP
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 75/320 (23%), Positives = 131/320 (40%), Gaps = 65/320 (20%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECE 90
E+ NN+ IG+G FG V++AR VAVK+ + F E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------------------ 132
+M + N++K++ C+ + L+ EYM +G L ++L S
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 133 -----NCILDIFQRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLS 184
L ++L I VA+ + YL F +H DL N L+ +NMV ++
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIA 216
Query: 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
DF +++ + D I +M PE R + DV+++G++L E F+ G +P
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 244 TDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVES 303
+ + E+ + + V D N+L+ E C ++NL C +
Sbjct: 277 YYGMAHEEV-IYY------------VRDGNILAC-------PENCPLELYNLMRLCWSKL 316
Query: 304 PEQRINAKEIVKKLLKIRDS 323
P R + I + L ++ +
Sbjct: 317 PADRPSFCSIHRILQRMCER 336
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 68/317 (21%), Positives = 124/317 (39%), Gaps = 65/317 (20%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKSFNVECE 90
EF NL +G+G FG V KA VAVK+ L+ E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------------------ 132
++K + H ++IK+ +CS + L++EY +GSL +L S
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 133 -----NCILDIFQRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLS 184
L + ++ ++ ++YL +H DL N+L+ + +S
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKIS 192
Query: 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
DF +++ + ED + ++Q + +MA E + + DV+SFG++L E T G P
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 244 TDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVES 303
I + + + + + + C ++ L + C +
Sbjct: 253 YPGIPPERL-FNL------------LKTGHRMER-------PDNCSEEMYRLMLQCWKQE 292
Query: 304 PEQRINAKEIVKKLLKI 320
P++R +I K L K+
Sbjct: 293 PDKRPVFADISKDLEKM 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 75/309 (24%), Positives = 130/309 (42%), Gaps = 54/309 (17%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL--------GDGMEVAVKVFNLQCG-RALKSFNVE 88
EF + L +G+G FG V A + + VAVK+ + L E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 89 CEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--------------- 132
EMMK I +H+N+I ++ +C+ + +++EY G+L +YL +
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
+ ++ +A +EYL S IH DL NVL+ +N V ++DF +A+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251
D T + +MAPE + + DV+SFG+++ E FT G P I E
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK 311
+ K + + + + + C + ++ + C P QR K
Sbjct: 268 L-FKL------------LKEGHRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFK 307
Query: 312 EIVKKLLKI 320
++V+ L +I
Sbjct: 308 QLVEDLDRI 316
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 64/309 (20%), Positives = 115/309 (37%), Gaps = 53/309 (17%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKSFNVECE 90
EF N L +G G FG V +A M VAVK+ ++ E +
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------------YSS 132
++ + H N++ ++ +C+ ++ EY +G L +L
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
LD+ L+ VA + +L S IH DL N+LL + + DF +A+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251
+ + + + +MAPE + DV+S+GI L E F+ G P +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK 311
K + + + E + ++++ C P +R K
Sbjct: 256 KFYKM------------IKEGFRMLS-------PEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 312 EIVKKLLKI 320
+IV+ + K
Sbjct: 297 QIVQLIEKQ 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 75/309 (24%), Positives = 130/309 (42%), Gaps = 54/309 (17%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL--------GDGMEVAVKVFNLQCG-RALKSFNVE 88
EF + L +G+G FG V A + + VAVK+ + L E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 89 CEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--------------- 132
EMMK I +H+N+I ++ +C+ + +++EY G+L +YL +
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
+ ++ +A +EYL S IH DL NVL+ +N V ++DF +A+ +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251
D T + +MAPE + + DV+SFG+++ E FT G P I E
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK 311
+ K + + + + + C + ++ + C P QR K
Sbjct: 314 L-FKL------------LKEGHRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFK 353
Query: 312 EIVKKLLKI 320
++V+ L +I
Sbjct: 354 QLVEDLDRI 362
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 80/347 (23%), Positives = 137/347 (39%), Gaps = 56/347 (16%)
Query: 6 LILRYRQRGKRPSNDASMPLVAMWRTFSYLELCQATD-EFSENNL-----IGKGGFGSVY 59
+ P+ + M S EL + E + L +G+G FG V
Sbjct: 28 YHHHHHHDYDIPTTENLYF-QGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVV 86
Query: 60 KARL--------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSN 109
A +VAVK+ + L E EMMK I +H+N+I ++ +C+
Sbjct: 87 LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146
Query: 110 EEFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEY 154
+ +++EY G+L +YL + L ++ VA +EY
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
L S IH DL NVL+ ++ V ++DF +A+ + D T + +MAPE
Sbjct: 207 LA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 263
Query: 215 YGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273
+ + DV+SFG++L E FT G P + E+ K + + +
Sbjct: 264 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKL------------LKEGH 310
Query: 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ + C + ++ + C P QR K++V+ L +I
Sbjct: 311 RMDK-------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 65/318 (20%), Positives = 126/318 (39%), Gaps = 71/318 (22%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECE 90
E S + + +G+ FG VYK L VA+K + G + F E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCI 135
+ ++H N++ ++ + ++ +++ Y HG L ++L +
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 136 LDIFQRLNIMIDVASALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
L+ ++++ +A+ +EYL H +H DL NVL+ D + +SD + + +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251
D + I +MAPE G+ S + D++S+G++L E F+ G +P N
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 236
Query: 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAMACAVESP 304
Q+ + + + C ++V+ L + C E P
Sbjct: 237 -------------------------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFP 271
Query: 305 EQRINAKEIVKKLLKIRD 322
+R K+I +L +
Sbjct: 272 SRRPRFKDIHSRLRAWGN 289
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-32
Identities = 61/315 (19%), Positives = 112/315 (35%), Gaps = 76/315 (24%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
+F E ++G+G FG V KAR D A+K L + E ++ S+ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 100 LIKVISSCSNEEFKA-------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 146
+++ ++ + +EY +G+L ++S N + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-------VGEDQSM 199
+ AL Y+H S IIH DLKP N+ +D++ + DF +AK + + Q++
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 200 TQTQTFAT--IG---YMAPE-------YGREGRVSANGDVYSFGIMLME----TFTGK-- 241
+ T IG Y+A E Y + D+YS GI+ E TG
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYPFSTGMER 234
Query: 242 -KPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACA 300
++ + + +E ++
Sbjct: 235 VNILKKLRSVSIEFPPD--FDDNKMKVE---KKIIRL---------------------LI 268
Query: 301 VESPEQRINAKEIVK 315
P +R A+ ++
Sbjct: 269 DHDPNKRPGARTLLN 283
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 64/308 (20%), Positives = 117/308 (37%), Gaps = 52/308 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECE 90
EF + L +G+G FG V +A VAVK+ ++ E +
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSS---------------N 133
++ I H N++ ++ +C+ +V +E+ G+L YL S
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 134 CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193
L + + VA +E+L S IH DL N+LL + V + DF +A+ +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
+ + + + +MAPE + + DV+SFG++L E F+ G P + E
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKE 312
+ + + + + ++ + C P QR E
Sbjct: 260 FCRR------------LKEGTRMRA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSE 300
Query: 313 IVKKLLKI 320
+V+ L +
Sbjct: 301 LVEHLGNL 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 68/305 (22%), Positives = 121/305 (39%), Gaps = 49/305 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECE 90
EF NNL +G G FG V +A ++VAVK+ ++ E +
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-------------YSSNCIL 136
+M + +H N++ ++ +C++ ++ EY +G L +L +N
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
L+ VA + +L S IH D+ NVLL + VA + DF +A+ ++ +
Sbjct: 162 STRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 255
+ + + +MAPE + + DV+S+GI+L E F+ G P I K
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 256 HWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
V D ++Q ++++ AC P R ++I
Sbjct: 279 L------------VKDGYQMAQ-------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319
Query: 316 KLLKI 320
L +
Sbjct: 320 FLQEQ 324
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 61/299 (20%), Positives = 124/299 (41%), Gaps = 38/299 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRN 99
+ ++++G+G +V++ R G A+KVFN + R + E E++K + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 100 LIK---VISSCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEY 154
++K + + L++E+ P GSL L + L + L ++ DV + +
Sbjct: 69 IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 155 LHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIG 209
L I+H ++KP N++ D V L+DF A+ L +D+ + T
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFV---SLYGTEE 180
Query: 210 YMAPE-YGREGRVSANG-------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261
Y+ P+ Y R + D++S G+ TG P F +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEVM 236
Query: 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
I T + A Q+ + + + ++ ++C++ S ++ ++ +L+
Sbjct: 237 YKIITGKPSGAISGVQKA-----ENGPIDWSGDMPVSCSL-SRGLQVLLTPVLANILEA 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 60/309 (19%), Positives = 103/309 (33%), Gaps = 67/309 (21%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECE-MMKSIRHRNL 100
+ ++G G G+V G VAVK + +E + + +S H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------NIMIDVASALEY 154
I+ S + + F + LE +L+ + S N + + +++ +AS + +
Sbjct: 72 IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 155 LHFGYSAPIIHCDLKPSNVLLD-------------DNMVAHLSDFSIAKLLVGEDQSMTQ 201
LH S IIH DLKP N+L+ +N+ +SDF + K L S
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 202 TQTFA--TIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGKKP--------T 244
T G+ APE E D++S G + + K
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 245 DEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESP 304
I G +L L E +++ P
Sbjct: 248 SNIIRGIFSLDEMKCLHDR----------SLIAEATDLISQ-------------MIDHDP 284
Query: 305 EQRINAKEI 313
+R A ++
Sbjct: 285 LKRPTAMKV 293
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 60/319 (18%), Positives = 122/319 (38%), Gaps = 44/319 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRN 99
+ ++++G+G +V++ R G A+KVFN + R + E E++K + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 100 LIK---VISSCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEY 154
++K + + L++E+ P GSL L + L + L ++ DV + +
Sbjct: 69 IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 155 LHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIG 209
L I+H ++KP N++ D V L+DF A+ L +D+ + T
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFV---SLYGTEE 180
Query: 210 YMAPE-YGREGRVSANG-------DVYSFGIMLMETFTGKKP---------TDEIFNGEM 252
Y+ P+ Y R + D++S G+ TG P E+ +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 253 TLK--HWVNDWLPISTLEVVDANLLSQED-IHFVAKEQCVSFVFNLAMACAVESPEQRIN 309
T K ++ + + + + + + N+ E+
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI----LEADQEKCWG 296
Query: 310 AKEIVKKLLKIRDSLLRNV 328
+ + I ++ +V
Sbjct: 297 FDQFFAETSDILHRMVIHV 315
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 7e-31
Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 19/231 (8%)
Query: 39 QATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIR 96
Q + +G GGFG V + G +VA+K + + + + +E ++MK +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 97 HRNLIKVI------SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDV 148
H N++ + + L +EY G L KYL + + C L ++ D+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+SAL YLH IIH DLKP N++L ++ + D AK L + +
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-V 184
Query: 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T+ Y+APE + + + D +SFG + E TG +P +
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 45/221 (20%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHRN 99
+F +G+GGFG V++A+ D A+K L A + E + + + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 100 LIKVISSCSNEEFKA------------LVLEYMPHGSLEKYL--YSSNCILDIFQRLNIM 145
+++ ++ + + ++ +L+ ++ + + L+I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+ +A A+E+LH S ++H DLKPSN+ + V + DF + + +++ T
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 206 ATIG----------YMAPEYGREGRVSANGDVYSFGIMLME 236
YM+PE S D++S G++L E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 66/314 (21%), Positives = 113/314 (35%), Gaps = 58/314 (18%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKSFNVECE 90
EF NL +G G FG V A G ++VAVK+ + ++ E +
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-------------------- 129
MM + H N++ ++ +C+ L+ EY +G L YL
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 130 --YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187
+L L VA +E+L +H DL NVL+ V + DF
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDE 246
+A+ ++ + + + + +MAPE EG + DV+S+GI+L E F+ G P
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277
Query: 247 IFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ 306
I K + + + Q ++ + +C +
Sbjct: 278 IPVDANFYKL------------IQNGFKMDQ-------PFYATEEIYIIMQSCWAFDSRK 318
Query: 307 RINAKEIVKKLLKI 320
R + + L
Sbjct: 319 RPSFPNLTSFLGCQ 332
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 41/242 (16%), Positives = 78/242 (32%), Gaps = 36/242 (14%)
Query: 41 TDEFSENNLIGKGGFGSVYKARLGD------GMEVAVKVFNLQCGRALKSFNVECEMMKS 94
+ ++L+G+G F VY+A GD + +KV E +K
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSL----EKYLYSSNCILDIFQRLNIMIDVAS 150
+K S+ + LV E +G+L Y + ++ ++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH-----------LSDFSIAKLLVGEDQSM 199
+E +H IIH D+KP N +L + + L D + + +
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 200 TQTQTFATIGYMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 253
T T G+ E + + D + + G + GE
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQ------IDYFGVAATVYCMLFGTYMKVKNEGGECK 294
Query: 254 LK 255
+
Sbjct: 295 PE 296
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 38/346 (10%), Positives = 84/346 (24%), Gaps = 61/346 (17%)
Query: 11 RQRGKRPSNDASMPLVAMWRTFSYL----ELCQATDEFSENNLIGKGGFGSVYKAR-LGD 65
+ K P+ +W + L Q + + G V+ R +
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86
Query: 66 GMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA-------- 114
+ A+KVF L+ + + + +
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 115 ------------------LVLEYM-----PHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
L++ S ++Y I + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L S ++H P N+ + + L D S VG + + Y
Sbjct: 207 AANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-KVGTRGPASSV----PVTYA 258
Query: 212 APEY--GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
E+ + + + G+ + + P F + + +
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----F--------GLVTPGIKGSWKR 306
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ + + F + FV L +R+ E ++
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 48 NLIGKGGFGSVYKARL---GDGMEVAVKVFNLQCG---RALKSFNVECEMMKSI-RHRNL 100
++IG+G FG V KAR+ G M+ A+K ++ + F E E++ + H N+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCILDIFQRLNIM 145
I ++ +C + + L +EY PHG+L +L S+ L Q L+
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
DVA ++YL IH DL N+L+ +N VA ++DF +++ G++ + +T
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 202
Query: 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MA E + N DV+S+G++L E + G P
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 33/236 (13%), Positives = 70/236 (29%), Gaps = 45/236 (19%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCG---------------------------- 79
++G+ + +A G V V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 80 RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM-PHGSLEKYL------YSS 132
+ F +++K + + +I+V + + Y +L+ + S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
+ L RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 193 VGEDQSMTQTQTFATIGYMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP 243
G + FA A ++ D ++ G+ + + P
Sbjct: 262 -GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 67/305 (21%), Positives = 114/305 (37%), Gaps = 60/305 (19%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISS 106
++ +GGF VY+A+ +G G E A+K ++ E MK + H N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 107 CS-------NEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHF 157
S + + L+L + G L ++L S L L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA----------T 207
PIIH DLK N+LL + L DF A + Q A T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 208 IGYMAPE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDE-----IFNGEMTLKHWV 258
Y PE Y + D+++ G +L + P ++ I NG+ ++
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIP--- 269
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
H +L A +PE+R++ E+V +L
Sbjct: 270 -PHDTQY------------TVFH------------SLIRAMLQVNPEERLSIAEVVHQLQ 304
Query: 319 KIRDS 323
+I +
Sbjct: 305 EIAAA 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
+++ IG+G G+VY A + G EVA++ NLQ + E +M+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ + S + +V+EY+ GSL + + +D Q + + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGRE 218
S +IH D+K N+LL + L+DF + ++ T T +MAPE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
D++S GIM +E G+ P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 20/229 (8%)
Query: 27 AMWRTFSYLELCQATD---EFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAL 82
+M ++ Y + + D + +G G FG VYKA+ G A KV + L
Sbjct: 1 SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL 60
Query: 83 KSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 142
+ + VE E++ + H ++K++ + ++ +++E+ P G+++ + + L Q
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 143 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202
+ + AL +LH S IIH DLK NVL+ L+DF ++ +++ +
Sbjct: 121 VVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKR 174
Query: 203 QTFATIG---YMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP 243
+F IG +MAPE ++ D++S GI L+E + P
Sbjct: 175 DSF--IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 47/237 (19%)
Query: 48 NLIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKV 103
+GKG FG+VY AR +A+KV L+ E E+ +RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHF 157
+ L+LEY P G++ + L + + + ++A+AL Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH- 126
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE-- 214
S +IH D+KP N+LL ++DF + + T+ Y+ PE
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMI 179
Query: 215 ----YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWV 258
+ + D++S G++ E GK P + I E T +V
Sbjct: 180 EGRMHDEK------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 79/293 (26%), Positives = 117/293 (39%), Gaps = 56/293 (19%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
+ F +G+G +GSVYKA G VA+K ++ L+ E +M+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++K S +V+EY GS+ + N L + I+ LEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--- 142
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAPEYG 216
IH D+K N+LL+ A L+DF +A L +M + T IG +MAPE
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEVI 197
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKPTDEI------F----NGEMTLKHWVNDWLPIST 266
+E + D++S GI +E GK P +I F N T +
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR----------- 246
Query: 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
L S FV + C V+SPEQR A + LL+
Sbjct: 247 ----KPELWSDNFTDFVKQ-------------CLVKSPEQRATATQ----LLQ 278
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
IG+G G V AR G +VAVK+ +L+ + + E +M+ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++++ S E +++E++ G+L + S L+ Q + V AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH--- 158
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAPEYG 216
+ +IH D+K ++LL + LSDF + + + + ++ +G +MAPE
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWMAPEVI 213
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S GIM++E G+ P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRA-LKSFNVECEMMKSIRHRN 99
D+F + + +G G G V+K G+ +A K+ +L+ A E +++
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ + ++ ++ +E+M GSL++ + + + I V L YL +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGRE 218
I+H D+KPSN+L++ L DF ++ L+ + +F T YM+PE +
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQG 204
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-29
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHR 98
+ F++ IGKG FG V+K VA+K+ +L + ++ E ++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
+ K S + +++EY+ GS L LD Q I+ ++ L+YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH-- 136
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAPEY 215
S IH D+K +NVLL ++ L+DF +A L + + TF +G +MAPE
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAPEV 190
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
++ + D++S GI +E G+ P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 57/302 (18%), Positives = 110/302 (36%), Gaps = 59/302 (19%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSI-R 96
T EF E IG G FGSV+K DG A+K ++ E + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALE 153
H ++++ S+ + ++ + EY GSL + + I+ F + ++++ V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ------------SMTQ 201
Y+H S ++H D+KPSN+ + + + + + ++ ++
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 202 TQTFA-TIGYMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
Q ++A E Y + D+++ + ++ + NG+
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGAEPLP---RNGDQ--- 236
Query: 256 HWVNDWLPI--STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
W I L + LSQE + PE+R +A +
Sbjct: 237 -----WHEIRQGRLPRIPQV-LSQEFTELLKV-------------MIHPDPERRPSAMAL 277
Query: 314 VK 315
VK
Sbjct: 278 VK 279
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 72/291 (24%), Positives = 110/291 (37%), Gaps = 40/291 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-LKSFNVECE-MMKSIRHR 98
++ + IG+G +GSV K G +AVK K ++ + +M+S
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASAL 152
+++ + E + +E M S +K+ + + I + AL
Sbjct: 82 YIVQFYGALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+L IIH D+KPSN+LLD + L DF I+ LV S+ +T+ YMA
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMA 193
Query: 213 PE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268
PE DV+S GI L E TG+ P + + L V P L
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP--QLS 251
Query: 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
+ S I+FV C + +R KE LLK
Sbjct: 252 NSEEREFSPSFINFVNL-------------CLTKDESKRPKYKE----LLK 285
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 32/232 (13%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
L+GKG F VY+A + G+EVA+K+ + + ++ E ++ ++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ + + LVLE +G + +YL + + + M + + + YLH S I+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE------YGR 217
H DL SN+LL NM ++DF +A L + T T Y++PE +G
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGL 191
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVND 260
E DV+S G M G+ P D + + + +++
Sbjct: 192 E------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 61/305 (20%), Positives = 108/305 (35%), Gaps = 60/305 (19%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFN---LQCGRALKSFNV--------------ECEMM 92
+ +G F + D A+K + L+ R N E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-------YSSNCILDIFQRLNIM 145
I++ + +N + ++ EYM + S+ K+ + C + I I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
V ++ Y+H I H D+KPSN+L+D N LSDF ++ +V + +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210
Query: 206 A-TIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDE----------IFNGEM 252
T +M PE A D++S GI L F P I +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
Query: 253 TL--KHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA 310
+ + N LS EDI F+ ++P +RI +
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL-------------FLRKNPAERITS 317
Query: 311 KEIVK 315
++ +K
Sbjct: 318 EDALK 322
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 45/235 (19%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKG FG+VY AR + +A+KV L+ E E+ +RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFG 158
+ + + L+LE+ P G L K L R + M ++A AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE---- 214
+IH D+KP N+L+ ++DF + +T T+ Y+ PE
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRT-MCGTLDYLPPEMIEG 186
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWV 258
+ + D++ G++ E G P D I N ++ ++
Sbjct: 187 KTHDEK------VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 70/301 (23%), Positives = 117/301 (38%), Gaps = 51/301 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHRN 99
D++ +IG G V A +VA+K NL +C ++ E + M H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSL-------EKYLYSSNCILDIFQRLNIMIDVASAL 152
++ +S ++ LV++ + GS+ + +LD I+ +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ--TFATIG- 209
EYLH IH D+K N+LL ++ ++DF ++ L TF +G
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF--VGT 189
Query: 210 --YMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDE------IFNGEMTLKHWVND 260
+MAPE + R D++SFGI +E TG P + + +TL+ ND
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQ---ND 243
Query: 261 --WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + ++ C + PE+R A E LL
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISL-------------CLQKDPEKRPTAAE----LL 286
Query: 319 K 319
+
Sbjct: 287 R 287
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 47/232 (20%), Positives = 91/232 (39%), Gaps = 33/232 (14%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKGGF ++ A K+ L + ++E + +S+ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +F +VLE SL + + + R + + +YLH +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE------YGR 217
H DLK N+ L++++ + DF +A + + + + T Y+APE +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSF 220
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVND 260
E DV+S G ++ GK P + I E ++ +N
Sbjct: 221 E------VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-LKSFNVECEM-MKSIRHR 98
D+ +G+G +G V K R + G +AVK K ++ ++ M+++
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASAL 152
+ + E + +E M SL+K+ ++D Q + I + + AL
Sbjct: 67 FTVTFYGALFREGDVWICMELMD-TSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKAL 122
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYM 211
E+LH S +IH D+KPSNVL++ + DF I+ LV + + A YM
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKD-IDAGCKPYM 176
Query: 212 APE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267
APE + S D++S GI ++E + P D LK V + P L
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE--PSPQL 234
Query: 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
A+ S E + F ++ C ++ ++R E L++
Sbjct: 235 ---PADKFSAEFVDFTSQ-------------CLKKNSKERPTYPE----LMQ 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 47/232 (20%), Positives = 90/232 (38%), Gaps = 33/232 (14%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKGGF ++ A K+ L + ++E + +S+ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +F +VLE SL + + + R + + +YLH +I
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE------YGR 217
H DLK N+ L++++ + DF +A + + + T Y+APE +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPEVLSKKGHSF 194
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVND 260
E DV+S G ++ GK P + I E ++ +N
Sbjct: 195 E------VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 36/242 (14%), Positives = 78/242 (32%), Gaps = 56/242 (23%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNL----------------QCGRALK-------- 83
++G+ + +A G V V R L+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 84 ----SFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM-PHGSLEKYL------YSS 132
F +++K + + +I+V + + Y +L+ + S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
+ L RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 193 VGEDQSMTQTQTFATIGYMAPEY-----------GREGRVSANGDVYSFGIMLMETFTGK 241
D + + + G+ PE R ++ + D ++ G+++ +
Sbjct: 255 --RDGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 242 KP 243
P
Sbjct: 311 LP 312
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 44/216 (20%), Positives = 82/216 (37%), Gaps = 16/216 (7%)
Query: 41 TDEFSENNLIGKG--GFGSVYKAR-LGDGMEVAVKVFNL--QCGRALKSFNVECEMMKSI 95
+ +IGKG +V AR G V V+ NL + E + K
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEY 154
H N++ ++ + +V +M +GS + + ++ I+ V AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT--IG--- 209
+H +H +K S++L+ + +LS ++ Q F +
Sbjct: 144 IH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 210 YMAPEYGREGRVSANG--DVYSFGIMLMETFTGKKP 243
+++PE ++ + D+YS GI E G P
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-27
Identities = 61/287 (21%), Positives = 104/287 (36%), Gaps = 37/287 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA-LKSFNVECE-MMKSIRHR 98
++ +G G G V+K R G +AVK + K ++ + ++KS
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL-DIFQRLNIMIDVASALEYLHF 157
+++ + + +E M + + I I + + + + AL YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKE 142
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--- 214
+ +IH D+KPSN+LLD+ L DF I+ LV + ++ YMAPE
Sbjct: 143 KHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERID 197
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
+ DV+S GI L+E TG+ P L + + L
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE--EPPLLP--GH 253
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319
S + FV C + +R + LL+
Sbjct: 254 MGFSGDFQSFVKD-------------CLTKDHRKRPKYNK----LLE 283
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 61/213 (28%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---LKSFNVECEMMKSIR 96
FS+ IG G FG+VY AR + + VA+K + ++ + E ++ +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N I+ E LV+EY GS L L + + L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAP 213
S +IH D+K N+LL + + L DF A M +F +G +MAP
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSF--VGTPYWMAP 219
Query: 214 E---YGREGRVSANGDVYSFGIMLMETFTGKKP 243
E EG+ DV+S GI +E K P
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 29/242 (11%)
Query: 22 SMPLVAMWRTFSYLELCQATD---EFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ 77
SM + R+ ++L D F L+G G +G VYK R + G A+KV ++
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 78 CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKA------LVLEYMPHGSL-EKYL 129
G + E M+K HRN+ + + LV+E+ GS+ +
Sbjct: 61 -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 130 YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
+ L I ++ L +LH +IH D+K NVLL +N L DF ++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 190 KLLVGEDQSMTQTQTFATIG---YMAPEYGREGRVSANG-----DVYSFGIMLMETFTGK 241
L D+++ + TF IG +MAPE D++S GI +E G
Sbjct: 177 AQL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
Query: 242 KP 243
P
Sbjct: 232 PP 233
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 29/224 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSF----------NVECE 90
++F ++G+G F +V AR E A+K+ K E +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERD 82
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
+M + H +K+ + ++E L Y +G L KY+ + R ++ S
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVS 141
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIG 209
ALEYLH IIH DLKP N+LL+++M ++DF AK+L E + +F T
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQ 197
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIF 248
Y++PE E + D+++ G ++ + G P IF
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 241
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 55/250 (22%), Positives = 97/250 (38%), Gaps = 45/250 (18%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRH 97
++ + +G G +G V R +E A+K+ + E ++K + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASAL 152
N++K+ ++ LV+E G L + ++ I+ V S +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV------DAAVIIKQVLSGV 149
Query: 153 EYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
YLH I+H DLKP N+LL + + + + DF ++ + + M + T
Sbjct: 150 TYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAY 203
Query: 210 YMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTLK 255
Y+APE Y + DV+S G++L G P EI G+ T
Sbjct: 204 YIAPEVLRKKYDEK------CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257
Query: 256 HWVNDWLPIS 265
+W +S
Sbjct: 258 SP--EWKNVS 265
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 60/251 (23%), Positives = 102/251 (40%), Gaps = 46/251 (18%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIR 96
+D + ++GKG FG V + G E AVKV + ++ +S E +++K +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASA 151
H N++K+ ++ + LV E G L + +S I ++ V S
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSG 138
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
+ Y+H I+H DLKP N+LL + + DF ++ + M T
Sbjct: 139 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTA 192
Query: 209 GYMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTL 254
Y+APE Y + DV+S G++L +G P +I G+ T
Sbjct: 193 YYIAPEVLHGTYDEK------CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246
Query: 255 KHWVNDWLPIS 265
+ W +S
Sbjct: 247 EL--PQWKKVS 255
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 44/207 (21%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV--ECEMMKSIRHRNLIKVISS 106
+GKG F V + + G E A + N + A + E + + ++H N++++ S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 107 CSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 157
S E L+ + + G L + YS S+CI I A+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCH- 127
Query: 158 GYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAP 213
++H +LKP N+LL L+DF +A + GE Q+ FA T GY++P
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSP 182
Query: 214 E------YGREGRVSANGDVYSFGIML 234
E YG+ D+++ G++L
Sbjct: 183 EVLRKDPYGKP------VDLWACGVIL 203
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-23
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 58/232 (25%)
Query: 39 QATDEFSEN----NLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV------ 87
+T F EN ++G+G V + E AVK+ ++ G + + V
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 88 ---ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNC 134
E ++++ + H N+I++ + F LV + M G L EK S
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 135 ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194
+ + + LH I+H DLKP N+LLDD+M L+DF + +
Sbjct: 130 MRALL----------EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLD 175
Query: 195 EDQSMTQTQTFATIGYMAPE------------YGREGRVSANGDVYSFGIML 234
+ + + T Y+APE YG+E D++S G+++
Sbjct: 176 PGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-23
Identities = 57/258 (22%), Positives = 96/258 (37%), Gaps = 60/258 (23%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN--------------------LQCGRALKSFNV 87
IGKG +G V A D A+KV + G ++
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 88 ------ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYL----YSSNC 134
E ++K + H N++K V+ + + +V E + G + + S +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 135 ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194
FQ D+ +EYLH IIH D+KPSN+L+ ++ ++DF ++ G
Sbjct: 139 ARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 195 EDQSMTQTQTFA-TIGYMAPEYGREGRVSANG---DVYSFGIMLMETFTGKKPTDE---- 246
D T +MAPE E R +G DV++ G+ L G+ P +
Sbjct: 190 SD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 247 -----IFNGEMTLKHWVN 259
I + + +
Sbjct: 247 CLHSKIKSQALEFPDQPD 264
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-23
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 49/213 (23%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKV-----FNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
IGKG F V + G + AVK+ F G + + E + ++H +++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 104 ISSCSNEEFKALVLEYMPHGSL---------EKYLYS----SNCILDIFQRLNIMIDVAS 150
+ + S++ +V E+M L ++YS S+ + I
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
AL Y H IIH D+KP VLL +++ L F +A L T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196
Query: 208 IGYMAPE------YGREGRVSANGDVYSFGIML 234
+MAPE YG+ DV+ G++L
Sbjct: 197 PHFMAPEVVKREPYGKP------VDVWGCGVIL 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-23
Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 23/229 (10%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN----LQCGRALKSFNVECEMMKSIRHRNLIK- 102
L+G+G +G V + AVK+ + + E ++++ +RH+N+I+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 103 --VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
V+ + ++ +V+EY G E + Q + LEYLH S
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--YGRE 218
I+H D+KP N+LL +S +A+ L T + + + PE G +
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWV 258
D++S G+ L TG P + I G +
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC 236
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-23
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 45/207 (21%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
+GKG F V + G+E A K+ N R + E + + ++H N++++ S
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 107 CSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 157
E F LV + + G L + YS S+CI I ++ Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH- 145
Query: 158 GYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAP 213
S I+H +LKP N+LL L+DF +A V + ++ FA T GY++P
Sbjct: 146 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWH---GFAGTPGYLSP 199
Query: 214 E------YGREGRVSANGDVYSFGIML 234
E Y + D+++ G++L
Sbjct: 200 EVLKKDPYSKP------VDIWACGVIL 220
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-23
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IGKG FG V + D ++ A+K N +++ E ++M+ + H L+ +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
S +EE +V++ + G L +L + + +L I ++ AL+YL + II
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQ---NQRII 137
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPE--------- 214
H D+KP N+LLD++ H++DF+IA +L E TQ T A T YMAPE
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP 243
Y V D +S G+ E G++P
Sbjct: 194 YSFA--V----DWWSLGVTAYELLRGRRP 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 9e-23
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 49/220 (22%)
Query: 41 TDEFSEN----NLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKSFNVECEMMK 93
+ +FS+N +GKG F V + G+E A K+ N + R + E + +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 94 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNI 144
++H N++++ S E F LV + + G L + YS S+CI I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----- 115
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQ 201
++ Y H S I+H +LKP N+LL L+DF +A V + ++
Sbjct: 116 -----ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWH- 165
Query: 202 TQTFA-TIGYMAPE------YGREGRVSANGDVYSFGIML 234
FA T GY++PE Y + D+++ G++L
Sbjct: 166 --GFAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 197
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 59/250 (23%), Positives = 99/250 (39%), Gaps = 45/250 (18%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRH 97
+ ++ ++GKG FG V K + E AVKV N + + E E++K + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASAL 152
N++K+ + +V E G L ++ +S + I+ V S +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH------DAARIIKQVFSGI 134
Query: 153 EYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
Y+H I+H DLKP N+LL + + + DF ++ ++ M T
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAY 188
Query: 210 YMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTLK 255
Y+APE Y + DV+S G++L +G P +I G+
Sbjct: 189 YIAPEVLRGTYDEK------CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 256 HWVNDWLPIS 265
W IS
Sbjct: 243 L--PQWRTIS 250
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 44/206 (21%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
++G G F V+ + G A+K S E ++K I+H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 108 SNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFG 158
+ LV++ + G L E+ +Y+ S I + SA++YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----------SAVKYLH-- 123
Query: 159 YSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPE 214
I+H DLKP N+L ++N ++DF ++K+ ++ M+ T T GY+APE
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMS---TACGTPGYVAPE 177
Query: 215 ------YGREGRVSANGDVYSFGIML 234
Y + D +S G++
Sbjct: 178 VLAQKPYSKA------VDCWSIGVIT 197
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEM-----MKSI 95
D F + ++G+GGFG V+ ++ ++ A K L R K + M + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASAL 152
R ++ + + + LV+ M G + ++Y+ + F R + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYM 211
E+LH II+ DLKP NVLLDD+ +SD +A L T+T+ +A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFM 356
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
APE + D ++ G+ L E + P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-22
Identities = 30/204 (14%), Positives = 57/204 (27%), Gaps = 43/204 (21%)
Query: 49 LIGKGGFGSVYKA---RLGDGMEVAVKVFNLQCGRA---LKSFNVECEMMKSIRHRNLIK 102
G ++A L +VA+ + Q L+ + I + +
Sbjct: 38 FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
V+ +V E++ GSL++ +S + M +A+A + H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS 222
+ PS V + + L+ M +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPD-------AN 180
Query: 223 ANGDVYSFGIMLMETFTGKKPTDE 246
D+ G L + P E
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPE 204
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-22
Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 54/219 (24%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECE-MMKSIRHR 98
TD + IG G + + ME AVK+ + ++ + E E +++ +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHP 76
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------------NIMI 146
N+I + + ++ +V E M G L ++ ++
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLF 123
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLVGEDQSMTQT 202
+ +EYLH + ++H DLKPSN+L + + DF AK L E+ +
Sbjct: 124 TITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-- 178
Query: 203 QTFA-TIGYMAPE------YGREGRVSANGDVYSFGIML 234
T T ++APE Y D++S G++L
Sbjct: 179 -TPCYTANFVAPEVLERQGYDAA--C----DIWSLGVLL 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 5e-22
Identities = 55/278 (19%), Positives = 101/278 (36%), Gaps = 77/278 (27%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQ-CGRALKSFNVECE 90
EF + L +G+G FG V +A VAVK+ ++ E +
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYL------------------- 129
++ I H N++ ++ +C+ +V +E+ G+L YL
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQ 137
Query: 130 ---YSSNCILDIFQRLNIMI------------------------------DVASALEYLH 156
Y +D+ +RL+ + D + +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197
Query: 157 FGY----------SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+ + S IH DL N+LL + V + DF +A+ + + + +
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-22
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 52/209 (24%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSC 107
+G+G F K AVK+ + R + E +K H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYL 155
++ LV+E + G L F+R+ IM + SA+ ++
Sbjct: 76 HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 156 HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYM 211
H ++H DLKP N+L +DN+ + DF A+L ++Q + T T+ Y
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK---TPCFTLHYA 176
Query: 212 APE------YGREGRVSANGDVYSFGIML 234
APE Y D++S G++L
Sbjct: 177 APELLNQNGYDES------CDLWSLGVIL 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-22
Identities = 60/231 (25%), Positives = 91/231 (39%), Gaps = 52/231 (22%)
Query: 40 ATDEFSEN---------NLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVEC 89
+TD FS +++G+G V L E AVK+ Q G E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 90 EMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------ 142
EM+ + HRN++++I E+ LV E M GS+ +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHF 108
Query: 143 ------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLL- 192
++ DVASAL++LH + I H DLKP N+L + + DF + +
Sbjct: 109 NELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165
Query: 193 VGEDQSMTQTQTFATI----GYMAPEYGREGRVSANG-----DVYSFGIML 234
+ D S T T YMAPE A+ D++S G++L
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 48/208 (23%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
+GKG FG V K + E AVKV N + + E E++K + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEY 154
+ +V E G L F + I+ V S + Y
Sbjct: 90 LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 155 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+H I+H DLKP N+LL + + + DF ++ ++ M T Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYI 190
Query: 212 APE-----YGREGRVSANGDVYSFGIML 234
APE Y + DV+S G++L
Sbjct: 191 APEVLRGTYDEK------CDVWSAGVIL 212
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 50/213 (23%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVEC--------EMM 92
++FS + +IG+GGFG VY R D ++ A+K L R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLV 246
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+ ++ + + + + +L+ M G L +L + R ++ L
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGL 305
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYM 211
E++H + +++ DLKP+N+LLD++ +SD +A + + T GYM
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYM 357
Query: 212 APE-YGREGRVSANGDVYSFGIMLMETFTGKKP 243
APE + ++ D +S G ML + G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 47/212 (22%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN--------LQCGRALKSFNVECEMMKSIRHRNL 100
+G G G V A +VA+++ + + + E E++K + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 101 IKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYL 155
IK+ + E++ +VLE M G L F + A++YL
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255
Query: 156 HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYM 211
H IIH DLKP NVLL +++ + ++DF +K ++GE M T T Y+
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 308
Query: 212 APE---------YGREGRVSANGDVYSFGIML 234
APE Y R V D +S G++L
Sbjct: 309 APEVLVSVGTAGYNRA--V----DCWSLGVIL 334
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 51/238 (21%), Positives = 95/238 (39%), Gaps = 49/238 (20%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKV-------------FNLQCGRALKSFN 86
+ + + +G G +G V + E A+KV N + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 87 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQR 141
E ++KS+ H N+IK+ ++++ LV E+ G L ++ + +I ++
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 142 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQS 198
+ S + YLH I+H D+KP N+LL + + + DF ++ +D
Sbjct: 155 ------ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYK 204
Query: 199 MTQTQTFATIGYMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
+ T Y+APE Y + DV+S G+++ G P F G+
Sbjct: 205 L--RDRLGTAYYIAPEVLKKKYNEK------CDVWSCGVIMYILLCGYPP----FGGQ 250
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 23/204 (11%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
D + +G G FG V++ G K N + E +M + H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASAL 152
LI + + ++ L+LE++ G L E Y S + I N M L
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI-------NYMRQACEGL 162
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLVGEDQSMTQTQTFATIGY 210
+++H I+H D+KP N++ + + + DF +A L D+ + T AT +
Sbjct: 163 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIV--KVTTATAEF 216
Query: 211 MAPEYGREGRVSANGDVYSFGIML 234
APE V D+++ G++
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-21
Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 32/199 (16%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G +G V A G + A K + F E E+MKS+ H N+I++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 109 NEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
+ LV+E G L K ++ + I + DV SA+ Y H +
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127
Query: 164 IHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-----Y 215
H DLKP N L + L DF +A + M T Y++P+ Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSPQVLEGLY 184
Query: 216 GREGRVSANGDVYSFGIML 234
G E D +S G+M+
Sbjct: 185 GPE------CDEWSAGVMM 197
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 58/231 (25%), Positives = 91/231 (39%), Gaps = 33/231 (14%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN--------LQCGRALKSFNVECEMMKSIRHRNL 100
+G G FG V+ A EV VK L +E ++ + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILD------IFQRLNIMIDVASALE 153
IKV+ N+ F LV+E G L+ + + + LD IF++L SA+
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQL------VSAVG 144
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL IIH D+K N+++ ++ L DF A L E + T TI Y AP
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCAP 198
Query: 214 E-YGREGRVSANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVND 260
E +++S G+ L + P +E + + V+
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSK 249
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-21
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 47/212 (22%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNV-----ECEMMKSIRHRNL 100
+G G G V A +VA+K+ + G A ++ E E++K + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 101 IKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYL 155
IK+ + E++ +VLE M G L F + A++YL
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130
Query: 156 HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYM 211
H IIH DLKP NVLL +++ + ++DF +K ++GE M T T Y+
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 183
Query: 212 APE---------YGREGRVSANGDVYSFGIML 234
APE Y R V D +S G++L
Sbjct: 184 APEVLVSVGTAGYNRA--V----DCWSLGVIL 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-21
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 29/235 (12%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHRNLIK---V 103
+G+G +G V A VAVK+ ++ + ++ E + K + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFG 158
N ++ L LEY G L + + F +L + + YLH
Sbjct: 74 RRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH-- 122
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-YGR 217
I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE R
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN------DWLPIST 266
+ DV+S GI+L G+ P D+ + W W I +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 8e-21
Identities = 54/241 (22%), Positives = 101/241 (41%), Gaps = 30/241 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEM-----MKSI 95
+ F + ++GKGGFG V ++ ++ A K L+ R K + ++ +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKV 241
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASAL 152
R ++ + + ++ LVL M G L+ ++Y + F + ++ L
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGL 299
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYM 211
E LH I++ DLKP N+LLDD+ +SD +A + + T+GYM
Sbjct: 300 EDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYM 352
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKHWVNDWL 262
APE + R + + D ++ G +L E G+ P +E+ + ++
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
Query: 263 P 263
Sbjct: 413 S 413
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-21
Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 37/232 (15%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN----LQCGRALKSFNV--ECEMMKSIRHR--N 99
L+G GGFGSVY + D + VA+K G V E ++K +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 100 LIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
+I+++ + L+LE P L ++ + + R + V A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166
Query: 159 YSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEY- 215
+ ++H D+K N+L+D N L DF LL T F T Y PE+
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVYSPPEWI 220
Query: 216 ------GREGRVSANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWV 258
GR V+S GI+L + G P +EI G++ + V
Sbjct: 221 RYHRYHGRS------AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 58/272 (21%), Positives = 98/272 (36%), Gaps = 56/272 (20%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVK-------------VFN--LQCGRALKSFNVECEMMKS 94
I G +G+V +G+ VA+K + + C R L+ E ++
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR----EIRLLNH 85
Query: 95 IRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
H N++ + LV E M L + ++ ++ M +
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
L LH A ++H DL P N+LL DN + DF++A+ D + T
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK--THYVTHRW 198
Query: 210 YMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262
Y APE + + D++S G ++ E F K +F G + N
Sbjct: 199 YRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK----ALFRG----STFYNQLN 244
Query: 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFN 294
I +EVV ED+ + ++ N
Sbjct: 245 KI--VEVVGT--PKIEDVVMFSSPSARDYLRN 272
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 59/219 (26%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNL--------QCGRALKSFNVECEMMKSIR-HRN 99
IG+G V + G E AVK+ + Q ++ E +++ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------------NIMID 147
+I +I S + F LV + M G L F L +IM
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRS 208
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
+ A+ +LH + I+H DLKP N+LLDDNM LSDF + + + + + T
Sbjct: 209 LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKL--RELCGT 262
Query: 208 IGYMAPE------------YGREGRVSANGDVYSFGIML 234
GY+APE YG+E D+++ G++L
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKE------VDLWACGVIL 295
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 39/234 (16%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN----LQCGRALKSFNV--ECEMMKSIR----H 97
L+GKGGFG+V+ L D ++VA+KV L S E ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 98 RNLIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+I+++ +E LVLE +P L Y+ + + R V +A+++ H
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 157 FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPE 214
S ++H D+K N+L+D A L DF LL D+ T F T Y PE
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYT---DFDGTRVYSPPE 208
Query: 215 Y-------GREGRVSANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWV 258
+ V+S GI+L + G P EI E+ V
Sbjct: 209 WISRHQYHALP------ATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 23/202 (11%)
Query: 43 EFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
S+ ++G G FG V+K G+++A K+ + + + E +M + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 102 KVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALEY 154
++ + ++ LV+EY+ G L E Y + + I M + + +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-------LFMKQICEGIRH 202
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H Y I+H DLKP N+L + + DF +A+ + + F T ++A
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKL--KVNFGTPEFLA 256
Query: 213 PEYGREGRVSANGDVYSFGIML 234
PE VS D++S G++
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 51/281 (18%)
Query: 11 RQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVA 70
S ++ +++ + +G+G +G VYKA+ G VA
Sbjct: 2 HHHHHHSSGRENLYF------------QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVA 49
Query: 71 VKVFNLQCGR------ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 124
+K L A++ E ++K + H N++ +I +E LV E+M
Sbjct: 50 LKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104
Query: 125 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 184
L+K L + L Q + + + + H I+H DLKP N+L++ + L+
Sbjct: 105 LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLA 161
Query: 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGK- 241
DF +A+ +S T T+ Y AP+ G + + S + D++S G + E TGK
Sbjct: 162 DFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKP 218
Query: 242 -------------------KPTDEIFNGEMTLKHWVNDWLP 263
P + L W
Sbjct: 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 62/247 (25%), Positives = 91/247 (36%), Gaps = 47/247 (19%)
Query: 11 RQRGKRPSNDASMPLVAMWRTFSYLELCQATDEFSEN----NLIGKGGFGSVYKAR-LGD 65
S AS Y D S+ + +G+G VY+ + G
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77
Query: 66 GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 125
A+KV K E ++ + H N+IK+ +LVLE + G L
Sbjct: 78 QKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 126 -----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL- 175
EK YS ++ + I A+ YLH I+H DLKP N+L
Sbjct: 136 FDRIVEKGYYSERDAADAVKQIL----------EAVAYLH---ENGIVHRDLKPENLLYA 182
Query: 176 --DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE------YGREGRVSANGDV 227
+ ++DF ++K +V M T GY APE YG E V D+
Sbjct: 183 TPAPDAPLKIADFGLSK-IVEHQVLM--KTVCGTPGYCAPEILRGCAYGPE--V----DM 233
Query: 228 YSFGIML 234
+S GI+
Sbjct: 234 WSVGIIT 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 45/204 (22%), Positives = 75/204 (36%), Gaps = 23/204 (11%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
D + + +G G FG V++ G A K ++ E + M +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASAL 152
L+ + + ++ ++ E+M G L E S + M V L
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-------EYMRQVCKGL 268
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLVGEDQSMTQTQTFATIGY 210
++H +H DLKP N++ L DF + L QS+ T T +
Sbjct: 269 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSV--KVTTGTAEF 322
Query: 211 MAPEYGREGRVSANGDVYSFGIML 234
APE V D++S G++
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-20
Identities = 65/301 (21%), Positives = 106/301 (35%), Gaps = 68/301 (22%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC------GRALKSFNVECEMMKSIRHRNLIK 102
IG+G +G V+K R G VA+K F AL+ E M+K ++H NL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
++ + LV EY H ++ L + +I A+ + H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-------Y 215
IH D+KP N+L+ + V L DF A+LL G AT Y +PE Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQY 180
Query: 216 GREGRVSANGDVYSFGIMLMETFTGK--------------------KPTDEIFNGEMTLK 255
G V DV++ G + E +G T +
Sbjct: 181 GPP--V----DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234
Query: 256 HWVN----DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK 311
++ D + LE+ N +S + + + P +R+ +
Sbjct: 235 YFSGVKIPDPEDMEPLELKFPN-ISYPALGLLKG----CLHMD---------PTERLTCE 280
Query: 312 E 312
+
Sbjct: 281 Q 281
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 58/259 (22%), Positives = 87/259 (33%), Gaps = 70/259 (27%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSIRHRNLIKV 103
IG+G +G V A A+K+ N R + +V E +MK + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--------------------- 142
+E++ LV+E G L L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 143 ------------------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL- 183
NIM + SAL YLH + I H D+KP N L N +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 184 -SDFSIAKLLVGEDQSMTQ--TQTFATIGYMAPE--------YGREGRVSANGDVYSFGI 232
DF ++K + T T ++APE YG + D +S G+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK------CDAWSAGV 264
Query: 233 MLMETFTGKKPTDEIFNGE 251
+L G P F G
Sbjct: 265 LLHLLLMGAVP----FPGV 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 25/198 (12%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
+G G FG V+ G+E +K N + ++ E E++KS+ H N+IK+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGYSAPII 164
+ +V+E G L + + S+ +M + +AL Y H S ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 165 HCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-----YG 216
H DLKP N+L + + DF +A+ L D+ T T YMAPE
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS--TNAAGTALYMAPEVFKRDVT 203
Query: 217 REGRVSANGDVYSFGIML 234
+ D++S G+++
Sbjct: 204 FK------CDIWSAGVVM 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-20
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 29/235 (12%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHRNLIK---V 103
+G+G +G V A VAVK+ ++ + ++ E + K + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFG 158
N ++ L LEY G L + + F +L + + YLH
Sbjct: 74 RRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH-- 122
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-YGR 217
I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE R
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN------DWLPIST 266
+ DV+S GI+L G+ P D+ + W W I +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-20
Identities = 69/313 (22%), Positives = 114/313 (36%), Gaps = 68/313 (21%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR------ALKSFNVECE 90
Q+ +++ L+G+G +G V K R G VA+K F A++ E +
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIK 76
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
++K +RH NL+ ++ C ++ LV E++ H ++ L LD + + +
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
+ + H S IIH D+KP N+L+ + V L DF A+ L + AT Y
Sbjct: 136 GIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWY 190
Query: 211 MAPE-------YGREGRVSANGDVYSFGIMLMETFTGK--------------------KP 243
APE YG+ V DV++ G ++ E F G+
Sbjct: 191 RAPELLVGDVKYGKA--V----DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL 244
Query: 244 TDEIFNGEMTLKHWVN----DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 299
+ + LE L V +LA C
Sbjct: 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEV--------------VIDLAKKC 290
Query: 300 AVESPEQRINAKE 312
P++R E
Sbjct: 291 LHIDPDKRPFCAE 303
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-20
Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR------ALKSFNVECEMMKS 94
++ + IG+G +G+V+KA+ VA+K L AL+ E ++K
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
++H+N++++ +++ LV E+ L+KY S N LD + + + L +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
H S ++H DLKP N+L++ N L++F +A+ + + T+ Y P+
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPD 171
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
+G + S + D++S G + E +P +F G
Sbjct: 172 VLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 6e-20
Identities = 37/175 (21%), Positives = 73/175 (41%), Gaps = 15/175 (8%)
Query: 84 SFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQR 141
+ +V+ M +N + + S + + + ++ +L+ ++ + +
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 142 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201
L+I I +A A+E+LH S ++H DLKPSN+ + V + DF + + +++ T
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 202 TQTFA----------TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T YM+PE S D++S G++L E E
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 16/93 (17%), Positives = 35/93 (37%), Gaps = 2/93 (2%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHRN 99
+F +G+GGFG V++A+ D A+K L A + E + + + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 132
+++ ++ + E ++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-20
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 44/233 (18%)
Query: 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVK-VFNLQC--GRALKSFNVECEMMKSI 95
Q ++ +IG G FG V++A+L + EVA+K V + R E ++M+ +
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIV 89
Query: 96 RHRNLIK----VISSCSNEEFKA--LVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMI 146
+H N++ S+ ++ LVLEY+P ++ + + + M
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+ +L Y+H S I H D+KP N+LLD + V L DF AK+L+ +
Sbjct: 149 QLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPN--VSYI 202
Query: 206 ATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
+ Y APE Y + N D++S G ++ E G +P +F GE
Sbjct: 203 CSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQG-QP---LFPGE 245
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIK-- 102
+G G FG V G +VAVK+ N ++ + E + +K RH ++IK
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 103 -VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH 156
VIS+ + F +V+EY+ G L Y+ + +FQ++ SA++Y H
Sbjct: 78 QVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVDYCH 128
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG---YMAP 213
++H DLKP NVLLD +M A ++DF ++ ++ D +T + G Y AP
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT----SCGSPNYAAP 179
Query: 214 E-YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVN 259
E D++S G++L G P D+ I G + ++N
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 61/233 (26%), Positives = 92/233 (39%), Gaps = 37/233 (15%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK----VFNLQ--CGRALKSFNVECEMMK 93
+ IG G G V A VA+K F Q RA + E +MK
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79
Query: 94 SIRHRNLIKV----ISSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDIFQRLNI 144
+ H+N+I + S EEF+ +V+E M ++ L ++Q L
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC- 138
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
+++LH SA IIH DLKPSN+++ + + DF +A+ S T
Sbjct: 139 ------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 186
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
T Y APE N D++S G ++ E G +F G + W
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 41/235 (17%)
Query: 39 QATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVK-VFN--LQCGRALKSFNVECEMMKS 94
+ D F + G+G FG+V + GM VA+K V R L+ + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ----IMQDLAV 75
Query: 95 IRHRNLIK---VISSCSNEEFK----ALVLEYMP---HGSLEKYLYSSNCILDIFQRLNI 144
+ H N+++ + + + +V+EY+P H Y I ++
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-F 134
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ + ++ LH S + H D+KP NVL++ + L DF AK L +
Sbjct: 135 LFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPN--VA 190
Query: 204 TFATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
+ Y APE Y + D++S G + E G +P IF G+
Sbjct: 191 YICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG-EP---IFRGD 235
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 47/226 (20%), Positives = 89/226 (39%), Gaps = 43/226 (19%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVEC-----EMMKSI 95
++F +IG+G FG V +L + +V A+K+ L LK C +++ +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNG 131
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID-------- 147
+ + + + ++ LV++Y G L L + +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYL 181
Query: 148 --VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQ 203
+ A++ +H +H D+KP N+L+D N H L+DF L+ + Q+
Sbjct: 182 AEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDG--TVQSS 234
Query: 204 TF-ATIGYMAPEYGREGRVSANG-----DVYSFGIMLMETFTGKKP 243
T Y++PE + D +S G+ + E G+ P
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 44/235 (18%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSIRHRNLIKV 103
IGKG F V AR + G EVA+K+ + L ++ E +MK + H N++K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-----IFQRLNIMIDVASALEYLHFG 158
E+ L++EY G + YL + + + F+++ SA++Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCH-- 131
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI----GYMAPE 214
I+H DLK N+LLD +M ++DF G T Y APE
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADF-------GFSNEFTVGGKLDAFCGAPPYAAPE 183
Query: 215 -YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVN 259
+ + DV+S G++L +G P D + G+ + +++
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKS---FNVECEMMKSIRH 97
+++ +IG+G FG V R +V A+K+ + F E ++M
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA-------- 149
++++ + ++ + +V+EYMP G L + ++ A
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAEVV 178
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQTF-A 206
AL+ +H S IH D+KP N+LLD + H L+DF + E M + T
Sbjct: 179 LALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEG--MVRCDTAVG 231
Query: 207 TIGYMAPE----------YGREGRVSANGDVYSFGIMLMETFTGKKP 243
T Y++PE YGRE D +S G+ L E G P
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRE--C----DWWSVGVFLYEMLVGDTP 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 45/232 (19%)
Query: 41 TDEFSENNLIGKGGFGSVYKARLGD-GMEVAVK-VFNLQ--CGRALKSFNVECEMMKSIR 96
+++ +IG G FG VY+A+L D G VA+K V + R E ++M+ +
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLD 105
Query: 97 HRNLIKVI------SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMID 147
H N++++ +E + LVL+Y+P + Y + + I+ +L M
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQ 164
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+ +L Y+H S I H D+KP N+LLD D V L DF AK LV +
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPN--VSYIC 218
Query: 207 TIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
+ Y APE Y +++ DV+S G +L E G +P IF G+
Sbjct: 219 SRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-19
Identities = 75/313 (23%), Positives = 127/313 (40%), Gaps = 62/313 (19%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK-SFNV----E 88
L++ + + + +G+G F +VYKAR VA+K L K N E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 89 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
++++ + H N+I ++ + ++ +LV ++M LE + ++ +L M+
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
LEYLH I+H DLKP+N+LLD+N V L+DF +AK +++ T T
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTR 176
Query: 209 GYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGK-------------------- 241
Y APE YG V D+++ G +L E
Sbjct: 177 WYRAPELLFGARMYGVG--V----DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230
Query: 242 KPTDEIFNGEMTLKHWVN--DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 299
PT+E + +L +V + I + A + + + F+FN
Sbjct: 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA--AGDDLLDLIQG----LFLFN----- 279
Query: 300 AVESPEQRINAKE 312
P RI A +
Sbjct: 280 ----PCARITATQ 288
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 46/202 (22%), Positives = 76/202 (37%), Gaps = 30/202 (14%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G F V K R G+E A K + G + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 103 VISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 156
+ N L+LE + G L +K S + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132
Query: 157 FGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+ I H DLKP N++L L DF +A + + F T ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVA 186
Query: 213 PEYGREGRVSANGDVYSFGIML 234
PE + D++S G++
Sbjct: 187 PEIVNYEPLGLEADMWSIGVIT 208
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 63/272 (23%), Positives = 109/272 (40%), Gaps = 48/272 (17%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKSFNVECEMMK 93
+ +G G +GSV A G +VA+K F + RA + E ++K
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78
Query: 94 SIRHRNLIK----VISSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDIFQRLNI 144
++H N+I + S F LV+ +M + ++Q L
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK- 137
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
L+Y+H SA ++H DLKP N+ ++++ + DF +A+ D M T
Sbjct: 138 ------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGY 183
Query: 205 FATIGYMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
T Y APE + D++S G ++ E TGK +F G K +++
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKG----KDYLDQLTQ 235
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNL 295
I L+V E + + + S++ +L
Sbjct: 236 I--LKVTGV--PGTEFVQKLNDKAAKSYIQSL 263
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-19
Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 30/202 (14%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G F V K R G G E A K + G + + E +++ IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 103 VISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 156
+ N+ L+LE + G L EK + + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQILDGVHYLH 125
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
S I H DLKP N++L D V + L DF IA + F T ++A
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGTPEFVA 179
Query: 213 PEYGREGRVSANGDVYSFGIML 234
PE + D++S G++
Sbjct: 180 PEIVNYEPLGLEADMWSIGVIT 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-19
Identities = 60/302 (19%), Positives = 118/302 (39%), Gaps = 57/302 (18%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR------ALKSFNVECEMMKSI 95
+++ IG+G +G VYKA+ G A+K L+ ++ E ++K +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+H N++K+ ++ LV E++ L+K L L+ + ++ + + + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE- 214
H ++H DLKP N+L++ ++DF +A+ + T T+ Y AP+
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDV 171
Query: 215 -YGREGRVSANGDVYSFGIMLMETFTGK--------------------KPTDEIFNGEMT 253
G + + S D++S G + E G P + +
Sbjct: 172 LMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 254 LKHWVND---WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA 310
L + + + P+ + L + I ++K + P QRI A
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKG--LDESGIDLLSK----MLKLD---------PNQRITA 275
Query: 311 KE 312
K+
Sbjct: 276 KQ 277
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-19
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSF---NVECEMMKSIRH 97
D+F +G G FG V + + A+K+ + Q LK E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+ G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE-- 214
S +I+ DLKP N+L+D ++DF AK + G +T T T +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEII 210
Query: 215 ----YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
Y + V D ++ G+++ E G P +I+
Sbjct: 211 LSKGYNKA--V----DWWALGVLIYEMAAGYPPFFADQPIQIYE 248
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 38/197 (19%), Positives = 75/197 (38%), Gaps = 28/197 (14%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV--ECEMMKSIRHRNLIKVISS 106
+G+G FG V++ K + V E ++ RHRN++ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 107 CSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGY 159
+ E ++ E++ + + + + + + V AL++LH
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQVCEALQFLHSHN 122
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
I H D++P N++ + + +F A+ L + F Y APE +
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNF--RLLFTAPEYYAPEVHQ 176
Query: 218 EGRVSANGDVYSFGIML 234
VS D++S G ++
Sbjct: 177 HDVVSTATDMWSLGTLV 193
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 51/240 (21%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV------ECEMMKSIRHRNLI 101
+G G FG V + G +VAVK+ N Q ++S +V E + +K RH ++I
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 102 K---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALE 153
K VIS+ ++ F +V+EY+ G L Y+ + + +FQ++ S ++
Sbjct: 80 KLYQVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVD 130
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI----G 209
Y H ++H DLKP NVLLD +M A ++DF ++ + M+ + T
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPN 180
Query: 210 YMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVN 259
Y APE D++S G++L G P D+ I +G ++N
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 46/202 (22%), Positives = 77/202 (38%), Gaps = 30/202 (14%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G F V K R G+E A K + G + + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 103 VISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 156
+ N L+LE + G L +K S + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132
Query: 157 FGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+ I H DLKP N++L L DF +A + + F T ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPEFVA 186
Query: 213 PEYGREGRVSANGDVYSFGIML 234
PE + D++S G++
Sbjct: 187 PEIVNYEPLGLEADMWSIGVIT 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 65/336 (19%), Positives = 118/336 (35%), Gaps = 63/336 (18%)
Query: 14 GKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK 72
+ + S + D + +G+G +G VYKA VA+K
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65
Query: 73 VFNLQCGR------ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 126
L+ A++ E ++K ++HRN+I++ S + L+ EY + L+
Sbjct: 66 RIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLK 120
Query: 127 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH---- 182
KY+ N + + + + + + + + H S +H DLKP N+LL + +
Sbjct: 121 KYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVL 176
Query: 183 -LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFT 239
+ DF +A+ + T T+ Y PE G S + D++S + E
Sbjct: 177 KIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLM 233
Query: 240 GK--------------------KPTDEIFNGEMTLKHWVND---WLPISTLEVVDANLLS 276
P D + G L W + + V+ LL
Sbjct: 234 KTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL-GALLD 292
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKE 312
E + + + P +RI+AK
Sbjct: 293 DEGLDLLTA----MLEMD---------PVKRISAKN 315
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 38/236 (16%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV----ECEMM 92
C ++ + IG+G FG V+KAR G +VA+K ++ + F + E +++
Sbjct: 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKIL 70
Query: 93 KSIRHRN---LIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
+ ++H N LI++ + ++ + LV ++ H L L + + + +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ--T 202
M + + L Y+H I+H D+K +NVL+ + V L+DF +A+ S T
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 203 QTFATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
T+ Y PE YG + D++ G ++ E +T + P I G
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPP--I----DLWGAGCIMAEMWT-RSP---IMQGN 232
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 58/212 (27%), Positives = 83/212 (39%), Gaps = 32/212 (15%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV--ECEMMKSIRHRNLIKVIS 105
IG G FG R VAVK A NV E +S+RH N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERG---AAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGYS 160
A+++EY G L + + ++ FQ+L S + Y H S
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH---S 134
Query: 161 APIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLVGEDQSMTQTQTFATIG---YMAPE- 214
I H DLK N LLD + L DF +K S ++ T+G Y+APE
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQPKS----TVGTPAYIAPEV 188
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
R+ DV+S G+ L G P ++
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 48/211 (22%), Positives = 80/211 (37%), Gaps = 30/211 (14%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFN------LQCGRALKSFNVECEMMK 93
D + +G G F V K R G++ A K + G + + E ++K
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 94 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIMID 147
I+H N+I + N+ L+LE + G L EK + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQ 122
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ + + YLH S I H DLKP N++L + DF +A +
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF--KN 176
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIML 234
F T ++APE + D++S G++
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 68/274 (24%), Positives = 125/274 (45%), Gaps = 47/274 (17%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK---VFN--LQCGRALKSFNVECEMMKS 94
++ + IG+G +G V A + + VA+K F C R L+ E +++
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLR 81
Query: 95 IRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
RH N+I +I + + E+ K +V + M L K L + + + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICY-FLYQIL 138
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATI 208
L+Y+H SA ++H DLKPSN+LL+ + DF +A++ + T+ AT
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 209 GYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261
Y APE Y + + D++S G +L E + + IF G KH+++
Sbjct: 196 WYRAPEIMLNSKGY------TKSIDIWSVGCILAEMLSNR----PIFPG----KHYLDQL 241
Query: 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNL 295
I L ++ + SQED++ + + +++ +L
Sbjct: 242 NHI--LGILGS--PSQEDLNCIINLKARNYLLSL 271
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 32/226 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEM-----MKSI 95
+EF L+GKG FG V + A+K+ L+ + V + +++
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH L + S + V+EY G L +L + R ++ SAL+YL
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYL 264
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE 214
H + +++ DLK N++LD + ++DF + K + + + +TF T Y+APE
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPE 319
Query: 215 ------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
YGR V D + G+++ E G+ P +++F
Sbjct: 320 VLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 40/228 (17%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVEC-----EMMKSI 95
+F +G G FG V+ R A+KV L+ ++ VE M+ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +I++ + + + ++++Y+ G L L S + + +V ALEYL
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYL 122
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQTF-ATIGYMA 212
H S II+ DLKP N+LLD N H ++DF AK + T T T Y+A
Sbjct: 123 H---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP------DVTYTLCGTPDYIA 171
Query: 213 PE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
PE Y + S D +SFGI++ E G P T + +
Sbjct: 172 PEVVSTKPYNK----SI--DWWSFGILIYEMLAGYTPFYDSNTMKTYE 213
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 37/233 (15%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKSFNVECEMMK 93
+ IG G G V A VA+K F RA + E +MK
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116
Query: 94 SIRHRNLIKVI----SSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDIFQRLNI 144
+ H+N+I ++ + EEF+ LV+E M ++ L ++Q L
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC- 175
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
+++LH SA IIH DLKPSN+++ + + DF +A+ G M T
Sbjct: 176 ------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM--TPY 223
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
T Y APE N D++S G ++ E K +F G + W
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQW 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMM-----KSIRHRNLIK 102
L+GKG FG V R A+K+ L+ + V + ++ RH L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ + + V+EY G L +L + R ++ SALEYLH S
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH---SRD 125
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE------Y 215
+++ D+K N++LD + ++DF + K + + + +TF T Y+APE Y
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDNDY 182
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
GR V D + G+++ E G+ P + +F
Sbjct: 183 GRA--V----DWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 51/239 (21%), Positives = 88/239 (36%), Gaps = 50/239 (20%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEM-----MKSI 95
D+F +IG+G F V ++ +V A+K+ + LK V C + +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNG 118
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID-------- 147
R + ++ + +E + LV+EY G L L + I
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYL 168
Query: 148 --VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQ 203
+ A++ +H +H D+KP N+LLD H L+DF L + ++
Sbjct: 169 AEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG--TVRSL 221
Query: 204 TF-ATIGYMAPEYGREGRVSANGDVY-------SFGIMLMETFTGKKP-----TDEIFN 249
T Y++PE + Y + G+ E F G+ P T E +
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 67/269 (24%), Positives = 113/269 (42%), Gaps = 41/269 (15%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKSFNVECEMMK 93
+ + + +G G +GSV A G+ VAVK F + R + E ++K
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLK 83
Query: 94 SIRHRNLIKV----ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 147
++H N+I + + S EEF LV M L + D Q ++
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQ 140
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
+ L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ M T AT
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEM--TGYVAT 192
Query: 208 IGYMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266
Y APE + D++S G ++ E TG+ +F G ++ I
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPG----TDHIDQLKLI-- 242
Query: 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNL 295
L +V E + ++ E +++ +L
Sbjct: 243 LRLVGT--PGAELLKKISSESARNYIQSL 269
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMM------KS 94
+F+ ++GKG FG V + E+ AVK+ L+ ++ +VEC M+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALP 398
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ L ++ S + V+EY+ G L ++ + ++A L +
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFF 457
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAP 213
L S II+ DLK NV+LD ++DF + K + + T+TF T Y+AP
Sbjct: 458 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAP 511
Query: 214 E------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
E YG+ V D ++FG++L E G+ P DE+F
Sbjct: 512 EIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMM------KSIRHRNLI 101
++GKG FG V AR+ + ++ AVKV L+ L+ +VEC M + H L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ + V+E++ G L ++ S + R ++ SAL +LH
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---DK 143
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE------ 214
II+ DLK NVLLD L+DF + K + + T TF T Y+APE
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPEILQEML 200
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
YG V D ++ G++L E G P D++F
Sbjct: 201 YGPA--V----DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 72/222 (32%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMM------KSIRHRNLI 101
+IGKG FG V AR AVKV LQ LK + M K+++H L+
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ S + VL+Y+ G L +L C L+ R ++ASAL YLH S
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH---SL 158
Query: 162 PIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE---- 214
I++ DLKP N+LLD H L+DF + K + + + T TF T Y+APE
Sbjct: 159 NIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHK 213
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
Y R V D + G +L E G P T E+++
Sbjct: 214 QPYDRT--V----DWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 46/207 (22%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV----ECEMMKSIR 96
+ + + + +G+G + +VYK + VA+K L+ + E ++K ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE---HEEGAPCTAIREVSLLKDLK 58
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++ + E+ LV EY+ L++YL I+++ + + L Y H
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-- 214
++H DLKP N+L+++ L+DF +A+ ++ T+ Y P+
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPDIL 172
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGK 241
G S D++ G + E TG+
Sbjct: 173 LGST-DYSTQIDMWGVGCIFYEMATGR 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 40/199 (20%), Positives = 77/199 (38%), Gaps = 26/199 (13%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHR-NLIKVIS 105
+G+G F V + G E A K + E +++ + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 106 SCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRL------NIMIDVASALEYLHFG 158
N L+LEY G + C+ ++ + + ++ + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSL------CLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAH---LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
I+H DLKP N+LL + DF +++ + G + + T Y+APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACEL--REIMGTPEYLAPEI 204
Query: 216 GREGRVSANGDVYSFGIML 234
++ D+++ GI+
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMM------KSIRHRNLI 101
++GKG FG V+ A + A+K L+ L +VEC M+ + H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ + +E V+EY+ G L ++ S + ++ L++LH S
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLH---SK 137
Query: 162 PIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE---- 214
I++ DLK N+LLD + H ++DF + K + D T TF T Y+APE
Sbjct: 138 GIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEILLG 192
Query: 215 --YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
Y D +SFG++L E G+ P +E+F+
Sbjct: 193 QKYNHS------VDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 45/215 (20%), Positives = 84/215 (39%), Gaps = 60/215 (27%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECE---MMKSIRHRNLIKVI 104
++G G G V + G + A+K+ S E ++ +++ ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 105 ----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVA 149
+ + +++E M G L I +R + IM D+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+A+++LH S I H D+KP N+L + + V L+DF AK ++ T
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQ---TPC 190
Query: 207 -TIGYMAPE------YGREGRVSANGDVYSFGIML 234
T Y+APE Y + D++S G+++
Sbjct: 191 YTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 48/222 (21%), Positives = 97/222 (43%), Gaps = 24/222 (10%)
Query: 15 KRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK- 72
+R + +S P +M R S ++ D + +LIG G +G V +A + VA+K
Sbjct: 29 QRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK 85
Query: 73 ---VFN--LQCGRALKSFNVECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPH 122
VF + C R L+ E ++ + H +++K ++ E+F +VLE
Sbjct: 86 ILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS 141
Query: 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 182
+K + + ++ + ++ ++ ++Y+H SA I+H DLKP+N L++ +
Sbjct: 142 -DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVK 196
Query: 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
+ DF +A+ + + +Q M +
Sbjct: 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 53/272 (19%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK---VFN--LQCGRALKSFNVECEMMKSIRHRNLIK- 102
+G+G +G V A G VA+K F+ L R L+ E +++K +H N+I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 103 --VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
+ S E F ++ E M L + + S+ + D + + A++ LH
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-STQMLSDDHIQY-FIYQTLRAVKVLH-- 129
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ--------TQTFATIGY 210
+ +IH DLKPSN+L++ N + DF +A+++ ++ + AT Y
Sbjct: 130 -GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 211 MAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
APE Y S DV+S G +L E F + IF G + + + L
Sbjct: 189 RAPEVMLTSAKY------SRAMDVWSCGCILAELFLRRP----IFPG----RDYRHQLLL 234
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNL 295
I ++ S D+ + + ++ +L
Sbjct: 235 I--FGII-GTPHSDNDLRCIESPRAREYIKSL 263
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 43/213 (20%), Positives = 79/213 (37%), Gaps = 57/213 (26%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECE---MMKSIRHRNLIKVI- 104
+G G G V + + A+K+ E ++ + ++++++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122
Query: 105 ---SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVAS 150
+ + + +V+E + G L I R + IM +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
A++YLH S I H D+KP N+L N + L+DF AK + T T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYT 226
Query: 208 IGYMAPE------YGREGRVSANGDVYSFGIML 234
Y+APE Y + D++S G+++
Sbjct: 227 PYYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 26/221 (11%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-ALKSFNV----ECEM 91
AT + IG G +G+VYKAR G VA+K + G + E +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 92 MKSIR---HRN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCI-LDIFQRL 142
++ + H N L+ V ++ + LV E++ L YL + L
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 143 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202
++M L++LH + I+H DLKP N+L+ L+DF +A++ M T
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177
Query: 203 QTFATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGK 241
T+ Y APE + D++S G + E F K
Sbjct: 178 PVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 44/225 (19%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMM------KSIRHRNLI 101
++GKG FG V + E+ AVK+ L+ ++ +VEC M+ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEYLHFG 158
++ S + V+EY+ G L ++ F ++A L +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ-- 138
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE- 214
S II+ DLK NV+LD H ++DF + K + + T+TF T Y+APE
Sbjct: 139 -SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAPEI 192
Query: 215 -----YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
YG+ V D ++FG++L E G+ P DE+F
Sbjct: 193 IAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 52/240 (21%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV------ECEMMKSIRHRNLI 101
+G+G FG V A +VA+K + Q LK ++ E +K +RH ++I
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 102 K---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALE 153
K VI++ + +V+EY G L Y+ + FQ++ A+E
Sbjct: 73 KLYDVITT-PTDIV--MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI------ICAIE 122
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI----G 209
Y H I+H DLKP N+LLDDN+ ++DF ++ + MT T
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-------MTDGNFLKTSCGSPN 172
Query: 210 YMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVN 259
Y APE + DV+S GI+L G+ P D+ + + + +++
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLS 232
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 63/260 (24%), Positives = 112/260 (43%), Gaps = 41/260 (15%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G +G+V A G +VA+K F L RA + E ++K +RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 103 VI----SSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
++ + ++F LV+ +M L K + L + ++ + L Y+H
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH 145
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY- 215
+A IIH DLKP N+ ++++ + DF +A+ D M T T Y APE
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--TGYVVTRWYRAPEVI 197
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
R + D++S G ++ E TGK +F G ++ I ++V
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK----TLFKG----SDHLDQLKEI--MKVTGT--P 245
Query: 276 SQEDIHFVAKEQCVSFVFNL 295
E + + ++ +++ L
Sbjct: 246 PAEFVQRLQSDEAKNYMKGL 265
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 61/335 (18%), Positives = 118/335 (35%), Gaps = 76/335 (22%)
Query: 36 ELCQATDEFS-ENNLIGKGGFGSVYKAR---LGDGMEVAVKVFNLQCGRALKSFNVECEM 91
E + D F E +G+G +G VYKA+ D + A+K G ++ + E+
Sbjct: 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSAC---REI 69
Query: 92 --MKSIRHRN---LIKVISSCSNEEFKALVLEYMPHGSLEKYL--------YSSNCILDI 138
++ ++H N L KV S ++ + L+ +Y H L + L
Sbjct: 70 ALLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPR 127
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIAKLLVG 194
+++ + + YLH + ++H DLKP+N+L+ ++D A+L
Sbjct: 128 GMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 195 EDQSMTQ-TQTFATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGK----- 241
+ + T Y APE Y + + D+++ G + E T +
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKA--I----DIWAIGCIFAELLTSEPIFHC 238
Query: 242 ------------------------KPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
P D+ + + + +L+
Sbjct: 239 RQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKY 298
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKE 312
+ H V + S F+L P +RI +++
Sbjct: 299 MEKHKVKPD---SKAFHLLQKLLTMDPIKRITSEQ 330
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 55/301 (18%), Positives = 109/301 (36%), Gaps = 70/301 (23%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK----VFN--LQCGRALKSFNVECEMMKSIRHRNLIK 102
IG+G +G VY A VA+K +F + C R L+ E ++ ++ +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 103 ---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
+I +F +VLE L+K + + + + I+ ++ ++H
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH- 146
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF------------ 205
+ IIH DLKP+N LL+ + + DF +A+ + E +
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 206 --------ATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---- 246
T Y APE Y + + D++S G + E +
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENY------TKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 247 ---IFNGEMTLKHWVNDWLPISTLE-VVD-----ANLL---SQEDIHFVAKEQCVSFVFN 294
+F G + + D N++ +++D+ + K + + ++
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318
Query: 295 L 295
Sbjct: 319 F 319
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 29/209 (13%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMM------KSIRHRNLI 101
+IG+G + V RL + A+KV ++ +++ ++ H L+
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ S E V+EY+ G L ++ + + R +++ AL YLH
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ER 129
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE------ 214
II+ DLK NVLLD L+D+ + K + T TF T Y+APE
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGED 186
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP 243
YG V D ++ G+++ E G+ P
Sbjct: 187 YGFS--V----DWWALGVLMFEMMAGRSP 209
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 54/252 (21%), Positives = 96/252 (38%), Gaps = 71/252 (28%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVI---- 104
+G G FG V + + G A+K + E ++MK + H N+IK++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 105 ----------------------------------SSCSNEEFKALVLEYMP---HGSLEK 127
+ S ++ +++EY+P H L+
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 128 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDF 186
++ S I + + + A+ ++H S I H D+KP N+L++ + L DF
Sbjct: 131 FIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 187 SIAKLLVGEDQSMTQTQTFATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFT 239
AK L+ + + Y APE Y + + D++S G + E
Sbjct: 187 GSAKKLI-PSEPS--VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGELIL 237
Query: 240 GKKPTDEIFNGE 251
G KP +F+GE
Sbjct: 238 G-KP---LFSGE 245
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 42/236 (17%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKAR--LGDGMEVAVKVFNLQCGR------------ALK 83
C+A ++ IG+G +G V+KAR G VA+K +Q G L+
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 84 SFNVECEMMKSIRHRN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYS-SNCILD 137
+++ H N L V + + LV E++ L YL +
Sbjct: 67 -------HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
++M + L++LH S ++H DLKP N+L+ + L+DF +A++
Sbjct: 119 TETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SF 172
Query: 198 SMTQTQTFATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
M T T+ Y APE + D++S G + E F +KP +F G
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFR-RKP---LFRGS 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 45/226 (19%)
Query: 49 LIGKGGFGSVYKARLGDGMEV----AVKVFNLQCGRALKSFNVECEM----MKSIRHRNL 100
++G+G FG V+ + G + A+KV L+ V +M + + H +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEYLHF 157
+K+ + E L+L+++ G L L F + + + ++A AL++LH
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALALDHLH- 143
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE 214
S II+ DLKP N+LLD+ H L+DF ++K + ++ +F T+ YMAPE
Sbjct: 144 --SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPE 196
Query: 215 ------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
+ + SA D +SFG+++ E TG P E
Sbjct: 197 VVNRRGHTQ----SA--DWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 63/318 (19%), Positives = 117/318 (36%), Gaps = 73/318 (22%)
Query: 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR--ALKSFNVECE------ 90
++ +F + +G G + +VYK N G ALK ++ E
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGL------------NKTTGVYVALKEVKLDSEEGTPST 49
Query: 91 ------MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIF 139
+MK ++H N++++ E LV E+M + L+KY+ S L++
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELN 108
Query: 140 QRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199
+ L + H I+H DLKP N+L++ L DF +A+ +
Sbjct: 109 LVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165
Query: 200 TQTQTFATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGK---------------- 241
+ T+ Y AP+ G S + D++S G +L E TGK
Sbjct: 166 --SSEVVTLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222
Query: 242 ----KPTDEIFNGEMTLKHWVND---WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFN 294
P + ++ L + + P +V+ + D + + +
Sbjct: 223 DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLM----------D 272
Query: 295 LAMACAVESPEQRINAKE 312
+P+ R++AK+
Sbjct: 273 FLHGLLQLNPDMRLSAKQ 290
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 29/209 (13%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMM------KSIRHRNLI 101
+IG+G + V RL + A++V ++ +++ ++ H L+
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ S E V+EY+ G L ++ + + R +++ AL YLH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ER 172
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE------ 214
II+ DLK NVLLD L+D+ + K + T TF T Y+APE
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGED 229
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP 243
YG V D ++ G+++ E G+ P
Sbjct: 230 YGFS--V----DWWALGVLMFEMMAGRSP 252
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-16
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 47/228 (20%)
Query: 49 LIGKGGFGSVYKARL----GDGMEVAVKVFNLQCGRALKSFN-VECEMM-----KSIRHR 98
++GKGG+G V++ R G A+KV L+ +++ + ++H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEYL 155
++ +I + L+LEY+ G L L IF + +++ AL +L
Sbjct: 82 FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHL 137
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQTFA-TIGYMA 212
H II+ DLKP N++L+ H L+DF + K + + T TF TI YMA
Sbjct: 138 H---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTFCGTIEYMA 189
Query: 213 PE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 249
PE + R V D +S G ++ + TG P + +
Sbjct: 190 PEILMRSGHNRA--V----DWWSLGALMYDMLTGAPPFTGENRKKTID 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 54/236 (22%), Positives = 97/236 (41%), Gaps = 48/236 (20%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK--VFN--LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+G GG G V+ A VA+K V AL+ E ++++ + H N++KV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 105 ------------SSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
S E + +V EYM L L + + + M +
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHAR--LFMYQLLR 131
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATI 208
L+Y+H SA ++H DLKP+N+ ++ +++V + DF +A+++ ++ T
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 209 GYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
Y +P Y + D+++ G + E TGK +F G L+
Sbjct: 189 WYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK----TLFAGAHELEQM 234
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 49 LIGKGGFGSVYKARLGDGMEV----AVKVFN----LQCGRALKSFNVECEMMKSIRHRN- 99
++G G +G V+ R G + A+KV +Q + + E ++++ IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI------MIDVASALE 153
L+ + + E L+L+Y+ G L +L +R + ++ ALE
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALE 173
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQTQTFA-TIGY 210
+LH II+ D+K N+LLD N H L+DF ++K V ++ F TI Y
Sbjct: 174 HLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER--AYDFCGTIEY 226
Query: 211 MAPEYGREGRVSANGDV--YSFGIMLMETFTGKKP 243
MAP+ R G + V +S G+++ E TG P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 64/282 (22%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK-VFN-----LQCGRALKSFNVECEMMKSIR-HRNLI 101
+GKG +G V+K+ G VAVK +F+ R + E ++ + H N++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 102 KVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+++ + + LV +YM L + ++ IL+ + ++ + ++YLH
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH--- 126
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-------------- 205
S ++H D+KPSN+LL+ ++DF +++ V +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 206 -----ATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 253
AT Y APE Y + D++S G +L E G KP IF G
Sbjct: 187 LTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCG-KP---IFPG--- 233
Query: 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNL 295
+N I + V+D S ED+ + + + +L
Sbjct: 234 -SSTMNQLERI--IGVIDF--PSNEDVESIQSPFAKTMIESL 270
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 35/171 (20%), Positives = 63/171 (36%), Gaps = 48/171 (28%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECE---MMKSIRHRNLIKVI- 104
+G G G V + + A+K+ E ++ + ++++++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 105 ---SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--------------NIMID 147
+ + + +V+E + G L F R+ IM
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGE 195
+ A++YLH S I H D+KP N+L N + L+DF AK GE
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 48/220 (21%), Positives = 94/220 (42%), Gaps = 46/220 (20%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIR-HRNLIK---- 102
+G+G + V++A + + +V VK+ + + + E ++++++R N+I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGY 159
V S ALV E++ + ++ + + +++ L AL+Y H
Sbjct: 100 VKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCH--- 147
Query: 160 SAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE---- 214
S I+H D+KP NV++D ++ L D+ +A+ Q A+ + PE
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEY--NVRVASRYFKGPELLVD 204
Query: 215 ---YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
Y + D++S G ML K+P F+G
Sbjct: 205 YQMY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI-KVISSC 107
IG G FG + + L VA+K+ ++ ++E K + + I +V
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 108 SNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
++ A+VLE + G SLE + + L I I + S +EY+H S +I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129
Query: 167 DLKPSNVLL------DDNMVAHLSDFSIAK 190
D+KP N L+ ++ H+ DF++AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 44/245 (17%), Positives = 86/245 (35%), Gaps = 56/245 (22%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN----VECEMMKSIR------- 96
+G G F +V+ A+ + + VA+K+ R K + E ++++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 97 -HRNLIKVISSCSNEEFKA-------LVLEYMPHGSLEKYLYSSNCILDIFQRLN----- 143
++ + K +V E + +L + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-----HRGIPLIYVK 134
Query: 144 -IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH------LSDFSIAKLLVGED 196
I + L+Y+H IIH D+KP NVL++ ++D A D
Sbjct: 135 QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYD 189
Query: 197 QSMTQT-QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
+ T + QT Y +PE D++S ++ E TG +F +
Sbjct: 190 EHYTNSIQTRE---YRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPDEGHS 242
Query: 256 HWVND 260
+ +D
Sbjct: 243 YTKDD 247
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 42/212 (19%), Positives = 79/212 (37%), Gaps = 30/212 (14%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI-KVISSC 107
IG+G FG +++ L + +VA+K + E K + I V
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
LV++ + SLE L + + + ++ +H +++ D
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131
Query: 168 LKPSNVLL------DDNMVAHLSDFSIAKLLVG----------EDQSMTQTQTFATIGYM 211
+KP N L+ + NM+ ++ DF + K E ++++ T + +I
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI--- 187
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
GRE S D+ + G + M G P
Sbjct: 188 NTHLGREQ--SRRDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI-KVISSC 107
IG G FG +Y + G EVA+K+ ++ ++E ++ K ++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+ ++ +V+E + SLE + + L + + S +EY+H S IH D
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130
Query: 168 LKPSNVLL---DDNMVAHLSDFSIAK----------LLVGEDQSMTQTQTFATIGYMAPE 214
+KP N L+ + ++ DF +AK + E++++T T +A+I
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI---NTH 187
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP 243
G E S D+ S G +LM G P
Sbjct: 188 LGIEQ--SRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI-KVISSC 107
IG G FG +Y + EVA+K+ N++ E ++ + ++ I V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
++ LV++ + SLE + L + L + + + +E++H S +H D
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 168 LKPSNVLLDDNMVAH---LSDFSIAKLLVG----------EDQSMTQTQTFATIGYMAPE 214
+KP N L+ A+ + DF +AK E++++T T +A++
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV---NTH 185
Query: 215 YGRE-GRVSANGDVYSFGIMLMETFTGKKP 243
G E R D+ S G +LM G P
Sbjct: 186 LGIEQSRRD---DLESLGYVLMYFLRGSLP 212
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 46/224 (20%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN----VECEMMKSIRHR----- 98
+IGKG FG V KA VA+K+ R K F+ E +++ +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 99 -NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASA 151
N+I ++ + + + E + +L + + + FQ + +
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNK-----FQGFSLPLVRKFAHSILQC 212
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQT-QT-FAT 207
L+ LH IIHCDLKP N+LL + + DF + E Q + Q+ F
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQSRF-- 264
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
Y APE R D++S G +L E TG + GE
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGE 302
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 2e-11
Identities = 37/208 (17%), Positives = 63/208 (30%), Gaps = 57/208 (27%)
Query: 31 TFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKV--------FNLQCGRAL 82
FS+ C T++ IG+G FG V++ D VA+K+ N +
Sbjct: 12 PFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 83 KSFNVECEMMKSI---------RHRNLIKVISSC-------------------------- 107
+ E + K + R I + S
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 108 ----SNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
++ +VLE+ G LE+ + + +I+ + ++L
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR-- 182
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
H DL NVLL + L K
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 33/166 (19%), Positives = 62/166 (37%), Gaps = 31/166 (18%)
Query: 50 IGKGGFGSVYKAR---------LGDGMEVAVKV-------FNLQ--CGRALKSFNVECEM 91
+ G +Y+A + ++K+ FN Q RA K V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 92 -MKSIRHRNLIKVISSCSNE-EFKALVLEYMPHG-SLEKYL-YSSNCILDIFQRLNIMID 147
+ S + + ++ +++ LVL + G SL+ L S +L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAK 190
+ ALE+LH +H ++ N+ + D + V L+ + A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 37/167 (22%), Positives = 69/167 (41%), Gaps = 31/167 (18%)
Query: 49 LIGKGGFGSVYKAR------LGDGMEVAVKVFNLQCG------RALKSFNVECEMMKSIR 96
IG+GGFG +Y A +G VKV G + + ++ K IR
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 97 HRNLIKV---------ISSCSNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMI 146
R L + + + + ++ ++++ G L+K ++ L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAK 190
+ LEY+H +H D+K SN+LL + + V +L D+ +A
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 36/170 (21%), Positives = 70/170 (41%), Gaps = 40/170 (23%)
Query: 49 LIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRA---------LKSFNVECEMMKSIRHR 98
IG GGFG +Y A + A V ++ + + + K I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 99 NLIKV---------ISSCSNEEFKALVLEYMPHG-SLEKYL-----YSSNCILDIFQRLN 143
L + ++ ++ +V+E + G L+K + + +L + R
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIR-- 159
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAK 190
M+DV LEY+H +H D+K +N+LL + + V +L+D+ ++
Sbjct: 160 -MLDV---LEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 40/216 (18%)
Query: 47 NNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN----VECEMMKSIRHR--- 98
++LIGKG FG V KA + VA+K+ + K+F +E +++ +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 99 ---NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVA 149
++ + LV E + +L L ++N F+ ++ +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTN-----FRGVSLNLTRKFAQQMC 167
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH--LSDFSIAKLLVGEDQSMTQ-TQT-F 205
+AL +L IIHCDLKP N+LL + + + DF + Q + Q Q+ F
Sbjct: 168 TALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQYIQSRF 223
Query: 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 241
Y +PE D++S G +L+E TG+
Sbjct: 224 ----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 51/242 (21%), Positives = 87/242 (35%), Gaps = 76/242 (31%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN----VECEMMKSIRHR----- 98
+G G FG V + + + AVKV R +K + +E +++K I++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 99 NLIKVISS-------CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IM 145
N++K C L+ E + SL + + +N + +
Sbjct: 97 NIVKYHGKFMYYDHMC-------LIFEPL-GPSLYEIITRNN-----YNGFHIEDIKLYC 143
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ-------- 197
I++ AL YL + H DLKP N+LLDD + Q
Sbjct: 144 IEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 198 --------SMTQTQTFATI----GYMAPE------YGREGRVSANGDVYSFGIMLMETFT 239
+ ++ +I Y APE + + D++SFG +L E +T
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYT 254
Query: 240 GK 241
G
Sbjct: 255 GS 256
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 42/238 (17%), Positives = 79/238 (33%), Gaps = 72/238 (30%)
Query: 49 LIGKGGFGSVYKA--RLGDGMEVAVKVFNLQCGRALKSFN----VECEMMKSIRHR---- 98
+G+G FG V + +VA+K+ R + + +E ++K I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 99 --NLIKVISS-------CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------ 143
+ + C + E + + ++L +N FQ
Sbjct: 81 KFLCVLMSDWFNFHGHMC-------IAFELL-GKNTFEFLKENN-----FQPYPLPHVRH 127
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ------ 197
+ + AL +LH + H DLKP N+L ++ L + +
Sbjct: 128 MAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 198 ----SMTQTQTFATI----GYMAPE------YGREGRVSANGDVYSFGIMLMETFTGK 241
+ + TI Y PE + + DV+S G +L E + G
Sbjct: 185 DFGSATFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 39/231 (16%), Positives = 79/231 (34%), Gaps = 58/231 (25%)
Query: 49 LIGKGGFGSVYKA--RLGDGMEVAVKVFNLQCGRALKSFN----VECEMMKSIRHR---- 98
+G+G FG V + G VAVK+ + + + E ++++ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 99 --NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVAS 150
++++ + +V E + S ++ + F + +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG-----FLPFRLDHIRKMAYQICK 129
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS----------MT 200
++ +LH S + H DLKP N+L + + I +
Sbjct: 130 SVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 201 QTQTFATI----GYMAPE------YGREGRVSANGDVYSFGIMLMETFTGK 241
+ +T+ Y APE + S DV+S G +L+E + G
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLGF 231
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 70/370 (18%), Positives = 113/370 (30%), Gaps = 127/370 (34%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-----HRNLIKV 103
+G G F +V+ + + VA+KV ++ E ++KS+R N V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 104 ISSCSNEEFK---------ALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASA 151
+ ++FK +V E + H L K++ SN L ++ I+ V
Sbjct: 104 VQLL--DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQG 158
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLL------------------------------------ 175
L+YLH IIH D+KP N+LL
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 176 -------------DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS 222
+ + ++D A + QT+ Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 223 ANGDVYSFGIMLMETFTGK------------------------------------KPTDE 246
D++S M E TG K + E
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331
Query: 247 IFNGEMTLKHWVNDWLPISTLEV-VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPE 305
F + LKH P EV V+ SQE+ F+ + PE
Sbjct: 332 FFTKKGDLKHITKLK-PWGLFEVLVEKYEWSQEE-----AAGFTDFL----LPMLELIPE 381
Query: 306 QRINAKEIVK 315
+R A E ++
Sbjct: 382 KRATAAECLR 391
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 5e-04
Identities = 56/357 (15%), Positives = 120/357 (33%), Gaps = 88/357 (24%)
Query: 9 RYRQRGKRPSNDASMPLVAM--WRTFSYLELCQATDEFSENNLI---GKGGFGSVYKARL 63
Y ++ R ND R YL+L QA E + G G G K +
Sbjct: 111 MYIEQRDRLYNDNQ-VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV 166
Query: 64 GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 123
A+ V S+ V+C+M I NL +C++ E +L+ + +
Sbjct: 167 ------ALDV--------CLSYKVQCKMDFKIFWLNL----KNCNSPETVLEMLQKLLYQ 208
Query: 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--- 180
+ S+ +I R++ + + L L + + ++L + V
Sbjct: 209 IDPNWTSRSDHSSNIKLRIH---SIQAELRRL-------LKSKPYENCLLVLLN--VQNA 256
Query: 181 AHLSDFSI-AKLLV-GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETF 238
+ F++ K+L+ + +T + AT +++ ++ L+ +
Sbjct: 257 KAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK------SLLLKY 310
Query: 239 TGKKPTD---EIFN---------GEMTLKHWVNDW-----LPISTL-EVVDA--NLLSQE 278
+P D E+ E ++ + W + L ++++ N+L
Sbjct: 311 LDCRPQDLPREVLTTNPRRLSIIAES-IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 279 DI--HFVAKEQCVSFVFN---------LAMA-CAVESPEQRINAKEIVKKLLKIRDS 323
+ F ++ VF L++ V + + ++ K L +
Sbjct: 370 EYRKMF---DRL--SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP 421
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 339 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.68 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.51 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.1 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.93 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.89 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.73 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.56 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.52 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.19 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.28 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.87 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.27 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=408.69 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=213.3
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
+.|++.++||+|+||+||+|... +|+.||||++........+.+.+|+++|++++||||++++++|.+++.+|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 57999999999999999999754 79999999998776666677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
+||+|.+++.+. .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++..+.. ....
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR 226 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCC
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCc
Confidence 999999999764 5999999999999999999999 99999999999999999999999999999987632 2223
Q ss_pred cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+. ...+.... ..
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~~~----------------~~ 288 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRDNL----------------PP 288 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSS----------------CC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHHcCC----------------CC
Confidence 4456799999999999999999999999999999999999999976422111 11111000 00
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+++++++||.+||+.||++|||++|+++|
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111234567889999999999999999999999987
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-57 Score=401.42 Aligned_cols=268 Identities=26% Similarity=0.389 Sum_probs=213.6
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
|+...+++++.++||+|+||+||+|++. ..||||+++.. .....+.|.+|++++++++||||+++++++.. +.++
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 3455689999999999999999999874 36999998654 34556789999999999999999999998865 5688
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||++||+|.+++......+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+|||++.....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999999877778999999999999999999999 99999999999999999999999999999986543
Q ss_pred CCCccccccccCCCCccCCccccC---CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
...........||+.|+|||++.+ ..|+.++|||||||++|||+||+.||...................+
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p------- 257 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP------- 257 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC-------
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-------
Confidence 333334455679999999998864 3589999999999999999999999976533221111110000000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
.....+..++.++.+||.+||+.||++|||+.||+++|+.++..+.
T Consensus 258 --------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 258 --------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp --------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred --------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 0011234677889999999999999999999999999999887654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=403.51 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=218.8
Q ss_pred hcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
.++|.+.+.||+|+||+||+|++. ++..||||+++.......+.+.+|+++|++++||||+++++++.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 367899999999999999999752 47889999998777777788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEE
Q 019568 115 LVLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAH 182 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~ 182 (339)
+||||+++|+|.+++.+.. ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence 9999999999999997542 46999999999999999999999 99999999999999999999999
Q ss_pred EcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhh
Q 019568 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
|+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||......+... .+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~--~i~~- 245 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE--CITQ- 245 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--HHHH-
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHc-
Confidence 999999986644333333445568999999999999999999999999999999998 899998754322111 1100
Q ss_pred ccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
......+..+|+++.+||.+||+.||++|||+++|++.|+++.+.
T Consensus 246 -----------------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 246 -----------------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 001122456788899999999999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-57 Score=404.13 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=212.3
Q ss_pred hcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
.++|.+.++||+|+||+||+|++. +++.||||+++.......+.|.+|+++|++++||||+++++++.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 367888999999999999999753 47889999998777777788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC--------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 115 LVLEYMPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
+||||+++|+|.+++.... .++++..++.++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence 9999999999999997542 35899999999999999999999 999999999999999999999
Q ss_pred EEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhh
Q 019568 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~ 259 (339)
+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ..+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~--~~i~ 274 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI--DCIT 274 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH--HHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH--HHHH
Confidence 99999999987644444444455678999999999999999999999999999999999 89999865432211 1110
Q ss_pred hhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 260 DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
. ..+...+..+++++.+||.+||+.||++|||++||+++|+.+.+.
T Consensus 275 ~------------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 Q------------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp H------------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred c------------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 0 011122456788899999999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=407.59 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=205.5
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
.++|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 47999999999999999999975 479999999997653 445678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 118 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
||++||+|.+++.... ..+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-- 177 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence 9999999999997554 45789999999999999999999 99999999999999999999999999999986521
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||......+..... .... .
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-~~~~-------------~- 242 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISGS-------------F- 242 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHTC-------------C-
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-HcCC-------------C-
Confidence 111233456999999999999999999999999999999999999999764322111110 0000 0
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...+..+++++++||.+||+.||.+|||++|+++|
T Consensus 243 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 -----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01133467789999999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=402.18 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=214.2
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++|++++||||++++++|.+++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999975 479999999997542 34457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||++||+|.+++.+.+ .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||++..+....
T Consensus 111 mEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999997654 7999999999999999999999 9999999999999999999999999999999875444
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||......+.... ....
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~-i~~~---------------- 249 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK-IIKL---------------- 249 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHT----------------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHcC----------------
Confidence 44445567899999999999999999999999999999999999999976432211110 0000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+..+++++++||.+||+.||++|||++|++.+-+
T Consensus 250 ----~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~ 287 (311)
T 4aw0_A 250 ----EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 287 (311)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHH
T ss_pred ----CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHH
Confidence 00112345778999999999999999999999766543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=401.24 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=214.2
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.+.|++.++||+|+||+||+|++ .+|+.||||+++.... ..+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45688899999999999999985 4699999999976522 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-cEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-~v~l~Dfg~~~~~~~~~~~ 198 (339)
++||+|.+++.+.+ .+++..++.++.|++.||.||| +++|+||||||+|||++.+| .+||+|||++..+......
T Consensus 132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999999997654 7999999999999999999999 99999999999999999887 6999999999876432211
Q ss_pred ---cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 199 ---MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 199 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
......+||+.|+|||++.+..|+.++|||||||++|+|++|++||...............
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---------------- 271 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---------------- 271 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS----------------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC----------------
Confidence 1223356999999999999999999999999999999999999999875444322211100
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
.......++.+++++.+||.+||+.||.+|||+.|++++|..+.+....
T Consensus 272 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 272 --PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp --CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred --CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 0000112456788899999999999999999999999999998877653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=409.93 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=213.5
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.+.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+++|+.++||||++++++|.+.+.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999754 7999999999877666667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
|+||+|.+++... .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++..+.. ...
T Consensus 230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVP 302 (423)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCC
T ss_pred CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCc
Confidence 9999999999754 4999999999999999999999 99999999999999999999999999999987632 222
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ ...+.....
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~~~~---------------- 364 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRDNLP---------------- 364 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCC----------------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHHcCCC----------------
Confidence 34456799999999999999999999999999999999999999975432111 111110000
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........+++++++||.+||+.||++|||++|+++|
T Consensus 365 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111134567789999999999999999999999997
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=399.29 Aligned_cols=257 Identities=24% Similarity=0.439 Sum_probs=213.6
Q ss_pred hcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
.+++++.+.||+|+||+||+|.+ .+++.||||+++... ....+.|.+|+.++++++||||+++++++..++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 35677889999999999999975 246889999986543 34457799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC
Q 019568 114 ALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN 178 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~ 178 (339)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +++++||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCC
Confidence 99999999999999996432 35899999999999999999999 9999999999999999999
Q ss_pred CcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhH
Q 019568 179 MVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHW 257 (339)
Q Consensus 179 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~ 257 (339)
+.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+| |..||......+. ...
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~--~~~ 259 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--VEM 259 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH--HHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH--HHH
Confidence 9999999999987644443444455678999999999999999999999999999999998 8999986543221 111
Q ss_pred hhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 258 VNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
+.. ......++.+++++.+||.+||+.||++|||++||+++|+.+
T Consensus 260 i~~------------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRN------------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHT------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHc------------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 100 011122456788899999999999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=385.70 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=195.1
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|++.+.||+|+||+||+|.. .+|+.||||+++... ......+.+|+++++.++||||+++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999975 479999999997542 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+ +|+|.+++.+.. .+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 mEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-- 164 (275)
T ss_dssp EECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence 9999 569999987654 7999999999999999999999 99999999999999999999999999999976532
Q ss_pred CccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ..... ..
T Consensus 165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~--~~~i~--~~------------ 227 (275)
T 3hyh_A 165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL--FKNIS--NG------------ 227 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH--HT------------
T ss_pred -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH--cC------------
Confidence 222345679999999999998876 6899999999999999999999975422111 00000 00
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+..+++++++||.+||+.||++|||++|+++|=+
T Consensus 228 -----~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 228 -----VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 00112345778999999999999999999999999743
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=385.90 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=202.0
Q ss_pred cCC-CCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeec----Ccee
Q 019568 42 DEF-SENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSN----EEFK 113 (339)
Q Consensus 42 ~~y-~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 113 (339)
.+| ++.+.||+|+||+||+|.+ .++..||+|++... .....+.+.+|++++++++||||++++++|.. .+.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 6778899999999999975 46999999998654 24455778999999999999999999999864 4568
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeC-CCCcEEEcccccce
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLD-DNMVAHLSDFSIAK 190 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~-~~~~v~l~Dfg~~~ 190 (339)
|+||||++||+|.+++.+.. .+++..+..++.|++.||.||| +++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999999997654 7999999999999999999999 888 99999999999997 58999999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
... .......+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||............. ..
T Consensus 181 ~~~----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i-~~---------- 244 (290)
T 3fpq_A 181 LKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-TS---------- 244 (290)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-TT----------
T ss_pred eCC----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH-Hc----------
Confidence 532 223345679999999998865 69999999999999999999999997543221111110 00
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+..+++++++||.+||+.||.+|||++|+++|
T Consensus 245 -------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 245 -------GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111234456779999999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=398.13 Aligned_cols=270 Identities=23% Similarity=0.369 Sum_probs=221.6
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCC-cceeeEeee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRH-RNLIKVISS 106 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~ 106 (339)
.+++...++|++.+.||+|+||+||+|.+. .++.||||.+.... ....+.+.+|+++|.++.| |||++++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 355666789999999999999999999742 23679999987653 3445678999999999965 899999999
Q ss_pred eec-CceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCC
Q 019568 107 CSN-EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP 170 (339)
Q Consensus 107 ~~~-~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p 170 (339)
|.. .+.+++||||+++|+|.++++... ..+++..+..++.|++.||.||| +++++||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence 865 456899999999999999997532 34889999999999999999999 99999999999
Q ss_pred CCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCccccc
Q 019568 171 SNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFN 249 (339)
Q Consensus 171 ~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~ 249 (339)
+|||++.++.+||+|||+++.+.............+|+.|+|||++.+..|+.++|||||||++|||+| |..||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654444444455678999999999999999999999999999999998 8999986543
Q ss_pred CccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 250 GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
........ . ...+...++.+++++.+||.+||+.||++|||+++|++||+++.++..+
T Consensus 294 ~~~~~~~i-~------------------~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 294 DEEFCRRL-K------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp SHHHHHHH-H------------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred HHHHHHHH-H------------------cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 32111111 0 0111222456678899999999999999999999999999999876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-56 Score=391.95 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=201.0
Q ss_pred cCCCCCceeeecCccEEEEEEe----CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
++|++.+.||+|+||+||+|+. .+++.||||+++... ......+.+|+++|++++||||+++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 6799999999999999999964 257899999987542 2233467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||++||+|.+++.+.. .+++..++.++.|++.||.||| ++||+||||||+|||++.+|.+||+|||++.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~- 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID- 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC-
Confidence 999999999999997654 7999999999999999999999 99999999999999999999999999999986532
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||......+..... .. .
T Consensus 179 -~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-~~---~------------ 241 (304)
T 3ubd_A 179 -HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-LK---A------------ 241 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HH---C------------
T ss_pred -CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-Hc---C------------
Confidence 222334567999999999999999999999999999999999999999764322111110 00 0
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
....+..+++++++||.+||+.||++||| ++|+++|
T Consensus 242 -----~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 242 -----KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -----CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 00113446788999999999999999998 4788876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=377.60 Aligned_cols=275 Identities=23% Similarity=0.304 Sum_probs=202.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc----eeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE----FKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 116 (339)
..+|.+.+.||+|+||+||+|++ +|+.||||++....... .....|+..+.+++||||+++++++..++ .+|+|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45788999999999999999988 68999999987553221 22334566667889999999999997543 57999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC--------CeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA--------PIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~--------~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
|||+++|+|.+++... .+++..+..++.|++.||+||| ++ +|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999765 4899999999999999999999 76 999999999999999999999999999
Q ss_pred ceeccCCCCcc--ccccccCCCCccCCccccCC------CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh
Q 019568 189 AKLLVGEDQSM--TQTQTFATIGYMAPEYGREG------RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 189 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~ 260 (339)
+.......... ......||+.|+|||++.+. .++.++|||||||++|||+||..||.........+......
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98764332221 22345699999999988764 46789999999999999999988876543322211110000
Q ss_pred hccc-ccc-ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 261 WLPI-STL-EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 261 ~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
.... ... ........+.. ........++..+.+||.+||+.||++|||+.||++.|+++.++
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~-p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNI-PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCC-CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHHhcccCCCCC-CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0000 000 00000000000 01112335677899999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=373.26 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=191.6
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-------
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE------- 111 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 111 (339)
.++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|++++||||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 457999999999999999999754 79999999997654 344567889999999999999999999986543
Q ss_pred -----eeEEEEEecCCCCHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEc
Q 019568 112 -----FKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 184 (339)
Q Consensus 112 -----~~~lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~ 184 (339)
.+|+||||++|++|.+++..... ..+...++.++.|+++||.||| ++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence 47899999999999999976542 3456678899999999999999 9999999999999999999999999
Q ss_pred ccccceeccCCCCcc----------ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccch
Q 019568 185 DFSIAKLLVGEDQSM----------TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~ 254 (339)
|||++..+....... .....+||+.|+|||++.+..|+.++|||||||++|+|++ ||..........
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 999998764322111 1223469999999999999999999999999999999996 765422111000
Q ss_pred HhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 255 KHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. .... ... .......++.+.+||.+||+.||++|||+.|+++|
T Consensus 238 ~----~~~~--------------~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 T----DVRN--------------LKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H----HHHT--------------TCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H----HHhc--------------CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 0000 000 01133445667899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=372.70 Aligned_cols=273 Identities=21% Similarity=0.258 Sum_probs=204.0
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEe----CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeec
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSN 109 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (339)
..+....++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+|+++|+.+ +||||++++++|.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 34455778999999999999999999964 257889999886543 234677899999998 69999999999999
Q ss_pred CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-CcEEEccccc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSI 188 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~-~~v~l~Dfg~ 188 (339)
.+.+|+||||++|++|.+++. .+++..++.++.|++.||.||| ++||+||||||+|||++.+ +.+||+|||+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999999983 4899999999999999999999 9999999999999999876 8999999999
Q ss_pred ceeccCCCCc--------------------------cccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCC
Q 019568 189 AKLLVGEDQS--------------------------MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241 (339)
Q Consensus 189 ~~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~ 241 (339)
+......... ......+||+.|+|||++.+. .|+.++||||+||++|+|++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9765322111 112234699999999988775 5899999999999999999999
Q ss_pred CCCcccccCccchHhHhhhhcccc-----------c---ccc--------c---------ccc---ccCccchhhhhhHH
Q 019568 242 KPTDEIFNGEMTLKHWVNDWLPIS-----------T---LEV--------V---------DAN---LLSQEDIHFVAKEQ 287 (339)
Q Consensus 242 ~P~~~~~~~~~~~~~~~~~~~~~~-----------~---~~~--------~---------~~~---~~~~~~~~~~~~~~ 287 (339)
.||....+....+........... . ... . .+. ..............
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 999654322111111110000000 0 000 0 000 00000011112245
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 288 CVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 288 ~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
+++++++||.+||++||++|||++|+|+|
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 67889999999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=378.72 Aligned_cols=269 Identities=25% Similarity=0.268 Sum_probs=205.3
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec------Cc
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN------EE 111 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 111 (339)
.++|++++.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|+.++||||+++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999975 479999999996542 3445678899999999999999999998753 46
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
.+|+||||++ |+|.+++.+.. .+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||++..
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999996 58999996554 8999999999999999999999 99999999999999999999999999999986
Q ss_pred ccCCC--CccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 192 LVGED--QSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 192 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
+.... ........+||+.|+|||++.+. .++.++||||+||++|+|++|++||........ +.........+. ..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~-~~ 285 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPS-PA 285 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCC-GG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCC-hH
Confidence 53221 12233456799999999988775 569999999999999999999999976432211 111111111110 00
Q ss_pred cccc-----------cccCccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 VVDA-----------NLLSQEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 ~~~~-----------~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.... ......... ....+.+++++.+||.+||++||.+|||++|+|+|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000000000 01123457789999999999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=390.07 Aligned_cols=254 Identities=19% Similarity=0.269 Sum_probs=215.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
..++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+|+++|+.++||||++++++|.+.+.+|+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 347899999999999999999975 4799999999987766667788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC--CCcEEEcccccceeccCCC
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~--~~~v~l~Dfg~~~~~~~~~ 196 (339)
|++||+|.+++......+++..+..++.||+.||.||| +++|+||||||+|||++. .+.+||+|||++..+..
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 99999999999776668999999999999999999999 999999999999999975 48999999999987632
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+.... +.. .
T Consensus 310 -~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~--i~~---------------~ 371 (573)
T 3uto_A 310 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN--VKS---------------C 371 (573)
T ss_dssp -TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH--HHT---------------T
T ss_pred -CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH--HHh---------------C
Confidence 2233455799999999999999999999999999999999999999976433221111 000 0
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...........++.++++||.+||+.||.+|||+.|+++|
T Consensus 372 ~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 372 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111112234567889999999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=381.17 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=204.5
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHH---HHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSF---NVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ....... ..++.+++.++||||++++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999754 79999999997542 1112223 3446677788999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
|+||||++||+|.+++.+.. .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999997654 7999999999999999999999 9999999999999999999999999999998763
Q ss_pred CCCCccccccccCCCCccCCcccc-CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
. ......+||+.|+|||++. +..|+.++|+|||||++|+|++|.+||.......... .......
T Consensus 344 ~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-i~~~i~~---------- 408 (689)
T 3v5w_A 344 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT---------- 408 (689)
T ss_dssp S----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-HHHHHHH----------
T ss_pred C----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhhcC----------
Confidence 2 2234467999999999986 4579999999999999999999999997654332111 0000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
.....+..+++++++||.+||+.||.+|++ ++||++|
T Consensus 409 -------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 409 -------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 011123456788999999999999999998 7999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=350.53 Aligned_cols=291 Identities=32% Similarity=0.491 Sum_probs=232.2
Q ss_pred cccccceeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceee
Q 019568 23 MPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102 (339)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 102 (339)
...+.....+++.++....++|++.+.||+|+||+||+|...+++.||||++..........+.+|+++++.++||||++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 99 (321)
T 2qkw_B 20 YLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99 (321)
T ss_dssp ----------CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCC
T ss_pred cCCCCcceeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEee
Confidence 33344456778888888999999999999999999999998789999999988776666788999999999999999999
Q ss_pred EeeeeecCceeEEEEEecCCCCHHHHHhhcC---CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC
Q 019568 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 179 (339)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~ 179 (339)
+++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~ 176 (321)
T 2qkw_B 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENF 176 (321)
T ss_dssp EEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTC
T ss_pred EEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCC
Confidence 9999999999999999999999999986543 35899999999999999999999 99999999999999999999
Q ss_pred cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccc-hHhHh
Q 019568 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT-LKHWV 258 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~-~~~~~ 258 (339)
.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ...+.
T Consensus 177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 256 (321)
T 2qkw_B 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256 (321)
T ss_dssp CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT
T ss_pred CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh
Confidence 99999999998654333333334455789999999998889999999999999999999999999865443321 11121
Q ss_pred hhhccc-cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 259 NDWLPI-STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 259 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
...... ......+ ........+.++..+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 257 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 257 VESHNNGQLEQIVD------PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHHTTTCCCSSSS------SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccccHHHhcC------hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 111111 1111111 111222346778889999999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=344.97 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=214.3
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
+....++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 344668999999999999999999974 4799999999987766666778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999999765 4899999999999999999999 999999999999999999999999999998765322
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
........+|+.|+|||.+.+..++.++||||||+++|+|++|..||...............
T Consensus 170 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---------------- 231 (297)
T 3fxz_A 170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---------------- 231 (297)
T ss_dssp --TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH----------------
T ss_pred --ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------------
Confidence 22334556899999999999999999999999999999999999999754322111110000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+..++..+.+||.+||+.||.+|||++|+++|
T Consensus 232 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 232 --GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp --CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000111234567789999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=343.33 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=221.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.++|++.+.||+|+||+||+|... +++.||+|++..........+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 578999999999999999999854 6999999998776677778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999887778999999999999999999999 9999999999999999999999999999998763322111
Q ss_pred c------------cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 200 T------------QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 200 ~------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
. .....||+.|+|||.+.+..++.++||||||+++|+|++|..|+.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~---------- 235 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---------- 235 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC----------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh----------
Confidence 1 114468999999999999999999999999999999999999987643322111100
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
.........+..+++.+.+|+.+||+.||++|||+.++++.|+.++..+..
T Consensus 236 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 236 --------VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp --------HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred --------hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 001111112345667799999999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=347.30 Aligned_cols=275 Identities=26% Similarity=0.383 Sum_probs=210.5
Q ss_pred eeeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeee
Q 019568 31 TFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCS 108 (339)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (339)
.+.-..+....++|++.+.||+|+||+||+|.. +++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 344455556678999999999999999999987 68999999986653 344567889999999999999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeCCCCcEEEc
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLS 184 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~~~~~v~l~ 184 (339)
..+..++||||+++++|.+++..... .+++..++.++.|++.||.||| +.| ++|+||||+||+++.++.++|+
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 99999999999999999999976542 3899999999999999999999 999 9999999999999999999999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
|||++..... .........+|+.|+|||.+.+..++.++||||||+++|+|++|..||........... ...
T Consensus 182 Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~--~~~---- 253 (309)
T 3p86_A 182 DFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA--VGF---- 253 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH--HHH----
T ss_pred CCCCCccccc--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHh----
Confidence 9999875421 22223445689999999999999999999999999999999999999976532211110 000
Q ss_pred cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccccC
Q 019568 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGG 330 (339)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~~ 330 (339)
.......+..+++.+.+||.+||+.||.+|||++++++.|+.+.++...++..
T Consensus 254 -------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 254 -------------KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp -------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred -------------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 00011123456778999999999999999999999999999999887766554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=343.49 Aligned_cols=284 Identities=36% Similarity=0.552 Sum_probs=228.8
Q ss_pred cceeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEee
Q 019568 27 AMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVIS 105 (339)
Q Consensus 27 ~~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (339)
.....+++.++....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34578999999999999999999999999999999877899999999876532 23346888999999999999999999
Q ss_pred eeecCceeEEEEEecCCCCHHHHHhhcC---CccCHHHHHHHHHHHHHHHHHhhccCCC---CeEecCCCCCCeEeCCCC
Q 019568 106 SCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSA---PIIHCDLKPSNVLLDDNM 179 (339)
Q Consensus 106 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~---~i~h~di~p~Nil~~~~~ 179 (339)
++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +. +++|+||||+||+++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCC
Confidence 9999999999999999999999997653 34899999999999999999999 88 999999999999999999
Q ss_pred cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCccccc---CccchHh
Q 019568 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN---GEMTLKH 256 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~---~~~~~~~ 256 (339)
.++|+|||++....... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..||..... .......
T Consensus 172 ~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999999998653222 2223345589999999999888999999999999999999999999974321 2222222
Q ss_pred HhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
+............ ..............+..+.+++.+||+.||.+|||+++++++|+.
T Consensus 251 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 251 WVKGLLKEKKLEA-----LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHTTTTSSCCSTT-----SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHhhchhhhh-----hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 3222221111110 111112223356678889999999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=342.18 Aligned_cols=277 Identities=22% Similarity=0.280 Sum_probs=213.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc----eeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE----FKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l 115 (339)
..++|++.+.||+|+||+||+|+. .++.||||++..... .......|+.++++++||||+++++++.... .+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 357999999999999999999987 489999999875533 3344556889999999999999999987643 4799
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC----------CeEecCCCCCCeEeCCCCcEEEcc
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA----------PIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~----------~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
||||+++++|.+++.... +++..++.++.|++.||.||| +. +++|+||||+||+++.++.++|+|
T Consensus 100 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999997654 999999999999999999999 88 999999999999999999999999
Q ss_pred cccceeccCCCCccccccccCCCCccCCccccCC-----CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHh-Hhh
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH-WVN 259 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~-~~~ 259 (339)
||++..+.............+|+.|+|||++.+. .++.++||||||+++|+|++|..||............ ...
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876544433334446789999999998763 4667899999999999999999999765432211100 000
Q ss_pred hhccc-cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 260 DWLPI-STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 260 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
..... .......................++.++.+||.+||+.||++|||+.++++.|+.+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00000 00000000000111111222345677899999999999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=344.36 Aligned_cols=254 Identities=25% Similarity=0.327 Sum_probs=211.1
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
+.....++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+++++.++||||+++++++...+.
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 3345678999999999999999999985 57999999998765 34456678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.|+||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 999999999999999997654 6999999999999999999999 999999999999999999999999999998765
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCC-CcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVS-ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
.. ........+|+.|+|||++.+..++ .++||||||+++|+|++|..||........... ... .
T Consensus 165 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--i~~--~-------- 229 (328)
T 3fe3_A 165 TV---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER--VLR--G-------- 229 (328)
T ss_dssp SS---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH--C--------
T ss_pred CC---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH--HHh--C--------
Confidence 32 2233456789999999999888764 799999999999999999999976432211110 000 0
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....+..+++++.+|+.+||+.||.+|||++++++|=
T Consensus 230 ---------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 230 ---------KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred ---------CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 0011233567799999999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=331.07 Aligned_cols=283 Identities=30% Similarity=0.464 Sum_probs=227.6
Q ss_pred eeeeeHHHHhhhhcCCCCC------ceeeecCccEEEEEEeCCCcEEEEEEeecc----chhhhHHHHHHHHHHHhCCCc
Q 019568 29 WRTFSYLELCQATDEFSEN------NLIGKGGFGSVYKARLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHR 98 (339)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~------~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~----~~~~~~~~~~e~~~l~~l~h~ 98 (339)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++... .......+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4778999999999998887 9999999999999987 6889999998653 234457788999999999999
Q ss_pred ceeeEeeeeecCceeEEEEEecCCCCHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC
Q 019568 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 176 (339)
Q Consensus 99 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~ 176 (339)
||+++++++...+..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.|++|+||+|+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999998643 246899999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHh
Q 019568 177 DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256 (339)
Q Consensus 177 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~ 256 (339)
.++.++|+|||++................+++.|+|||.+.+ .++.++||||||+++|+|++|..||............
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999987643333333445568999999998765 5889999999999999999999999876543322211
Q ss_pred Hhhhhc-cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 257 WVNDWL-PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 257 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
...... ........+... ...+..++..+.+++.+||+.||.+|||+++++++|+.+.++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKM-------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSC-------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred HHHhhhhhhhhhhhccccc-------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 111000 001111111111 112456678899999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=345.78 Aligned_cols=263 Identities=27% Similarity=0.442 Sum_probs=217.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEe--------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeec
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL--------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSN 109 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~--------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 109 (339)
..++|++.+.||+|+||.||+|.. .++..||||++.... ......+.+|+++++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 347899999999999999999974 235679999987653 34567789999999999 89999999999999
Q ss_pred CceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeE
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 174 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil 174 (339)
.+.+|+||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEE
Confidence 999999999999999999997643 34788999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccc
Q 019568 175 LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253 (339)
Q Consensus 175 ~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~ 253 (339)
++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999987644333333444556788999999999999999999999999999999 99999764322111
Q ss_pred hHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
..... ......+..++.++.+||.+||+.||.+||++.|++++|+++.....
T Consensus 316 --~~~~~------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 316 --KLLKE------------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp --HHHHT------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --HHHhc------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 10000 00111234567789999999999999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=347.46 Aligned_cols=274 Identities=23% Similarity=0.368 Sum_probs=223.1
Q ss_pred eeeeHHHHhhhhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCccee
Q 019568 30 RTFSYLELCQATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLI 101 (339)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~ 101 (339)
..+....+....++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+++++++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3455667777889999999999999999999962 246899999997643 34456789999999999 789999
Q ss_pred eEeeeeecCc-eeEEEEEecCCCCHHHHHhhcCC----------------------------------------------
Q 019568 102 KVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNC---------------------------------------------- 134 (339)
Q Consensus 102 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~---------------------------------------------- 134 (339)
++++++...+ ..++||||+++++|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999987754 48999999999999999976532
Q ss_pred -------------------ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 135 -------------------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 135 -------------------~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
.+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 2889999999999999999999 999999999999999999999999999999866443
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||................
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------- 312 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------------- 312 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--------------
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--------------
Confidence 33334445567889999999999999999999999999999998 999997654332211111110
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
.....+..+++++.++|.+||+.||.+|||++++++||+.+.+...
T Consensus 313 -----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 358 (359)
T 3vhe_A 313 -----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358 (359)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHhc
Confidence 0011123456779999999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.96 Aligned_cols=274 Identities=22% Similarity=0.278 Sum_probs=212.5
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
......++|++.+.||+|+||+||+|...+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 3445779999999999999999999998789999999987553 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++||||+++ +|.+.+......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999999976 899988877777999999999999999999999 9999999999999999999999999999998653
Q ss_pred CCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc--cccc-
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS--TLEV- 269 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~- 269 (339)
. .........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||............ ........ ....
T Consensus 171 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 171 I--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI-FSILGTPNPREWPQV 247 (311)
T ss_dssp S--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH-HHHHCCCCTTTSGGG
T ss_pred C--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHHCCCChHHhhhh
Confidence 2 2223344567999999998876 56899999999999999999999999865443322111 11111100 0000
Q ss_pred cc-----ccc--cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VD-----ANL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~-----~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ... ...........+.++.++.+||.+||+.||.+|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 000 000011112234567789999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=333.51 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=215.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|++.+.||+|+||+||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3478999999999999999999987888999999876532 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||++...... ...
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 162 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT 162 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc-ccc
Confidence 9999999999877778999999999999999999999 999999999999999999999999999998754221 111
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||........... ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~--~~~~----------------- 223 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--ISTG----------------- 223 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--HHTT-----------------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HhcC-----------------
Confidence 2233445778999999998999999999999999999999 9999976432211110 0000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
.....+..++..+.+++.+||+.||.+|||+++++++|+++.++
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 01111233467799999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=341.27 Aligned_cols=264 Identities=27% Similarity=0.427 Sum_probs=215.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|++.+.||+|+||+||+|... .+..||||++... .......+.+|+++++.++||||+++++++...+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3578999999999999999999853 3456999999765 3445567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999877678999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 195 EDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 195 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||........... ...
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~--~~~------------ 269 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--VEE------------ 269 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH--HHT------------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH--HHc------------
Confidence 2221 12233345778999999998999999999999999999999 9999976533221111 000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
......+..++..+.+||.+||..||.+|||+.++++.|+.+.++...
T Consensus 270 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 270 ------GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ------CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 001112345677899999999999999999999999999999875443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=332.87 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=215.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|++.+.||+|+||.||+|...++..||+|++..... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4678999999999999999999988888999999876532 335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++......+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YV 160 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hh
Confidence 9999999999887767999999999999999999999 9999999999999999999999999999998653221 22
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||............. .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--~------------------ 220 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS--Q------------------ 220 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--T------------------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH--c------------------
Confidence 2233445678999999999899999999999999999999 999997653322111100 0
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
......+..+++.+.+++.+||+.||.+|||+.+++++|+.++++
T Consensus 221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 221 GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000111233466799999999999999999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=340.70 Aligned_cols=255 Identities=19% Similarity=0.270 Sum_probs=213.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
+.++|++.+.||+|+||+||+|... +++.+|+|++.... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4689999999999999999999754 68999999987553 344668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC--CCcEEEcccccceeccCCC
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~--~~~v~l~Dfg~~~~~~~~~ 196 (339)
|+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||++..+..
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 99999999999777667999999999999999999999 999999999999999987 78999999999987632
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
........+|+.|+|||++.+..++.++||||||+++|+|++|..||........... ... .
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~----------------~ 218 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN-IMN----------------A 218 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHH----------------T
T ss_pred -CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-HHc----------------C
Confidence 2223445689999999999998899999999999999999999999976432211100 000 0
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.........+.++.++.+||.+||..||.+|||+.|+++|-+
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 011111223456788999999999999999999999999765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=342.85 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=211.3
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchh------hhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGR------ALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
...++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+|+.+++++.||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 35688999999999999999999754 6999999999765322 3467889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC----cEEEcccc
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFS 187 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~----~v~l~Dfg 187 (339)
..++||||++|++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999999996544 7999999999999999999999 99999999999999998776 79999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
++...... .......||+.|+|||++.+..++.++|+||||+++|+|++|..||......+... ....
T Consensus 165 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~-~i~~-------- 232 (361)
T 2yab_A 165 LAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-NITA-------- 232 (361)
T ss_dssp SCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-HHHT--------
T ss_pred CceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh--------
Confidence 99876322 22344568999999999999999999999999999999999999997643211100 0000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
............++.++++||.+||..||.+|||+.|+++|=
T Consensus 233 --------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 233 --------VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp --------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred --------cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 001111222345678899999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=349.74 Aligned_cols=266 Identities=28% Similarity=0.437 Sum_probs=218.4
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..+....++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 344455689999999999999999999865 79999999987543 3445678889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999999877667999999999999999999999 999999999999999999999999999998764
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ......
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~~~~~~----------- 330 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--REFVEK----------- 330 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--HHHHHT-----------
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc-----------
Confidence 32111111122234667999999998899999999999999999998 9999976533211 111110
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
......+..+++++.+||.+||+.||++|||++++++.|+.++..
T Consensus 331 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 331 -------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 001112345677899999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=340.35 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=211.8
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+..++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 45689999999999999999999754 799999999875532 3346688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999986543 6999999999999999999999 9999999999999999999999999999998654333
Q ss_pred CccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.........+|+.|+|||++.+..+ +.++||||||+++|+|++|..||............+.....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------- 226 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------- 226 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-------------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-------------
Confidence 3333445678999999999887765 78999999999999999999999865443333322221110
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.......++..+.+||.+||+.||.+|||++|+++|-+
T Consensus 227 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 227 -----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp -----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred -----cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 11112445677899999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=334.91 Aligned_cols=265 Identities=23% Similarity=0.412 Sum_probs=215.6
Q ss_pred HHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 34 YLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 34 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
+..+....++|++.+.||+|+||+||++...++..||+|++..... ....+.+|++++++++||||+++++++...+..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 3445556789999999999999999999988888999999976532 235688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++||||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999999876667999999999999999999999 9999999999999999999999999999987652
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.. .........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||........... ....
T Consensus 172 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~--~~~~----------- 237 (283)
T 3gen_A 172 DD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQG----------- 237 (283)
T ss_dssp CH-HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--HHTT-----------
T ss_pred cc-ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH--Hhcc-----------
Confidence 21 1112233345778999999998899999999999999999998 9999976533211111 0000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
.....+..+++.+.+||.+||+.||.+|||+++++++|+++.++
T Consensus 238 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 238 -------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00111233456799999999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=338.11 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=208.5
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 478999999999999999999754 69999999997642 33456788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||++|++|.+++.+.. .+++..++.++.|++.||.||| +.|++|+||||+||+++.+|.++|+|||++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence 99999999999987654 7899999999999999999999 99999999999999999999999999999875321
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.........||+.|+|||++.+..++.++|+||||+++|+|++|..||.......... .... .
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-~i~~---~------------- 220 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-LILM---E------------- 220 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHH---C-------------
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH-HHHc---C-------------
Confidence 1223345568999999999999999999999999999999999999997542211100 0000 0
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....+..+++++.+||.+||+.||.+|| +++++++|
T Consensus 221 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 ----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0011234577899999999999999999 99999997
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=335.60 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=217.8
Q ss_pred eeeeHHHHhhhhcC----------CCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCc
Q 019568 30 RTFSYLELCQATDE----------FSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHR 98 (339)
Q Consensus 30 ~~~~~~~~~~~~~~----------y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~ 98 (339)
..+++.++..+.+. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778887776654 778889999999999999865 7999999999877666667888999999999999
Q ss_pred ceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC
Q 019568 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN 178 (339)
Q Consensus 99 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~ 178 (339)
||+++++++...+..++||||+++++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999998654 5999999999999999999999 9999999999999999999
Q ss_pred CcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh
Q 019568 179 MVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 179 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~ 258 (339)
+.++|+|||++...... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..||....... .....
T Consensus 178 ~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~~ 253 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRL 253 (321)
T ss_dssp CCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH
T ss_pred CcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 99999999998765322 222345568999999999999999999999999999999999999997542211 11111
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..... ........++..+.+||.+||+.||++|||+.++++|-+
T Consensus 254 ~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 254 RDSPP----------------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HHSSC----------------CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hcCCC----------------CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000 001113345677999999999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=331.75 Aligned_cols=275 Identities=20% Similarity=0.271 Sum_probs=214.5
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc--eeE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE--FKA 114 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 114 (339)
...++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.... ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 34678999999999999999999864 59999999987543 334566788999999999999999999987654 789
Q ss_pred EEEEecCCCCHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe----CCCCcEEEccccc
Q 019568 115 LVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSI 188 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~----~~~~~v~l~Dfg~ 188 (339)
+||||+++++|.+++..... .+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999976542 3899999999999999999999 9999999999999999 7888899999999
Q ss_pred ceeccCCCCccccccccCCCCccCCcccc--------CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGR--------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~ 260 (339)
+...... .......+|+.|+|||++. +..++.++||||||+++|+|++|..||................
T Consensus 163 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 163 ARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CEECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ceecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 9876322 2233456899999999875 5678999999999999999999999997654433222222111
Q ss_pred hccc--cccccccccc------cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 261 WLPI--STLEVVDANL------LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 261 ~~~~--~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.... .......... .............++..+.+|+.+||+.||++|||++|+++|..+
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 1111 1100000000 000111123346778889999999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=336.49 Aligned_cols=279 Identities=26% Similarity=0.400 Sum_probs=214.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-----CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec--Cce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN--EEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 112 (339)
..++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|++++++++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 458999999999999999999973 3689999999987777777889999999999999999999999854 356
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 89999999999999999887767999999999999999999999 999999999999999999999999999999865
Q ss_pred cCCCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+........ ............ ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~-~~~ 240 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIGNDKQGQMI-VFH 240 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH---HHHCTTCCTHHH-HHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH---hhhcCccccchh-HHH
Confidence 332221 122334466779999999999999999999999999999999999875422100 000000000000 000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
.............+..+++++.+||.+||+.||++|||++++++.|+.+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 000000011112245677889999999999999999999999999999988764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=329.00 Aligned_cols=269 Identities=22% Similarity=0.258 Sum_probs=208.0
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 68999999999999999999854 69999999997653 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|+++ ++.+.+......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... ..
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PV 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--cc
Confidence 9976 777777776668999999999999999999999 99999999999999999999999999999986532 22
Q ss_pred cccccccCCCCccCCccccCCC-CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc--cc----
Q 019568 199 MTQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV--VD---- 271 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---- 271 (339)
.......+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||...................+..... ..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2334456799999999987765 8999999999999999999988864332222222211111111100000 00
Q ss_pred ---ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 ---ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..............+.++.++++||.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000001111223567789999999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=349.15 Aligned_cols=259 Identities=21% Similarity=0.283 Sum_probs=210.3
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
......++|++.+.||+|+||+||+|.. .+|+.+|+|++.... ......+.+|+++++.++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 3445778999999999999999999975 479999999987653 3445678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC---CCCcEEEcccccc
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIA 189 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~---~~~~v~l~Dfg~~ 189 (339)
.|+||||++|++|.+.+.... .+++..++.++.|++.||.||| +.|++|+||||+||+++ .++.++|+|||++
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 999999999999999987654 7999999999999999999999 99999999999999998 5688999999999
Q ss_pred eeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
...... ........||+.|+|||++.+..++.++||||||+++|+|++|..||............ ...
T Consensus 161 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i-~~~--------- 228 (444)
T 3soa_A 161 IEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-KAG--------- 228 (444)
T ss_dssp BCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHT---------
T ss_pred EEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH-HhC---------
Confidence 765322 22233456899999999999999999999999999999999999999754322111110 000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.........+.+++++.+||.+||+.||.+|||+.|+++|=
T Consensus 229 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 229 -------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp -------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred -------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 00011111235577899999999999999999999999973
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=334.71 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=210.0
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchh------hhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGR------ALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
...++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++||||+++++++...+
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 35678999999999999999999754 6999999998765321 3567889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC----cEEEcccc
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFS 187 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~----~v~l~Dfg 187 (339)
..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .++|+|||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999999654 47999999999999999999999 99999999999999998877 89999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
++...... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||......+.... ...
T Consensus 164 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--~~~------- 231 (326)
T 2y0a_A 164 LAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN--VSA------- 231 (326)
T ss_dssp TCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH--HHH-------
T ss_pred CCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH--HHh-------
Confidence 99876322 223345689999999999999999999999999999999999999975432111000 000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
............++..+.+||.+||+.||.+|||+.++++|
T Consensus 232 --------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 232 --------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111112234567789999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=334.73 Aligned_cols=264 Identities=24% Similarity=0.392 Sum_probs=218.2
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeec
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSN 109 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (339)
+.-..++|++.+.||+|+||.||+|.. .++..||||++.... ......+.+|+++++.++||||+++++++..
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 334568999999999999999999974 245889999987653 4556778899999999999999999999999
Q ss_pred CceeEEEEEecCCCCHHHHHhhcC-----------------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEec
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~ 166 (339)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccc
Confidence 999999999999999999997643 24889999999999999999999 9999999
Q ss_pred CCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCc
Q 019568 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTD 245 (339)
Q Consensus 167 di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~ 245 (339)
||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987644333333444556788999999998899999999999999999999 999997
Q ss_pred ccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 246 EIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
........ ...... .....+..++..+.+||.+||+.||.+|||+.+++++|+++..+
T Consensus 255 ~~~~~~~~--~~~~~~------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPERLF--NLLKTG------------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGGGHH--HHHHTT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHH--HHhhcC------------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 65332211 111000 00111345577899999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=342.77 Aligned_cols=270 Identities=27% Similarity=0.409 Sum_probs=220.6
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe--------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeee
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL--------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSC 107 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~--------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (339)
....++|++.+.||+|+||+||+|.. ..+..||||++.... ......+.+|+++++.+ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 44568999999999999999999974 224679999987653 44557788999999999 999999999999
Q ss_pred ecCceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCC
Q 019568 108 SNEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSN 172 (339)
Q Consensus 108 ~~~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~N 172 (339)
...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence 99999999999999999999997653 35899999999999999999999 9999999999999
Q ss_pred eEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCc
Q 019568 173 VLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251 (339)
Q Consensus 173 il~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~ 251 (339)
|+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987644333334445557888999999999999999999999999999999 999987543221
Q ss_pred cchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccccC
Q 019568 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGG 330 (339)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~~ 330 (339)
. ....... .....+..++.++.+||.+||+.||++|||+++++++|+.+.........+
T Consensus 302 ~--~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 302 L--FKLLKEG------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp H--HHHHHTT------------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred H--HHHHHcC------------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 1 1100000 001112345677999999999999999999999999999999766544433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=340.16 Aligned_cols=269 Identities=26% Similarity=0.424 Sum_probs=217.2
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSC 107 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (339)
..+....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445556789999999999999999999753 35889999997653 34456789999999999999999999999
Q ss_pred ecCceeEEEEEecCCCCHHHHHhhcC-----------------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeE
Q 019568 108 SNEEFKALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSAPII 164 (339)
Q Consensus 108 ~~~~~~~lv~e~~~~~~L~~~i~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~ 164 (339)
...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 99999999999999999999997642 46899999999999999999999 99999
Q ss_pred ecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCC
Q 019568 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243 (339)
Q Consensus 165 h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P 243 (339)
|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999876533322233344557888999999998899999999999999999999 9999
Q ss_pred CcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 244 TDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
|......+... ..... . ....+..++..+.+||.+||+.||.+|||+.+++++|+++.+.
T Consensus 277 ~~~~~~~~~~~--~~~~~---~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 277 YYGMAHEEVIY--YVRDG---N---------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTSCHHHHHH--HHHTT---C---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCCChHHHHH--HHhCC---C---------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 97643221110 00000 0 0011335567899999999999999999999999999998776
Q ss_pred Hcc
Q 019568 324 LLR 326 (339)
Q Consensus 324 ~~~ 326 (339)
+..
T Consensus 337 ~~~ 339 (343)
T 1luf_A 337 AEG 339 (343)
T ss_dssp ---
T ss_pred hhh
Confidence 543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=338.19 Aligned_cols=269 Identities=23% Similarity=0.349 Sum_probs=214.7
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCS 108 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (339)
+.-..++|++.+.||+|+||.||+|.. .++..||||++.... ......+.+|+.+++++ .||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344568999999999999999999974 246789999987542 34456788999999999 8999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcCC----------------------ccCHHHHHHHHHHHHHHHHHhhccCCCCeEec
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSNC----------------------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~~----------------------~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~ 166 (339)
..+..++||||+++++|.+++..... .+++..++.++.|++.||.||| +.|++|+
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 99999999999999999999976542 3788999999999999999999 9999999
Q ss_pred CCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCc
Q 019568 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTD 245 (339)
Q Consensus 167 di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~ 245 (339)
||||+||+++.++.++|+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987644333333445557888999999998899999999999999999998 999997
Q ss_pred ccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 246 EIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
............... .....+..++.++.+||.+||+.||.+|||+.+++++|+.+.....
T Consensus 277 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 277 GIPVDANFYKLIQNG-------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TCCCSHHHHHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cCCcHHHHHHHHhcC-------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 654332111111000 0111123456779999999999999999999999999999887655
Q ss_pred cc
Q 019568 326 RN 327 (339)
Q Consensus 326 ~~ 327 (339)
+.
T Consensus 338 ~~ 339 (344)
T 1rjb_A 338 EA 339 (344)
T ss_dssp --
T ss_pred HH
Confidence 43
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=342.42 Aligned_cols=255 Identities=19% Similarity=0.264 Sum_probs=212.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
...++|++.+.||+|+||.||+|... +++.+|+|++..........+.+|+++++.++||||+++++++.+....++||
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 35678999999999999999999754 68999999998776556677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC--CCCcEEEcccccceeccCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~--~~~~v~l~Dfg~~~~~~~~ 195 (339)
||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++ .++.++|+|||++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999999876667999999999999999999999 99999999999999997 4578999999999876322
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.......+|+.|+|||++.+..++.++||||||+++|+|++|..||........... ....
T Consensus 205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~--i~~~-------------- 265 (387)
T 1kob_A 205 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN--VKRC-------------- 265 (387)
T ss_dssp ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH--HHHC--------------
T ss_pred ---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH--HHhC--------------
Confidence 223345689999999999999999999999999999999999999976432111000 0000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...........++.++.+||.+||+.||.+|||+.++++|
T Consensus 266 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 266 -DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000111123457789999999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=340.03 Aligned_cols=263 Identities=21% Similarity=0.323 Sum_probs=211.7
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeee
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCS 108 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (339)
+.+.....+.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 444444556789999999999999999999754 69999999997653 345567889999999999999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC---CcEEEcc
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSD 185 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~---~~v~l~D 185 (339)
+.+..|+||||+++++|.+.+.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.+ +.++|+|
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLAD 174 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEee
Confidence 9999999999999999999986554 7899999999999999999999 9999999999999999764 4599999
Q ss_pred cccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 265 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~ 265 (339)
||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.......... .....
T Consensus 175 fG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--~i~~~---- 245 (362)
T 2bdw_A 175 FGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA--QIKAG---- 245 (362)
T ss_dssp CTTCBCCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHT----
T ss_pred cCcceEecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHhC----
Confidence 9999765321 22334568999999999999999999999999999999999999997643211110 00000
Q ss_pred ccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
...........+++++.+||.+||+.||.+|||+.++++|-+
T Consensus 246 -----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 246 -----------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp -----------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred -----------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000011113456778999999999999999999999998743
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=330.05 Aligned_cols=262 Identities=23% Similarity=0.392 Sum_probs=210.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 457899999999999999999975 46999999998554 23455778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 89 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999997654 7999999999999999999999 999999999999999999999999999998765221
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.........+|+.|+|||.+.+..++.++||||||+++|+|++|..||...............
T Consensus 165 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~---------------- 227 (294)
T 4eqm_A 165 -SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD---------------- 227 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS----------------
T ss_pred -cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc----------------
Confidence 112233456899999999999999999999999999999999999999764322211111000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-NAKEIVKKLLKIRD 322 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~l~~~~~ 322 (339)
............+++.+.++|.+||+.||.+|| +++++.+.|+.+..
T Consensus 228 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 228 SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 001111122345678899999999999999998 89999888877643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=328.46 Aligned_cols=268 Identities=21% Similarity=0.281 Sum_probs=205.3
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|++.+.||+|+||+||+|...+++.||+|++..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999887899999999866532 2346778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++ +|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... ...
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence 976 999999877678999999999999999999999 99999999999999999999999999999876521 112
Q ss_pred ccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc---cccc-----cc
Q 019568 200 TQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI---STLE-----VV 270 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~ 270 (339)
......+|+.|+|||++.+. .++.++||||||+++|+|++|..||............. ...... .... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHHCCCChhhchhhhccccc
Confidence 22344679999999988764 58999999999999999999999997653322111111 100000 0000 00
Q ss_pred cccccC-ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLS-QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
+..... ...........++.++.+||.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 0000001123467789999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=338.77 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=208.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch-----hhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG-----RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
+.++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++...+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457899999999999999999975 4699999999865421 2356788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc---EEEcccc
Q 019568 114 ALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFS 187 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~---v~l~Dfg 187 (339)
|+||||+++++|.+.+... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++. ++|+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998887543 235899999999999999999999 999999999999999976554 9999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
++...... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||...... .......
T Consensus 179 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~i~~-------- 246 (351)
T 3c0i_A 179 VAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--LFEGIIK-------- 246 (351)
T ss_dssp TCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--HHHHHHH--------
T ss_pred ceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--HHHHHHc--------
Confidence 99876322 22234456899999999999999999999999999999999999999763210 0000000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
............++.++.+||.+||+.||.+|||+.++++|-+
T Consensus 247 --------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 247 --------GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp --------TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --------CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 0001111223456788999999999999999999999998643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=331.40 Aligned_cols=265 Identities=23% Similarity=0.359 Sum_probs=219.0
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecC
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCSNE 110 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (339)
-..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3458999999999999999999973 357899999997653 34457788999999999 999999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCC-----------------ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCe
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNC-----------------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV 173 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~-----------------~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Ni 173 (339)
+..++||||+++++|.+++..... .+++..++.++.|++.||.+|| +.+++|+||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence 999999999999999999976542 4899999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCcc
Q 019568 174 LLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252 (339)
Q Consensus 174 l~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~ 252 (339)
+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999987644333333344556788999999998999999999999999999999 9999976543321
Q ss_pred chHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
........ .....+..++..+.+||.+||+.||.+|||+.+++++|+++..+..
T Consensus 257 ~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 257 FYKMIKEG-------------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHT-------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHhccC-------------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 11111000 0011123456779999999999999999999999999999887654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=340.08 Aligned_cols=250 Identities=25% Similarity=0.319 Sum_probs=203.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|.++++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3589999999999999999999754 6999999999764 233456678899999998 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||++|++|.+++.+.. .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~- 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI- 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc-
Confidence 9999999999999997654 6999999999999999999999 9999999999999999999999999999987532
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.........+||+.|+|||++.+..++.++|+||||+++|+|++|..||........... ....
T Consensus 176 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-i~~~-------------- 239 (353)
T 3txo_A 176 -CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA-ILND-------------- 239 (353)
T ss_dssp -C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHC--------------
T ss_pred -cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH-HHcC--------------
Confidence 122234455689999999999999999999999999999999999999976432211110 0000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA------KEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 316 (339)
....+..++.++.+||.+||+.||.+||++ +++++|
T Consensus 240 ------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 240 ------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 001123356779999999999999999998 888885
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=330.56 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=207.6
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|..+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 478999999999999999999754 69999999987642 23456678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||++|++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.+|.++|+|||++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 99999999999997654 6899999999999999999999 99999999999999999999999999999986522
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
......||+.|+|||++.+..++.++|+||||+++|+|++|..||........ .......
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~---------------- 218 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNA---------------- 218 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHC----------------
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC----------------
Confidence 23345689999999999999999999999999999999999999975422111 0000000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....+..++.++.+||.+||+.||++|| +++++++|
T Consensus 219 ----~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 219 ----ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0011234567799999999999999999 89999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=327.61 Aligned_cols=274 Identities=22% Similarity=0.305 Sum_probs=208.3
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
......++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+++++.++||||+++++++...+
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3344668999999999999999999975 47999999998753 2445667889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 112 FKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
..++||||+++++|.+++.. ....+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 99999999999999999864 3456899999999999999999999 99999999999999999999999999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
+...... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||..................
T Consensus 183 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 254 (310)
T 2wqm_A 183 GRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD------ 254 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC------
T ss_pred eeeecCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc------
Confidence 8765321 12223446789999999999999999999999999999999999999754322211111111100
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccccCc
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGR 331 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~~~ 331 (339)
........++.++.+||.+||+.||.+|||+.+++++|++++......+..+
T Consensus 255 -----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~~ 306 (310)
T 2wqm_A 255 -----------YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHH 306 (310)
T ss_dssp -----------SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred -----------CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhhh
Confidence 0001123456779999999999999999999999999999999887766543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=323.99 Aligned_cols=269 Identities=14% Similarity=0.114 Sum_probs=218.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+++++.+ +|++++++++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 467899999999999999999984 579999999986542 335678899999999 7999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc-----EEEcccccceec
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-----AHLSDFSIAKLL 192 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~-----v~l~Dfg~~~~~ 192 (339)
||+ +++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++. ++|+|||++...
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 88999999877767999999999999999999999 999999999999999987776 999999999876
Q ss_pred cCCCCc-----cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 193 VGEDQS-----MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 193 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 237 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 237 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc----
Confidence 433221 12344568999999999999999999999999999999999999998754322111100000000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
...........++.++.+|+.+||+.||.+||++++|++.|+++.+++...
T Consensus 238 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 238 ---------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp ---------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ---------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 000001112356788999999999999999999999999999999876544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=338.23 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=206.8
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecC
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNE 110 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (339)
......++|++.+.||+|+||.||+|+.. +++.||||+++... ......+..|.++++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 34456789999999999999999999864 68999999997642 23445677899999887 999999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
+..|+||||++|++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.+|.++|+|||++.
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999999997654 6899999999999999999999 9999999999999999999999999999987
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
.... .........||+.|+|||++.+..++.++|+||||+++|+|++|..||........... .. ..
T Consensus 167 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--i~--~~------- 233 (345)
T 1xjd_A 167 ENML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS--IR--MD------- 233 (345)
T ss_dssp CCCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH--HC-------
T ss_pred hccc--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HH--hC-------
Confidence 5421 12234456789999999999999999999999999999999999999975432211100 00 00
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK-EIVKK 316 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~ 316 (339)
....+..++.++.+||.+||+.||++||++. ++++|
T Consensus 234 ----------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 234 ----------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 0001233567799999999999999999997 77764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=335.03 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=207.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 458999999999999999999985 579999999987542 2234578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+ +++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 87 v~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~- 160 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD- 160 (336)
T ss_dssp EECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred EEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence 99999 669999886654 6999999999999999999999 99999999999999999999999999999876532
Q ss_pred CCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......... ....
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------------~i~~-- 222 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------KVNS-- 222 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------------CCCS--
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------------HHHc--
Confidence 222344568999999999988876 789999999999999999999997643221100 0000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.....+..+++++.+||.+||+.||.+|||++|+++|=+
T Consensus 223 -----~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 223 -----CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp -----SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred -----CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 011123446778999999999999999999999999855
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=331.15 Aligned_cols=272 Identities=23% Similarity=0.366 Sum_probs=220.3
Q ss_pred eHHHHhhhhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEe
Q 019568 33 SYLELCQATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVI 104 (339)
Q Consensus 33 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~ 104 (339)
...++.-..++|++.+.||+|+||+||+|.+ .+++.||||++.... ......+.+|+.+++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3345556679999999999999999999963 357899999987653 34456788999999999 789999999
Q ss_pred eeeecCc-eeEEEEEecCCCCHHHHHhhcCC---------------ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCC
Q 019568 105 SSCSNEE-FKALVLEYMPHGSLEKYLYSSNC---------------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168 (339)
Q Consensus 105 ~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~---------------~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di 168 (339)
+++...+ ..++||||+++++|.+++..... .+++..++.++.|++.||.||| +.+++|+||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence 9987654 58999999999999999976543 2889999999999999999999 999999999
Q ss_pred CCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCccc
Q 019568 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEI 247 (339)
Q Consensus 169 ~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~ 247 (339)
||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987644333333445567889999999999999999999999999999998 99999765
Q ss_pred ccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 248 FNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
.............. ....+..+++.+.++|.+||+.||.+|||+.+++++|+.+.+....
T Consensus 255 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 255 KIDEEFCRRLKEGT-------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314 (316)
T ss_dssp CCSHHHHHHHHHTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred chhHHHHHHhccCc-------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence 43321111111100 0111233566799999999999999999999999999999886653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=339.59 Aligned_cols=261 Identities=25% Similarity=0.463 Sum_probs=204.6
Q ss_pred hcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999753 5778999998765 34455678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999887778999999999999999999999 999999999999999999999999999999865332
Q ss_pred CCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 196 DQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 196 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... .....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~--~~i~~------------- 265 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--KAVDE------------- 265 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH--HHHHT-------------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHc-------------
Confidence 211 11122334678999999999999999999999999999998 99999765322111 00000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
......+..++..+.+||.+||+.||.+||++.++++.|+.+....
T Consensus 266 -----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 266 -----GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -----TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -----CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0011112345677999999999999999999999999999998643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=341.83 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=214.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..++|++.+.||+|+||+||+|... ++..||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4578999999999999999999732 4678999998654 34445578889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcC------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC---cEEE
Q 019568 113 KALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHL 183 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~---~v~l 183 (339)
.++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .++|
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999997643 35899999999999999999999 99999999999999998555 5999
Q ss_pred cccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhc
Q 019568 184 SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ .......
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~~i~~~- 302 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LEFVTSG- 302 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHHHHTT-
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcC-
Confidence 99999976533333333445567889999999999999999999999999999998 9999976432211 1110000
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
.....+..++..+.+||.+||+.||.+|||+.+++++|+.+.+...
T Consensus 303 -----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 303 -----------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -----------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 0011133456779999999999999999999999999999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=334.32 Aligned_cols=267 Identities=26% Similarity=0.430 Sum_probs=200.8
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeCC-C---cEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLGD-G---MEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCS 108 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~-~---~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (339)
.++....++|++.+.||+|+||+||+|.... + ..||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3445567899999999999999999997543 3 27999998765 3455678899999999999999999999997
Q ss_pred cCcee------EEEEEecCCCCHHHHHhhcC-----CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC
Q 019568 109 NEEFK------ALVLEYMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD 177 (339)
Q Consensus 109 ~~~~~------~lv~e~~~~~~L~~~i~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~ 177 (339)
..... ++|+||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcC
Confidence 76654 89999999999999986432 25899999999999999999999 999999999999999999
Q ss_pred CCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHh
Q 019568 178 NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKH 256 (339)
Q Consensus 178 ~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~ 256 (339)
++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||............
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 99999999999986643333333344556788999999999999999999999999999999 99999865433211110
Q ss_pred HhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
... .....+..++.++.+|+.+||+.||++|||+.++++.|+++....
T Consensus 253 --~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 --IGG------------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp --HTT------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --hcC------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 000 001113345677999999999999999999999999999988643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=324.60 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=214.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3578999999999999999999987888999999876533 236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 160 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYT 160 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHH
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-ccc
Confidence 9999999999887777999999999999999999999 999999999999999999999999999998764221 111
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......... ......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~i~~~----------------- 221 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--EDISTG----------------- 221 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHTT-----------------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH--HHHhcC-----------------
Confidence 2233446778999999998889999999999999999999 89998764322110 000000
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
.....+..++..+.+++.+||+.||.+|||+++++++|+++.++
T Consensus 222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 222 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00111233467799999999999999999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=324.97 Aligned_cols=277 Identities=26% Similarity=0.372 Sum_probs=214.0
Q ss_pred eeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhC--CCcceeeEeeee
Q 019568 30 RTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107 (339)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~ 107 (339)
...+........++|++.+.||+|+||.||+|+. +++.||||++..... .....|.+++..+ +||||+++++++
T Consensus 25 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 25 SGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp SSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CCCCcccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 3455566677889999999999999999999987 489999999864422 3444566666655 899999999998
Q ss_pred ecC----ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC--------CeEecCCCCCCeEe
Q 019568 108 SNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA--------PIIHCDLKPSNVLL 175 (339)
Q Consensus 108 ~~~----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~--------~i~h~di~p~Nil~ 175 (339)
... ...++||||+++++|.+++... .+++..++.++.|++.||.||| +. +++|+||||+||++
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEE
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEE
Confidence 776 6889999999999999999765 4999999999999999999999 88 99999999999999
Q ss_pred CCCCcEEEcccccceeccCCCCcc--ccccccCCCCccCCccccCCCCCCc------chhhHHHHHHHHHHhC-------
Q 019568 176 DDNMVAHLSDFSIAKLLVGEDQSM--TQTQTFATIGYMAPEYGREGRVSAN------GDVYSFGIMLMETFTG------- 240 (339)
Q Consensus 176 ~~~~~v~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~il~~ll~g------- 240 (339)
+.++.++|+|||++..+....... ......+|+.|+|||++.+...+.+ +||||||+++|+|++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999997653322211 1224568999999999988776665 9999999999999999
Q ss_pred ---CCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 241 ---KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 241 ---~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
..||.................... ..............++.++.+||.+||+.||.+|||+.+++++|
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIK---------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTS---------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhh---------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 555554433332222221111100 00111111222457889999999999999999999999999999
Q ss_pred HHHHHHH
Q 019568 318 LKIRDSL 324 (339)
Q Consensus 318 ~~~~~~~ 324 (339)
+.+.++.
T Consensus 327 ~~l~~~~ 333 (337)
T 3mdy_A 327 AKMSESQ 333 (337)
T ss_dssp HHHHHTT
T ss_pred HHHHhhc
Confidence 9998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=340.29 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=207.1
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCcee
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 113 (339)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|..+++++ +||||+++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34579999999999999999999854 68899999997652 33445678899999887 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
|+||||++|++|.+++.+.. .+++..++.++.||+.||.||| +.||+||||||+||+++.++.++|+|||++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999999987654 7999999999999999999999 9999999999999999999999999999997532
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccch---HhHhhhhccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL---KHWVNDWLPISTLEVV 270 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 270 (339)
.........+||+.|+|||++.+..++.++|+||||+++|+|++|..||.......... ........
T Consensus 205 --~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-------- 274 (396)
T 4dc2_A 205 --RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------- 274 (396)
T ss_dssp --CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--------
T ss_pred --cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--------
Confidence 12233445678999999999999999999999999999999999999997543221100 00000000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA------KEIVKK 316 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 316 (339)
.......+..++.++++||.+||+.||.+||++ +|+++|
T Consensus 275 -------~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 275 -------LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -------HHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -------hccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 000111234467789999999999999999985 788876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=326.58 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=198.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccch----hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG----RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||+|.. .++.+|||++..... ...+.+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 357899999999999999999987 589999999865432 335678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCC---eEecCCCCCCeEeCC--------CCcEEEc
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP---IIHCDLKPSNVLLDD--------NMVAHLS 184 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~---i~h~di~p~Nil~~~--------~~~v~l~ 184 (339)
||||+++++|.+++... .+++..++.++.|++.||.+|| +.+ ++|+||||+||+++. ++.++|+
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999999999998543 6999999999999999999999 888 999999999999985 7789999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
|||++..... .......+++.|+|||.+.+..++.++||||||+++++|++|..||...............
T Consensus 159 Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----- 229 (271)
T 3dtc_A 159 DFGLAREWHR----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN----- 229 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-----
T ss_pred cCCccccccc----ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-----
Confidence 9999876522 1223456899999999999989999999999999999999999999764322111110000
Q ss_pred cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
......+..+++.+.++|.+||+.||.+|||+.+++++|+++
T Consensus 230 --------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 --------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 001112345567799999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=322.93 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=208.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchh-------hhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGR-------ALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
..++|++.+.||+|+||+||+|.. .+++.||||++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 348999999999999999999975 47999999998654321 1267889999999999999999999997665
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeCCCCc-----EEEc
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMV-----AHLS 184 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~~~~~-----v~l~ 184 (339)
++||||+++++|.+.+......+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++. ++|+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 6999999999999999877778999999999999999999999 999 999999999999988776 9999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCcccc--CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR--EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
|||++... ........+++.|+|||.+. ...++.++||||||+++|+|++|..||.................
T Consensus 172 Dfg~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~- 245 (287)
T 4f0f_A 172 DFGLSQQS-----VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE- 245 (287)
T ss_dssp CCTTCBCC-----SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-
T ss_pred CCCccccc-----cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-
Confidence 99998743 22334456899999999984 45678999999999999999999999986544433222211110
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
......+..+++.+.+||.+||+.||.+|||++++++.|+++
T Consensus 246 ----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 ----------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 011112345677899999999999999999999999999753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=333.10 Aligned_cols=270 Identities=24% Similarity=0.374 Sum_probs=218.9
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeC-CC-----cEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeee
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLG-DG-----MEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSC 107 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~-----~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 107 (339)
.+....++|++.+.||+|+||.||+|... ++ ..||+|.+.... ......+.+|+++++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 44556689999999999999999999753 23 479999987653 34556788999999999 899999999999
Q ss_pred ecCceeEEEEEecCCCCHHHHHhhc-------------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeE
Q 019568 108 SNEEFKALVLEYMPHGSLEKYLYSS-------------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 174 (339)
Q Consensus 108 ~~~~~~~lv~e~~~~~~L~~~i~~~-------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil 174 (339)
...+..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence 9999999999999999999998653 235789999999999999999999 999999999999999
Q ss_pred eCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccc
Q 019568 175 LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253 (339)
Q Consensus 175 ~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~ 253 (339)
++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999986643333333344556788999999998899999999999999999998 99998765433211
Q ss_pred hHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
... .... .....+..++..+.+||.+||+.||.+|||+.+++++|+.+.....++
T Consensus 277 ~~~-~~~~------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 277 YKL-VKDG------------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp HHH-HHHT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHH-HhcC------------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 111 1000 001112334667999999999999999999999999999998765543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=326.51 Aligned_cols=263 Identities=26% Similarity=0.397 Sum_probs=200.4
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
+...++|++.+.||+|+||+||+|... ..+|+|++.... ....+.+.+|++++++++||||++++++. .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 345689999999999999999999863 359999986553 44567789999999999999999999965 4556889
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999999877778999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCccccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
..........+++.|+|||.+. +..++.++||||||+++|+|++|..||.....................
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 246 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD------- 246 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-------
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-------
Confidence 3333334556899999999886 566888999999999999999999999765432211111111000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
.......++..+.+||.+||+.||.+|||+.++++.|+++.
T Consensus 247 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 247 --------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00012345678999999999999999999999999998864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=347.94 Aligned_cols=293 Identities=18% Similarity=0.211 Sum_probs=223.9
Q ss_pred hhhHHHHHhcCCCCCCCCcccc--ccceeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--
Q 019568 4 ILLILRYRQRGKRPSNDASMPL--VAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-- 78 (339)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-- 78 (339)
++.+++.+..++.+.++..... ....-.+.+..+....++|++.+.||+|+||+||+|+.. +++.||+|++....
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~ 113 (437)
T 4aw2_A 34 LICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML 113 (437)
T ss_dssp HHHHHHHHHTSTTTTSHHHHHHHHHHHHHHHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH
T ss_pred HHHHHHHhccChhhhhhhHHHhhhccCcccchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh
Confidence 3455666665544433221111 111122345556667789999999999999999999865 58899999987532
Q ss_pred -hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhc
Q 019568 79 -GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157 (339)
Q Consensus 79 -~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~ 157 (339)
......+.+|..++..++||||+++++++.+.+..|+||||++|++|.+++.+....+++..++.++.|++.||.|||
T Consensus 114 ~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH- 192 (437)
T 4aw2_A 114 KRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH- 192 (437)
T ss_dssp HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 223345888999999999999999999999999999999999999999999876668999999999999999999999
Q ss_pred cCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCcccc-----CCCCCCcchhhHHHH
Q 019568 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGI 232 (339)
Q Consensus 158 ~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~ 232 (339)
+.+|+|+||||+|||++.++.+||+|||++...... .........||+.|+|||++. ...++.++|||||||
T Consensus 193 --~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGv 269 (437)
T 4aw2_A 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269 (437)
T ss_dssp --HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHH
T ss_pred --hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHH
Confidence 999999999999999999999999999999765322 122233457999999999886 567899999999999
Q ss_pred HHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCH
Q 019568 233 MLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ--RINA 310 (339)
Q Consensus 233 il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~ 310 (339)
++|+|++|+.||......+.... ......... .. .....+++++++||.+||+.+|.+ ||++
T Consensus 270 il~elltG~~Pf~~~~~~~~~~~-i~~~~~~~~---------~p------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~ 333 (437)
T 4aw2_A 270 CMYEMLYGETPFYAESLVETYGK-IMNHKERFQ---------FP------TQVTDVSENAKDLIRRLICSREHRLGQNGI 333 (437)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHH-HHTHHHHCC---------CC------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTT
T ss_pred HHHHHHhCCCCCCCCChhHHHHh-hhhcccccc---------CC------cccccCCHHHHHHHHHHhcccccccCCCCH
Confidence 99999999999976432211111 000000000 00 001235677999999999999988 9999
Q ss_pred HHHHHH
Q 019568 311 KEIVKK 316 (339)
Q Consensus 311 ~ell~~ 316 (339)
+|+++|
T Consensus 334 ~eil~H 339 (437)
T 4aw2_A 334 EDFKKH 339 (437)
T ss_dssp HHHHTS
T ss_pred HHHhCC
Confidence 999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=334.63 Aligned_cols=252 Identities=25% Similarity=0.296 Sum_probs=207.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3578999999999999999999754 68999999987542 3345678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+.|++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.+|.++|+|||++..+..
T Consensus 93 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 167 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR- 167 (384)
T ss_dssp EECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence 999999999999997654 7999999999999999999999 99999999999999999999999999999987532
Q ss_pred CCccccccccCCCCccCCccccC---CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 168 --~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----------- 234 (384)
T 4fr4_A 168 --ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----------- 234 (384)
T ss_dssp --TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-----------
T ss_pred --CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-----------
Confidence 223345668999999999864 4589999999999999999999999975433221111000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-AKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~ 316 (339)
.....+..++..+.+||.+||+.||.+||+ ++++++|
T Consensus 235 -------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 235 -------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 001113345678999999999999999998 7877764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=325.87 Aligned_cols=263 Identities=22% Similarity=0.352 Sum_probs=204.9
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
+....++|++.+.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.++++++||||+++++++. ++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 3445689999999999999999999753 25579999986543 445567889999999999999999999985 45
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..++||||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccc
Confidence 688999999999999999877667999999999999999999999 99999999999999999999999999999976
Q ss_pred ccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......... .....
T Consensus 166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~--~i~~~--------- 233 (281)
T 1mp8_A 166 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG--RIENG--------- 233 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH--HHHTT---------
T ss_pred cCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH--HHHcC---------
Confidence 53221 112233446778999999988899999999999999999997 999997654322111 10000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
.....+..++..+.++|.+||+.||.+|||+.+++++|+++.++.
T Consensus 234 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 234 ---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 001113456778999999999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=329.73 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=199.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch--------------------------hhhHHHHHHHHHH
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--------------------------RALKSFNVECEMM 92 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~--------------------------~~~~~~~~e~~~l 92 (339)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 458999999999999999999975 4689999999865431 1235688999999
Q ss_pred HhCCCcceeeEeeeeec--CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCC
Q 019568 93 KSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP 170 (339)
Q Consensus 93 ~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p 170 (339)
++++||||+++++++.. .+..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp 165 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP 165 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence 99999999999999976 5688999999999999886533 36999999999999999999999 99999999999
Q ss_pred CCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCC---CCCcchhhHHHHHHHHHHhCCCCCccc
Q 019568 171 SNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEI 247 (339)
Q Consensus 171 ~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~P~~~~ 247 (339)
+||+++.++.++|+|||++...... ........+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999876322 22234456899999999987765 478899999999999999999999754
Q ss_pred ccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 248 FNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
..... ...... ........+.++.++.+||.+||+.||.+|||+.|+++|=
T Consensus 244 ~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 244 RIMCL--HSKIKS-----------------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp SHHHH--HHHHHH-----------------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred cHHHH--HHHHhc-----------------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 22110 000000 0000111234567799999999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=336.58 Aligned_cols=276 Identities=18% Similarity=0.250 Sum_probs=210.2
Q ss_pred hhhhcCCCCCceeeec--CccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 38 CQATDEFSENNLIGKG--GFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g--~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
....++|++.+.||+| +||+||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3567899999999999 99999999865 69999999997653 4455678889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 113 KALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
.++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999765 246999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCCCC-----ccccccccCCCCccCCccccC--CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc
Q 019568 192 LVGEDQ-----SMTQTQTFATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 192 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
...... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 432111 111223467888999999887 5789999999999999999999999976543332221111000000
Q ss_pred ------ccccc-------------------ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 265 ------STLEV-------------------VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 265 ------~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... ...............+..+++++.+||.+||+.||.+|||++|+++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 00000000001112345567889999999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=321.01 Aligned_cols=256 Identities=23% Similarity=0.275 Sum_probs=211.1
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
..+.++|++.+.||+|+||.||+|... ++..+|+|++..........+.+|++++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 346789999999999999999999754 5889999999876556667889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---CCCCcEEEcccccceecc
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~---~~~~~v~l~Dfg~~~~~~ 193 (339)
|||+++++|.+++.... .+++..++.++.|++.||.+|| +.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 85 MELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999886654 6899999999999999999999 9999999999999999 788999999999998753
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
. ........+|+.|+|||.+.+. ++.++||||||+++|+|++|..||............. .
T Consensus 161 ~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~-------------- 221 (277)
T 3f3z_A 161 P---GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-E-------------- 221 (277)
T ss_dssp T---TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-H--------------
T ss_pred C---ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-h--------------
Confidence 2 2233445689999999988655 8999999999999999999999997643321111100 0
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
............+++.+.+||.+||+.||.+|||+.++++|-+
T Consensus 222 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 222 --GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp --CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred --CCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 0001111112346778999999999999999999999998744
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=324.12 Aligned_cols=268 Identities=23% Similarity=0.385 Sum_probs=218.8
Q ss_pred hhcCCCCCc-eeeecCccEEEEEEe---CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENN-LIGKGGFGSVYKARL---GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~-~ig~g~~~~v~~~~~---~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|.+.. .||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++.++||||+++++++. .+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcE
Confidence 346777776 999999999999974 257889999997653 445677889999999999999999999994 55689
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999999777667999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 195 EDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 195 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .......
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~i~~~----------- 229 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFIEQG----------- 229 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHHHHTT-----------
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHhcC-----------
Confidence 2221 11223345788999999988889999999999999999998 9999976533211 1111100
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccccCc
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGR 331 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~~~ 331 (339)
.....+..+++.+.++|.+||+.||.+||++.+++++|+.+..+......++
T Consensus 230 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 230 -------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred -------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 0011134567789999999999999999999999999999999887766554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=328.85 Aligned_cols=268 Identities=19% Similarity=0.179 Sum_probs=216.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||+||+|.. .+++.||||++..... ...+.+|+++++.+ +||||+++++++...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 457899999999999999999985 5799999999875532 34678899999999 9999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc-----EEEcccccceec
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV-----AHLSDFSIAKLL 192 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~-----v~l~Dfg~~~~~ 192 (339)
||+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++. ++|+|||++..+
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999 88999999876668999999999999999999999 999999999999999998887 999999999876
Q ss_pred cCCCCcc-----ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 193 VGEDQSM-----TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 193 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...................
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~---- 236 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK---- 236 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH----
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh----
Confidence 4322211 1245568999999999999999999999999999999999999998754322111100000000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
. ..........++ ++.+|+.+||+.||.+||++++|++.|+.+.+.....
T Consensus 237 -------~--~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 237 -------R--ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp -------H--HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -------c--cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 0 000000112244 7999999999999999999999999999998876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=337.21 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=204.3
Q ss_pred cCCCC--CceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSE--NNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~--~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
+.|.+ .+.||+|+||.||+|.. .+|+.||+|++..........+.+|++++++++||||+++++++...+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34444 56899999999999975 4699999999987766666788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe--CCCCcEEEcccccceeccCCC
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL--DDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~--~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||++..+...
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 99999999998776667999999999999999999999 9999999999999999 67789999999999876322
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.......+|+.|+|||++.+..++.++||||||+++|+|++|..||......... .......
T Consensus 243 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~i~~~~--------------- 304 (373)
T 2x4f_A 243 --EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL-NNILACR--------------- 304 (373)
T ss_dssp --CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHHTC---------------
T ss_pred --cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcc---------------
Confidence 2233456899999999999999999999999999999999999999764322111 1110000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..........++.++++||.+||+.||.+|||+.|+++|=+
T Consensus 305 -~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 305 -WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp -CCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -CCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 00011112345778999999999999999999999999643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.59 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=206.0
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcE----EEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGME----VAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~----v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
.++|++.+.||+|+||+||+|.+. +++. |++|.+.... ......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 478999999999999999999743 4443 5788775432 344567889999999999999999999998754 77
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
++++++.+++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999887778999999999999999999999 99999999999999999999999999999987644
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
...........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......... ......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~~------------ 235 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--SILEKG------------ 235 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHHHTT------------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH--HHHHcC------------
Confidence 433333444556888999999999999999999999999999999 99999765432211 111100
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
.....+..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 236 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 236 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 01111334567799999999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=323.43 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=209.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--ceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNE--EFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 115 (339)
..++|++.+.||+|+||+||+|.. +++.||||++.... ....+.+.+|+.++++++||||+++++++... +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 457899999999999999999998 58999999987653 34556789999999999999999999999876 78899
Q ss_pred EEEecCCCCHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 116 VLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
||||+++++|.+++..... .+++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.++++|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999977653 5899999999999999999999 999 999999999999999999999998876532
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCC---cchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSA---NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
......+|+.|+|||.+.+..++. ++||||||+++|+|++|..||...............
T Consensus 164 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------- 226 (271)
T 3kmu_A 164 -------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE---------- 226 (271)
T ss_dssp -------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS----------
T ss_pred -------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc----------
Confidence 223346789999999988766554 799999999999999999999765332211111000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
......+..++.++.+++.+||+.||++|||++++++.|+++++
T Consensus 227 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 ---------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00111134567789999999999999999999999999998864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=322.44 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=191.8
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
+....++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 445668999999999999999999985 479999999987543 2234678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++||||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 99999999999999999877678999999999999999999999 999999999999999999999999999998865
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------------- 223 (278)
T 3cok_A 163 KMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----------------- 223 (278)
T ss_dssp C------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------
T ss_pred cCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-----------------
Confidence 3211 122335578999999999999999999999999999999999999976432211000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.... ....+..++.++.+||.+||+.||++|||++++++|-
T Consensus 224 ~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 224 VVLA----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CCSS----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred Hhhc----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 0000 0011234567799999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=329.37 Aligned_cols=264 Identities=27% Similarity=0.433 Sum_probs=216.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe--------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeee
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL--------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCS 108 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~--------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (339)
...++|++.+.||+|+||.||+|.. .++..||||++.... ......+.+|+++++.+ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3468999999999999999999975 246789999987653 34567788999999999 8999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCe
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV 173 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Ni 173 (339)
..+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence 9999999999999999999997653 24889999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCcc
Q 019568 174 LLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252 (339)
Q Consensus 174 l~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~ 252 (339)
+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 999999999999999987644333333344556788999999988889999999999999999999 9999876432111
Q ss_pred chHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
....... .....+..++..+.+||.+||+.||.+|||+.+++++|+++.....
T Consensus 269 --~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 269 --FKLLKEG------------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp --HHHHHHT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --HHHHhcC------------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1000000 0011133456779999999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=320.83 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=206.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHh--CCCcceeeEeeeeec----Ccee
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKS--IRHRNLIKVISSCSN----EEFK 113 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~ 113 (339)
..++|++.+.||+|+||+||+|.. +++.||||++.... ...+..|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 568999999999999999999988 78999999986542 3445567777776 799999999998643 4568
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhcc-----CCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-----~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
++||||+++++|.++++.. .+++..++.++.|++.||.|||.. .+.+++|+||||+||+++.++.++|+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999999999999654 599999999999999999999921 146899999999999999999999999999
Q ss_pred ceeccCCCCcc--ccccccCCCCccCCccccCC------CCCCcchhhHHHHHHHHHHhC----------CCCCcccccC
Q 019568 189 AKLLVGEDQSM--TQTQTFATIGYMAPEYGREG------RVSANGDVYSFGIMLMETFTG----------KKPTDEIFNG 250 (339)
Q Consensus 189 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g----------~~P~~~~~~~ 250 (339)
+.......... ......+|+.|+|||.+.+. .++.++||||||+++|+|++| ..||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 97654322221 12334689999999998876 456799999999999999999 7787665444
Q ss_pred ccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 251 EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
................ ............++..+.+||.+||+.||++|||+.++++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQ---------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHHHHHHTTSCC---------CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhhhhHHHhccCC---------CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3333222221111000 000011122456788899999999999999999999999999876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=321.03 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=212.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 45689999999999999999999864 69999999987553 34456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
+||+++++|.+++... ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999999988654 36899999999999999999999 9999999999999999999999999999997653322
Q ss_pred CccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||............+.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------- 226 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------- 226 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-------------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-------------
Confidence 2223345568999999999987765 78999999999999999999999875443332222211100
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.......++..+.+||.+||+.||.+|||++++++|-
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 227 -----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp -----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred -----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 0111234577799999999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=331.79 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=207.1
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (339)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 478999999999999999999854 6899999999765 234456788899999988 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++.+.. .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~- 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 162 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence 999999999999997654 6999999999999999999999 99999999999999999999999999999875321
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccc---hHhHhhhhccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT---LKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 272 (339)
.........||+.|+|||++.+..++.++|+|||||++|+|++|..||......... ......... ..
T Consensus 163 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i-------~~- 233 (345)
T 3a8x_A 163 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------LE- 233 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH-------HH-
T ss_pred -CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH-------Hc-
Confidence 122334557899999999999999999999999999999999999999753221110 000000000 00
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA------KEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 316 (339)
. ....+..++.++++||.+||+.||.+||++ .++++|
T Consensus 234 -----~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 -----K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -----C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -----C--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0 011133467789999999999999999995 788876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=330.22 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=199.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEe----CCCcEEEEEEeeccc----hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
..++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 458999999999999999999975 479999999987542 234456788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..|+||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999997654 6889999999999999999999 99999999999999999999999999999875
Q ss_pred ccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
... .........||+.|+|||++.+..++.++||||||+++|+|++|..||.......... .....
T Consensus 171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~i~~~----------- 236 (327)
T 3a62_A 171 SIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID-KILKC----------- 236 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHT-----------
T ss_pred ccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH-HHHhC-----------
Confidence 421 1122334568999999999999999999999999999999999999997643221100 00000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKKL 317 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~l 317 (339)
....++.++.++.+||.+||..||.+|| ++.++++|=
T Consensus 237 ---------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 237 ---------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred ---------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 0011234567799999999999999999 888999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=332.66 Aligned_cols=248 Identities=21% Similarity=0.252 Sum_probs=208.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3478999999999999999999854 69999999987542 2345678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||++|++|.+++.+.. .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.....
T Consensus 119 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 999999999999997654 6899999999999999999999 99999999999999999999999999999986532
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
......||+.|+|||++.+..++.++|+||||+++|+|++|..||........ .......
T Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~--------------- 253 (350)
T 1rdq_E 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-YEKIVSG--------------- 253 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC---------------
T ss_pred ----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-HHHHHcC---------------
Confidence 22345689999999999999999999999999999999999999975422111 0000000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKKL 317 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~l 317 (339)
....+..++.++.+||.+||+.||.+||+ ++++++|-
T Consensus 254 -----~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 254 -----KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -----CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 00112345777999999999999999998 99999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=329.38 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=206.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CC-------cEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DG-------MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~-------~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
..++|++.+.||+|+||+||+|... ++ ..||+|++........+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3578999999999999999999743 33 579999997776667788999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc--------EEE
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--------AHL 183 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~--------v~l 183 (339)
..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++. ++|
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999999887767999999999999999999999 999999999999999988877 999
Q ss_pred cccccceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 184 SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
+|||++.... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..|+............... .
T Consensus 163 ~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-~- 234 (289)
T 4fvq_A 163 SDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-R- 234 (289)
T ss_dssp CCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-T-
T ss_pred ccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-c-
Confidence 9999886431 1223446888999999887 67899999999999999999965543322211111111000 0
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccccC
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGG 330 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~~ 330 (339)
...+...+.++.+||.+||+.||.+|||+.+++++|+.+...-+-.+++
T Consensus 235 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~ 283 (289)
T 4fvq_A 235 -------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283 (289)
T ss_dssp -------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---------
T ss_pred -------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCc
Confidence 0001122445889999999999999999999999999988765555444
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=335.66 Aligned_cols=257 Identities=23% Similarity=0.246 Sum_probs=199.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
...++|++.+.||+|+||+||+++.. +++.||||++.... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 35689999999999999999999865 79999999987543 23356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc--EEEcccccceeccCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--AHLSDFSIAKLLVGE 195 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~--v~l~Dfg~~~~~~~~ 195 (339)
||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++. ++|+|||++....
T Consensus 96 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~-- 169 (361)
T 3uc3_A 96 EYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-- 169 (361)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc--
Confidence 9999999999986654 6999999999999999999999 999999999999999987665 9999999987432
Q ss_pred CCccccccccCCCCccCCccccCCCCCCc-chhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSAN-GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.........+|+.|+|||++.+..++.+ +||||||+++|+|++|..||...................
T Consensus 170 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~----------- 237 (361)
T 3uc3_A 170 -LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV----------- 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT-----------
T ss_pred -ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC-----------
Confidence 1222344568999999999988877655 899999999999999999998754433222211111000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.........+++++++||.+||+.||.+|||+.|+++|=+
T Consensus 238 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 238 ----KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp ----CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred ----CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 0001112234677999999999999999999999999854
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.69 Aligned_cols=277 Identities=25% Similarity=0.339 Sum_probs=216.0
Q ss_pred hcCCCCCceeeecCccEEEEEEe-----CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeee--cCcee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS--NEEFK 113 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 113 (339)
.++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++||||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47899999999999999999973 368999999998777777788999999999999999999999875 55678
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++||||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999999876667999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
..... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||............... ..........
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 255 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER---DVPALSRLLE 255 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-------CCHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc---ccccHHHHHH
Confidence 32221 1223445788899999999989999999999999999999999998754321100000000 0000000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
..........+..+++.+.+||.+||+.||.+|||+++++++|+.+.....
T Consensus 256 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 256 --LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp --HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred --HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 000011112245667889999999999999999999999999999876443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=342.83 Aligned_cols=257 Identities=31% Similarity=0.455 Sum_probs=213.2
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-eeE
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE-FKA 114 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 114 (339)
.+....++|++.+.||+|+||.||+|.. .++.||||+++... ..+.+.+|++++++++||||+++++++.... ..+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 3444568999999999999999999987 47899999987653 4567899999999999999999999976554 789
Q ss_pred EEEEecCCCCHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 115 LVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
+||||+++++|.+++..... .++...++.++.|++.||.||| +++++|+||+|+||+++.++.+||+|||++....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999987653 4789999999999999999999 9999999999999999999999999999987542
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
. ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.... ..
T Consensus 341 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~--i~------------- 400 (450)
T 1k9a_A 341 S-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VE------------- 400 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH--HH-------------
T ss_pred c-----cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HH-------------
Confidence 1 1222346788999999999999999999999999999998 9999986543321110 00
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
...+...+..+++.+.+||.+||+.||.+|||+.++++.|+.++..
T Consensus 401 -----~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 401 -----KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0011122456778899999999999999999999999999998864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=327.22 Aligned_cols=270 Identities=24% Similarity=0.323 Sum_probs=193.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3578999999999999999999754 69999999997654 234467888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcC-----CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 118 EYMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
||+++ +|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99985 9999886532 35899999999999999999999 999999999999999999999999999999865
Q ss_pred cCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc--ccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--STLEV 269 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~ 269 (339)
... ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+.. .......... ..+..
T Consensus 159 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 159 GIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL-KLIFDIMGTPNESLWPS 235 (317)
T ss_dssp TSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCTTTCGG
T ss_pred CCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhHhhh
Confidence 321 222334568999999998876 46899999999999999999999999765332111 1111100000 00000
Q ss_pred ------cccccc--Cccc----hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 ------VDANLL--SQED----IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ------~~~~~~--~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...... .... ........++.++.+||.+||+.||.+|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 0000 0111123467789999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=327.85 Aligned_cols=270 Identities=25% Similarity=0.405 Sum_probs=206.8
Q ss_pred eHHHHhhhhcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeee
Q 019568 33 SYLELCQATDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106 (339)
Q Consensus 33 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 106 (339)
.+..+....++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 33555556789999999999999999999642 35589999987653 4455778899999999999999999999
Q ss_pred eecCc-----eeEEEEEecCCCCHHHHHhh-----cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC
Q 019568 107 CSNEE-----FKALVLEYMPHGSLEKYLYS-----SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD 176 (339)
Q Consensus 107 ~~~~~-----~~~lv~e~~~~~~L~~~i~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~ 176 (339)
+...+ ..++|+||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEc
Confidence 87654 45899999999999999853 2356999999999999999999999 99999999999999999
Q ss_pred CCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchH
Q 019568 177 DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 255 (339)
Q Consensus 177 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~ 255 (339)
.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 999999999999876543332233344456788999999999999999999999999999999 8899876533221111
Q ss_pred hHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 256 HWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
.... .....+..++..+.+||.+||..||.+|||+.+++++|+++.+++.
T Consensus 262 --~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 262 --LLHG------------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --HHTT------------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --HHcC------------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0000 0011133456779999999999999999999999999999988764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=321.05 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=209.9
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
.+.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35689999999999999999999754 69999999987653 3455678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc---EEEcccccceec
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFSIAKLL 192 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~---v~l~Dfg~~~~~ 192 (339)
||||+++++|.+.+.... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 83 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999998886654 6899999999999999999999 999999999999999976655 999999999765
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.. ........+++.|+|||.+.+..++.++||||||+++|+|++|..||............. ...
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~----------- 223 (284)
T 3kk8_A 159 ND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-AGA----------- 223 (284)
T ss_dssp CS---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTC-----------
T ss_pred cc---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH-hcc-----------
Confidence 32 222334568999999999999999999999999999999999999997643221111100 000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..........+++++.+||.+||+.||.+|||+.++++|-+
T Consensus 224 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 224 -----YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp -----CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred -----ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 00011112345677999999999999999999999999754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=328.07 Aligned_cols=273 Identities=22% Similarity=0.374 Sum_probs=211.3
Q ss_pred hcCCCCCceeeecCccEEEEEE-----eCCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC--ce
Q 019568 41 TDEFSENNLIGKGGFGSVYKAR-----LGDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNE--EF 112 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~-----~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 112 (339)
..+|++.+.||+|+||.||+|. ..+++.||||++.... ......+.+|+++++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4669999999999999999998 2368999999987553 33456788999999999999999999999776 66
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++||||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 89999999999999999777778999999999999999999999 999999999999999999999999999999876
Q ss_pred cCCCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.......... ..............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM---IGPTHGQMTVTRLV 253 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH---HCSCCGGGHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhc---cCCcccccCHHHHH
Confidence 433221 22334557888999999999999999999999999999999999865432110000 00000000000000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
. ..........+..+++.+.+||.+||+.||.+|||+.++++.|+++.
T Consensus 254 ~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 N--TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp H--HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0 00001111223456788999999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=332.79 Aligned_cols=259 Identities=23% Similarity=0.374 Sum_probs=208.5
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcE----EEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGME----VAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~----v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
.++|++.+.||+|+||+||+|.+. +++. |++|.+.... ......+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 478999999999999999999753 4554 7777765432 334456778999999999999999999986 45688
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+|+||+.+++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999877667999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||........... .....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--~~~~~----------- 234 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL--LEKGE----------- 234 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH--HHTTC-----------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH--HHcCC-----------
Confidence 444444455567889999999998999999999999999999999 9999986543322111 11000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
....+..++.++.+||.+||..||.+|||+.+++++|+.+...
T Consensus 235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111223455688999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=326.89 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=209.8
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchh------hhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGR------ALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
...++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++++.||||+++++++...+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 35688999999999999999999854 6999999998765321 3567889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC----cEEEcccc
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFS 187 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~----~v~l~Dfg 187 (339)
..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999999764 37899999999999999999999 99999999999999999887 79999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
++...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+... . .. .
T Consensus 165 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~-i~---~---- 232 (321)
T 2a2a_A 165 LAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-N-IT---S---- 232 (321)
T ss_dssp TCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-H-HH---T----
T ss_pred cceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH-H-HH---h----
Confidence 99875322 22334568999999999999999999999999999999999999997542211100 0 00 0
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
............++..+.+||.+||+.||.+|||+.++++|
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 233 --------VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --------TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --------cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00011112234567789999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=323.20 Aligned_cols=255 Identities=29% Similarity=0.403 Sum_probs=204.1
Q ss_pred hcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
.++|++.+.||+|+||+||+|.. .++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 46899999999999999999987 5789999998644 345678899999999999999999999874 378999999
Q ss_pred CCCCHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHhhccCC---CCeEecCCCCCCeEeCCCCc-EEEcccccceeccC
Q 019568 121 PHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYS---APIIHCDLKPSNVLLDDNMV-AHLSDFSIAKLLVG 194 (339)
Q Consensus 121 ~~~~L~~~i~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~---~~i~h~di~p~Nil~~~~~~-v~l~Dfg~~~~~~~ 194 (339)
++++|.+++..... .++...++.++.|++.||.||| + .+++|+||||+||+++.++. ++|+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH---SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH---TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH---hCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999976543 4788899999999999999999 7 89999999999999988886 79999999875421
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||..................
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------ 221 (307)
T 2eva_A 159 -----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------------ 221 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC------------
T ss_pred -----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC------------
Confidence 123345899999999999999999999999999999999999999765433221111111000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
.......++..+.+||.+||+.||++|||+++++++|+.+.+.+..
T Consensus 222 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 222 ------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0011234567799999999999999999999999999999876644
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=332.12 Aligned_cols=271 Identities=21% Similarity=0.382 Sum_probs=220.0
Q ss_pred eeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCccee
Q 019568 29 WRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLI 101 (339)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~ 101 (339)
.+.+...++....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+
T Consensus 12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred ccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 344555677778899999999999999999999643 37889999987543 34455788999999999999999
Q ss_pred eEeeeeecCceeEEEEEecCCCCHHHHHhhcC---------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCC
Q 019568 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSN 172 (339)
Q Consensus 102 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~N 172 (339)
++++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.+|| +.|++|+||||+|
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~N 168 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARN 168 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGG
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccce
Confidence 99999999999999999999999999986532 35689999999999999999999 9999999999999
Q ss_pred eEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCc
Q 019568 173 VLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251 (339)
Q Consensus 173 il~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~ 251 (339)
|+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 9999999999999999876533322233344456888999999998899999999999999999999 899987643221
Q ss_pred cchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
.. ..... .. ....+..++..+.+||.+||+.||.+|||+.+++++|+++..
T Consensus 249 ~~--~~~~~---~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 VL--RFVME---GG---------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HH--HHHHT---TC---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH--HHHHc---CC---------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 00000 00 001123456779999999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=323.49 Aligned_cols=269 Identities=25% Similarity=0.415 Sum_probs=213.1
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeCC----CcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeee-ec
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLGD----GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSC-SN 109 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~----~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 109 (339)
.+.....+|++.+.||+|+||+||+|.... ...+++|.+.... ......+.+|+.++++++||||+++++++ ..
T Consensus 19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 345566789999999999999999997432 3358899886543 44567788999999999999999999985 55
Q ss_pred CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
++..++||||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||++
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccc
Confidence 67889999999999999999877777999999999999999999999 999999999999999999999999999999
Q ss_pred eeccCCCC--ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccc
Q 019568 190 KLLVGEDQ--SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 190 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
........ ........+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||............ ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~--~~~----- 248 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--LQG----- 248 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH--HTT-----
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--hcC-----
Confidence 76532221 112233446788999999999999999999999999999999 55566544322211110 000
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
.....+..+++.+.+++.+||+.||.+|||++++++.|+++...+..+
T Consensus 249 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 249 -------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred -------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 001112345677999999999999999999999999999998876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=330.01 Aligned_cols=257 Identities=19% Similarity=0.249 Sum_probs=186.9
Q ss_pred hhcCCCCC---ceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeE
Q 019568 40 ATDEFSEN---NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~---~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 114 (339)
+.++|++. +.||+|+||+||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 34556654 88999999999999764 6999999998644 3356778999999996 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC---cEEEccccccee
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKL 191 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~---~v~l~Dfg~~~~ 191 (339)
+||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .++|+|||++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EEECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999997654 7999999999999999999999 99999999999999997665 899999999986
Q ss_pred ccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCcc--chHhHhhhhcccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM--TLKHWVNDWLPISTLEV 269 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~ 269 (339)
... .........+|+.|+|||++.+..++.++||||||+++|+|++|..||........ ..........
T Consensus 159 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~------- 229 (325)
T 3kn6_A 159 KPP--DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK------- 229 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT-------
T ss_pred cCC--CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH-------
Confidence 532 22223445679999999999999999999999999999999999999986533210 0000000000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.............+++++++||.+||+.||.+|||++++++|=
T Consensus 230 -----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 230 -----KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp -----TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred -----cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 0011112222345678899999999999999999999998763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=327.52 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=201.3
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-----
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE----- 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 111 (339)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 35678999999999999999999865 79999999997654 345577899999999999999999999875432
Q ss_pred ----------------------------------------------------eeEEEEEecCCCCHHHHHhhcCC--ccC
Q 019568 112 ----------------------------------------------------FKALVLEYMPHGSLEKYLYSSNC--ILD 137 (339)
Q Consensus 112 ----------------------------------------------------~~~lv~e~~~~~~L~~~i~~~~~--~~~ 137 (339)
..++||||+++++|.+++..... ..+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 37999999999999999976542 356
Q ss_pred HHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc----------cccccccCC
Q 019568 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS----------MTQTQTFAT 207 (339)
Q Consensus 138 ~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~----------~~~~~~~~~ 207 (339)
...++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......... .......+|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 6678999999999999999 999999999999999999999999999999876432211 122345689
Q ss_pred CCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHH
Q 019568 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287 (339)
Q Consensus 208 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (339)
+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ...... ..........
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-------~~~~~~---------------~~~~~~~~~~ 297 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-------IITDVR---------------NLKFPLLFTQ 297 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-------HHHHHH---------------TTCCCHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-------HHHHhh---------------ccCCCccccc
Confidence 999999999999999999999999999999998877432211 000000 0001112345
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 288 CVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 288 ~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.++.+.+||.+||+.||.+|||++++++|
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 56778999999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=331.32 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=194.7
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
....++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 446688999999999999999999865 58899999987553 335677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC---CCcEEEcccccceecc
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLV 193 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~---~~~v~l~Dfg~~~~~~ 193 (339)
|||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++. ++.++|+|||++....
T Consensus 127 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp ECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999986554 6899999999999999999999 999999999999999975 8899999999987652
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
. ........+|+.|+|||++.+..++.++||||||+++|+|++|..||..................
T Consensus 203 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~----------- 268 (349)
T 2w4o_A 203 H---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY----------- 268 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-----------
T ss_pred c---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-----------
Confidence 2 12233456899999999999999999999999999999999999999754332211111111000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.........++.++.+||.+||+.||++|||+.++++|
T Consensus 269 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 -----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011123456779999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.44 Aligned_cols=270 Identities=22% Similarity=0.267 Sum_probs=202.6
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
.++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 478999999999999999999864 69999999986553 234566788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-- 155 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--
Confidence 999998888877544 47999999999999999999999 999999999999999999999999999999875322
Q ss_pred ccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhh--h--------hccccc
Q 019568 198 SMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN--D--------WLPIST 266 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~--~--------~~~~~~ 266 (339)
........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||............... . ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 222334568899999998876 66899999999999999999999999765332211110000 0 000000
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...................+.++.++.+||.+||+.||.+|||++++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000000111124567789999999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=319.20 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=205.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999754 68899999986542 2234568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+.+.... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~-- 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCC--
Confidence 999999999999987654 6899999999999999999999 9999999999999999999999999999885432
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
........+++.|+|||.+.+..++.++||||||+++|+|++|..||........... ...
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~--------------- 221 (279)
T 3fdn_A 161 --SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR--ISR--------------- 221 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HHH---------------
T ss_pred --cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH--HHh---------------
Confidence 2223445689999999999999999999999999999999999999975432111100 000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.....+..++..+.+||.+||+.||.+|||++|+++|-+
T Consensus 222 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 222 ----VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp ----TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred ----CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 001112345677999999999999999999999999865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=330.77 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=209.6
Q ss_pred eeeHHHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc-----chhhhHHHHHHHHHHHhCCCcceeeEe
Q 019568 31 TFSYLELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ-----CGRALKSFNVECEMMKSIRHRNLIKVI 104 (339)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~ 104 (339)
.+.--++..+.++|++.+.||+|+||+||+|.. .++..||+|++... .......+.+|+++++.++||||++++
T Consensus 15 ~~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 94 (345)
T 3hko_A 15 YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY 94 (345)
T ss_dssp CCCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence 344455677889999999999999999999975 46899999998654 234557788999999999999999999
Q ss_pred eeeecCceeEEEEEecCCCCHHHHHhhc---------------------------------------CCccCHHHHHHHH
Q 019568 105 SSCSNEEFKALVLEYMPHGSLEKYLYSS---------------------------------------NCILDIFQRLNIM 145 (339)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~---------------------------------------~~~~~~~~~~~i~ 145 (339)
+++.+.+..++||||+++++|.+++... ...+++..++.++
T Consensus 95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred hhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 9999999999999999999999998521 1124677889999
Q ss_pred HHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC--cEEEcccccceeccCCCCc--cccccccCCCCccCCccccC--C
Q 019568 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM--VAHLSDFSIAKLLVGEDQS--MTQTQTFATIGYMAPEYGRE--G 219 (339)
Q Consensus 146 ~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~--~v~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~ 219 (339)
.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||++..+...... .......+|+.|+|||.+.+ .
T Consensus 175 ~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 175 RQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 99999999999 99999999999999998776 8999999999865332211 12345568999999998865 6
Q ss_pred CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhh
Q 019568 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 299 (339)
Q Consensus 220 ~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 299 (339)
.++.++||||||+++|+|++|..||............. . ............+++++.+||.+|
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~----------------~~~~~~~~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL-N----------------KKLCFENPNYNVLSPLARDLLSNL 314 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-H----------------CCCCTTSGGGGGSCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH-h----------------cccccCCcccccCCHHHHHHHHHH
Confidence 78999999999999999999999997653322111100 0 000111112234577899999999
Q ss_pred cCCCCCCCCCHHHHHHHH
Q 019568 300 AVESPEQRINAKEIVKKL 317 (339)
Q Consensus 300 l~~dP~~Rps~~ell~~l 317 (339)
|+.||.+||++.++++|=
T Consensus 315 l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 315 LNRNVDERFDAMRALQHP 332 (345)
T ss_dssp SCSCTTTSCCHHHHHHSH
T ss_pred cCCChhHCCCHHHHhcCh
Confidence 999999999999999964
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=330.24 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=204.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcE----EEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGME----VAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~----v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
.++|++.+.||+|+||+||+|.+. +++. |++|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 578999999999999999999743 4554 466766433 2345577889999999999999999999998765 77
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
++++++.+++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999887778999999999999999999999 99999999999999999999999999999987644
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......... ....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~--~~~~------------- 234 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS--ILEK------------- 234 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH--HHHT-------------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHc-------------
Confidence 333333444556788999999999999999999999999999999 999997654332111 1100
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
......+..++.++.+||.+||..||.+|||+.++++.|+++...
T Consensus 235 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 235 -----GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 001111344567799999999999999999999999999999853
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=324.40 Aligned_cols=265 Identities=26% Similarity=0.415 Sum_probs=218.8
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
..+....++|++.+.||+|+||+||+|.+. ++..||+|++... ....+.+.+|++++++++||||+++++++...+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 344556789999999999999999999865 5889999998754 33457788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 114 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
++||||+++++|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999997643 46899999999999999999999 999999999999999999999999999999765
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......... ....
T Consensus 162 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~--~~~~----------- 227 (288)
T 3kfa_A 162 TGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--LLEK----------- 227 (288)
T ss_dssp CSS-SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH--HHHT-----------
T ss_pred cCC-ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHhc-----------
Confidence 322 2222334446788999999998999999999999999999999 999987653322111 1000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
......+..++..+.+|+.+||+.||.+|||++++++.|+.+.+..
T Consensus 228 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 228 -------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0011123455678999999999999999999999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=327.09 Aligned_cols=277 Identities=23% Similarity=0.379 Sum_probs=215.0
Q ss_pred hhcCC-CCCceeeecCccEEEEEEe-----CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeec--C
Q 019568 40 ATDEF-SENNLIGKGGFGSVYKARL-----GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSN--E 110 (339)
Q Consensus 40 ~~~~y-~~~~~ig~g~~~~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 110 (339)
+.++| ++.+.||+|+||+||++.+ .+++.||||++.... ......+.+|+++++.++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34566 9999999999999988853 268899999997653 3456678999999999999999999999976 4
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
...++||||+++++|.+++.... +++..++.++.|++.||.+|| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 67899999999999999997654 899999999999999999999 9999999999999999999999999999998
Q ss_pred eccCCCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc-ccccc
Q 019568 191 LLVGEDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP-ISTLE 268 (339)
Q Consensus 191 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~ 268 (339)
........ .......+++.|+|||.+.+..++.++||||||+++|+|++|..||............+...... .....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 76432221 12334457788999999999899999999999999999999999987643211100000000000 00000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
.. ........+..++.++.+||.+||+.||.+|||++++++.|+.+.+++...
T Consensus 263 ~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 263 LL------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HH------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HH------hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 00 001111223456788999999999999999999999999999999887643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=331.12 Aligned_cols=250 Identities=21% Similarity=0.273 Sum_probs=207.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+..|..++..+ .||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4579999999999999999999865 58899999987652 23456678899999988 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||++|++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.+|.++|+|||++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999997654 6999999999999999999999 99999999999999999999999999999875321
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.........||+.|+|||++.+..++.++|+||||+++|+|++|..||......+.. ......
T Consensus 174 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~~i~~~-------------- 236 (353)
T 2i0e_A 174 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-QSIMEH-------------- 236 (353)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHC--------------
T ss_pred --CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH-HHHHhC--------------
Confidence 122334567899999999999999999999999999999999999999764321110 000000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
....+..++.++.+||.+||+.||.+||+ ++++++|
T Consensus 237 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00112345778999999999999999994 6889887
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=333.19 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=201.5
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCC--cceeeEeeeeecCceeE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRH--RNLIKVISSCSNEEFKA 114 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 114 (339)
...++|++.+.||+|+||.||++...+++.||||++.... ......+.+|+.+++.+.| |||+++++++...+..+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 4567899999999999999999988889999999987553 4455778899999999976 99999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+|||+ .+++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++ ++.++|+|||++.....
T Consensus 86 lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99995 4779999997654 7899999999999999999999 99999999999999997 67899999999987643
Q ss_pred CCCccccccccCCCCccCCccccC-----------CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGRE-----------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~ 263 (339)
...........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-- 237 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN-- 237 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT--
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC--
Confidence 333333445678999999998864 6688999999999999999999999975432211111111000
Q ss_pred ccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.....+...+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 238 ----------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 238 ----------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp ----------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 000112223456899999999999999999999999855
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.98 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=210.9
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeee----cCcee
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS----NEEFK 113 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~ 113 (339)
...++|++.+.||+|+||.||++.. .+++.||||++..........+.+|+++++.++||||+++++++. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3467999999999999999999985 579999999997776677788999999999999999999999986 34578
Q ss_pred EEEEEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 114 ALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
++|+||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999999876 3457999999999999999999999 9999999999999999999999999999887
Q ss_pred eccCCCCcc-------ccccccCCCCccCCccccCCC---CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh
Q 019568 191 LLVGEDQSM-------TQTQTFATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 191 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~ 260 (339)
......... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||................
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 542111100 012334688999999987654 6899999999999999999999997643322222111110
Q ss_pred hccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 261 WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
.........++..+.+||.+||+.||.+|||+++++++|+.++.
T Consensus 263 ------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 263 ------------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ------------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ------------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00111123456779999999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=331.59 Aligned_cols=281 Identities=23% Similarity=0.243 Sum_probs=215.7
Q ss_pred cccceeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-----Cc
Q 019568 25 LVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-----HR 98 (339)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----h~ 98 (339)
..+....+++.+.....++|++.+.||+|+||+||+|.. .+++.||||++... ......+..|+++++.+. ||
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 344567788888888999999999999999999999985 46899999998643 344466778999999996 99
Q ss_pred ceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC
Q 019568 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD 177 (339)
Q Consensus 99 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~ 177 (339)
||+++++++...+..++||||+ +++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDD 172 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcc
Confidence 9999999999999999999999 889999997654 35899999999999999999999 999999999999999975
Q ss_pred -------------------------CCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHH
Q 019568 178 -------------------------NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGI 232 (339)
Q Consensus 178 -------------------------~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 232 (339)
++.++|+|||++..... ......+|+.|+|||++.+..++.++|||||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 88999999999986422 223456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCcccccCccchHhHhhhhcccc-----------ccccccccc----cCccc-----------hhhhhhH
Q 019568 233 MLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS-----------TLEVVDANL----LSQED-----------IHFVAKE 286 (339)
Q Consensus 233 il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~----~~~~~-----------~~~~~~~ 286 (339)
++|+|++|+.||........... ........+ ......... ..... .......
T Consensus 248 il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 248 VLAELYTGSLLFRTHEHMEHLAM-MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHH-HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHHHCCCCCCCCcHHHHHHH-HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 99999999999976432211100 000000000 000000000 00000 0000112
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 287 QCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 287 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..++.+.+||.+||+.||.+|||++|+++|
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 223678899999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=327.94 Aligned_cols=284 Identities=25% Similarity=0.320 Sum_probs=205.7
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHH--HHhCCCcceeeEeeee-----ecCc
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM--MKSIRHRNLIKVISSC-----SNEE 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~-----~~~~ 111 (339)
...++|++.+.||+|+||+||+|+. +++.||||++..... ..+..|.++ +..++||||+++++.+ ....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3568999999999999999999987 789999999875532 333344444 4458999999999754 3344
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC---------CeEecCCCCCCeEeCCCCcEE
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA---------PIIHCDLKPSNVLLDDNMVAH 182 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~---------~i~h~di~p~Nil~~~~~~v~ 182 (339)
.+++||||+++++|.+++.... .++..++.++.|++.||.||| +. +++|+||||+||+++.++.++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence 6789999999999999997665 588889999999999999999 88 999999999999999999999
Q ss_pred EcccccceeccCCCC------ccccccccCCCCccCCccccC-------CCCCCcchhhHHHHHHHHHHhCCCCCccccc
Q 019568 183 LSDFSIAKLLVGEDQ------SMTQTQTFATIGYMAPEYGRE-------GRVSANGDVYSFGIMLMETFTGKKPTDEIFN 249 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~P~~~~~~ 249 (339)
|+|||++..+..... ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643211 112234468999999999877 4567899999999999999999777643322
Q ss_pred CccchHhHhhhhcccccccc-----ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 250 GEMTLKHWVNDWLPISTLEV-----VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
.......+............ ..................+++.+.+||.+||+.||++|||++|+++.|+.+...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 11111111000000000000 0000011111112223457788999999999999999999999999999999888
Q ss_pred cccccCc
Q 019568 325 LRNVGGR 331 (339)
Q Consensus 325 ~~~~~~~ 331 (339)
.++-++.
T Consensus 321 ~~~~~~~ 327 (336)
T 3g2f_A 321 ERNKSVS 327 (336)
T ss_dssp CC-----
T ss_pred HhcccCC
Confidence 8776543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=340.49 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=210.3
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNE 110 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (339)
..+....++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|..+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344556689999999999999999999864 68999999987532 22334578899999999999999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
+..|+||||++|++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999999764 4899999999999999999999 9999999999999999999999999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCCC----CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGR----VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
...... ........||+.|+|||++.+.. ++.++|+||||+++|+|++|..||......... .......
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~i~~~~----- 289 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-SKIMNHK----- 289 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHTHH-----
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH-HHHHhcc-----
Confidence 653221 12233567999999999987665 889999999999999999999999754321111 1100000
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ--RINAKEIVKKL 317 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~l 317 (339)
....+.....++.++++||.+||+.+|.+ ||+++||++|-
T Consensus 290 -----------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 290 -----------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp -----------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred -----------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 00111112345778999999999999998 99999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=325.09 Aligned_cols=247 Identities=21% Similarity=0.206 Sum_probs=198.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.++||+|+||+||+|... +++.||||++.... .........|+..+..+ .||||+++++++...+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4478999999999999999999865 79999999986542 23333445555555555 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~- 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT- 209 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeeccc-
Confidence 99999 56999998877778999999999999999999999 99999999999999999999999999999876532
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
........+|+.|+|||++.+ .++.++||||||+++|+|++|..|+..... ....
T Consensus 210 --~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~------------------ 264 (311)
T 3p1a_A 210 --AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQL------------------ 264 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHH------------------
T ss_pred --CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHH------------------
Confidence 222334558999999998876 789999999999999999999766543211 0000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.........+..++.++.+||.+||+.||++|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 00011122244567889999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=318.53 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=210.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
...++|++.+.||+|+||+||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 35689999999999999999999742 2346999998765 334567788999999999999999999998754 56
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++||||+++++|.+++......+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 8999999999999999877767999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......... ......
T Consensus 165 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~--~~~~~~---------- 231 (281)
T 3cc6_A 165 DED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG--VLEKGD---------- 231 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH--HHHHTC----------
T ss_pred ccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH--HHhcCC----------
Confidence 221 112233446788999999988899999999999999999998 999997543322111 100000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
....+..+++.+.++|.+||..||.+|||+.+++++|+.+.+..
T Consensus 232 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 232 --------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 01112345677999999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=330.96 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=206.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch--------hhhHHHHHHHHHHHhCCCcceeeEeeeeec
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--------RALKSFNVECEMMKSIRHRNLIKVISSCSN 109 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (339)
...++|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4678999999999999999999974 4799999999876531 133467789999999999999999999999
Q ss_pred CceeEEEEEecCCC-CHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccc
Q 019568 110 EEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188 (339)
Q Consensus 110 ~~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~ 188 (339)
.+..++||||+.++ +|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 99999999998666 9999986654 6999999999999999999999 99999999999999999999999999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
+...... .......+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||.......
T Consensus 177 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------- 237 (335)
T 3dls_A 177 AAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------- 237 (335)
T ss_dssp CEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred ceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence 9875322 22334568999999999988776 889999999999999999999997532110
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.. ....+..++.++.+||.+||+.||.+|||++++++|-+
T Consensus 238 ---~~--------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 238 ---EA--------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp ---TT--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred ---hh--------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00 00012234677999999999999999999999999843
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=320.52 Aligned_cols=266 Identities=25% Similarity=0.410 Sum_probs=214.7
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
++....++|++.+.||+|+||.||+|...++..||||++.... .....+.+|+++++.++||||+++++++.. +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 3455668999999999999999999998778899999987553 234678899999999999999999999874 45889
Q ss_pred EEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||||+++++|.+++.... ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999986542 25899999999999999999999 99999999999999999999999999999987632
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
.. ........+++.|+|||.+.+..++.++||||||+++++|++ |..||......+... .....
T Consensus 162 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~--~~~~~------------ 226 (279)
T 1qpc_A 162 NE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ--NLERG------------ 226 (279)
T ss_dssp SC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--HHHTT------------
T ss_pred cc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH--HHhcc------------
Confidence 21 122233446778999999988889999999999999999999 999987643221110 00000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
.....+..++..+.+|+.+||..||++|||++++++.|+.+......+
T Consensus 227 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 227 ------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred ------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 001113345678999999999999999999999999999998765443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=328.57 Aligned_cols=267 Identities=21% Similarity=0.281 Sum_probs=201.3
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchh-hhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|++.+.||+|+||+||+|... +++.||||++...... ....+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999864 7999999998755322 222445699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+++ +|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... ...
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 975 999999887778999999999999999999999 99999999999999999999999999999875421 122
Q ss_pred ccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc-----
Q 019568 200 TQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN----- 273 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 273 (339)
......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+... . ................
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~-i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH-F-IFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-H-HHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H-HHHHhCCCChHhchhhhcchh
Confidence 2334567999999998876 568999999999999999999999997653222111 1 1110000000000000
Q ss_pred ----cc--CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 274 ----LL--SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 274 ----~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ..........+.++.++.+||.+||+.||.+|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 00011122234567889999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=328.93 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=202.3
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce-
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF- 112 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 112 (339)
....++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 34678999999999999999999985 579999999997652 3445678899999999999999999999866543
Q ss_pred ---eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 113 ---KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 113 ---~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
.|+||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred CcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999997654 7899999999999999999999 999999999999999999999999999999
Q ss_pred eeccCCCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 190 KLLVGEDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 190 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
..+...... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--------- 234 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--------- 234 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC---------
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC---------
Confidence 765332221 2223455899999999999999999999999999999999999999764332211111000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH-HHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK-LLKI 320 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~-l~~~ 320 (339)
...........++.++.+||.+||+.||.+||++.+++.+ +.++
T Consensus 235 --------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 235 --------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0111111234467889999999999999999977766654 4433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=335.37 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=201.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCC--CcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIR--HRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 115 (339)
...+|++.+.||+|+||.||+|...+++.||||++.... ......+.+|+++++.+. ||||+++++++...+..|+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 346799999999999999999987779999999987653 445677899999999996 5999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||| +.+++|.+++.... .+++..++.++.||+.||.||| +.+|+|+||||+||+++ ++.++|+|||++..+...
T Consensus 134 v~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 999 45779999997655 7889899999999999999999 99999999999999995 589999999999866433
Q ss_pred CCccccccccCCCCccCCccccC-----------CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGRE-----------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~-- 285 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-- 285 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS--
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc--
Confidence 22223345678999999998765 36889999999999999999999999754321111111110000
Q ss_pred cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+...+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 286 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 286 ----------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp ----------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 00011222566899999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=334.20 Aligned_cols=280 Identities=20% Similarity=0.268 Sum_probs=217.6
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc--eeE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE--FKA 114 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 114 (339)
...++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+ ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 34678999999999999999999864 59999999987543 234566788999999999999999999987654 779
Q ss_pred EEEEecCCCCHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe----CCCCcEEEccccc
Q 019568 115 LVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNMVAHLSDFSI 188 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~----~~~~~v~l~Dfg~ 188 (339)
+||||+++++|.+++..... .+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999976442 3899999999999999999999 9999999999999999 7888899999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccC--------CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGRE--------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~ 260 (339)
+..... ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||................
T Consensus 163 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 163 ARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp CEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred ceEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 987532 222334568999999998765 567889999999999999999999998655433332222221
Q ss_pred hcccc--ccccccccc------cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 261 WLPIS--TLEVVDANL------LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 261 ~~~~~--~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
....+ ......... .............++..+.+++.+||+.||++||++.++++.++.+....
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 11111 100000000 00011112234677888999999999999999999999999998887643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=337.71 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=212.1
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeee
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSC 107 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 107 (339)
+++.++....++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344556667799999999999999999999864 79999999987532 23445688899999999999999999999
Q ss_pred ecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccc
Q 019568 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187 (339)
Q Consensus 108 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg 187 (339)
.+.+..|+||||++|++|.+++.+....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999999876667999999999999999999999 9999999999999999999999999999
Q ss_pred cceeccCCCCccccccccCCCCccCCcccc-------CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGR-------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~ 260 (339)
++....... ........||+.|+|||++. +..++.++|+|||||++|+|++|+.||......+... .....
T Consensus 208 la~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-~i~~~ 285 (412)
T 2vd5_A 208 SCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG-KIVHY 285 (412)
T ss_dssp TCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HHHTH
T ss_pred hheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH-HHHhc
Confidence 998653221 11223457899999999886 4568999999999999999999999997643221111 10000
Q ss_pred hccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCC---CCHHHHHHH
Q 019568 261 WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR---INAKEIVKK 316 (339)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~ell~~ 316 (339)
..... . ......++.++++||.+||+ +|.+| |+++|+++|
T Consensus 286 ~~~~~---------~------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 286 KEHLS---------L------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHCC---------C------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccCcC---------C------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00000 0 00123467789999999999 99998 599999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=327.73 Aligned_cols=274 Identities=16% Similarity=0.206 Sum_probs=210.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCC------CcEEEEEEeeccchhhh-----------HHHHHHHHHHHhCCCcceee
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGD------GMEVAVKVFNLQCGRAL-----------KSFNVECEMMKSIRHRNLIK 102 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~------~~~v~vK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~ 102 (339)
..++|++.+.||+|+||+||+|.+.. ++.||||++........ .....|+..++.+.||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45699999999999999999997643 47899999876542111 12334666777788999999
Q ss_pred EeeeeecC----ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC--
Q 019568 103 VISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-- 176 (339)
Q Consensus 103 ~~~~~~~~----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-- 176 (339)
+++++... ...++||||+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 99998664 5689999999 88999999887678999999999999999999999 99999999999999998
Q ss_pred CCCcEEEcccccceeccCCCCcc-----ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCc
Q 019568 177 DNMVAHLSDFSIAKLLVGEDQSM-----TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251 (339)
Q Consensus 177 ~~~~v~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~ 251 (339)
.++.++|+|||++..+....... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 89999999999998764322111 1123448999999999999999999999999999999999999998643332
Q ss_pred cchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
........ ..........+. ......++.++.+|+..||..||.+||++.+|++.|+.+..++...
T Consensus 269 ~~~~~~~~-~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 269 KYVRDSKI-RYRENIASLMDK---------CFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHH-HHHHCHHHHHHH---------HSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHH-HhhhhHHHHHHH---------hcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 11111100 000000000000 0001345788999999999999999999999999999998876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=340.08 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=208.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3578999999999999999999864 79999999997543 2334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 94 v~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 94 VMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999654 47999999999999999999999 999999999999999999999999999999875322
Q ss_pred CCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ .......
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~-------------- 231 (476)
T 2y94_A 170 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-FKKICDG-------------- 231 (476)
T ss_dssp ---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-HHHHHTT--------------
T ss_pred ---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-HHHHhcC--------------
Confidence 22334568999999999988765 7899999999999999999999976432211 0000000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+..+++++.+||.+||+.||.+|||++++++|=+
T Consensus 232 ------~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 232 ------IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred ------CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 00112335677999999999999999999999999744
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=319.16 Aligned_cols=263 Identities=23% Similarity=0.379 Sum_probs=209.4
Q ss_pred cCCCCCceeeecCccEEEEEEeC-C---CcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee-EE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-D---GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK-AL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~---~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~l 115 (339)
..|.+.+.||+|+||+||+|... + +..+|+|++.... ....+.+.+|+.+++.++||||+++++++...+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35667799999999999999742 2 3379999987543 34567788999999999999999999999766554 89
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
++||+.+++|.+++......+++..++.++.|++.||.+|| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999999887778999999999999999999999 999999999999999999999999999999755322
Q ss_pred C--CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 196 D--QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 196 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
. .........+++.|+|||.+.+..++.++||||||+++|+|++|..|+........ .........
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~----------- 245 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGR----------- 245 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTTC-----------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcCC-----------
Confidence 1 11222344568889999999999999999999999999999996655433222211 111111000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
....+..+++.+.+|+.+||+.||.+|||++++++.|+.+...+..
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0111334567799999999999999999999999999999887653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=317.05 Aligned_cols=270 Identities=19% Similarity=0.209 Sum_probs=210.3
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeee-ecCceeEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC-SNEEFKALV 116 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 116 (339)
...++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+|+++++.+.|++++..+..+ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3568999999999999999999985 579999999876542 234578899999999887766666554 667788999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---CCCCcEEEcccccceecc
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~---~~~~~v~l~Dfg~~~~~~ 193 (339)
|||+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 88999999876668999999999999999999999 9999999999999999 789999999999998764
Q ss_pred CCCCc-----cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 194 GEDQS-----MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 194 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 234 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 234 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-----
Confidence 33221 12234568999999999999999999999999999999999999998754332211110000000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
. ..........+++++.+||.+||+.||.+|||++++++.|+++..+....
T Consensus 235 ------~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 235 ------M--STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp ------H--HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred ------c--cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 0 00001112345778999999999999999999999999999999877543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=321.39 Aligned_cols=271 Identities=23% Similarity=0.281 Sum_probs=203.3
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch-----hhhHHHHHHHHHHHhC---CCcceeeEeeeeec
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG-----RALKSFNVECEMMKSI---RHRNLIKVISSCSN 109 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~ 109 (339)
...++|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+++++.+ .||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3568999999999999999999985 4799999999875431 1234566677777766 49999999999876
Q ss_pred Cc-----eeEEEEEecCCCCHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEE
Q 019568 110 EE-----FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL 183 (339)
Q Consensus 110 ~~-----~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l 183 (339)
.. ..++||||+.+ +|.+++..... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 54 57899999975 99999876653 4899999999999999999999 999999999999999999999999
Q ss_pred cccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc
Q 019568 184 SDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~ 263 (339)
+|||++.... .........+|+.|+|||++.+..++.++||||||+++|+|++|..||........... .......
T Consensus 162 ~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~ 237 (308)
T 3g33_A 162 ADFGLARIYS---YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDLIGL 237 (308)
T ss_dssp CSCSCTTTST---TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH-HHHHHCC
T ss_pred eeCccccccC---CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCC
Confidence 9999987642 22233455689999999999999999999999999999999999999976533221111 1111100
Q ss_pred cccccccc-----ccccCc--cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 264 ISTLEVVD-----ANLLSQ--EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 264 ~~~~~~~~-----~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
........ ...... ........+.++.++.+||.+||+.||.+|||+.|+++|=
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 00000000 000000 0011122345678899999999999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=325.22 Aligned_cols=272 Identities=22% Similarity=0.265 Sum_probs=204.4
Q ss_pred hhhcCCCCC-ceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEE
Q 019568 39 QATDEFSEN-NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 39 ~~~~~y~~~-~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (339)
...++|++. +.||+|+||+||+|.. .+++.||||++..........+.+|++++.++ .||||+++++++...+..++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 356789985 7899999999999985 47999999999876655667888999999995 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc---EEEcccccceec
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDFSIAKLL 192 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~---v~l~Dfg~~~~~ 192 (339)
||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++. ++|+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999997654 6899999999999999999999 999999999999999988776 999999998755
Q ss_pred cCCCC-----ccccccccCCCCccCCccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 193 VGEDQ-----SMTQTQTFATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 193 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
..... ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||..................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32111 111223458999999998875 55899999999999999999999999865432211100000000
Q ss_pred -cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 263 -PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 263 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.......+... ...........++.++++||.+||+.||.+|||+.|+++|=
T Consensus 245 ~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 245 CQNMLFESIQEG---KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHHC---CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHHhcc---CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 00000000000 00111111234677899999999999999999999999963
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=322.84 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=207.3
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
.+.++|.+.+.||+|+||+||++... +++.||+|++..........+.+|+++++.++||||+++++++...+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45689999999999999999999864 69999999998665445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---CCCCcEEEcccccceeccC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~---~~~~~v~l~Dfg~~~~~~~ 194 (339)
||+++++|.+++.... .+++..++.++.|++.||.+|| +.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~- 160 (304)
T 2jam_A 86 QLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ- 160 (304)
T ss_dssp CCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC-
T ss_pred EcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC-
Confidence 9999999999986654 6899999999999999999999 9999999999999999 788999999999986532
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
........+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ........
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~------------ 223 (304)
T 2jam_A 161 ---NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--FEKIKEGY------------ 223 (304)
T ss_dssp ---CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHCC------------
T ss_pred ---CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHcCC------------
Confidence 1223344589999999999999999999999999999999999999976432111 00000000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
..........++.++.+||.+||..||.+|||++++++|-+
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 224 ---YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ---CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 00011112345778999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=326.59 Aligned_cols=276 Identities=24% Similarity=0.368 Sum_probs=217.0
Q ss_pred cceeeeeHHHHhh-hhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCc
Q 019568 27 AMWRTFSYLELCQ-ATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHR 98 (339)
Q Consensus 27 ~~~~~~~~~~~~~-~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~ 98 (339)
-...+.+...+.. ..++|++.+.||+|+||.||+|.. .++..||||++... .......+.+|+.++++++||
T Consensus 14 ~~~~sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ 93 (327)
T 2yfx_A 14 FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93 (327)
T ss_dssp ETTEEECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCT
T ss_pred ccCCccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCC
Confidence 3445556666654 558999999999999999999973 25778999998654 344556788899999999999
Q ss_pred ceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcC------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCC
Q 019568 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSN 172 (339)
Q Consensus 99 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~N 172 (339)
||+++++++......++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||+|+|
T Consensus 94 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~N 170 (327)
T 2yfx_A 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARN 170 (327)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred CCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhH
Confidence 99999999999999999999999999999997653 35889999999999999999999 9999999999999
Q ss_pred eEeCC---CCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccc
Q 019568 173 VLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248 (339)
Q Consensus 173 il~~~---~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~ 248 (339)
|+++. +..++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 171 Ili~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 171 CLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp EEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 99984 44699999999876543333333344567889999999988899999999999999999998 999987543
Q ss_pred cCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 249 NGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
... ......... ....+..++..+.+||.+||+.||.+||++.+++++|+.+.....
T Consensus 251 ~~~--~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 251 NQE--VLEFVTSGG------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHH--HHHHHHTTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHH--HHHHHhcCC------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 211 111110000 001123456779999999999999999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=337.07 Aligned_cols=265 Identities=23% Similarity=0.234 Sum_probs=199.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecC------
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE------ 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 110 (339)
..++|++.+.||+|+||+||+|.. .+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 468999999999999999999975 46999999999764 344567788999999999999999999998654
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
...|+||||+++ +|.+.+.. .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 457999999976 67776643 4889999999999999999999 9999999999999999999999999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........ .+.+..+..
T Consensus 213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~-lg~p~~~~~ 287 (464)
T 3ttj_A 213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQ-LGTPCPEFM 287 (464)
T ss_dssp -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH-HCSCCHHHH
T ss_pred ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCCCHHHH
Confidence 6522 223345678999999999999999999999999999999999999997643211 01110000 000000000
Q ss_pred c---------------------ccccCc--cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 D---------------------ANLLSQ--EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~---------------------~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ...... ...........++++++||.+||++||.+|||++|+++|
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000 000111223347789999999999999999999999997
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=326.49 Aligned_cols=278 Identities=26% Similarity=0.395 Sum_probs=217.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-----CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc--e
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-----GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE--F 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 112 (339)
..++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 457899999999999999999973 368999999998776677788999999999999999999999986543 7
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++||||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 89999999999999999887767999999999999999999999 999999999999999999999999999999876
Q ss_pred cCCCCccc-cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc-ccc
Q 019568 193 VGEDQSMT-QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL-EVV 270 (339)
Q Consensus 193 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 270 (339)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..|+......-. ............ ...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIGNDKQGQMIVFHL 272 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH---HHHCTTCCTHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH---HhhccccchhhhHHHH
Confidence 43222111 2233467779999999988899999999999999999999999764321100 000000000000 000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
.... ........+..++.++.+||.+||+.||.+|||+.++++.|+.+++++.
T Consensus 273 ~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 273 IELL--KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHH--HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHh--hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0000 0000111234567889999999999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=343.37 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=198.9
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
...++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+++++.++||||+++++++...+..+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 3457899999999999999999975 46999999998754 2334456778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
+||||+++++|.+++.... .+++..++.++.|++.||.||| + .|++|+||||+||+++.++.++|+|||++....
T Consensus 225 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999986654 7899999999999999999999 8 999999999999999999999999999987532
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
. .........||+.|+|||++.+..++.++||||||+++|+|++|..||........... ... .
T Consensus 301 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--i~~--~---------- 364 (446)
T 4ejn_A 301 K--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL--ILM--E---------- 364 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH--C----------
T ss_pred C--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH--HHh--C----------
Confidence 1 22233456789999999999999999999999999999999999999975432111100 000 0
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....+..+++++.+||.+||+.||.+|| +++|+++|
T Consensus 365 -------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 365 -------EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0011234567799999999999999999 99999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=321.94 Aligned_cols=271 Identities=20% Similarity=0.212 Sum_probs=204.0
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
.....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++..++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 3445689999999999999999999854 68999999987542 3345678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++|+||+++++|.+++.... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999999997654 6899999999999999999999 999999999999999999999999999998765
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ........
T Consensus 185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~----------- 250 (309)
T 2h34_A 185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV--MGAHINQA----------- 250 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH--HHHHHHSC-----------
T ss_pred cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH--HHHHhccC-----------
Confidence 3221 122234568899999999999999999999999999999999999997643221 11000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHHHHHHcccccC
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-NAKEIVKKLLKIRDSLLRNVGG 330 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~l~~~~~~~~~~~~~ 330 (339)
.......++.++.++.++|.+||+.||++|| +++++++.|+.+......+...
T Consensus 251 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~~ 304 (309)
T 2h34_A 251 -----IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRAT 304 (309)
T ss_dssp -----CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--------
T ss_pred -----CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccchh
Confidence 0001112345677799999999999999999 9999999999887665544433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=316.31 Aligned_cols=259 Identities=23% Similarity=0.325 Sum_probs=208.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch------hhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG------RALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++...+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4578999999999999999999865 699999999876532 135678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC----cEEEccccc
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSI 188 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~----~v~l~Dfg~ 188 (339)
.++||||+++++|.+++.... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++ .++|+|||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999996644 6899999999999999999999 99999999999999998877 899999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......... .....
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~--------- 225 (283)
T 3bhy_A 159 AHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-TNISA--------- 225 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHT---------
T ss_pred ceeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-HHhHh---------
Confidence 9865321 2223455889999999999999999999999999999999999999764321110 00000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKIRD 322 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~~~ 322 (339)
............++..+.+|+.+||+.||.+|||+.++++| ++.++.
T Consensus 226 -------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 226 -------VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp -------TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred -------cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 00111122234567789999999999999999999999996 444443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.19 Aligned_cols=274 Identities=21% Similarity=0.248 Sum_probs=200.6
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
.......++|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++...+
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 34455678999999999999999999974 4799999999875532 23456778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe-----CCCCcEEEccc
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL-----DDNMVAHLSDF 186 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~-----~~~~~v~l~Df 186 (339)
..++||||+++ +|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+||
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 99999999975 9999997665 6899999999999999999999 9999999999999999 45556999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc-
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI- 264 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~- 264 (339)
|++..... .........+|+.|+|||++.+. .++.++||||||+++|+|++|..||............ ......+
T Consensus 182 g~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~ 258 (329)
T 3gbz_A 182 GLARAFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI-FEVLGLPD 258 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHHHCCCC
T ss_pred CCccccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH-HHHhCCCc
Confidence 99976522 12223345578999999998775 4899999999999999999999999764332211111 1100000
Q ss_pred -ccccc------ccc--cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 265 -STLEV------VDA--NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 265 -~~~~~------~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... ... ...............++.++.+||.+||+.||.+|||++|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000 000 00111222233344567889999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=342.03 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=208.5
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..+.++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 356789999999999999999999864 79999999986542 334567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC---CCCcEEEccccccee
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKL 191 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~---~~~~v~l~Dfg~~~~ 191 (339)
+||||+.+++|.+.+.... .+++..++.++.|++.||.||| +.|++|+||||+||+++ .++.++|+|||++..
T Consensus 98 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999999886654 7999999999999999999999 99999999999999994 566799999999876
Q ss_pred ccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
+.. ........+|+.|+|||++.+ .++.++||||||+++|+|++|..||......+... ....
T Consensus 174 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~i~~----------- 236 (486)
T 3mwu_A 174 FQQ---NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK--RVET----------- 236 (486)
T ss_dssp BCC---C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH-----------
T ss_pred CCC---CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHh-----------
Confidence 522 223345568999999999876 58999999999999999999999997643221110 0000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
............+++++++||.+||+.||.+|||+.++++|-+
T Consensus 237 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 237 ----GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp ----TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred ----CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 0011111223456788999999999999999999999999844
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=333.32 Aligned_cols=270 Identities=23% Similarity=0.333 Sum_probs=196.5
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCC-CcceeeEeeeeecC--ce
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIR-HRNLIKVISSCSNE--EF 112 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~ 112 (339)
...++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++.+. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3568999999999999999999975 47999999998543 3455667888999999997 99999999999654 37
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.|+||||+++ +|.+++... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+
T Consensus 86 ~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCSE-EHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccCc-CHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 8999999975 999998764 5899999999999999999999 999999999999999999999999999999865
Q ss_pred cCCC-------------------CccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCcc
Q 019568 193 VGED-------------------QSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 252 (339)
Q Consensus 193 ~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~ 252 (339)
.... .........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3211 1112234568999999998876 6789999999999999999999999976432211
Q ss_pred chHhHhhhhccccccccccc--------------------cccCccc--------hhhhhhHHHHHHHHHHHhhhcCCCC
Q 019568 253 TLKHWVNDWLPISTLEVVDA--------------------NLLSQED--------IHFVAKEQCVSFVFNLAMACAVESP 304 (339)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP 304 (339)
....... ...+..+.... ....... ........+++++.+||.+||+.||
T Consensus 240 -~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 240 -LERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp -HHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred -HHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 1111111 11000000000 0000000 0000112557789999999999999
Q ss_pred CCCCCHHHHHHH
Q 019568 305 EQRINAKEIVKK 316 (339)
Q Consensus 305 ~~Rps~~ell~~ 316 (339)
.+|||++|+++|
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=315.61 Aligned_cols=267 Identities=19% Similarity=0.223 Sum_probs=214.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeee-ecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC-SNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.+++.+.|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 468999999999999999999985 5799999999865532 34678899999999988766655554 6677889999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---CCCCcEEEcccccceeccC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~---~~~~~v~l~Dfg~~~~~~~ 194 (339)
||+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 88999999866668999999999999999999999 9999999999999999 4889999999999987643
Q ss_pred CCCcc-----ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHh--Hhhhhcccccc
Q 019568 195 EDQSM-----TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH--WVNDWLPISTL 267 (339)
Q Consensus 195 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~--~~~~~~~~~~~ 267 (339)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||............ ......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 235 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM----- 235 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-----
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc-----
Confidence 32211 124456899999999999999999999999999999999999999875432211110 000000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
..........+++++.+|+.+||+.||.+|||++++++.|+++..+....
T Consensus 236 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 236 ----------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp ----------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ----------CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 00001112456788999999999999999999999999999998877554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=324.70 Aligned_cols=262 Identities=27% Similarity=0.460 Sum_probs=207.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCC-----CcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGD-----GMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~-----~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
..++|++.+.||+|+||+||+|.... +..||||++.... ......+.+|++++++++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34678889999999999999997432 3459999987653 34456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++||||+++++|.+++......+++..++.++.|++.||.+|| +.|++|+||||+||+++.++.++|+|||++....
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999877678999999999999999999999 9999999999999999999999999999997653
Q ss_pred CCCCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 194 GEDQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 194 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .......
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~~~~~~---------- 266 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MKAINDG---------- 266 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTT----------
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHHCC----------
Confidence 22211 11223345778999999998999999999999999999999 9999975432211 1000000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
.....+..++..+.++|.+||+.||.+||++.+++++|+.+....
T Consensus 267 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 267 --------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp --------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 001112345677999999999999999999999999999988643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=316.42 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=208.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999754 68899999986542 2234678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++.... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 999999999999997654 6899999999999999999999 99999999999999999999999999999876422
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... ... .
T Consensus 167 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~----~----------- 227 (284)
T 2vgo_A 167 ---LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR-IVN----V----------- 227 (284)
T ss_dssp ---SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHT----T-----------
T ss_pred ---cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH-Hhc----c-----------
Confidence 223345688999999999999999999999999999999999999976432211100 000 0
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+..++..+.+||.+||+.||.+|||++++++|-+
T Consensus 228 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 228 -----DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred -----ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 00112345677999999999999999999999999744
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=321.17 Aligned_cols=255 Identities=27% Similarity=0.356 Sum_probs=205.0
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+|+++++.+.||||+++++++...+..++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 346789999999999999999999764 69999999987653 346788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+++++|.+++......+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT- 178 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence 9999999999999766668999999999999999999999 999999999999999999999999999999765322
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
........+++.|+|||.+.+..++.++||||||+++|+|++|..||.......... .... .
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~-~-------------- 240 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--MIPT-N-------------- 240 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHH-S--------------
T ss_pred -ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhc-C--------------
Confidence 222334568899999999999999999999999999999999999997543211100 0000 0
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.......+..++..+.+||.+||+.||.+|||+.++++|-
T Consensus 241 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 241 -PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp -CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred -CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 0001111344567799999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=319.16 Aligned_cols=280 Identities=23% Similarity=0.339 Sum_probs=218.3
Q ss_pred eeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHh--CCCcceeeEeeee
Q 019568 30 RTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKS--IRHRNLIKVISSC 107 (339)
Q Consensus 30 ~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~ 107 (339)
...+......+.++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|.++++. ++||||+++++++
T Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 3455566667789999999999999999999988 6899999998644 23566778999888 6899999999999
Q ss_pred ecCc----eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhcc-----CCCCeEecCCCCCCeEeCCC
Q 019568 108 SNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSAPIIHCDLKPSNVLLDDN 178 (339)
Q Consensus 108 ~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-----~~~~i~h~di~p~Nil~~~~ 178 (339)
.... ..++||||+++++|.+++.+. .+++..++.++.|++.||.|||.. .+.+++|+||||+||+++.+
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence 8765 789999999999999999765 489999999999999999999921 03689999999999999999
Q ss_pred CcEEEcccccceeccCCCCcc--ccccccCCCCccCCccccCC------CCCCcchhhHHHHHHHHHHhC----------
Q 019568 179 MVAHLSDFSIAKLLVGEDQSM--TQTQTFATIGYMAPEYGREG------RVSANGDVYSFGIMLMETFTG---------- 240 (339)
Q Consensus 179 ~~v~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g---------- 240 (339)
+.++|+|||++.......... ......+|+.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 999999999997764332211 22345689999999998765 234689999999999999999
Q ss_pred CCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 241 KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 241 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
..||..................... ..... ........++..+.+||.+||+.||.+|||+.+++++|+.+
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRKVVCEQK--------LRPNI-PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSC--------CCCCC-CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCccccCcCcccHHHHHHHHHHHH--------hCCCC-cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6787765443333332222111100 00000 01112346778899999999999999999999999999999
Q ss_pred HHHH
Q 019568 321 RDSL 324 (339)
Q Consensus 321 ~~~~ 324 (339)
.++.
T Consensus 335 ~~~~ 338 (342)
T 1b6c_B 335 SQQE 338 (342)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=329.45 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=206.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 346799999999999999999975 579999999987542 3345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+.| +|.+.+......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 132 v~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 132 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9999974 898888766678999999999999999999999 99999999999999999999999999999875421
Q ss_pred CCccccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
.....+|+.|+|||++. +..++.++||||||+++|+|++|..||........... ......
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--~~~~~~--------- 270 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNES--------- 270 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHSCC---------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHhcCC---------
Confidence 23456899999999874 56789999999999999999999999875432111100 000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.......++..+.+||.+||+.||.+|||++++++|-+-
T Consensus 271 --------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 271 --------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 001123446679999999999999999999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=326.97 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=209.2
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--------hhhHHHHHHHHHHHhC-CCcceeeEe
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--------RALKSFNVECEMMKSI-RHRNLIKVI 104 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~i~~~~ 104 (339)
.....+.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++++ .||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344556688999999999999999999864 799999999876531 2245678899999999 799999999
Q ss_pred eeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEc
Q 019568 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 184 (339)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~ 184 (339)
+++...+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999987543 6899999999999999999999 9999999999999999999999999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCccccC------CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~ 258 (339)
|||++..+... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||........ ....
T Consensus 243 DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~i 317 (365)
T 2y7j_A 243 DFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM--LRMI 317 (365)
T ss_dssp CCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH
T ss_pred ecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--HHHH
Confidence 99998876322 22344568999999998753 3588999999999999999999999975422110 0000
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ............++..+.+||.+||+.||.+|||+.++++|
T Consensus 318 ~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 ME---------------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HH---------------TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Hh---------------CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 00001111223456779999999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=331.40 Aligned_cols=257 Identities=22% Similarity=0.288 Sum_probs=205.6
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 116 (339)
.+.++|++.+.||+|+||.||+|... +++.||||++..... ...+|++++.++ +||||+++++++.+.+..|+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 46789999999999999999999754 699999999875532 234688888888 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC----CcEEEcccccceec
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN----MVAHLSDFSIAKLL 192 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~----~~v~l~Dfg~~~~~ 192 (339)
|||++|++|.+.+.... .+++..++.++.|++.||.||| +.|++|+||||+||++... +.++|+|||++...
T Consensus 95 ~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp ECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999997654 7999999999999999999999 9999999999999998432 35999999999875
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||....... ...........
T Consensus 171 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~~~-------- 238 (342)
T 2qr7_A 171 RAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARIGSG-------- 238 (342)
T ss_dssp BCT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHHHHC--------
T ss_pred cCC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHHccC--------
Confidence 322 222334568999999999988889999999999999999999999997542211 11111000000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
...........++.++.+||.+||..||.+|||+.++++|=+-
T Consensus 239 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 239 ----KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp ----CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ----CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 0000111134567789999999999999999999999998664
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=318.95 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=202.3
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..+.++|++.+.||+|+||.||+|.. .++..+|+|++.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 45678999999999999999999975 468999999987653 3345778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---CCCCcEEEcccccc
Q 019568 116 VLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIA 189 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~---~~~~~v~l~Dfg~~ 189 (339)
||||+++++|.+.+... ...+++..++.++.|++.||.+|| +.|++|+||+|+||++ +.++.++|+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999988543 357999999999999999999999 9999999999999999 55688999999999
Q ss_pred eeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
..... ........+++.|+|||.+. ..++.++||||||+++|+|++|..||............... ....
T Consensus 175 ~~~~~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~~~--- 244 (285)
T 3is5_A 175 ELFKS---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK---EPNY--- 244 (285)
T ss_dssp CC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---CCCC---
T ss_pred eecCC---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC---Cccc---
Confidence 76532 22234456899999999875 46889999999999999999999999764322111110000 0000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+++++.+||.+||+.||.+|||+.|+++|
T Consensus 245 ------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 245 ------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011245678999999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=333.99 Aligned_cols=273 Identities=20% Similarity=0.229 Sum_probs=202.0
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE----- 110 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 110 (339)
...++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+++|++++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 35689999999999999999999754 6899999998654 334557788999999999999999999998765
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
...|+||||+++ +|.+++... ..+++..++.++.||+.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEecCCc-CHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 578999999965 999999654 47999999999999999999999 9999999999999999999999999999998
Q ss_pred eccCCCCc--------------------cccccccCCCCccCCccc-cCCCCCCcchhhHHHHHHHHHHhCCCCCccccc
Q 019568 191 LLVGEDQS--------------------MTQTQTFATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 249 (339)
Q Consensus 191 ~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~ 249 (339)
........ .......+|+.|+|||++ .+..++.++|||||||++|+|++|..||.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 76432211 122456689999999975 566799999999999999999997666553211
Q ss_pred Cccch--------------------------HhHhhhhcccccccccc------------ccccCccchhhhhhHHHHHH
Q 019568 250 GEMTL--------------------------KHWVNDWLPISTLEVVD------------ANLLSQEDIHFVAKEQCVSF 291 (339)
Q Consensus 250 ~~~~~--------------------------~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~ 291 (339)
+.... ........+.+..+... ..............+.++++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 10000 00000000000000000 00000000000112456788
Q ss_pred HHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 292 VFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 292 l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
+.+||.+||+.||.+|||++|+++|
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999996
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=325.40 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=195.2
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeeee--------
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSC-------- 107 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-------- 107 (339)
.....+|++.+.||+|+||.||+|.. .+++.||||++..........+.+|+.+++++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34456999999999999999999985 479999999997776677778899999999995 99999999998
Q ss_pred ecCceeEEEEEecCCCCHHHHHhh--cCCccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeCCCCcEEE
Q 019568 108 SNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLDDNMVAHL 183 (339)
Q Consensus 108 ~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~~~~~v~l 183 (339)
......++++||+. ++|.+++.. ....+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.++|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEE
Confidence 34556899999996 599998865 3446999999999999999999999 999 999999999999999999999
Q ss_pred cccccceeccCCCCcc----------ccccccCCCCccCCccc---cCCCCCCcchhhHHHHHHHHHHhCCCCCcccccC
Q 019568 184 SDFSIAKLLVGEDQSM----------TQTQTFATIGYMAPEYG---REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~ 250 (339)
+|||++.......... ......+++.|+|||++ .+..++.++||||||+++|+|++|..||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998653322111 11134588999999988 5667899999999999999999999999754221
Q ss_pred ccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 251 EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
..... .........++..+.+||.+||+.||.+|||+.+++++|+.+.....
T Consensus 260 ~~~~~-----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 RIVNG-----------------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HhhcC-----------------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 11000 00011122234458899999999999999999999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=324.06 Aligned_cols=263 Identities=27% Similarity=0.454 Sum_probs=210.0
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEE--EEEEeecc-chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEV--AVKVFNLQ-CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v--~vK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 115 (339)
.++|++.+.||+|+||.||+|... ++..+ ++|.+... .......+.+|+++++++ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 378999999999999999999753 56644 89988653 234556788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 116 VLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
||||+++++|.+++.... ..+++..++.++.|++.||.+|| +.|++|+||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence 999999999999997643 46899999999999999999999 999999999999999999999
Q ss_pred EEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhh
Q 019568 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~ 259 (339)
++|+|||++.... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 181 ~kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-----~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----YE 252 (327)
T ss_dssp EEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HH
T ss_pred EEEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-----HH
Confidence 9999999987431 1122233446788999999988889999999999999999998 9999976432211 00
Q ss_pred hhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccccc
Q 019568 260 DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVG 329 (339)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~ 329 (339)
.... ......+..++..+.+||.+||+.||.+|||+.+++++|+.+..+......
T Consensus 253 ~~~~---------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 307 (327)
T 1fvr_A 253 KLPQ---------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 307 (327)
T ss_dssp HGGG---------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred Hhhc---------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccc
Confidence 0000 001111334567799999999999999999999999999999886544433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=341.56 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=209.4
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-------------hhhHHHHHHHHHHHhCCCcce
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-------------RALKSFNVECEMMKSIRHRNL 100 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i 100 (339)
.....+.++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++||||
T Consensus 29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 108 (504)
T 3q5i_A 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNI 108 (504)
T ss_dssp EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTB
T ss_pred ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCC
Confidence 344557899999999999999999999854 689999999875431 234678899999999999999
Q ss_pred eeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-
Q 019568 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM- 179 (339)
Q Consensus 101 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~- 179 (339)
+++++++.+....++||||+++++|.+.+.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTC
T ss_pred CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCC
Confidence 999999999999999999999999999886654 6999999999999999999999 99999999999999998766
Q ss_pred --cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhH
Q 019568 180 --VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257 (339)
Q Consensus 180 --~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~ 257 (339)
.++|+|||++..+.. ........+|+.|+|||++. ..++.++||||||+++|+|++|..||...........
T Consensus 185 ~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-- 258 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK-- 258 (504)
T ss_dssp CSSEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--
T ss_pred CccEEEEECCCCEEcCC---CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence 699999999987632 22334556899999999887 4689999999999999999999999976432211100
Q ss_pred hhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 258 VNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.. .............+++++++||.+||+.||.+|||++++++|-+
T Consensus 259 i~---------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 259 VE---------------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HH---------------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HH---------------cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 00 00011122223456788999999999999999999999999754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=344.12 Aligned_cols=264 Identities=25% Similarity=0.414 Sum_probs=216.1
Q ss_pred HHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 34 YLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 34 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
...+....++|++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 345566778999999999999999999998788999999987653 34578899999999999999999999987 5678
Q ss_pred EEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 114 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
++||||+++++|.+++.... ..++...++.++.|++.||.||| +++++|+||||+||+++.++.+||+|||++...
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999997543 35888899999999999999999 999999999999999999999999999999765
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+... .+..
T Consensus 335 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~--~i~~----------- 400 (454)
T 1qcf_A 335 EDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR--ALER----------- 400 (454)
T ss_dssp CCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH--HHHH-----------
T ss_pred CCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH--HHHc-----------
Confidence 2211 111223345678999999998899999999999999999999 999997653322111 0000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
......+..+++++.+||.+||+.||++|||+++|++.|+.+...
T Consensus 401 -------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 401 -------GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 011112345678899999999999999999999999999887543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=319.54 Aligned_cols=257 Identities=30% Similarity=0.435 Sum_probs=204.6
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec-CceeEE
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN-EEFKAL 115 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 115 (339)
+....++|++.+.||+|+||+||++.. +++.||||++.... ..+.+.+|++++++++||||+++++++.. .+..++
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 344568999999999999999999987 58999999987543 45678899999999999999999998654 457899
Q ss_pred EEEecCCCCHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||||+++++|.+++..... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999999976542 3789999999999999999999 99999999999999999999999999999875421
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||........ ......
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~~~~------------- 229 (278)
T 1byg_A 170 -----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEK------------- 229 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHHHTT-------------
T ss_pred -----cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHhc-------------
Confidence 1223346788999999998899999999999999999998 9999876432211 100000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
......+..+++.+.++|.+||+.||.+|||+.++++.|+.++...
T Consensus 230 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 230 -----GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 0011113455778999999999999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=317.08 Aligned_cols=252 Identities=19% Similarity=0.283 Sum_probs=210.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.+.||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 5578999999999999999999864 58899999987542 3455678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++.... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999886644 7899999999999999999999 999999999999999999999999999999875322
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
........+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+... .....
T Consensus 169 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~------------ 230 (294)
T 2rku_A 169 --GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIKKN------------ 230 (294)
T ss_dssp --TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHTT------------
T ss_pred --ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhhc------------
Confidence 222334568999999999999999999999999999999999999997643221100 00000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+..++..+.+||.+||+.||++|||++++++|-+
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 231 -----EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred -----cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 00112344667999999999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=330.02 Aligned_cols=257 Identities=20% Similarity=0.242 Sum_probs=197.7
Q ss_pred hhcCCCCC-ceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHh-CCCcceeeEeeeeec----Cce
Q 019568 40 ATDEFSEN-NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKS-IRHRNLIKVISSCSN----EEF 112 (339)
Q Consensus 40 ~~~~y~~~-~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~ 112 (339)
..++|.+. +.||+|+||+||+|... +++.||||++... ..+.+|++++.+ .+||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 45677776 78999999999999754 6999999998633 456678888754 589999999998865 667
Q ss_pred eEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC---CCcEEEccccc
Q 019568 113 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSI 188 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~---~~~v~l~Dfg~ 188 (339)
+|+||||++|++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999997654 36999999999999999999999 999999999999999987 78999999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
+..... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||...................
T Consensus 211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~----- 282 (400)
T 1nxk_A 211 AKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----- 282 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-----
T ss_pred ccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-----
Confidence 986532 222334568999999999999999999999999999999999999997654322110000000000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
...........++.++.+||.+||+.||.+|||+.++++|-+-.
T Consensus 283 --------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 283 --------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp --------CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred --------cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 00001111235677899999999999999999999999986643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=326.97 Aligned_cols=277 Identities=19% Similarity=0.208 Sum_probs=206.9
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc-----------hhhhHHHHHHHHHHHhCCCcce
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC-----------GRALKSFNVECEMMKSIRHRNL 100 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i 100 (339)
....++....++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 44677888999999999999999999999988789999999985532 1223678899999999999999
Q ss_pred eeEeeeee-----cCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe
Q 019568 101 IKVISSCS-----NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 175 (339)
Q Consensus 101 ~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~ 175 (339)
+++++++. .....++||||+++ +|.+.+......+++..++.++.|++.||.||| +.|++|+||||+||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 99999983 34468999999974 999988877778999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccch
Q 019568 176 DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254 (339)
Q Consensus 176 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~ 254 (339)
+.++.++|+|||++.... .........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDT---ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCCEEEEecCcccccc---cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999987532 2222344567889999998876 678999999999999999999999997643211111
Q ss_pred HhHhhhhcccc-----------cccccccccc-CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 255 KHWVNDWLPIS-----------TLEVVDANLL-SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 255 ~~~~~~~~~~~-----------~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........+. .......... ..........+.+++.+.+||.+||+.||.+|||+.++++|
T Consensus 245 -~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 -KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0100000000 0000000000 00111122234557789999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=318.44 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=207.8
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec--------
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN-------- 109 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 109 (339)
....+|++.+.||+|+||.||+|... +++.||+|++.... ..+.+|+++++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 45688999999999999999999865 79999999987653 346679999999999999999998754
Q ss_pred --------CceeEEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 110 --------EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 110 --------~~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
....++||||+++++|.+++... ...+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence 45689999999999999999754 347899999999999999999999 999999999999999999999
Q ss_pred EEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh
Q 019568 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~ 260 (339)
++|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ....
T Consensus 161 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-------FFTD 230 (284)
T ss_dssp EEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-------HHHH
T ss_pred EEECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-------HHHH
Confidence 999999998876322 123344589999999999999999999999999999999999988653211 0000
Q ss_pred hccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 261 WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
... . ..+..++..+.+||.+||+.||.+|||+.+++++|+.++.+...+
T Consensus 231 ~~~---------~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 231 LRD---------G---------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHT---------T---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred hhc---------c---------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 000 0 012234567899999999999999999999999999998765543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=342.11 Aligned_cols=258 Identities=21% Similarity=0.310 Sum_probs=205.5
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
.....+.++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109 (494)
T ss_dssp CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 334456778999999999999999999864 68999999987653 334567889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC---CCcEEEccccc
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSI 188 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~---~~~v~l~Dfg~ 188 (339)
..|+||||+++++|.+.+.... .+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||+
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 9999999999999999886654 6899999999999999999999 999999999999999976 44599999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
+..+... .......+|+.|+|||++. ..++.++||||||+++|+|++|..||......+.... ....
T Consensus 186 a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--i~~~------- 252 (494)
T 3lij_A 186 SAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK--VEKG------- 252 (494)
T ss_dssp CEECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHT-------
T ss_pred CeECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhC-------
Confidence 9876322 2334456899999999876 4689999999999999999999999976533211111 0000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
...........++..+++||.+||+.||.+|||+.++++|=
T Consensus 253 --------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 253 --------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp --------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred --------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 00011111245677899999999999999999999999973
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=325.49 Aligned_cols=273 Identities=23% Similarity=0.314 Sum_probs=205.7
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45689999999999999999999864 59999999986543 3344567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.++.... ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 102 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999998888776443 47999999999999999999999 999999999999999999999999999999765321
Q ss_pred CCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh----------hccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND----------WLPI 264 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~----------~~~~ 264 (339)
........+++.|+|||.+.+. .++.++||||||+++|+|++|..||................ ....
T Consensus 178 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 --GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred --ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 2223345689999999988775 78999999999999999999999997654322111110000 0000
Q ss_pred cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.....................+.++..+.+||.+||+.||.+|||++|+++|=
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000000001111111222345678899999999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=322.87 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=204.7
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
...++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 35689999999999999999999865 58999999998776666788899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++......+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T 170 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--H
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--c
Confidence 999999999998876667999999999999999999999 99999999999999999999999999998753211 1
Q ss_pred ccccccccCCCCccCCccc-----cCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 198 SMTQTQTFATIGYMAPEYG-----REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
........+++.|+|||.+ .+..++.++||||||+++|+|++|..||........... ....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~------------ 237 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKS------------ 237 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHS------------
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-Hhcc------------
Confidence 1112334578999999987 466789999999999999999999999976432211100 0000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 238 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 238 -----DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -----CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -----CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000111234557779999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=313.77 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=202.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec----Cce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN----EEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 112 (339)
....|++.+.||+|+||+||+|.. .++..|++|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345689999999999999999975 468899999987542 4456778899999999999999999998754 466
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeC-CCCcEEEcccccc
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLD-DNMVAHLSDFSIA 189 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~-~~~~v~l~Dfg~~ 189 (339)
.++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+ ++|+||+|+||+++ .++.++|+|||++
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 899999999999999997653 6899999999999999999999 998 99999999999997 8899999999998
Q ss_pred eeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
.... ........+++.|+|||.+.+ .++.++||||||+++|+|++|..||................
T Consensus 180 ~~~~----~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 245 (290)
T 1t4h_A 180 TLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--------- 245 (290)
T ss_dssp GGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT---------
T ss_pred cccc----ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc---------
Confidence 6532 222334568999999998764 58999999999999999999999997643322111111000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+...++++.+||.+||+.||.+|||++++++|
T Consensus 246 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 ---------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00111133345679999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=323.85 Aligned_cols=264 Identities=19% Similarity=0.254 Sum_probs=203.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeeeeec--CceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSCSN--EEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~l 115 (339)
..++|++.+.||+|+||+||+|.. .+++.||||++.... ...+.+|+++++++. ||||+++++++.. ....++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 457899999999999999999974 579999999987443 356788999999997 9999999999987 667899
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-cEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-~v~l~Dfg~~~~~~~ 194 (339)
||||+++++|.+++. .+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999874 3889999999999999999999 99999999999999999766 899999999986532
Q ss_pred CCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc--
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD-- 271 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 271 (339)
. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........................
T Consensus 184 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 G---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp T---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred C---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 2 22344568889999998877 67899999999999999999999999543322211111111000000000000
Q ss_pred -------------ccc--cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 -------------ANL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 -------------~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
... .............++.++.+||.+||+.||.+|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 000001111233467889999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.10 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=211.1
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
..+.++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346689999999999999999999864 79999999986542 34456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---CCCCcEEEcccccce
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAK 190 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~---~~~~~v~l~Dfg~~~ 190 (339)
++||||+.+++|.+.+.... .+++..++.++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999999986654 7899999999999999999999 9999999999999999 578899999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
.+... .......+|+.|+|||++.+ .++.++||||||+++|+|++|.+||.......... .+..
T Consensus 178 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~i~~---------- 241 (484)
T 3nyv_A 178 HFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK--KVEK---------- 241 (484)
T ss_dssp HBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH----------
T ss_pred Ecccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHc----------
Confidence 65322 22344568999999998876 68999999999999999999999997643221110 0000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
............+++++++||.+||+.||.+|||+.++++|-+
T Consensus 242 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 242 -----GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp -----CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred -----CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 0011111223456788999999999999999999999999755
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=326.16 Aligned_cols=274 Identities=23% Similarity=0.275 Sum_probs=203.7
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-----hhhHHHHHHHHHHHhCCCcceeeEeeeeecC
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-----RALKSFNVECEMMKSIRHRNLIKVISSCSNE 110 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (339)
+....++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 4556789999999999999999999864 699999999875422 2235678899999999999999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
+..++||||+++ +|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999999986 999998877667899999999999999999999 9999999999999999999999999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc---c
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS---T 266 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~---~ 266 (339)
.+.. .........+|+.|+|||.+.+. .++.++||||||+++|+|++|.+||........ ..........+. .
T Consensus 161 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTS
T ss_pred eccC--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHcCCCChhhh
Confidence 6532 22233445689999999988654 589999999999999999999999876532211 111111111100 0
Q ss_pred ccc------ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 267 LEV------VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 267 ~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
... .......... .......++.++.+||.+||+.||.+|||++|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIP-LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCC-HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhccCcccccccccCCCC-hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 000 0000000000 01112456788999999999999999999999999754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=330.95 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=203.3
Q ss_pred cCCCCCceeeecCccEEEEEEeC--C--CcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeee-cCceeEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG--D--GMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCS-NEEFKAL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~--~--~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 115 (339)
..|.+.+.||+|+||+||+|... + +..||+|.+... .......+.+|+.++++++||||+++++++. .++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 45778899999999999999742 2 246899988654 3455678899999999999999999999864 4567899
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999877777899999999999999999999 999999999999999999999999999999765322
Q ss_pred CCc--cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 196 DQS--MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 196 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
... .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.......... .....
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~--~~~~~----------- 312 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV--YLLQG----------- 312 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH--HHHTT-----------
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH--HHHcC-----------
Confidence 211 11233446788999999999999999999999999999999 677776543322111 11000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
.....+..++..+.++|.+||+.||.+|||+++++++|+.+...+..+
T Consensus 313 -------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 313 -------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 011113446777999999999999999999999999999999876643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=342.80 Aligned_cols=265 Identities=26% Similarity=0.408 Sum_probs=211.6
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..+....++|++.+.||+|+||.||+|.+..+..||||+++... ...+.+.+|++++++++||||+++++++.. +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 44555678899999999999999999998777889999987653 234678899999999999999999999876 6789
Q ss_pred EEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 115 LVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
+||||+++++|.+++... ...+++..++.++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++....
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 999999999999999753 346899999999999999999999 9999999999999999999999999999997653
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+... ...
T Consensus 332 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~--~i~------------- 395 (452)
T 1fmk_A 332 DNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD--QVE------------- 395 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--HHH-------------
T ss_pred CCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH--HHH-------------
Confidence 211 112223345778999999998899999999999999999999 999997653321110 000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
...+...+..++..+.+||.+||+.||++|||++++++.|+.+..+..
T Consensus 396 -----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 396 -----RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp -----TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -----cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 001111234567889999999999999999999999999988765443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=316.77 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=211.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.+.||||+++++++...+..++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999975 469999999997653 345677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......
T Consensus 100 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-- 172 (303)
T ss_dssp ECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--
T ss_pred EeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc--
Confidence 999999999998653 5899999999999999999999 999999999999999999999999999999776322
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........+++.|+|||.+.+..++.++|+||||+++|+|++|..||......... .......
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~--------------- 235 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL--FLIPKNN--------------- 235 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHSC---------------
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH--HHhhcCC---------------
Confidence 22234456889999999999999999999999999999999999998754321110 0000000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
....+..++..+.+||.+||+.||.+|||+.++++|.+-.
T Consensus 236 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 236 ---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp ---CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred ---CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 0011234466799999999999999999999999986643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=340.56 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=210.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4578999999999999999999754 79999999987542 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||||++|++|.+++.... ..+++..++.++.||+.||.||| +.||+|+||||+||+++.+|.++|+|||++..+..
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999987654 35999999999999999999999 99999999999999999999999999999987532
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
. .......||+.|+|||++.+..++.++|+||||+++|+|++|..||...................
T Consensus 339 ~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----------- 404 (576)
T 2acx_A 339 G---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------- 404 (576)
T ss_dssp T---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----------
T ss_pred C---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----------
Confidence 2 22334578999999999999999999999999999999999999998654322111111000000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....+..++.++++||.+||+.||.+|| +++|+++|
T Consensus 405 ------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 ------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0011234577899999999999999999 78999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=322.74 Aligned_cols=253 Identities=19% Similarity=0.294 Sum_probs=210.3
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
...++|.+.+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 35679999999999999999999754 5889999998754 2345567888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999999886643 7899999999999999999999 99999999999999999999999999999987532
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
. ........+++.|+|||++.+..++.++||||||+++|+|++|..||......+.... ... .
T Consensus 194 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~---~----------- 256 (335)
T 2owb_A 194 D--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-IKK---N----------- 256 (335)
T ss_dssp T--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHH---T-----------
T ss_pred C--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-Hhc---C-----------
Confidence 2 2223445689999999999999999999999999999999999999975432111000 000 0
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+..++..+.+||.+||+.||++|||++++++|-+
T Consensus 257 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 257 ------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 00112344667899999999999999999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=329.74 Aligned_cols=251 Identities=27% Similarity=0.312 Sum_probs=197.5
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHH-HHhCCCcceeeEeeeeecCcee
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEM-MKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ......+..|..+ ++.++||||+++++++.+.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34578999999999999999999864 68999999997653 2233455667666 5678999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
|+||||++|++|.+++.+.. .+++..++.++.|++.||.||| +.|++|+||||+||+++.+|.++|+|||++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999997654 6889999999999999999999 9999999999999999999999999999987532
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
. .........||+.|+|||++.+..++.++|+||||+++|+|++|..||......+... .... .
T Consensus 191 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~-~i~~---~---------- 254 (373)
T 2r5t_A 191 E--HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD-NILN---K---------- 254 (373)
T ss_dssp C--CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH-HHHH---S----------
T ss_pred c--CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHh---c----------
Confidence 1 2223445678999999999999999999999999999999999999997543221110 0000 0
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA----KEIVKK 316 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~ell~~ 316 (339)
....++.++.++++||.+||+.||.+||++ .++++|
T Consensus 255 -------~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 255 -------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp -------CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred -------ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 001123456779999999999999999987 466665
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.28 Aligned_cols=276 Identities=21% Similarity=0.275 Sum_probs=207.7
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec-----
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN----- 109 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 109 (339)
+...++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 34568999999999999999999986 479999999986553 2334567789999999999999999999876
Q ss_pred ---CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 110 ---EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 110 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
.+..++||||+++ +|.+.+......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+||
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999976 888888777678999999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCC--ccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhh-hhc
Q 019568 187 SIAKLLVGEDQ--SMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN-DWL 262 (339)
Q Consensus 187 g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~-~~~ 262 (339)
|++..+..... ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||............... ...
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987642221 222344567999999998876 45899999999999999999999999864322111110000 000
Q ss_pred cccccccc------cccccC---cc-chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 263 PISTLEVV------DANLLS---QE-DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 263 ~~~~~~~~------~~~~~~---~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
........ ...... .. ..........++.+.+||.+||+.||.+|||++|+++|=
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 00000000 000000 00 001111122356799999999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=335.88 Aligned_cols=271 Identities=21% Similarity=0.235 Sum_probs=189.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeec-----Cc
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSN-----EE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 111 (339)
..++|++.+.||+|+||+||+|... +++.||||++... .......+.+|+++|+.++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4589999999999999999999754 7999999998653 33455778899999999999999999999843 35
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..|+||||+. ++|.+++... ..+++..++.++.||+.||.||| +.||+|+||||+|||++.++.+||+|||++..
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred eEEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 7899999985 5999998654 47999999999999999999999 99999999999999999999999999999986
Q ss_pred ccCCCCc-------------------------cccccccCCCCccCCccc-cCCCCCCcchhhHHHHHHHHHHh------
Q 019568 192 LVGEDQS-------------------------MTQTQTFATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFT------ 239 (339)
Q Consensus 192 ~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~------ 239 (339)
....... .......+|+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 5322111 122345679999999975 56679999999999999999999
Q ss_pred -----CCCCCcccccCc-------------------cchHhHhhhhccccccccccc-----------cc-cCccchhhh
Q 019568 240 -----GKKPTDEIFNGE-------------------MTLKHWVNDWLPISTLEVVDA-----------NL-LSQEDIHFV 283 (339)
Q Consensus 240 -----g~~P~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~-----------~~-~~~~~~~~~ 283 (339)
|.++|.....-. ........ ..+....+.+.. .. .........
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN-ILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHH-HHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHH-HcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 555554322100 00000000 000000000000 00 000000011
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 284 AKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 284 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..+.++.++.+||.+||.+||.+|||++|+++|
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 123457889999999999999999999999997
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=322.69 Aligned_cols=258 Identities=16% Similarity=0.160 Sum_probs=211.5
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEE------eCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC---CcceeeEeeee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKAR------LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR---HRNLIKVISSC 107 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~------~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~ 107 (339)
+....++|++.+.||+|+||+||+|. ..+++.||||++..... ..+..|.++++.+. |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34456789999999999999999993 44689999999876543 45667888888876 89999999999
Q ss_pred ecCceeEEEEEecCCCCHHHHHhh----cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC------
Q 019568 108 SNEEFKALVLEYMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD------ 177 (339)
Q Consensus 108 ~~~~~~~lv~e~~~~~~L~~~i~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~------ 177 (339)
...+..++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+|+|+||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999975 3457999999999999999999999 999999999999999988
Q ss_pred -----CCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCcc
Q 019568 178 -----NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 252 (339)
Q Consensus 178 -----~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~ 252 (339)
++.++|+|||++..+.............||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 899999999999766433344445566799999999999999999999999999999999999999876543221
Q ss_pred chHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCC-CCHHHHHHHHHHHHHHHc
Q 019568 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR-INAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-ps~~ell~~l~~~~~~~~ 325 (339)
... . ... ....++.+.+++..||+.+|.+| |+++++.+.|+.+.....
T Consensus 294 ~~~----------------~-~~~--------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 294 KPE----------------G-LFR--------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EEC----------------S-CCT--------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred eec----------------h-hcc--------ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 100 0 000 00125568899999999999999 588888888888876643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=326.08 Aligned_cols=269 Identities=13% Similarity=0.141 Sum_probs=210.9
Q ss_pred hcCCCCCceeeecCccEEEEEEeC---------CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceee---------
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG---------DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK--------- 102 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~--------- 102 (339)
.++|++.+.||+|+||.||+|... .++.||||++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 479999999999999999999764 3789999998754 46778999999999999987
Q ss_pred ------Eeeeeec-CceeEEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeE
Q 019568 103 ------VISSCSN-EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 174 (339)
Q Consensus 103 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil 174 (339)
+++++.. .+..++||||+ +++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 4556554 67889999999 88999999875 357999999999999999999999 999999999999999
Q ss_pred eCCCC--cEEEcccccceeccCCCCc-----cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCccc
Q 019568 175 LDDNM--VAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 247 (339)
Q Consensus 175 ~~~~~--~v~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~ 247 (339)
++.++ .++|+|||++..+...... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999765322211 1113346899999999999999999999999999999999999999876
Q ss_pred ccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 248 FNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
................. ...... .......++.++.+||.+||+.||.+|||++++++.|+.+.++....
T Consensus 272 ~~~~~~~~~~~~~~~~~-~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDK-PGPFVG---------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TTCHHHHHHHHHHHHHS-CCCEEC---------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CcCHHHHHHHHHhccCC-hhhhhh---------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 53332222221111000 000000 00001234677999999999999999999999999999999887644
Q ss_pred c
Q 019568 328 V 328 (339)
Q Consensus 328 ~ 328 (339)
.
T Consensus 342 ~ 342 (352)
T 2jii_A 342 P 342 (352)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=317.95 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=212.4
Q ss_pred hhhhcCCCCCc-eeeecCccEEEEEEe---CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 38 CQATDEFSENN-LIGKGGFGSVYKARL---GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 38 ~~~~~~y~~~~-~ig~g~~~~v~~~~~---~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
....++|++.+ .||+|+||+||+|.+ .+++.||||++.... ......+.+|+++++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 33457888888 999999999999953 347889999987653 33456788999999999999999999999 556
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..++||||+++++|.+++.... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 7889999999999999997654 6899999999999999999999 99999999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccc
Q 019568 192 LVGEDQSM-TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 192 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~-------- 236 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEKG-------- 236 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHTT--------
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHcC--------
Confidence 64322211 1222335678999999988889999999999999999999 9999976433211 1111000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccc
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNV 328 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~ 328 (339)
.....+..++..+.++|.+||+.||.+||++.++++.|+++-.+....-
T Consensus 237 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 237 ----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 0011134567789999999999999999999999999999988766543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=337.10 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=208.6
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+++++.++||||+++++++...+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 478999999999999999999864 69999999997543 23346788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcC---CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 117 LEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
|||++|++|.+++.... ..+++..++.++.||+.||.||| +.|++|+||||+||+++.+|.++|+|||++..+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987542 36999999999999999999999 9999999999999999999999999999998753
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
.. ........||+.|+|||++.+..++.++|+|||||++|+|++|..||...................
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---------- 408 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---------- 408 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC----------
T ss_pred CC--CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc----------
Confidence 22 122334578999999999999999999999999999999999999998653321111111000000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
....+..++.++.+||.+||+.||++||+ ++++++|
T Consensus 409 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 409 -------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 00113456778999999999999999996 4788875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=331.16 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=197.0
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--------hhhhHHHHHHHHHHHhCCCcceeeEeeeee
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--------GRALKSFNVECEMMKSIRHRNLIKVISSCS 108 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (339)
....++|.+.+.||+|+||+||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34678999999999999999999975 468999999987542 122335788999999999999999999986
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC---cEEEcc
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSD 185 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~---~v~l~D 185 (339)
.. ..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .++|+|
T Consensus 211 ~~-~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AE-DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SS-EEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cC-ceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEee
Confidence 54 578999999999999988654 47999999999999999999999 99999999999999996544 599999
Q ss_pred cccceeccCCCCccccccccCCCCccCCccccC---CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
||++.... .........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||................
T Consensus 286 FG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~-- 360 (419)
T 3i6u_A 286 FGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-- 360 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT--
T ss_pred cccceecC---CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC--
Confidence 99997652 2222344568999999998854 567889999999999999999999997643322111111000
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
...........++..+.+||.+||+.||.+|||++++++|=
T Consensus 361 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 361 --------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp --------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred --------------CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 00111122345678899999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=340.44 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=215.9
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
..+....++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|++++++++||||+++++++...+..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 334455678999999999999999999865 48999999987553 3457789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 114 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
++||||+++++|.+++.... ..+++..++.++.|++.||.||| +++++|+||||+||+++.++.+||+|||++...
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999997643 46899999999999999999999 999999999999999999999999999999865
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ .....
T Consensus 369 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--~~~~~------------ 433 (495)
T 1opk_A 369 TGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLE------------ 433 (495)
T ss_dssp TTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHH------------
T ss_pred cCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHHHH------------
Confidence 322 1122233445678999999998999999999999999999999 9999976533221 11110
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
...+...+..++..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 434 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 434 ------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ------cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 01111224456788999999999999999999999999998763
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.66 Aligned_cols=269 Identities=21% Similarity=0.304 Sum_probs=208.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3578999999999999999999864 69999999987653 445577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
||+++++|.+++.... .+++..++.++.|++.||.||| +. |++|+||||+||+++.++.++|+|||++....
T Consensus 111 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--- 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 183 (360)
T ss_dssp CCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH---
T ss_pred ECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc---
Confidence 9999999999997654 6899999999999999999999 86 89999999999999999999999999886542
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc-------------
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP------------- 263 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~------------- 263 (339)
........+++.|+|||++.+..++.++||||||+++|+|++|..||...................
T Consensus 184 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 184 -DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp -HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred -cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 112234568999999999999999999999999999999999999997643222111000000000
Q ss_pred ------------ccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 264 ------------ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 264 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.......+.. ............++.++.+||.+||+.||.+|||++++++|-+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYI--VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp -----------CCCHHHHHHHH--HHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred cccccccCCCCcccchhhhhHH--hccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000000000 0000001112335778999999999999999999999999765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=319.67 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=201.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC--CCc--EEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG--DGM--EVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~--~~~--~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..++|++.+.||+|+||+||+|.+. +++ .||||++... .......+.+|++++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3578999999999999999999742 333 6899998754 2345678889999999999999999999998765
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.++|+||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 78999999999999999877667999999999999999999999 999999999999999999999999999999876
Q ss_pred cCCCCcc-ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccc
Q 019568 193 VGEDQSM-TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 193 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......... .... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~~~~--~------- 240 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--KIDK--E------- 240 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHHT--S-------
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH--HHHc--c-------
Confidence 4322211 2233446778999999988889999999999999999999 999997653221110 0000 0
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
......+..++.++.++|.+||..||.+|||+.+++++|++++..
T Consensus 241 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 241 --------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 001111334577899999999999999999999999999988754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=313.29 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=202.6
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.++|.....||+|+||.||+|.. .++..||||.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 34566677999999999999985 46899999999877666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-CCcEEEcccccceeccCCC
Q 019568 120 MPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 120 ~~~~~L~~~i~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-~~~v~l~Dfg~~~~~~~~~ 196 (339)
+++++|.+++.... ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++. ++.++|+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 99999999997653 24678889999999999999999 999999999999999987 899999999999865321
Q ss_pred CccccccccCCCCccCCccccCCC--CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|..||................
T Consensus 177 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 241 (295)
T 2clq_A 177 -NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-------------- 241 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--------------
T ss_pred -CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--------------
Confidence 22233456889999999987653 7899999999999999999999997543221111100000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+..++.++.+||.+||+.||++|||+.++++|
T Consensus 242 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 242 ----KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00001133456779999999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=326.10 Aligned_cols=268 Identities=18% Similarity=0.216 Sum_probs=203.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeeccchh-----------hhHHHHHHHHHHHhCCCcceeeEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQCGR-----------ALKSFNVECEMMKSIRHRNLIKVI 104 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~ 104 (339)
..++|++.+.||+|+||.||+|... ++..+|||++...... ....+.+|+..++.+.||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3478999999999999999999854 5788999998765321 112356788999999999999999
Q ss_pred eeeec----CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-
Q 019568 105 SSCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM- 179 (339)
Q Consensus 105 ~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~- 179 (339)
+++.. ....++||||+ +++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence 99877 78899999999 889999997655 7999999999999999999999 99999999999999998777
Q ss_pred -cEEEcccccceeccCCCCc-----cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccc
Q 019568 180 -VAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 253 (339)
Q Consensus 180 -~v~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~ 253 (339)
.++|+|||++..+...... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876322111 1123456899999999999999999999999999999999999999754332222
Q ss_pred hHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
........... .............++.++.+||.+||+.||.+||++++|++.|+.+..
T Consensus 270 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAKTNLLDE----------LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHT----------TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHhhccc----------ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 21111110000 000000000112567789999999999999999999999999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=317.89 Aligned_cols=254 Identities=21% Similarity=0.299 Sum_probs=205.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeee--ecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSC--SNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~ 114 (339)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++ ......+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4579999999999999999999764 69999999997643 34556788999999999999999999987 4467899
Q ss_pred EEEEecCCCCHHHHHhhcC---CccCHHHHHHHHHHHHHHHHHhhccCCCC-----eEecCCCCCCeEeCCCCcEEEccc
Q 019568 115 LVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAP-----IIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~~-----i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
+||||+++++|.+++.... ..+++..++.++.|++.||.+|| +.+ ++|+||+|+||+++.++.++|+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999986532 35899999999999999999999 888 999999999999999999999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
|.+...... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ........
T Consensus 161 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~i~~~~---- 232 (279)
T 2w5a_A 161 GLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AGKIREGK---- 232 (279)
T ss_dssp CHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHTC----
T ss_pred chheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--HHHHhhcc----
Confidence 998765221 1122344588999999999998999999999999999999999999976532111 11100000
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
. ...+..++.++.++|.+||+.||++|||+.+++++++
T Consensus 233 --------~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 --------F------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp --------C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred --------c------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0 0112345677999999999999999999999999865
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.28 Aligned_cols=256 Identities=23% Similarity=0.297 Sum_probs=206.8
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---------hhhhHHHHHHHHHHHhCC-CcceeeEee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---------GRALKSFNVECEMMKSIR-HRNLIKVIS 105 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 105 (339)
.....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 3456789999999999999999999864 68999999987543 223456788999999995 999999999
Q ss_pred eeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 106 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
++...+..++||||+++++|.+++.... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999997653 6899999999999999999999 99999999999999999999999999
Q ss_pred cccceeccCCCCccccccccCCCCccCCcccc------CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhh
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~ 259 (339)
||++...... .......+++.|+|||++. ...++.++||||||+++|+|++|..||........ .....
T Consensus 168 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~ 242 (298)
T 1phk_A 168 FGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LRMIM 242 (298)
T ss_dssp CTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred ccchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--HHHHh
Confidence 9999865322 2233456889999999874 45688999999999999999999999975432111 00000
Q ss_pred hhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 260 DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ...........++..+.+||.+||+.||.+|||+.++++|
T Consensus 243 ~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 243 SG---------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HT---------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cC---------------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 00 0000111124567789999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=321.39 Aligned_cols=267 Identities=22% Similarity=0.228 Sum_probs=198.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-----
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE----- 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 111 (339)
..++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4589999999999999999999754 6899999998754 2345567889999999999999999999987654
Q ss_pred -eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 112 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 112 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred cceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999976 88888753 4889999999999999999999 9999999999999999999999999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
.... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||........ ...... .......+..
T Consensus 176 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~-~~~~~~~~~~ 250 (371)
T 2xrw_A 176 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIE-QLGTPCPEFM 250 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC--CCCCCHHHH
T ss_pred cccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-HhCCCCHHHH
Confidence 6421 2223345689999999999999999999999999999999999999976432111 000000 0000000000
Q ss_pred c---------------------ccccCc--cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 271 D---------------------ANLLSQ--EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 271 ~---------------------~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
. ...... ...........+.++++||.+||+.||.+|||++|+++|=+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 0 000000 00011123445788999999999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=324.97 Aligned_cols=264 Identities=25% Similarity=0.317 Sum_probs=199.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc----
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE---- 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 111 (339)
...++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|++++++++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 3568999999999999999999975 47999999998554 2344567889999999999999999999987653
Q ss_pred --eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 112 --FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 112 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
.+|+||||+ +++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 77999998764 5899999999999999999999 999999999999999999999999999999
Q ss_pred eeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
..... ......+|+.|+|||++.+ ..++.++|||||||++++|++|+.||........ ....... .+....+
T Consensus 176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~-~g~~~~~ 248 (367)
T 1cm8_A 176 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKV-TGTPPAE 248 (367)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHH-HCCCCHH
T ss_pred ccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-cCCCCHH
Confidence 86521 2334567999999998877 6799999999999999999999999976432111 1111110 0000000
Q ss_pred cccc-----------cc--cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 VVDA-----------NL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 ~~~~-----------~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.... .. ...... ....+.+++.+.+|+.+||+.||.+|||++++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000 00 000000 01123557789999999999999999999999996
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=312.45 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=199.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4589999999999999999999865 79999999987543 2334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++++|.+++.... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999999997654 6899999999999999999999 999999999999999999999999999998765321
Q ss_pred CCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.......+++.|+|||.+.+..+ +.++|+||||+++++|++|..||........ ...... .
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~------------~- 226 (276)
T 2h6d_A 165 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL--FKKIRG------------G- 226 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH------------C-
T ss_pred ---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHhhc------------C-
Confidence 22234457899999999887765 6899999999999999999999975422111 000000 0
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+..++..+.++|.+||+.||.+|||++++++|=+
T Consensus 227 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 227 ------VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ------cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 00012334667999999999999999999999999743
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=321.62 Aligned_cols=268 Identities=24% Similarity=0.311 Sum_probs=189.8
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
..+....++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34555678999999999999999999975 368999999986553 3345677889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhh-------cCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 113 KALVLEYMPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~-------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
.++||||+++++|.+++.. ....+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEe
Confidence 9999999999999999864 2346899999999999999999999 99999999999999999999999999
Q ss_pred cccceeccCCCC---ccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh
Q 019568 186 FSIAKLLVGEDQ---SMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 186 fg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
||++........ ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...............
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 242 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN-- 242 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--
Confidence 999876532211 111234468999999998876 56899999999999999999999999865432211111000
Q ss_pred ccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...... ...........++.++.+||.+||+.||.+|||+.++++|
T Consensus 243 ~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLE---------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTT---------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccc---------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000000 0000011123456679999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=322.51 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=203.4
Q ss_pred eeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeee
Q 019568 29 WRTFSYLELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISS 106 (339)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 106 (339)
.+.+.+.++....++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.+++++ .||||++++++
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 34455667777889999999999999999999985 479999999987553 3346788899999999 79999999999
Q ss_pred eec------CceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC
Q 019568 107 CSN------EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM 179 (339)
Q Consensus 107 ~~~------~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~ 179 (339)
+.. .+..++||||+++++|.+++.... ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCC
Confidence 865 467899999999999999997643 46899999999999999999999 99999999999999999999
Q ss_pred cEEEcccccceeccCCCCccccccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccch
Q 019568 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~ 254 (339)
.++|+|||++...... ........+++.|+|||++. +..++.++||||||+++|+|++|..||..........
T Consensus 167 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 244 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CEEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 9999999998765221 11223446889999999886 5668999999999999999999999997543211110
Q ss_pred HhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 255 KHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....... .......++..+.+||.+||..||.+||++.++++|-
T Consensus 245 --~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 245 --LIPRNPA-----------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp --HHHHSCC-----------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred --HhhcCcc-----------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 0000000 0001233466799999999999999999999999963
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=323.95 Aligned_cols=273 Identities=24% Similarity=0.294 Sum_probs=203.6
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec------
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN------ 109 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 109 (339)
+....++|++.+.||+|+||+||+|.. .+++.||||++..... ...+|+++++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999975 5799999999865422 22369999999999999999999833
Q ss_pred --------------------------------CceeEEEEEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHH
Q 019568 110 --------------------------------EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEY 154 (339)
Q Consensus 110 --------------------------------~~~~~lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~ 154 (339)
....++||||+++ +|.+.+.. ....+++..++.++.|++.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3348899999975 88777653 34579999999999999999999
Q ss_pred hhccCCCCeEecCCCCCCeEeC-CCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHH
Q 019568 155 LHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGI 232 (339)
Q Consensus 155 LH~~~~~~i~h~di~p~Nil~~-~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~ 232 (339)
|| +.|++|+||||+||+++ .++.++|+|||++..+... .......+|+.|+|||.+.+. .++.++||||+||
T Consensus 157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99 99999999999999997 6899999999999875322 233445678999999988765 5899999999999
Q ss_pred HHHHHHhCCCCCcccccCccchHhHhhhhcccc----------ccccccccccCccchhhhhhHHHHHHHHHHHhhhcCC
Q 019568 233 MLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS----------TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVE 302 (339)
Q Consensus 233 il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 302 (339)
++|+|++|..||........ ..........+. ...... ............+..++.++.+||.+||+.
T Consensus 231 il~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRF-PTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCC-CCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccC-CccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999999986432211 111111000000 000000 001112222333455778899999999999
Q ss_pred CCCCCCCHHHHHHH--HHHHHH
Q 019568 303 SPEQRINAKEIVKK--LLKIRD 322 (339)
Q Consensus 303 dP~~Rps~~ell~~--l~~~~~ 322 (339)
||.+|||+.|+++| ++.++.
T Consensus 309 dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SGGGSCCHHHHHTSGGGHHHHH
T ss_pred ChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999999985 555554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=316.02 Aligned_cols=255 Identities=23% Similarity=0.274 Sum_probs=192.8
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
...++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.++...++.+.||||+++++++...+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 4568999999999999999999985 479999999987652 2233344555666888899999999999999999999
Q ss_pred EEEecCCCCHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 116 VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
||||+++ +|.+++.. ....+++..++.++.|++.||.||| +. |++|+||||+||+++.++.++|+|||++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999975 88887754 4457999999999999999999999 87 999999999999999999999999999876
Q ss_pred ccCCCCccccccccCCCCccCCccc----cCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYG----REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
... ........+++.|+|||.+ .+..++.++||||||+++|+|++|..||..................
T Consensus 160 ~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----- 231 (290)
T 3fme_A 160 LVD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS----- 231 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-----
T ss_pred ccc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-----
Confidence 532 2223334689999999985 5667899999999999999999999999754332222211111100
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.......++.++.+||.+||+.||++|||+.++++|=+
T Consensus 232 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 232 -------------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp -------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred -------------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 00112345677999999999999999999999999644
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=320.53 Aligned_cols=264 Identities=19% Similarity=0.240 Sum_probs=210.9
Q ss_pred eeHHHHhhhhcCCCCC-ceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhC-CCcceeeEeee
Q 019568 32 FSYLELCQATDEFSEN-NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSI-RHRNLIKVISS 106 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~-~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 106 (339)
..+.....+.++|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ .||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3445666788899998 89999999999999754 69999999987643 23356788899999999 56999999999
Q ss_pred eecCceeEEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC---CCcEE
Q 019568 107 CSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAH 182 (339)
Q Consensus 107 ~~~~~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~---~~~v~ 182 (339)
+...+..++||||+++++|.+++... ...+++..++.++.|++.||.+|| +.|++|+||||+||+++. ++.++
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999988643 357999999999999999999999 999999999999999987 78999
Q ss_pred EcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
|+|||++..... ........+++.|+|||++.+..++.++||||||+++|+|++|..||............. ..
T Consensus 175 L~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--~~- 248 (327)
T 3lm5_A 175 IVDFGMSRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS--QV- 248 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HT-
T ss_pred EeeCccccccCC---ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH--hc-
Confidence 999999987532 222334568999999999999999999999999999999999999997643322111100 00
Q ss_pred cccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 263 PISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
...........++..+.+||.+||+.||.+|||++++++|-+
T Consensus 249 --------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 249 --------------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp --------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred --------------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 000111112345677999999999999999999999998743
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=312.36 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=202.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc----hhhhHHHHHHHHHHHhCCCcceeeEeeee--ecCc
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC----GRALKSFNVECEMMKSIRHRNLIKVISSC--SNEE 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 111 (339)
...++|++.+.||+|+||.||++... +++.+|+|++.... ......+.+|+++++.++||||+++++++ ....
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35689999999999999999999864 68999999987653 23456788999999999999999999998 4556
Q ss_pred eeEEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 112 FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
..++||||++++ |.+++... ...+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 889999999875 77776553 456999999999999999999999 9999999999999999999999999999998
Q ss_pred eccCCCCccccccccCCCCccCCccccCCC--CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
...............+++.|+|||++.+.. ++.++||||||+++|+|++|..||....... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~i~~~---- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-----LFENIGKG---- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHC----
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-----HHHHHhcC----
Confidence 764333333444556899999999987654 4789999999999999999999997542111 00000000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+..++..+.+||.+||+.||.+|||+.++++|-+
T Consensus 229 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 229 ------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp ------------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred ------------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 00112345677999999999999999999999999854
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=322.01 Aligned_cols=267 Identities=19% Similarity=0.279 Sum_probs=208.2
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhh-----------------hHHHHHHHHHHHhCCCcceee
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRA-----------------LKSFNVECEMMKSIRHRNLIK 102 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~ 102 (339)
..++|++.+.||+|+||.||+|.. +++.||||++....... ...+.+|++++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 458999999999999999999988 89999999987553211 177889999999999999999
Q ss_pred EeeeeecCceeEEEEEecCCCCHHHH------Hhhc-CCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeE
Q 019568 103 VISSCSNEEFKALVLEYMPHGSLEKY------LYSS-NCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVL 174 (339)
Q Consensus 103 ~~~~~~~~~~~~lv~e~~~~~~L~~~------i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil 174 (339)
+++++...+..++||||+++++|.++ +... ...+++..++.++.|++.||.+|| + .|++|+||+|+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 99999999999999999999999998 5442 457999999999999999999999 8 99999999999999
Q ss_pred eCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCC-CCCC-cchhhHHHHHHHHHHhCCCCCcccccCcc
Q 019568 175 LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSA-NGDVYSFGIMLMETFTGKKPTDEIFNGEM 252 (339)
Q Consensus 175 ~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~il~~ll~g~~P~~~~~~~~~ 252 (339)
++.++.++|+|||.+...... ......+++.|+|||.+.+. .++. ++||||||+++|+|++|..||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999865321 34455689999999999877 6666 99999999999999999999986544221
Q ss_pred chHhHhhhhcccccc-ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 253 TLKHWVNDWLPISTL-EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 253 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
............+.. ....... ...........++.++.+||.+||+.||.+|||+.++++|
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPL--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTT--CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCcCCccchhhhhccc--cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111110000000 0000000 0000011124567889999999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=323.40 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=206.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEe----CCCcEEEEEEeeccc----hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecC
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKSFNVECEMMKSI-RHRNLIKVISSCSNE 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 110 (339)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+++++.+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 347999999999999999999975 368999999986542 23345667799999999 799999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999997654 6899999999999999999999 9999999999999999999999999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCC--CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
.+... .........+|+.|+|||++.+. .++.++||||||+++|+|++|..||...................
T Consensus 208 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----- 281 (355)
T 1vzo_A 208 EFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----- 281 (355)
T ss_dssp ECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred ecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-----
Confidence 65321 12223345689999999998763 47899999999999999999999997543322111111000000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKKLL 318 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~l~ 318 (339)
....+..++..+.+||.+||..||.+|| +++++++|.+
T Consensus 282 ------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 ------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0011334567799999999999999999 9999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=327.20 Aligned_cols=258 Identities=12% Similarity=0.095 Sum_probs=188.6
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhC--CCcceeeEe-------
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSI--RHRNLIKVI------- 104 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l--~h~~i~~~~------- 104 (339)
.....+|++.+.||+|+||+||+|.+. +++.||||++.... ......+.+|+.+++.+ .||||++++
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 344566999999999999999999854 79999999998754 24455677785544444 699988755
Q ss_pred eeeecC-----------------ceeEEEEEecCCCCHHHHHhhcCCccCHHHH------HHHHHHHHHHHHHhhccCCC
Q 019568 105 SSCSNE-----------------EFKALVLEYMPHGSLEKYLYSSNCILDIFQR------LNIMIDVASALEYLHFGYSA 161 (339)
Q Consensus 105 ~~~~~~-----------------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~------~~i~~ql~~~l~~LH~~~~~ 161 (339)
+++... ...|+||||++ ++|.+++......+..... +.++.|++.||.||| ++
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~ 213 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SK 213 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HC
Confidence 333222 34799999998 6999999875444555555 678899999999999 99
Q ss_pred CeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccC--CCCCCcchhhHHHHHHHHHHh
Q 019568 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFT 239 (339)
Q Consensus 162 ~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~ 239 (339)
|++|+||||+||+++.++.++|+|||++.... .......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999998652 12224456799999999987 679999999999999999999
Q ss_pred CCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 240 GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 240 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
|+.||........... ..............+.....++..+.+||.+||+.||++|||+.++++|
T Consensus 289 g~~Pf~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSW------------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SSCSTTBCCTTCTTCC------------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCCcCcccccch------------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999987643211100 0000000011111222234567889999999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=315.83 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=200.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--------hhhhHHHHHHHHHHHhCCCcceeeEeeeeec
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--------GRALKSFNVECEMMKSIRHRNLIKVISSCSN 109 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (339)
...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 35689999999999999999999754 68999999986542 1223457889999999999999999999876
Q ss_pred CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc---EEEccc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLSDF 186 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~---v~l~Df 186 (339)
.. .++||||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++. ++|+||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred Cc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 65 88999999999999988654 47899999999999999999999 999999999999999987664 999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~ 263 (339)
|++..... ........+++.|+|||++. +..++.++||||||+++|+|++|..||.................
T Consensus 162 g~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 236 (322)
T 2ycf_A 162 GHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-- 236 (322)
T ss_dssp TTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC--
T ss_pred ccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc--
Confidence 99986521 12223445899999999863 56789999999999999999999999976533221111110000
Q ss_pred ccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..........++..+.+||.+||+.||.+|||+.++++|
T Consensus 237 --------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 --------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --------------cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 000111234567789999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=331.71 Aligned_cols=249 Identities=16% Similarity=0.183 Sum_probs=194.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc---chhhhHHHHHHHH---HHHhCCCcceeeEe-------
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ---CGRALKSFNVECE---MMKSIRHRNLIKVI------- 104 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~------- 104 (339)
...++|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+. ++++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3458899999999999999999985 46999999999743 3445677889995 45555899999998
Q ss_pred eeeecCc-----------------eeEEEEEecCCCCHHHHHhhcCC------ccCHHHHHHHHHHHHHHHHHhhccCCC
Q 019568 105 SSCSNEE-----------------FKALVLEYMPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASALEYLHFGYSA 161 (339)
Q Consensus 105 ~~~~~~~-----------------~~~lv~e~~~~~~L~~~i~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~~~~ 161 (339)
+++...+ ..|+||||+ +|+|.+++..... .+++..++.++.|++.||.||| +.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 225 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HY 225 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hC
Confidence 5554443 378999999 5699999976431 2335788899999999999999 99
Q ss_pred CeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCC-----------CCCCcchhhHH
Q 019568 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-----------RVSANGDVYSF 230 (339)
Q Consensus 162 ~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Diwsl 230 (339)
|++|+||||+||+++.++.++|+|||++... ........| +.|+|||++.+. .++.++|||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 9999999999999999999999999999853 112334456 899999999887 89999999999
Q ss_pred HHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH
Q 019568 231 GIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA 310 (339)
Q Consensus 231 G~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 310 (339)
|+++|+|++|..||............ ......+++++.+||.+||+.||.+|||+
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGSEWI-------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHHHSSCCC------CCSGGG-------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HHHHHHHHHCCCCCcccccccchhhh-------------------------hhhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence 99999999999999754322110000 00013456779999999999999999999
Q ss_pred HHHHHH--HHHHHH
Q 019568 311 KEIVKK--LLKIRD 322 (339)
Q Consensus 311 ~ell~~--l~~~~~ 322 (339)
.++++| ++.+++
T Consensus 355 ~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 355 LQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHTSHHHHHHHH
T ss_pred HHHhhChHHHHHHH
Confidence 999984 444443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=342.93 Aligned_cols=265 Identities=23% Similarity=0.385 Sum_probs=211.4
Q ss_pred CCCCCc-eeeecCccEEEEEEeC---CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 43 EFSENN-LIGKGGFGSVYKARLG---DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 43 ~y~~~~-~ig~g~~~~v~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++.+.. .||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333444 7999999999999642 46779999997653 3456788999999999999999999999976 5689999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++......+++..++.++.|++.||.||| +++++|+||||+||+++.++.+||+|||++..+.....
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999877777999999999999999999999 99999999999999999999999999999976532211
Q ss_pred c-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 198 S-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 198 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..+..
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~--~~i~~--------------- 554 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM--AFIEQ--------------- 554 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH--HHHHT---------------
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH--HHHHc---------------
Confidence 1 11122335678999999998999999999999999999998 99999875432211 11110
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccccCc
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGR 331 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~~~ 331 (339)
......+..++.++.+||.+||+.||.+||++.+|++.|+.+..+........
T Consensus 555 ---~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~ 607 (613)
T 2ozo_A 555 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607 (613)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence 00112234577889999999999999999999999999999988876655544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=320.42 Aligned_cols=271 Identities=21% Similarity=0.230 Sum_probs=206.1
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----c
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNE-----E 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 111 (339)
...++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34679999999999999999999754 68999999987543 34457788999999999999999999998654 4
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..++|+||+++ +|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 68999999975 999998765 4999999999999999999999 99999999999999999999999999999986
Q ss_pred ccCCCCcc-ccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 192 LVGEDQSM-TQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 192 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
........ ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ........+ ..+.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~-~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN-HILGILGSP-SQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH-HHHHHHCSC-CHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH-HHHHHhCCC-CHHH
Confidence 53222111 1234568999999997654 558999999999999999999999997653322111 111100000 0000
Q ss_pred ccc-----------cccCc-cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 270 VDA-----------NLLSQ-EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 270 ~~~-----------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
... ..... ........+.++.++.+||.+||+.||.+|||++++++|=
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000 00000 0000111234577899999999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=323.92 Aligned_cols=267 Identities=21% Similarity=0.227 Sum_probs=204.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC--------CcceeeEeeeee--
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR--------HRNLIKVISSCS-- 108 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~-- 108 (339)
..++|++.+.||+|+||+||+|.. .+++.||||++... ......+.+|+++++.+. |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 458999999999999999999975 46899999998754 344567888999999985 788999999987
Q ss_pred --cCceeEEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeCCCC-----
Q 019568 109 --NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNM----- 179 (339)
Q Consensus 109 --~~~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~~~~----- 179 (339)
.....++||||+. ++|.+.+... ...+++..++.++.||+.||.||| ++ |++|+||||+||+++.++
T Consensus 114 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence 5668999999995 5666666544 357999999999999999999999 88 999999999999998776
Q ss_pred --------------------------------------------cEEEcccccceeccCCCCccccccccCCCCccCCcc
Q 019568 180 --------------------------------------------VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215 (339)
Q Consensus 180 --------------------------------------------~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 215 (339)
.++|+|||++..... ......+|+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChh
Confidence 799999999986532 2334568999999999
Q ss_pred ccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHh----Hhhhhccc-c---------cccccccc----cc--
Q 019568 216 GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH----WVNDWLPI-S---------TLEVVDAN----LL-- 275 (339)
Q Consensus 216 ~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~----~~~~~~~~-~---------~~~~~~~~----~~-- 275 (339)
+.+..++.++|||||||++|+|++|..||............ ........ + ........ ..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999865433221100 00000000 0 00000000 00
Q ss_pred -Cc------cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 -SQ------EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 -~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. .......+...+..+.+||.+||+.||++|||++|+++|
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 000112245678889999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=311.71 Aligned_cols=247 Identities=19% Similarity=0.263 Sum_probs=201.3
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (339)
...++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|+..+..+ +||||+++++++...+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35688999999999999999999865 79999999987642 34456778899999999 9999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcC---CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-------------
Q 019568 115 LVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN------------- 178 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~------------- 178 (339)
+||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999997642 46899999999999999999999 9999999999999999844
Q ss_pred ------CcEEEcccccceeccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCc
Q 019568 179 ------MVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251 (339)
Q Consensus 179 ------~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~ 251 (339)
..++|+|||.+..... .....+++.|+|||.+.+. .++.++||||||+++|+|++|.+|+.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred cccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 4799999999886532 1233488999999998766 567899999999999999999987643211
Q ss_pred cchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....... .. ...+..++..+.+||.+||+.||.+|||+.++++|-
T Consensus 237 --~~~~~~~-------------~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 237 --WHEIRQG-------------RL------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp --HHHHHTT-------------CC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred --HHHHHcC-------------CC------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 1100000 00 011234567799999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=344.16 Aligned_cols=250 Identities=21% Similarity=0.254 Sum_probs=208.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc---chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ---CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|++.+.||+|+||.||+|... +++.||||++... .......+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999754 6889999998754 234456778899999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||++|++|.+++.... .+++..++.++.||+.||.||| +.+|+|+||||+|||++.++.++|+|||++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999997654 6999999999999999999999 99999999999999999999999999999985422
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
.........||+.|+|||++.+..++.++|+||||+++|+|++|..||......+.... ....
T Consensus 495 --~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~----------- 557 (674)
T 3pfq_A 495 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEH----------- 557 (674)
T ss_dssp --TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHSS-----------
T ss_pred --CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH----HHhC-----------
Confidence 22234456799999999999999999999999999999999999999976432211110 0000
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINA-----KEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 316 (339)
....+..++.++.+||.+||+.||++||++ +||++|
T Consensus 558 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 558 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 011133567789999999999999999997 888875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=316.77 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=204.8
Q ss_pred eeeeeHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCC--CcceeeEe
Q 019568 29 WRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIR--HRNLIKVI 104 (339)
Q Consensus 29 ~~~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~~ 104 (339)
.+.+++..+....++|++.+.||+|+||.||++...+++.||||++.... ......+.+|+++++++. |+||++++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 45566666777789999999999999999999998789999999987543 445677899999999996 59999999
Q ss_pred eeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEc
Q 019568 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 184 (339)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~ 184 (339)
+++...+..++|||+ .+++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||++++ +.++|+
T Consensus 95 ~~~~~~~~~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp EEEECSSEEEEEECC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEEC
T ss_pred EEeecCCEEEEEEec-CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEe
Confidence 999999999999995 5779999997654 7899999999999999999999 999999999999999964 899999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCccccC-----------CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccc
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE-----------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 253 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~ 253 (339)
|||++................+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.........
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 9999986543332223344568999999998865 46788999999999999999999999764322111
Q ss_pred hHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 254 LKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
......... ....+..++..+.+||.+||+.||.+|||+.++++|-+
T Consensus 249 ~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 249 LHAIIDPNH------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHHHHCTTS------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHhccc------------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 111110000 00112223567999999999999999999999999755
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=344.70 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=214.9
Q ss_pred HHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 34 YLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 34 ~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
...+....++|++.+.||+|+||.||+|.+..+..||||++.... ...+.+.+|+++|++++||||+++++++.. +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 344555678899999999999999999998777889999987653 234678899999999999999999999876 678
Q ss_pred EEEEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 114 ALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
++||||+++++|.+++... ...+++..++.++.|++.||.||| +++++|+||||+|||++.++.++|+|||++...
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 9999999999999999753 346899999999999999999999 999999999999999999999999999999764
Q ss_pred cCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 193 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+... .+..
T Consensus 414 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~--~i~~----------- 479 (535)
T 2h8h_A 414 EDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD--QVER----------- 479 (535)
T ss_dssp CCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH--HHHT-----------
T ss_pred CCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHHc-----------
Confidence 211 1111223345678999999998899999999999999999999 999997653321110 0000
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
..+...+..++..+.+||.+||+.||++|||+++|++.|+.+....
T Consensus 480 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 480 -------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 0111123456778999999999999999999999999998775443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=325.20 Aligned_cols=270 Identities=20% Similarity=0.228 Sum_probs=205.7
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhC------CCcceeeEeeeeecC
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSI------RHRNLIKVISSCSNE 110 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 110 (339)
.....+|++.+.||+|+||+||+|... +++.||||++... ......+.+|+++++.+ .|+||+++++++...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 345678999999999999999999754 6899999998754 33445677788888877 577999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc--EEEcccc
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV--AHLSDFS 187 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~--v~l~Dfg 187 (339)
+..++||||+. ++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++. ++|+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999996 59999987654 35899999999999999999999 999999999999999999887 9999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc--
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS-- 265 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~-- 265 (339)
++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||......... .........+.
T Consensus 248 ~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l-~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 248 SSCYEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL-ACMIELLGMPSQK 321 (429)
T ss_dssp TCEETT-----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHH
T ss_pred cceecC-----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCCHH
Confidence 997542 2233456899999999999999999999999999999999999999765332111 10000000000
Q ss_pred -------ccccccc---------------c------------c---cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 019568 266 -------TLEVVDA---------------N------------L---LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308 (339)
Q Consensus 266 -------~~~~~~~---------------~------------~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 308 (339)
...+++. . . ..........+...++++.+||.+||+.||++||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 0000000 0 0 0000011111223467799999999999999999
Q ss_pred CHHHHHHHHH
Q 019568 309 NAKEIVKKLL 318 (339)
Q Consensus 309 s~~ell~~l~ 318 (339)
|++|+++|=+
T Consensus 402 ta~e~L~Hpw 411 (429)
T 3kvw_A 402 TPGQALRHPW 411 (429)
T ss_dssp CHHHHHTSTT
T ss_pred CHHHHhCChh
Confidence 9999999743
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=324.93 Aligned_cols=267 Identities=18% Similarity=0.185 Sum_probs=213.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC-cceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH-RNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++.+.| +++..+..++...+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 458999999999999999999985 5799999998765532 2457789999999976 55666666667788889999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---CCCCcEEEcccccceeccC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~---~~~~~v~l~Dfg~~~~~~~ 194 (339)
||+ +++|.+++......+++..++.++.||+.||.||| +.+|+|+||||+|||+ +.++.++|+|||++..+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 88999999876678999999999999999999999 9999999999999999 5889999999999987643
Q ss_pred CCCcc-----ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 195 EDQSM-----TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 195 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~-------- 230 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-------- 230 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH--------
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh--------
Confidence 32211 12355689999999999999999999999999999999999999987644322111110000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
... ..........++.++.+||.+||+.||.+||++.+|++.|+.+.....
T Consensus 231 --~~~---~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 231 --KKV---ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp --HHH---HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --ccc---cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 000 000111224567889999999999999999999999999999976543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=309.64 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=206.6
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
.....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4556789999999999999999999864 69999999986543 33456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC---CcEEEcccccce
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAK 190 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~---~~v~l~Dfg~~~ 190 (339)
++|+||+++++|.+.+.... .+++..++.++.|++.||.+|| +.|++|+||+|+||+++.+ +.++|+|||++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999999886554 6899999999999999999999 9999999999999999654 469999999987
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
..... .......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||....... ........
T Consensus 173 ~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~--------- 237 (287)
T 2wei_A 173 CFQQN---TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVETG--------- 237 (287)
T ss_dssp TBCCC---SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC---------
T ss_pred eecCC---CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcC---------
Confidence 65321 122334578889999988754 8999999999999999999999997643211 11100000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
...........++.++.+||.+||+.||++|||+.++++|-
T Consensus 238 ------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 238 ------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp ------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred ------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 00001111234577899999999999999999999999963
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=322.48 Aligned_cols=265 Identities=23% Similarity=0.286 Sum_probs=188.1
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE----- 110 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 110 (339)
...++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+++++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 4558999999999999999999974 47999999998654 234556788999999999999999999998653
Q ss_pred -ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 111 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 111 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
...++++|++ +++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred CCeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 5679999999 67999988653 5999999999999999999999 999999999999999999999999999999
Q ss_pred eeccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....... ..+.+..+
T Consensus 180 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~-~~g~p~~~ 252 (367)
T 2fst_X 180 RHTA-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILR-LVGTPGAE 252 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH-HHCSCCHH
T ss_pred cccc-----ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCCHH
Confidence 7642 12334568999999998877 678999999999999999999999997643211 1111111 01110000
Q ss_pred cccc-----------cccCccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 VVDA-----------NLLSQEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 ~~~~-----------~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.... ......... ....+.+++.+.+||.+||+.||.+|||+.++++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 000000000 01123456789999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.63 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=196.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec---------
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN--------- 109 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 109 (339)
..++|++.+.||+|+||.||+|.. .+++.||||++... ......+.+|++++++++||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 567899999999999999999985 47999999998654 3455778899999999999999999998754
Q ss_pred ----CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 110 ----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 110 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
.+..++||||+++++|.+++......+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence 46789999999999999999877767889999999999999999999 99999999999999999999999999
Q ss_pred cccceeccCCCC------------ccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCcc
Q 019568 186 FSIAKLLVGEDQ------------SMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 252 (339)
Q Consensus 186 fg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~ 252 (339)
||++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 999876532110 1122344578999999998764 68999999999999999998 5442211111
Q ss_pred chHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........ ........+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 237 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKKLRSV----------------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHST----------------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHhcccc----------------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 01100000 0000111133456678999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=319.60 Aligned_cols=263 Identities=21% Similarity=0.242 Sum_probs=200.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee---
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK--- 113 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--- 113 (339)
..++|.+.+.||+|+||+||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 5689999999999999999999754 6999999998764 234457788999999999999999999999876654
Q ss_pred ---EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 114 ---ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 114 ---~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
++||||+.+ +|.+.+. ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.
T Consensus 120 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 120 YDFYLVMPFMQT-DLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCCEEEEECCCE-EHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eeEEEEEccccc-cHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 999999974 8888763 24899999999999999999999 9999999999999999999999999999987
Q ss_pred eccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||............ .. .......+.
T Consensus 193 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-~~-~~~~~~~~~ 265 (371)
T 4exu_A 193 HAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI-LK-VTGVPGTEF 265 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HH-HHCCCCHHH
T ss_pred ccc-----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HH-HhCCCcHHH
Confidence 542 22334567999999998877 67899999999999999999999999764322111110 00 000000000
Q ss_pred cc-----------ccccC-ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VD-----------ANLLS-QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~-----------~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.. ..... .........+.+++++.+||.+||+.||.+|||++++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00000 0000111224567889999999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=313.79 Aligned_cols=272 Identities=20% Similarity=0.250 Sum_probs=200.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeee----------
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS---------- 108 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------- 108 (339)
..++|++.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 5689999999999999999999865 59999999998777777788999999999999999999998873
Q ss_pred ----cCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-CCCcEEE
Q 019568 109 ----NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHL 183 (339)
Q Consensus 109 ----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-~~~~v~l 183 (339)
.....++||||+++ +|.+++... .+++..++.++.|++.||.+|| +.|++|+||||+||+++ .++.++|
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMET-DLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp --CCSCSEEEEEEECCSE-EHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccCceeEEeeccCC-CHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEE
Confidence 34678999999975 999998653 5899999999999999999999 99999999999999997 6779999
Q ss_pred cccccceeccCCCC-ccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh
Q 019568 184 SDFSIAKLLVGEDQ-SMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 184 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
+|||++........ ........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......... .......
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-QLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhc
Confidence 99999976532111 112234456889999998765 67899999999999999999999999865322111 1000000
Q ss_pred cccc----------ccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 262 LPIS----------TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 262 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.... ....................+.++.++.+||.+||+.||.+|||++++++|=+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 0000 00000000000000011122456788999999999999999999999998743
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=310.81 Aligned_cols=271 Identities=24% Similarity=0.329 Sum_probs=205.6
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe--CCCcEEEEEEeeccch--hhhHHHHHHHHHHHhC---CCcceeeEeeeee--
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL--GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSI---RHRNLIKVISSCS-- 108 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~--~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-- 108 (339)
....++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 45678999999999999999999986 4688999999875432 2234566788777766 8999999999986
Q ss_pred ---cCceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEc
Q 019568 109 ---NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS 184 (339)
Q Consensus 109 ---~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~ 184 (339)
.....++||||+++ +|.+++.... ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence 56788999999975 9999987654 35899999999999999999999 9999999999999999999999999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
|||++.... .........+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ..........+
T Consensus 163 Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~ 238 (326)
T 1blx_A 163 DFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLP 238 (326)
T ss_dssp SCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred cCccccccc---CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCC
Confidence 999987642 12223445689999999999999999999999999999999999999976533211 11111100000
Q ss_pred ccccccc-----cccc--CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 265 STLEVVD-----ANLL--SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 265 ~~~~~~~-----~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....... .... ............++..+.+||.+||+.||.+|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 0000 00000111234567889999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=322.47 Aligned_cols=271 Identities=21% Similarity=0.298 Sum_probs=206.3
Q ss_pred eHHHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC
Q 019568 33 SYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNE 110 (339)
Q Consensus 33 ~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 110 (339)
....+....++|++.+.||+|+||.||+|.... .+++|++.... ......+.+|+.++++++||||+++++++...
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345555567999999999999999999998743 59999987543 23345677899999999999999999999999
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
+..++|+||+++++|.+++......+++..++.++.|++.||.+|| +.|++|+||+|+||+++ ++.++|+|||++.
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 9999999999999999999877667999999999999999999999 99999999999999998 6899999999876
Q ss_pred eccCCC---CccccccccCCCCccCCccccC---------CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh
Q 019568 191 LLVGED---QSMTQTQTFATIGYMAPEYGRE---------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 191 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~ 258 (339)
...... .........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~ 255 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ--M 255 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH--H
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--h
Confidence 542111 1122233457889999998764 3478899999999999999999999976432211110 0
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccc
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNV 328 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~ 328 (339)
...... ......++.++.+||.+||+.||.+|||+.++++.|+.+.....+..
T Consensus 256 ~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~ 308 (319)
T 2y4i_B 256 GTGMKP-----------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308 (319)
T ss_dssp HTTCCC-----------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------
T ss_pred ccCCCC-----------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence 000000 00011245568999999999999999999999999999988765543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=320.09 Aligned_cols=271 Identities=24% Similarity=0.300 Sum_probs=201.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecC------ce
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNE------EF 112 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 112 (339)
....+|++.+.||+|+||+||+|+...+..+|+|++..... ...+|+++++.++||||+++++++... ..
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 35578999999999999999999876666799998764422 223699999999999999999998433 34
Q ss_pred eEEEEEecCCCCHHHHHh---hcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-CCCcEEEccccc
Q 019568 113 KALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSI 188 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~---~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-~~~~v~l~Dfg~ 188 (339)
.++||||+++ ++.+.+. .....+++..++.++.|++.||.||| +.|++|+||||+||+++ .++.++|+|||+
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 7899999977 5544433 23457999999999999999999999 99999999999999998 899999999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc---
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--- 264 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--- 264 (339)
+..+... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ..........+
T Consensus 189 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 189 AKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSRE 264 (394)
T ss_dssp CEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHH
T ss_pred cccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHH
Confidence 9875322 223345679999999988765 589999999999999999999999976432211 11111100000
Q ss_pred -------cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHHHH
Q 019568 265 -------STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKIRD 322 (339)
Q Consensus 265 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~~~ 322 (339)
........ ...........+..+++++.+||.+||++||.+|||+.|+++| ++.++.
T Consensus 265 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFP-QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHHCGGGSSSCCC-CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHhhChhhhhhccc-cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00000000 0111112222334567889999999999999999999999997 444443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=312.01 Aligned_cols=266 Identities=19% Similarity=0.247 Sum_probs=205.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEe--CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCc------ceeeEeeeeecCc
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL--GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHR------NLIKVISSCSNEE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~ 111 (339)
..++|++.+.||+|+||+||+|.. .+++.||||++... ......+.+|+++++.++|+ +++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457999999999999999999975 36899999998644 34456788899999988665 4999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-------------
Q 019568 112 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD------------- 177 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~------------- 177 (339)
..++||||+ +++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 779999987654 36889999999999999999999 999999999999999987
Q ss_pred ------CCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCc
Q 019568 178 ------NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251 (339)
Q Consensus 178 ------~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~ 251 (339)
++.++|+|||++.... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6789999999987642 12234568999999999999999999999999999999999999997643322
Q ss_pred cchHhHhhhhccc--cccccccc----------------------cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCC
Q 019568 252 MTLKHWVNDWLPI--STLEVVDA----------------------NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR 307 (339)
Q Consensus 252 ~~~~~~~~~~~~~--~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 307 (339)
.... ........ ........ ...............++.++.+||.+||+.||.+|
T Consensus 242 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 242 HLAM-MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHH-HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHH-HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 1110 00000000 00000000 00000000011234567889999999999999999
Q ss_pred CCHHHHHHH
Q 019568 308 INAKEIVKK 316 (339)
Q Consensus 308 ps~~ell~~ 316 (339)
||+.|+++|
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.39 Aligned_cols=272 Identities=22% Similarity=0.235 Sum_probs=204.3
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecC-----c
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNE-----E 111 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 111 (339)
...++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+++++.++||||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 45689999999999999999999864 69999999986543 34456778899999999999999999987654 6
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..++|+||+.+ +|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 88 ~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 88 EVYIIQELMQT-DLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CEEEEECCCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEeccCc-cHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 78999999975 999998764 5899999999999999999999 99999999999999999999999999999987
Q ss_pred ccCCCCcc--------ccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhc
Q 019568 192 LVGEDQSM--------TQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 262 (339)
Q Consensus 192 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~ 262 (339)
........ ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||........... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~ 240 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL-IFGIIG 240 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhC
Confidence 63221111 1223467999999997654 6789999999999999999999999976532211110 000000
Q ss_pred cccccc---ccc--------cccc-CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 263 PISTLE---VVD--------ANLL-SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 263 ~~~~~~---~~~--------~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.+.... ... .... ..........+.+++++.+||.+||+.||.+|||++++++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000 000 0000 000000112245678899999999999999999999999863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.40 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=202.9
Q ss_pred ceeeecCccEEEEEEe---CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARL---GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~---~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||.||+|.+ .+++.||||+++... ......+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999953 346889999987643 3345788999999999999999999999975 457899999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc-ccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-MTQ 201 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~-~~~ 201 (339)
++|.+++.... .+++..++.++.||+.||.||| +++|+|+||||+||+++.++.++|+|||++..+...... ...
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999996543 7899999999999999999999 999999999999999999999999999999765332211 122
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.... +.. ..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~--i~~------------------~~ 589 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--LEK------------------GE 589 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--HHT------------------TC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HHc------------------CC
Confidence 23345778999999999999999999999999999998 9999976543221110 000 00
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
....+..++.++.+||.+||+.||++||++++|++.|+++..++.
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 111234567889999999999999999999999999999887653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=323.57 Aligned_cols=275 Identities=20% Similarity=0.240 Sum_probs=188.8
Q ss_pred hhhhcCCCC-CceeeecCccEEEEEEeC---CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeee--ecCc
Q 019568 38 CQATDEFSE-NNLIGKGGFGSVYKARLG---DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC--SNEE 111 (339)
Q Consensus 38 ~~~~~~y~~-~~~ig~g~~~~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 111 (339)
....+.|++ .++||+|+||+||+|... +++.||||++.... ....+.+|+++++.++||||+++++++ ....
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 345567877 568999999999999853 58899999986542 234677899999999999999999999 4577
Q ss_pred eeEEEEEecCCCCHHHHHhhc--------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe----CCCC
Q 019568 112 FKALVLEYMPHGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL----DDNM 179 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~----~~~~ 179 (339)
..++||||+++ +|.+++... ...+++..++.++.||+.||.||| +.+++|+||||+||++ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCC
Confidence 89999999975 888887532 124899999999999999999999 9999999999999999 7789
Q ss_pred cEEEcccccceeccCCCC-ccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCc------
Q 019568 180 VAHLSDFSIAKLLVGEDQ-SMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGE------ 251 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~------ 251 (339)
.++|+|||++..+..... ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999986532211 1223345689999999988774 58999999999999999999999997543211
Q ss_pred --cchHhHhhhhcccc--cccccc-------------ccccCccch-h--hhhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 019568 252 --MTLKHWVNDWLPIS--TLEVVD-------------ANLLSQEDI-H--FVAKEQCVSFVFNLAMACAVESPEQRINAK 311 (339)
Q Consensus 252 --~~~~~~~~~~~~~~--~~~~~~-------------~~~~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 311 (339)
............+. .+.... ......... . .......+..+.+||.+||+.||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 01111111110000 000000 000000000 0 000011256789999999999999999999
Q ss_pred HHHHHHH
Q 019568 312 EIVKKLL 318 (339)
Q Consensus 312 ell~~l~ 318 (339)
|+++|=+
T Consensus 330 e~L~hp~ 336 (405)
T 3rgf_A 330 QAMQDPY 336 (405)
T ss_dssp HHHTSGG
T ss_pred HHhcChh
Confidence 9999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=319.55 Aligned_cols=265 Identities=25% Similarity=0.301 Sum_probs=198.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec------Cce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN------EEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 112 (339)
...+|++.+.||+|+||.||+|... +++.||||++.... ....+|+++++.++||||+++++++.. ...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 3457999999999999999999864 69999999986542 223469999999999999999998843 234
Q ss_pred eEEEEEecCCCCHHHHHh---hcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-CcEEEccccc
Q 019568 113 KALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSI 188 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~---~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~-~~v~l~Dfg~ 188 (339)
+++||||+++ ++.+.+. .....+++..++.++.|++.||.||| +.||+|+||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 6799999976 7776654 23457999999999999999999999 9999999999999999854 6789999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc---
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI--- 264 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~--- 264 (339)
+..+... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+.........+
T Consensus 204 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 204 AKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTRE 279 (420)
T ss_dssp CEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHH
T ss_pred hhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence 9875322 223345689999999988765 78999999999999999999999997643211 111111110000
Q ss_pred -------cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 265 -------STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 265 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
......... ..........++.++.++.+||.+||++||.+|||+.|+++|-
T Consensus 280 ~~~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHCSCCCCCCCCC-CCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhhChhhhhhccCc-cCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 000000000 0111111122345678899999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=312.58 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=193.7
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch------hhhHHHHHHHHHHHhC----CCcceeeE
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG------RALKSFNVECEMMKSI----RHRNLIKV 103 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~~ 103 (339)
.......++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 45566789999999999999999999975 4689999999865532 1233456799999998 89999999
Q ss_pred eeeeecCceeEEEEEe-cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-CCCcE
Q 019568 104 ISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVA 181 (339)
Q Consensus 104 ~~~~~~~~~~~lv~e~-~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-~~~~v 181 (339)
++++...+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++ .++.+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeE
Confidence 9999999999999999 78899999997654 6899999999999999999999 99999999999999998 89999
Q ss_pred EEcccccceeccCCCCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhh
Q 019568 182 HLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 182 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~ 260 (339)
+|+|||++..... .......+++.|+|||++.+..+ +.++||||||+++|+|++|+.||..... ....
T Consensus 180 kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~ 248 (312)
T 2iwi_A 180 KLIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILEA 248 (312)
T ss_dssp EECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHT
T ss_pred EEEEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhhh
Confidence 9999999887532 22334558899999998877665 4589999999999999999999875311 0000
Q ss_pred hccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 261 WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
....+..++..+.+||.+||+.||++|||++++++|-
T Consensus 249 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 249 --------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp --------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred --------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0001234567799999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=336.54 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=210.2
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE 111 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 111 (339)
.....++|++.+.||+|+||.||+|... .+..||||.+... .....+.+.+|+.++++++||||+++++++.+ +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence 3445578999999999999999999753 2567999988654 34445778899999999999999999999854 5
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 688999999999999999877667999999999999999999999 99999999999999999999999999999976
Q ss_pred ccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... ......
T Consensus 541 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~--~~i~~~--------- 608 (656)
T 2j0j_A 541 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GRIENG--------- 608 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHHT---------
T ss_pred cCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHcC---------
Confidence 53221 112233446788999999988899999999999999999997 99999765332111 010000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
.....+..+++.+.+||.+||+.||.+|||+.++++.|+++.+.
T Consensus 609 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 ---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00112345677899999999999999999999999999998764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=310.47 Aligned_cols=257 Identities=19% Similarity=0.239 Sum_probs=179.3
Q ss_pred hhhcCCCCCc-eeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec----Cce
Q 019568 39 QATDEFSENN-LIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN----EEF 112 (339)
Q Consensus 39 ~~~~~y~~~~-~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 112 (339)
...++|.+.+ .||+|+||+||+|... +++.||||++.... ....+....++.+.||||+++++++.. ...
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 4678999965 6999999999999865 69999999986431 112223334667799999999999865 456
Q ss_pred eEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC---CCcEEEccccc
Q 019568 113 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSI 188 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~---~~~v~l~Dfg~ 188 (339)
.++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999997654 46999999999999999999999 999999999999999976 45599999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
+.... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..||...............
T Consensus 178 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (336)
T 3fhr_A 178 AKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR--------- 244 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecc----ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh---------
Confidence 97652 22233456789999999998889999999999999999999999999765432211100000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
. ..............++.++.+||.+||+.||.+|||++++++|-+-
T Consensus 245 -~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 245 -I---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred -h---hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0 0000011111123567789999999999999999999999998653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.94 Aligned_cols=275 Identities=20% Similarity=0.231 Sum_probs=192.4
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc--
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE-- 111 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 111 (339)
.......++|++.+.||+|+||+||+|... +++.||||++... ........++++.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667799999999999999999999864 6999999988654 233356677888899999999999999985433
Q ss_pred -----eeEEEEEecCCCCHHHHHh---hcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-CCcEE
Q 019568 112 -----FKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAH 182 (339)
Q Consensus 112 -----~~~lv~e~~~~~~L~~~i~---~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-~~~v~ 182 (339)
..++||||+++ +|.+.+. .....+++..++.++.|++.||.|||. .+.|++|+||||+||+++. ++.++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence 37899999976 6655543 244578999999999999999999992 2678999999999999986 89999
Q ss_pred EcccccceeccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh
Q 019568 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 183 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
|+|||++..... ........+|+.|+|||++.+. .++.++||||||+++|+|++|..||.......... ......
T Consensus 173 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~-~~~~~~ 248 (360)
T 3e3p_A 173 LCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH-EIVRVL 248 (360)
T ss_dssp ECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHH
T ss_pred EeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH-HHHHHc
Confidence 999999986532 2223345679999999988654 48999999999999999999999998643221111 111000
Q ss_pred ccc------------cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 262 LPI------------STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 262 ~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..+ ............-..........++.++.+||.+||+.||.+|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 0000000000000000001112357889999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.31 Aligned_cols=209 Identities=24% Similarity=0.295 Sum_probs=176.0
Q ss_pred eeHHHHhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-Cc-----ceeeEe
Q 019568 32 FSYLELCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HR-----NLIKVI 104 (339)
Q Consensus 32 ~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~ 104 (339)
+.......+.++|++.+.||+|+||+||+|... +++.||||++... ......+..|+++++.+. |+ +|++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 344455567799999999999999999999754 6899999998744 334566777888888874 44 499999
Q ss_pred eeeecCceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC--CCCcE
Q 019568 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVA 181 (339)
Q Consensus 105 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~--~~~~v 181 (339)
+++...+..++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||. ...||+|+||||+||+++ .++.+
T Consensus 123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCE
T ss_pred eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcE
Confidence 999999999999999965 9999987654 468999999999999999999991 126899999999999994 57889
Q ss_pred EEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccc
Q 019568 182 HLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF 248 (339)
Q Consensus 182 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~ 248 (339)
+|+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 201 kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 201 KIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987521 2334568899999999999999999999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=313.52 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=202.8
Q ss_pred eeeHHHHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchh------hhHHHHHHHHHHHhCC--Cccee
Q 019568 31 TFSYLELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGR------ALKSFNVECEMMKSIR--HRNLI 101 (339)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~ 101 (339)
..+..+.....++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.+++++. |+||+
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 344456666789999999999999999999974 47899999998765321 2245667999999996 59999
Q ss_pred eEeeeeecCceeEEEEEecCC-CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC-CCC
Q 019568 102 KVISSCSNEEFKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD-DNM 179 (339)
Q Consensus 102 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~-~~~ 179 (339)
++++++...+..++|+|++.+ ++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++ .++
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCC
Confidence 999999999999999999975 79999987644 7899999999999999999999 99999999999999998 789
Q ss_pred cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh
Q 019568 180 VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258 (339)
Q Consensus 180 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~ 258 (339)
.++|+|||++..... .......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||..... ..
T Consensus 188 ~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~ 256 (320)
T 3a99_A 188 ELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------II 256 (320)
T ss_dssp EEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HH
T ss_pred CEEEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hh
Confidence 999999999987532 22334568999999998877665 7889999999999999999999975321 00
Q ss_pred hhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
.. . ...+..++.++.+||.+||+.||.+|||++++++|-
T Consensus 257 ~~------------~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 257 RG------------Q--------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp HC------------C--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred cc------------c--------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00 0 001223466799999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=312.17 Aligned_cols=264 Identities=21% Similarity=0.241 Sum_probs=199.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce----
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF---- 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 112 (339)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 4579999999999999999999754 69999999986542 3445678899999999999999999999977654
Q ss_pred --eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 113 --KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 113 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
.++||||+++ +|.+++.. .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eeEEEEeccccC-CHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 4999999974 88877642 4899999999999999999999 9999999999999999999999999999987
Q ss_pred eccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........ ...... ..+....+.
T Consensus 175 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~-~~~~~~~~~ 247 (353)
T 3coi_A 175 HAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILK-VTGVPGTEF 247 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHH-HHCBCCHHH
T ss_pred CCC-----CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-HhCCCCHHH
Confidence 542 12234567899999998876 6789999999999999999999999986432111 110000 000000000
Q ss_pred ccc-----------cccCccc-hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 019568 270 VDA-----------NLLSQED-IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317 (339)
Q Consensus 270 ~~~-----------~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l 317 (339)
... ....... .-....+.++.++.+||.+||+.||.+|||++++++|=
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000 0000000 00111235678899999999999999999999999873
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.57 Aligned_cols=266 Identities=21% Similarity=0.261 Sum_probs=202.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CC-cEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc------eeeEeeeeecCc
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DG-MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN------LIKVISSCSNEE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~-~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~ 111 (339)
..++|++.+.||+|+||+||+|... ++ +.||||++... ......+.+|+++++.+.|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 5689999999999999999999753 44 78999998644 344567788999999987655 899999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEe---------------
Q 019568 112 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL--------------- 175 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~--------------- 175 (339)
..++||||+ ++++.+.+.... ..+++..++.++.|++.||.||| +.|++|+||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 557777765543 57999999999999999999999 9999999999999999
Q ss_pred ----CCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCc
Q 019568 176 ----DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251 (339)
Q Consensus 176 ----~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~ 251 (339)
+.++.++|+|||++.... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999997642 22234568999999999999999999999999999999999999998643321
Q ss_pred cchHhHhhhhcccc--cc-------ccccccc---------------cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCC
Q 019568 252 MTLKHWVNDWLPIS--TL-------EVVDANL---------------LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR 307 (339)
Q Consensus 252 ~~~~~~~~~~~~~~--~~-------~~~~~~~---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 307 (339)
.... ........+ .. ....... ..............+.++.+||.+||+.||.+|
T Consensus 247 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 HLVM-MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHH-HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHH-HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 1110 000000000 00 0000000 000000111223456789999999999999999
Q ss_pred CCHHHHHHH
Q 019568 308 INAKEIVKK 316 (339)
Q Consensus 308 ps~~ell~~ 316 (339)
||+.++++|
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=313.57 Aligned_cols=268 Identities=16% Similarity=0.211 Sum_probs=201.2
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-----------CcceeeEeeeee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-----------HRNLIKVISSCS 108 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~ 108 (339)
.++|++.+.||+|+||+||+|.. .+++.||||++... ......+.+|+.+++++. |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 47999999999999999999985 47999999998754 334466788999999886 789999999987
Q ss_pred cCc----eeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeC------
Q 019568 109 NEE----FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLD------ 176 (339)
Q Consensus 109 ~~~----~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~------ 176 (339)
..+ ..+++||++ +++|.+++.... ..+++..++.++.|++.||.||| ++ |++|+||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence 544 789999999 779999997643 45999999999999999999999 88 999999999999994
Q ss_pred CCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccc---
Q 019568 177 DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT--- 253 (339)
Q Consensus 177 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~--- 253 (339)
..+.++|+|||++..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 455899999999986522 233456899999999999999999999999999999999999999865322111
Q ss_pred --hHhHhhhhcccc------------------ccccccccccC----ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC
Q 019568 254 --LKHWVNDWLPIS------------------TLEVVDANLLS----QEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN 309 (339)
Q Consensus 254 --~~~~~~~~~~~~------------------~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 309 (339)
...........+ ........... ........+..++.++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 000000000000 00000000000 000111234677889999999999999999999
Q ss_pred HHHHHHHHH
Q 019568 310 AKEIVKKLL 318 (339)
Q Consensus 310 ~~ell~~l~ 318 (339)
++|+++|=+
T Consensus 328 ~~ell~hp~ 336 (373)
T 1q8y_A 328 AGGLVNHPW 336 (373)
T ss_dssp HHHHHTCGG
T ss_pred HHHHhhChh
Confidence 999999643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=308.53 Aligned_cols=258 Identities=26% Similarity=0.332 Sum_probs=183.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHH-HHHhCCCcceeeEeeeeecCceeEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECE-MMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+..|+. +++.+.||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4589999999999999999999864 69999999997653 233344555555 67778999999999999999999999
Q ss_pred EEecCCCCHHHHHhh----cCCccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 117 LEYMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
|||+++ +|.+++.. ....+++..++.++.|++.||.+|| +. |++|+||+|+||+++.++.++|+|||++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999976 88887753 2457899999999999999999999 88 999999999999999999999999999876
Q ss_pred ccCCCCccccccccCCCCccCCccc----cCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYG----REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
... ........+++.|+|||.+ .+..++.++||||||+++|+|++|..||............
T Consensus 176 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----------- 241 (327)
T 3aln_A 176 LVD---SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ----------- 241 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC-----------
T ss_pred ccc---ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH-----------
Confidence 532 1222334688999999998 4567899999999999999999999999754221110000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
.... ............++..+.+||.+||+.||.+|||+.++++|-+-
T Consensus 242 -~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 242 -VVKG---DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp -CCCS---CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred -HhcC---CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 0000 00000011123456779999999999999999999999996443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.96 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=190.2
Q ss_pred hcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.+.|.+.+.||+|+||+||.+...+|+.||||++.... ...+.+|+++++++ +||||+++++++...+..++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 35566778999999999987766689999999986542 34567899999886 899999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCc------cCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-------------Cc
Q 019568 120 MPHGSLEKYLYSSNCI------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-------------MV 180 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~------~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~-------------~~ 180 (339)
+. ++|.+++...... .++..++.++.|++.||.||| +.+++|+||||+||+++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 5999999765421 123345789999999999999 9999999999999999654 48
Q ss_pred EEEcccccceeccCCCCcc--ccccccCCCCccCCccccC-------CCCCCcchhhHHHHHHHHHHh-CCCCCcccccC
Q 019568 181 AHLSDFSIAKLLVGEDQSM--TQTQTFATIGYMAPEYGRE-------GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNG 250 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~ 250 (339)
++|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998764322111 1234568999999998865 568999999999999999999 99999754322
Q ss_pred ccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 251 EMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
... ....... ...........++.++.+||.+||+.||.+|||+.++++|
T Consensus 247 ~~~---i~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ESN---IIRGIFS-------------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHH---HHHTCCC-------------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH---HhcCCCC-------------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 211 1110000 0011112235677889999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=306.15 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=187.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccch--hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
...++|++.+.||+|+||.||+|... +++.||||++..... .....+.++..+++.+.||||+++++++...+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34678999999999999999999864 699999999976532 223344555667888899999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||||+ ++.+..+.......+++..++.++.|++.||.||| ++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999 55777766655567999999999999999999999 85 999999999999999999999999999876532
Q ss_pred CCCccccccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
........+++.|+|||.+. +..++.++||||||+++|+|++|..||.................. .
T Consensus 178 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~---- 248 (318)
T 2dyl_A 178 ---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP--P---- 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC--C----
T ss_pred ---CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC--C----
Confidence 12223446889999999884 456889999999999999999999999764322111111111000 0
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
.......++.++.+||.+||+.||.+||+++++++|-+
T Consensus 249 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 249 -----------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp -----------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred -----------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 00011234677999999999999999999999999643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.30 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=192.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
....+|.+.+.||+|+||+|+.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....|+||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34467999999999999997655555899999999865432 3456799999999 7999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-----CCcEEEcccccceec
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----NMVAHLSDFSIAKLL 192 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-----~~~v~l~Dfg~~~~~ 192 (339)
||+.+ +|.+++...........++.++.|++.||.||| +.+++|+||||+||+++. ...++|+|||++...
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 99965 999999877655666667899999999999999 999999999999999953 235789999999865
Q ss_pred cCCCC-ccccccccCCCCccCCcccc---CCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccc
Q 019568 193 VGEDQ-SMTQTQTFATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 193 ~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
..... ........||+.|+|||++. ...++.++|||||||++|+|++ |..||.......... . ......
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~---~---~~~~~~ 247 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---L---LGACSL 247 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH---H---TTCCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH---H---hccCCc
Confidence 32211 12234456899999999987 4567889999999999999999 999986432211100 0 000000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.........+..+.+||.+||+.||.+|||++++++|
T Consensus 248 ------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 ------------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ------------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0001123456678999999999999999999999965
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.72 Aligned_cols=268 Identities=24% Similarity=0.323 Sum_probs=199.6
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeec------
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSN------ 109 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 109 (339)
....++|++.+.||+|+||+||+|.. .+|+.||||++... .......+.+|+++++.++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 34458999999999999999999975 46999999998764 34456778899999999999999999998765
Q ss_pred CceeEEEEEecCCCCHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc---EEEc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV---AHLS 184 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~---v~l~ 184 (339)
.+..++||||++|++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++. ++|+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999997644 25888899999999999999999 999999999999999987665 9999
Q ss_pred ccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc
Q 019568 185 DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264 (339)
Q Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~ 264 (339)
|||++..... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||....... .|.......
T Consensus 167 DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~----~~~~~i~~~ 239 (676)
T 3qa8_A 167 DLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV----QWHGKVREK 239 (676)
T ss_dssp SCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH----HSSTTCC--
T ss_pred cccccccccc---ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh----hhhhhhhcc
Confidence 9999986532 222344568999999999999999999999999999999999999997532211 000000000
Q ss_pred -----cccccccccc-c-CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 019568 265 -----STLEVVDANL-L-SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315 (339)
Q Consensus 265 -----~~~~~~~~~~-~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 315 (339)
.......... . ............++..+.+||.+||..||++|||++++++
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 0000000000 0 0001111224557888999999999999999999998543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=292.99 Aligned_cols=236 Identities=14% Similarity=0.054 Sum_probs=189.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++...+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4578999999999999999999864 59999999997653 3445778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||++|++|.+++... .....+..++.|++.||.||| +.|++|+||||+||+++.++.++|++++
T Consensus 109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999998543 355578889999999999999 9999999999999999999999997443
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
|++| ++.++||||||+++|+|++|+.||.......... .......
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------------~~~~~~~ 219 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------------PAERDTA 219 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------------ECCBCTT
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------------HHHHHhc
Confidence 3332 6789999999999999999999998654322100 0000000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
............++.++.+||.+||+.||.+| |+.++++.|+.+.....
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 01111112234567889999999999999999 99999999999876443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=288.91 Aligned_cols=238 Identities=19% Similarity=0.263 Sum_probs=187.4
Q ss_pred hhhhcCCCCC-ceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHH-HhCCCcceeeEeeeeec----C
Q 019568 38 CQATDEFSEN-NLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMM-KSIRHRNLIKVISSCSN----E 110 (339)
Q Consensus 38 ~~~~~~y~~~-~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~ 110 (339)
....++|.+. +.||+|+||.||+|.. .+++.||||++... ..+.+|++++ +..+||||+++++++.. .
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 3456778887 7899999999999975 47999999998643 4566788888 55699999999999876 6
Q ss_pred ceeEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC---CCcEEEccc
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDF 186 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~---~~~v~l~Df 186 (339)
...++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++. ++.++|+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 78899999999999999997754 46999999999999999999999 999999999999999987 789999999
Q ss_pred ccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc
Q 019568 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 266 (339)
Q Consensus 187 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 266 (339)
|++.... +..++.++||||||+++|+|++|..||...........
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----------- 209 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----------- 209 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----------
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----------
Confidence 9886531 23467799999999999999999999975432211000
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
...................++.++.+||.+||+.||.+|||+.|+++|-+-.
T Consensus 210 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 210 --MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp --SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 0000000111111222345688899999999999999999999999986643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=321.63 Aligned_cols=244 Identities=20% Similarity=0.302 Sum_probs=197.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC--CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce----
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF---- 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~--~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 112 (339)
..++|++.+.||+|+||+||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4589999999999999999999864 58999999986543 3455678899999999999999999999976654
Q ss_pred -eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 113 -KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 113 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
.|+||||++|++|.+++.. .+++..++.++.|++.+|.||| +.||+|+||||+||+++.+ .++|+|||++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999987754 5899999999999999999999 9999999999999999885 999999999986
Q ss_pred ccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
.... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||........
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------- 284 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------- 284 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------------
Confidence 5321 4456899999999887654 8899999999999999999988764321110
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-NAKEIVKKLLKIRDSL 324 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~l~~~~~~~ 324 (339)
. ........++.+.+||.+||+.||.+|| +++++...|..+....
T Consensus 285 ----~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 285 ----P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp ----C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred ----c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0 0011223456799999999999999999 5666777777766544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=304.22 Aligned_cols=253 Identities=17% Similarity=0.183 Sum_probs=188.7
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCC-cceee--------
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRH-RNLIK-------- 102 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~~-------- 102 (339)
+++....+|...+.||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|+.+++.+.| ++...
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 3444556788999999999999999984 479999999987443 2336778899999999976 22111
Q ss_pred -------------Eeeeeec-----CceeEEEEEecCCCCHHHHHh------hcCCccCHHHHHHHHHHHHHHHHHhhcc
Q 019568 103 -------------VISSCSN-----EEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHFG 158 (339)
Q Consensus 103 -------------~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~------~~~~~~~~~~~~~i~~ql~~~l~~LH~~ 158 (339)
+..++.. ....+++|+.. +++|.+++. .....+++..++.++.|++.||.|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-- 228 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-- 228 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 1111111 22456777776 569999884 22446788899999999999999999
Q ss_pred CCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccc----------cCCCCCCcchhh
Q 019568 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG----------REGRVSANGDVY 228 (339)
Q Consensus 159 ~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Diw 228 (339)
+++++|+||||+|||++.++.+||+|||++.... .......| +.|+|||++ .+..++.++|||
T Consensus 229 -~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 229 -HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp -HTTEECSCCCGGGEEECTTCCEEECCGGGCEETT-----EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred -hCCcccCCcccceEEEecCCeEEEEeccceeecC-----CccccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 9999999999999999999999999999987642 12344456 899999988 556688999999
Q ss_pred HHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC
Q 019568 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308 (339)
Q Consensus 229 slG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 308 (339)
||||++|+|++|+.||........... . +.....++..+.+||.+||+.||.+||
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~~~~------------------~-------~~~~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGGSEW------------------I-------FRSCKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSCSGG------------------G-------GSSCCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhHHH------------------H-------HhhcccCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999976432211000 0 000123457799999999999999999
Q ss_pred CHHHHHHH--HHHHHHH
Q 019568 309 NAKEIVKK--LLKIRDS 323 (339)
Q Consensus 309 s~~ell~~--l~~~~~~ 323 (339)
++.++++| ++.+++.
T Consensus 357 t~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 357 LPLQAMETPEYEQLRTE 373 (413)
T ss_dssp CHHHHTTSHHHHHHHHH
T ss_pred CHHHHHhCHHHHHHHHH
Confidence 99999876 5555443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=291.20 Aligned_cols=246 Identities=16% Similarity=0.172 Sum_probs=187.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--------hhhhHHHHHHHHHHHhCC---------C-----
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--------GRALKSFNVECEMMKSIR---------H----- 97 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h----- 97 (339)
..++|++.+.||+|+||+||+|.. +|+.||||++.... ....+.+.+|+++++.++ |
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 357899999999999999999988 78999999997653 223467888999999886 4
Q ss_pred ------------cceeeEeeeeec-------------CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHH
Q 019568 98 ------------RNLIKVISSCSN-------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152 (339)
Q Consensus 98 ------------~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l 152 (339)
|||+++++++.. .+..|+||||++++++.+.+.+ ..+++..++.++.|++.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 555555555543 6789999999999877666644 3589999999999999999
Q ss_pred HHhhccCCCCeEecCCCCCCeEeCCCC--------------------cEEEcccccceeccCCCCccccccccCCCCccC
Q 019568 153 EYLHFGYSAPIIHCDLKPSNVLLDDNM--------------------VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212 (339)
Q Consensus 153 ~~LH~~~~~~i~h~di~p~Nil~~~~~--------------------~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 212 (339)
.|||. +.+|+|+||||+|||++.++ .+||+|||++..... ....||+.|+|
T Consensus 175 ~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTC
T ss_pred HHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccC
Confidence 99993 48999999999999999887 899999999986532 23468999999
Q ss_pred CccccCCCCCCcchhhHHHHH-HHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHH
Q 019568 213 PEYGREGRVSANGDVYSFGIM-LMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSF 291 (339)
Q Consensus 213 PE~~~~~~~~~~~DiwslG~i-l~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (339)
||++.+.. +.++||||++++ .+++++|..||............... . ............+.++++
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~------------~-~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK------------Q-MTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH------------T-CCCSSCCCSHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh------------h-hccCcccchhhhhhcCHH
Confidence 99998776 889999998777 77888899998542100000000000 0 000011112235678999
Q ss_pred HHHHHhhhcCCCCCCCCCHHHHH-HH
Q 019568 292 VFNLAMACAVESPEQRINAKEIV-KK 316 (339)
Q Consensus 292 l~~li~~~l~~dP~~Rps~~ell-~~ 316 (339)
+++||.+||+.| |++|++ +|
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHhccC-----CHHHHHhcC
Confidence 999999999977 999999 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=261.02 Aligned_cols=184 Identities=20% Similarity=0.111 Sum_probs=130.0
Q ss_pred eecCccEEEEEE-eCCCcEEEEEEeeccc----------hhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEEEE
Q 019568 51 GKGGFGSVYKAR-LGDGMEVAVKVFNLQC----------GRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 51 g~g~~~~v~~~~-~~~~~~v~vK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
+.|+.+....++ .-.|+.+++|++.... ....+.+.+|+++|+++ .|+||+++++++++++..|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 345555444432 2258889999986541 23346689999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
|++|++|.+++.+.. +++.. .++.||+.||.|+| ++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 323 yv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~ 393 (569)
T 4azs_A 323 KLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--C 393 (569)
T ss_dssp CCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred cCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--C
Confidence 999999999997654 66654 47899999999999 999999999999999999999999999999865322 2
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCC
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT 244 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~ 244 (339)
......+||+.|+|||++.+. +..++|+||+|++++.+.++..++
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 223445689999999998764 567899999999988877665543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-27 Score=226.65 Aligned_cols=189 Identities=15% Similarity=0.163 Sum_probs=142.2
Q ss_pred hcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--------hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--------GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
...+...+.||+|+||.||+|.. .+..+++|...... ....+.+.+|++++++++||||+++..++...+.
T Consensus 335 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 413 (540)
T 3en9_A 335 KKRKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN 413 (540)
T ss_dssp -------------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT
T ss_pred cccCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc
Confidence 33445677999999999999965 67889999864332 1123457899999999999999955555556667
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceec
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
.|+||||++|++|.+++.. +..++.|++.+|.||| +++++|+||||+||+++. .++|+|||++...
T Consensus 414 ~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred cEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 7999999999999999865 5689999999999999 999999999999999998 9999999999876
Q ss_pred cCCCCcc-----ccccccCCCCccCCccccC--CCCCCcchhhHHHHHHHHHHhCCCCC
Q 019568 193 VGEDQSM-----TQTQTFATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPT 244 (339)
Q Consensus 193 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~P~ 244 (339)
....... ......+|+.|+|||++.+ ..|+...|+|+...-..+-+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3211111 1234568999999999987 56788899999988888877776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-24 Score=187.71 Aligned_cols=163 Identities=17% Similarity=0.142 Sum_probs=126.6
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccch------------------hhhHHHHHHHHHHHhCCC
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG------------------RALKSFNVECEMMKSIRH 97 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~------------------~~~~~~~~e~~~l~~l~h 97 (339)
.+......|.+.+.||+|+||.||+|...+|+.||||+++.... .....+.+|+++++.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444556667799999999999999887799999999865321 13456889999999999
Q ss_pred cceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC
Q 019568 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD 177 (339)
Q Consensus 98 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~ 177 (339)
| +++.+++.. +..++||||++|++|.+ +.. .....++.|++.||.+|| +.|++|+||||+||+++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence 4 666665543 56699999999999988 421 124579999999999999 99999999999999999
Q ss_pred CCcEEEcccccceeccCCCCccccccccCCCCccCCccccC----------CCCCCcchhhH
Q 019568 178 NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE----------GRVSANGDVYS 229 (339)
Q Consensus 178 ~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~~~Diws 229 (339)
++.++|+|||++... ..+.|||++.. ..++..+|+|.
T Consensus 228 ~~~vkl~DFG~a~~~---------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 228 EEGIWIIDFPQSVEV---------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TTEEEECCCTTCEET---------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCcEEEEECCCCeEC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999998642 34678887643 34556666665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=8e-20 Score=158.49 Aligned_cols=139 Identities=19% Similarity=0.222 Sum_probs=106.9
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcE--EEEEEeeccchh------------------------hhHHHHHHHHHHHh
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGME--VAVKVFNLQCGR------------------------ALKSFNVECEMMKS 94 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~--v~vK~~~~~~~~------------------------~~~~~~~e~~~l~~ 94 (339)
.-|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+++++.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999986 67888 999987543211 11357889999999
Q ss_pred CCCcce--eeEeeeeecCceeEEEEEecCC-C----CHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecC
Q 019568 95 IRHRNL--IKVISSCSNEEFKALVLEYMPH-G----SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167 (339)
Q Consensus 95 l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~d 167 (339)
+.|+++ ..++.. ...++||||+.+ | +|.+.... .++..+..++.|++.+|.+||. +.|++|+|
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrD 196 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHAD 196 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSS
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCC
Confidence 987754 333332 356899999942 3 67766432 2244567899999999999995 57999999
Q ss_pred CCCCCeEeCCCCcEEEcccccceec
Q 019568 168 LKPSNVLLDDNMVAHLSDFSIAKLL 192 (339)
Q Consensus 168 i~p~Nil~~~~~~v~l~Dfg~~~~~ 192 (339)
|||+|||++. .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999998753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.5e-18 Score=153.85 Aligned_cols=144 Identities=15% Similarity=0.179 Sum_probs=102.4
Q ss_pred HHhhhhcC---CCCCceeeecCccEEEEEEeCCCcEEEEEEeeccch--------------hhh--------HHHHHHHH
Q 019568 36 ELCQATDE---FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG--------------RAL--------KSFNVECE 90 (339)
Q Consensus 36 ~~~~~~~~---y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~--------------~~~--------~~~~~e~~ 90 (339)
.+....++ |.+.+.||.|++|.||+|...+|+.||||+++.... ... -....|..
T Consensus 86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 44444444 999999999999999999988899999998754210 000 01234666
Q ss_pred HHHhCCCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCC
Q 019568 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP 170 (339)
Q Consensus 91 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p 170 (339)
.|.++.+.++. +...+.. ...++||||++|.+|.++.. . .....++.|++.+|.+|| ..|++|+||||
T Consensus 166 nL~rL~~~gv~-vp~p~~~-~~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH---~~gIVHrDLKp 233 (397)
T 4gyi_A 166 FMKALYEEGFP-VPEPIAQ-SRHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLA---KHGLIHGDFNE 233 (397)
T ss_dssp HHHHHHHTTCS-CCCEEEE-ETTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHH---HTTEECSCCST
T ss_pred HHHHHHhcCCC-CCeeeec-cCceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHH---HCCCcCCCCCH
Confidence 67766443332 1111111 22469999999988865431 1 234568899999999999 99999999999
Q ss_pred CCeEeCCCC----------cEEEccccccee
Q 019568 171 SNVLLDDNM----------VAHLSDFSIAKL 191 (339)
Q Consensus 171 ~Nil~~~~~----------~v~l~Dfg~~~~ 191 (339)
.|||+++++ .+.|+||+.+..
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999998776 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=9.5e-14 Score=120.28 Aligned_cols=148 Identities=15% Similarity=0.082 Sum_probs=115.2
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEE
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 115 (339)
+....+.|++...++.|+.+.||++.. .++.+++|+...........+.+|+++++.+. +..+.++++++...+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 345567899999999999999999976 47899999986532223356888999999984 6678889999988889999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhcc-------------------------------------
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG------------------------------------- 158 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~------------------------------------- 158 (339)
||||++|.+|.+.+.. ......++.+++.++..||.-
T Consensus 88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999876321 112346788999999999930
Q ss_pred -------------------CCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 159 -------------------YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 159 -------------------~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
....++|+|++|.||++++++.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 004599999999999998765667999987653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.4e-12 Score=112.53 Aligned_cols=143 Identities=14% Similarity=0.063 Sum_probs=103.1
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc--eeeEeeeeecCceeE
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN--LIKVISSCSNEEFKA 114 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~ 114 (339)
+......+.+....+.|+.+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+..+
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred HHHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34444566665444566779999998767888999997543 2356778999999985434 556888888878899
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccC-----------------------------------
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY----------------------------------- 159 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~----------------------------------- 159 (339)
+||||++|.++. ... .. ...++.+++..+..||...
T Consensus 92 ~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999999998874 211 11 1356677788888888210
Q ss_pred --------------------CCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 160 --------------------SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 160 --------------------~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998776667999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=6.6e-11 Score=107.19 Aligned_cols=144 Identities=13% Similarity=0.145 Sum_probs=106.2
Q ss_pred CCCCceeeecCccEEEEEEeCCCcEEEEEEee--ccc-hhhhHHHHHHHHHHHhCC--CcceeeEeeeeecC---ceeEE
Q 019568 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFN--LQC-GRALKSFNVECEMMKSIR--HRNLIKVISSCSNE---EFKAL 115 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~l 115 (339)
....+.|+.|.++.+|+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..|+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 445778999999999999874 5688999876 322 123356788999999996 34578888888765 45889
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccC------------------------------------
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY------------------------------------ 159 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~------------------------------------ 159 (339)
||||++|..+.+.. ...++......++.+++.+|..||.-.
T Consensus 119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999997775421 123667778889999999999999410
Q ss_pred -------------------CCCeEecCCCCCCeEeCCCCc--EEEccccccee
Q 019568 160 -------------------SAPIIHCDLKPSNVLLDDNMV--AHLSDFSIAKL 191 (339)
Q Consensus 160 -------------------~~~i~h~di~p~Nil~~~~~~--v~l~Dfg~~~~ 191 (339)
...++|+|+++.||+++.++. +.++||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 157999999999999987653 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.05 E-value=2.7e-10 Score=100.72 Aligned_cols=189 Identities=17% Similarity=0.156 Sum_probs=119.9
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-Ccc--eeeEeeeeecCc---eeEEEEEe
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRN--LIKVISSCSNEE---FKALVLEY 119 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~ 119 (339)
..+.++.|....+|+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..|+||++
T Consensus 24 ~i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eeEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 35678999999999863 56899985433 34567888999999883 322 345555443333 45799999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhcc-----------------------------------------
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG----------------------------------------- 158 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~----------------------------------------- 158 (339)
++|.++.+.... .++......++.+++..+..||..
T Consensus 98 i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999888653321 355666677777777777777730
Q ss_pred --------------CCCCeEecCCCCCCeEeCC--CCcEEEcccccceeccCCCCccccccccCCCCccCCccccC--CC
Q 019568 159 --------------YSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE--GR 220 (339)
Q Consensus 159 --------------~~~~i~h~di~p~Nil~~~--~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~ 220 (339)
....++|+|++|.||++++ ++.+.++||+.+..... ............-.+|+.... ..
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~---~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP---DNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT---THHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh---HHHHHHHHhhccccCHHHHHHHHHH
Confidence 0135899999999999987 55678999998765311 000000000000012221110 00
Q ss_pred CC------------CcchhhHHHHHHHHHHhCCCCCcc
Q 019568 221 VS------------ANGDVYSFGIMLMETFTGKKPTDE 246 (339)
Q Consensus 221 ~~------------~~~DiwslG~il~~ll~g~~P~~~ 246 (339)
|. .-.+.|+++.+++.+.+|..+|-.
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 11 125899999999999999987543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=7.4e-08 Score=83.31 Aligned_cols=135 Identities=16% Similarity=0.078 Sum_probs=97.0
Q ss_pred eeeecCcc-EEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 49 LIGKGGFG-SVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 49 ~ig~g~~~-~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
.+..|..+ .||+.... ++..+++|+.... ....+.+|...|+.+. +-.+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44455554 68988754 4678999986533 3456778999999884 33477888888888899999999999888
Q ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccC----------------------------------------------
Q 019568 126 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY---------------------------------------------- 159 (339)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---------------------------------------------- 159 (339)
.+...... .....+..++...|..||.-.
T Consensus 108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 77654321 122345666667777777300
Q ss_pred ---------CCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 160 ---------SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 160 ---------~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
...++|+|+++.||+++.++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01389999999999999877778999987753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.2e-07 Score=81.99 Aligned_cols=137 Identities=14% Similarity=0.121 Sum_probs=90.8
Q ss_pred CCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCc---ceeeEeeeee-cCceeEEEEEecC
Q 019568 46 ENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHR---NLIKVISSCS-NEEFKALVLEYMP 121 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~ 121 (339)
-.+.++.|....+|+. +..+++|+.. .......+.+|.++|+.+.+. .+.+++.+.. ..+..+++|++++
T Consensus 23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp CEEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 3567888888899987 5778999843 234456788999999999642 3556666663 4566789999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhcc-------------------------------------------
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG------------------------------------------- 158 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~------------------------------------------- 158 (339)
|.++.+..-. .++......++.++...|..||.-
T Consensus 97 G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9887653211 122223333333333333333310
Q ss_pred --------------CCCCeEecCCCCCCeEeCC---CCcE-EEccccccee
Q 019568 159 --------------YSAPIIHCDLKPSNVLLDD---NMVA-HLSDFSIAKL 191 (339)
Q Consensus 159 --------------~~~~i~h~di~p~Nil~~~---~~~v-~l~Dfg~~~~ 191 (339)
....++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1446799999999999987 4554 8999987754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=2e-07 Score=84.04 Aligned_cols=80 Identities=6% Similarity=-0.010 Sum_probs=55.4
Q ss_pred Ccee-eecCccEEEEEEeC-------CCcEEEEEEeeccch--h-hhHHHHHHHHHHHhCCC---cceeeEeeeeecC--
Q 019568 47 NNLI-GKGGFGSVYKARLG-------DGMEVAVKVFNLQCG--R-ALKSFNVECEMMKSIRH---RNLIKVISSCSNE-- 110 (339)
Q Consensus 47 ~~~i-g~g~~~~v~~~~~~-------~~~~v~vK~~~~~~~--~-~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~-- 110 (339)
.+.| +.|....+|+.... ++..+++|+...... . ....+.+|+.+++.+.. -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 78888899988653 267899998654320 0 12467789999888842 3467777776554
Q ss_pred -ceeEEEEEecCCCCHH
Q 019568 111 -EFKALVLEYMPHGSLE 126 (339)
Q Consensus 111 -~~~~lv~e~~~~~~L~ 126 (339)
+..++|||+++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 4568999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=5e-06 Score=74.11 Aligned_cols=138 Identities=17% Similarity=0.145 Sum_probs=77.4
Q ss_pred ceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC--cceeeEeee------eecCceeEEEEEe
Q 019568 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH--RNLIKVISS------CSNEEFKALVLEY 119 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~------~~~~~~~~lv~e~ 119 (339)
+.|+.|..+.+|+....++ .+++|+.... . ..+..|..+++.+.. -.+.+++.. ....+..+++++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987544 5899998753 1 233345666665531 123344431 1345678899999
Q ss_pred cCCCCHH-----------HHH---hh--cCC--c---------cCHHH-------------------------------H
Q 019568 120 MPHGSLE-----------KYL---YS--SNC--I---------LDIFQ-------------------------------R 141 (339)
Q Consensus 120 ~~~~~L~-----------~~i---~~--~~~--~---------~~~~~-------------------------------~ 141 (339)
++|.++. ..+ .. ... + ..+.. +
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986432 111 11 000 0 01110 0
Q ss_pred HHHHHHHHHHHHHhhc----------cCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 142 LNIMIDVASALEYLHF----------GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 142 ~~i~~ql~~~l~~LH~----------~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
..+...+..++..|+. .....++|+|+++.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111123334555541 015789999999999999888899999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=6.1e-06 Score=75.41 Aligned_cols=76 Identities=16% Similarity=0.158 Sum_probs=50.0
Q ss_pred CCceeeecCccEEEEEEeC-CCcEEEEEEeeccch-------hhhHHHHHHHHHHHhCCC--c-ceeeEeeeeecCceeE
Q 019568 46 ENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCG-------RALKSFNVECEMMKSIRH--R-NLIKVISSCSNEEFKA 114 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~ 114 (339)
..+.||.|.++.||++... +++.++||....... .....+..|.++++.+.. + .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 4568999999999999643 478899998653211 123456779999988732 3 34455544 234467
Q ss_pred EEEEecCCC
Q 019568 115 LVLEYMPHG 123 (339)
Q Consensus 115 lv~e~~~~~ 123 (339)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.18 E-value=1.2e-05 Score=66.05 Aligned_cols=103 Identities=14% Similarity=0.042 Sum_probs=70.8
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~ 202 (339)
.+|.+++...+.++++.++|.++.|.+.+|..+-. .+.-...=+.|..|++..+|.|.+.+ ....
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 48999999999999999999999999999888721 11112334567899999999998764 1110
Q ss_pred cccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCC
Q 019568 203 QTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243 (339)
Q Consensus 203 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P 243 (339)
.....+.|||... ...+.+.=|||||+++|..+-...|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122366888763 3456788999999999999976655
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.10 E-value=2.4e-05 Score=68.06 Aligned_cols=79 Identities=16% Similarity=0.150 Sum_probs=59.0
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC---cceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH---RNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e 118 (339)
....-.+.+|.|..+.||+.+..+|+.+++|+...........+..|+..|+.+.. -.+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 45667788999999999999988899999998765544444567889999998842 2344555542 2468999
Q ss_pred ecCCCC
Q 019568 119 YMPHGS 124 (339)
Q Consensus 119 ~~~~~~ 124 (339)
|+++..
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.98 E-value=8.9e-05 Score=65.27 Aligned_cols=77 Identities=14% Similarity=0.139 Sum_probs=61.1
Q ss_pred CCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC---CcceeeEeeeeecCceeEEEEEecC
Q 019568 45 SENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 45 ~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
.-.+.|+.|....+|+... ++..++||+.... ....+..|.+.|+.+. ...+.+++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 4457889999999999987 5778899987643 3456788999998883 3567888888887888999999999
Q ss_pred CCCH
Q 019568 122 HGSL 125 (339)
Q Consensus 122 ~~~L 125 (339)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.93 E-value=4.8e-05 Score=66.65 Aligned_cols=74 Identities=9% Similarity=0.077 Sum_probs=47.2
Q ss_pred CCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEEEEec-C
Q 019568 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYM-P 121 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~ 121 (339)
+.-.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++.... +.-++++||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCC
Confidence 444889999999999998 56899987654222 2233568888887742222 45555433 3346899999 6
Q ss_pred CCCH
Q 019568 122 HGSL 125 (339)
Q Consensus 122 ~~~L 125 (339)
|.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00012 Score=64.66 Aligned_cols=157 Identities=15% Similarity=0.150 Sum_probs=86.0
Q ss_pred eeeHHHHhhhhcCCCC-----CceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc--eeeE
Q 019568 31 TFSYLELCQATDEFSE-----NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN--LIKV 103 (339)
Q Consensus 31 ~~~~~~~~~~~~~y~~-----~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 103 (339)
.++..++.....+|.+ .+.|+.|....+|+....++ .+++|+.... .....+..|..+++.+...+ +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3455666666666765 34556688889999987544 6889988652 12234556888877773222 3333
Q ss_pred eee------eecCceeEEEEEecCCCCHHH-----------H---Hhhc----CCc----cCHHHHHH------------
Q 019568 104 ISS------CSNEEFKALVLEYMPHGSLEK-----------Y---LYSS----NCI----LDIFQRLN------------ 143 (339)
Q Consensus 104 ~~~------~~~~~~~~lv~e~~~~~~L~~-----------~---i~~~----~~~----~~~~~~~~------------ 143 (339)
+.. ....+..+++++|++|..+.. . +... ..+ .....-..
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 322 122356789999998864311 0 1110 000 11100000
Q ss_pred ---HHHHHHHHHHHhhc----cCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 144 ---IMIDVASALEYLHF----GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 144 ---i~~ql~~~l~~LH~----~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
+...+...+..+.. ....+++|+|+++.||++++++.+.++||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00012233333331 113579999999999999887666899998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00028 Score=62.58 Aligned_cols=140 Identities=12% Similarity=0.111 Sum_probs=73.2
Q ss_pred CceeeecCccE-EEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC--cceeeEeeeeecCceeEEEEEecCCC
Q 019568 47 NNLIGKGGFGS-VYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 47 ~~~ig~g~~~~-v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
.+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34565554443 6677654467788887544321 334457777777632 23455666543333 6899999776
Q ss_pred CHHHHHhhcC-------------------------CccCHHHHH-------HHH-------------HHHHHHHHHhh--
Q 019568 124 SLEKYLYSSN-------------------------CILDIFQRL-------NIM-------------IDVASALEYLH-- 156 (339)
Q Consensus 124 ~L~~~i~~~~-------------------------~~~~~~~~~-------~i~-------------~ql~~~l~~LH-- 156 (339)
.+.+.+.... ..+...... .+. ..+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6654332110 011111100 000 01111122220
Q ss_pred -ccCCCCeEecCCCCCCeEeCCC----CcEEEccccccee
Q 019568 157 -FGYSAPIIHCDLKPSNVLLDDN----MVAHLSDFSIAKL 191 (339)
Q Consensus 157 -~~~~~~i~h~di~p~Nil~~~~----~~v~l~Dfg~~~~ 191 (339)
......++|+|+++.||+++.+ +.+.++||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 0115689999999999999874 6899999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00023 Score=65.46 Aligned_cols=75 Identities=11% Similarity=0.092 Sum_probs=46.2
Q ss_pred CCCceeeecCccEEEEEEeCCCcEEEEEEeeccc----hh---hhHHHHHHHHHHHhC---CCcceeeEeeeeecCceeE
Q 019568 45 SENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC----GR---ALKSFNVECEMMKSI---RHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 45 ~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~----~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~ 114 (339)
...+.||.|..+.||++.. ++..++||...... .. .......|.+++..+ ....+.+++.+. .+..+
T Consensus 37 ~~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 37 LVIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp CEEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred eEEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 3467889999999999965 56789999432210 00 012223344444333 234566666665 45678
Q ss_pred EEEEec-CC
Q 019568 115 LVLEYM-PH 122 (339)
Q Consensus 115 lv~e~~-~~ 122 (339)
+||||+ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00054 Score=60.48 Aligned_cols=157 Identities=13% Similarity=0.102 Sum_probs=88.3
Q ss_pred eeeHHHHhhhhcCCCC-----CceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc--eeeE
Q 019568 31 TFSYLELCQATDEFSE-----NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN--LIKV 103 (339)
Q Consensus 31 ~~~~~~~~~~~~~y~~-----~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 103 (339)
.++...+......|.+ ...++ |....+|+....+|+.+++|...... .....+..|..+++.+...+ +.++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence 3444455554444433 34566 88889999877667789999986431 12345666888888774222 3444
Q ss_pred eee-----eecCceeEEEEEecCCCCHH-----HH------H---hh--cC------CccCHHH----------------
Q 019568 104 ISS-----CSNEEFKALVLEYMPHGSLE-----KY------L---YS--SN------CILDIFQ---------------- 140 (339)
Q Consensus 104 ~~~-----~~~~~~~~lv~e~~~~~~L~-----~~------i---~~--~~------~~~~~~~---------------- 140 (339)
+.. ....+..++++++++|.++. .. + .. .. ...+...
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 443 12245567899999875431 11 1 00 00 0111111
Q ss_pred ------HHHHHHHHHHHHHHhhc-cCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 141 ------RLNIMIDVASALEYLHF-GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 141 ------~~~i~~ql~~~l~~LH~-~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
....+..++..+..+-. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01112222222222210 0156789999999999998 4 899999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00011 Score=66.38 Aligned_cols=140 Identities=14% Similarity=0.155 Sum_probs=81.9
Q ss_pred CceeeecCccEEEEEEeC--------CCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCceeEEEE
Q 019568 47 NNLIGKGGFGSVYKARLG--------DGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~--------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 117 (339)
.+.|..|....+|++... ++..+++|+.... ........+|.++++.+. +.-..++++.+.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 466777888889998764 2578999986332 123355568999998884 2223566666654 2999
Q ss_pred EecCCCCHHH--------------HH---hhc----CCccC--HHHHHHHHHHHHH-------------------HHHH-
Q 019568 118 EYMPHGSLEK--------------YL---YSS----NCILD--IFQRLNIMIDVAS-------------------ALEY- 154 (339)
Q Consensus 118 e~~~~~~L~~--------------~i---~~~----~~~~~--~~~~~~i~~ql~~-------------------~l~~- 154 (339)
||++|.+|.. .+ ... .+... ...+..+..++.. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998855421 11 011 11111 3445555544422 1122
Q ss_pred ---hhc-cCCCCeEecCCCCCCeEeCCC----CcEEEccccccee
Q 019568 155 ---LHF-GYSAPIIHCDLKPSNVLLDDN----MVAHLSDFSIAKL 191 (339)
Q Consensus 155 ---LH~-~~~~~i~h~di~p~Nil~~~~----~~v~l~Dfg~~~~ 191 (339)
|.. .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 113579999999999999876 7899999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00012 Score=67.55 Aligned_cols=73 Identities=19% Similarity=0.241 Sum_probs=48.9
Q ss_pred CCceeeecCccEEEEEEeCC--------CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEE
Q 019568 46 ENNLIGKGGFGSVYKARLGD--------GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALV 116 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv 116 (339)
..+.|+.|....+|++...+ +..+++|+..... ....+..|..+++.+...++ .++++.+.+ .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 35677888889999997642 5789999984321 11344568898888843333 566666543 289
Q ss_pred EEecCCCC
Q 019568 117 LEYMPHGS 124 (339)
Q Consensus 117 ~e~~~~~~ 124 (339)
+||++|.+
T Consensus 151 ~e~l~G~~ 158 (429)
T 1nw1_A 151 EEYIPSRP 158 (429)
T ss_dssp ECCCCEEE
T ss_pred EEEeCCcc
Confidence 99998643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00029 Score=65.40 Aligned_cols=75 Identities=15% Similarity=0.153 Sum_probs=48.5
Q ss_pred CCceeeecCccEEEEEEeCC-CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce-eeEeeeeecCceeEEEEEecCCC
Q 019568 46 ENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHG 123 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~ 123 (339)
..+.|+.|....+|++...+ +..+++|+........ -...+|..+++.+...++ .++++.+.. .+|+||++|.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~ 186 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGY 186 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCc
Confidence 34678888889999998754 4789999875432221 122579999999865444 566776632 2599999875
Q ss_pred CH
Q 019568 124 SL 125 (339)
Q Consensus 124 ~L 125 (339)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00018 Score=64.86 Aligned_cols=73 Identities=12% Similarity=0.192 Sum_probs=44.7
Q ss_pred CceeeecCccEEEEEEeCC---------CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc-eeeEeeeeecCceeEEE
Q 019568 47 NNLIGKGGFGSVYKARLGD---------GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN-LIKVISSCSNEEFKALV 116 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 116 (339)
.+.|+.|....+|+....+ +..+++|+...... .......|.++++.+...+ ..++++.+. -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 5577788888999997643 26899998754322 2223466888888884333 345555442 2689
Q ss_pred EEecCCCC
Q 019568 117 LEYMPHGS 124 (339)
Q Consensus 117 ~e~~~~~~ 124 (339)
++|++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0019 Score=57.53 Aligned_cols=66 Identities=11% Similarity=0.125 Sum_probs=43.0
Q ss_pred cCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC---CcceeeEeee------eecCceeEEEEEecCCC
Q 019568 53 GGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR---HRNLIKVISS------CSNEEFKALVLEYMPHG 123 (339)
Q Consensus 53 g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~------~~~~~~~~lv~e~~~~~ 123 (339)
|....||+....+| .+++|+...... ..|+.+++.|. -|.+++++.. ....+..+++|+|++|.
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 33678999987666 899998765431 34666666663 2224444432 23356788999999986
Q ss_pred CH
Q 019568 124 SL 125 (339)
Q Consensus 124 ~L 125 (339)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 55
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0062 Score=55.81 Aligned_cols=75 Identities=12% Similarity=0.216 Sum_probs=48.7
Q ss_pred CCceeeecCccEEEEEEeCC--------CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc-eeeEeeeeecCceeEEE
Q 019568 46 ENNLIGKGGFGSVYKARLGD--------GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN-LIKVISSCSNEEFKALV 116 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 116 (339)
..+.+..|....+|+....+ +..+++++..... ...-+..+|..+++.+...+ ..++++.+. -++|
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 35667778888999997642 5889999865432 22233456888888884222 345555433 2689
Q ss_pred EEecCCCCH
Q 019568 117 LEYMPHGSL 125 (339)
Q Consensus 117 ~e~~~~~~L 125 (339)
++|++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.28 E-value=0.011 Score=53.78 Aligned_cols=30 Identities=27% Similarity=0.392 Sum_probs=25.6
Q ss_pred CeEecCCCCCCeEe------CCCCcEEEccccccee
Q 019568 162 PIIHCDLKPSNVLL------DDNMVAHLSDFSIAKL 191 (339)
Q Consensus 162 ~i~h~di~p~Nil~------~~~~~v~l~Dfg~~~~ 191 (339)
.+||+|+.+.||++ ++++.+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.87 E-value=0.8 Score=37.35 Aligned_cols=121 Identities=10% Similarity=0.219 Sum_probs=79.1
Q ss_pred CCcceeeEeeeeecCceeEEEEEecC-CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeE
Q 019568 96 RHRNLIKVISSCSNEEFKALVLEYMP-HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVL 174 (339)
Q Consensus 96 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil 174 (339)
.||+.++. .+-...+.+.+.++.-+ +.++.. + +..+....+.++.+|+....+++ .-+|--++|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence 56777765 45555555545444433 222222 2 24778888999999998885544 3467789999999
Q ss_pred eCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhh-HHHHHHHHHHhCCCCCcccccCcc
Q 019568 175 LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY-SFGIMLMETFTGKKPTDEIFNGEM 252 (339)
Q Consensus 175 ~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw-slG~il~~ll~g~~P~~~~~~~~~ 252 (339)
++.++.+++.--|+...+ +|. .. ...|.| ..=|++..++++++.|+..-++..
T Consensus 112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~-~ee~fL~qyKAliiall~~K~~Fe~l~~G~l 165 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PV-SEAEFLTRYKALVICAFNEKQSFDALVEGNL 165 (215)
T ss_dssp ECTTSCEEESCCEETTTB-------------------SCC-----CC-CHHHHHHHHHHHHHHHHCTTCCHHHHHHSCG
T ss_pred EcCCCCEEEEEccCccCC-------------------CCC-----CC-CHHHHHHHHHHHHHHHHcCCCCHHHHHcChH
Confidence 999999999876654322 221 01 122333 477889999999999988765544
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.27 E-value=2.2 Score=34.82 Aligned_cols=116 Identities=11% Similarity=0.101 Sum_probs=75.3
Q ss_pred CCcceeeEeeeeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHH-HhhccCCCCeEecCCCCCCeE
Q 019568 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE-YLHFGYSAPIIHCDLKPSNVL 174 (339)
Q Consensus 96 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~-~LH~~~~~~i~h~di~p~Nil 174 (339)
.||++ -..+-.+.+.+.+.++.-++..-...++ ..+....+.++.+|+.... +++ .-+|--++|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 56777 3334455666666666543332223332 4678888988888888776 444 4467789999999
Q ss_pred eCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhh-HHHHHHHHHHhCCCCCccc
Q 019568 175 LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY-SFGIMLMETFTGKKPTDEI 247 (339)
Q Consensus 175 ~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw-slG~il~~ll~g~~P~~~~ 247 (339)
++.++.+++.-.|+-..+ +|.- ....|.| +.=|++..++.+++.|+..
T Consensus 117 f~~~~~p~i~hRGi~~~l-------------------pP~e------~~ee~fl~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESL-------------------PPDE------WDDERLLREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp ECTTCCEEESCCEETTTB-------------------SSCS------CCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred EeCCCcEEEEEcCCcccC-------------------CCCC------CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 999999999877754322 2211 0122333 4678888999998887765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 339 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 2e-70
Identities = 70/288 (24%), Positives = 126/288 (43%), Gaps = 26/288 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRN 99
+ + IG G FG+VYK + +VAVK+ N+ + L++F E +++ RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ + + A+V ++ SL +L+ ++ + ++I A ++YLH
Sbjct: 66 ILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY---G 216
IIH DLK +N+ L +++ + DF +A + S Q +I +MAPE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
+ S DVY+FGI+L E TG+ P I N + + +L +V
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------- 234
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324
+ C + L C + ++R +I+ + + SL
Sbjct: 235 --------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 8e-62
Identities = 63/277 (22%), Positives = 118/277 (42%), Gaps = 26/277 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+ +G G FG V+ +VAVK Q + +F E +MK ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYS 160
++ + + E ++ EYM +GSL +L + + I L I + L++ +A + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
IH DL+ +N+L+ D + ++DF +A+L+ +++ + I + APE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280
+ DV+SFGI+L E T + +++ +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM----------------- 229
Query: 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + C ++ L C E PE R + L
Sbjct: 230 --VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 1e-61
Identities = 69/315 (21%), Positives = 133/315 (42%), Gaps = 45/315 (14%)
Query: 31 TFSYLELCQATDEFSEN---------NLIGKGGFGSVYKARL----GDGMEVAVKVFNLQ 77
F++ + +A EF++ +IG G FG V L + VA+K
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 78 -CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
+ + F E +M H N+I + + ++ E+M +GSL+ +L ++
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ Q + ++ +A+ ++YL +H DL N+L++ N+V +SDF +++ L +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 197 QSMTQTQT---FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
T T I + APE + + ++ DV+S+GI++ E + G++P ++ N ++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKE 312
+ LP C S + L + C + R +
Sbjct: 243 INAIEQDYRLPPP--------------------MDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 313 IVKKLLKIRDSLLRN 327
IV L D ++RN
Sbjct: 283 IVNTL----DKMIRN 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-61
Identities = 68/282 (24%), Positives = 120/282 (42%), Gaps = 24/282 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
E + IG G FG V+ + +VA+K + + F E E+M + H L+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ C + LV E+M HG L YL + + L + +DV + YL A
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
+IH DL N L+ +N V +SDF + + ++ + + + T + + +PE R
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRY 179
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
S+ DV+SFG+++ E F+ K E + ++ + + L S
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKPRLASTH--- 230
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V+ + C E PE R ++++L +I +S
Sbjct: 231 ----------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-60
Identities = 60/279 (21%), Positives = 121/279 (43%), Gaps = 24/279 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+ + +G G FG V + +VA+K+ + + F E ++M ++ H L+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ C+ + ++ EYM +G L YL Q L + DV A+EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
+H DL N L++D V +SDF +++ ++ +D+ + + + + PE +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
S+ D+++FG+++ E ++ K E F T +H +L S++
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------YRPHLASEK--- 229
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
V+ + +C E ++R K ++ +L +
Sbjct: 230 ----------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-59
Identities = 65/302 (21%), Positives = 120/302 (39%), Gaps = 31/302 (10%)
Query: 36 ELCQATDEFS-ENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQCGRA-LKSFNVECE 90
+L D + +G G FGSV + ++VA+KV +A + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
+M + + ++++I C E LV+E G L K+L + + ++ V+
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIG 209
++YL +H DL NVLL + A +SDF ++K L +D T +
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLE 268
+ APE + S+ DV+S+G+ + E + G+KP ++ E+ +
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP--- 234
Query: 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNV 328
+C ++ L C + E R + + +++ SL V
Sbjct: 235 -----------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
Query: 329 GG 330
G
Sbjct: 278 EG 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-58
Identities = 75/282 (26%), Positives = 115/282 (40%), Gaps = 32/282 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
E IGKG FG V G +VAVK ++F E +M +RH NL+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLV 63
Query: 102 KVISSCSNEEFK-ALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGY 159
+++ E+ +V EYM GSL YL S +L L +DV A+EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
+H DL NVL+ ++ VA +SDF + K S TQ + + APE RE
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREK 175
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
+ S DV+SFGI+L E ++ + + + +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---------------- 219
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
A + C V+ + C R + ++ ++L I+
Sbjct: 220 ---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 7e-58
Identities = 63/277 (22%), Positives = 115/277 (41%), Gaps = 26/277 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+ +G+G FG V+ VA+K + ++F E ++MK +RH L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF-QRLNIMIDVASALEYLHFGYS 160
++ + S E +V EYM GSL +L Q +++ +AS + Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
+H DL+ +N+L+ +N+V ++DF +A+ L+ +++ + I + APE GR
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280
+ DV+SFGI+L E T + L +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------- 233
Query: 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+C + +L C + PE+R + + L
Sbjct: 234 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-57
Identities = 62/306 (20%), Positives = 125/306 (40%), Gaps = 34/306 (11%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKS-FNVECEMM 92
+EL D+F + + +G G G V+K G+ +A K+ +L+ A+++ E +++
Sbjct: 1 MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
++ + ++ ++ +E+M GSL++ L + + + I V L
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
YL I+H D+KPSN+L++ L DF ++ L SM + T YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMS 171
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH------WVNDWLPIST 266
PE + S D++S G+ L+E G+ P E+ L + P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 267 LEVVDANLLSQEDIHFVAKEQCVSFVFN-----------------LAMACAVESPEQRIN 309
+ + +A + + ++ N C +++P +R +
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 310 AKEIVK 315
K+++
Sbjct: 292 LKQLMV 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-57
Identities = 62/277 (22%), Positives = 109/277 (39%), Gaps = 25/277 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHRN 99
+++ +G+G +G V A VAVK+ ++ + ++ E + K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++K + L LEY G L + + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 220 RVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
A DV+S GI+L G+ P D+ + W ++ + +D+ L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL--- 237
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
L VE+P RI +I K
Sbjct: 238 ---------------ALLHKILVENPSARITIPDIKK 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 8e-57
Identities = 64/289 (22%), Positives = 125/289 (43%), Gaps = 29/289 (10%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDG-----MEVAVKVFNLQCG-RALKSFNVECEMMKSI 95
+ +IG G FG VYK L + VA+K + F E +M
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H N+I++ S + ++ EYM +G+L+K+L + + Q + ++ +A+ ++YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPE 214
+ +H DL N+L++ N+V +SDF ++++L + + T + I + APE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
+ ++ DV+SFGI++ E T + + +K + + + ++ A
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA-- 241
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
++ L M C + +R +IV L K+ +
Sbjct: 242 -----------------IYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-56
Identities = 59/281 (20%), Positives = 110/281 (39%), Gaps = 29/281 (10%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
D + +G G FG VYKA+ + A KV + + L+ + VE +++ S H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++K++ + E +++E+ G+++ + L Q + AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY---- 215
IIH DLK N+L + L+DF ++ Q +MAPE
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT--PYWMAPEVVMCE 185
Query: 216 -GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
++ DV+S GI L+E + P E+ + LK ++ ++ +N
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ C ++ + R ++++
Sbjct: 246 K------------------DFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (461), Expect = 5e-56
Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 26/281 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
+ + + +G G +G VY+ + VAVK ++ F E +MK I+H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGY 159
++++ C+ E ++ E+M +G+L YL N + L + ++SA+EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
IH DL N L+ +N + ++DF +++L+ G D I + APE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
+ S DV++FG++L E T + + ++D
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------------EKD 232
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
E C V+ L AC +P R + EI + +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 7e-56
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 22/292 (7%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IGKG FG V++ + G EVAVK+F+ + R+ E +RH N++ I++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 110 EEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGYS 160
+ LV +Y HGSL YL + + + + + AS L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT--QTQTFATIGYMAPEY--- 215
I H DLK N+L+ N ++D +A ++ T YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 216 ---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN-DWLPISTLEVVD 271
+ D+Y+ G++ E + ++ V D +VV
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
L + + + + + C + R+ A I K L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-55
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 30/288 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQCGRA-LKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + F E +MK H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 102 KVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E +VL YM HG L ++ + + + + VA +++L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED--QSMTQTQTFATIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T + +MA E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P N + + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP------------ 256
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
E C ++ + + C E R + E+V ++ I + +
Sbjct: 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-55
Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 32/284 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHR 98
+++ IG G +G K R DG + K + + E +++ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 99 NLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALE 153
N+++ + L V+EY G L + LD L +M + AL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 154 YLHF--GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
H ++H DLKP+NV LD L DF +A++L D S + T YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVG-TPYYM 181
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271
+PE + D++S G +L E P E+ K + I
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP------ 235
Query: 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ + + R + +EI++
Sbjct: 236 --------------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-55
Identities = 62/279 (22%), Positives = 111/279 (39%), Gaps = 32/279 (11%)
Query: 46 ENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNL 100
E+ +G G FG+V K VAVK+ + E +M+ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + + ++ V+ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L ++ + + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ S+ DV+SFG+++ E F+ G+KP + E+T + +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP------------- 232
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
C +++L C E R + +L
Sbjct: 233 -------AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 1e-54
Identities = 65/283 (22%), Positives = 104/283 (36%), Gaps = 38/283 (13%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRALKSFNVECEMMKSIR 96
FS+ IG G FG+VY AR + + VA+K + Q + E ++ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N I+ E LV+EY + + L + + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEY 215
S +IH D+K N+LL + + L DF A + M +F T +MAPE
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-------MAPANSFVGTPYWMAPEV 182
Query: 216 ---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
EG+ DV+S GI +E K P + N+ + +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS------ 236
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ N +C + P+ R ++ ++K
Sbjct: 237 -------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-54
Identities = 59/306 (19%), Positives = 108/306 (35%), Gaps = 51/306 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRA-LKSFNVECEMMKS 94
+ ++G G FG V A G ++VAVK+ + + ++ E +MM
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 95 I-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-------------------- 133
+ H N++ ++ +C+ L+ EY +G L YL S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 134 --CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191
+L L VA +E+L +H DL NVL+ V + DF +A+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
++ + + + + +MAPE EG + DV+S+GI+L E F+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK 311
+ Q ++ + +C +R +
Sbjct: 274 ANFYKLI------------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 312 EIVKKL 317
+ L
Sbjct: 316 NLTSFL 321
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-54
Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 35/278 (12%)
Query: 47 NNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKV 103
+ IG+G F +VYK +EVA + + F E EM+K ++H N+++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 104 ISSC----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
S ++ LV E M G+L+ YL ++ I + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 160 SAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGR 217
+ PIIH DLK N+ + + D +A L + + T +MAPE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFMAPEM-Y 185
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
E + + DVY+FG+ ++E T + P E N + + P S +V +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK-- 243
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ C ++ ++R + K+++
Sbjct: 244 ----------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-53
Identities = 62/278 (22%), Positives = 115/278 (41%), Gaps = 33/278 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRH 97
++F +GKG FG+VY AR +A+KV L+ E E+ +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N++++ + L+LEY P G++ + L + D + + ++A+AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +IH D+KP N+LL ++DF + ++ T+ Y+ PE
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIE 177
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
D++S G++ E GK P F + + IS +E + +++
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR----ISRVEFTFPDFVTE 229
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+++ +P QR +E+++
Sbjct: 230 GARDLISR-------------LLKHNPSQRPMLREVLE 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 1e-53
Identities = 68/313 (21%), Positives = 120/313 (38%), Gaps = 57/313 (18%)
Query: 43 EFSENNL-----IGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECE 90
E+ NN+ IG+G FG V++AR VAVK+ + F E
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------------- 133
+M + N++K++ C+ + L+ EYM +G L ++L S +
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 134 ------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187
L ++L I VA+ + YL +H DL N L+ +NMV ++DF
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 247
+++ + D I +M PE R + DV+++G++L E F+
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 248 FNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR 307
E + + + + E C ++NL C + P R
Sbjct: 246 MAHEEVIYYVRDGNIL-------------------ACPENCPLELYNLMRLCWSKLPADR 286
Query: 308 INAKEIVKKLLKI 320
+ I + L ++
Sbjct: 287 PSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-53
Identities = 59/304 (19%), Positives = 112/304 (36%), Gaps = 46/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRA-LKSFNVECEMMKS 94
+ S +G G FG V +A M VAVK+ ++ E +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 95 I-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-----------------NCIL 136
+ H N++ ++ +C+ ++ EY +G L +L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
D+ L+ VA + +L S IH DL N+LL + + DF +A+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
+ + + +MAPE + DV+S+GI L E F+ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
+ +E ++ E + ++++ C P +R K+IV+
Sbjct: 260 MI------------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 317 LLKI 320
+ K
Sbjct: 302 IEKQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-53
Identities = 69/288 (23%), Positives = 99/288 (34%), Gaps = 30/288 (10%)
Query: 42 DEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFN---LQCGRALKSFNVECEMMKS 94
+ +G G FG V + G + VAVK L A+ F E M S
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ HRNLI++ K +V E P GSL L + + VA + Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAP 213
L S IH DL N+LL + + DF + + L D + + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273
E + S D + FG+ L E FT + NG L
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229
Query: 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
E E C ++N+ + C PE R + LL+ +
Sbjct: 230 ----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-53
Identities = 65/276 (23%), Positives = 110/276 (39%), Gaps = 26/276 (9%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
+++ IG+G G+VY A + G EVA++ NLQ + E +M+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ + S + +V+EY+ GSL + + D Q + + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH--- 133
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
S +IH D+K N+LL + L+DF + E + T +MAPE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRK 191
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
D++S GIM +E G+ P N + E + A
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR---- 247
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ C E+R +AKE+++
Sbjct: 248 --------------DFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-52
Identities = 70/307 (22%), Positives = 127/307 (41%), Gaps = 45/307 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSI-R 96
++ ++IG+G FG V KAR+ G M+ A+K + + F E E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQR 141
H N+I ++ +C + + L +EY PHG+L +L S + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 142 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201
L+ DVA ++YL IH DL N+L+ +N VA ++DF +++ G++ + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261
T + +MA E + N DV+S+G++L E + + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243
Query: 262 LPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
C V++L C E P +R + +I+ L ++
Sbjct: 244 RL-------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
Query: 322 DSLLRNV 328
+ V
Sbjct: 285 EERKTYV 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-52
Identities = 65/279 (23%), Positives = 111/279 (39%), Gaps = 29/279 (10%)
Query: 39 QATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKS 94
+ ++F ++G+G F +V AR L E A+K+ + + E ++M
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ H +K+ + ++E L Y +G L KY+ D ++ SALEY
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
LH IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
E + D+++ G ++ + G P F + I LE
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQK----IIKLEYDFPEK 232
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
+ V K V +R+ +E+
Sbjct: 233 FFPKARDLVEK-------------LLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (441), Expect = 3e-52
Identities = 51/277 (18%), Positives = 100/277 (36%), Gaps = 26/277 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
D + + +G G FG V++ G A K ++ E + M +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ + + ++ ++ E+M G L + + + + + + M V L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142
Query: 161 APIIHCDLKPSNVLL--DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+H DLKP N++ + L DF + L + T T + APE
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG---TAEFAAPEVAEG 199
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
V D++S G++ +G P + E DW + + +S++
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF----SGISED 255
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ K + P R+ + ++
Sbjct: 256 GKDFIRK-------------LLLADPNTRMTIHQALE 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-52
Identities = 66/286 (23%), Positives = 118/286 (41%), Gaps = 31/286 (10%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKV-----FNLQCGRALKSFNVECEMMKSI 95
EF + ++G G FG+VYK + +G +V + V +A K E +M S+
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 216 GREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
+ DV+S+G+ + E T G KP D I E++ + LP
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP--------- 235
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C V+ + + C + + R +E++ + K+
Sbjct: 236 -----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 168 bits (427), Expect = 5e-51
Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 31/292 (10%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR---ALKSFNVECEMMKSIR 96
+D + ++G GG V+ AR L +VAVKV R F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 97 HRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
H ++ V + E +V+EY+ +L +++ + + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYM 211
+ H IIH D+KP+N+++ + DF IA+ + S+TQT T Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271
+PE R V A DVYS G +L E TG+ P + +H D +P S
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH--- 238
Query: 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-NAKEIVKKLLKIRD 322
LS + V K ++PE R A E+ L+++ +
Sbjct: 239 -EGLSADLDAVVLK-------------ALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (433), Expect = 5e-51
Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 26/277 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
D + +G G FG V++ G K N + E +M + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
I + + ++ L+LE++ G L + + + + + +N M L+++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145
Query: 161 APIIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I+H D+KP N++ + + DF +A L ++ T AT + APE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDR 202
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
V D+++ G++ +G P + E DW + +S E
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA----FSSVSPE 258
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ + P +R+ + ++
Sbjct: 259 AKDFIKN-------------LLQKEPRKRLTVHDALE 282
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 7e-51
Identities = 57/303 (18%), Positives = 119/303 (39%), Gaps = 38/303 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQCG-RALKSFNVECEMMKS 94
++ + + +G+G FG VY+ VA+K N R F E +MK
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCILDIFQRLNIM 145
++++++ S + +++E M G L+ YL + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 265
+ +M+PE ++G + DV+SFG++L E T + + + E L+ + L
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD- 255
Query: 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ C +F L C +P+ R + EI+ + + +
Sbjct: 256 ------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 326 RNV 328
R V
Sbjct: 298 REV 300
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-49
Identities = 61/287 (21%), Positives = 114/287 (39%), Gaps = 31/287 (10%)
Query: 42 DEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIR 96
+ IG+G FG V++ + VA+K +++ F E M+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H +++K+I + E +++E G L +L LD+ + +++AL YL
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
S +H D+ NVL+ N L DF +++ + + ++ I +MAPE
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 181
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
R ++ DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---------- 231
Query: 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
C +++L C P +R E+ +L I +
Sbjct: 232 ----------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-48
Identities = 72/304 (23%), Positives = 118/304 (38%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVYKARL--------GDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D +G+G FG V A +VAVK+ + L E EMM
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCIL 136
K I +H+N+I ++ +C+ + +++EY G+L +YL ++ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
++ VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG++L E FT E K
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
C + ++ + C P QR K++V+
Sbjct: 250 LKEGHRM-------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 317 LLKI 320
L +I
Sbjct: 291 LDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-46
Identities = 54/295 (18%), Positives = 117/295 (39%), Gaps = 33/295 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
+++ +G+G FG V++ K ++ G E ++ RHRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ + S + E ++ E++ + + + +S L+ + ++ + V AL++LH S
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---S 120
Query: 161 APIIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I H D++P N++ + + +F A+ L F Y APE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQH 177
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
VS D++S G ++ +G P + +++ +N + +S E
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAE-TNQQIIENIMNAEYTFDEEAFKE---ISIE 233
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV------KKLLKIRDSLLRN 327
+ FV + V+ + R+ A E + +K+ ++ ++R
Sbjct: 234 AMDFVDR-------------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-45
Identities = 59/306 (19%), Positives = 108/306 (35%), Gaps = 45/306 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKAR------LGDGMEVAVKVFNLQCGRA-LKSFNVECEMMKS 94
D +G+G FG V +A VAVK+ + ++ E +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 95 IRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNC---------------ILD 137
I H + + + L ++E+ G+L YL S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
+ + VA +E+L S IH DL N+LL + V + DF +A+ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
+ + + +MAPE + + DV+SFG++L E F+ +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 258 VNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+ +E A + ++ + C P QR E+V+ L
Sbjct: 250 L------------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 318 LKIRDS 323
+ +
Sbjct: 292 GNLLQA 297
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-44
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 32/280 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECE-MMKSIR 96
++F + ++GKG FG V+ A A+K + ++ VE + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H L + + +E V+EY+ G L ++ S + D+ + ++ L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
S I++ DLK N+LLD + ++DF + K + D T Y+APE
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEIL 175
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
+ + + D +SFG++L E G+ P + E D L
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYP-------RWLE 227
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
+E + K V PE+R+ + +++
Sbjct: 228 KEAKDLLVK-------------LFVREPEKRLGVRGDIRQ 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (379), Expect = 6e-44
Identities = 62/291 (21%), Positives = 112/291 (38%), Gaps = 41/291 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRAL---------KSFNVECEM 91
+ + ++G+G V + E AVK+ ++ G + ++ E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 92 MKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
++ + H N+I++ + F LV + M G L YL + L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
+ LH I+H DLKP N+LLDD+M L+DF + L D + T Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175
Query: 211 MAPEYGREGRVSANG------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+APE + D++S G+++ G P + L+ ++
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQF 234
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ E D S V++ V P++R A+E +
Sbjct: 235 GSPEWDD---YSDTVKDLVSR-------------FLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 7e-44
Identities = 48/277 (17%), Positives = 98/277 (35%), Gaps = 23/277 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHR 98
D + +++G G F V A VA+K + S E ++ I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++ + + L+++ + G L + ++ V A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
LD++ +SDF ++K+ ED + T GY+APE +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D +S G++ G P + + ++ + ++ S + +S
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW----DDISDS 239
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ + PE+R ++ ++
Sbjct: 240 AKDFIRH-------------LMEKDPEKRFTCEQALQ 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (378), Expect = 3e-43
Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 22/234 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRH 97
+F +G G FG V+ R +G A+KV + + ++ N E M+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
+I++ + + + ++++Y+ G L + +V ALEYLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH- 121
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S II+ DLKP N+LLD N ++DF AK + ++ T Y+APE
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVS 174
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKHWVNDWL 262
+ + D +SFGI++ E G P ++I N E+ + N+ +
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-42
Identities = 49/276 (17%), Positives = 101/276 (36%), Gaps = 32/276 (11%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
++G G G V + + A+K+ C +A + + ++ + ++++++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL---HWRASQCPHIVRIVDVY 74
Query: 108 ----SNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ + +V+E + G L + + + IM + A++YLH S
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 163 IIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
I H D+KP N+L N + L+DF AK + T T Y+APE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPE 188
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
+ + D++S G+++ G P ++ + + + +S+E
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ P QR+ E +
Sbjct: 249 KMLIRN-------------LLKTEPTQRMTITEFMN 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (363), Expect = 2e-41
Identities = 55/284 (19%), Positives = 114/284 (40%), Gaps = 15/284 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRN 99
+++ IG+G +G VYKA+ G A+K L+ + E ++K ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++K+ ++ LV E++ L+K L L+ + ++ + + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
++H DLKP N+L++ ++DF +A+ G +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW-------VNDWLPISTLEVVDA 272
+ S D++S G + E G + + ++ + +W ++ L D
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 273 NLLSQEDIHFVAKEQCVSFVF-NLAMACAVESPEQRINAKEIVK 315
N E + + + + + +L P QRI AK+ ++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-41
Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 29/291 (9%)
Query: 44 FSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L G VA+K + + N E ++M+ + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 103 VISSC------SNEEFKALVLEYMPHGSLE--KYLYSSNCILDIFQRLNIMIDVASALEY 154
+ +E + LVL+Y+P ++ + L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 155 LHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
+H S I H D+KP N+LLD D V L DF AK LV + +++ + Y AP
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAP 191
Query: 214 -EYGREGRVSANGDVYSFGIMLMETFTGKKP------TDEIFNGEMTLKHWVNDWLPIST 266
+++ DV+S G +L E G+ D++ L + +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 267 LEVVDANL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ + V + + L +P R+ E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-41
Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 28/286 (9%)
Query: 48 NLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC-----GRALKSFNVECEMMKSIRHRNLI 101
+ +G+G F +VYKAR VA+K L ++ E ++++ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ + ++ +LV ++M + ++ +L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
I+H DLKP+N+LLD+N V L+DF +AK + T T Y APE R+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 222 -SANGDVYSFGIMLMETFTGKKP---------TDEIFN--GEMTLKHWVNDWLPISTLEV 269
D+++ G +L E IF G T + W + +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ I A + + + + +P RI A + +K
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLI----QGLFLFNPCARITATQALK 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (366), Expect = 4e-41
Identities = 53/238 (22%), Positives = 99/238 (41%), Gaps = 24/238 (10%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL------QCGRALKSFNVECEMMKS 94
++FS + +IG+GGFG VY R G A+K + Q + + ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
++ + + + + +L+ M G L +L + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+H + +++ DLKP+N+LLD++ +SD +A + T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPE 175
Query: 215 YGREGR-VSANGDVYSFGIMLMETFTGKKPTD--------EIFNGEMTLKHWVNDWLP 263
++G ++ D +S G ML + G P EI +T+ + D
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-41
Identities = 64/298 (21%), Positives = 119/298 (39%), Gaps = 26/298 (8%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKSFNVECE---- 90
LC+A ++ IG+G +G V+KAR G VA+K +Q G + E
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 91 -MMKSIRHRNLIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
+++ H N++++ C+ LV E++ + ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
M + L++LH S ++H DLKP N+L+ + L+DF +A++ M T
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
T+ Y APE + + D++S G + E F K + + L ++
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLP 234
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFV-------FNLAMACAVESPEQRINAKEIVK 315
+ L ++ H + + FV +L + C +P +RI+A +
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-40
Identities = 60/286 (20%), Positives = 109/286 (38%), Gaps = 17/286 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ + S+ + + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-YGR 217
S ++H DLKP N+L++ L+DF +A+ ++ T + Y APE
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT--LWYRAPEILLG 176
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
S D++S G + E T + + + + P + ++
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 278 EDIHFVAKEQCVSFVF--------NLAMACAVESPEQRINAKEIVK 315
+ Q S V +L P +RI+AK +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-40
Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 35/285 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL------QCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + G + + E ++K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L + + L + + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270
+APE + D++S G++ +G P F G+ + N E
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 238
Query: 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ S F+ + V+ P++R+ ++ ++
Sbjct: 239 YFSNTSALAKDFIRR-------------LLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 7e-40
Identities = 56/291 (19%), Positives = 109/291 (37%), Gaps = 19/291 (6%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHR 98
++ + IG+G +G V A + + VA+K + + + E +++ RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLH 156
N+I + + + Y+ + LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEY 215
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 216 GREGRVSAN-GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
+ D++S G +L E + + + P NL
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 275 LSQEDIHFVAKEQCVSF----------VFNLAMACAVESPEQRINAKEIVK 315
++ + + + V + +L +P +RI ++ +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 1e-39
Identities = 53/281 (18%), Positives = 94/281 (33%), Gaps = 27/281 (9%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
IG G FG +Y + G EVA+K+ ++ ++E ++ K ++ I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +++ + SLE + + L + + S +EY+H S IH D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 168 LKPSNVL---LDDNMVAHLSDFSIAKLLVGED-----QSMTQTQTFATIGYMAPEYGREG 219
+KP N L + ++ DF +AK T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
S D+ S G +LM G P + K+ +ST V E
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
++ C + + + + + +
Sbjct: 249 ATYLNF-------------CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-38
Identities = 60/281 (21%), Positives = 97/281 (34%), Gaps = 51/281 (18%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC------GRALKSFNVECEMMKSIR--HRN 99
L+G GGFGSVY + D + VA+K +E ++K +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I+++ + L+LE + L + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 160 SAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ ++H D+K N+L+D + L DF LL + T T Y PE+ R
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRY 183
Query: 219 GRV-SANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
R + V+S GI+L + G P +EI G++ + V
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------------- 227
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
S E H + C P R +EI
Sbjct: 228 -SSECQHLIRW-------------CLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 8e-37
Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRA---LKSFNVECEMMKSIRH 97
++F L+GKG FG V R G A+K+ + A + E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + + + V+EY G L +L S + + ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +++ D+K N++LD + ++DF + K + + +M T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-36
Identities = 52/286 (18%), Positives = 110/286 (38%), Gaps = 17/286 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHR 98
++ + IG+G +G+V+KA+ VA+K L S E ++K ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++++ +++ LV E+ + + + + D + + + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS- 119
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
++H DLKP N+L++ N L++F +A+ G +
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN--------DWLPISTLEVV 270
S + D++S G + E +P + + LK W ++ L
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 271 DANLLSQEDIHFVAKEQCVSFVF-NLAMACAVESPEQRINAKEIVK 315
+ V ++ +L +P QRI+A+E ++
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 59/304 (19%), Positives = 114/304 (37%), Gaps = 29/304 (9%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMK 93
C ++ + IG+G FG V+KAR G +VA+K ++ + E ++++
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 94 SIRHRNLIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 145
++H N++ +I C + LV ++ H + + +M
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT- 204
+ + L Y+H I+H D+K +NVL+ + V L+DF +A+ S T
Sbjct: 124 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 205 -FATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTD-----------EIFNGE 251
T+ Y PE R D++ G ++ E +T G
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK 311
+T + W N ++ ++ + + +L V P QRI++
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 312 EIVK 315
+ +
Sbjct: 301 DALN 304
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 6e-36
Identities = 41/287 (14%), Positives = 83/287 (28%), Gaps = 29/287 (10%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
IG+G FG +++ L + +VA+K + E K + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +++ + SLE L + + + ++ +H +++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 168 LKPSNVLLDDNMVAH-----LSDFSIAKLLVGEDQSMTQTQTFA-----TIGYMAPEYGR 217
+KP N L+ + + DF + K T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
S D+ + G + M G P + K+ ST +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324
E + + + + + K+ + L
Sbjct: 247 E-------------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 1e-34
Identities = 48/230 (20%), Positives = 92/230 (40%), Gaps = 20/230 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRH 97
D+F +G G FG V + G A+K+ + + + ++ E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+ G + +L + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G ++ T +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE---MTLKHWVNDWLPI 264
+ D ++ G+++ E G P F + + V+ +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVRF 257
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-34
Identities = 67/307 (21%), Positives = 110/307 (35%), Gaps = 33/307 (10%)
Query: 32 FSYLELCQATDEFSEN----NLIGKGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRALKS 84
F E+ + E +G G +G+V A G +VA+K Q K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 85 FNVECEMMKSIRHRNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNCILDI 138
E ++K +RH N+I ++ + +E LV+ +M G+ L L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGE 120
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
+ ++ + L Y+H +A IIH DLKP N+ ++++ + DF +A+ + S
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADS 173
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFN 249
R + D++S G ++ E TGK EI
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 250 GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVF-NLAMACAVESPEQRI 308
T L + L E F + S + NL V EQR+
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 309 NAKEIVK 315
A E +
Sbjct: 294 TAGEALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-34
Identities = 61/290 (21%), Positives = 110/290 (37%), Gaps = 34/290 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFN----LQCGRALKSFNVECEMMK 93
+ F ++G G +G V+ R G A+KV +Q + + E ++++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 94 SIRHR-NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
IR L+ + + E L+L+Y+ G L +L F + I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
L + II+ D+K N+LLD N L+DF ++K V ++ TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMA 198
Query: 213 PEYGREGRVSANG--DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270
P+ R G + D +S G+++ E TG P F + I E
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISRRILKSEPP 254
Query: 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-NAKEIVKKLLK 319
+S + + ++ P++R+ ++ +
Sbjct: 255 YPQEMSALAKDLIQR-------------LLMKDPKKRLGCGPRDADEIKE 291
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-32
Identities = 68/307 (22%), Positives = 116/307 (37%), Gaps = 31/307 (10%)
Query: 31 TFSYLELCQATDEFSEN----NLIGKGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E + +G G +GSV A G+ VAVK + Q K
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 84 SFNVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIF 139
E ++K ++H N+I ++ + EF + L G+ + L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDD 121
Query: 140 QRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199
++ + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 173
Query: 200 TQTQTFATIGYMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFN 249
T AT Y APE + D++S G ++ E TG+ I
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 250 GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVS-FVFNLAMACAVESPEQRI 308
T + + + +L ++F + +L V ++RI
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 309 NAKEIVK 315
A + +
Sbjct: 294 TAAQALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (303), Expect = 2e-32
Identities = 52/297 (17%), Positives = 116/297 (39%), Gaps = 36/297 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRN 99
D++ +G+G + V++A + + +V VK+ K E ++++++R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPN 91
Query: 100 LIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
+I + + + ALV E++ + ++ + L + M ++ AL+Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH- 146
Query: 158 GYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
S I+H D+KP NV++D ++ L D+ +A+ A+ + PE
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELL 201
Query: 217 REGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH--------WVNDWLPISTL 267
+ + + D++S G ML K+P + L + D++ +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 268 EV---------VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
E+ + + +H + + + R+ A+E ++
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 1e-29
Identities = 52/311 (16%), Positives = 103/311 (33%), Gaps = 47/311 (15%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
+G G F +V+ A+ + + VA+K+ ++ E ++++ + + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 108 SNEEFK---------------ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+N K +V E + L + + + I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+Y+H IIH D+KP NVL++ + +L IA L T + T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP---------------------------T 244
+PE D++S ++ E TG +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 245 DEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESP 304
+ NG+ T + + L + ++ L + + + + P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 305 EQRINAKEIVK 315
+R +A +V
Sbjct: 317 RKRADAGGLVN 327
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-29
Identities = 61/297 (20%), Positives = 109/297 (36%), Gaps = 40/297 (13%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVIS 105
IG G G V A VA+K + Q K E +MK + H+N+I +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 106 SCSNEEFK------ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+ ++ LV+E M + D + ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
SA IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 220 RVSANGDVYSFGIMLMETFTGKKP---------------------TDEIFNGEMTLKHWV 258
N D++S G ++ E K + + + T++++V
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ + L S + S +L V P +RI+ + ++
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 4e-20
Identities = 28/203 (13%), Positives = 64/203 (31%), Gaps = 31/203 (15%)
Query: 48 NLIGKGGFGSVYKARLGDGMEVAVKVFNL----------QCGRALKSFNVECEMMKSIRH 97
L+G+G +V+ E VK + + F+V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 98 RNLIKVISSCSNEEF----KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
R L K+ + + A+++E + + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVA 117
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
+ I+H DL NVL+ + + + DF + V + + + +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQS---VEVGEEGWREILERDVRNIIT 170
Query: 214 EYGREGRVSANGDVYSFGIMLME 236
+ R R D+ S +++
Sbjct: 171 YFSRTYRTEK--DINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 339 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.73 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.49 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-57 Score=392.47 Aligned_cols=256 Identities=23% Similarity=0.335 Sum_probs=212.1
Q ss_pred hhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
+..++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 3567899999999999999999985 469999999997653 33446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+++++|.+++... ..+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|||++..+....
T Consensus 82 mEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999998654 47999999999999999999999 9999999999999999999999999999998765444
Q ss_pred CccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||................
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~--------------- 222 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--------------- 222 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT---------------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---------------
Confidence 3444456679999999999988775 678999999999999999999997654433222221111
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.........+++++.+||.+||+.||++|||++|+++|
T Consensus 223 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 223 ---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111134567789999999999999999999999886
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=390.55 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=213.3
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35899999999999999999975 47999999999877655667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
++|++|.+++.+. .+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||++..+.. ...
T Consensus 99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQS 171 (293)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTC
T ss_pred cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccc
Confidence 9999999988664 5999999999999999999999 99999999999999999999999999999987632 223
Q ss_pred ccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCccc
Q 019568 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (339)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~------------------~~ 233 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN------------------GT 233 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH------------------CS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------------CC
Confidence 345567999999999999999999999999999999999999999754322111110000 00
Q ss_pred hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 280 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.....+..++.++++||.+||+.||.+|||++|+++|
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112245567889999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=389.65 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=212.6
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
...++|++.+.||+|+||+||+|+++ ..||||+++.. .....+.+.+|++++++++||||+++++++.. +.+++|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34688999999999999999999864 36999998654 34556788999999999999999999998754 567899
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+++++|.+++......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999877778999999999999999999999 9999999999999999999999999999997664333
Q ss_pred CccccccccCCCCccCCccccCC---CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 197 QSMTQTQTFATIGYMAPEYGREG---RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
.........||+.|+|||++.+. .++.++|||||||++|||+||+.||...................
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---------- 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS---------- 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC----------
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----------
Confidence 33344556789999999988643 47899999999999999999999998653322111111110000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHc
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~ 325 (339)
......+..+++++.+||.+||+.||.+|||+++|+++|+.++++++
T Consensus 229 -----p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 229 -----PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp -----CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -----CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 00111234567889999999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-56 Score=388.39 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=212.9
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEec
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 120 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 120 (339)
+.|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+++|++++||||+++++++.+++..|+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5799999999999999999985 479999999998877777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCccc
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~ 200 (339)
++++|.+++.+...++++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC--Cccc
Confidence 999999998777678999999999999999999999 99999999999999999999999999999876421 1122
Q ss_pred cccccCCCCccCCcccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 201 QTQTFATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 201 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
.....||+.|+|||++. +..|+.++|||||||++|+|++|+.||......+........
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---------------- 230 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---------------- 230 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS----------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----------------
Confidence 34567899999999874 456899999999999999999999999765432221111000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+..+++++++||.+||+.||.+|||++|+++|
T Consensus 231 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 231 --EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112245567889999999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=383.27 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=208.8
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 69999999987542 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+++++|.+++.+.. .+++..++.++.||+.||.||| ++|++||||||+|||++.++.+||+|||++....
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~---- 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 157 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC----
Confidence 9999999999997654 7999999999999999999999 9999999999999999999999999999997652
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.. .....
T Consensus 158 ~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~i~~------------------ 218 (263)
T d2j4za1 158 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-KRISR------------------ 218 (263)
T ss_dssp CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHT------------------
T ss_pred CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-HHHHc------------------
Confidence 22234556899999999999999999999999999999999999999754321110 00000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.....+..+++++++||.+||+.||++|||++|+++|
T Consensus 219 --~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 219 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0011134467789999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-55 Score=377.89 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=205.6
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
++|++.+.||+|+||+||+|.+.+++.||||++.... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5789999999999999999998788899999987543 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+++|.+++......+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........ ...
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence 99999999887778999999999999999999999 99999999999999999999999999999976533222 222
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhC-CCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG-KKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....+|+.|+|||++.+..++.++||||||+++|||+|+ .+||......+ ....+.. ..
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~~i~~------------------~~ 219 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST------------------GF 219 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHHHHHH------------------TC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HHHHHHh------------------cC
Confidence 345688999999999999999999999999999999995 55554332111 1111110 01
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
+...+..+++++.+||.+||+.||++|||+++|+++|++++++
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 1112345567899999999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-55 Score=379.62 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=196.9
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec--CceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN--EEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 115 (339)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47899999999999999999975 479999999987653 3445678899999999999999999999854 566899
Q ss_pred EEEecCCCCHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHhhccCCCC-----eEecCCCCCCeEeCCCCcEEEcccc
Q 019568 116 VLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAP-----IIHCDLKPSNVLLDDNMVAHLSDFS 187 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~-----i~h~di~p~Nil~~~~~~v~l~Dfg 187 (339)
||||+++|+|.+++.+. ...+++..++.++.|++.||.||| +++ |+||||||+|||++.++.+||+|||
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 99999999999998643 457999999999999999999999 655 9999999999999999999999999
Q ss_pred cceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
++..+.. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. ...+.. ..
T Consensus 160 ~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~--~~~i~~---~~-- 230 (269)
T d2java1 160 LARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AGKIRE---GK-- 230 (269)
T ss_dssp HHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH---TC--
T ss_pred ceeeccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH--HHHHHc---CC--
Confidence 9987532 22223456689999999999999999999999999999999999999976432211 100000 00
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. ...+..+++++.+||.+||+.||.+|||++|+++|
T Consensus 231 -------~------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 -------F------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -------C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------C------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 01133467789999999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-55 Score=382.76 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=207.7
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999975 479999999987542 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||++||+|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999887654 7999999999999999999999 99999999999999999999999999999987654444
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........||+.|+|||++.+..++.++|||||||++|+|++|..||......... . .....
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~---~i~~~-------------- 225 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-Q---KIIKL-------------- 225 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-H---HHHTT--------------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-H---HHHcC--------------
Confidence 44445567999999999999999999999999999999999999999754221110 0 00000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....+..+++++++||.+||+.||.+|||++|++++-+
T Consensus 226 ---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 226 ---EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ---CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ---CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 00112345778999999999999999999999876644
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.9e-54 Score=387.97 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=213.9
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++||||+++++++.+++.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 56899999999999999999975 47999999999877666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC--CCCcEEEcccccceeccCCCC
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~--~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
++|++|.+++......+++..++.++.||+.||.||| ++|++||||||+|||++ .++.+||+|||++..+..
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--- 178 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 178 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc---
Confidence 9999999999766668999999999999999999999 99999999999999995 468899999999987632
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.... ... ..
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-i~~----------------~~ 241 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-VKS----------------CD 241 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHH----------------TC
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH-HHh----------------CC
Confidence 2233456789999999999999999999999999999999999999975432211110 000 00
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..........++.++++||.+||+.||.+|||++|+++|
T Consensus 242 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112234567889999999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-54 Score=385.33 Aligned_cols=254 Identities=19% Similarity=0.286 Sum_probs=196.2
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.+.++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|+++|++++||||+++++++.+++.+|+|
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45688999999999999999999754 69999999987653 23345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC---CCCcEEEcccccceecc
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~---~~~~v~l~Dfg~~~~~~ 193 (339)
|||++|++|.+++.... .+++..+..++.||+.||.||| +++++|+||||+||++. +++.+||+|||++....
T Consensus 86 mE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999996644 7999999999999999999999 99999999999999994 57899999999997642
Q ss_pred CCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||........... ...
T Consensus 162 ~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~--i~~------------- 223 (307)
T d1a06a_ 162 P---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ--ILK------------- 223 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHT-------------
T ss_pred C---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH--Hhc-------------
Confidence 2 2223445699999999999999999999999999999999999999976432211111 000
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..........+.+++++++||.+||+.||++|||++|+++|
T Consensus 224 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 224 --AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00111112234567889999999999999999999999987
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=372.51 Aligned_cols=253 Identities=23% Similarity=0.433 Sum_probs=215.4
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecC
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 121 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 121 (339)
++|++.+.||+|+||+||+|++++++.||||+++.... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999988888999999876533 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcccc
Q 019568 122 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ 201 (339)
Q Consensus 122 ~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~ 201 (339)
+|+|.+++......+++..++.++.|+++||.||| +.|++|+||||+||+++.++.+||+|||++....... ....
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceee
Confidence 99999998877778999999999999999999999 9999999999999999999999999999997654322 2233
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+.... +.. ..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~--i~~------------------~~ 218 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IAQ------------------GL 218 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH--HHT------------------TC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH--HHh------------------CC
Confidence 34568899999999999999999999999999999998 8999987643322111 110 01
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLK 319 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~ 319 (339)
+...+..++.++.+||.+||+.||++|||++++++||.+
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 112234556789999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-54 Score=387.59 Aligned_cols=254 Identities=19% Similarity=0.254 Sum_probs=214.7
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
..++|++.+.||+|+||+||+|.. .+|+.||||+++.........+.+|+++|++++||||++++++|.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457899999999999999999975 4799999999987766666778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC--CCCcEEEcccccceeccCCC
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD--DNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~--~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|++|++|.+.+......+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||++..+..
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCC--
Confidence 99999999988777768999999999999999999999 99999999999999997 678999999999987632
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
........+|+.|+|||++.+..++.++|||||||++|+|++|..||............. . .
T Consensus 182 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~-~----------------~ 243 (352)
T d1koba_ 182 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-R----------------C 243 (352)
T ss_dssp -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-H----------------C
T ss_pred -CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-h----------------C
Confidence 223344568999999999999999999999999999999999999997643221111000 0 0
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...........+++++++||.+||+.||.+|||++|+++|
T Consensus 244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011111234567889999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=386.81 Aligned_cols=269 Identities=21% Similarity=0.289 Sum_probs=209.0
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||+||+|.. .+|+.||+|+++... ......+.+|+.+|++++||||++++++|.+++..|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467899999999999999999985 479999999997653 344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCC-CeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
||++|++|.+++.+.. .+++..++.++.|++.||.||| ++ ||+||||||+|||++.++.+||+|||++..+..
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 9999999999997654 6999999999999999999999 75 899999999999999999999999999986532
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc-----------
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS----------- 265 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~----------- 265 (339)
.......||+.|+|||++.+..|+.++||||+||++|+|++|+.||......+..............
T Consensus 158 --~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2223457999999999999999999999999999999999999999764432221111000000000
Q ss_pred ccccccccccC------------ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 266 TLEVVDANLLS------------QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 266 ~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........... ............+.++++||.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000000 0000000112356789999999999999999999999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=369.39 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=201.2
Q ss_pred cCC-CCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec----Ccee
Q 019568 42 DEF-SENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN----EEFK 113 (339)
Q Consensus 42 ~~y-~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 113 (339)
.+| ++.+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+++|++++||||+++++++.. ...+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 6778899999999999975 468999999987653 4456678999999999999999999999854 4568
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCC--eEecCCCCCCeEeC-CCCcEEEcccccce
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP--IIHCDLKPSNVLLD-DNMVAHLSDFSIAK 190 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--i~h~di~p~Nil~~-~~~~v~l~Dfg~~~ 190 (339)
|+||||+++++|.+++.+.. .+++..++.++.|++.||.||| +++ |+||||||+|||++ +++.+||+|||++.
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999999999999997654 7999999999999999999999 888 99999999999996 58999999999997
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
... ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||...............
T Consensus 164 ~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~----------- 227 (270)
T d1t4ha_ 164 LKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----------- 227 (270)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-----------
T ss_pred ecc----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-----------
Confidence 532 223345679999999998865 5999999999999999999999999754322211111100
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.......+..+++++.+||.+||+.||++|||++|+++|
T Consensus 228 -------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 228 -------GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -------TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 000111233456779999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-54 Score=378.29 Aligned_cols=259 Identities=24% Similarity=0.433 Sum_probs=204.4
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CC---cEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DG---MEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~---~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
.++|++.+.||+|+||+||+|... ++ ..||||.+... .....+.+.+|+++|++++||||+++++++...+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 367888999999999999999754 23 35888887654 34456779999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++|+|.+++......+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++..+...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999887778999999999999999999999 999999999999999999999999999999876432
Q ss_pred CCccc---cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 196 DQSMT---QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 196 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
..... .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||......+. ...+..
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~--~~~i~~----------- 248 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV--INAIEQ----------- 248 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHT-----------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH--HHHHHc-----------
Confidence 22211 223346889999999999999999999999999999998 8999976533211 111100
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
..+...+..++.++.+||.+||+.||.+|||+.+|+++|+++.+
T Consensus 249 -------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 249 -------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 01111244567889999999999999999999999999998865
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=372.97 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=211.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc------hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCce
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC------GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEF 112 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 112 (339)
+.++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 457899999999999999999985 479999999986542 1235678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC----cEEEccccc
Q 019568 113 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSI 188 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~----~v~l~Dfg~ 188 (339)
+|+||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .+|++|||+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999997654 7999999999999999999999 99999999999999998776 499999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
+...... .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||......+.... ..
T Consensus 164 a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~--i~--------- 229 (293)
T d1jksa_ 164 AHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN--VS--------- 229 (293)
T ss_dssp CEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH---------
T ss_pred hhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH--HH---------
Confidence 9876322 233445689999999999999999999999999999999999999976432211000 00
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..........++.++.++++||.+||+.||++|||++|+++|
T Consensus 230 ------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 230 ------AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------TTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------hcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111222345677889999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=380.99 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=210.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCC-C-----cEEEEEEeecc-chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCc
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGD-G-----MEVAVKVFNLQ-CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~-~-----~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 111 (339)
..++|++.+.||+|+||+||+|+... + ..||+|.+... .......+.+|+.+++++ +||||+++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 45789999999999999999997432 2 36899988654 334556788999999998 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcC----------------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCC
Q 019568 112 FKALVLEYMPHGSLEKYLYSSN----------------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~----------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~ 169 (339)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +++|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence 9999999999999999997543 24788999999999999999999 9999999999
Q ss_pred CCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccc
Q 019568 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248 (339)
Q Consensus 170 p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~ 248 (339)
|+||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|+| |..||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654444434445667999999999999999999999999999999998 899998654
Q ss_pred cCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 019568 249 NGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318 (339)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~ 318 (339)
....... ... ...++..+..+++++++||.+||+.||++|||++||+++|.
T Consensus 272 ~~~~~~~-~~~------------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDANFYK-LIQ------------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHHHHH-HHH------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHH-HHh------------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3322111 111 01112224556788999999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=369.92 Aligned_cols=267 Identities=23% Similarity=0.400 Sum_probs=218.7
Q ss_pred hcCCCCCce-eeecCccEEEEEEeC---CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 41 TDEFSENNL-IGKGGFGSVYKARLG---DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 41 ~~~y~~~~~-ig~g~~~~v~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
.++|.+... ||+|+||+||+|.+. ++..||||+++... ....+.+.+|+++|++++||||+++++++..+ ..|+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence 356777774 999999999999642 45679999987553 44567889999999999999999999998754 5789
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+++|+|.+++......+++..++.++.|++.||.||| +++++|+||||+||+++.++.+||+|||++..+...
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999998777778999999999999999999999 999999999999999999999999999999876433
Q ss_pred CCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 196 DQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 196 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||......+. ...+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~~i~-------------- 226 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFIE-------------- 226 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHHHH--------------
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HHHHH--------------
Confidence 222 22234457889999999999999999999999999999998 8999986543221 11110
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccccCc
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGR 331 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~~~ 331 (339)
...+...++.+|+++.+||.+||+.||++|||+.+|++.|+.+..++.....++
T Consensus 227 ----~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~~ 280 (285)
T d1u59a_ 227 ----QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280 (285)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred ----cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccchh
Confidence 011112245678889999999999999999999999999998887776655443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-53 Score=376.31 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=203.4
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
+.|++++.||+|+||+||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4599999999999999999975 478999999987653 344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+.+++|..++... ..+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|||++....
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~---- 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---- 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS----
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC----
Confidence 999998887665443 47999999999999999999999 9999999999999999999999999999997542
Q ss_pred ccccccccCCCCccCCccccC---CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 198 SMTQTQTFATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
......||+.|+|||++.+ ..|+.++|||||||++|+|++|..||............. . .
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~-~---~----------- 229 (309)
T d1u5ra_ 167 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-Q---N----------- 229 (309)
T ss_dssp --SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-H---S-----------
T ss_pred --CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-h---C-----------
Confidence 2234569999999998864 458999999999999999999999997543221111000 0 0
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
......+..+++++++||.+||+.||.+|||++|+++|
T Consensus 230 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 ----ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ----CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 00011123457789999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=368.66 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=210.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
...++|++.+.||+|+||+||+|.+++++.||||+++... ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3457899999999999999999998888899999987543 334678999999999999999999998865 45789999
Q ss_pred ecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++..+... .
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-E 163 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-C
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-c
Confidence 999999999875443 35899999999999999999999 999999999999999999999999999999876422 2
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
........+|+.|+|||++.+..++.++||||||+++|||+||..|+........... .+.
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~-~i~------------------ 224 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ-NLE------------------ 224 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHH------------------
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH-HHH------------------
Confidence 2233445688999999999999999999999999999999996655443221111111 000
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
...+...+..+++++.+||.+||+.||++|||+++|++.|+.+-.
T Consensus 225 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 011112244567789999999999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-54 Score=377.06 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=214.1
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
++...++|++.+.||+|+||+||+|.+. +++.||||+++... ...+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3344578999999999999999999864 68999999987553 345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
||||+++|+|.+++... ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++.....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999998754 457899999999999999999999 99999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
. .........+++.|+|||++.+..++.++||||||+++|+|++|..|+........ .......
T Consensus 168 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~-------------- 231 (287)
T d1opja_ 168 D-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEK-------------- 231 (287)
T ss_dssp S-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHT--------------
T ss_pred C-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhc--------------
Confidence 2 22233344578899999999999999999999999999999997776543222111 1111100
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
......+..+++++.+||.+||+.||++|||+++|++.|+.+.
T Consensus 232 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 232 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111224456788999999999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=375.54 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=211.2
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
.++|++++.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 47899999999999999999985 479999999997542 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||++||+|.+++.+.. .+++..++.++.|++.||.||| ++|++||||||+|||++.+|.+||+|||++.....
T Consensus 84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-- 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc--
Confidence 99999999999987655 7899999999999999999999 99999999999999999999999999999986532
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
........+||+.|+|||++.+..|+.++|+|||||++|+|++|++||........... ...
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-i~~----------------- 219 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-ILM----------------- 219 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHH-----------------
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH-Hhc-----------------
Confidence 22234456799999999999999999999999999999999999999986533211110 000
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
.....+..+++++++||.+||+.||.+||+ ++|+++|
T Consensus 220 ---~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 220 ---EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 001113456788999999999999999994 8999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=373.11 Aligned_cols=254 Identities=19% Similarity=0.276 Sum_probs=212.4
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
.+.++|++.+.||+|+||+||+|... +++.||||+++..... ...+.+|+++|+.++||||+++++++.+++.+|+||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 35689999999999999999999754 7899999999766433 356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC--CCcEEEcccccceeccCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD--NMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~--~~~v~l~Dfg~~~~~~~~ 195 (339)
||++|++|.+++......+++..++.++.||+.||.||| +.||+||||||+||+++. .+.++|+|||++.....
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence 999999999999877767999999999999999999999 999999999999999974 45899999999987532
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (339)
........+++.|+|||...+..++.++|||||||++|+|++|..||........... ...
T Consensus 157 --~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~-i~~---------------- 217 (321)
T d1tkia_ 157 --GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN-IMN---------------- 217 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHH----------------
T ss_pred --CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh----------------
Confidence 2233455689999999999999999999999999999999999999976432211110 000
Q ss_pred CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..........+.+++++++||.+||+.||.+|||++|+++|
T Consensus 218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111122234567889999999999999999999999997
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-52 Score=369.23 Aligned_cols=245 Identities=26% Similarity=0.320 Sum_probs=207.9
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 6799999999999999999985 469999999987542 344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||++|++|..++.... .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++.....
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc---
Confidence 9999999999886655 7888899999999999999999 99999999999999999999999999999987532
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+..... .. .
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-~~----------------~- 216 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-LN----------------A- 216 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HH----------------C-
T ss_pred --ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH-Hc----------------C-
Confidence 233467999999999999999999999999999999999999999764322111100 00 0
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....++.+++++.+++.+||..||.+|+ |++++++|
T Consensus 217 ---~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 ---ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0111344577799999999999999996 99999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=364.39 Aligned_cols=260 Identities=25% Similarity=0.431 Sum_probs=205.4
Q ss_pred cCCCCCceeeecCccEEEEEEeCC-C----cEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGD-G----MEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~-~----~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
+.|++.+.||+|+||+||+|.+.. + ..||||++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 578899999999999999997532 2 479999986543 3445578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
||||+.++++.+.+......+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++..+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999998887778999999999999999999999 999999999999999999999999999999876432
Q ss_pred CCc-cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQS-MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
... .......||+.|+|||++.+..++.++||||||+++|||++|..|+........ ....+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~-------------- 228 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAIND-------------- 228 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHT--------------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhc--------------
Confidence 222 223344578999999999999999999999999999999997666543222111 1111110
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
..+...+..++..+.+||.+||+.||++|||+.||++.|+.+.+.
T Consensus 229 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 229 ----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 011122345677899999999999999999999999999988763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=365.55 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=204.9
Q ss_pred ceeeecCccEEEEEEeC---CCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEecCC
Q 019568 48 NLIGKGGFGSVYKARLG---DGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 122 (339)
Q Consensus 48 ~~ig~g~~~~v~~~~~~---~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 122 (339)
+.||+|+||+||+|.+. +++.||||+++.. .....+.+.+|+++|++++||||+++++++..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999642 3578999998654 234456789999999999999999999999754 56899999999
Q ss_pred CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc-cc
Q 019568 123 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQ 201 (339)
Q Consensus 123 ~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~-~~ 201 (339)
|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..+....... ..
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999987654 7999999999999999999999 9999999999999999999999999999998764332222 22
Q ss_pred ccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccCccch
Q 019568 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280 (339)
Q Consensus 202 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+. ...+.. ..
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~~i~~------------------~~ 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEK------------------GE 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHT------------------TC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HHHHHc------------------CC
Confidence 34568899999999999999999999999999999998 8999986543221 111110 01
Q ss_pred hhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcc
Q 019568 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326 (339)
Q Consensus 281 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~ 326 (339)
+...+..+|+++.+||.+||+.||++|||+++|++.|+.+-.+...
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence 1122455678899999999999999999999999999887655443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=365.17 Aligned_cols=259 Identities=23% Similarity=0.379 Sum_probs=204.6
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC----CCcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG----DGMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA 114 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 114 (339)
..++|++.+.||+|+||.||+|.+. .+..||||.++.. .......+.+|++++++++||||+++++++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3578999999999999999999753 2456888887654 3445567899999999999999999999996 46789
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccC
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG 194 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~ 194 (339)
+||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999998877778999999999999999999999 99999999999999999999999999999986532
Q ss_pred CCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccccc
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (339)
.. ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+.... +..
T Consensus 161 ~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~--i~~------------- 224 (273)
T d1mp8a_ 161 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--IEN------------- 224 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH--HHT-------------
T ss_pred Cc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH--HHc-------------
Confidence 22 223344557899999999999999999999999999999998 8999887544322111 110
Q ss_pred ccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
......++.+|+++.+||.+||+.||.+|||++||+++|+++.++
T Consensus 225 -----~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 -----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 001112456678899999999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.2e-52 Score=362.10 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=208.9
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch---------hhhHHHHHHHHHHHhCC-CcceeeEeeeeec
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG---------RALKSFNVECEMMKSIR-HRNLIKVISSCSN 109 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 109 (339)
.++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57999999999999999999975 4799999999876531 22346788999999996 9999999999999
Q ss_pred CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
++..|+||||+++++|.+++.... .+++..++.++.||+.||.||| ++|++|+||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999999997654 7999999999999999999999 999999999999999999999999999999
Q ss_pred eeccCCCCccccccccCCCCccCCccccC------CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc
Q 019568 190 KLLVGEDQSMTQTQTFATIGYMAPEYGRE------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263 (339)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~ 263 (339)
..... ........||+.|+|||.+.+ ..++.++||||+||++|+|++|++||........... ....
T Consensus 158 ~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~-i~~~--- 230 (277)
T d1phka_ 158 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-IMSG--- 230 (277)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHT---
T ss_pred eEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH-HHhC---
Confidence 87632 223345678999999998753 3578899999999999999999999986532221111 0000
Q ss_pred ccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
...........+|+++++||.+||+.||++|||++|+++|
T Consensus 231 -------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 231 -------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0011122244677889999999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.5e-52 Score=362.25 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=206.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc----
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE---- 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 111 (339)
+.++|++.+.||+|+||+||+|.. .+|+.||||+++... ......+.+|+++++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 468899999999999999999975 479999999997543 344567899999999999999999999986543
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..|+||||++|++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++++|||.+..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred eEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence 4889999999999999886654 7999999999999999999999 99999999999999999999999999998876
Q ss_pred ccCCCC-ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 192 LVGEDQ-SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 192 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
...... ........||+.|+|||++.+..++.++|||||||++|+|+||.+||......+........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~----------- 229 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE----------- 229 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc-----------
Confidence 532222 22334556899999999999999999999999999999999999999764322211111000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-NAKEIVKKLLKIR 321 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~l~~~~ 321 (339)
.........+.+|+++.+||.+||+.||.+|| |++++++.|.+++
T Consensus 230 ------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 230 ------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00111112345678899999999999999999 8999999988875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-51 Score=370.89 Aligned_cols=245 Identities=21% Similarity=0.243 Sum_probs=208.1
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 117 (339)
++|++++.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++|+.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6899999999999999999975 479999999987542 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
||+.+++|.+.+.+.. .+++..++.++.||+.||.||| +++|+||||||+|||++.+|.+||+|||++..+..
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 9999999999987654 7999999999999999999999 99999999999999999999999999999987632
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCc
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
......||+.|+|||++.+..++.++|||||||++|+|+||..||........ ...+. ..
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~--~~-------------- 253 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--YEKIV--SG-------------- 253 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH--HC--------------
T ss_pred --ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH--HHHHh--cC--------------
Confidence 22345689999999999999999999999999999999999999975422111 00000 00
Q ss_pred cchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 278 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....+..+++++.+||.+||+.||.+|+ |++++++|
T Consensus 254 ---~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 254 ---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0111344677899999999999999994 99999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=367.06 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=208.3
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCc----EEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGM----EVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~----~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 115 (339)
++|++++.||+|+||+||+|.+. +|+ +||+|.+... .....+.+.+|++++++++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 57999999999999999999753 444 5888887643 344567889999999999999999999999865 4678
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~ 195 (339)
+++++.+++|.+.+......+++..++.++.|++.||.||| +++++||||||+||+++.++.+||+|||++..+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 88999999999999888888999999999999999999999 999999999999999999999999999999876544
Q ss_pred CCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccc
Q 019568 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274 (339)
Q Consensus 196 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (339)
..........+|+.|+|||.+.+..++.++||||||+++|||+| |..||......+. ...+..
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~~~i~~-------------- 228 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSILEK-------------- 228 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--HHHHHH--------------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--HHHHHc--------------
Confidence 44444445568999999999999999999999999999999998 7889876543321 111110
Q ss_pred cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
..+...++.++.++.+||.+||+.||.+|||+.+|+++|..+...
T Consensus 229 ----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 229 ----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111122455678899999999999999999999999999988653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.5e-51 Score=369.42 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=203.2
Q ss_pred hcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc---hhhhHHH---HHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC---GRALKSF---NVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+ .+++++++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999854 69999999986532 1111223 3457777788999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
|+||||++|++|.+++.+.. .+++..++.++.||+.||.||| ++|++||||||+|||++.+|.+||+|||++..+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999997654 7889999999999999999999 9999999999999999999999999999998763
Q ss_pred CCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccc
Q 019568 194 GEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272 (339)
Q Consensus 194 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (339)
. .......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||............. ...
T Consensus 159 ~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~--~~~---------- 222 (364)
T d1omwa3 159 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--MTL---------- 222 (364)
T ss_dssp S----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH--HSS----------
T ss_pred C----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcc----------
Confidence 2 22344579999999998864 568999999999999999999999998654332111100 000
Q ss_pred cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 019568 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN-----AKEIVKK 316 (339)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 316 (339)
......+..+++++++||.+||+.||.+||| ++|+++|
T Consensus 223 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 ------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0011113356778999999999999999999 7999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=364.99 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=203.8
Q ss_pred hhcCCCCCc-eeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHh-CCCcceeeEeeeeec----Cce
Q 019568 40 ATDEFSENN-LIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKS-IRHRNLIKVISSCSN----EEF 112 (339)
Q Consensus 40 ~~~~y~~~~-~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~ 112 (339)
..++|.+.. .||+|+||+||+|.. .+++.||||+++.. ..+.+|++++.+ .+||||++++++|.+ ...
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 457898875 599999999999975 57999999998643 456779998765 489999999999865 467
Q ss_pred eEEEEEecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC---CCcEEEccccc
Q 019568 113 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSI 188 (339)
Q Consensus 113 ~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~---~~~v~l~Dfg~ 188 (339)
+|+||||++||+|.+++.+.. ..+++..++.++.|++.||.||| +.|++||||||+||+++. ++.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence 899999999999999997653 57999999999999999999999 999999999999999975 56799999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (339)
+..... ........||+.|+|||++.+..|+.++|||||||++|+|+||+.||.............
T Consensus 161 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~----------- 226 (335)
T d2ozaa1 161 AKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----------- 226 (335)
T ss_dssp CEECCC---CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeccC---CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH-----------
Confidence 987633 223345679999999999999999999999999999999999999997653322111000
Q ss_pred cccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.................+++++++||.+||+.||++|||+.|+++|
T Consensus 227 --~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 227 --TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000111111222345678899999999999999999999999997
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-52 Score=358.91 Aligned_cols=253 Identities=30% Similarity=0.447 Sum_probs=203.4
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeee-cCceeEEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS-NEEFKALVLE 118 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e 118 (339)
..++|++.+.||+|+||.||+|.. .|+.||||+++.+ ...+.+.+|++++++++||||+++++++. .++.+++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 356889999999999999999998 5889999998654 34467899999999999999999999885 4567899999
Q ss_pred ecCCCCHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+++|+|.+++.+.. ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~---- 154 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---- 154 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecC----
Confidence 999999999996543 35899999999999999999999 9999999999999999999999999999987642
Q ss_pred ccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.......+++.|+|||.+.+..++.++||||||+++|||+| |++||........ ...+..
T Consensus 155 -~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~--~~~i~~---------------- 215 (262)
T d1byga_ 155 -STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEK---------------- 215 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHHHTT----------------
T ss_pred -CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH--HHHHHc----------------
Confidence 22334457889999999999999999999999999999998 6888776533221 111110
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~ 323 (339)
..+...+..+++++.+||.+||+.||.+|||+.+++++|+.++..
T Consensus 216 --~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 216 --GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 111122445677899999999999999999999999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=361.44 Aligned_cols=268 Identities=23% Similarity=0.361 Sum_probs=207.3
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISS 106 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 106 (339)
.+++-..++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344455689999999999999999999742 34689999987543 34456677788888777 68999999998
Q ss_pred eec-CceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCC
Q 019568 107 CSN-EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP 170 (339)
Q Consensus 107 ~~~-~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p 170 (339)
+.. ...+++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +++|+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCc
Confidence 755 456899999999999999996532 34889999999999999999999 99999999999
Q ss_pred CCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCC-CCCccccc
Q 019568 171 SNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK-KPTDEIFN 249 (339)
Q Consensus 171 ~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~P~~~~~~ 249 (339)
+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++|. +||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765444444455667899999999999999999999999999999999875 57765433
Q ss_pred CccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 250 GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
....... ... ......+..+++++.+||.+||+.||++|||++|+++||+++.++.
T Consensus 243 ~~~~~~~-~~~------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 243 DEEFCRR-LKE------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp SHHHHHH-HHH------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHH-Hhc------------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 2211111 110 0111223456778999999999999999999999999999987754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=359.61 Aligned_cols=270 Identities=25% Similarity=0.388 Sum_probs=210.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
..++|++.+.||+|+||.||+|.+.+++.||||+++.... ..+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 3578999999999999999999987778899999875533 34678999999999999999999999865 457899999
Q ss_pred cCCCCHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 120 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 120 ~~~~~L~~~i~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
+++|+|.+++... ...+++..++.++.|++.||+||| +.+++|+||||+|||++.++.+||+|||++..+... ..
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~ 168 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EY 168 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC-Cc
Confidence 9999999888653 346899999999999999999999 999999999999999999999999999999765322 22
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+............ +..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~-i~~------------------ 229 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VER------------------ 229 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHT------------------
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-HHh------------------
Confidence 2334456899999999999999999999999999999999977665543222111111 100
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHcccccCceecccCC
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGRCIRQSNL 338 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~~~~~~~~~~~~ 338 (339)
..+...+..++.++.+||.+||+.||++|||+++|++.|+++..+.. +...+|.|+
T Consensus 230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~----p~~~p~~~~ 285 (285)
T d1fmka3 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE----PQYQPGENL 285 (285)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC----CCCCCSCCC
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC----CCCCCCCCC
Confidence 00111244567789999999999999999999999988887665443 344455553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=364.65 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=205.2
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc---hhhhHHHHHHHHHHH-hCCCcceeeEeeeeecCceeEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC---GRALKSFNVECEMMK-SIRHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 116 (339)
++|++.+.||+|+||+||+|+. .+++.||||+++... ......+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999975 479999999997542 233455666777665 68999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCC
Q 019568 117 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~ 196 (339)
|||+++|+|.+++.... .+++..++.++.||+.||.||| +++++|+||||+|||++.++.++|+|||++.....
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~-- 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-- 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc--
Confidence 99999999999997654 7899999999999999999999 99999999999999999999999999999986532
Q ss_pred CccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccC
Q 019568 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276 (339)
Q Consensus 197 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (339)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ... .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~--i~~-~-------------- 218 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS--IRM-D-------------- 218 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH-C--------------
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH--HHc-C--------------
Confidence 22334456789999999999999999999999999999999999999976432211110 000 0
Q ss_pred ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHHH
Q 019568 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK-EIVKK 316 (339)
Q Consensus 277 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~ 316 (339)
....+..+++++.+||.+||+.||.+|||+. ++++|
T Consensus 219 ----~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 219 ----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 0111334677899999999999999999995 78764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=360.25 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=201.7
Q ss_pred hcCCCCCceeeecCccEEEEEEeC--C--CcEEEEEEeecc---chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCcee
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLG--D--GMEVAVKVFNLQ---CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFK 113 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~--~--~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 113 (339)
.++|++.+.||+|+||.||+|+.. + ...||||++... .....+.+.+|+++|++++||||+++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 367999999999999999999742 2 346899998654 34456788999999999999999999999976 467
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
++||||++++++.+.+....+.+++..++.++.|++.||.||| +++++||||||+||+++.++.+||+|||++..+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999998877778999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCccc-cccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 194 GEDQSMT-QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 194 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
....... .....+++.|+|||.+.+..++.++||||||+++|||+| |.+||......+... .+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~--~i~------------ 228 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--KID------------ 228 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHH------------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH--HHH------------
Confidence 3333222 233446788999999999999999999999999999998 899997543322111 100
Q ss_pred ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 019568 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320 (339)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~ 320 (339)
....++..+..+|+++.+||.+||+.||++|||+++|++.|+++
T Consensus 229 -----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 229 -----KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----hCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01111222455677899999999999999999999999988875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=358.81 Aligned_cols=268 Identities=23% Similarity=0.287 Sum_probs=204.3
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|++++.||+|+||+||+|.. .+|+.||||+++... ......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999975 579999999997653 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHH-hhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCC
Q 019568 119 YMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197 (339)
Q Consensus 119 ~~~~~~L~~~i-~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~ 197 (339)
|+.+ .+.+.+ ......+++..++.++.|++.||.||| ++||+||||||+||+++.++.++|+|||.+..... .
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--P 155 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--C
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC--C
Confidence 9976 554444 445567999999999999999999999 99999999999999999999999999999976532 2
Q ss_pred ccccccccCCCCccCCccccCCC-CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc---cc--c-
Q 019568 198 SMTQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL---EV--V- 270 (339)
Q Consensus 198 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~--~- 270 (339)
........+|+.|+|||.+.... ++.++|+||+|+++|+|++|+.||............. .....+... .. .
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF-RTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCTTTSTTGGGST
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHH-HhcCCCchhhcccccccc
Confidence 33344557899999999876655 5899999999999999999999997643221111111 100000000 00 0
Q ss_pred --cccc-cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 --DANL-LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 --~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.... .............++.++++||.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 000000111223566789999999999999999999999997
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-51 Score=361.87 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=214.6
Q ss_pred HHhhhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeee
Q 019568 36 ELCQATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCS 108 (339)
Q Consensus 36 ~~~~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 108 (339)
+++-..++|++.+.||+|+||+||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445689999999999999999999742 35789999987654 334567899999999999999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcC-----------------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEe
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h 165 (339)
..+..++++||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence 9999999999999999999986432 24888899999999999999999 999999
Q ss_pred cCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCC-CCC
Q 019568 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK-KPT 244 (339)
Q Consensus 166 ~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~P~ 244 (339)
|||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998664444444445566889999999999999999999999999999999986 577
Q ss_pred cccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 019568 245 DEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321 (339)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~ 321 (339)
......+... .+... .....+..+++++.+||.+||+.||++|||+.||++.|+++.
T Consensus 244 ~~~~~~e~~~--~v~~~------------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEVIY--YVRDG------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHHHH--HHHTT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHHHH--HHHcC------------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6543322111 11100 011123456778999999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=357.67 Aligned_cols=263 Identities=23% Similarity=0.256 Sum_probs=197.6
Q ss_pred CCceeeecCccEEEEEEe-CCCcEEEEEEeeccch-----hhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 46 ENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG-----RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 46 ~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
.+++||+|+||+||+|.. .+|+.||||+++.... .....+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999985 4699999999865432 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+.++++..+. .....+++..+..++.||+.||.||| ++|++|+||||+||+++.++.+||+|||++..... ...
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNR 155 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCC
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCC--Ccc
Confidence 9886555544 45557999999999999999999999 99999999999999999999999999999976532 222
Q ss_pred ccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc---------
Q 019568 200 TQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV--------- 269 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 269 (339)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+.. .........+.....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l-~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL-TRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH-HHHHHhcCCCChhhccchhccchh
Confidence 3344568999999998765 46799999999999999999999999764322211 111111000000000
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........... ......+++++++||.+||+.||++|||++|+|+|
T Consensus 235 ~~~~~~~~~~~-~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPL-HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCH-HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCCh-HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000110 11123456789999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=352.91 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=210.3
Q ss_pred CceeeecCccEEEEEEeCC----CcEEEEEEeecc-chhhhHHHHHHHHHHHhCCCcceeeEeeeeec-CceeEEEEEec
Q 019568 47 NNLIGKGGFGSVYKARLGD----GMEVAVKVFNLQ-CGRALKSFNVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYM 120 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 120 (339)
.++||+|+||+||+|.+.. ...||||.++.. .....+.+.+|+++|++++||||+++++++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5689999999999997532 236899998643 45566889999999999999999999999754 56889999999
Q ss_pred CCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc--
Q 019568 121 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-- 198 (339)
Q Consensus 121 ~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~-- 198 (339)
++++|.+++.......++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||++.........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999877777888899999999999999999 999999999999999999999999999999876433222
Q ss_pred cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccccccccCcc
Q 019568 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (339)
.......+|+.|+|||.+.+..++.++||||||+++|||+||..||................
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g------------------ 250 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------------------ 250 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT------------------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------------
Confidence 22234457899999999999999999999999999999999888876543322211111110
Q ss_pred chhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHccc
Q 019568 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327 (339)
Q Consensus 279 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~~~~ 327 (339)
.+...+..+++.+.+||.+||+.||++|||+.||+++|+++.+++..+
T Consensus 251 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 251 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 011123456778999999999999999999999999999999876665
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-50 Score=352.90 Aligned_cols=268 Identities=21% Similarity=0.272 Sum_probs=204.0
Q ss_pred cCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEEe
Q 019568 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 119 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 119 (339)
++|++.+.||+|+||+||+|++.+|+.||||++.... ......+.+|+.+|++++||||+++++++..++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999998889999999997653 33356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCcc
Q 019568 120 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199 (339)
Q Consensus 120 ~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~ 199 (339)
+.++.+ ..+....+.+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+|++|||.+..... ...
T Consensus 82 ~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~ 155 (286)
T d1ob3a_ 82 LDQDLK-KLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (286)
T ss_dssp CSEEHH-HHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhH-HHHHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceeccc--Ccc
Confidence 977544 444455568999999999999999999999 99999999999999999999999999999976532 222
Q ss_pred ccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc--------c
Q 019568 200 TQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV--------V 270 (339)
Q Consensus 200 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 270 (339)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||............ ......+..... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI-FRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH-HHhhCCCChhhccchhhhhhc
Confidence 33445688999999987654 5799999999999999999999999765322211111 111111000000 0
Q ss_pred cccc-cCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 271 DANL-LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 271 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.... ...........+.+++++++||++||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000111111234556789999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=358.08 Aligned_cols=272 Identities=22% Similarity=0.358 Sum_probs=219.9
Q ss_pred eeeeHHH-HhhhhcCCCCCceeeecCccEEEEEEe------CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcce
Q 019568 30 RTFSYLE-LCQATDEFSENNLIGKGGFGSVYKARL------GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNL 100 (339)
Q Consensus 30 ~~~~~~~-~~~~~~~y~~~~~ig~g~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i 100 (339)
++++++. ++-..++|++.+.||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++.+ +||||
T Consensus 10 ~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp TTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCE
Confidence 3444433 333458999999999999999999974 346789999997654 34556788999999999 69999
Q ss_pred eeEeeeeecCceeEEEEEecCCCCHHHHHhhcC-----------------CccCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 019568 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-----------------CILDIFQRLNIMIDVASALEYLHFGYSAPI 163 (339)
Q Consensus 101 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i 163 (339)
+++++++.+.+..++||||+++++|.+++.+.. ..+++..+..++.||+.|+.||| ++++
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~i 166 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNC 166 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 999999999999999999999999999986542 25889999999999999999999 9999
Q ss_pred EecCCCCCCeEeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhC-CC
Q 019568 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTG-KK 242 (339)
Q Consensus 164 ~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~ 242 (339)
+|+||||+||+++.++.++++|||.+................+|+.|+|||.+.+..++.++||||||+++|+|+|+ .+
T Consensus 167 vHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence 99999999999999999999999999877554444455566789999999999999999999999999999999995 55
Q ss_pred CCcccccCccchHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 243 PTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 243 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
||......+ ........ ..+...+..++.++.+||.+||+.||.+|||+++|++.|++..+
T Consensus 247 ~~~~~~~~~-~~~~~i~~------------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 247 PYPGMPVDS-KFYKMIKE------------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SSTTCCSSH-HHHHHHHH------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHH-HHHHHHhc------------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 554432221 11111111 11122234567789999999999999999999999999988765
Q ss_pred H
Q 019568 323 S 323 (339)
Q Consensus 323 ~ 323 (339)
+
T Consensus 308 ~ 308 (311)
T d1t46a_ 308 E 308 (311)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=356.96 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=211.9
Q ss_pred hhhcCCCCCceeeecCccEEEEEEeC--------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhC-CCcceeeEeeeee
Q 019568 39 QATDEFSENNLIGKGGFGSVYKARLG--------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSI-RHRNLIKVISSCS 108 (339)
Q Consensus 39 ~~~~~y~~~~~ig~g~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 108 (339)
...++|++.+.||+|+||.||+|+.. ++..||||+++... ......+.+|...+.++ +||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34579999999999999999999632 23479999997654 34457788899999888 7999999999999
Q ss_pred cCceeEEEEEecCCCCHHHHHhhcC---------------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCe
Q 019568 109 NEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNV 173 (339)
Q Consensus 109 ~~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Ni 173 (339)
+++..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence 9999999999999999999996543 35899999999999999999999 99999999999999
Q ss_pred EeCCCCcEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHh-CCCCCcccccCcc
Q 019568 174 LLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252 (339)
Q Consensus 174 l~~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~P~~~~~~~~~ 252 (339)
|++.++.+||+|||++................+++.|+|||.+.++.++.++||||||+++|+|++ |.+||.......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~- 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence 999999999999999987765555555566678999999999999999999999999999999998 688887543321
Q ss_pred chHhHhhhhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 253 TLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
....+.. ......+..+++++.+||.+||+.||.+|||+.||++.|+++.+
T Consensus 246 -~~~~i~~------------------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 -LFKLLKE------------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHHT------------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHc------------------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111110 01111234567789999999999999999999999999998865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=356.82 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=199.9
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccch------hhhHHHHHHHHHHHhCC--CcceeeEeeeeecC
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCG------RALKSFNVECEMMKSIR--HRNLIKVISSCSNE 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 110 (339)
+.++|++.+.||+|+||+||+|.. .+|+.||||++..... .....+.+|+.++++++ ||||+++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 568999999999999999999975 4799999999875421 12234667999999996 89999999999999
Q ss_pred ceeEEEEEecCC-CCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-CCcEEEccccc
Q 019568 111 EFKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSI 188 (339)
Q Consensus 111 ~~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-~~~v~l~Dfg~ 188 (339)
+..++||||+.+ +++.+++.... .+++..++.++.|++.||.||| +++++||||||+||+++. ++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CeEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence 999999999975 57778776544 7999999999999999999999 999999999999999985 57999999999
Q ss_pred ceeccCCCCccccccccCCCCccCCccccCCCC-CCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccc
Q 019568 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTL 267 (339)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 267 (339)
+.... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ....
T Consensus 158 a~~~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i~~~------- 219 (273)
T d1xwsa_ 158 GALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRG------- 219 (273)
T ss_dssp CEECC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHC-------
T ss_pred ceecc----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------Hhhc-------
Confidence 98652 222345668999999999887665 6789999999999999999999975321 0000
Q ss_pred ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
....+..+|+++++||.+||+.||++|||++|+++|
T Consensus 220 -------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 -------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000123456789999999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=354.87 Aligned_cols=272 Identities=22% Similarity=0.292 Sum_probs=206.1
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CC-CcEEEEEEeeccc--hhhhHHHHHHHHHHHhC---CCcceeeEeeeee--
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GD-GMEVAVKVFNLQC--GRALKSFNVECEMMKSI---RHRNLIKVISSCS-- 108 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~-~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-- 108 (339)
|...++|++++.||+|+||+||+|.. .+ ++.||||+++... ......+.+|+.+++.+ +||||++++++|.
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 45678999999999999999999975 34 6779999987653 22334566788877766 7999999999984
Q ss_pred ---cCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 109 ---NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 109 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
.....++++|+++++.+..........+++..++.++.|++.||.||| +++|+||||||+|||++.++.++|+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence 345789999999887776666566668999999999999999999999 99999999999999999999999999
Q ss_pred cccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccc
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 265 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~ 265 (339)
||++... ..........||+.|+|||++.+..++.++||||+||++|+|++|++||........ ..........+.
T Consensus 160 fg~~~~~---~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~ 235 (305)
T d1blxa_ 160 FGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPG 235 (305)
T ss_dssp CCSCCCC---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCC
T ss_pred hhhhhhh---cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCc
Confidence 9998754 223344566789999999999999999999999999999999999999976532211 111111110000
Q ss_pred ccccc------ccccc-CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 266 TLEVV------DANLL-SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 266 ~~~~~------~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... ..... ............+++.+.+||.+||++||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00000 00001111234567789999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=351.33 Aligned_cols=277 Identities=23% Similarity=0.300 Sum_probs=203.8
Q ss_pred hcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHH--HHHHHHhCCCcceeeEeeeeecCc----eeE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNV--ECEMMKSIRHRNLIKVISSCSNEE----FKA 114 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 114 (339)
..+|.+.+.||+|+||.||+|+. +|+.||||+++.... ..+.. |+..+++++||||+++++++...+ .+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 46788899999999999999987 689999999875532 23333 455556789999999999986543 578
Q ss_pred EEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhcc-----CCCCeEecCCCCCCeEeCCCCcEEEcccccc
Q 019568 115 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-----~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~ 189 (339)
+||||+++++|.+++++. .+++..++.++.|++.||+|+|.. ...+|+|+||||+|||++.++.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999999765 488999999999999999999921 0259999999999999999999999999999
Q ss_pred eeccCCCCcc--ccccccCCCCccCCccccCCC------CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh
Q 019568 190 KLLVGEDQSM--TQTQTFATIGYMAPEYGREGR------VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 261 (339)
Q Consensus 190 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~ 261 (339)
.......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 8764332221 233566899999999887643 57789999999999999999988765433222111100000
Q ss_pred ccc-ccc-ccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 262 LPI-STL-EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 262 ~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
... ... ........+ ..........++..+.+|+.+||+.||++|||+.||+++|+.+.+..
T Consensus 236 ~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRP-NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTTSCCCC-CCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCC-CCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 000 000 000001100 01112224456677999999999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=356.08 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=206.7
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCc--EEEEEEeecc-chhhhHHHHHHHHHHHhC-CCcceeeEeeeeecCceeEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGM--EVAVKVFNLQ-CGRALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALV 116 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~--~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 116 (339)
++|++.+.||+|+||+||+|.+. ++. .||||.+... .....+.+.+|+++|+++ +||||+++++++.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 78999999999999999999754 444 4677876543 344566789999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhc---------------CCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcE
Q 019568 117 LEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA 181 (339)
Q Consensus 117 ~e~~~~~~L~~~i~~~---------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v 181 (339)
|||+++|+|.+++... ...+++..++.++.|++.||.||| +.+++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999998654 246899999999999999999999 9999999999999999999999
Q ss_pred EEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCC-CCCcccccCccchHhHhhh
Q 019568 182 HLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK-KPTDEIFNGEMTLKHWVND 260 (339)
Q Consensus 182 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~P~~~~~~~~~~~~~~~~~ 260 (339)
||+|||++.... .........+|+.|+|||.+.+..++.++||||||+++|+|++|. +||......+. ...+.
T Consensus 167 kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~--~~~i~- 240 (309)
T d1fvra_ 167 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKLP- 240 (309)
T ss_dssp EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHGG-
T ss_pred EEcccccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH--HHHHH-
Confidence 999999987542 222233455889999999999999999999999999999999976 56655422211 11110
Q ss_pred hccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 261 WLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
...+...+..+++++++||.+||+.||++|||++||+++|+++.++.
T Consensus 241 -----------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 -----------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -----------------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -----------------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 01112224456788999999999999999999999999999998653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=352.32 Aligned_cols=263 Identities=22% Similarity=0.382 Sum_probs=215.5
Q ss_pred HhhhhcCCCCCceeeecCccEEEEEEeC------CCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeec
Q 019568 37 LCQATDEFSENNLIGKGGFGSVYKARLG------DGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSN 109 (339)
Q Consensus 37 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 109 (339)
++...++|++.+.||+|+||+||+|.+. +++.||||+++... ......+.+|++++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3444589999999999999999999642 35789999987543 3445678899999999999999999999999
Q ss_pred CceeEEEEEecCCCCHHHHHhhcC---------CccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCc
Q 019568 110 EEFKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180 (339)
Q Consensus 110 ~~~~~lv~e~~~~~~L~~~i~~~~---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~ 180 (339)
.+..++||||+++|+|.+++.... ..++...+..++.|++.||.||| +.+++||||||+|||++.++.
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCce
Confidence 999999999999999999886432 34788999999999999999999 999999999999999999999
Q ss_pred EEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCC-CCCcccccCccchHhHhh
Q 019568 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK-KPTDEIFNGEMTLKHWVN 259 (339)
Q Consensus 181 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~P~~~~~~~~~~~~~~~~ 259 (339)
+||+|||++..+.............+++.|+|||.+.+..++.++||||||+++|||+||. .||......+... .+.
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~--~i~ 249 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--FVM 249 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH--HHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH--HHH
Confidence 9999999998765444444455566899999999999999999999999999999999985 6776543222111 000
Q ss_pred hhccccccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 019568 260 DWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322 (339)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~ 322 (339)
. ......++.++..+.+||.+||+.||.+|||+++|+++|++..+
T Consensus 250 ---~---------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 ---E---------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---T---------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---h---------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 00111234567789999999999999999999999999877644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=338.30 Aligned_cols=269 Identities=20% Similarity=0.237 Sum_probs=208.1
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCceeEEEEE
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 118 (339)
++|++++.||+|+||+||+|++ .+++.||||+++... ......+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999985 479999999987653 3456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceeccCCCCc
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~~~~~~ 198 (339)
++.++++..++.. .+.+++..++.++.|++.||.||| +++|+|+||||+||+++.++.++|+|||.+...... .
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V 155 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--C
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC--C
Confidence 9988888777654 447899999999999999999999 999999999999999999999999999999876322 2
Q ss_pred cccccccCCCCccCCccccCCC-CCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc------ccccc
Q 019568 199 MTQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST------LEVVD 271 (339)
Q Consensus 199 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 271 (339)
.......+++.|.|||.+.+.. ++.++||||+||++|+|++|..||....+................. .....
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 2333445678899999877654 6999999999999999999999975433222222211111111100 00000
Q ss_pred ---ccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 ---ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
.................+.++.+||.+||+.||.+|||++|+|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111111122234567789999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=346.33 Aligned_cols=270 Identities=20% Similarity=0.203 Sum_probs=201.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc-hhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc----ee
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSCSNEE----FK 113 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 113 (339)
+.++|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 457899999999999999999974 579999999997553 445667889999999999999999999986543 23
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccceecc
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~~~ 193 (339)
+++++++.+++|.+++... .+++..++.++.|++.||.||| ++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 4555666688999999765 5999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCc-cccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccccc
Q 019568 194 GEDQS-MTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271 (339)
Q Consensus 194 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (339)
..... .......+|+.|+|||++.. ..++.++||||+||++|+|++|..||.............. ...... .....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~-~~~~~~-~~~~~ 238 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG-ILGSPS-QEDLN 238 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCSCC-HHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh-hccCCC-hhhhh
Confidence 32222 22345568999999998854 5678999999999999999999999976533211111110 000000 00000
Q ss_pred c-----------cccC-ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 272 A-----------NLLS-QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 272 ~-----------~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
. .... .........+..++++++|+.+||+.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 0000011123456789999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=340.36 Aligned_cols=275 Identities=21% Similarity=0.281 Sum_probs=201.5
Q ss_pred hhhhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec-----
Q 019568 38 CQATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN----- 109 (339)
Q Consensus 38 ~~~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 109 (339)
+...++|++++.||+|+||+||+|.. .+|+.||||++.... ......+.+|+++|+.++||||+++++++..
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 34579999999999999999999985 479999999986553 3445678899999999999999999998754
Q ss_pred ---CceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccc
Q 019568 110 ---EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186 (339)
Q Consensus 110 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Df 186 (339)
.+..|++|||+.++ +..........+++..++.++.|++.||.||| +.||+||||||+||+++.++.++++||
T Consensus 86 ~~~~~~~~iv~e~~~~~-~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -----CEEEEEECCCEE-HHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cccCceEEEEEeccCCC-ccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeec
Confidence 34689999999774 44555555568999999999999999999999 999999999999999999999999999
Q ss_pred ccceeccCCCCc--cccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHh-hhhc
Q 019568 187 SIAKLLVGEDQS--MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV-NDWL 262 (339)
Q Consensus 187 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~-~~~~ 262 (339)
|++..+...... .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.............. ....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999766432221 222345689999999988765 689999999999999999999999975432111111000 0000
Q ss_pred cccccccc---------cccccCccc-hhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 263 PISTLEVV---------DANLLSQED-IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 263 ~~~~~~~~---------~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
........ ......... .........++++++||.+||++||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000000 000000011 1111223345678899999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=347.71 Aligned_cols=270 Identities=23% Similarity=0.270 Sum_probs=200.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeecc--chhhhHHHHHHHHHHHhCCCcceeeEeeeeecCc-----
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNEE----- 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 111 (339)
..++|++++.||+|+||+||+|.. .+|+.||||+++.. +....+.+.+|+++|++++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 468999999999999999999975 46999999999754 3345567889999999999999999999997654
Q ss_pred -eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 112 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 112 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
.+|+||||+ +.+|..+++.. .+++..++.++.|++.||.||| ++||+|+||||+|||++.++.++++|||++.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence 579999999 55888877654 5999999999999999999999 9999999999999999999999999999998
Q ss_pred eccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccc--c
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST--L 267 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~ 267 (339)
.... ......+|+.|+|||.+.+ ..++.++||||+||++|+|++|..||......... ..........+. .
T Consensus 170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHH
T ss_pred ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH-HHHHhccCCCcHHHH
Confidence 6522 2344568999999998876 45799999999999999999999999764321111 111000000000 0
Q ss_pred ccc--------cccccC-ccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHHH
Q 019568 268 EVV--------DANLLS-QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKIR 321 (339)
Q Consensus 268 ~~~--------~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~~ 321 (339)
... ...... ...........+++++.+||.+||..||.+|||++|+|+| ++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000 000000 0000011123456789999999999999999999999997 55543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=342.22 Aligned_cols=268 Identities=25% Similarity=0.297 Sum_probs=198.5
Q ss_pred cCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcceeeEeeeeec------CceeE
Q 019568 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN------EEFKA 114 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~ 114 (339)
.+|+..+.||+|+||+||+|+.. +|+.||||++..... ...+|+++|++++||||++++++|.. ..+++
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 36889999999999999999864 799999999875532 23469999999999999999999843 33578
Q ss_pred EEEEecCCCCHHHHHh---hcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCC-cEEEcccccce
Q 019568 115 LVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNM-VAHLSDFSIAK 190 (339)
Q Consensus 115 lv~e~~~~~~L~~~i~---~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~-~v~l~Dfg~~~ 190 (339)
+||||++++ +.+.+. .....+++..++.++.|++.||.||| ++||+||||||+|||++.++ .+||+|||++.
T Consensus 96 lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 999999764 443332 34457999999999999999999999 99999999999999999765 89999999998
Q ss_pred eccCCCCccccccccCCCCccCCccccC-CCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc-----
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI----- 264 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~----- 264 (339)
.+... .......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||......... ..........
T Consensus 172 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l-~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 172 QLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL-VEIIKVLGTPTREQI 247 (350)
T ss_dssp ECCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH-HHHHHHHCCCCHHHH
T ss_pred hccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH-HHHHHHhCCChHHhh
Confidence 76322 23344578999999997765 57899999999999999999999999764322111 1110000000
Q ss_pred -----cccccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHHHH
Q 019568 265 -----STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK--LLKIRD 322 (339)
Q Consensus 265 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--l~~~~~ 322 (339)
.......... ..........+..++++.+||.+||+.||++|||+.|+++| ++.++.
T Consensus 248 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQI-KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHCC---CCCCCCC-CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccchhhcccccc-ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000000000 01111112234567789999999999999999999999987 555544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-46 Score=332.09 Aligned_cols=265 Identities=18% Similarity=0.195 Sum_probs=206.9
Q ss_pred hcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc-eeeEeeeeecCceeEEEEE
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN-LIKVISSCSNEEFKALVLE 118 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e 118 (339)
.++|++.+.||+|+||+||+|.+ .+|+.||||++.... ....+..|+++++.++|++ |+.+..++...+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46899999999999999999975 468999999987653 2345788999999997765 5555666678888999999
Q ss_pred ecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeC---CCCcEEEcccccceeccCC
Q 019568 119 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGE 195 (339)
Q Consensus 119 ~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~---~~~~v~l~Dfg~~~~~~~~ 195 (339)
|+ ++++.+.+......+++..+..++.|++.||.||| ++|++||||||+||+++ .+..++++|||++..+...
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99 45888888777778999999999999999999999 99999999999999985 4557999999999887543
Q ss_pred CCc-----cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccccccccc
Q 019568 196 DQS-----MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270 (339)
Q Consensus 196 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (339)
... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||...................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~------- 232 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------- 232 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-------
Confidence 322 12234568999999999999999999999999999999999999998754433222111000000
Q ss_pred cccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
...........+|+++.+||.+||+.||++||+++++.+.|+.+..+.
T Consensus 233 ------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 233 ------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 000011123457788999999999999999999999998888876544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.4e-47 Score=338.05 Aligned_cols=264 Identities=19% Similarity=0.239 Sum_probs=201.1
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeeeeec--CceeEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSCSN--EEFKAL 115 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~l 115 (339)
..++|++++.||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++|+.+. ||||++++++|.. ....++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 347899999999999999999985 479999999987543 356788999999995 9999999999864 457899
Q ss_pred EEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCC-CcEEEcccccceeccC
Q 019568 116 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN-MVAHLSDFSIAKLLVG 194 (339)
Q Consensus 116 v~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~-~~v~l~Dfg~~~~~~~ 194 (339)
||||+.+++|.... +.+++..++.++.||+.||.||| ++||+|+||||+|||++.+ +.++|+|||++.....
T Consensus 110 v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 110 VFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999999987653 35899999999999999999999 9999999999999999864 4699999999987632
Q ss_pred CCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhh------------
Q 019568 195 EDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW------------ 261 (339)
Q Consensus 195 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~------------ 261 (339)
. .......+|+.|+|||.+.+. .++.++|+||+||+++++++|..||.................
T Consensus 183 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 G---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp T---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred C---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 2 233455689999999987765 479999999999999999999999976433211111100000
Q ss_pred ccccc---cccccc--cccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 262 LPIST---LEVVDA--NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 262 ~~~~~---~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
..... ...... ...............+++++++||++||++||++|||++|+|+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000000 00001111122334567889999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=341.77 Aligned_cols=266 Identities=23% Similarity=0.203 Sum_probs=195.3
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec------C
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN------E 110 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 110 (339)
+.++|++++.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.++++++||||++++++|.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4478999999999999999999854 69999999997553 4455678899999999999999999999853 4
Q ss_pred ceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 111 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 111 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
..+|+||||+.+ ++.+.+. ..+++..++.++.|++.||.||| ++|++|+||||+||+++.++.++++|||++.
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence 678999999976 5555443 35899999999999999999999 9999999999999999999999999999887
Q ss_pred eccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcc-------
Q 019568 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP------- 263 (339)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~------- 263 (339)
... .........+|+.|+|||++.+..++.++||||+||++++|++|+.||........... .......
T Consensus 168 ~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~-i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 168 TAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK-VIEQLGTPCPEFMK 243 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCHHHHT
T ss_pred ccc---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHH-HHHhccCCCHHHHH
Confidence 642 23334455689999999999999999999999999999999999999975432111000 0000000
Q ss_pred -------------cccccccccccc--CccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 264 -------------ISTLEVVDANLL--SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 264 -------------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
............ .............++++++||++||..||++|||++|+|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 00111223345678889999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-46 Score=328.99 Aligned_cols=265 Identities=14% Similarity=0.136 Sum_probs=213.8
Q ss_pred hhcCCCCCceeeecCccEEEEEEeC-CCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC-cceeeEeeeeecCceeEEEE
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH-RNLIKVISSCSNEEFKALVL 117 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 117 (339)
..++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.+.| +|++.+++++......++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 3578999999999999999999854 69999999876542 23457789999999965 89999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCC-----CCcEEEcccccceec
Q 019568 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD-----NMVAHLSDFSIAKLL 192 (339)
Q Consensus 118 e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~-----~~~v~l~Dfg~~~~~ 192 (339)
||+ +++|.+++......++...+..++.|++.||.+|| ++|++||||||+||+++. ++.++|+|||++..+
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999 67999999887778999999999999999999999 999999999999999964 678999999999876
Q ss_pred cCCCCc-----cccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhH-hhhhccccc
Q 019568 193 VGEDQS-----MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW-VNDWLPIST 266 (339)
Q Consensus 193 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~-~~~~~~~~~ 266 (339)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||............. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--- 233 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH---
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC---
Confidence 432221 12234568999999999999999999999999999999999999998654432221111 000000
Q ss_pred cccccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 019568 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324 (339)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~l~~~~~~~ 324 (339)
..........+|+++.+++..|+..+|++||+++.+.+.|+++.++.
T Consensus 234 -----------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 234 -----------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -----------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00011112456778999999999999999999999999888876654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=340.20 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=206.3
Q ss_pred hcCCCCCceeeecCccEEEEEEe----CCCcEEEEEEeeccc----hhhhHHHHHHHHHHHhCCC-cceeeEeeeeecCc
Q 019568 41 TDEFSENNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQC----GRALKSFNVECEMMKSIRH-RNLIKVISSCSNEE 111 (339)
Q Consensus 41 ~~~y~~~~~ig~g~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 111 (339)
.++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37899999999999999999963 258899999986542 2345677889999999966 89999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..++++||+.+++|.+++.... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999997665 6788899999999999999999 99999999999999999999999999999976
Q ss_pred ccCCCCccccccccCCCCccCCccccCC--CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhcccccccc
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (339)
+.... ........+++.|+|||.+.+. .++.++|||||||++|+|++|..||...................
T Consensus 179 ~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~------ 251 (322)
T d1vzoa_ 179 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------ 251 (322)
T ss_dssp CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------
T ss_pred hcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC------
Confidence 53222 2223445689999999988654 46889999999999999999999998765443322221111110
Q ss_pred ccccccCccchhhhhhHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 019568 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI-----NAKEIVKK 316 (339)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 316 (339)
....+..+++++++||.+||++||.+|| +++|+++|
T Consensus 252 -----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1111345678899999999999999999 48999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=338.71 Aligned_cols=267 Identities=22% Similarity=0.235 Sum_probs=198.5
Q ss_pred hhcCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccc--hhhhHHHHHHHHHHHhCCCcceeeEeeeeec-----Cc
Q 019568 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISSCSN-----EE 111 (339)
Q Consensus 40 ~~~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 111 (339)
+.++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+++|++++||||+++++++.. +.
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 457999999999999999999975 479999999997553 3445678899999999999999999999853 23
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 112 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 112 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
..+++++++.+++|.+++... .+++..++.++.||+.||.||| ++||+||||||+||+++.++.++++|||.+..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence 446677788899999998654 5999999999999999999999 99999999999999999999999999999875
Q ss_pred ccCCCCccccccccCCCCccCCccccCC-CCCCcchhhHHHHHHHHHHhCCCCCcccccCccchHhHhhhhccc-cccc-
Q 019568 192 LVGEDQSMTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI-STLE- 268 (339)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~- 268 (339)
. ........+++.|+|||...+. .++.++|||||||++|+|++|..||.................... ....
T Consensus 171 ~-----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 171 T-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp C-----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred c-----CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 4 2333445678899999986665 568999999999999999999999975432111111000000000 0000
Q ss_pred -------cccccccCccchh-hhhhHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 019568 269 -------VVDANLLSQEDIH-FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316 (339)
Q Consensus 269 -------~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 316 (339)
............. ......+++++++||.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000000 01123457789999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-41 Score=307.40 Aligned_cols=266 Identities=16% Similarity=0.181 Sum_probs=190.2
Q ss_pred cCCCCCceeeecCccEEEEEEe-CCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-----------CcceeeEeeeeec
Q 019568 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-----------HRNLIKVISSCSN 109 (339)
Q Consensus 42 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 109 (339)
.+|++++.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+++++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999985 479999999997653 23456778999888875 5789999988754
Q ss_pred --CceeEEEEEecCCCCH--HHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCC-CCeEecCCCCCCeEeCCCC-----
Q 019568 110 --EEFKALVLEYMPHGSL--EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APIIHCDLKPSNVLLDDNM----- 179 (339)
Q Consensus 110 --~~~~~lv~e~~~~~~L--~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~-~~i~h~di~p~Nil~~~~~----- 179 (339)
....+++++++..... ..........+++..++.++.|++.|+.||| + .||+|+||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCccccc
Confidence 3455666666544332 2223334457899999999999999999999 6 8999999999999997655
Q ss_pred -cEEEcccccceeccCCCCccccccccCCCCccCCccccCCCCCCcchhhHHHHHHHHHHhCCCCCcccccCccc-----
Q 019568 180 -VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT----- 253 (339)
Q Consensus 180 -~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P~~~~~~~~~~----- 253 (339)
.++++|||.+.... .......+|+.|+|||++.+..++.++|+||+||++++|++|+.||.........
T Consensus 169 ~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 49999999987542 2334566899999999999999999999999999999999999999754321110
Q ss_pred hHhHhhhhccc------------------cccccccccccCc----cchhhhhhHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 019568 254 LKHWVNDWLPI------------------STLEVVDANLLSQ----EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK 311 (339)
Q Consensus 254 ~~~~~~~~~~~------------------~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 311 (339)
........... ............. ...........+.++.+||.+||.+||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 00000000000 0000000000000 0011222356788999999999999999999999
Q ss_pred HHHHH
Q 019568 312 EIVKK 316 (339)
Q Consensus 312 ell~~ 316 (339)
|+|+|
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=2.5e-24 Score=176.45 Aligned_cols=164 Identities=16% Similarity=0.139 Sum_probs=119.4
Q ss_pred CCCCceeeecCccEEEEEEeCCCcEEEEEEeeccch------------------hhhHHHHHHHHHHHhCCCcceeeEee
Q 019568 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCG------------------RALKSFNVECEMMKSIRHRNLIKVIS 105 (339)
Q Consensus 44 y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 105 (339)
+.+.++||+|+||+||+|...+|+.||||+++.... ........|+..+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999887899999998754211 11233456889999999999988876
Q ss_pred eeecCceeEEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccCCCCeEecCCCCCCeEeCCCCcEEEcc
Q 019568 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSD 185 (339)
Q Consensus 106 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i~h~di~p~Nil~~~~~~v~l~D 185 (339)
+.. .+++|||+++..+.+ ++...+..++.|++.++.+|| +.|++|+||||+|||++++ .++|+|
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence 632 369999998855433 344456789999999999999 9999999999999999865 488999
Q ss_pred cccceeccCCCCccccccccCCCCccCC--c---cccCCCCCCcchhhHHHHH
Q 019568 186 FSIAKLLVGEDQSMTQTQTFATIGYMAP--E---YGREGRVSANGDVYSFGIM 233 (339)
Q Consensus 186 fg~~~~~~~~~~~~~~~~~~~~~~y~aP--E---~~~~~~~~~~~DiwslG~i 233 (339)
||.+...... .. . .|... + ......|+.++|+||+.--
T Consensus 146 FG~a~~~~~~--~~--~------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEE--GW--R------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTST--TH--H------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred CCCcccCCCC--Cc--H------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 9998754211 10 0 01110 0 0123567889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.98 E-value=2e-09 Score=90.71 Aligned_cols=150 Identities=15% Similarity=0.097 Sum_probs=106.0
Q ss_pred HHHhhhhcCCCCCceeeecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCC-CcceeeEeeeeecCcee
Q 019568 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVISSCSNEEFK 113 (339)
Q Consensus 35 ~~~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 113 (339)
.++......|++.+..+.++.+.||+... +++.++||+...........+.+|...++.+. +-.+.+++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35566667888888776666789999875 56778899877665555556788999988874 33467778888888899
Q ss_pred EEEEEecCCCCHHHHHhhcCCccCHHHHHHHHHHHHHHHHHhhccC----------------------------------
Q 019568 114 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY---------------------------------- 159 (339)
Q Consensus 114 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---------------------------------- 159 (339)
++||++++|.++.+...... ....++.++...+..||...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999988766542211 12224445555555555210
Q ss_pred ----------------------CCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 160 ----------------------SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 160 ----------------------~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12489999999999999876667999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.44 E-value=4.5e-07 Score=75.45 Aligned_cols=130 Identities=16% Similarity=0.111 Sum_probs=85.5
Q ss_pred eeeecCc-cEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCC--cceeeEeeeeecCceeEEEEEecCCCCH
Q 019568 49 LIGKGGF-GSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 49 ~ig~g~~-~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L 125 (339)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4445554 68899988778889999865443 3456778888887743 3356778888888889999999988665
Q ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHhhc------------------------------------------------
Q 019568 126 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF------------------------------------------------ 157 (339)
Q Consensus 126 ~~~i~~~~~~~~~~~~~~i~~ql~~~l~~LH~------------------------------------------------ 157 (339)
.+.. ... ...+.++...+..||.
T Consensus 94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3210 010 0111222233333331
Q ss_pred -------cCCCCeEecCCCCCCeEeCCCCcEEEcccccce
Q 019568 158 -------GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190 (339)
Q Consensus 158 -------~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~ 190 (339)
.....++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 002248999999999999987667899998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=8e-06 Score=72.36 Aligned_cols=76 Identities=17% Similarity=0.164 Sum_probs=49.8
Q ss_pred CceeeecCccEEEEEEeC-CCcEEEEEEeeccc-------hhhhHHHHHHHHHHHhCC-C--cceeeEeeeeecCceeEE
Q 019568 47 NNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-------GRALKSFNVECEMMKSIR-H--RNLIKVISSCSNEEFKAL 115 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~-~~~~v~vK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~l 115 (339)
.+.||.|....||++... +++.++||.-.+.. +....+...|++.|+.+. + ..+.+++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 557899999999999754 47789999754321 123345667898888773 2 3455566543 345568
Q ss_pred EEEecCCCC
Q 019568 116 VLEYMPHGS 124 (339)
Q Consensus 116 v~e~~~~~~ 124 (339)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.73 E-value=0.00019 Score=61.04 Aligned_cols=158 Identities=14% Similarity=0.061 Sum_probs=87.4
Q ss_pred eeeHHHHhhhhcCCCCCceee-----ecCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc--eeeE
Q 019568 31 TFSYLELCQATDEFSENNLIG-----KGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN--LIKV 103 (339)
Q Consensus 31 ~~~~~~~~~~~~~y~~~~~ig-----~g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 103 (339)
..+-.++..+.++|.+.+... .|.--+.|+.+..+| .+++|++... .....+..|.+++..|...+ +...
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccc
Confidence 456678888889998866554 455567899987555 5899998643 22344555777777773222 1111
Q ss_pred eee------eecCceeEEEEEecCCCCHHH-----H------H---hh----c----------------------CCccC
Q 019568 104 ISS------CSNEEFKALVLEYMPHGSLEK-----Y------L---YS----S----------------------NCILD 137 (339)
Q Consensus 104 ~~~------~~~~~~~~lv~e~~~~~~L~~-----~------i---~~----~----------------------~~~~~ 137 (339)
... ....+..+.++.++.+..... . + .. . .....
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 111 122344556666665532210 0 0 00 0 00011
Q ss_pred HHHHHHHHHHHHHHHHHhhc-cCCCCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 138 IFQRLNIMIDVASALEYLHF-GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 138 ~~~~~~i~~ql~~~l~~LH~-~~~~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
.......+......+...+. .-..|++|+|+.++||+++.+...-++||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 11122233333333444331 1246899999999999999888778999998763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.60 E-value=0.0002 Score=61.34 Aligned_cols=136 Identities=13% Similarity=0.136 Sum_probs=79.7
Q ss_pred cCccEEEEEEeCCCcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcce--eeEee-----eeecCceeEEEEEecCCCCH
Q 019568 53 GGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL--IKVIS-----SCSNEEFKALVLEYMPHGSL 125 (339)
Q Consensus 53 g~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~-----~~~~~~~~~lv~e~~~~~~L 125 (339)
+..-.||+++..+|+.+|+|+.+.. ......+..|...+..|...++ +.... .+...+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3345899999888999999997654 3344667778888888742222 11111 22345677889999876432
Q ss_pred -----HHH------Hh---h----c----C-------------------CccC---HHHHHHHHHHHHHHHHHhh-ccCC
Q 019568 126 -----EKY------LY---S----S----N-------------------CILD---IFQRLNIMIDVASALEYLH-FGYS 160 (339)
Q Consensus 126 -----~~~------i~---~----~----~-------------------~~~~---~~~~~~i~~ql~~~l~~LH-~~~~ 160 (339)
... +. . . . ..++ .......+..+...+...- ....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 111 10 0 0 0 0011 1122333444444443332 1124
Q ss_pred CCeEecCCCCCCeEeCCCCcEEEccccccee
Q 019568 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191 (339)
Q Consensus 161 ~~i~h~di~p~Nil~~~~~~v~l~Dfg~~~~ 191 (339)
.+++|+|+++.||+++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 679999999999999743 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.49 E-value=0.00016 Score=63.71 Aligned_cols=73 Identities=19% Similarity=0.229 Sum_probs=48.8
Q ss_pred CceeeecCccEEEEEEeCC--------CcEEEEEEeeccchhhhHHHHHHHHHHHhCCCcc-eeeEeeeeecCceeEEEE
Q 019568 47 NNLIGKGGFGSVYKARLGD--------GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN-LIKVISSCSNEEFKALVL 117 (339)
Q Consensus 47 ~~~ig~g~~~~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 117 (339)
++.|+.|-.-.+|++...+ ...|++++.... . ......+|..+++.+...+ ..++++++.+ ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4577778888999997533 356777776522 2 2234567899988884333 3577777754 4889
Q ss_pred EecCCCCH
Q 019568 118 EYMPHGSL 125 (339)
Q Consensus 118 e~~~~~~L 125 (339)
||++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|